<SEC-DOCUMENT>0001140361-21-009381.txt : 20210322
<SEC-HEADER>0001140361-21-009381.hdr.sgml : 20210322
<ACCEPTANCE-DATETIME>20210319181901
ACCESSION NUMBER:		0001140361-21-009381
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20210322
DATE AS OF CHANGE:		20210319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gain Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001819411
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				851726310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-253303
		FILM NUMBER:		21759366

	BUSINESS ADDRESS:	
		STREET 1:		4800 HAMPDEN LANE
		STREET 2:		SUITE 200
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814
		BUSINESS PHONE:		(301) 500-1556

	MAIL ADDRESS:	
		STREET 1:		4800 HAMPDEN LANE
		STREET 2:		SUITE 200
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>nt10015006x17_424b4.htm
<DESCRIPTION>424B4
<TEXT>
<html><head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head><body style="color: #000000;" bgcolor="#ffffff">
<!--Begin Page 1-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 456pt;"><a name="nt10015006x17_424b4_101-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 456pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Filed pursuant to Rule 424(b)(4) <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Registration No. 333-253303 </div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 44.5pt; text-align: center;">3,636,364 Shares</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 25.25pt; text-align: center;"><img style="height: 109px; width: 229px;" src="nt10015006x11_logo.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">Common Stock<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; text-align: center;">$11.00 per share</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 18pt; margin-left: 0pt; text-align: justify;">This is the initial public offering of shares of common stock of Gain Therapeutics, Inc. We are offering 3,636,364 shares of our common stock. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Prior to this offering, there has been no public market for our common stock. The initial public offering price per share of common stock $11.00. We have been approved to list our common stock on the Nasdaq Global Market under the symbol &#8220;GANX.&#8221;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We are an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended, and will be subject to reduced public company reporting requirements. This prospectus complies with the requirements that apply to an issuer that is an emerging growth company. See &#8220;Summary&#8212;Implications of Being an Emerging Growth Company and Smaller Reporting Company.&#8221;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Investing in our common stock is highly speculative and involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page <a href="#tRF">14</a>.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 456pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 68.42%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Per Share</div></td><td class="gutter" style="width: 2.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 13.71%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td></tr><tr><td style="width: 68.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Public offering price<font style="padding-left: 0.27pt;"></font></div></td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;">$<font style="padding-left: 0.37pt;">&#8203;</font>11.00</div></td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.71%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;$40,000,004.00</div></td></tr><tr><td style="width: 68.42%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Underwriting discount and commissions<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 1.78pt;"></font></div></td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;">$<font style="padding-left: 5pt;">0.77</font></div></td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.71%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 5pt;">2,800,000.28</font></div></td></tr><tr><td style="width: 68.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Proceeds, before expenses, to Gain Therapeutics, Inc. <font style="padding-left: 2.01pt;"></font></div></td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;">$10.23</div></td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.71%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;$37,200,003.70</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">See &#8220;Underwriting&#8221; for a complete description on the compensation payable to the underwriters.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We have granted the underwriters the option for a period of 30 days to purchase up to an additional 545,454 shares of common stock at the initial price to the public less the underwriting discount.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The underwriters expect to deliver the shares against payment in New York, New York on March 22, 2021 through the book-entry facilities of The Depository Trust Company.</div><table cellspacing="0" cellpadding="0" class="txttab" style="margin-top: 4pt; border-collapse: collapse; width: 456pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 48.68%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 18pt; font-weight: bold; margin-top: 0pt; text-align: center;">BTIG</div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 48.68%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 18pt; font-weight: bold; margin-top: 0pt; text-align: center;">Oppenheimer &amp; Co.</div></td></tr><tr><td style="width: 48.68%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 48.68%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td></tr><tr><td colspan="4" style="width: 100%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 0pt; text-align: center;">National Securities Corporation</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 36.5pt; margin-left: 0pt; text-align: left;">Prospectus dated March 17, 2021</div></div></div></div>
<!--End Page 1-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 2-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_102-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS</div></div><div class="columns" style="width: 468pt; margin-left: 0pt;"><div class="block-main-columns" style="width: 228pt; float: left;"><a name="TOC"><!--Anchor--></a><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 228pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.21%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page</div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tATP">ABOUT THIS PROSPECTUS<font style="padding-left: 1.33pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tATP"><font style="padding-left: 4.44pt;">ii</font></a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSUM">SUMMARY<font style="padding-left: 0.39pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tSUM"><font style="padding-left: 5pt;">1</font></a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">RISK FACTORS<font style="padding-left: 1.32pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tRF">14</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tCSR">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS<font style="padding-left: 2.89pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tCSR">43</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUOP">USE OF PROCEEDS<font style="padding-left: 2.07pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tUOP">45</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDP">DIVIDEND POLICY<font style="padding-left: 3.2pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDP">46</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCAP">CAPITALIZATION<font style="padding-left: 0.66pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tCAP">47</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDIL">DILUTION<font style="padding-left: 3.74pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDIL">48</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tSCH">SELECTED CONSOLIDATED HISTORICAL FINANCIAL DATA<font style="padding-left: 3.81pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tSCH">49</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tMDA">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS<font style="padding-left: 3.57pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tMDA">50</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tOB">OUR BUSINESS<font style="padding-left: 4.85pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tOB">63</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tMAN">MANAGEMENT<font style="padding-left: 4.3pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tMAN">93</a></div></td></tr></table></div><div class="block-main-columns" style="margin-left: 12pt; width: 228pt; float: left;"><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 228pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.21%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page</div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tEAD">EXECUTIVE AND DIRECTOR COMPENSATION<font style="padding-left: 4.3pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tEAD"><font style="padding-left: 5pt;">99</font></a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPS">PRINCIPAL STOCKHOLDERS<font style="padding-left: 4.11pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tPS">105</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tCRA">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS<font style="padding-left: 1.37pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tCRA">107</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOC">DESCRIPTION OF CAPITAL STOCK<font style="padding-left: 0.11pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tDOC"><font style="padding-left: 0.37pt;">112</font></a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tUSF">U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS<font style="padding-left: 0.4pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tUSF"><font style="padding-left: 0.37pt;">118</font></a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSEF">SHARES ELIGIBLE FOR FUTURE SALE<font style="padding-left: 1.54pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tSEF">121</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUND">UNDERWRITING<font style="padding-left: 4.3pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tUND">123</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">LEGAL MATTERS<font style="padding-left: 0.22pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tLM">129</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXP">EXPERTS<font style="padding-left: 3.77pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tEXP">129</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tWYC">WHERE YOU CAN FIND MORE INFORMATION<font style="padding-left: 2.63pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tWYC">130</a></div></td></tr><tr><td style="width: 89.47%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tITF">INDEX TO FINANCIAL STATEMENTS<font style="padding-left: 0.86pt;"></font></a></div></td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.66%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.21%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tITF"><font style="padding-left: 1.11pt;">F-</font>1</a></div></td></tr></table></div><div style="clear: both;"> </div></div><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Neither we nor any of the underwriters have authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any related free writing prospectuses. Neither we nor any of the underwriters take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of common stock offered by this prospectus, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date regardless of the time of delivery of this prospectus or any sale of shares of common stock. Our business, financial condition, results of operations and prospects may have changed since that date.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For investors outside the United States: We have not, and the underwriters have not, done anything that would permit this offering or the possession or distribution of this prospectus or any free writing prospectus we may provide to you in connection with this offering in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside the United States. See &#8220;Underwriting.&#8221;</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">i<br></div></div></div>
<!--End Page 2-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 3-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_103-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tATP"><!--Anchor--></a>ABOUT THIS PROSPECTUS</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;20, 2020, we consummated the corporate reorganization as described in this prospectus under the section titled &#8220;Certain Relationships and Related Party Transactions&#8212;Corporate Reorganization with GT Gain Therapeutics SA,&#8221; pursuant to which all of the issued and outstanding stock of GT Gain Therapeutics SA, a Swiss company formed in 2017, were exchanged for common stock or preferred stock, as applicable, of Gain Therapeutics, Inc., the issuer of the common stock being offered in this offering (the &#8220;Corporate Reorganization&#8221;). As a result of the Corporate Reorganization, GT Gain Therapeutics SA became a wholly-owned subsidiary of Gain Therapeutics, Inc., a holding company incorporated under the laws of the state of Delaware.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Corporate Reorganization is accounted for as a recapitalization for accounting purposes, with GT Gain Therapeutics SA as the predecessor entity. For periods and at dates prior to the Corporate Reorganization, the financial statements included in this prospectus were prepared based on the historical financial statements of GT Gain Therapeutics SA, adjusted to give retroactive effect to the share exchange transaction for all periods presented.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain monetary amounts, percentages and other figures included in this prospectus have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables or charts may not be the arithmetic aggregation of the figures that precede them, and figures expressed as percentages in the text may not total 100% or, as applicable, when aggregated may not be the arithmetic aggregation of the percentages that precede them.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Market, Industry, and Other Data</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus includes statistics and other data relating to markets, market sizes and other industry data pertaining to our business that we have obtained from industry publications, surveys and other information available to us as well as our own estimates based on our management&#8217;s knowledge of, and experience in, the industry and markets in which we compete. Industry publications and surveys generally state that the information contained therein has been obtained from sources believed to be reliable. Although we have not independently verified the accuracy or completeness of the data contained in these industry publications and reports, based on our industry experience we believe that the publications are reliable, the conclusions contained in the publications and reports are reasonable and the third-party information included in this prospectus and in our estimates is accurate and complete. Nevertheless, market data and statistics are inherently predictive and speculative and are not necessarily reflective of actual market conditions. Such statistics are based on market research, which itself is based on sampling and subjective judgments by both the researchers and the respondents, including judgments about what types of products and transactions should be included in the relevant market. In addition, the value of comparisons of statistics for different markets is limited by many factors, including that (i)&#160;the markets are defined differently, (ii)&#160;the underlying information was gathered by different methods, and (iii)&#160;different assumptions were applied in compiling the data. Accordingly, the market statistics included in this prospectus should be viewed with caution. We believe that information from these industry publications included in this prospectus is reliable.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain statistical data estimates and forecasts contained in this prospectus are based on the following independent industry publications or reports:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Grand View Research, Enzyme Replacement Therapy Market Size, Share &amp; Trends Analysis Report By Enzyme (Pancreatic Enzymes, Agalsidase Beta), By Therapeutic Condition, By Route Of Administration, By End Use, And Segment Forecasts, 2019-2026, October 2019;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Fortune, Neurodegenerative Diseases Drugs Market Size, Share and Industry Analysis By Drug Class (Immunomodulator, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Others), By Disease Indication (Multiple Sclerosis, Parkinson&#8217;s Disease, Alzheimer&#8217;s Disease, Spinal Muscular Atrophy (SMA), Others), By Route of Administration (Oral, Injection, Transdermal, Others), By End User and Regional Forecast 2019-2026; June 2019. </div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Trademarks, Service Marks, and Trade Names</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus includes our trademarks, and trade names, including but not limited to Site-Directed Enzyme Enhancement Therapy, or SEE-Tx<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>, which are protected under applicable intellectual property laws. This prospectus also may contain trademarks, service marks, trade names, and copyrights of other companies, which are the property of their respective owners. Solely for convenience, the trademarks, service marks, trade names, and copyrights referred to in this prospectus are listed without the TM, SM, &#169;, and &#174; symbols, but we will assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors, if any, to these trademarks, service marks, trade names, and copyrights. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">ii<br></div></div></div>
<!--End Page 3-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 4-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSUM"><!--Anchor--></a>SUMMARY</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary highlights information contained elsewhere in this prospectus. This summary may not contain all of the information that you should consider before deciding to invest in shares of our common stock. You should read this entire prospectus carefully, including the &#8220;Risk Factors&#8221; section immediately following this summary, &#8220;Cautionary Statement Regarding Forward-Looking Statements,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and the consolidated financial statements and related notes thereto included elsewhere in this prospectus, before making an investment decision to purchase shares of our common stock. Unless the context otherwise requires, all references to &#8220;Gain,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; and similar designations refer to Gain Therapeutics, Inc, a Delaware company, and its wholly-owned Swiss subsidiary, GT Gain Therapeutics SA.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Overview</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are a development stage biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on lysosomal storage disorders (&#8220;LSDs&#8221;), including rare genetic diseases and neurological disorders. We use our exclusively in-licensed proprietary platform, Site-Directed Enzyme Enhancement Therapy (&#8220;SEE-Tx&#8221;), to discover novel allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites and restore protein folding, potentially treating the underlying disease. These small molecule binding sites, away from the protein&#8217;s active areas, are called allosteric sites. We believe targeting the allosteric binding site instead of the active binding site can provide a number of advantages: superior regulation of misfolded proteins implicated in disease, enhanced specificity by being non-competitive with the natural substrate and the potential for molecules with favorable drug-like properties. While the SEE-Tx platform is novel and has not been used to develop approved drugs yet, these advantages have the potential to ultimately enhance both tolerability and response.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of February&#160;19, 2021, we have already identified and filed three patent applications and one provisional patent application (such applications do not cover the United States) for our novel Structurally Targeted Allosteric Regulators (&#8220;STARs&#8221;), which are small molecules with the potential to treat diseases with high unmet medical need for which there are currently few or no available therapies. These diseases include Morquio B, GM1 Gangliosidosis (GM1), neuronopathic Gaucher disease, <font style="font-style: italic;">GBA1</font> Parkinson&#8217;s disease, Krabbe disease and Mucopolysaccharidosis type 1.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are currently advancing the development of our STAR candidates through preclinical studies where we will continue to identify optimal lead compounds for each indication that we will advance into clinical trials. Through academic partnerships, co-development and licensing arrangements, we intend to develop a broad pipeline of therapeutics to catalyze a new approach to the treatment of diseases caused by misfolded enzymes. We expect to obtain additional preclinical data and commence IND-enabling studies for lead compound candidates beginning 2021, at which point we will begin the process to prepare and submit investigational new drug, or IND, submissions to the FDA seeking clearance to commence clinical research.</div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">1<br></div></div></div>
<!--End Page 4-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 5-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Protein Misfolding and Disease</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Proteins are large biomolecules that have a vast array of functions in different cell types in the body. Enzymes are a type of protein that accelerate and facilitate chemical reactions inside of cells by acting on substrates and converting those substrates into different chemical products. To perform their function in the body, enzymes and other proteins must be folded into the correct three-dimensional shape. Misfolded enzymes may not function properly, which can lead to the toxic accumulation of unprocessed substrate which is the cause of many rare genetic diseases, including LSDs and some neurodegenerative diseases such as certain forms of Parkinson&#8217;s disease. Enzyme misfolding may arise from genetic mutations that disrupt the folding pattern as well as from cellular stress due to aging and inflammation. Therapeutic small molecules that facilitate the folding of enzymes into their correct shape can restore function and the proper processing of substrate. As illustrated below, in LSDs, the gene that codes for an enzyme is mutated and results in a misfolded enzyme. The misfolded enzyme cannot traffic through the cell resulting in toxic protein accumulation. We believe that our STARs will have the ability to bind to the allosteric site of the defective enzyme and restore wild type activity and thus serve as potential therapeutic treatments for diseases.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 349px; width: 599px;" src="nt10015006x17_graphic8.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Limitations on Current Therapeutic Treatments</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Current therapeutic approaches to address misfolded enzymes have inherent limitations. In standard chaperone therapy, the drug binds to the active site of the enzyme or other target protein which impairs the protein&#8217;s function to some degree by competing with the active substrate, decreasing efficacy and potentially leading to selectivity issues. Other treatments such as enzyme replacement therapy, or ERT, in which new functional enzymes are infused into the patient, are not optimal for treating neurological conditions because currently available ERT cannot cross the blood-brain barrier. Gene therapy, which aims to create new, functional enzymes, is not readily accepted for treating neurological conditions because the procedure is invasive in nature and the efficacy of treating neurological conditions remains to be established. Given these limitations on current therapies, we believe patients would benefit from a new therapeutic approach both on its own and, potentially, in combination with existing therapies. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe our therapeutic approach represents a potentially significant change from current approaches by addressing protein misfolding using our efficient and proprietary ability to identify previously undiscovered allosteric sites and compounds that avoid the active sites of enzymes and cross the blood-brain barrier or penetrate other hard-to-treat organs such as bone and cartilage. Additionally, our approach enables the less-invasive process of oral administration.</div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">2<br></div></div></div>
<!--End Page 5-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 6-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Our Platform &#8211; Computational Identification Approach</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Overview</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our exclusively in-licensed and proprietary SEE-Tx platform allows us to identify previously undiscovered sites on an enzyme where a small molecule can attach and potentially facilitate the enzyme into the correct folding pathway, all without disrupting its function. We refer to the small molecules we identify that bind to these allosteric sites as STARs to reflect their mechanism of action and how they are discovered.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 232px; width: 603px;" src="nt10015006x17_graphic1.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Allosteric Site Identification</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Using the three-dimensional structure of enzymes and our computational technology, our SEE-Tx platform identifies and maps, through molecular simulations, previously uncharacterized binding sites called &#8220;binding hotspots.&#8221; These are key areas on the protein surface where a small molecule can potentially bind. The amount, density, nature and quality of these hotspots determine the druggability of the protein, that is, if the drug-like small molecules can effectively bind to the particular site with an appropriate potency. We then use our proprietary structure-based virtual screening methodology to filter a pool of seven to ten million commercially-available compounds to identify those that may potentially bind to the hotspot and have a functional effect. Using this information, we develop structural templates to guide the development of a narrowed pool of unique and proprietary small molecules that bind to the newly discovered allosteric sites and could potentially facilitate the enzyme into the correct folding structure and treat diseases. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As illustrated below, we believe our ability to identify and target previously uncharacterized allosteric binding sites has the potential to ultimately enhance both tolerability and response.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 213px; width: 563px;" src="nt10015006x17_graphic2.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">3<br></div></div></div>
<!--End Page 6-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 7-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">STAR Identification &#8211; Our Molecular Hypothesis</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe our STAR identification process is a more efficient and effective drug discovery tool than random screening because we use a validated-target approach. In random screening, very large libraries of molecules are tested for their ability to perform a specific function such as binding to a target. This approach typically results in a large number of positive responses that must then be laboriously screened to identify product candidates that are worth pursuing. In contrast, every small molecule generated by our platform is analyzed based on a two-part molecular hypothesis: (i)&#160;the restoration of the function of the target enzyme could be a treatment for the disease and (ii)&#160;our SEE-Tx platform could identify druggable allosteric binding sites that could be exploited to restore the enzyme&#8217;s functional activity. This validated-target approach confers a great advantage during the lead compound optimization process compared to random screening approaches. The lead compound optimization (&#8220;Lead OP&#8221;) process is the process by which drug candidates are synthetically refined from their original state into an agent that is safer, more potent and more useful. The goal during the lead optimization stage is to maintain favorable properties in lead compounds, while improving on deficiencies in lead structure. We can identify an allosteric site in five to six weeks, screen hits in two to three weeks and validate compounds in two to three months. In addition, compared to random screening, our validated-target approach is less expensive and requires less time to produce results with a higher success rate because this approach eliminates a number of false-hits by requiring each output to meet our two-part molecular hypothesis. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe each STAR has high specificity to its allosteric binding site and does not interact with the active site of the enzyme target, which is designed to enhance both tolerability and response. Our technology allows us to identify STARs that have the ability to bind to both mutant and wild-type enzymes. Because they are small molecules, STARs can be administered orally, have the ability to cross the blood-brain barrier and enter hard-to-treat tissues such as bone and cartilage. We believe the ability to cross the blood-brain barrier is essential to effectively treat diseases with neurological symptoms. In addition, we believe our STARs could be used in combination with ERT or gene therapy approaches to more completely address the patient&#8217;s needs. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Our Pipeline of STARs</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are leveraging our SEE-Tx technology platform to develop a pipeline of novel drug candidates to address diseases caused by protein misfolding. We are initially focusing on several LSDs with high unmet medical need, with the ability to expand our pipeline as we continue to discover new targets. We have entered into a number of academic collaborations to advance the development of our programs, such as with the University of Minnesota and the University of Maryland; these collaborations are understandings to work together in the research of specific demyelinating diseases and neither we, nor the institutions we collaborate with, are under contractual obligations to continue the collaboration and all parties retain their respective intellectual property. Additionally, in June 2020, we entered into a two-year research collaboration agreement with Sumitomo Dainippon Pharma Co., Ltd. (&#8220;Sumitomo&#8221;) for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 194px; width: 596px;" src="nt10015006x17_graphic3.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">4<br></div></div></div>
<!--End Page 7-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 8-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">GLB Enzyme-Related Disorders: GM1 Gangliosidosis and Morquio B</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are investigating restoration of GLB function as a treatment for GM1 and Morquio B. GLB is an enzyme found in lysosomes, which are compartments within cells that digest and recycle different types of molecules, especially toxic ones. GLB is essential for the breakdown of GM1 and keratan sulfate, which serve important functions in the brain and other tissues. Misfolding of GLB allows these substrates to build up to toxic levels and lead to the diseases GM1 and Morquio B.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Currently, there are no cures for these diseases. Currently available treatment options include substrate reduction therapy, which cannot cross the blood-brain barrier or reach either bone or cartilage and can therefore only help manage select symptoms. Additionally, while gene therapy approaches are being explored, they are still in early clinical development, require surgical procedures and are prone to immunological responses from the vectors. Conversely, our STARs in our <font style="font-style: italic;">GLB1</font> program are designed to cross the blood-brain barrier, and STARs in our GM1 program are designed to penetrate bone tissue, which is an important target tissue for treatment of Morquio B.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified novel STARs targeting GLB, and the four most promising compounds have been selected as leads: GT-00413, GT-00493, GT-00513 and GT-00546. Data from our preclinical studies have shown that our STARs do not inhibit the normal activity of GLB in healthy cells, whereas competitive chaperone compounds typically do. Preclinical studies indicate that our STARs help mutated &#946;-galactosidase escape premature degradation and travel to the lysosome where it can perform its catalytic activity. In addition, preclinical studies of these STARs in GM1-affected cells and Morquio B-affected cells show an increase in GLB activity and a reduction in the accumulation of a GM1 ganglioside substrate.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15pt; margin-left: 0pt; text-align: left;">GCase Enzyme-Related Disorders: Neuronopathic Gaucher Disease and GBA1 Parkinson&#8217;s Disease </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are investigating the restoration of GCase enzymatic function as a treatment for neuronopathic Gaucher disease (nGD), a LSD. Unlike other types of Gaucher disease, none of the existing therapeutics are effective in treating nGD. GCase is an enzyme encoded by the GBA1 gene and found in lysosomes that is needed to breakdown the large molecule glucocerebroside (a component of the cell membrane) into sugar and fat. The misfolding of GCase can lead to accumulation of these substrates to toxic levels in the liver, spleen, bone marrow and nervous system and can result in lysosomal storage and neurodegenerative diseases. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The GCase mutation most commonly associated with nGD is also found in the most pathogenic form of Parkinson&#8217;s disease. Reduced GCase activity may enhance the risk for Parkinson&#8217;s disease by facilitating alpha-synuclein accumulation, which is a pathological hallmark of Parkinson&#8217;s disease. As a result, we are also investigating restoration of GCase function in patients with GBA1 Parkinson&#8217;s disease (GBA1+PD). Currently, there is no cure for nGD or for GBA1+PD, and there are very limited treatment options. Current treatments such as ERT cannot address central nervous system symptoms because they cannot cross the blood-brain barrier, unlike our STARs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified novel STARs targeting GCase and are continuing characterization of our most promising compounds. Data from our preclinical studies have shown that in normal cell lysates these STARs do not inhibit the normal activity of GCase, while competitive chaperone compounds typically do. In transfected cells with either normal GCase expression or GCase with relevant mutations, STARs increase lysosomal GCase. In addition, preclinical studies of these STARs in both healthy and GCase-affected cells show a dose-dependent increase in GCase activity and in a relevant neuronal model a reduction in the accumulation of toxic GCase substrate in Gaucher patient-derived fibroblasts was observed. A reduction of alpha-synuclein accumulation was also observed in the same neuronal model as well as two other neuronal <font style="font-style: italic;">in vitro</font> models. A preclinical in vivo animal study indicated that these STARs enhance GCase wild-type enzyme activities and a rotenone induced Parkinson&#8217;s disease animal demonstrated that oral administration of STARs lead to depletion of alpha-synuclein, increase in tyrosine hydroxylase and improvement in locomotor activity.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15pt; margin-left: 0pt; text-align: left;">IDUA Enzyme-Related Disorders: Mucopolysaccharidosis Type 1</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are investigating restoration of IDUA function as a treatment for Mucopolysaccharidosis type 1 (MPS 1). IDUA is an enzyme in lysosomes needed to breakdown large sugar molecules called glycosaminoglycans (GAGs), especially heparan sulfate and dermatan sulfate. The misfolding of IDUA can allow substrate to build up to toxic levels in the bone and cartilage and can result in MPS 1. Currently, there is no cure for MPS 1, and the treatment options to address the underlying symptoms including ERT, laronidase, and bone marrow transplants, are limited.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified a STAR targeting IDUA and are applying medicinal chemistry approaches to generate proprietary compounds. Preclinical studies of this molecule have shown that in healthy cells, this STAR can stabilize </div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">5<br></div></div></div>
<!--End Page 8-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 9-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">recombinant IDUA and increase its activity. Additionally, when this STAR is co-administrated with laronidase, there is a dose-dependent increase in IDUA activity levels <font style="font-style: italic;">in vitro</font> and in mice. As we continue our development process, we will continue to evaluate partnership opportunities in which a strategic partner could help us to accelerate the development of our program, provide access to synergistic combinations, or provide expertise that could allow us to expand potential treatment applications.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">GALC Enzyme-Related Disorders: Krabbe Disease</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are investigating the restoration of GALC function as a treatment for Krabbe disease. GALC is an enzyme in lysosomes needed to breakdown galactolipids, which are fats primarily found in the nervous system and kidneys. Among the galactolipids that GALC breaks down are galactosylceramide, which is an essential component of neuronal myelin, and psychosine which is formed during myelin production and is toxic to cells. The misfolding of GALC can result in the toxic accumulation of galactosylceramide, inhibiting myelin production, and of psychosine, leading to demyelination of cells and ultimately to Krabbe disease. There is currently no available cure for Krabbe disease. Current developments in invasive procedures such as bone marrow transplants have not been shown to provide significant neurological improvements. In addition, most gene therapy treatments in development are still in the preclinical stages. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified several compounds that bind to allosteric sites on GALC and stabilize the enzyme <font style="font-style: italic;">in vitro</font>. We are continuing our development of these promising molecules. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Our Key Strengths and Competitive Advantages</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe that we have a number of key strengths driven by our SEE-Tx platform and highly experienced team and deep expertise. These strengths uniquely position us to develop therapeutics for various protein misfolding diseases, successfully implement our strategy outlined below, and positively transform the lives of patients suffering from these life-threatening diseases.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">SEE-Tx, our </font><font style="font-weight: bold;">in-licensed </font><font style="font-weight: bold;">proprietary, efficient and transformative technology platform. </font>SEE-Tx addresses a unique challenge: the identification of small-molecule drugs that can usher their protein targets into the correct folding pathway and protect them from unfolding, thus potentially providing novel treatment options for protein misfolding diseases. We believe SEE-Tx provides several unique advantages:</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Novel allosteric site identification.<font style="font-style: normal;"> SEE-Tx has allowed us to identify and exploit novel allosteric sites that </font><font style="font-style: normal;">historically were not </font><font style="font-style: normal;">targeted with small molecules. </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Efficiency.<font style="font-style: normal;"> The computational platform allows us to quickly select allosteric site targets with the greatest </font><font style="font-style: normal;">potential, scan millions of commercially-available compounds and identify initial hit compounds with minimal </font><font style="font-style: normal;">monetary and human capital investment. We can identify an allosteric site in five to six weeks, screen hits in two to </font><font style="font-style: normal;">three weeks and validate compounds in a couple of months.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Validated-target approach.<font style="font-style: normal;"> </font><font style="font-style: normal;">SEE-Tx allows every molecule we test to be based on our two-part molecular hypothesis. </font><font style="font-style: normal;">This rational approach confers a great advantage during lead optimization compared to random screening approaches.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Proprietary small molecules.<font style="font-style: normal;"> SEE-Tx allows us to only work on target sites that can yield </font><font style="font-style: normal;">molecules</font><font style="font-style: normal;"> with </font><font style="font-style: normal;">suitable pharmacokinetic properties. This includes the ability to cross the blood-brain barrier. These small molecules </font><font style="font-style: normal;">do not block the natural function of the target protein (i.e., do not bind to the active site of the enzyme), providing </font><font style="font-style: normal;">a wider therapeutic window and simpler dose regimes due to the bioavailability nature of the drug. We believe this </font><font style="font-style: normal;">is essential to achieve efficacy in diseases with neurological manifestations.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Flexible technology.<font style="font-style: normal;"> SEE-Tx can be adapted to the specific druggability and unique hit identification </font><font style="font-style: normal;">requirements for each program.</font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">We have an experienced management team and board of directors with global and broad-based </font><font style="font-weight: bold;">scientific, medical and commercial expertise</font>. Our senior management team and international board of directors have valuable global and diversified expertise in the biotech and pharmaceutical industries and orphan, metabolic and central nervous system (&#8220;CNS&#8221;) diseases space both from a scientific perspective, product development and commercial perspective. Members of our management team have experience advancing pharmaceutical products from discovery stage through to commercialization. Senior representatives of the management derive their experience among others from companies, such as Vifor Pharma, Helsinn Healthcare, PwC, Jazz Pharmaceuticals, Pharmacia &amp; Upjohn, Newron Pharmaceuticals and MedImmune. As scientific expertise is a cornerstone to our business model, our board of directors (the &#8220;board of directors&#8221;) is comprised </div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">6<br></div></div></div>
<!--End Page 9-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 10-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">of industry experts with experience from companies focused on small molecules, rare and niche diseases, and CNS diseases, including Sanofi, SmithKline Beecham, Pfizer, Salmedix, Sarepta Therapeutics, Collegium Pharmaceutical, Vasopharm, MedImmune, LEV Pharma, Minerva Bioscience Inc and ADMA biologics.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Our Strategy</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our vision is to redefine drug discovery, with the goal of developing and ultimately commercializing therapies that dramatically and positively transform the lives of patients suffering from life-threatening rare diseases and CNS disorders with limited or no approved treatment options. Patients are considered in every decision we make. Our goal is to expedite preclinical studies of our lead product candidates to advance them into clinical trials with the goal of commercializing treatments for these diseases if our product candidates are approved. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Key elements of this strategy include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">A</font><font style="font-weight: bold;">dvance our lead product candidates into clinical development. </font>We are focused on applying our in-licensed and proprietary SEE-Tx platform to discover and develop new small molecule drugs to treat diseases resulting from protein misfolding and to improve outcomes for patients with these serious, life-threatening conditions. We hold worldwide development and commercial rights to our product candidates and believe we have selected optimal product candidates for certain indications based on extensive preclinical data, including data with disease-specific animal models and biomarkers, thus supporting the potential of clinical success of our product candidates. Our goal is to advance these product candidates into clinical trials. If our clinical trials are successful, we plan to meet with regulatory authorities to discuss whether expedited regulatory approval strategies would be available. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Initially focus on rare, underserved indications for which we can have a transformative impact on </font><font style="font-weight: bold;">patients&#8217; lives.</font> We believe that our ability to redefine drug discovery has the potential to have a transformative impact on rare, monogenic CNS disorders, LSDs, protein misfolding diseases and on patients&#8217; lives, by providing them with a treatment for life-threatening diseases with no approved disease-modifying treatments.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Expand our pipeline by identifying and developing additional product candidates and identifying </font><font style="font-weight: bold;">additional target indications</font>. We believe our differentiated therapeutic approach utilizing our SEE-Tx platform will allow us to address a broad range of rare, LSD and neurodegenerative disorders, thus expanding our pipeline. Approximately 70% of LSDs present as progressive neurodegenerative diseases, highlighting how vulnerable the central nervous system is to lysosomal dysfunction. Additionally, LSDs, through convergent pathogenic mechanisms, can aid our understanding of pathogenesis in more common neurodegenerative diseases, infectious diseases, cancers and other genetic diseases. We intend to continue to expand our pipeline in the area of rare diseases to provide multiple opportunities for clinical and commercial success and demonstrate the breadth of our platform&#8217;s abilities across multiple organ systems, tissues and therapeutic modalities. We believe that in the near-term we can direct our highly efficient platform technology to identify clinically relevant allosteric binding sites that lead to treatments for more prevalent indications where there is a genetic subset of patients that might benefit from small molecules such as metabolic diseases and other diseases caused by protein misfolding.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Continue to expand our patent portfolio</font>. We have made a significant investment in our patent portfolio to protect our technologies and programs and we intend to continue to do so. We have filed three patent applications and one provisional patent application for our STARs and have exclusive licenses for one additional patent related to our platform SEE-Tx (including the exploitation of SEE-Tx). We continue to actively pursue further patent protection and exclusivity opportunities. Our focus is on protecting our small molecule programs based on structurally targeted allosteric modulators. Protection is sought for a relevant scope to obtain commercial exclusivity in key geographies including the United States and Europe (via the European Patent Convention), as well as additional geographic areas of interest specific for each disease program. Currently, we have PCT, national phase applications or provisional patents for our core intellectual property. We currently do not have issued patents nor pending patent applications in the United States.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Selectively enter into new discovery relationships with premier research institutions and commercial </font><font style="font-weight: bold;">partners and expand our existing collaborations</font>. Our current academic partners include the University of Minnesota, University of Maryland, University of Oxford, University of Graz, the University of Adelaide, the National Institute of Health, Universit&#225; della Svizzera italiana, Telethon, University of </div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">7<br></div></div></div>
<!--End Page 10-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 11-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">Cambridge and the Children's Hospital of Pittsburgh. We strive to further develop our expertise within our therapeutic areas of interest through close collaborations with academic experts. Neither we nor the organizations we collaborate with are under any contractual obligation to work with one another and all parties retain their respective intellectual property. Additionally, in June 2020, we entered into a two-year research collaboration agreement with Sumitomo for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. Through these partnerships, we support the advancement of molecular, pharmacological and clinical understandings of the relevant diseases and perform preclinical evaluations in various biological models. Through these collaborations, we are conducting a number of preclinical studies that provide insights into the precise mechanism of action of our product candidates and the improvement of therapeutic strategies for LSDs and CNS diseases. In connection with all of our partnerships and collaborations, we have the exclusive right to use the data generated by these arrangements, with the exception of certain of our arrangements with academic institutions, which allow those institutions to use such data for teaching, internal research and other non-commercial purposes.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Extend existing and establish new relationships with patients and patient advocacy groups.</font> Patients are the core of what we do. We have been engaging with patients and advocacy groups (such as CureGM1, the National Tay-Sachs &amp; Allied Diseases Association, Inc., the International Gaucher Alliance and MPS Lisosomales) since our inception and have acquired an intimate understanding of how we can positively impact their lives. These relationships deeply inform us as we develop and ultimately seek to commercialize our product candidates.</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Risks Associated with our Business</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Investing in our common stock involves substantial risks. Before you participate in this offering, you should carefully consider all of the information contained in this prospectus, including the information set forth under the heading &#8220;Risk Factors.&#8221; Some of the more significant risks include the following:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we have a history of operating losses and expect to incur losses for the foreseeable future. We may never generate revenues or, if we are able to generate revenues, achieve profitability;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we have a limited operating history and we expect a number of factors to cause our operating results to fluctuate on a quarterly and annual basis, which may make it difficult to predict our future performance;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if preclinical studies or clinical trials for our product candidates cannot be initiated or completed or if they are unsuccessful or delayed, we will be unable to meet our future development and commercialization goals;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the disorders we seek to treat have low prevalence and it may be difficult to identify patients with these disorders, which may lead to delays in enrollment for our trials or slower commercial revenue if approved;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our product candidates are novel and still in development. If we are unable to successfully develop, receive regulatory approval for and commercialize our current or future product candidates, our business will be harmed;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we have not tested any of our product candidates in clinical trials. Success in early preclinical studies or clinical trials may not be indicative of results obtained in later preclinical studies and clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">clinical trials required for our product candidates are expensive and time-consuming, may face enrollment challenges and their outcome is uncertain;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our business and operations may be adversely affected by the evolving and ongoing COVID-19 global pandemic;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we are subject to extensive and costly government regulation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">even if we obtain regulatory approval to market our product candidates, our product candidates may not be accepted by the market; and</div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">8<br></div></div></div>
<!--End Page 11-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 12-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we rely on a license to use the technology that is material to our business and if the agreements underlying the licenses were to be terminated or if other rights that may be necessary for commercializing our intended products cannot be obtained, it would halt our ability to market our products and technology, as well as have an immediate material adverse effect on our business, operating results and financial condition.</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Corporate Information</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We were incorporated under the laws of the state of Delaware on June 26, 2020 under the name Gain Therapeutics, Inc. On July&#160;20, 2020, we consummated the Corporate Reorganization pursuant to which all of the issued and outstanding stock of GT Gain Therapeutics SA, a Swiss company formed in 2017, were exchanged for common stock or preferred stock, as applicable, of Gain Therapeutics, Inc. As a result of the Corporate Reorganization, GT Gain Therapeutics SA became a wholly-owned subsidiary of Gain Therapeutics, Inc., a holding company incorporated under the laws of the state of Delaware. Our principal executive offices are located at 4800&#160;Hampden Lane, Suite 200, Bethesda, MD 20814. Our telephone number is (301) 500-1556. Our website address is http://www.gaintherapeutics.com. Information contained on, or that can be accessed through, our website is not incorporated by reference into this prospectus, and you should not consider information on our website to be part of this prospectus.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Implications of Being an Emerging Growth Company and Smaller Reporting Company</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We qualify as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An emerging growth company may take advantage of certain reduced reporting and other requirements that are otherwise generally applicable to public companies. As a result:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we are required to have only two years of audited financial statements and only two years of related selected financial data and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations disclosure;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we are not required to engage an auditor to report on our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we are permitted to take advantage of extended transition periods for complying with new or revised accounting standards which allows an emerging growth company to delay the adoption of some accounting standards until those standards would otherwise apply to private companies;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we are not required to submit certain executive compensation matters to stockholder advisory votes, such as &#8220;say-on-pay,&#8221; &#8220;say-on-frequency,&#8221; and &#8220;say-on-golden parachutes;&#8221; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we are not required to comply with certain disclosure requirements related to executive compensation, such as the requirement to disclose the correlation between executive compensation and performance and the requirement to present a comparison of our Chief Executive Officer&#8217;s compensation to our median employee compensation.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may take advantage of these reduced reporting and other requirements until the last day of our fiscal year following the fifth anniversary of the completion of this offering, or such earlier time that we are no longer an emerging growth company. If certain events occur prior to the end of such five-year period, including if we have more than $1.07&#160;billion in annual gross revenue, have more than $700&#160;million in market value of our common stock held by non-affiliates, or issue more than $1.0&#160;billion of non-convertible debt over a three-year period, we will cease to be an emerging growth company prior to the end of such five-year period. We may choose to take advantage of some but not all of these reduced requirements. We have elected to adopt the reduced requirements with respect to our financial statements and the related selected financial data and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure. We have also elected to take advantage of the extended transition periods for complying with certain new or revised accounting standards. As a result, the information that we provide to stockholders may be different than the information you may receive from other public companies in which you hold equity.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are also a &#8220;smaller reporting company,&#8221; meaning that the market value of our shares held by non-affiliates plus the proposed aggregate amount of gross proceeds to us as a result of this offering is less than $700&#160;million and our annual revenue was less than $100&#160;million during the most recently completed fiscal year. We may continue to be a smaller reporting company after this offering if either (i)&#160;the market value of our shares held by non-affiliates is less than $250&#160;million or (ii)&#160;our annual revenue was less than $100&#160;million during the most recently completed </div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">9<br></div></div></div>
<!--End Page 12-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 13-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">fiscal year and the market value of our shares held by non-affiliates is less than $700&#160;million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">10<br></div></div></div>
<!--End Page 13-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 14-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">THE OFFERING</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 7pt; margin-left: 0pt; text-align: left;">Issuer<font style="font-weight: normal; padding-left: 1.4pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -10pt; margin-left: 240pt; text-align: left;">Gain Therapeutics, Inc.</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Common stock offered by us<font style="font-weight: normal; padding-left: 4.18pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -10pt; margin-left: 240pt; text-align: left;">3,636,364 shares</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Underwriters&#8217; option to purchase additional shares<font style="font-weight: normal; padding-left: 2.47pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">We have granted the underwriters the option for a period of 30 days to purchase up to an additional 545,454 shares of common stock.</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Common stock to be outstanding after this offering<font style="font-weight: normal; padding-left: 1.63pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">11,331,006 shares (or 11,876,460 shares if the underwriters exercise their option to purchase additional shares in full).</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Use of proceeds<font style="font-weight: normal; padding-left: 1.38pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">We estimate that our net proceeds from this offering will be approximately $35.4&#160;million (or approximately $40.98&#160;million if the underwriters exercise their option to purchase additional shares in full), after deducting underwriting discounts and commissions and estimated offering expenses.</div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">We intend to use the net proceeds that we receive in this offering to advance our lead programs in preclinical studies and into clinical trials, to advance our discovery and candidate selection stage programs and for general corporate purposes. See &#8220;Use of Proceeds.&#8221;</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Risk factors<font style="font-weight: normal; padding-left: 5.3pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Investing in our common stock involves substantial risks. See &#8220;Risk Factors&#8221; for a discussion of risks you should carefully consider before deciding to invest in our common stock.</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Dividend policy<font style="font-weight: normal; padding-left: 1.73pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">We currently intend to retain all available funds and any future earnings to fund the development and growth of our business and to repay indebtedness, and therefore we do not anticipate declaring or paying any cash dividends on our common stock in the foreseeable future. In addition, future debt instruments may materially restrict our ability to pay dividends on our common stock. Payment of future cash dividends, if any, will be at the discretion of our board of directors after taking into account various factors, including our financial condition, operating results, current and anticipated cash needs, the requirements of then-existing debt instruments and other factors our board of directors deems relevant. See &#8220;Dividend Policy.&#8221;</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Listing<font style="font-weight: normal; padding-left: 3.5pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">We have been approved to list our common stock on the Nasdaq Global Market under the symbol &#8220;GANX.&#8221;</div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">11<br></div></div></div>
<!--End Page 14-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 15-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The number of shares of our common stock to be outstanding after completion of this offering is based on 8,736,125 shares (without taking into account any stock splits) of our common stock outstanding as of December 31, 2020, after giving effect to the automatic conversion of all outstanding shares of (i)&#160;our Series A Preferred Stock (the &#8220;Series A Preferred Stock&#8221;) into 1,346,390 shares of our common stock and (ii)&#160;our Series&#160;B Preferred Stock (the &#8220;Series B Preferred Stock&#8221;) into 3,366,999 shares of our common stock, referred to herein as the Preferred Conversion immediately prior to the closing of this offering, and excludes:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">1,153,827 shares of common stock reserved for future issuance under our share option plans as described in &#8220;Executive and Director Compensation &#8211; Gain Therapeutics Inc. 2020 Omnibus Incentive Plan&#8221; and reflects the stock split described below;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the exercise of warrants to purchase 237,249 shares of our common stock outstanding as of December 31, 2020, which will result in the issuance of 237,249 shares of common stock in connection with this offering, and reflects the stock split described below; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">517,902 shares of common stock issuable upon the exercise of stock options outstanding as of February 28, 2021, at a weighted average exercise price of $3.37 per share, and reflects the stock split described below. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless otherwise indicated or the context otherwise requires, all information in this prospectus assumes or gives effect to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a 0.88-for-1 stock split which will occur prior to the closing of this offering;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the effectiveness of our restated certificate of incorporation and restated bylaws in connection with the completion of this offering;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">no exercise by the underwriters of their option to purchase up to 545,454 additional shares of common stock from us to cover over-allotments; and </div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">12<br></div></div></div>
<!--End Page 15-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 16-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10015006x17_424b4_104-summary_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">SUMMARY FINANCIAL DATA</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following tables summarize our selected financial and other data. The summary consolidated statements of operations data presented below for the years ended December&#160;31, 2020, 2019, 2018 and the balance sheet data as of December&#160;31, 2020 and 2019 are derived from our audited consolidated financial statements included elsewhere in this prospectus. For periods and at dates prior to the Corporate Reorganization, our financial statements were prepared based on the historical financial statements of GT Gain Therapeutics SA. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our historical results are not necessarily indicative of the results that may be expected in any future period. You should read the following summary consolidated financial data together with the information in the sections titled &#8220;Use of Proceeds,&#8221; &#8220;Selected Historical Financial Data,&#8221; &#8220;Capitalization,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our audited consolidated financial statements and related notes included elsewhere in this prospectus. </div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 39.43%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.08%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.08%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 2.08%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.08%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenues:<br></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other income<font style="padding-left: 0.97pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.53pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">28,881</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.53pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">41,301</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.53pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">20,609</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total revenues<font style="padding-left: 2.22pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">28,881</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">41,301</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">20,609</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Research and development<font style="padding-left: 2.1pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">2,259,204</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1,586,245</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">826,880</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 1.55pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">1,249,126</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">555,165</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">222,047</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 0.57pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.53pt;">&#8203;</font><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">3,508,330</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">2,141,410</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.53pt;">&#8203;</font><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">1,048,927</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss from operations<font style="padding-left: 4.87pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(3,479,449</font><font style="padding-left: 0.2pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(</font>2,100,109<font style="padding-left: 0.2pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(</font>1,028,318<font style="padding-left: 0.2pt;">)</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest (income)/expense, net<font style="padding-left: 4.06pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(3,637</font><font style="padding-left: 0.2pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">20,540</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">52,477</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Foreign exchange (gain)/loss, net<font style="padding-left: 0.72pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">96,484</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">65,682</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">14,964</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before income tax provision<font style="padding-left: 4.33pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(3,572,296</font><font style="padding-left: 0.2pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">(</font>2,186,331<font style="padding-left: 0.2pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">(</font>1,095,759<font style="padding-left: 0.2pt;">)</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Income tax provision<font style="padding-left: 4.86pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">5,386</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 26.2pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">7,114</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">9,781</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 3.18pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.53pt;">&#8203;</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">(3,577,682</font><font style="padding-left: 0.2pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;"></font><font style="min-width: 48.53pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">(</font><font style="border-bottom: 1pt solid #000000; min-width: 48.53pt;">2,193,445</font><font style="padding-left: 0.2pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;"></font><font style="min-width: 48.53pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.53pt;">&#8203;</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;">(</font><font style="border-bottom: 1pt solid #000000; min-width: 48.53pt;">1,105,540</font><font style="padding-left: 0.2pt; border-bottom: 1pt solid #000000; min-width: 48.53pt;"></font><font style="min-width: 48.53pt;">)</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss per ordinary share:<br></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Basic and diluted loss per share<font style="padding-left: 1.01pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 48.53pt;">&#8203;</font><font style="padding-left: 27.5pt; border-bottom: 3pt double #000000; min-width: 48.53pt;">(1.17</font><font style="padding-left: 0.2pt; border-bottom: 3pt double #000000; min-width: 48.53pt;"></font><font style="min-width: 48.53pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 3pt double #000000; min-width: 48.53pt;">(</font><font style="border-bottom: 3pt double #000000; min-width: 48.53pt;">0.97</font><font style="padding-left: 0.2pt; border-bottom: 3pt double #000000; min-width: 48.53pt;"></font><font style="min-width: 48.53pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 48.53pt;">&#8203;</font><font style="padding-left: 27.5pt; border-bottom: 3pt double #000000; min-width: 48.53pt;">(</font><font style="border-bottom: 3pt double #000000; min-width: 48.53pt;">0.49</font><font style="padding-left: 0.2pt; border-bottom: 3pt double #000000; min-width: 48.53pt;"></font><font style="min-width: 48.53pt;">)</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted-average ordinary shares used in per share calculations &#8211; basic and diluted<font style="padding-left: 3.23pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 48.53pt;">3,046,355</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 48.53pt;">2,250,000</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 48.53pt;">2,250,000</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma net loss per share attributable to common stockholders - basic and diluted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 2.11pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 28.48pt;">(0.69</font><font style="padding-left: 0.2pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 28.85pt;">(1.11</font><font style="padding-left: 0.2pt;">)</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 28.48pt;">(0.56</font><font style="padding-left: 0.2pt;">)</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma weighted-average common shares outstanding - basic and diluted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 4.81pt;"></font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.09pt;">5,161,660</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.09pt;">1,981,764</font></div></td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.08%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.37%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.09pt;">1,981,764</font></div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.61%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 38.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, </div></td></tr><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.61%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.61%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.61%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 2.61%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.61%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents:<font style="padding-left: 0.99pt;"></font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$7,492,910</div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">303,320</font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 7.5pt;">400,694</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total current assets<font style="padding-left: 2.8pt;"></font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">8,</font>987,828</div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">4</font>29,525</div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">494,638</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total non-current assets<font style="padding-left: 4.47pt;"></font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">616,530</font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">2</font>30,761</div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">3</font>16,996</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total current liabilities<font style="padding-left: 3.9pt;"></font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5.37pt;">2,114,831</font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">879,052</font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">530,786</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total non-current liabilities<font style="padding-left: 0.57pt;"></font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">1,287,538</font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">231,090</font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">1,231,756</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total stockholders&#8217; equity (deficit)<font style="padding-left: 0.77pt;"></font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">6,201,989</font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(449,856)</font></div></td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.61%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 9.17pt;">(950,908)</font></div></td></tr></table></div><div class="block-footnote" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">1<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The unaudited pro-forma basic and diluted net loss per share attributable to common stockholders, for the year ended December 31, 2020, has been computed using the weighted-average number of common shares outstanding after giving pro-forma effect to (i) the conversion of all outstanding shares of convertible preferred stock into shares of common stock, and (ii) a 0.88-for-1 stock split which will occur prior to the closing of this offering, as if such conversion and stock split had occurred at the beginning of the period presented or the date of original issuance, whichever is later. As of December 31, 2020, there were 1,346,390 shares of Series A Preferred Stock and 3,366,999 Shares of Series B Preferred Stock issued and outstanding. For the year ended December 31, 2020, see Note 17 to our audited consolidated financial statements appearing elsewhere in this prospectus for further details on the calculation of pro forma basic and diluted net loss per share attributable to common stockholders. The unaudited pro-forma basic and diluted net loss per share attributable to common stockholders, for the years ended December 31, 2019 and 2018, has been computed using the weighted-average number of common shares outstanding after giving pro-forma effect to the 0.88-for-1 stock split which will occur prior to the closing of this offering, as if such stock split had occurred at the beginning of the period presented or the date of original issuance, whichever is later.</div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">13<br></div></div></div>
<!--End Page 16-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 17-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tRF"><!--Anchor--></a>RISK FACTORS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Investing in our securities involves a high degree of risk. You should consider carefully the risks described below, together with all of the other information included or incorporated by reference in this prospectus. The risks described below are material risks currently known, expected or reasonably foreseeable by us. However, the risks described below are not the only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also affect our business, operating results, prospects or financial condition. If any of these risks actually materialize, our business, prospects, financial condition and results of operations could be seriously harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Risks Related to Our Business</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have a history of operating losses and expect to incur losses for the foreseeable future. We may never generate revenues or, if we are able to generate revenues, achieve profitability.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are focused on product development, and we have not generated any revenues to date. We have incurred losses in each year of our operations, and we expect to continue to incur operating losses for the foreseeable future. These operating losses have adversely affected and are likely to continue to adversely affect our working capital, total assets and shareholders&#8217; equity.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We and our prospects should be examined in light of the risks and difficulties frequently encountered by new and early-stage companies in new and rapidly evolving markets. These risks include, among other things, the speed at which we can scale up operations, our complete dependence upon development of our product candidates that currently have no market acceptance, our ability to establish and expand our brand name, our ability to expand our operations to meet the commercial demand of our clients, our development of and reliance on strategic and customer relationships and our ability to minimize fraud and other security risks.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The process of developing our product candidates requires significant preclinical, clinical and regulatory development. In addition, commercialization of our product candidates will require that we obtain necessary regulatory approvals and establish sales, marketing and manufacturing capabilities, either through internal hiring or through contractual relationships with others. We expect to incur substantial losses for the foreseeable future as a result of anticipated increases in our research and development costs, including costs associated with conducting preclinical studies and clinical trials and regulatory compliance activities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We expect to incur substantial additional operating expenses over the next several years as our research, development, preclinical studies and clinical trial activities increase. The amount of future losses and when, if ever, we will achieve profitability are uncertain. We have no products that have generated any commercial revenue, do not expect to generate revenues from the commercial sale of products in the near future, and might never generate revenues from the sale of products. Our ability to generate revenue and achieve profitability will depend on, among other things, successful completion of preclinical development and testing and clinical trials of our product candidates; obtaining necessary regulatory approvals from the FDA; establishing manufacturing, sales and marketing arrangements with third parties; successfully commercializing our products; establishing a favorable competitive position; and raising sufficient funds to finance our activities. Many of these factors will depend on circumstances beyond our control. We might not succeed at any of these undertakings. If we are unsuccessful at some or all of these undertakings, our business, prospects and results of operations may be materially adversely affected.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: justify;">We have a limited operating history and we expect a number of factors to cause our operating results to fluctuate on a quarterly and annual basis, which may make it difficult to predict our future performance.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are a preclinical stage biopharmaceutical company with a limited operating history. Our operations to date have been primarily limited to organizing and staffing our company, acquiring, developing and securing our proprietary technology and preclinical development of our product candidates. We have not yet begun or successfully completed any clinical trials, completed Investigational New Drug (&#8220;IND&#8221;) enabling or Good Laboratory Practice (&#8220;GLP&#8221;) compliant studies for any of our target enzymes, manufactured our products at clinical or commercial scale or conducted sales and marketing activities that will be necessary to successfully commercialize our product candidates. Consequently, any predictions made about our future success or viability may not be as accurate as they could be if we had a longer operating history or commercialized products. Our financial condition has varied significantly in the past and will continue to fluctuate from quarter-to-quarter or year-to-year due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">14<br></div></div></div>
<!--End Page 17-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 18-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">fluctuations include other factors described elsewhere in this prospectus and also include, among other things:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to obtain additional funding to develop our product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our ability to conduct and complete preclinical studies, including GLP-compliant and IND-enabling preclinical studies;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in the commencement, enrollment and timing of clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the success of our preclinical studies and clinical trials through all phases of development;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any delays in regulatory review and approval of product candidates in clinical development;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our ability to obtain and maintain regulatory approval for our product candidates in the United States and foreign jurisdictions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">potential toxicity and/or side effects of our product candidates that could delay or prevent commercialization, limit the indications for any approved drug, require the establishment of risk evaluation and mitigation strategies (&#8220;REMS&#8221;), or cause an approved drug to be taken off the market;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to establish or maintain collaborations, licensing or other arrangements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">market acceptance of our product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">competition from existing products, new products or new therapeutic approaches that may emerge;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the ability of patients or healthcare providers to obtain coverage of or sufficient reimbursement for our products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our ability to leverage our proprietary technology platform to discover and develop additional product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our ability and our licensors&#8217; abilities to successfully obtain, maintain, defend and enforce intellectual property rights important to our business; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">potential product liability claims;</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Accordingly, the results of any quarterly or annual periods should not be relied upon as indications of future operating performance.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Until such time, if ever, as we can generate substantial revenue, we may finance our cash needs through a combination of equity offerings, government or private party grants, debt financings and license and collaboration agreements. We do not currently have any other committed external sources of funds. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may be required to relinquish valuable rights to our technologies, future revenue streams or product candidates, grant licenses on terms that may not be favorable to us or commit to future payment streams. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Risks Related to Product Development, Regulatory Approval, Manufacturing and Commercialization</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">If preclinical studies or clinical trials for our product candidates are unsuccessful or delayed, we will be unable to meet our future development and commercialization goals.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We rely and expect to continue to rely on third parties, including contract research organizations, or CROs, and outside consultants, to conduct, supervise or monitor some or all aspects of preclinical studies and clinical trials </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">15<br></div></div></div>
<!--End Page 18-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 19-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">involving our product candidates. We have less control over the timing and other aspects of these preclinical studies and clinical trials than if we performed the monitoring and supervision entirely on our own. Third parties may not perform their responsibilities for our preclinical studies and clinical trials on our anticipated schedule or, for clinical trials, consistent with a clinical trial protocol. To date, we have not conducted any IND-enabling studies or GLP compliant preclinical studies. We may not be able to initiate or successfully complete those studies in the future which could delay or restrict the advancement of our programs into the clinic. Delays in preclinical studies and clinical trials could significantly increase our product development costs and delay product commercialization. In addition, many of the factors that may cause, or lead to, a delay in the clinical trials may also ultimately lead to denial of regulatory approval of a product candidate.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The commencement of clinical trials can be delayed for a variety of reasons, including delays in:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">demonstrating sufficient safety and efficacy to obtain regulatory approval to commence a clinical trial;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reaching agreement on acceptable terms with prospective CROs and study sites;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">developing a stable formulation of a product candidate;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">manufacturing sufficient quantities of a product candidate; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining institutional review board (&#8220;IRB&#8221;) approval to conduct a clinical trial at a prospective site.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Once a clinical trial has begun, it may be delayed, suspended or terminated by us or the FDA or other regulatory authorities due to a number of factors, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">ongoing discussions with the FDA or other regulatory authorities regarding the scope or design of our clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to conduct clinical trials in accordance with regulatory requirements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">lower than anticipated recruitment or retention rate of patients in clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">inspection of the clinical trial operations or study sites by the FDA or other regulatory authorities resulting in the imposition of a clinical hold;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">lack of adequate funding to continue clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">negative results of clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">investigational drug product out-of-specification; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">nonclinical or clinical safety observations, including adverse events and SAEs.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If clinical trials are unsuccessful, and we are not able to obtain regulatory approvals for our product candidates under development, we will not be able to commercialize these products, and therefore may not be able to generate sufficient revenues to support our business.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The disorders we seek to treat have low prevalence and it may be difficult to identify patients with these disorders, which may lead to delays in enrollment for our trials or slower commercial revenue if approved.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Genetically defined disorders generally, and especially those for which our current product candidates are targeted, have low incidence and prevalence. For example, the reported incidence of infantile GM1 is approximately 1.4 in 100,000 live births and the incidence of Krabbe disease is approximately 2.6 in 100,000 births. While certain states currently have mandatory newborn genetic screening for Krabbe disease, there is no mandatory screening for GM1. Without mandatory screening, it may be difficult for us to identify a sufficient number of eligible patients to conduct our clinical trials. These could be significant obstacles to the timely recruitment and enrollment of a sufficient number of eligible patients into our trials. Further, we expect to rely in part on relationships with clinical centers of excellence, key opinion leaders and patient advocacy groups to assist in identifying eligible patients, and any deterioration of those relationships could impede our ability to successfully enroll patients. Patient enrollment may be affected by other factors including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the severity of the disease under investigation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">design of the study protocol;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the eligibility criteria for the trial;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">16<br></div></div></div>
<!--End Page 19-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 20-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the perceived risks, benefits and convenience of administration of the product candidate being studied;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our efforts to facilitate timely enrollment in clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the availability of other clinical trials being conducted for the same indication;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the patient referral practices of physicians; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the proximity and availability of clinical trial sites to prospective patients.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our inability to enroll a sufficient number of patients with these diseases for our future clinical trials would result in significant delays and could require us to not initiate or to abandon clinical trials for one or more indications altogether. Enrollment delays in our clinical trials may result in increased development costs for our product candidates, which would cause the value of our company to decline and limit our ability to obtain additional financing.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, the reported number of people who have GM1, Krabbe disease and other indications we aim to treat, as well as the people with these diseases who have the potential to benefit from treatment with our product candidates, are based on estimates. The total addressable market opportunity for our product candidates will ultimately depend upon, among other things, the final approved product labeling for each of our product candidates, if our product candidates are approved for sale in our target indications, acceptance by the medical community and patient access, drug pricing and reimbursement. The number of patients globally may turn out to be lower than expected, patients may not be otherwise amenable to treatment with our products, or new patients may become increasingly difficult to identify or gain access to, all of which would adversely affect our results of operations and our business.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Our product candidates are novel and still in development. If we are unable to successfully develop, receive regulatory approval for and commercialize our current or future product candidates, our business will be harmed</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Because the SEE-Tx platform remains untested and our product candidates are in early stages of development, they will require extensive preclinical and clinical testing. None of our product candidates are currently ready for clinical trials. Our drug development methods may not lead to commercially viable drugs for any of several reasons. Also, third parties we rely on for preclinical development such as the providers of supercomputer time needed for our SEE-Tx platform and collaborators that provide us with materials and resources may fail to fulfill their obligations to us in a timely manner or at all and the development of our product candidates could be significantly delayed as a result. For example, we may fail to identify appropriate targets or compounds, our product candidates may fail to be safe and effective in clinical trials, or we may have inadequate financial or other resources to pursue development efforts for our product candidates. In addition, our product candidates will require significant additional development, preclinical and IND-enabling studies and clinical trials, regulatory clearances and additional investment by us or our collaborators before they can be commercialized. In addition, we are still developing proof of concept for our product candidates in animals and positive data from animal models may not be predictive of positive human results and patients may have side effects that were not observed in animals.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, we and our product candidates are subject to extensive regulation by the FDA and comparable regulatory authorities in other countries governing, among other things, research, testing, clinical trials, manufacturing, labeling, promotion, selling, adverse event reporting and recordkeeping. Obtaining FDA approval is a lengthy, expensive and uncertain process. If required regulatory registrations or approvals are delayed, denied, withdrawn or if the regulatory authorities question the efficacy of our new small molecules as a treatment, such events are likely to have a material adverse effect on our business, results of operations, cash flows, financial condition and/or prospects.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We have not tested any of our product candidates in clinical trials. Success in early preclinical studies or clinical trials may not be indicative of results obtained in later preclinical studies and clinical trials.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our programs largely remain in the early drug discovery stage and few have progressed into initial preclinical studies that will inform future plans to conduct IND-enabling and GLP-compliant preclinical studies. We have not tested any of our product candidates in clinical trials and minimal preclinical work has been conducted to date. Success in early preclinical studies or any clinical trials we may conduct not be indicative of results obtained in later preclinical studies and clinical trials.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will be required to demonstrate through adequate and well-controlled clinical trials that our product candidates are safe and effective, with a favorable benefit-risk profile, for use in their target indications before we </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">17<br></div></div></div>
<!--End Page 20-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 21-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">can seek regulatory approvals for their commercial sale. Trial designs and results from early-phase trials are not necessarily predictive of future clinical trial designs or results, and initial positive results we may observe may not be confirmed in later-phase clinical trials. Our product candidates may also fail to show the desired safety and efficacy in later stages of clinical development even if they successfully advance through initial clinical trials. We may not be able to demonstrate the safety and efficacy of our STAR molecules in our clinical trials. Even if our clinical trials demonstrate acceptable safety and efficacy of STAR molecules for a targeted disease, the labeling we obtain through negotiations with the FDA or foreign regulatory authorities may not include data on secondary endpoints and may not provide us with a competitive advantage over other products approved for the same or similar indications.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Many companies in the biotechnology industry have suffered significant setbacks in late-stage clinical trials after achieving positive results in early-stage development and there is a high failure rate for product candidates proceeding through clinical trials. In addition, different methodologies, assumptions and applications we utilize to assess particular safety or efficacy parameters may yield different statistical results. Even if we believe the data collected from clinical trials of our product candidates are promising, these data may not be sufficient to support approval by the FDA or foreign regulatory authorities. Preclinical and clinical data can be interpreted in different ways. Accordingly, the FDA or foreign regulatory authorities could interpret these data in different ways from us or our partners, which could delay, limit or prevent regulatory approval. If our study data do not consistently or sufficiently demonstrate the safety or efficacy of any of our product candidates, then the regulatory approvals for such product candidates could be significantly delayed as we work to meet approval requirements, or, if we are not able to meet these requirements, such approvals could be withheld or withdrawn. Regulatory delays or rejections may be encountered as a result of many factors, including changes in regulatory policy during the period of product development. We may face similar setbacks.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The approach we are taking to discover and develop our product candidates is novel and may never lead to marketable products. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have concentrated our efforts and research and development activities on our novel small molecules for potential treatment of rare and genetic diseases caused by protein misfolding and SEE-Tx, our target identification platform. Our future success depends on the successful development of such product candidates, including our ability to initiate and successfully complete IND-enabling and GLP-compliant preclinical studies, and the effectiveness of our platform. The scientific discoveries that form the basis for our efforts to discover and develop new drugs are relatively new. The scientific evidence to support the feasibility of developing drugs based on these discoveries is both preliminary and limited. Skepticism as to the feasibility of developing small molecules of this type that can cross the blood-brain barrier generally has been, and may continue to be, expressed in scientific literature. In addition, decisions by other companies with respect to their therapeutic development efforts may increase skepticism in the marketplace regarding the potential for potential therapeutics. There are currently no companies with approved drugs for these indications that have the ability to cross the blood-brain barrier.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Because we have limited financial and managerial resources, we focus on research programs and product candidates that we identify for specific indications. As a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs and product candidates for specific indications may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Clinical trials required for our product candidates are expensive and time-consuming, and their outcome is uncertain.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To obtain FDA approval to market a new pharmaceutical product, we must demonstrate proof of safety and effectiveness in humans. To meet these requirements, we must conduct &#8220;adequate and well controlled&#8221; clinical trials. Conducting clinical trials is a lengthy, time-consuming, and expensive process. The length of time may vary </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">18<br></div></div></div>
<!--End Page 21-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 22-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">substantially according to the type, complexity, novelty, and intended use of the product candidate, and often can be several years or more per study. Delays in clinical trials for our product candidates may cause us to incur additional operating expenses. The commencement and rate of completion of clinical trials may be delayed by many factors, including, for example: inability to manufacture sufficient quantities of stable and qualified materials under current good manufacturing practices (&#8220;cGMPs&#8221;) for use in clinical trials; slower than expected rates of patient recruitment; failure to recruit a sufficient number of patients, which is a common issue in studies for rare disorders such as the indications we are currently pursuing; modification of clinical trial protocols; changes in regulatory requirements for clinical trials; the lack of effectiveness during clinical trials; the emergence of unforeseen safety issues; delays, suspension, or termination of the clinical trials due to the investigatory authority responsible for overseeing the trial at a particular trial site; and government or regulatory delays or &#8220;clinical holds&#8221; requiring suspension or termination of the studies.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our clinical trials may be conducted in patients with neurodegenerative diseases, and in some cases, our product candidates are expected to be used in combination with approved therapies that themselves have significant adverse event profiles. During the course of treatment, these patients could suffer adverse medical events or die for reasons that may or may not be related to our product candidates. Any safety issues that arise with respect to our product candidates may delay or prevent clinical development. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The failure of clinical trials to demonstrate safety and effectiveness for the desired indications could harm the development of that product candidate and other product candidates that use a similar therapeutic approach. This failure could cause us to abandon a product candidate and could delay development of other product candidates. Any delay in, or termination of, our clinical trials would delay our ability to obtain regulatory approvals for and commercialize our product candidates and generate product revenues. Any change in, or termination of, our clinical trials could materially harm our business, financial condition and results of operations.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We have limited experience as a company conducting clinical trials and may be unable to complete pivotal clinical trials for any product candidates we may develop.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are not yet a clinical stage company and our success is dependent upon our ability to initiate and successfully complete clinical trials and obtain regulatory approval for and commercialization of our product candidates. We have not demonstrated an ability to perform the functions necessary for the approval or successful commercialization of any product candidate. The successful commercialization of any product candidate may require us to perform a variety of functions, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">continuing to undertake preclinical development;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining approval to commence clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">successfully planning and enrolling subjects in clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">participating in regulatory approval processes;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">formulating and manufacturing products; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">conducting sales and marketing activities.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have limited experience designing, conducting and enrolling subjects in clinical trials. While certain members of our management and staff have significant experience in conducting clinical trials, to date, we have not successfully begun or completed any clinical trials as a company. Until recently, our operations have been limited primarily to organizing and staffing our company, acquiring, developing and securing our proprietary technology and preclinical development of our product candidates. These operations provide a limited basis to assess our ability to develop and commercialize our product candidates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Because of this lack of experience, any future clinical trials we may conduct may not be completed on time, if at all. Large-scale trials require significant additional financial and management resources, monitoring and oversight, and reliance on third-party clinical investigators, consultants or contract research organizations (&#8220;CROs&#8221;). Relying on third-party clinical investigators, CROs and manufacturers, which are all also subject to governmental oversight and regulations, may also cause us to encounter delays that are outside of our control.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, we are still in the drug discovery and preclinical development stage for our product candidates and have not yet begun discussions with the FDA as to the design, structure and number of clinical trials that our product candidates would require for approval. Consequently, we may be unable to successfully and efficiently advance any </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">19<br></div></div></div>
<!--End Page 22-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 23-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">candidates we select for clinical trials or execute and complete necessary GLP-compliant preclinical and IND-enabling studies in a way that leads to IND submission and approval of any product candidate. We may require more time and incur greater costs than our competitors and may not succeed in obtaining regulatory approvals of any product candidates that we develop. Failure to commence or complete, or delays in, future planned clinical trials, could prevent us from or delay us in commercializing our product candidates.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">We are subject to extensive and costly government regulation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Product candidates employing our technology are subject to extensive and rigorous domestic government regulation including regulation by the FDA, the Centers for Medicare and Medicaid Services, other divisions of the United States Department of Health and Human Services, the United States Department of Justice, state and local governments and their respective foreign equivalents. The FDA regulates the research, development, preclinical studies and clinical trials, manufacture, safety, effectiveness, record-keeping, reporting, labeling, storage, approval, advertising, promotion, sale, distribution, import and export of biopharmaceutical products. If products employing our technologies are marketed abroad, they will also be subject to extensive regulation by foreign governments, whether or not they have obtained the FDA&#8217;s approval for a given product and its uses. Such foreign regulation may be equally or more demanding than corresponding United States regulation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Government regulation substantially increases the cost and risk of researching, developing, manufacturing and selling our products. The regulatory review and approval process, which includes preclinical studies and clinical trials of each product candidate, is lengthy, expensive, and uncertain. We or our collaborators must obtain and maintain regulatory authorization to conduct clinical trials. We or our collaborators must obtain regulatory approval for each product we intend to market, and the manufacturing facilities used for the products must be inspected and meet legal requirements. Securing regulatory approval requires the submission of extensive preclinical and clinical data and other supporting information for each proposed therapeutic indication in order to establish the product&#8217;s safety and efficacy, and in the case of biologics also potency and purity, for each intended use. The development and approval process takes many years, requires substantial resources, and may never lead to the approval of a product.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Even if we are able to obtain regulatory approval for a particular product, the approval may limit the indicated medical uses for the product, may otherwise limit our ability to promote, sell, and distribute the product, may require that we conduct costly post-marketing surveillance, and/or may require that we conduct ongoing post-marketing studies. Material changes to an approved product, such as, for example, manufacturing changes or revised labeling, may require further regulatory review and approval. Once obtained, any approvals may be withdrawn, including, for example, if there is a later discovery of previously unknown problems with the product, such as a previously unknown safety issue.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If we, our collaborators, or our manufacturers fail to comply with applicable regulatory requirements at any stage during the regulatory process, such noncompliance could result in, among other things delays in the approval of applications or supplements to approved applications; refusal of a regulatory authority, including the FDA, to review pending market approval applications or supplements to approved applications; warning letters; fines; import and/or export restrictions; product recalls or seizures; injunctions; total or partial suspension of production; civil penalties; withdrawals of previously approved marketing applications or licenses; recommendations by the FDA or other regulatory authorities against governmental contracts; and/or criminal prosecutions.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">If we decide to pursue a Fast Track Designation for some of our product candidates, it may not lead to a faster development or regulatory review or approval process.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may seek Fast Track Designation for one or more of our product candidates. If a drug is intended for the treatment of a serious or life-threatening condition and the drug demonstrates the potential to address unmet medical needs for this condition, the product sponsor may apply for FDA Fast Track Designation. The FDA has broad discretion whether or not to grant this designation, so even if we believe a particular product candidate is eligible for this designation, the FDA may decide not to grant it. Even if we do receive Fast Track Designation, we may not experience a faster development process, review or approval compared to conventional FDA procedures. The FDA may withdraw Fast Track Designation if it believes that the designation is no longer supported by data from our clinical development program.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">20<br></div></div></div>
<!--End Page 23-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 24-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">If we decide to seek Orphan Drug Designation for some of our product candidates, we may be unsuccessful or may be unable to maintain the benefits associated with Orphan Drug Designation, including the potential for supplemental market exclusivity.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As part of our business strategy, we may seek Orphan Drug Designation for one or more of our product candidates, and we may be unsuccessful. Regulatory authorities in some jurisdictions, including the United States and Europe, may designate drugs for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000 individuals in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States. In the United States, Orphan Drug Designation entitles a party to financial incentives such as a 25% tax credit. Opportunities for grant funding toward clinical trial costs may also be available for clinical trials of drugs for rare diseases, regardless of whether the drugs are designated for the orphan use. In addition, if a product that has Orphan Drug Designation subsequently receives the first FDA approval for the disease for which it has such designation, the product is entitled to orphan drug exclusivity, which means that the FDA may not approve any other applications to market the same product for the same indication for seven years, except in limited circumstances. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Even if we obtain Orphan Drug Designation for our product candidates in specific indications, we may not be the first to obtain marketing approval of these product candidates for the orphan-designated indication due to the uncertainties associated with developing pharmaceutical products. If a competitor with a product that is determined by the FDA to be the same as one of our product candidates obtains marketing approval before us for the same indication we are pursuing and obtains orphan drug exclusivity, our product candidate may not be approved until the period of exclusivity ends unless we are able to demonstrate that our product candidate is clinically superior. Even after obtaining approval, we may be limited in our ability to market our product. In addition, exclusive marketing rights in the United States may be limited if we seek approval for an indication broader than the orphan-designated indication or may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. Further, even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different drugs with different principal molecular structural features can be approved for the same condition. Orphan Drug Designation neither shortens the development time or regulatory review time of a drug nor gives the drug any advantage in the regulatory review or approval process. While we may seek Orphan Drug Designation for our product candidates, we may never receive such designation.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">We do not have, and may never obtain, the regulatory approvals we need to market our product candidates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following completion of clinical trials, the results are evaluated and, depending on the outcome, an NDA is submitted to the FDA to obtain the FDA&#8217;s approval of the product and authorization to commence commercial marketing. In responding to an NDA, the FDA may require additional testing or information, may require that the product labeling be modified, may impose post-approval study and other commitments or reporting requirements or other restrictions on product distribution, or may deny the application. The FDA has established performance goals for review of NDAs: six months for priority applications and ten months for standard applications. However, the FDA is not required to complete its review within these time periods. The timing of final review by the FDA and action varies greatly but can take years in some cases and may involve the input of an FDA advisory committee of outside experts. Product sales in the United States may commence only when an NDA is approved.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To date, we have not applied for or received the regulatory approvals required for the commercial sale of any of our products in the United States or in any foreign jurisdiction. None of our product candidates have been determined to be safe and effective, and we have not submitted an IND or an NDA to the FDA or an equivalent application to any foreign regulatory authorities for any of our product candidates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">It is possible that none of our product candidates will be approved for marketing. Failure to obtain regulatory approvals, or delays in obtaining regulatory approvals, may adversely affect the successful commercialization of any drugs or biologics that we or our partners develop, may impose additional costs on us or our collaborators, may diminish any competitive advantages that we or our partners may attain, and/or may adversely affect our receipt of revenues or royalties.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">21<br></div></div></div>
<!--End Page 24-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 25-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Our product candidates may cause serious adverse events (&#8220;SAEs&#8221;) or undesirable side effects which may delay or prevent marketing approval, or, if approval is received, require them to be taken off the market, require them to include safety warnings or otherwise limit their sales.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">SAEs or undesirable side effects from our product candidates could arise either during development or, if approved, after the approved product has been marketed. The results of future clinical trials may show that our product candidates cause SAEs or undesirable side effects, which could interrupt, delay or halt clinical trials, resulting in delay of, or failure to obtain, marketing approval from the FDA and other regulatory authorities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If any of our product candidates cause SAEs or undesirable side effects or suffer from quality control issues:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">regulatory authorities may impose a clinical hold or REMS, which could result in substantial delays, significantly increase the cost of development, and/or adversely impact our ability to continue development of the product;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">regulatory authorities may require the addition of statements, specific warnings, or contraindications to the product label, or restrict the product&#8217;s indication to a smaller potential treatment population;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we may be required to change the way the product is administered or conduct additional clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we may be required to implement a risk minimization action plan, which could result in substantial cost increases and have a negative impact on our ability to commercialize the product; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we may be required to limit the participants who can receive the product;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we may be subject to limitations on how we promote the product;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we may, voluntarily or involuntarily, initiate field alerts for product recall, which may result in shortages;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">sales of the product may decrease significantly;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory authorities may require us to take our approved product off the market;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we may be subject to litigation or product liability claims; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our reputation may suffer.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any of these events could prevent us from achieving or maintaining market acceptance of the affected product or could substantially increase commercialization costs and expenses, which in turn could delay or prevent us from generating significant revenues from the sale of our products.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Even if approved, our products will be subject to extensive post-approval regulation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Once a product is approved, numerous post-approval requirements apply. Among other things, the holder of an approved NDA is subject to periodic and other monitoring and reporting obligations by the FDA, including obligations to monitor and report adverse events and instances of the failure of a product to meet the specifications in the NDA. Application holders must submit new or supplemental applications and obtain the FDA&#8217;s approval for certain changes to the approved product, product labeling, or manufacturing process. Application holders must also submit advertising and other promotional material to the FDA and report on ongoing clinical trials.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Depending on the circumstances, failure to meet these post-approval requirements can result in criminal prosecution, fines, injunctions, recall or seizure of products, total or partial suspension of production, denial or withdrawal of pre-marketing product approvals or refusal to allow us to enter into supply contracts, including government contracts. In addition, even if we comply with the FDA&#8217;s and others&#8217; requirements, new information regarding the safety or effectiveness of a product could lead the FDA to modify or withdraw product approval.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: justify;">Even if we obtain regulatory approval to market our product candidates, our product candidates may not be accepted by the market.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Even if the FDA approves one or more of our product candidates, physicians and patients may not accept it or use it. Even if physicians and patients would like to use our products, our products may not gain market acceptance among healthcare payors such as managed care formularies, insurance companies or government programs such as Medicare or Medicaid. Acceptance and use of our products will depend upon a number of factors including: perceptions by members of the health care community, including physicians, about the safety and effectiveness of our </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">22<br></div></div></div>
<!--End Page 25-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 26-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">drug or device product; cost-effectiveness of our product relative to competing products; availability of reimbursement for our product from government or other healthcare payors; and effectiveness of marketing and distribution efforts by us and our licensees and distributors, if any.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The degree of market acceptance of any pharmaceutical product that we develop will depend on a number of factors, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">cost-effectiveness;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the safety and effectiveness of our products, including any significant potential side effects (including drowsiness and dry mouth), as compared to alternative products or treatment methods;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing of market entry as compared to competitive products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the rate of adoption of our products by doctors and nurses;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">product labeling or product insert required by the FDA for each of our products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reimbursement policies of government and third-party payors;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">effectiveness of our sales, marketing and distribution capabilities and the effectiveness of such capabilities of our collaborative partners, if any; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">unfavorable publicity concerning our products or any similar products.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Because we expect sales of our current product candidates, if approved, to generate substantially all of our product revenues for the foreseeable future, the failure of these products to find market acceptance would harm our business and could require us to seek additional financing, which may not be available, See &#8220;Risks Related to Our Financial Condition and Capital Requirements; Competition&#8221; for additional discussion regarding our ability to raise additional funds.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We may use our financial and human resources to pursue a particular research program or product candidate and fail to capitalize on programs or product candidates that may be more profitable or for which there is a greater likelihood of success.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Because we have limited financial and human resources, we are currently focusing primarily on the development of our GLB program (which includes our STARs for Morquio B and GM1) and our GBA program (which includes our STARs for nGD and GBA1+PD). As a result of this focus, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on existing and future product candidates for specific indications may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through strategic alliance, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate, or we may allocate internal resources to a product candidate in a therapeutic area in which it would have been more advantageous to enter into a partnering arrangement.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Risks Related to Our Financial Condition and Capital Requirements; Competition</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We will need additional capital. If additional capital is not available or is available at unattractive terms, we may be forced to delay, reduce the scope of or eliminate our research and development programs, reduce our commercialization efforts or curtail our operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To develop and bring our product candidates to market, we must commit substantial resources to costly and time-consuming research, preclinical studies and clinical trials and marketing activities. We anticipate that our existing cash and cash equivalents will enable us to maintain our current operations for at least the next 12 months. We anticipate using our cash and cash equivalents to fund further research and development with respect to our product candidates. We will, however, need to raise additional funding sooner if our business or operations change in a manner that consumes available resources more rapidly than we anticipate. Our requirements for additional capital will depend on many factors, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the time and expense for preclinical studies and clinical trials for our product candidates;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">23<br></div></div></div>
<!--End Page 26-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 27-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the time and costs involved in obtaining regulatory approval for our product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">costs associated with protecting our intellectual property rights;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">successful commercialization of our product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">development of marketing and sales capabilities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">payments received under current and future collaborative agreements, if any; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">market acceptance of our products. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To the extent we raise additional capital through the sale of equity securities, the issuance of those securities could result in dilution to our shareholders. In addition, if we obtain debt financing, a substantial portion of our operating cash flow may be dedicated to the payment of principal and interest on such indebtedness, thus limiting funds available for our business activities. If adequate funds are not available, we may be required to delay, reduce the scope of or eliminate our research and development programs, reduce our commercialization efforts or curtail our operations. In addition, we may be required to obtain funds through arrangements with collaborative partners or others that may require us to relinquish rights to technologies, product candidates or products that we would otherwise seek to develop or commercialize ourselves or license rights to technologies, product candidates or products on terms that are less favorable to us than might otherwise be available.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will require substantial additional funds to support our research and development activities, and the anticipated costs of preclinical studies and clinical trials, regulatory approvals and eventual commercialization. Such additional sources of financing may not be available on favorable terms, if at all. If we do not succeed in raising additional funds on acceptable terms, we may be unable to commence or complete clinical trials or obtain approval of any product candidates from the FDA and other regulatory authorities. In addition, we could be forced to discontinue product development, forego sales and marketing efforts and forego attractive business opportunities. Any additional sources of financing will likely involve the issuance of our equity securities, which will have a dilutive effect on our shareholders.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may not be successful in raising the additional funds needed to fund our business plan. If we are not able to raise sufficient capital in the near future, our continued operations will be in jeopardy and we may be forced to cease operations and sell or otherwise transfer all or substantially all of our remaining assets.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: justify;">Our business and operations may be adversely affected by the evolving and ongoing COVID-19 global pandemic.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our business and operations may be adversely affected by the effects of the recent and evolving COVID-19 virus, which was declared by the World Health Organization as a global pandemic. The COVID-19 pandemic has resulted in travel and other restrictions in order to reduce the spread of the disease, including public health directives and orders in the United States and the European Union that, among other things and for various periods of time, directed individuals to shelter at their places of residence, directed businesses and governmental agencies to cease non-essential operations at physical locations, prohibited certain non-essential gatherings and events and ordered cessation of non-essential travel. Future remote work policies and similar government orders or other restrictions on the conduct of business operations and travel related to the COVID-19 pandemic may negatively impact productivity and may disrupt our ongoing and planned research and development activities, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations on our ability to conduct our business, including our continued drug discovery efforts and preclinical studies, in the ordinary course.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The spread of COVID-19, which has caused a broad impact globally, may materially affect us economically. While the potential economic impact brought by, and the duration of, COVID-19 may be difficult to assess or predict, a widespread pandemic could result in significant disruption of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity. In addition, a recession or market correction resulting from the spread of COVID-19 could materially affect our business and the value of our common stock.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We face intense competition in the markets targeted by our product candidates. Many of our competitors have substantially greater resources than we do, and we expect that all of our product candidates under development will face intense competition from existing or future drugs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We expect that all of our product candidates under development, if approved, will face intense competition from existing and future drugs marketed by large companies. These competitors may successfully market products that </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">24<br></div></div></div>
<!--End Page 27-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 28-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">compete with our products, successfully identify product candidates or develop products earlier than we do, or develop products that are more effective, have fewer side effects or cost less than our products. See &#8220;Our Business&#8212;Competition&#8221; for additional information regarding our current competitive landscape.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, if a competitor receives FDA approval before we do for a drug that is similar to one of our product candidates, FDA approval for our product candidate may be precluded or delayed due to periods of non-patent exclusivity and/or the listing with the FDA by the competitor of patents covering its newly-approved drug product. Periods of non-patent exclusivity for new versions of existing drugs can extend up to three and one-half years.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These competitive factors could require us to conduct substantial new research and development activities to establish new product targets, which would be costly and time consuming. These activities would adversely affect our ability to commercialize products and achieve revenue and profits.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Competition and technological change may make our product candidates and technologies less attractive or obsolete.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We compete with established pharmaceutical and biotechnology companies that are pursuing other forms of treatment for the same or similar indications we are pursuing and that have greater financial and other resources. Other companies may succeed in developing products earlier than us, obtaining FDA approval for products more rapidly, or developing products that are more effective than our product candidates. Research and development by others may render our technology or product candidates obsolete or noncompetitive, or result in treatments or cures superior to any therapy we develop. For example, other companies may succeed in developing a technology that addresses protein misfolding and proves to be more effective or is more readily accepted than STARs. We face competition from companies that internally develop competing technology or acquire competing technology from universities and other research institutions. As these companies develop their technologies, they may develop competitive positions that may prevent, make futile, or limit our product commercialization efforts, which would result in a decrease in the revenue we would be able to derive from the sale of any products.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may not be able to obtain marketplace acceptance for any of our product candidates as readily as these or other competing treatments. Furthermore, if our competitors&#8217; products are approved before ours, it could be more difficult for us to obtain approval from the FDA. Even if our products are successfully developed and approved for use by all governing regulatory bodies, physicians and patients may not accept our products as a treatment of choice.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Furthermore, the pharmaceutical research industry is diverse, complex, and rapidly changing. By its nature, the business risks associated therewith are numerous and significant. The effects of competition, intellectual property disputes, market acceptance, and FDA regulations preclude us from forecasting revenues or income with certainty or even confidence.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Risks Related to Our Intellectual Property Rights and Regulatory Exclusivity</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We rely on a license to use various technologies that are material to our business and if the agreements underlying the licenses were to be terminated or if other rights that may be necessary for commercializing our intended products cannot be obtained, it would halt our ability to market our products and technology, as well as have an immediate material adverse effect on our business, operating results and financial condition.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are significantly dependent upon our license with Minoryx Therapeutics SL (the &#8220;Minoryx License&#8221;), as described in the section &#8220;Business&#8212;License Agreement with Minoryx Therapeutics, S.I.&#8221;. The Minoryx License grants us exclusive, worldwide rights to certain patents and related intellectual property. If we breach the terms of the Minoryx License, for example, by failing to comply with any material terms thereof, Minoryx may have the right to terminate the license. If we were to lose our license under this agreement, including because we are unable to maintain the license on acceptable terms, we would not be able to market our products and technology, which would likely require us to cease our current operations which would have an immediate material adverse effect on our business, operating results and financial condition. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Our success depends substantially upon our ability to obtain and maintain intellectual property protection relating to our products and technologies.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are currently seeking patent protection for numerous compounds and methods of treating diseases. There is no assurance that these patents will be issued, and no assurance that, if they do issue, they will prevent other companies from competing with us. Our ability to obtain and enforce patents that may issue from any pending or </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">25<br></div></div></div>
<!--End Page 28-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 29-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">future patent applications is uncertain and involves complex legal, scientific and factual questions. Thus, we cannot be sure that any patents will issue from any pending or future patent applications owned by or licensed to us. Even if patents do issue, we cannot be sure that the claims of these patents will be held valid or enforceable by a court of law, will provide us with any significant protection against competing products, or will afford us a commercial advantage over competitive products. If, at some point in the future, one or more products resulting from our product candidates is approved for sale by the FDA and we do not have adequate intellectual property protection for those products, competitors could duplicate them for approval and sale in the United States without repeating the extensive testing required of us to obtain FDA approval. See &#8220;Our Business &#8211; Patents,&#8221; below.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">If we fail to protect our intellectual property rights, our ability to pursue the development of our technologies and products would be negatively affected.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our success will depend in part on our ability to obtain, maintain and protect intellectual property rights related to our product candidates. If we do not adequately maintain or protect our intellectual property, competitors may be able to use our technologies to produce and market drugs in direct competition with us and erode our competitive advantage. Furthermore, some foreign countries lack rules and methods for defending intellectual property rights and do not protect proprietary rights to the same extent as the United States. Many companies have had difficulty protecting their proprietary rights in these foreign countries. For example, the legal systems in India, China and certain other developing countries do not favor the enforcement of patents and other intellectual property rights. We may not be able to prevent misappropriation of our proprietary rights and intellectual property rights in these and other countries.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, the patent process is subject to numerous risks and uncertainties, and we may not be successful in protecting our products by obtaining and defending patents related to them. These risks and uncertainties include the following: patents that may be issued or licensed may be challenged, invalidated, or circumvented, or otherwise may not provide us any competitive advantage; our competitors, many of which have substantially greater resources than we and many of which have made significant investments in competing technologies, may seek, or may already have obtained, patents that will limit, interfere with, or eliminate our ability to make, use, and sell our potential products either in the United States or in international markets; there may be significant pressure on the United States government and other international governmental bodies to limit the scope of patent protection both inside and outside the United States for treatments that prove successful as a matter of public policy regarding worldwide health concerns; and countries other than the United States may have less robust patent laws than those upheld by United States courts, allowing foreign competitors the ability to exploit these laws to create, develop, and market competing products using our technologies and patents.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moreover, any patents issued to us may not provide us with meaningful protection, or others may challenge, circumvent or narrow our patents. Third parties may also independently develop products similar to our products, duplicate our unpatented products or design around any patents or proprietary technologies on products we develop. Additionally, extensive time is required for development, testing and regulatory review of a potential product. While extensions of patent terms due to regulatory delays may be available, it is possible that, before any of our product candidates can be commercialized, any related patent, even with an extension, may expire or remain in force for only a short period following commercialization, thereby reducing any advantages to us of the patent.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, the PTO and patent offices in other jurisdictions have often required that patent applications concerning pharmaceutical and/or biotechnology-related inventions be limited or narrowed substantially to cover only the innovations specifically exemplified in the patent application, thereby limiting the scope of protection against competitive challenges. Thus, even if we or our licensors are able to obtain patents, the patents may be substantially narrower than anticipated, which could deprive us of rights necessary for the successful commercialization of our product candidates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our success depends on our patents and patent applications that may be licensed exclusively to us and other patents and patent applications to which we may obtain assignment or licenses. We may not be aware, however, of all patents, published applications or published literature that may affect our business either by blocking our ability to commercialize our product candidates, by preventing the patentability of our product candidates by us or our licensors, or by covering the same or similar technologies. These patents, patent applications, and published literature may limit the scope of our future patent claims or adversely affect our ability to market our product candidates. We have not conducted any formal search of patents issued to third parties, and third-party patents containing claims </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">26<br></div></div></div>
<!--End Page 29-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 30-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">covering our product candidates that predate our patents may exist. Because of the number of patents issued and patent applications filed in our technical areas or fields, our competitors or other third parties may assert that our product candidates are covered by United States or foreign patents held by them.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to patents, we rely on a combination of trade secrets, confidentiality, nondisclosure and other contractual provisions, and security measures to protect our confidential and proprietary information. These measures may not adequately protect our trade secrets or other proprietary information. If they do not adequately protect our rights, third parties could use our technology, and we could lose any competitive advantage we may have. In addition, others may independently develop similar proprietary information or techniques or otherwise gain access to our trade secrets, which could impair any competitive advantage we may have.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Patent protection and other intellectual property protection is crucial to the success of our business and prospects, and there is a substantial risk that such protections will prove inadequate.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: justify;">We may be involved in lawsuits to protect or enforce our patents, which could be expensive and time consuming.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The pharmaceutical industry has been characterized by extensive litigation regarding patents and other intellectual property rights, and companies have employed intellectual property litigation to gain a competitive advantage. We may become subject to infringement claims or litigation arising out of present and future patents and other proceedings of our competitors. The defense and prosecution of intellectual property suits are costly and time-consuming to pursue, divert the attention of our management and scientific personnel, and their outcome is uncertain. Litigation may be necessary to determine the enforceability, scope, and validity of the proprietary rights of others. An adverse determination in litigation to which we may become a party could subject us to significant liabilities, require us to obtain licenses from third parties, or restrict or prevent us from selling our products in certain markets. Although patent and intellectual property disputes might be settled through licensing or similar arrangements, the costs associated with such arrangements may be substantial and could include our paying large fixed payments and ongoing royalties. Furthermore, the necessary licenses may not be available on satisfactory terms or at all.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Competitors may infringe our patents, and we may file infringement claims to counter infringement or unauthorized use. Third parties may assert that our patents are invalid and/or unenforceable in these proceedings. Such litigation can be expensive, particularly for a company of our size, and time-consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours is not valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover its technology. An adverse determination of any litigation or defense proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Third parties may also assert that our patents are invalid in patent office administrative proceedings. These proceedings include oppositions in the European Patent Office and <font style="font-style: italic;">inter partes</font> review and post-grant review proceedings in the PTO. The success rate of these administrative challenges to patent validity in the United States is higher than it is for validity challenges in litigation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Interference or derivation proceedings brought before the PTO may be necessary to determine priority of inventions disclosed in our patents or patent applications. Determining whether a product infringes a patent, as well as priority of inventions and other patent-related disputes, involves complex legal and factual issues and the outcome is often uncertain. During these proceedings, it may be determined that we do not have priority of invention for one or more aspects in our patents or patent applications and could result in the invalidation in part or whole of a patent or could put a patent application at risk of not issuing. Even if successful, an interference or derivation proceeding may result in substantial costs and distraction to our management. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or interference or derivation proceedings, there is a risk that some of our confidential information could be compromised by disclosure. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If investors or securities analysts perceive these results to be negative, the price of our common stock could be adversely affected.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Also, a third party may assert that our patents are invalid or unenforceable. There are not currently any unresolved communications, allegations, complaints or threats of litigation that claim our patents are invalid or unenforceable. Any litigation or claims against us, whether or not merited, may result in substantial costs, place a significant strain on our financial resources, divert the attention of management and harm our reputation. An adverse </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">27<br></div></div></div>
<!--End Page 30-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 31-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">decision in litigation or administrative proceedings could result in inadequate protection for our product candidates and/or reduce the value of any license agreements we have with third parties.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: justify;">If we infringe the rights of third parties, we could be prevented from selling products or forced to pay damages and defend against litigation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If our products, methods, processes and other technologies infringe the proprietary rights of other parties, we could incur substantial costs and we may have to: obtain licenses, which may not be available on commercially reasonable terms or at all; abandon an infringing product candidate; redesign our products or processes to avoid infringement; stop using the subject matter claimed in the patents held by others; pay damages; and/or defend litigation or administrative proceedings which may be costly whether we win or lose, and which could result in a substantial diversion of our financial and management resources.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, because patent applications can take many years to issue and because publication schedules for pending applications vary by jurisdiction, there may be applications now pending of which we are unaware, and which may result in issued patents that our future products would infringe. Also, because the claims of published patent applications can change between publication and patent grant, there may be published patent applications that may ultimately issue with claims that we infringe.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have licensed all of the rights, assets and technology related to the SEE-Tx platform from Minoryx and we believe that they owned all of such rights prior to our license. Although, to our knowledge, no third party has asserted a claim of infringement or other claim against us, others may hold or claim to hold proprietary or other rights that could prevent our SEE-Tx platform from being developed or marketed. Any legal action against us claiming damages and seeking to enjoin commercial activities relating to our SEE-Tx platform or our processes could subject us to potential liability for damages and require us to obtain a license to continue to manufacture or market any future product candidates based upon the SEE-Tx platform. We may not prevail in any such actions and any license required under any of these patents may not be made available on commercially acceptable terms, if at all. In addition, we may not be able to redesign any future product candidates or processes to avoid infringement, if necessary. Accordingly, an adverse determination in a judicial or administrative proceeding, or the failure to obtain necessary licenses, could prevent us from developing and commercializing our future product candidates, which could harm our business, financial condition and operating results. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Risks Related to Third Parties and Collaborators</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We intend to rely on third parties to conduct, supervise and monitor our clinical trials, and if those third parties perform in an unsatisfactory manner, it may harm our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We expect to rely on CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials. While we will have agreements governing their activities, we will have limited influence over their actual performance. We will control only certain aspects of our CROs&#8217; activities. Nevertheless, we will be responsible for ensuring that our clinical trials are conducted in accordance with the applicable protocol, legal, regulatory and scientific standards and our reliance on the CROs will not relieve us of our regulatory responsibilities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We and our CROs are required to comply with the FDA&#8217;s Good Clinical Practices (&#8220;GCPs&#8221;) for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of clinical trial participants are protected. The FDA enforces these GCPs through periodic inspections of study sponsors, principal investigators and clinical trial sites. If we or our CROs fail to comply with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA may require us to perform additional clinical trials before approving any marketing applications. Upon inspection, the FDA may determine that our clinical trials did not comply with GCPs. In addition, our clinical trials will require enrollment and participation of a sufficiently large number of patients to evaluate the effectiveness and safety of our product candidates. Accordingly, if our CROs fail to comply with these regulations or fail to recruit a sufficient number of participants, our clinical trials may be delayed or we may be required to repeat such clinical trials, which would delay the regulatory approval process.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our CROs are not our employees, and we are not able to control whether or not they devote sufficient time and resources to our clinical trials. These CROs may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials, or other drug development activities which could harm our competitive position.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">28<br></div></div></div>
<!--End Page 31-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 32-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If our CROs do not successfully carry out their contractual duties or obligations, fail to meet expected deadlines, or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements, or for any other reasons, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain regulatory approval for, or successfully commercialize our product candidates. As a result, our financial results and the commercial prospects for such product candidates would be harmed, our costs could increase, and our ability to generate revenues could be delayed.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">We intend to rely on third parties to manufacture the compounds used in our studies, and we intend to rely on them for the manufacture of any approved products for commercial sale. If these third parties do not manufacture our product candidates in sufficient quantities and at an acceptable cost, clinical development and commercialization of our product candidates could be delayed, prevented or impaired.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have no manufacturing facilities, and we have no experience in the clinical or commercial-scale manufacture of drugs or in designing drug manufacturing processes. We intend to rely on third party contract manufacturing organizations (&#8220;CMOs&#8221;) to manufacture some or all of our product candidates in future clinical trials and our products that reach commercialization. Initiation and completion of our clinical trials and commercialization of our product candidates requires the manufacture of a sufficient supply of our product candidates. If, for any reason, we become unable to rely on these third parties for the manufacture of our product candidates, either for clinical trials or, at some future date, for commercial quantities, then we would need to identify and contract with additional or replacement third-party manufacturers to manufacture compounds for preclinical, clinical and commercial purposes, which we may not be able to do on reasonable terms or at all, or we may be forced to manufacture the materials ourselves, for which we may not have the capabilities or resources. In either scenario, our clinical trials supply could be delayed significantly as we establish alternative supply sources. In some cases, the technical skills required to manufacture our products or product candidates may be unique or proprietary to the original CMO and we may have difficulty, or there may be contractual restrictions prohibiting us from, transferring such skills to a back-up or alternate supplier, or we may be unable to transfer such skills at all. In addition, if we are required to change CMOs for any reason, we will be required to verify that the new CMO maintains facilities and procedures that comply with quality standards and with all applicable regulations. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will also need to verify, such as through a manufacturing comparability study, that any new manufacturing process will produce our product candidates according to any specifications previously submitted to the FDA or another regulatory authority. The delays associated with the verification of a new CMO could negatively affect our ability to develop product candidates or commercialize our products in a timely manner or within budget. Furthermore, a CMO may possess technology related to the manufacture of our product candidate that such CMO owns independently. This would increase our reliance on such CMO or require us to obtain a license from such CMO in order to have another CMO manufacture our product candidates. In addition, changes in manufacturers often involve changes in manufacturing procedures and processes, which could require that we conduct bridging studies between our prior clinical supply used in our clinical trials and that of any new manufacturer. We may be unsuccessful in demonstrating the comparability of clinical supplies which could require the conduct of additional clinical trials.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe that there are a variety of manufacturers that we may be able to retain to produce these products. However, once we retain a manufacturing source, if our manufacturers do not perform in a satisfactory manner, we may not be able to develop or commercialize potential products as planned. Certain specialized manufacturers are expected to provide us with modified and unmodified pharmaceutical compounds, including finished products, for use in our preclinical studies and clinical trials. Some of these materials are available from only one supplier or vendor. Any interruption in or termination of service by such sole source suppliers could result in a delay or interruption in manufacturing until we locate an alternative source of supply. Any delay or interruption in our future supply chain and manufacturing operations (or failure to locate a suitable replacement for such suppliers), including on account of the ongoing COVID-19 pandemic, could materially adversely affect our business, prospects, or results of operations. If we fail to contract for manufacturing on acceptable terms or if third-party manufacturers do not perform as we expect, our development programs could be materially adversely affected. This may result in delays in filing for and receiving FDA approval for one or more of our products. Any such delays could cause our prospects to suffer significantly.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">29<br></div></div></div>
<!--End Page 32-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 33-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Failure by our third-party manufacturers to comply with the regulatory guidelines set forth by the FDA with respect to our product candidates could delay or prevent the completion of clinical trials, the approval of any product candidates or the commercialization of our products.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Third-party manufacturers must be inspected by the FDA for cGMP compliance before they can produce commercial products. Since March 2020, foreign and domestic inspections by the FDA have largely been on hold due to the COVID-19 pandemic with the FDA announcing plans in July 2020 to resume prioritized domestic inspections. Should the FDA determine that an inspections of manufacturing, establishments or clinical sites are necessary for approval and an inspection cannot be completed during the review cycle due to restrictions on travel, the FDA has stated that it generally intends to issue a complete response letter and several other companies have reported receiving complete response letters. Further, if there is inadequate information to make a determination on the acceptability of a facility, the FDA may defer action on the application until an inspection can be completed. It is unclear how long the COVID-19 pandemic will impact FDA inspection activities and whether foreign regulatory authorities may adopt similar limitations and policies.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may be in competition with other companies for access to these manufacturers&#8217; facilities and may be subject to delays in manufacture if the manufacturers give other clients higher priority than they give to us. If we are unable to secure and maintain third-party manufacturing capacity, the development and sales of our products and our financial performance may be materially affected. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Manufacturers are obligated to operate in accordance with FDA-mandated requirements. A failure of any of our third-party manufacturers to establish and follow cGMP requirements and to document their adherence to such practices may lead to significant delays in the availability of material for clinical trials, may delay or prevent filing or approval of marketing applications for our products, and may cause delays or interruptions in the availability of our products for commercial distribution following FDA approval. This could result in higher costs to us or deprive us of potential product revenues.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Drug manufacturers are subject to ongoing periodic unannounced inspections by the FDA, the Drug Enforcement Administration, or DEA, and corresponding state and foreign agencies to ensure strict compliance with cGMP requirements and other requirements under Federal drug laws, other government regulations and corresponding foreign standards. If we or our third-party manufacturers fail to comply with applicable regulations, sanctions could be imposed on us, including fines, injunctions, civil penalties, failure by the government to grant marketing approval of drugs, delays, suspension or withdrawal of approvals, seizures or recalls of product, operating restrictions and criminal prosecutions.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">Corporate and academic collaborators may take actions to delay, prevent, or undermine the success of our products.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our operating and financial strategy for the development, clinical testing, manufacture, and commercialization of product candidates is heavily dependent on our entering into collaborations with corporations, academic institutions, licensors, licensees, and other parties and we may not be successful in establishing such collaborations. Some of our existing collaborations are, and future collaborations may be, terminable at the sole discretion of the collaborator. Replacement collaborators might not be available on attractive terms, or at all. The activities of any collaborator will not be within our control and may not be within our power to influence. Any collaborators may not perform their obligations to our satisfaction, or at all, we may not derive any revenue or profits from such collaborations, and any collaborators may ultimately compete with us. If any collaboration is not pursued, we may require substantially greater capital to undertake development and marketing of our proposed products and may not be able to develop and market such products effectively, if at all. In addition, a lack of development and marketing collaborations may lead to significant delays in introducing proposed products into certain markets and/or reduced sales of proposed products in such markets.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">Data provided by collaborators and others upon which we rely that has not been independently verified could turn out to be false, misleading, or incomplete. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We rely on third-party vendors, scientists and collaborators to provide us with significant data and other information related to our projects, clinical trials and our business. If such third parties provide inaccurate, misleading or incomplete data, our business, prospects and results of operations could be materially adversely affected.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">30<br></div></div></div>
<!--End Page 33-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 34-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">If we fail to establish marketing, sales and distribution capabilities, or fail to enter into arrangements with third parties, we will not be able to create a market for our product candidates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our strategy for our product candidates is to control, directly or through contracted third parties, all or most aspects of the product development process, including marketing, sales and distribution. Currently, we do not have any sales, marketing or distribution capabilities. In order to generate sales of any product candidates that receive regulatory approval, we must either acquire or develop an internal marketing and sales force with technical expertise and with supporting distribution capabilities or make arrangements with third parties to perform these services for us. The acquisition or development of a sales and distribution infrastructure would require substantial resources, which may divert the attention of our management and key personnel and defer our product development efforts.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To the extent that we enter into marketing and sales arrangements with other companies, our revenues will depend on the efforts of others. These efforts may not be successful. If we fail to develop sales, marketing and distribution channels, or enter into arrangements with third parties, we will experience delays in product sales and incur increased costs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales of pharmaceutical products largely depend on the reimbursement of patients&#8217; medical expenses by government health care programs and private health insurers. Without the financial support of the government or third-party payors, the market for our products will be limited. These third-party payors are increasingly challenging the price and examining the cost effectiveness of medical products and services. Recent proposals to change the health care system in the United States have included measures that would limit or eliminate payments for medical products and services or subject the pricing of medical treatment products to government control. Significant uncertainty exists as to the reimbursement status of newly approved health care products. Third-party payors may not reimburse sales of our products or enable our collaborators to sell them at profitable prices.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our business strategy might involve out-licensing product candidates to or collaborating with larger firms with experience in marketing and selling pharmaceutical products. We may not be able to successfully establish marketing, sales, or distribution relationships and such relationships, if established, may not be successful. Further, we may not be successful in gaining market acceptance for our products. To the extent that we enter into any marketing, sales, or distribution arrangements with third parties, our product revenues will be lower than if we marketed and sold our products directly, and any revenues we receive will depend upon the efforts of such third-parties. If we are unable to establish such third-party sales and marketing relationships, or choose not to do so, we will have to establish and rely on our own in-house capabilities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We, as a company, have no experience in marketing or selling pharmaceutical products and currently have no sales, marketing, or distribution infrastructure. To market any of our products directly, we would need to develop a marketing, sales, and distribution force that both has technical expertise and the ability to support a distribution capability. The establishment of a marketing, sales, and distribution capability would significantly increase our costs, possibly requiring substantial additional capital. In addition, there is intense competition for proficient sales and marketing personnel, and we may not be able to attract individuals who have the qualifications necessary to market, sell, and distribute our products. We may not be able to establish internal marketing, sales, or distribution capabilities. If we are unable to, or choose not to establish these capabilities, or if the capabilities we establish are not sufficient to meet our needs, we will be required to establish collaborative marketing, sales, or distribution relationships with third parties.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">If any of our existing or future collaborative partners do not satisfy their obligations, we will be unable to develop our partnered product candidates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may not have day-to-day control over the activities of our existing and future collaborative partners with respect to any of these product candidates. Any collaborative partner may not fulfill its obligations under these agreements. If a collaborative partner fails to fulfill its obligations under an agreement with us, we may be unable to assume the development of the products covered by that agreement or enter into alternative arrangements with a third party. In addition, we may encounter delays in the commercialization of the product candidate that is the subject of the agreement. Accordingly, our ability to receive any revenue from the product candidates covered by these agreements will be dependent on the efforts of our collaborative partner. We could also become involved in disputes with a collaborative partner, which could lead to delays in or termination of our development and commercialization programs and time-consuming and expensive litigation or arbitration. In addition, any such dispute could diminish our collaborators&#8217; commitment to us and reduce the resources they devote to developing and commercializing our products. Conflicts or disputes with our collaborators, and competition from them, could harm our relationships with </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">31<br></div></div></div>
<!--End Page 34-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 35-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">our other collaborators, restrict our ability to enter future collaboration agreements and delay the research, development or commercialization of our product candidates. If any collaborative partner terminates or breaches its agreement, or otherwise fails to complete its obligations in a timely manner, our chances of successfully developing or commercializing these product candidates would be materially and adversely affected. We may not be able to enter into collaborative agreements with partners on terms favorable to us, or at all. Our inability to enter into collaborative arrangements with collaborative partners, or our failure to maintain such arrangements, would limit the number of product candidates that we could develop and ultimately decrease our sources of any future revenues.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We may face risks in connection with existing and future collaborations with respect to the development, manufacture and commercialization of our product candidates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We face a number of risks in connection with our current and future collaborations. Our collaboration agreements are subject to termination under various circumstances. Our collaborators may change the focus of their development and commercialization efforts or may have insufficient resources to effectively assist in the development of our products. Any future collaboration agreements may have the effect of limiting the areas of research and development that we may pursue, either alone or in collaboration with third parties. Further, disagreements with collaborators, including disagreements over proprietary rights, contract interpretation, or the preferred course of development, might cause delays, might result in litigation or arbitration, or might result in termination of the research, development or commercialization of our products. Any such disagreements would divert management attention and resources and be time-consuming and costly.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">General Company-Related Risks</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future that may cause us to fail to meet our reporting obligations or result in material misstatements in our financial statements. If we fail to remediate our material weaknesses, we may not be able to report our financial results accurately or to prevent fraud.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our management is responsible for establishing and maintaining internal control over financial reporting, disclosure controls, and compliance with the other requirements of the Sarbanes-Oxley Act and the rules promulgated by the SEC thereunder. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with applicable financial reporting standards. A material weakness is defined as a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company&#8217;s annual or interim financial statements will not be prevented or detected by the company&#8217;s internal controls on a timely basis. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to this offering, we have operated as a private company that was not required to comply with the obligations of a public company with respect to internal control over financial reporting. We have historically operated with limited accounting personnel and other resources with which to address our internal control over financial reporting. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the audits of our financial statements in preparation for this offering, we and our independent registered public accounting firm identified material weaknesses primarily related to a (i)&#160;lack of sufficient accounting and supervisory personnel who have the appropriate level of technical accounting experience and training, and (ii)&#160;lack of adequate procedures and controls to ensure that accurate financial statements can be prepared and reviewed on a timely basis for annual reporting purposes. These deficiencies constitute material weaknesses in our internal control over financial reporting in both design and operation. We have engaged outside advisors with expertise in these matters to assist us in the preparation of our financial statements and in our compliance with SEC reporting obligations related to this offering, and we expect to continue to do so while we remediate the material weaknesses.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have initiated a remediation plan to address these material weaknesses, including the hire of a full time additional employee in our accounting department and a more streamlined process in order to prepare and review financial information; however, our control environment needs improvements, and as a result we may be exposed to errors. We plan to take additional steps to remediate the material weaknesses and improve our accounting function, including hiring of additional senior level and staff accountants with US GAAP technical knowledge to support the timely completion of financial close procedures, implement robust processes, and provide additional needed technical expertise, and in the interim, continuing to engage third parties as required to assist with the preparation of our </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">32<br></div></div></div>
<!--End Page 35-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 36-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">financial statements and our compliance with SEC reporting obligations. Additionally, we intend to develop and implement consistent accounting policies, internal control procedures and provide additional training to our accounting and financial reporting personnel.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Although we are working to remediate such material weaknesses as quickly and efficiently as possible, we cannot at this time estimate how long it will take, and our initiatives may not prove to be successful in remediating the material weaknesses. If we are unable to successfully remediate our identified material weaknesses, if we discover additional material weaknesses or if we otherwise are unable to report our financial statements accurately or in a timely manner, we would be required to continue disclosing such material weaknesses in future filings with the SEC, which could adversely affect our business, investor confidence in our company and the market price of our common shares and could subject us to litigation or regulatory enforcement actions. As a result, shareholders could lose confidence in our financial and other public reporting, which would harm our business and the market value of our common shares.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We will need to expand our operations and increase the size of our company, and we may experience difficulties in managing growth.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As we advance our product candidates through preclinical studies and clinical trials, and develop new product candidates, we will need to increase our product development, scientific, regulatory and compliance and administrative headcount to manage these programs. In addition, to meet our obligations as a public company, we will need to increase our general and administrative capabilities. Our management, personnel and systems currently in place may not be adequate to support this future growth. Our need to effectively manage our operations, growth and various projects requires that we:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">successfully attract and recruit new employees with the expertise and experience we will require;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">manage our clinical programs effectively, which we anticipate being conducted at numerous clinical sites;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">develop a marketing, distribution and sales infrastructure in addition to a post-marketing surveillance program if we seek to market our products directly; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">continue to improve our operational, manufacturing, quality assurance, financial and management controls, reporting systems and procedures.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If we are unable to successfully manage this growth and increased complexity of operations, our business may be adversely affected.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Our executive officers and other key personnel are critical to our business, and our future success depends on our ability to retain them.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our success depends to a significant extent upon the continued services of Eric I. Richman, our Chief Executive Officer. Mr.&#160;Richman has overseen the company since July 2020 and provides leadership for our growth and operations strategy. Loss of the services of our key personnel would have a material adverse effect on our growth, revenues and prospective business. The loss of any of our key personnel, or the inability to attract and retain qualified personnel, may significantly delay or prevent the achievement of our research, development or business objectives and could materially adversely affect our business, financial condition and results of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any employment agreement we enter into will not ensure the retention of the employee who is a party to the agreement. In addition, we have only limited ability to prevent former employees from competing with us. Furthermore, our future success will also depend in part on the continued service of our key scientific and management personnel and our ability to identify, hire, and retain additional personnel. We experience intense competition for qualified personnel and may be unable to attract and retain the personnel necessary for the development of our business. Moreover, competition for personnel with the scientific and technical skills that we seek is extremely high and is likely to remain high. Because of this competition, our compensation costs may increase significantly.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Under applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors from benefiting from the expertise of some of our former employees.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our employment agreements generally include covenants not to compete. These agreements prohibit our employees, if they cease working for us, from competing directly with us or working for our competitors for a limited period. We may be unable to enforce these agreements under the laws of the jurisdictions in which our employees </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">33<br></div></div></div>
<!--End Page 36-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 37-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">work at all or for a sufficient duration of time to prevent members of our management team from competing with us. If we are unable to enforce these covenants not to compete, we may be unable to prevent our competitors from benefiting from the expertise of our former employees or consultants and our competitiveness may be diminished.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">If we are unable to hire additional qualified personnel, our ability to grow our business may be harmed.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Over time we will need to hire additional qualified personnel with expertise in drug development, product registration, clinical, preclinical and nonclinical research, quality compliance, government regulation, formulation and manufacturing, financial matters and sales and marketing. We compete for qualified individuals with numerous biopharmaceutical companies, universities and other research institutions. Competition for such individuals is intense, and our search for such personnel may not be successful. Attracting and retaining qualified personnel will be critical to our success.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Our relationships with customers, physicians, and third-party payors will be subject, directly or indirectly, to federal and state healthcare fraud and abuse laws, false claims laws, health information privacy and security laws, and other healthcare laws and regulations. If we are unable to comply, or have not fully complied, with such laws, we could face substantial penalties.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Healthcare providers, physicians and third-party payors in the United States and elsewhere will play a primary role in the recommendation and prescription of any product candidates for which we obtain marketing approval. Our current and future arrangements with healthcare professionals, principal investigators, consultants, customers and third-party payors may subject us to various federal and state fraud and abuse laws and other healthcare laws, including, without limitation, the federal Anti-Kickback Statute, the federal civil and criminal false claims laws and the law commonly referred to as the Physician Payments Sunshine Act and regulations. These laws will impact, among other things, our clinical research, proposed sales, marketing and educational programs. In addition, we may be subject to patient privacy laws by both the federal government and the states in which we conduct or may conduct our business. The laws that will affect our operations include, but are not limited to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting, receiving, offering or paying any remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind, in return for the purchase, recommendation, leasing or furnishing of an item or service reimbursable under a federal healthcare program, such as the Medicare and Medicaid programs;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">federal civil and criminal false claims laws, including, without limitation, the False Claims Act, and civil monetary penalty laws which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment or approval from Medicare, Medicaid or other government payors that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created new federal criminal statutes that prohibit a person from knowingly and willfully executing a scheme or making false or fraudulent statements to defraud any healthcare benefit program, regardless of the payor (e.g.,&#160;public or private);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and its implementing regulations, and as amended again by the final HIPAA omnibus rule, Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under HITECH and the Genetic Information Nondiscrimination Act; Other Modifications to HIPAA, published in January 2013, which imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization by entities subject to the rule, such as health plans, health care clearinghouses and health care providers, and their respective business associates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">federal transparency laws, including the federal Physician Payments Sunshine Act, which is part of PPACA, that require certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, to report annually to the Centers for Medicare &amp; Medicaid Services, or CMS, information related to: (i)&#160;payments or other &#8220;transfers of value&#8221; made to physicians and teaching hospitals; and (ii)&#160;ownership and investment interests held by physicians and their immediate family members;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">34<br></div></div></div>
<!--End Page 37-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 38-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">state and foreign law equivalents of each of the above federal laws, state laws that require manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures, and state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or to adopt compliance programs as prescribed by state laws and regulations, or that otherwise restrict payments that may be made to healthcare providers; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">state and foreign laws that govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could be subject to challenge under one or more of such laws.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 5pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion of drugs from government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of our operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 5pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The risk of our being found in violation of these laws is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply with multiple jurisdictions with different compliance and/or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">Coverage and adequate reimbursement may not be available for our current or any future product candidates, which could make it difficult for us to sell profitably, if approved.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Market acceptance and sales of any product candidates that we commercialize, if approved, will depend in part on the extent to which reimbursement for these drugs and related treatments will be available from third-party payors, including government health administration authorities, managed care organizations and other private health insurers. Third-party payors decide which therapies they will pay for and establish reimbursement levels. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own coverage and reimbursement policies. However, decisions regarding the extent of coverage and amount of reimbursement to be provided for any product candidates that we develop will be made on a payor-by-payor basis. One payor&#8217;s determination to provide coverage for a drug does not determine whether or not another payor will also provide coverage, and adequate reimbursement, for the drug. Additionally, a third-party payor&#8217;s decision to provide coverage for a therapy does not imply that an adequate reimbursement rate will be approved. Each payor determines whether or not it will provide coverage for a therapy, what amount it will pay the manufacturer for the therapy, and on what tier of its formulary it will be placed. The position on a payor&#8217;s list of covered drugs, or formulary, generally determines the co-payment that a patient will need to make to obtain the therapy and can strongly influence the adoption of such therapy by patients and physicians. Patients who are prescribed treatments for their conditions and providers prescribing such services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use our drugs unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of our drugs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 5pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Coverage and reimbursement may not be available for any drug that we commercialize and, if reimbursement is available, it is uncertain what the level of reimbursement will be. Inadequate coverage and reimbursement may </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">35<br></div></div></div>
<!--End Page 38-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 39-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">impact the demand for, or the price of, any drug for which we obtain marketing approval. If coverage and adequate reimbursement are not available, or are available only at limited levels, we may not be able to successfully commercialize our current and any future product candidates that we develop.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Healthcare legislative reform measures may have a negative impact on our business and results of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect our ability to profitably sell any product candidates for which we obtain marketing approval.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives. In March 2010, the PPACA was passed, which substantially changed the way healthcare is financed by both the government and private insurers, and significantly impacts the U.S. pharmaceutical industry. The PPACA, among other things: (i)&#160;addresses a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected; (ii)&#160;increases the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program to individuals enrolled in Medicaid managed care organizations; (iii)&#160;establishes annual fees and taxes on manufacturers of certain branded prescription drugs; (iv)&#160;expands the availability of lower pricing under the 340B drug pricing program by adding new entities to the program; and (v)&#160;establishes a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 50% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part D. Some of the provisions of the PPACA have yet to be fully implemented, while certain provisions have been subject to judicial and Congressional challenges. In January 2017, Congress voted to adopt a budget resolution for fiscal year 2017, or the Budget Resolution, that authorizes the implementation of legislation that would repeal portions of the PPACA. The Budget Resolution is not a law; however, it is widely viewed as the first step toward the passage of legislation that would repeal certain aspects of the PPACA. Further, on January&#160;20, 2017, President Trump signed an Executive Order directing federal agencies with authorities and responsibilities under the PPACA to waive, defer, grant exemptions from, or delay the implementation of any provision of the PPACA that would impose a fiscal or regulatory burden on states, individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. The PPACA remains subject to legislative efforts to repeal, modify or delay the implementation of the law. Recent efforts to repeal, modify or delay implementation of the ACA have resulted in some level of success. If the PPACA is repealed or further modified, or if implementation of certain aspects of the PPACA are delayed, such repeal, modification or delay may materially adversely impact our business, strategies, prospects, operating results or financial condition. Additionally, there has been heightened governmental scrutiny in the United States of pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs and reform government program reimbursement methodologies for products. In addition, changes to the political landscape in the United States (including as a result of the 2020 presidential elections) may impact the market sentiment surrounding the pharmaceutical industry.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We expect that these and other healthcare reform measures that may be adopted in the future may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved drug. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our drugs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our product candidates or additional pricing pressures.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">36<br></div></div></div>
<!--End Page 39-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 40-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">If we obtain approval to commercialize any approved products outside of the United States, a variety of risks associated with international operations could materially adversely affect our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If any of our product candidates are approved for commercialization outside of the United States, we intend to enter into agreements with third parties to market them on a worldwide basis or in more limited geographical regions. We expect that we will be subject to additional risks related to entering into international business relationships, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">different regulatory requirements for drug approvals;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reduced protection for intellectual property rights, including trade secret and patent rights;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">unexpected changes in tariffs, trade barriers and regulatory requirements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">economic weakness, including inflation, or political instability in particular foreign economies and markets;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">foreign taxes, including withholding of payroll taxes;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenues, and other obligations incident to doing business in another country;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">workforce uncertainty in countries where labor unrest is more common than in the United States;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">business interruptions resulting from geopolitical actions, including war and terrorism, or natural disasters including earthquakes, hurricanes, floods and fires; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">difficulty in importing and exporting clinical trial materials and study samples.</div></td></tr></table><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">We face the risk of product liability claims and may not be able to obtain insurance.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our business exposes us to the risk of product liability claims that are inherent in the development of drugs. If the use of one or more of our or our collaborators&#8217; drugs harms people, we may be subject to costly and damaging product liability claims brought against us by clinical trial participants, consumers, health care providers, pharmaceutical companies or others selling our products. Our inability to obtain sufficient product liability insurance at an acceptable cost to protect against potential product liability claims could prevent or inhibit the commercialization of pharmaceutical products we develop, alone or with collaborators. While we currently expect to carry clinical trial insurance and product liability insurance, the amount of insurance coverage up to $5&#160;million we hold now or in the future may not be adequate to cover all liabilities we might incur. We intend to expand our insurance coverage to include the sale of commercial products if we obtain marketing approval for our product candidates in development, but we may be unable to obtain commercially reasonable product liability insurance for any products approved for marketing. If we are unable to obtain insurance at an acceptable cost or otherwise protect against potential product liability claims, we will be exposed to significant liabilities, which may materially and adversely affect our business and financial position. If we are sued for any injury allegedly caused by our or our collaborators&#8217; products, our liability could exceed our total assets and our ability to pay the liability. A product liability claim or series of claims brought against us would decrease our cash and could cause our stock price to fall.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">Our insurance policies are expensive and protect us only from some business risks, which will leave us exposed to significant uninsured liabilities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We carry insurance for most categories of risk that our business may encounter; however, we may not have adequate levels of coverage. We currently maintain general liability, property, workers&#8217; compensation, products liability and directors&#8217; and officers&#8217; insurance, along with an umbrella policy, which collectively costs approximately $35,000 per annum. We may not be able to maintain existing insurance at current or adequate levels of coverage. Any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our cash position and results of operations.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">37<br></div></div></div>
<!--End Page 40-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 41-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Risks Related to Our Securities and the Offering</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">If we sell securities in future financings, stockholders may experience immediate dilution and, as a result, our stock price may decline.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may from time to time issue additional shares of common stock at a discount from the current market price of our common stock. As a result, our stockholders would experience immediate dilution upon the purchase of any of our securities sold at such discount. In addition, as opportunities present themselves, we may enter into financing or similar arrangements in the future, including the issuance of debt securities, preferred stock or common stock. If we issue common stock or securities convertible into common stock, our common stockholders could experience additional dilution and, as a result, our stock price may decline.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We will have broad discretion in how we use the net proceeds of this offering. We may not use these proceeds effectively, which could affect our results of operations and cause our stock price to decline.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will have considerable discretion in the application of the net proceeds of this offering, including for any of the purposes described in the section entitled &#8220;Use of Proceeds.&#8221; We intend to use the net proceeds from this offering to advance our lead programs in preclinical studies and into clinical trials, to advance our discovery and candidate selection stage programs and for general corporate purposes. As a result, investors will be relying upon management&#8217;s judgment with only limited information about our specific intentions for the use of the balance of the net proceeds of this offering. We may use the net proceeds for purposes that do not yield a significant return or any return at all for our stockholders. In addition, pending their use, we may invest the net proceeds from this offering in a manner that does not produce income or that loses value.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">No active trading market for our common stock currently exists. An active trading market may not develop and you may not be able to resell your shares of our common stock at or above the initial offering price, or at all.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to this offering, there has not been an active trading market for our common stock. If an active trading market for our common stock does not develop following this offering, you may not be able to sell your shares quickly or at the market price. Our ability to raise capital to continue to fund operations by selling shares of our common stock and our ability to acquire other companies or technologies by using shares of our common stock as consideration may also be impaired. The initial public offering price of our common stock will be determined by negotiations between us and representatives of the underwriters and may not be indicative of the market prices of our common stock that will prevail in the trading market.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The market price for our common stock may be volatile, and your investment in our securities could decline in value.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The stock market in general has experienced extreme price and volume fluctuations. The market prices of the securities of biotechnology and specialty pharmaceutical companies, particularly companies like ours without product revenues and earnings, have been highly volatile and may continue to be highly volatile in the future. This volatility has often been unrelated to the operating performance of particular companies. The following factors, in addition to other risk factors described in this section, may have a significant impact on the market price of our common stock:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">announcements of technological innovations or new products by us or our competitors;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">announcement of FDA approval or disapproval of our product candidates or other product-related actions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">developments involving our discovery efforts and clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">developments or disputes concerning patents or proprietary rights, including announcements of infringement, interference or other litigation against us or our potential licensees;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">developments involving our efforts to commercialize our products, including developments impacting the timing of commercialization;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">announcements concerning our competitors, or the biotechnology, pharmaceutical or drug delivery industry in general;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">public concerns as to the safety or efficacy of our product candidates or our competitors&#8217; products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in government regulation of the pharmaceutical or medical industry;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">38<br></div></div></div>
<!--End Page 41-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 42-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in the reimbursement policies of third party insurance companies or government agencies;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actual or anticipated fluctuations in our operating results;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in financial estimates or recommendations by securities analysts;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">developments involving corporate collaborators, if any;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in accounting principles; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the loss of any of our key scientific or management personnel.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the past, securities class action litigation has often been brought against companies that experience volatility in the market price of their securities. Whether or not meritorious, litigation brought against us could result in substantial costs and a diversion of management&#8217;s attention and resources, which could adversely affect our business, operating results and financial condition.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">If you purchase shares of our common stock in this offering, you will suffer immediate dilution of your investment.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The initial public offering price of our common stock is substantially higher than the net tangible book value (deficit) per share of our common stock. Therefore, if you purchase shares of our common stock in this offering, you will pay a price per share that substantially exceeds our pro forma as adjusted net tangible book value per share after this offering. Based on the initial public offering price of $11.00 per share, you will experience immediate dilution of $7.33 per share, representing the difference between our pro forma as adjusted net tangible book value per share after this offering and the assumed initial public offering price.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, as of February 28, 2021, we had outstanding stock options to purchase an aggregate of 517,902 shares of common stock at an exercise price of $3.37 per share. To the extent these outstanding options are exercised, there will be further dilution to investors in this offering.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives and corporate governance practices.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As a public company, and particularly after we no longer qualify as an emerging growth company, we will incur significant legal, accounting and other expenses that we did not incur previously. The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of Nasdaq, and other applicable securities rules and regulations impose various requirements on U.S. reporting public companies, including the establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more expensive for us to obtain director and officer liability insurance, which in turn could make it more difficult for us to attract and retain qualified senior management personnel or members for our board of directors. In addition, these rules and regulations are often subject to varying interpretations, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While we remain an emerging growth company, we will not be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To prepare for eventual compliance with Section 404, once we no longer qualify as an emerging growth company, we will be engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial reporting is effective as required by Section 404. If we identify one or more material weaknesses, it could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">39<br></div></div></div>
<!--End Page 42-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 43-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">We are an &#8220;emerging growth company,&#8221; and the reduced reporting requirements applicable to emerging growth companies may make our common stock less attractive to investors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We qualify as an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. For so long as we remain an emerging growth company, we are permitted and plan to rely on exemptions from certain disclosure requirements that are applicable to public companies that are not emerging growth companies. These provisions include, but are not limited to: being permitted to have only two years of audited financial statements and only two years of related selected financial data and management&#8217;s discussion and analysis of financial condition and results of operations disclosure; an exemption from compliance with the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act; not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board, or PCAOB, regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements; reduced disclosure obligations regarding executive compensation arrangements in our periodic reports, registration statements and proxy statements; and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. In addition, the JOBS Act permits emerging growth companies to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We intend to take advantage of the exemptions discussed above. As a result, the information we provide will be different than the information that is available with respect to other public companies. In this prospectus, we have not included all of the executive compensation-related information that would be required if we were not an emerging growth company. We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and the market price of our common stock may be more volatile.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will remain an emerging growth company until the earliest of (i)&#160;the end of the fiscal year following the fifth&#160;anniversary of the completion of this offering, (ii)&#160;the first fiscal year after our annual gross revenue exceeds $1.07&#160;billion, (iii)&#160;the date on which we have, during the immediately preceding three-year period, issued more than $1.00&#160;billion in non-convertible debt securities, or (iv)&#160;the end of any fiscal year in which the market value of our common stock held by non-affiliates exceeds $700&#160;million as of the end of the second quarter of that fiscal year.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">We do not anticipate paying dividends on our common stock and, accordingly, stockholders must rely on stock appreciation for any return on their investment.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have never declared or paid cash dividends on our common stock and do not expect to do so in the foreseeable future. The declaration of dividends is subject to the discretion of our board of directors and limitations under applicable law, and will depend on various factors, including our operating results, financial condition, future prospects and any other factors deemed relevant by our board of directors. You should not rely on an investment in our company if you require dividend income from your investment in our company. The success of your investment will likely depend entirely upon any future appreciation of the market price of our common stock, which is uncertain and unpredictable. There is no guarantee that our common stock will appreciate in value.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Sales of a substantial number of shares of our common stock by our existing stockholders in the public market could cause our stock price to fall.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market after the lock-up and other legal restrictions on resale discussed in this prospectus lapse, the trading price of our common stock could decline. Upon completion of this offering we will have outstanding a total of 11,331,006 shares of common stock. Of these shares, only the shares of common stock sold in this offering by us, plus any shares sold upon exercise of the underwriters&#8217; option to purchase additional shares, will be freely tradable without restriction in the public market immediately following this offering.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our directors, executive officers and the holders of a majority of our outstanding equity securities have entered into lock-up agreements pertaining to this offering that will expire 180 days from the date of this prospectus, subject to earlier release of all or a portion of the shares subject to such agreements by the representatives of the underwriters in their sole discretion. After the lock-up agreements expire, these shares of common stock will be eligible for sale in the public market, unless held by directors, executive officers and other affiliates, in which case such shares will be subject to certain limitations of Rule 144 under the Securities Act of 1933, as amended, or the Securities Act.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, shares of common stock that are either subject to outstanding options or reserved for future issuance under our existing equity compensation plans will become eligible for sale in the public market to the extent </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">40<br></div></div></div>
<!--End Page 43-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 44-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">permitted by the provisions of various vesting schedules, the lock-up agreements and Rule 144 and Rule 701 under the Securities Act. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline. Additionally, the number of shares of our common stock reserved for issuance under our 2020 Omnibus Incentive Plan will increase as determined by our compensation committee. Unless our board of directors elects not to increase the number of shares available for future grant each year, our stockholders may experience additional dilution.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">After this offering, the holders of 4,151,479 shares of our common stock will be entitled to rights with respect to the registration of their shares under the Securities Act, subject to the 180-day lock-up agreements described above. See &#8220;Description of Capital Stock&#8212;Registration Rights.&#8221; Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by affiliates, as defined in Rule 144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">The rights of the holders of our securities may be impaired by the potential issuance of preferred stock.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our articles of incorporation give our board of directors the ability to designate and issue preferred stock in one or more series. As a result, the board of directors may, without stockholder approval, issue preferred stock with voting, dividend, conversion, liquidation or other rights which could adversely affect the relative voting power and equity interest of the holders of common stock. Preferred stock, which could be issued with the right to more than one vote per share, could have the effect of discouraging, delaying or preventing a change of control of us. The possible impact on takeover attempts could adversely affect the price of our securities. Although we have no present intention to designate any series, or issue any shares, of preferred stock, other than pursuant to this offering, we may do so in the future.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: justify;">If securities or industry analysts do not publish research or reports about our business, or if they change their recommendations regarding our stock adversely, our stock price and trading volume could decline.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our business. Our research coverage by industry and financial analysts is currently limited. Even if our analyst coverage increases, if one or more of the analysts who cover us downgrade our stock, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: justify;">Anti-takeover provisions in our organizational documents and Delaware law might discourage or delay attempts to acquire us that you might consider favorable.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our amended and restated certificate of incorporation (the &#8220;Amended Charter&#8221;) and amended and restated bylaws (the &#8220;Amended Bylaws&#8221;) will contain provisions that may make the merger or acquisition of us more difficult without the approval of our board of directors. Among other things, these provisions will:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">allow us to authorize the issuance of undesignated preferred stock in connection with a stockholder rights plan or otherwise, the terms of which may be established and the shares of which may be issued without stockholder approval, and which may include super voting, special approval, dividend, or other rights or preferences superior to the rights of the holders of common stock;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">provide that our bylaws may be amended or repealed only by a majority vote of our board of directors or by the affirmative vote of the holders of at least 66 2/3% of the votes which all our stockholders would be entitled to cast in any annual election of directors; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">establish advance notice requirements for nominations for elections to our board or for proposing matters that can be acted upon by stockholders at stockholder meetings.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, as a Delaware corporation, we are also subject to provisions of Delaware law, which may impair a takeover attempt that our stockholders may find beneficial. These anti-takeover provisions and other provisions under Delaware law could discourage, delay, or prevent a transaction involving a change in control of us, including actions that our stockholders may deem advantageous, or could negatively affect the market price of our common stock. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">41<br></div></div></div>
<!--End Page 44-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 45-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_105-risk_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">elect directors of your choosing and to cause us to take other corporate actions you desire. See &#8220;Description of Capital Stock &#8211; Anti-Takeover Effects of Our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws and Certain Provisions of Delaware Law.&#8221;</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">Our Amended Charter will provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for substantially all disputes between us and our stockholders and federal district courts will be the sole and exclusive forum for Securities Act claims, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Amended Charter, which will become effective prior to the completion of this offering, will provide that, unless we consent to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for: (i)&#160;any derivative action or proceeding brought on our behalf; (ii)&#160;any action asserting a claim of breach of fiduciary duty owed by any of our directors, officers, or other employees to us or to our stockholders; (iii)&#160;any action asserting a claim arising pursuant to the Delaware General Corporation Law (the &#8220;DGCL&#8221;), the Amended Charter or the Amended Bylaws or as to which the DGCL confers exclusive jurisdiction on the Court of Chancery of the State of Delaware; or (iv)&#160;any action asserting a claim governed by the internal affairs doctrine, provided that the exclusive forum provisions will not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934, as amended, or the Exchange Act or to any claim for which the federal courts have exclusive jurisdiction. Our Amended Charter will further provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts are the sole and exclusive forum for the resolution of any complaint asserting a right under the Securities Act, subject to a final adjudication in the State of Delaware of the enforceability of such exclusive forum provision. We note that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. The choice of forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage such lawsuits against us and our directors, officers, and other employees. Alternatively, if a court were to find the choice of forum provisions contained in our Amended Charter to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations, and financial condition. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">Provisions in our organizational documents regarding exculpation and indemnification of our directors and officers may result in substantial expenditures by us and may discourage lawsuits against our directors and officers.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Amended Charter and Amended Bylaws will, to the maximum extent permissible under Delaware law, eliminate the personal liability of our directors and officers to us and our stockholders for damages for breach of fiduciary duty. These provisions may discourage us, or our stockholders through derivative litigation, from bringing a lawsuit against any of our current or former directors or officers for any breaches of their fiduciary duties, even if such legal actions, if successful, might benefit us or our stockholders. In addition, our Amended Charter and Amended Bylaws will provide that we will, to the fullest extent permitted by Delaware law, indemnify our directors and officers for costs or damages incurred by them in connection with any threatened, pending, or completed action, suit, or proceeding brought against them by reason of their positions as directors and officers. We also intend to enter into indemnification agreements with each of our directors and executive officers. See &#8220;Certain Relationships and Related Party Transactions &#8211; Agreements with Directors and Officers &#8211; Indemnification Agreements.&#8221; Although we expect to purchase directors' and officers' insurance, these indemnification obligations could result in our incurring substantial expenditures to cover the cost of settlement or damage awards against our directors or officers. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">42<br></div></div></div>
<!--End Page 45-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 46-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_106-fls_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCSR"><!--Anchor--></a>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Some of the statements made under the headings &#8220;Summary,&#8221; &#8220;Business,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this prospectus contain forward-looking statements that reflect our plans, beliefs, expectations and current views with respect to, among other things, future events and financial performance.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and are often characterized by the use of words such as &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;potential,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;goals,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;may,&#8221; &#8220;may have,&#8221; &#8220;would,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;expect&#8221; or by discussions of strategy, plans or intentions. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from historical results or any future results, performance or achievements expressed, suggested or implied by such forward-looking statements. These include, but are not limited to, statements about: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to develop, obtain regulatory approval for and commercialize our product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the timing of future IND submissions, initiation of preclinical studies and clinical trials, and timing of expected clinical results for our product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our success in early preclinical studies, which may not be indicative of results obtained in later studies or clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the outbreak of the novel strain of coronavirus disease, COVID-19, which could adversely impact our business, including our preclinical studies and any future clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the potential benefits of our product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our ability to obtain regulatory approval to commercialize our existing or any future product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our ability to identify patients with the diseases treated by our product candidates, and to enroll patients in clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the success of our efforts to expand our pipeline of product candidates and develop marketable products through the use of our SEE-Tx platform;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our expectations regarding collaborations and other agreements with third parties and their potential benefits;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to obtain, maintain and protect our intellectual property;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our reliance upon intellectual property licensed from third parties, including the license to use our SEE-Tx&#160;platform;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to identify, recruit and retain key personnel;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our expected use of net proceeds from this offering and the sufficiency of such net proceeds, together with our cash and cash equivalents, to fund our operations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our financial performance;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">developments or projections relating to our competitors or our industry; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the impact of laws and regulations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our expectations regarding the time during which we will be an emerging growth company under the JOBS&#160;Act; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">other factors and assumptions described in this prospectus under &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and &#8220;Our Business&#8221;, and elsewhere in this prospectus.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These statements are based on our historical performance and on our current plans, estimates and projections in light of information currently available to us, and therefore you should not place undue reliance on them. The inclusion of this forward-looking information should not be regarded as a representation by us, the underwriters or </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">43<br></div></div></div>
<!--End Page 46-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 47-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_106-fls_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">any other person that the future plans, estimates or expectations contemplated by us will be achieved. Forward-looking statements made in this prospectus speak only as of the date of this prospectus, and we undertake no obligation to update them in light of new information or future events, except as required by law. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You should carefully consider the above factors, as well as the factors discussed elsewhere in this prospectus, including under &#8220;Risk Factors,&#8221; before deciding to invest in our common stock. The factors identified above should not be construed as an exhaustive list of factors that could affect our future results and should be read in conjunction with the other cautionary statements that are included in this prospectus. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us. If any of these trends, risks or uncertainties actually occurs or continues, our business, revenue and financial results could be harmed, the trading prices of our securities could decline and you could lose all or part of your investment. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">44<br></div></div></div>
<!--End Page 47-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 48-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_107-use_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUOP"><!--Anchor--></a>USE OF PROCEEDS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We estimate that we will receive net proceeds of approximately $35.40&#160;million from the sale of 3,636,364 shares of common stock in this offering after deducting underwriting commissions and discounts of $2.80&#160;million and estimated offering expenses of $1.80&#160;million. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We currently intend to use the net proceeds we receive from this offering, as follows:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">approximately between $7.0&#160;million to $9.0&#160;million to fund expenses to advance the development of our GLB1 programs for our lead product candidates in ongoing preclinical studies and into Phase 1/2 clinical trials for the treatment of Morquio B and GM1 Gangliosidosis;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">approximately between $11.0&#160;million to $14.0&#160;million to fund expenses to advance the development of our GBA1 programs for our lead product candidates, in ongoing preclinical studies and into Phase 1/2 clinical trials for the treatment of neuronopathic Gaucher and GBA1 Parkinson (GBA1+PD) diseases; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">approximately between $3.0&#160;million to $5.0&#160; million to fund expenses to advance research and development activities that relate to all our other preclinical activities, including process development activities related to the advancement of our product candidates and the cost of research and development personnel; and,</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the remainder for planned general and administrative expenses, the costs of operating as a public company, working capital and general corporate purposes.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This expected use of net proceeds from this offering and our existing cash and cash equivalents represents our intentions based upon our current plans and business conditions, which could change in the future as our plans and business conditions evolve. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the progress of our development, the status of and results from clinical trials, as well as any collaborations that we may enter into with third parties for our drug candidates, and any unforeseen cash needs. As a result, our management will have broad discretion in the application of the net proceeds from this offering, and investors will be relying on the judgment of our management regarding the application of those net proceeds. The timing and amount of our actual expenditures will be based on many factors, including the focus, pace and timing of our development efforts and the existence of unforeseen opportunities or obstacles. As a result, we may find it necessary or advisable to use portions of the proceeds from this offering for other purposes. Pending these uses, we plan to invest these net proceeds in short-term, interest bearing obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the United States.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">45<br></div></div></div>
<!--End Page 48-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 49-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_107-use_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDP"><!--Anchor--></a>DIVIDEND POLICY</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have never declared or paid any cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings to fund the development and growth of our business, and therefore we do not anticipate declaring or paying any cash dividends on our common stock in the foreseeable future. Any future determination as to the declaration and payment of dividends, if any, will be at the discretion of our board of directors, subject to applicable laws, and will depend on a number of factors, including our business prospects, results of operations, financial condition, cash requirements and availability, debt repayment obligations, capital expenditure needs, contractual restrictions, covenants in the agreements governing our current and future indebtedness, industry trends, the provisions of Delaware law affecting the payment of dividends and distributions to stockholders and any other factors or considerations our board of directors may regard as relevant. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our ability to pay dividends may also be restricted by the terms of any credit agreement or any future debt or preferred equity securities agreement that we or our subsidiaries enter into. Accordingly, you may need to sell your shares of our common stock to realize a return on your investment, and you may not be able to sell your shares at or above the price you paid for them. See &#8220;Risk Factors&#8212;Risks Related to Our Securities and the Offering&#8212;We do not anticipate paying dividends on our common stock and, accordingly, stockholders must rely on stock appreciation for any return on their investment.&#8221;</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">46<br></div></div></div>
<!--End Page 49-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 50-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_107-use_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCAP"><!--Anchor--></a>CAPITALIZATION</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth our cash, cash equivalents and capitalization as of December 31, 2020:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">on an actual basis; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">on a pro forma basis to give effect to the following events, as if each event had occurred on December 31, 2020: (i)&#160;the Preferred Conversion; (ii)&#160;the 0.88-for-1 reverse stock split and the filing and effectiveness of our Amended Charter and the adoption of our Amended Bylaws; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">on a pro forma as adjusted basis giving further effect to the issuance and sale of 3,636,364 shares of common stock in this offering and the application of the proceeds from this offering as described in &#8220;Use of Proceeds,&#8221; and after deducting estimated underwriting discounts and commissions and estimated offering expenses.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You should read this table, together with the information contained in this prospectus, including &#8220;Use of Proceeds,&#8221; &#8220;Unaudited Pro Forma Consolidated Financial Information,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and the historical financial statements and related notes included elsewhere in this prospectus.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 469pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 63.97%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 34.75%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December 31, 2020</div></td></tr><tr class="header"><td style="width: 63.97%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Actual</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro Forma</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.87%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro Forma<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">as adjusted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td></tr><tr class="header"><td style="width: 63.97%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td colspan="7" style="width: 34.75%; text-align: center; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(unaudited)</div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 4.77pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 50pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 50pt;">&#8203;</font><font style="border-bottom: 3pt double #000000; min-width: 50pt;">7,492,910</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 50pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 50pt;">&#8203;</font><font style="border-bottom: 3pt double #000000; min-width: 50pt;">7,492,910</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 50pt;">&#8203;</font><font style="border-bottom: 3pt double #000000; min-width: 50pt;">$42,892,914</font></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; padding-top: 6.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Debt:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">&#8203;Loans<font style="padding-left: 3.06pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;<font style="padding-left: 17.5pt;">738,282</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">738,282</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 17.5pt;">738,282</font></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total debt<font style="padding-left: 1.54pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 50pt;">738,282</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 50pt;">738,282</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 50pt;">738,282</font></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Equity:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Series&#160;A Preferred Stock, $0.0001 par value per share; 1,346,390&#160;issued and outstanding as of December 31, 2020 and no shares issued and outstanding on a pro forma basis or pro forma as adjusted basis<font style="padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 35pt;">135</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">&#8203;Series&#160;B Preferred Stock, $0.0001 par value per share: 3,366,999&#160;shares issued and outstanding as of December 31, 2020 and no shares issued and outstanding on a pro forma basis or pro forma as adjusted basis<font style="padding-left: 1.99pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 35pt;">337</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Common stock, $0.0001 par value per share: 50,000,000&#160;shares authorized, 4,022,736, 7,694,642, 11,331,006 shares issued and outstanding as of December 31, 2020, on a pro forma basis, and on a pro forma as adjusted basis, respectively<font style="padding-left: 3.42pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 35pt;">402</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 35pt;">769</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 27.5pt;">1,133</font></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Additional paid-in capital<font style="padding-left: 3.09pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">13,</font>388,666</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">13,388,770</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">48,788,410</font></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other comprehensive loss<font style="padding-left: 1.99pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.17pt;">(</font>152,698)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.17pt;">(152,698)</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 14.17pt;">(152</font>,698)</div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Retained earnings<font style="padding-left: 4.75pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt;">(</font>7,034,853)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt;">(7,034,853)</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 6.67pt;">(7,034,853)</font></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total stockholders&#8217; equity<font style="padding-left: 2.3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 50pt;">6,201,989</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 50pt;">6,201,989</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 50pt;">41,601,992</font></div></td></tr><tr><td style="width: 63.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total capitalization<font style="padding-left: 4.89pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 50pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 50pt;">&#8203;</font><font style="border-bottom: 3pt double #000000; min-width: 50pt;">6,940,271</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 50pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 50pt;">&#8203;</font><font style="border-bottom: 3pt double #000000; min-width: 50pt;">6,940,271</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.87%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 50pt;">$</font><font style="border-bottom: 3pt double #000000; min-width: 50pt;">42,340,274</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.5pt; margin-left: 0pt; text-align: justify;"> </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">47<br></div></div></div>
<!--End Page 50-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 51-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_107-use_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDIL"><!--Anchor--></a>DILUTION</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Investors purchasing our common stock in this offering will experience immediate and substantial dilution in the pro forma net tangible book value of their shares of common stock. Dilution in pro forma net tangible book value represents the difference between the public offering price per share of our common stock and the pro forma as adjusted net tangible book value per share of our common stock after giving effect to this offering.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pro forma net tangible book value represents our total tangible assets less total liabilities, divided by the pro forma number of outstanding shares of common stock after a reverse stock split of 0.88-for-1 and giving effect to the Preferred Conversion. As of December 31, 2020, our pro forma net tangible book value was $6.20&#160;million, or $0.81 per share. After the sale and issuance of 3,636,364 shares of our common stock in this offering, after deducting the underwriting discount and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of December 31, 2020 would have been approximately $41.60&#160;million, or $3.67 per share. This represents an immediate increase in pro forma as adjusted net tangible book value of $2.86 per share to our existing stockholders and an immediate dilution of $7.33 per share to new investors participating in this offering. Dilution per share to new investors is determined by subtracting pro forma as adjusted net tangible book value per share after this offering from the initial public offering price per share paid by new investors. The following table illustrates this dilution on a per share basis. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table illustrates this dilution on a per share basis to new investors:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Initial public offering price per share of common stock<font style="padding-left: 2.67pt;"></font></div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.29%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">&#8195;&#8195;&#8195;&#8195;</font></div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$11.00</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma net tangible book value per share of common stock as of December 31, 2020<font style="padding-left: 3.25pt;"></font></div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 35pt;">0.81</font></div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.8%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Increase per share of common stock attributable to this offering<font style="padding-left: 2.14pt;"></font></div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 12.29%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 57.5pt;">$</font><font style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 57.5pt;">&#8203;</font><font style="border-bottom: 1pt solid #000000; min-width: 57.5pt;">2.86</font></div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma net tangible book value per share of common stock, as adjusted to give effect to this offering<font style="padding-left: 1.13pt;"></font></div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 12.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.8%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; min-width: 27.13pt;">3.67</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Dilution in pro forma net tangible book value per share of common stock to new investors<font style="padding-left: 2.4pt;"></font></div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 12.29%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.53%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 5.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 27.13pt;">$</font><font style="padding-left: 4.63pt; border-bottom: 3pt double #000000; min-width: 27.13pt;">&#8203;</font><font style="border-bottom: 3pt double #000000; min-width: 27.13pt;">7.33</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the underwriters exercise their option to purchase additional shares of our common stock in full, the pro forma as adjusted net tangible book value after this offering would be $3.97 per share, the increase in pro forma net tangible book value per share would be $0.49 per share and the dilution per share to new investors would be $1.04 per share. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table summarizes, on the pro forma as adjusted basis described above as of December 31, 2020, the differences between the number of shares of common stock purchased from us, the total consideration and the price per share paid by our existing stockholders and by investors participating in this offering.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 41.02%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 19.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares Purchased</div></td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total Consideration</div></td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 2.07%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price Per<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Share</div></td></tr><tr class="header"><td style="width: 41.02%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Percent</div></td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Percent</div></td><td class="gutter" style="width: 2.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td></tr><tr><td style="width: 41.02%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Existing stockholder<font style="padding-left: 1.18pt;"></font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 4.63pt;">7,694,642</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.57%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;"><font style="padding-left: 5pt;">68</font>%</div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 0.37pt;">14,211,250</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.57%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 5pt;">26</font>%</div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.93%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.65pt; text-align: left;">$<font style="padding-left: 4.63pt;">1.85</font></div></td></tr><tr><td style="width: 41.02%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">New investors<font style="padding-left: 1.19pt;"></font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 9.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 4.63pt; border-bottom: 1pt solid #000000; min-width: 44.63pt;">3,636,364</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">32</font><font style="min-width: 15pt;">%</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 50pt;">$40,000,004</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">74</font><font style="min-width: 15pt;">%</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.65pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 27.13pt;">$</font><font style="border-bottom: 1pt solid #000000; min-width: 27.13pt;">11.00</font></div></td></tr><tr><td style="width: 41.02%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="padding-left: 4.09pt;"></font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 9.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 44.63pt;">&#8203;</font><font style="border-bottom: 3pt double #000000; min-width: 44.63pt;">11,331,006</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 5.57%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 15pt;">100</font><font style="min-width: 15pt;">%</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 50pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; min-width: 50pt;">&#8203;</font><font style="border-bottom: 3pt double #000000; min-width: 50pt;">54,211,154</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 5.57%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 15pt;">100</font><font style="min-width: 15pt;">%</font></div></td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 6.93%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.65pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 27.13pt;">&#8203;</font><font style="padding-left: 17.13pt; border-bottom: 3pt double #000000; min-width: 27.13pt;">&#8195;</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.5pt; margin-left: 0pt; text-align: left;"> </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">48<br></div></div></div>
<!--End Page 51-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 52-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_108-selected_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSCH"><!--Anchor--></a>SELECTED HISTORICAL FINANCIAL DATA</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following tables summarize our selected financial and other data. The summary consolidated statements of operations data presented below for the years ended December&#160;31, 2020, 2019, 2018 and the balance sheet data as of December&#160;31, 2020 and 2019 are derived from our audited consolidated financial statements included elsewhere in this prospectus. For periods and at dates prior to the Corporate Reorganization, our financial statements were prepared based on the historical financial statements of GT Gain Therapeutics SA. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our historical results are not necessarily indicative of the results that may be expected in any future period. You should read the following summary consolidated financial data together with the information in the sections titled &#8220;Use of Proceeds,&#8221; &#8220;Selected Historical Financial Data,&#8221; &#8220;Capitalization,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our audited consolidated financial statements and related notes included elsewhere in this prospectus. </div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 39.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.1%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.1%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 2.1%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.1%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenues:<br></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other income<font style="padding-left: 0.97pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">28,881</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">41,301</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">20,609</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total revenues<font style="padding-left: 2.22pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.82pt;">28,881</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 20.83pt;">41,301</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.82pt;">20,609</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Research and development<font style="padding-left: 2.1pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt;">2,259,204</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt;">1,586,245</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.82pt;">826,880</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 1.55pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">1,249,126</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">555,165</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">222,047</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 0.57pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">3,508,330</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">2,141,410</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">1,048,927</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss from operations<font style="padding-left: 4.87pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(3,479,449)</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(</font>2,100,109)</div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(</font>1,028,318)</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest (income)/expense, net<font style="padding-left: 4.06pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(3,637)</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.82pt;">20,540</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.82pt;">52,477</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Foreign exchange (gain)/loss, net<font style="padding-left: 0.72pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">96,484</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">65,682</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">14,964</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before income tax provision<font style="padding-left: 4.33pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(3,572,296)</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">(</font>2,186,331)</div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">(</font>1,095,759)</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Income tax provision<font style="padding-left: 4.86pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">5,386</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 26.2pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">7,114</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">9,781</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 3.18pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">(3,577,682</font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">(</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">2,193,445</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">(</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">1,105,540</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss per ordinary share:<br></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Basic and diluted loss per share<font style="padding-left: 1.01pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 27.5pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">(1.17</font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">(</font><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;">0.97</font><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 27.5pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">(</font><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;">0.49</font><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 5.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted-average ordinary shares used in per share calculations &#8211; basic and diluted<font style="padding-left: 2.66pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">3,046,355</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">2,250,000</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">2,250,000</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 5.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma net loss per share attributable to common stockholders &#8211; basic and diluted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.14pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 27.5pt;">(0.69)</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 27.87pt;">(1.11)</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 27.5pt;">(0.56)</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma weighted-average common shares outstanding &#8211; basic and diluted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.34pt;"></font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">5,161,660</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1,981,764</font></div></td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1,981,764</font></div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.78%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 38.02%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.78%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.78%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.78%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 2.78%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.78%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents:<font style="padding-left: 0.99pt;"></font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;7,492,910</div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">303,320</font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 7.5pt;">400,694</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total current assets<font style="padding-left: 2.8pt;"></font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">8,987,828</div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">429,525</font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">494,638</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total non-current assets<font style="padding-left: 4.47pt;"></font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">616,530</font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 8.33pt;">230,761</font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;<font style="padding-left: 12.5pt;">316,996</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total current liabilities<font style="padding-left: 3.9pt;"></font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 0.37pt;">2,114,831</font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">879,052</font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">530,786</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total non-current liabilities<font style="padding-left: 0.57pt;"></font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,287,538</div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">231,090</font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">1,231,756</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total stockholders&#8217; equity (deficit)<font style="padding-left: 0.77pt;"></font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">6,201,989</div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(449,856)</font></div></td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 9.17pt;">(950,908)</font></div></td></tr></table></div><div class="block-footnote" style="width: 468pt; margin-left: 0pt;"><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-top: 3pt; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt;"> </div></div></div><div class="block-footnote" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">1<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The unaudited pro-forma basic and diluted net loss per share attributable to common stockholders, for the year ended December 31, 2020, has been computed using the weighted-average number of common shares outstanding after giving pro-forma effect to (i) the conversion of all outstanding shares of convertible preferred stock into shares of common stock, and (ii) a 0.88-for-1 stock split which will occur prior to the closing of this offering, as if such conversion and stock split had occurred at the beginning of the period presented or the date of original issuance, whichever is later. As of December&#160;31, 2020, there were 1,346,390 shares of Series A Preferred Stock and 3,366,999 shares of Series B Preferred Stock issued and outstanding. For the year ended December 31, 2020, see Note&#160;17 to our audited consolidated financial statements appearing elsewhere in this prospectus for further details on the calculation of pro forma basic and diluted net loss per share attributable to common stockholders. The unaudited pro-forma basic and diluted net loss per share attributable to common stockholders, for the years ended December 31, 2019 and 2018, has been computed using the weighted-average number of common shares outstanding after giving pro-forma effect to the 0.88-for-1 stock split which will occur prior to the closing of this offering, as if such stock split had occurred at the beginning of the period presented or the date of original issuance, whichever is later.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">49<br></div></div></div>
<!--End Page 52-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 53-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tMDA"><!--Anchor--></a>MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION <br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">AND RESULTS OF OPERATIONS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You should read the following discussion and analysis of our financial condition and operating results together with the section captioned &#8220;Selected Financial Data&#8221; and our financial statements and the related notes appearing at the end of this prospectus. This discussion contains forward-looking statements that involve risks and uncertainties. As a result of many factors, such as those set forth in the section of the prospectus captioned &#8220;Risk Factors&#8221; and elsewhere in this prospectus, our actual results may differ materially from those anticipated in these forward-looking statements.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Overview </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are a development stage biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on LSDs, including rare genetic diseases and neurological disorders. We use our exclusively in-licensed platform, SEE-Tx, to discover novel allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites and restore protein folding, potentially treating the underlying disease. These small molecule binding sites, away from the protein&#8217;s active areas, are called allosteric sites. We believe targeting the allosteric binding site instead of the active binding site can provide a number of advantages: superior regulation of misfolded proteins implicated in disease, enhanced specificity by being non-competitive with the natural substrate and the potential for molecules with favorable drug-like properties. While the SEE-Tx platform is novel and has not been used to develop approved drugs yet, these advantages have the potential to ultimately enhance both tolerability and response.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have already identified and filed three patent applications and one provisional patent application (such applications do not cover the Unites States) for our novel STARs, which are small molecules with the potential to treat diseases with high unmet medical need for which there are currently few or no available therapies. These diseases include Morquio B, GM1 Gangliosidosis (GM1), neuronopathic Gaucher disease, <font style="font-style: italic;">GBA1</font> Parkinson&#8217;s disease, Krabbe disease and Mucopolysaccharidosis type 1.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are currently advancing the development of our STAR candidates through preclinical studies where we will continue to identify optimal lead compounds for each indication that we will advance into clinical trials. Through academic partnerships, co-development and licensing arrangements, we intend to develop a broad pipeline of therapeutics to catalyze a new approach to the treatment of diseases caused by misfolded enzymes. We expect to obtain additional preclinical data and commence IND-enabling studies for lead compound candidates beginning in 2021, at which point we will begin the process to prepare and submit investigational new drug, or IND, submissions to the FDA seeking clearance to commence clinical research..</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Since our inception in 2017, we have devoted substantially all of our resources to identify and develop next-generation brain-penetrant allosteric small molecules for the treatment of devastating LSDs and CNS indications using our in-licensed proprietary SEE-Tx technology. To date, we do not have any product candidate approved for sale and have not generated any revenue from product sales. We have primarily financed our operations through a combination of sales of our securities and research grants. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have incurred recurring losses and negative cash flows from operations since inception and as of December&#160;31, 2019 and 2020, had an accumulated deficit of $3,457,171 and $7,034,853, respectively. We anticipate incurring additional losses until such time, if ever, that we can generate significant sales of our product candidates currently in development. We will need substantial additional capital to fund our operations and to develop our product candidates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our operations have consisted primarily of organizing the company, securing financing, developing licensed technology, performing research and conducting preclinical studies. We face risks associated with early-stage biotechnology companies whose product candidates are in development. Product candidates currently under development will require significant additional research and development efforts, including extensive preclinical and clinical testing and regulatory approval prior to commercialization. These efforts require significant amounts of additional capital for us to complete our research and development, achieve our research and development objectives, defend our intellectual property rights, and recruit and retain skilled personnel, and key members of management. Even if our product development efforts are successful, it is uncertain when, if ever, we will realize significant revenue from product sales. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">50<br></div></div></div>
<!--End Page 53-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 54-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We plan to seek additional funding through public or private equity offerings, debt financings, other collaborations, strategic alliances and licensing arrangements. We may not be able to obtain financing on acceptable terms, or at all, and we may not be able to enter into strategic alliances or other arrangements on favorable terms, or at all. The terms of any financing may adversely affect our holdings or the rights of our stockholders. If we are unable to obtain funding, we could be required to delay, reduce or eliminate research and development programs, product portfolio expansion or future commercialization efforts, which could adversely affect our business prospects. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Components of Results of Operations</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Revenue</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have not generated any revenue from product sales and do not expect to generate any revenue from the sale of products in the foreseeable future. If we fail to complete the development of our product candidates in a timely manner or fail to obtain their regulatory approval, we will not generate revenue in the future. Our current revenues are not related to our core business, but rather are residual and primarily consist of income from subleases of our office space. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Operating Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our expenses since inception have consisted solely of research and development costs and general and administrative costs.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Research and Development Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Research and development expenses consist primarily of costs incurred for our research activities, including our discovery efforts, and the development of our product candidates, which include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">expenses incurred under collaborations with third parties, including contract research organizations, or CROs, and Universities, that conduct research and preclinical studies, such as in-vitro and in-vivo absorption, distribution, metabolism and excretion (&#8220;ADME&#8221;), cell model studies, in-vivo pharmacology and pharmacokinetic studies, toxicology studies and chemical synthesis, on our behalf;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">employee salaries, benefits and other related costs, including share-based compensation expenses, for employees engaged in research and development functions and overhead allocations consisting of various support and facilities-related expenses, which include rent, utilities and maintenance of our Barcelona labs and Lugano office, depreciation, travel and congress expenses;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">fees paid to consultants who assist with research and development activities and related travel expenses; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the cost of sponsored research, which includes laboratory materials and supplies, manufacturing scale-up expenses and the cost of acquiring and manufacturing preclinical studies.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table provides a breakout of our research and development expenses by major categories of expense (in thousands):</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.4%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 33.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.4%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.4%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.4%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 2.4%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.4%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pre-clinical activities and outside services<font style="padding-left: 4.47pt;"></font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,297,694</div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;<font style="padding-left: 7.5pt;">599,125</font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">329,853</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Personnel expenses<font style="padding-left: 1.64pt;"></font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,100,722</div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">906,142</font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">390,824</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other<font style="padding-left: 2.73pt;"></font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.87pt;">176,611</font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">187,401</font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">106,203</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research grants<font style="padding-left: 1.09pt;"></font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 4.17pt;">(315,823)</font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 4.17pt;">(106,423)</font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total research and development expenses<font style="padding-left: 1.28pt;"></font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 40pt;">2,259,204</font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 40pt;">1,586,245</font></div></td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">826,880</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We recognize research and development costs as incurred and these costs are reflected in our financial statements as prepaid or accrued research and development expenses. We recognize external development costs based on an evaluation of the progress to completion of specific tasks using information provided to us by our vendors. Payments for these activities are based on the terms of the individual agreements, which may differ from the pattern of costs incurred, and are reflected in our financial statements as prepaid or accrued research and development </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">51<br></div></div></div>
<!--End Page 54-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 55-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">expenses. We anticipate that our research and development expenses will increase substantially in future periods to support progress in our research and development activities, including the commencement of the clinical trials for product candidates we are developing. These increases will likely also result from increased headcount, expanded infrastructure and increased insurance costs. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our primary research and development focus since inception has been the development of our in-licensed and proprietary SEE-Tx platform. We are using our platform to design and develop a broad pipeline of STARs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Research and development activities are central to our business model. Product candidates in later stages of clinical development generally incur higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. As a result, we expect that our research and development expenses will continue to increase in the foreseeable future as we (i)&#160;increase personnel costs, including stock-based compensation, (ii)&#160;continue preclinical development of our lead compounds, (iii)&#160;initiate clinical trials for certain product candidates, (iv)&#160;continue to discover and develop additional product candidates, and (v)&#160;pursue later stages of clinical development of product candidates.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">General and Administrative Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expenses consist primarily of salaries, bonus and other related costs, including share-based compensation, for personnel in our executive, finance, corporate and business development and administrative functions. General and administrative expenses also include legal fees relating to patent and corporate matters; professional fees for accounting, auditing, tax and consulting services, insurance costs, travel expenses, and facility-related expenses, and other operating costs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We anticipate that our general and administrative expenses will increase in the future, in the form of additional compensation, including salaries, benefits, incentive arrangements and share-based compensation awards, as we increase our headcount to support the expected growth and the potential commercialization of our product candidates. We also expect to incur increased expenses associated with being a public company, including increased costs of accounting, audit, legal, regulatory and tax-related services associated with maintaining compliance with exchange listing and SEC requirements, director and officer insurance costs and investor and public relations costs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect our general and administrative costs to increase as we attract and retain additional personnel.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Other Income (Expense)</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Other income (expense) consists of interest expense on convertible debts and foreign exchange gain or loss. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Income Taxes</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company is subject to taxation in the United States, Spain and Switzerland. Taxes are recorded on an accrual basis and represent the allowances for taxes paid or to be paid for the year, calculated according to the current enacted rates and applicable laws. The Company was incorporated on June&#160;26, 2020 and has not recorded an income tax provision or benefit for the United States (U.S.) federal and state incomes taxes during the year ended December 31, 2020. GT Gain Therapeutics SA, our wholly-owned subsidiary located in Lugano (Switzerland), has accumulated net operating losses since inception and has not recorded an income tax provision or benefit for the federal and cantonal Swiss taxes for the years ended 2020, 2019 and 2018. Gain Therapeutics Sucursal de Espana, our wholly-owned branch located in Barcelona (Spain), has recorded an income tax provision on an effective tax rate of 25%, which represents the statutory tax rate, as no discrete items were noted in the computation of incomes taxes, for taxes amounting to $5,386, $7,114 and $9,781, respectively for the years ended 2020, 2019 and 2018. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2020, the domestic NOLs carried forward amounted approximately to USD 532&#160;thousand. Due to the uncertainty regarding the realization of the related deferred tax assets, full valuation allowance has been posted as of December 31, 2020. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Foreign NOLs carried forward refer to our wholly-owned subsidiary GT Gain Therapeutics SA. This entity generated losses since its inception and for the year ended December 31, 2020, 2019 and 2018 NOL carried forward amount to USD 6,076 thousand, USD 3,660 thousand and USD 1,370 thousand, respectively. Due to the uncertainty regarding the realization of the related deferred tax assets, full valuation allowance has been posted as of December 31, 2020, 2019 and 2018. According to Swiss tax law, these NOLs can be carried forward for seven years and will begin to expire commencing from 2025 for the NOLs generated in 2017.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">52<br></div></div></div>
<!--End Page 55-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 56-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of each reporting date, we consider existing evidence, both positive and negative, that could impact our view with regard to future realization of deferred tax assets. We believe that it is more likely than not that the benefit for deferred tax assets will not be realized. In recognition of this uncertainty, a full valuation allowance was applied to the deferred tax assets. Future realization depends on our future earnings, if any, the timing and amount of which are uncertain as of December 31, 2020. In the future, should management conclude that it is more likely than not that the deferred tax assets are partially or fully realizable, the valuation allowance would be reduced to the extent of such expected realization and the amount would be recognized as a deferred income tax benefit in our consolidated statements of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There are open statutes of limitations for taxing authorities in federal and state jurisdictions to audit our tax returns from inception of the company. There have been no material income tax-related interests or penalties assessed or recorded. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">No liability related to uncertain tax positions is reported in our consolidated financial statements. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Results of Operations</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table summarizes our historical results of operations. The period-over-period comparison of results of operations is not necessarily indicative of results for future periods. You should read this discussion of our results of operations in conjunction with our consolidated financial statements and related notes thereto included elsewhere in this prospectus.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 42.8%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.96%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.96%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.96%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 2.96%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.96%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenues:<br></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other income<font style="padding-left: 1.97pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">28,881</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">41,301</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">20,609</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total revenues<font style="padding-left: 3.22pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.82pt;">28,881</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 20.83pt;">41,301</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 20.83pt;">20,609</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Research and development<font style="padding-left: 3.1pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt;">2,259,204</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt;">1,586,245</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.82pt;">826,880</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 2.55pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">1,249,126</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">555,165</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">222,047</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 1.57pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">3,508,330</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">2,141,410</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">1,048,927</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss from operations<font style="padding-left: 0.87pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(3,479,449)</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(</font>2,100,109)</div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(</font>1,028,318)</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest (income) expense, net<font style="padding-left: 4.51pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(3,637)</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.82pt;">20,540</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.82pt;">52,477</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Foreign exchange (gain)/loss, net<font style="padding-left: 1.72pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">96,484</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">65,682</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">14,964</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before income tax provision<font style="padding-left: 0.33pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">(3,572,296</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">(2,186,331</font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">(</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">1,095,759</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Income tax provision<font style="padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">5,386</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 26.2pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">7,114</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">9,781</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 4.18pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">(3,57</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">7</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">,</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">682</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">(</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">2,193,445</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">(</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;">1,105,540</font><font style="border-bottom: 1pt solid #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss per ordinary share:<br></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Basic and diluted loss per share<font style="padding-left: 2.01pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 27.5pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">(1.17</font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">(</font><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;">0.97</font><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;">&#8203;</font><font style="padding-left: 27.5pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">(</font><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;">0.49</font><font style="border-bottom: 3pt double #000000; min-width: 48.33pt;"></font><font style="min-width: 48.33pt;">)</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 5.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted-average ordinary shares used in per share calculations &#8211; basic and diluted<font style="padding-left: 3.66pt;"></font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">3,046,355</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">2,250,000</font></div></td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.96%; border-bottom: none; font-size: 2pt; padding-top: 5.5pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.5pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 48.33pt;">2,250,000</font></div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Comparison of the Years Ended December 31, 2020 and 2019</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 20pt; text-align: left;">Revenues</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the years ended December 31, 2020 and 2019 total revenues were $28,881 and $41,301 respectively and consist mainly of income from the sublease of the Lugano office space. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15pt; margin-left: 20pt; text-align: left;">Research and Development Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Research and development expenses increased by $672,959 to $2,259,204 for the year ended December 31, 2020 from $1,586,245 for the year ended December 31, 2019. The increase in research and development expenses was primarily attributable to increases in personnel-related costs as a result of hiring additional personnel for research and development, and increases in outside services as we continue to expand our research and development activities, including external collaborations chemical synthesis, toxicology studies, <font style="font-style: italic;">in vitro</font> ADME and model studies, and <font style="font-style: italic;">in </font><font style="font-style: italic;">vivo</font>. pharmacology and pharmacokinetic studies. As of December 31, 2020, and 2019, research and development expense are net of research grant of $315,823 and $106,423 respectively.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">53<br></div></div></div>
<!--End Page 56-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 57-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">General and Administrative Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expenses increased by $693,961 to $1,249,126 for the year ended December 31, 2020 from $555,165 for the year ended December 31, 2019. The increase in general and administrative expenses was primarily attributable to increases in personnel-related costs as a result of the hiring of our Chief Executive Officer, Eric Richman, in July 2020 and our Chief Financial Officer, Sal Calabrese, increase in expenses for legal fees relating to patent and corporate matters, professional fees for accounting, professional services and investor relations as we continue to expand our business and build management infrastructure.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Comparison of the Years Ended December&#160;31, 2019 and 2018</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 20pt; text-align: left;">Revenues</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the years ended December&#160;31, 2019 and 2018, total revenues were $41,301 and $20,609 respectively and refers mainly to income from sublease of Lugano office space. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Research and Development Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Research and development expenses increased by $759,365 to $1,586,245 for the year ended December&#160;31, 2019 from $826,880 for the year ended December&#160;31, 2018. The increase in research and development expenses was primarily attributable to increases in salaries and wages, travel and congress expenses and outside services as we continue to expand our research and development activities, including external collaborations, chemical synthesis, toxicology studies, <font style="font-style: italic;">in vitro</font> ADME and model studies, and <font style="font-style: italic;">in vivo</font> pharmacology and pharmacokinetic studies. As of December&#160;31, 2019 and 2018, research and development expense is net of research grants of $106,423 and nil, respectively.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">General and Administrative Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expenses increased by $333,118 to $555,165 for the year ended December&#160;31, 2019 from $222,047 for the year ended December&#160;31, 2018. The increase in general and administrative expenses was primarily attributable to increases in expenses for legal fees relating to patent and corporate matters, professional fees for accounting, auditing, tax and professional services as we continue to expand our business and build management infrastructure for our business.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Liquidity and Capital Resources</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Since our inception, we have not generated any revenue from product sales or otherwise and have incurred significant operating losses and negative cash flows from our operations. We have not yet commercialized any products or technologies, and we do not expect to generate revenue from sales of any products in the near term, if at all. We have funded our operations to date primarily through a combination of sales of our securities and research grants. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February 2019, our wholly-owned subsidiary, GT Gain Therapeutics SA, concluded a capital raise of CHF&#160;1,782,500 or USD 1,772,089 through the issuance of 58,119 shares of Series A Preferred Stock and incurred issuance costs of CHF 20,731 or USD 20,610. Concurrent with the capital raise, GT Gain Therapeutics SA issued 41,225 shares of Series A Preferred Stock in connection with the conversion of two outstanding convertible loan agreements. For additional information regarding this capital raise and notes conversion see &#8220;Certain Relationships and Related Party Transactions&#8212;February 2019 Capital Raise&#8221; and &#8220;Certain Relationships and Related Party Transactions&#8212;Convertible Notes and Exercise.&#8221; </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February 2020, our wholly-owned subsidiary, GT Gain Therapeutics SA, concluded a capital raise of CHF&#160;1,082,500 or USD 1,101,898 through the issuance of 35,295 shares of Series A Preferred Stock and incurred issuance costs of CHF 10,368 or USD 10,553. For additional information regarding this capital raise and notes conversion see &#8220;Certain Relationships and Related Party Transactions&#8212;February 2020 Capital Raise.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March 2020, our wholly-owned subsidiary, GT Gain Therapeutics SA obtained a CHF 14,600 or USD&#160;16,517 five-year loan. The loan has zero interest and it is due at maturity on March&#160;31, 2025. The loan is guaranteed through a joint and several sureties by the Swiss Confederation and Ticino Canton. The loan is part of the infrastructure put in place by the Federal Council and Swiss Parliament to assist companies in Switzerland in view of the economic consequences of the coronavirus.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">54<br></div></div></div>
<!--End Page 57-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 58-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July 2020, Gain Therapeutics Inc. completed a private placement of 3,366,999 shares of Series B Preferred Stock at a purchase price per share of $2.97. Gross proceeds from the offering were $10 million. The private placement offering cost amounted to $878,286. In connection with the private placement, we issued warrants to designees of the placement agent to purchase an aggregate of 269,360 shares of our common stock at an exercise price of $4.46 per share. The warrants provide for a cashless exercise right and are exercisable for a period of five years from July&#160;20, 2020. For additional information regarding this capital raise, see &#8220;Certain Relationships and Related Party Transactions&#8212;Series B Private Placement.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July 2020, GT Gain Therapeutics SA shareholders exchanged their shares in GT Gain Therapeutics SA for shares of Gain Therapeutics, Inc., which resulted in Gain Therapeutics Inc. issuing an aggregate of 2,250,000&#160;shares of our common stock and 1,346,390&#160;shares of our Series A Preferred Stock, reflecting a 10:1 stock split. The amounts of common stock and Series&#160;A Preferred Stock disclosed above have been retrospectively adjusted to reflect the share split as described in &#8220;Certain Relationships and Related Party Transactions&#8212;Series&#160;B Private Placement.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In August 2020, our wholly-owned subsidiary, GT Gain Therapeutics SA obtained a CHF 638,000 or USD&#160;699,139 nine-year&#160;loan. The loan has zero interest. The loan is due in quarterly installment of CHF 20,000 commencing on December&#160;31, 2021 and ending on September&#160;30, 2029. The loan is part of the infrastructure put in place by the Federal Council and Swiss Parliament to assist companies in Switzerland in view of the economic consequences of the coronavirus.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Cash Flows</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table provides information regarding our cash flows for the periods presented:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.16%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 42.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, </div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.16%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 3.16%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.16%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 3.16%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.16%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(audited)</div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 8.73%; text-align: center; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash used in operating activities<font style="padding-left: 3.68pt;"></font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;$<font style="padding-left: 1.67pt;">(3,240,237)</font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(1,868,509)</div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.73%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(774,514)</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash used in investing activities<font style="padding-left: 4.78pt;"></font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 19.17pt;">(20,826)</font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(13,723)</font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15pt;">(7,987)</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash provided by financing activities<font style="padding-left: 4.23pt;"></font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 50pt;">10,486,961</font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 48.33pt;">1,751,479</font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 8.73%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">983,778</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net change in cash and cash equivalents<font style="padding-left: 1.47pt;"></font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">7,190,581</font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(97,189)</font></div></td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.16%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">237,884</font></div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Net Cash Used in Operating Activities</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the years ended December 31, 2020 and 2019, net cash used in operating activities was $3,240,237 and $1,868,509, respectively, resulting from our net loss of $3,577,682 and $2,193,445, respectively and changes in operating assets and liabilities. The increase in cash used in operating activities resulted primarily from funding our operations related to the development of our product candidates and business expansion. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the years ended December&#160;31, 2019 and 2018, net cash used in operating activities was $1,868,509 and $774,514, respectively, resulting from our net loss of $2,193,445 and $1,105,540, respectively and changes in operating assets and liabilities. The increase in cash used in operating activities resulted primarily from funding our operation related to the development of our product candidates and business expansion.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Net Cash Used in Investing Activities</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the years ended December 31, 2020 and 2019, net cash used in investment activities was $20,826 and $13,723, respectively, primarily due to purchases of computers and office equipment.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the years ended December&#160;31, 2019 and 2018, net cash used in investment activities was $13,723 and $7,987, respectively, primarily due to purchases of computers and leasehold improvements.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Net Cash Provided by Financing Activities</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the year ended December 31, 2020 net cash provided by financing activities net of issuance cost was $10,486,961 primarily due to proceeds from (i)&#160;the issuance of Series A Preferred Stock in GT Gain Therapeutics SA for $1,091,345, (ii)&#160;the issuance of Series B Preferred Stock in the company pursuant to a private placement memorandum, for net proceeds of $9,127,902, (iii)&#160;access to long-term loans in the amount of $738,282, and (iv) payment of offering costs totaling $470,745. During the year ended December 31, 2019, net cash provided by financing activities was $1,751,479 primarily due to proceeds from the issuance of Series A Preferred Stock in GT Gain Therapeutics SA, net of issuance costs. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">55<br></div></div></div>
<!--End Page 58-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 59-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the years ended December&#160;31, 2019 and 2018, net cash provided by financing activities was $1,751,479 and $983,778, respectively, primarily from the issuance of Series A Preferred Stock in our wholly-owned subsidiary, GT Gain Therapeutics SA, net of issuance costs and from convertible notes.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Funding Requirements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our primary use of cash is to fund operating expenses, most significantly research and development expenditures. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable, accrued expenses and prepaid expenses. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Because of the numerous risks and uncertainties associated with research, development and commercialization of pharmaceutical products, we are unable to estimate the exact amount of our operating capital requirements. Our future funding requirements will depend on many factors, including, but not limited to: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the scope, timing, progress and results of discovery, preclinical development, laboratory testing and clinical trials for our product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the extent to which we enter into collaborations or other arrangements with additional third parties in order to further develop our product candidates; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the costs and fees associated with the discovery, acquisition or in-license of additional product candidates or technologies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to establish additional collaborations on favorable terms, if at all; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs required to scale up our clinical, regulatory and manufacturing capabilities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the costs of manufacturing our product candidates for clinical trials and in preparation for marketing approval and commercialization; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the costs of future commercialization activities, if any, including establishing sales, marketing, manufacturing and distribution capabilities, for any of our product candidates for which we receive marketing approval; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">revenue, if any, received from commercial sales of our product candidates, should any of our product candidates receive marketing approval. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will need additional funds to meet operational needs and capital requirements for clinical trials, other research and development expenditures, and business development activities. Because of the numerous risks and uncertainties associated with the development of our product candidates, we are unable to estimate the amounts of increased capital outlays and operating expenditures associated with our current and anticipated clinical trials. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe that the anticipated net proceeds from this offering, together with our cash on hand, cash equivalents and short-term investments, will enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or drug candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts, or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">56<br></div></div></div>
<!--End Page 59-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 60-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Contractual Obligations and Commitments</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table summarizes our contractual obligations converted to USD based on the exchange rate as of December 31, 2020 and the effects that such obligations are expected to have on our liquidity and cash flow in future periods:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div></td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2026 and <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">thereafter</div></td></tr><tr class="header"><td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td colspan="19" style="width: 59.11%; text-align: center; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands)</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loans<font style="padding-left: 1.06pt;"></font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.81%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 7.5pt;">738</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">23</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">90</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">90</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">91</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">&#8203;107</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">&#8203;337</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease commitments<font style="padding-left: 4.43pt;"></font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">612</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">155</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;"><font style="padding-left: 0.37pt;">116</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;"><font style="padding-left: 0.37pt;">116</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;"><font style="padding-left: 0.37pt;">116</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">109</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Collaborative agreement with research centers<font style="padding-left: 2.18pt;"></font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.81%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 7.5pt;">509</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">&#8203;<font style="padding-left: 0.37pt;">411</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">84</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">14</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total <font style="padding-left: 1.76pt;"></font></div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">1,859</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">589</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">290</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">220</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">207</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">216</div></td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">337</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Critical Accounting Policies and Use of Estimates</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to recognition of grants funds, accrued expenses, defined benefit pension liability, fair value measurements and stock-based compensation. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While our significant accounting policies are described in more detail in Note 2 to our audited consolidated financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Use of Estimates in the Preparation of Financial Statements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, our future results of operations will be affected.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15pt; margin-left: 0pt; text-align: left;">Research grants </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the terms of the research and development grants awarded (such as those awarded by the Michael J. Fox Foundation, the Silverstein Foundation, Eurostars and Eureka), we are entitled to receive reimbursement of our allowable direct expenses. Contributions from research and development activities under the grants are recorded based on management&#8217;s best estimate of the periods in which the related expenditures are incurred and activities performed and are classified in the statement of operations as a reduction to research and development expenses. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">Research and Development Expenses </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Several of our activities and related costs are designated research and development expenses, which primarily include salary and benefits payments to our direct employees, employee stock-based compensation expenses, preclinical activities, outside services, material and supplies and contracted services. The billings we receive from contract research organizations for services rendered may not be received for several months following the service. We accrue the estimated costs of the contract research organizations&#8217; related services based on our estimates. We are </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">57<br></div></div></div>
<!--End Page 60-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 61-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">in constant communication with our contract research organizations to assess their progress on the underlying studies and the reasonableness of their cost estimates. Differences between estimated preclinical costs and actual costs have not been material to date, and changes have been made when actual costs became known. Under this policy, research and development expenses can vary due to accrual adjustments related to the underlying preclinical activities and the expenses incurred by the contract research organizations.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Accrued expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As part of the process of preparing our financial statements, we are required to estimate our accrued expenses as of each balance sheet date. This process involves reviewing open contracts and purchase orders, communicating with our personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of the actual cost. We make estimates of our accrued expenses as of each balance sheet date based on facts and circumstances known to us at that time at the date of the preparation of the financial statements. There may be instances in which payments made to our vendors exceed the level of services provided, and result in a prepayment reported under other current assets, which are subsequently expenses in the statement of operations when the related activity has been performed rather than when the payment is made. To date, there have been no material differences between our estimates of accrued expenses reported at each balance sheet date and the amounts actually incurred. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Impairment of Long-Lived Assets </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We test long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the long-lived asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the sum of the expected undiscounted cash flow is less than the carrying amount of the asset, we recognize an impairment loss, which is the excess of the carrying amount over the fair value of the asset, using the expected future discounted cash flows.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the years ended December&#160;31, 2020, 2019 and 2018, we did not recognize an impairment loss on our long-lived assets.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Leases</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016 02, &#8220;Leases&#8221; (&#8220;ASC 842&#8221;) to enhance the transparency and comparability of financial reporting related to leasing arrangements. Under this new lease standard, most leases are required to be recognized on the balance sheet as right-of-use assets and lease liabilities. Disclosure requirements have been enhanced with the objective of enabling financial statement users to assess the amount, timing, and uncertainty of cash flows arising from leases. Prior to January&#160;1, 2019, GAAP did not require lessees to recognize assets and liabilities related to operating leases on the balance sheet. The new standard establishes a right-of-use (&#8220;ROU&#8221;) model that requires a lessee to recognize an ROU asset and corresponding lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement as well as the reduction of the right of use asset.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Effective January&#160;1, 2018, we adopted Accounting Standards Codification 842, Leases (&#8220;ASC 842&#8221;) using the additional transition method option provided by ASU 2018-11. Under this transition method, we applied the new accounting guidance as of the date of adoption. Upon adoption, a cumulative effect adjustment was not required. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subsequent to the adoption, we determine if an arrangement contains a lease at inception based on whether or not we have the right to control the asset during the contract period and other facts and circumstances. We are the lessee in a lease contact when it obtains the right to control the asset. Operating lease right of use (&#8220;ROU&#8221;) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease, both of which are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Leases with a term of 12 months or less at inception are expensed on a straight-line basis over the lease term in the statement of operations. We determine the lease term by assuming the exercise of renewal options that are reasonably certain.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">58<br></div></div></div>
<!--End Page 61-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 62-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Pension obligations </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We operate defined benefit pension plans and defined contribution pension plans in accordance with local regulations and practices. These plans are funded by regular contribution made by the employer and the employees to a third-party. For defined benefit pension plans, the liability recognized in the balance sheets is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The overfunded or underfunded status of the defined benefit plans is calculated as the difference between plan assets and the projected benefit obligations. Estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in &#8220;Accumulated Other Comprehensive Income (Loss)&#8221; in the statements of equity and are charged or credited to income over the employees&#8217; expected average remaining working lives. For defined contribution pension plans, we pay contributions to publicly or privately administered pension insurance plans on a mandatory, contractual or voluntary basis. We have no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expenses on an accrual basis. The measurement date used for our employee benefit plans is December 31. The funding policies of our plans are consistent with the local government and tax requirements.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Income Tax </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We account for income taxes under the liability method. Under this method deferred income tax liabilities and assets are determined based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities and for operating losses and tax credit carry forwards, using enacted tax rates in effect in the years in which the differences are expected to reverse. A valuation allowance is recorded if it is &#8220;more likely than not&#8221; that a portion or all of a deferred tax asset will not be realized.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of each reporting date, the Company considers existing evidence, both positive and negative, that could impact its view with regards to future realization of deferred tax assets. In consideration of the start-up status of the Company, a full valuation allowance has been established to offset the deferred tax assets, as the related realization is currently uncertain. In the future, should management conclude that it is more likely than not that the deferred tax assets are partially or fully realizable, the valuation allowance will be reduced to the extent of such expected realization, and the corresponding amount will be recognized as income tax benefit in the Company&#8217;s consolidated statement of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company recognizes tax liabilities from an uncertain tax position if it is more likely than not that the tax position will not be sustained upon examination by the taxing authorities, based on the technical merits of the tax position. There are no uncertain tax positions that have been recognized in the accompanying consolidated financial statements.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Fair Value Measurement</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Fair value is based on the price that would be received from the sale of an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that categorizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 40pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Level 1:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 40pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Level 2:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Observable prices that are based on inputs not quoted on active markets, but corroborated by market data. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 40pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Level 3:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and consider counterparty credit risk in their assessment of fair value. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">59<br></div></div></div>
<!--End Page 62-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 63-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Equity-based Compensation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We apply the fair value method of measuring equity-based compensation, which requires an entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. We issue stock-based awards with only service-based vesting conditions and record the expense for these awards using the straight-line method. We have not issued any stock-based awards with performance- or market-based vesting conditions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We recognize the related cost in the consolidated statement of operations and as additional paid in capital in the consolidated statement of shareholders&#8217; equity in accordance with the vesting period during which the award recipients are required to provide services in exchange for the awards. We account for forfeitures as they occur.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Given the absence of an active market for our common stock, we and the board of directors determined the estimated fair value of our equity instruments based on a number of factors, including prices paid for our convertible preferred stock, which we had sold to outside investors in arm&#8217;s-length transactions; our stage of development; and the fact that the grants of stock-based awards involved illiquid securities in a private company. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option pricing model. As there is no public market for our common stock, we determined the volatility and the expected term for awards granted based on an analysis of reported data for a peer group of similar biopharmaceuticals companies. We expect to continue to do so until such time as we have reliable historical data regarding the volatility of our traded stock price and expected term of exercise patterns. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. We have not paid, and do not anticipate paying, cash dividends on our common stock; therefore, the expected dividend yield is assumed to be zero.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The assumptions used in calculating the fair value of share-based awards represent management&#8217;s best estimates and involve inherent uncertainties and the application of management&#8217;s judgment. As a result, if factors change and management uses different assumptions, share-based compensation expense could be materially different. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">JOBS Act</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. Other exemptions and reduced reporting requirements under the JOBS Act for emerging growth companies include presentation of only two years audited financial statements in a registration statement for an initial public offering, an exemption from the requirement to provide an auditor&#8217;s report on internal controls over financial reporting pursuant to the Sarbanes-Oxley Act, an exemption from any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation, and less extensive disclosure about our executive compensation arrangements. We have elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that (i)&#160;we are no longer an emerging growth company or (ii)&#160;we affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As described in Note 2 to our financial statements, we adopted certain accounting standards, as the JOBS Act does not preclude an emerging growth company from adopting a new or revised accounting standard earlier than the time that such standard applies to private companies. We expect to use the extended transition period for any other new or revised accounting standards during the period in which we remain an emerging growth company. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will remain an emerging growth company until the earliest of (i)&#160;the last day of our first fiscal year in which we have total annual gross revenue of $1.07&#160;billion or more, (ii)&#160;the last day of the fiscal year following the fifth&#160;anniversary of completion of this offering, (iii)&#160;the date on which we have issued more than $1.0&#160;billion of non-convertible debt instruments during the previous three fiscal years or (iv)&#160;the date on which we are deemed a &#8220;large accelerated filer&#8221; under the rules of the SEC with at least $700.0&#160;million of outstanding equity securities held by non-affiliates.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">60<br></div></div></div>
<!--End Page 63-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 64-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Internal Control Over Financial Reporting</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Historically, we have been a private company and did not maintain the internal accounting and financial reporting resources necessary to comply with the obligations of a public reporting company, including maintaining effective internal control over financial reporting. We and our independent registered public accounting firm identified material weaknesses primarily related to a (i)&#160;lack of sufficient accounting and supervisory personnel who have the appropriate level of technical accounting experience and training, and (ii)&#160;lack of adequate procedures and controls to ensure that accurate financial statements could have been prepared and reviewed on a timely basis for annual reporting purposes.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have initiated a remediation plan to address the material weaknesses, including the hire of a full time additional employee in our accounting department and a more streamlined process in order to prepare and review financial information; however, our control environment needs improvements, and as a result we may be exposed to errors. Our remediation plan includes hiring additional senior level and staff accountants with US GAAP technical knowledge to support the timely completion of financial close procedures, implementing robust processes, and providing additional needed technical expertise, and in the interim, continuing to engage third parties as required to assist with the preparation of our financial statements and our compliance with SEC reporting obligations. Additionally, we intend to develop and implement consistent accounting policies, internal control procedures and provide additional training to our accounting and financial reporting personnel. While we are working to remediate such weaknesses as quickly and efficiently as possible, we cannot at this time, provide an estimate of the timeframe we expect in connection with implementing our plan to remediate the material weaknesses.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The process of designing and implementing an effective accounting and financial reporting system is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to expend significant resources to maintain an accounting and financial reporting system that is adequate to satisfy our reporting obligations. As we continue to evaluate and take actions to improve our internal control over financial reporting, we may determine to take additional actions to address control deficiencies or determine to modify certain of the remediation measures described above. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to remediate the material weaknesses we have identified or avoid potential future material weaknesses.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Off-Balance Sheet Arrangements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Recently Issued Accounting Pronouncements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 to our financial statements appearing elsewhere in this prospectus.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Quantitative and Qualitative Disclosures about Market Risk</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Interest Rate Risk</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2020, we had cash equivalents consisting primarily of $6,585,656 in money market mutual funds. Our primary exposure to market risk is interest income sensitivity, which is affected by changes in the general level of U.S. interest rates. Consequently, changes in market interest rates would not have a material impact on our financial position or results of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2020, we had debts outstanding of $715,656, guaranteed by the Swiss Federal Authority, at a zero percent interest rate, and are therefore not exposed to interest rate risk with respect to the cost of servicing and repaying debt.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Inflation-Related Risks</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We do not believe that the rate of inflation in Spain or Switzerland has had a material impact on our business to date. However, our costs in Spain and Switzerland will increase if the inflation rate in Spain or Switzerland exceeds the devaluation of the Euro or Swiss Franc against the U.S. dollar or if the timing of such devaluation lags behind inflation in either Spain or Switzerland.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">61<br></div></div></div>
<!--End Page 64-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 65-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_109-mda_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Foreign Currency Exchange Risk</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have operations in Switzerland and Spain as well as in the U.S. The functional currency of each foreign subsidiary is generally the local currency. We are exposed to foreign currency exchange risk as the functional currency financial statements of foreign subsidiaries are translated to U.S. dollars. The assets and liabilities of our foreign subsidiaries having a functional currency other than the U.S. dollar are translated into U.S. dollars at the exchange rate prevailing at the balance sheet date, and at the average exchange rate for the reporting period for revenue and expense accounts. The cumulative foreign currency translation adjustment is recorded as a component of accumulated other comprehensive loss in shareholders&#8217; equity. The reported results of our foreign subsidiaries will be influenced by their translation into U.S. dollars by currency movements against the U.S. dollar. Our primary currency translation exposure is related to our subsidiaries that have functional currencies denominated in CHF. A hypothetical 10% strengthening or weakening in the rates used to translate the results of our foreign subsidiaries that have functional currencies denominated in CHF would have increased or decreased net income for the year ended December&#160;31, 2020 by approximately $268,009.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">62<br></div></div></div>
<!--End Page 65-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 66-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tOB"><!--Anchor--></a>OUR BUSINESS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are a development stage biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on LSDs, including rare genetic diseases and neurological disorders. We use our exclusively in-licensed platform, SEE-Tx, to discover novel allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites and restore protein folding, potentially treating the underlying disease. These small molecule binding sites, away from the protein&#8217;s active areas, are called allosteric sites. We believe targeting the allosteric binding site instead of the active binding site can provide a number of advantages: superior regulation of misfolded proteins implicated in disease, enhanced specificity by being non-competitive with the natural substrate and the potential for molecules with favorable drug-like properties. While the SEE-Tx platform is novel and has not been used to develop approved drugs yet, these advantages have the potential to ultimately enhance both tolerability and response.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of February 19, 2021, we have already identified and filed three patent applications and one provisional patent application (such applications do not cover the United States) for our novel STARs, which are small molecules with the potential to treat diseases with high unmet medical need for which there are currently few or no available therapies. These diseases include Morquio B, GM1 Gangliosidosis (GM1), neuronopathic Gaucher disease, <font style="font-style: italic;">GBA1</font> Parkinson&#8217;s disease, Krabbe disease and Mucopolysaccharidosis type 1.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are currently advancing the development of our STAR candidates through preclinical studies where we will continue to identify optimal lead compounds for each indication that we will advance into clinical trials. Through academic partnerships, co-development and licensing arrangements, we intend to develop a broad pipeline of therapeutics to catalyze a new approach to the treatment of diseases caused by misfolded enzymes. We expect to obtain additional preclinical data and commence IND-enabling studies for lead compound candidates beginning in 2021, at which point we will begin the process to prepare and submit investigational new drug, or IND, submissions to the FDA seeking clearance to commence clinical research.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Protein Misfolding and Disease</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Proteins are large biomolecules that have a vast array of functions in different cell types in the body. Enzymes are a type of protein that accelerate and facilitate chemical reactions inside of cells by acting on substrates and converting those substrates into different chemical products. To perform their function in the body, enzymes and other proteins must be folded into the correct three-dimensional shape. Misfolded enzymes may not function properly, which can lead to the toxic accumulation of unprocessed substrate which is the cause of many rare genetic diseases, including LSDs and some neurodegenerative diseases such as certain forms of Parkinson&#8217;s disease. Enzyme misfolding may arise from genetic mutations that disrupt the folding pattern as well as from cellular stress due to aging and inflammation. Therapeutic small molecules that facilitate the folding of enzymes into their correct shape can restore function and the proper processing of substrate. As illustrated below, in LSDs, the gene that codes for an enzyme is mutated and results in a misfolded enzyme. The misfolded enzyme cannot traffic through the cell resulting in toxic protein accumulation. We believe that our STARs will have the ability to bind to the allosteric site of the defective enzyme and restore wild type activity and thus serve as potential therapeutic treatments for diseases.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">63<br></div></div></div>
<!--End Page 66-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 67-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; text-align: center;"><img style="height: 269px; width: 461px;" src="nt10015006x17_graphic8x1.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Limitations on Current Therapeutic Treatments</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Current therapeutic approaches to address misfolded enzymes have inherent limitations. In standard chaperone therapy, the drug binds to the active site of the enzyme or other target protein which impairs the protein&#8217;s function to some degree by competing with the active substrate, decreasing efficacy and potentially leading to selectivity issues. Other treatments such as ERT, in which new functional enzymes are infused into the patient, are not optimal for treating neurological conditions because currently available ERT cannot cross the blood-brain barrier. Gene therapy, which aims to create new, functional enzymes, is not readily accepted for treating neurological conditions because the procedure is invasive in nature and the efficacy of treating neurological conditions remains to be established. Given these limitations on current therapies, we believe patients would benefit from a new therapeutic approach both on its own and, potentially, in combination with existing therapies. We believe our therapeutic approach represents a potentially significant change from current approaches by addressing protein misfolding using our efficient and proprietary ability to identify previously undiscovered allosteric sites and compounds that avoid the active sites of enzymes and cross the blood-brain barrier or penetrate other hard-to-treat organs such as bone and cartilage. Additionally, our approach enables the less-invasive process of oral administration.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Our Platform &#8211; Computational Identification Approach</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;">Overview</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our exclusively in-licensed and proprietary SEE-Tx platform allows us to identify previously undiscovered sites on an enzyme where a small molecule can attach and potentially facilitate the enzyme into the correct folding pathway, all without disrupting its function. We refer to the small molecules we identify that bind to these allosteric sites as STARs to reflect their mechanism of action and how they are discovered. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; text-align: center;"><img style="height: 232px; width: 603px;" src="nt10015006x17_graphic1.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">64<br></div></div></div>
<!--End Page 67-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 68-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Allosteric Site Identification</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Using the three-dimensional structure of enzymes and our computational technology, our SEE-Tx platform identifies and maps, through molecular simulations, previously uncharacterized binding sites called &#8220;binding hotspots.&#8221; These are key points on the protein surface where a small molecule can potentially bind. The amount, density, nature and quality of these hotspots determine the druggability of the protein, that is, if the drug-like small molecules can effectively bind to the particular site with an appropriate potency. We then use our proprietary structure-based virtual screening methodology to filter a pool of seven to ten million commercially-available compounds to identify those that may potentially bind to the hotspot and have a functional effect. Using this information, we develop structural templates to guide the development of a narrowed pool of unique and proprietary small molecules that bind to the newly discovered allosteric sites and could potentially facilitate the enzyme into the correct folding structure and treat diseases. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As illustrated below, we believe our ability to identify and target previously uncharacterized allosteric binding sites has the potential to ultimately enhance both tolerability and response.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 213px; width: 563px;" src="nt10015006x17_graphic2.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">STAR Identification &#8211; Our Molecular Hypothesis</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe our STAR identification process is a more efficient and effective drug discovery tool than random screening because we use a validated-target approach. In random screening, very large libraries of molecules are tested for their ability to perform a specific function such as binding to a target. This approach typically results in a large number of positive responses that must then be laboriously screened to identify product candidates that are worth pursuing. In contrast, every small molecule generated by our platform is analyzed based on a two-part molecular hypothesis: (i)&#160;the restoration of the function of the target enzyme could be a treatment for the disease and (ii)&#160;our SEE-Tx platform could identify druggable allosteric binding sites that could be exploited to restore the enzyme&#8217;s functional activity. This validated-target approach confers a great advantage during the lead compound optimization process compared to random screening approaches. The lead compound optimization process is the process by which drug candidates are synthetically refined from their original state into an agent that is safer, more potent and more useful. The goal during the lead optimization stage is to maintain favorable properties in lead compounds, while improving on deficiencies in lead structure. We can identify an allosteric site in five to six weeks, screen hits in two to three weeks and validate compounds in two to three months. In addition, compared to random screening, our validated-target approach is comparatively less expensive, requires less time to produce results with a higher success rate because this approach eliminates a number of false-hits by requiring each output to meet our two-part molecular hypothesis. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe each STAR has high specificity to its allosteric binding site and does not interact with the active site of the enzyme target, which is designed to enhance both tolerability and response. Our technology allows us to identify STARs that have the ability to bind to both mutant and wild-type enzymes. Because they are small molecules, STARs can be administered orally, have the ability to cross the blood-brain barrier and enter hard-to-treat tissues such as bone and cartilage. We believe the ability to cross the blood-brain barrier is essential to effectively treating diseases with neurological symptoms. In addition, we believe our STARs could be used in combination with ERT or gene therapy approaches to more completely address the patient&#8217;s needs. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">65<br></div></div></div>
<!--End Page 68-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 69-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Our Pipeline of STARs</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are leveraging our SEE-Tx technology platform to develop a pipeline of novel drug candidates to address diseases caused by protein misfolding. We are initially focusing on several LSDs with high unmet medical need, with the ability to expand our pipeline as we continue to discover new targets. We have entered into a number of academic collaborations to advance the development of our programs, such as with the University of Minnesota and the University of Maryland; these collaborations are understandings to work together in the research of specific demyelinating diseases and neither we, nor the institutions we collaborate with, are under contractual obligations to continue the collaboration and all parties retain their respective intellectual property. Additionally, in June 2020, we entered into a two-year research collaboration agreement with Sumitomo for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; text-align: center;"><img style="height: 194px; width: 596px;" src="nt10015006x17_graphic3.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">Development Pipeline<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">GLB Enzyme-Related Disorders: GM1 Gangliosidosis and Morquio B</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are investigating restoration of GLB function as a treatment for GM1 and Morquio B. GLB is an enzyme found in lysosomes, which are compartments within cells that degrade and recycle different types of molecules, including toxic molecules. GLB is essential for the breakdown of GM1 and keratan sulfate, which serve important functions in the brain and other tissues. Misfolding of GLB allows these substrates to build up to toxic levels and leads to the diseases GM1 and Morquio B.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There are currently no cures for these diseases. Available treatment options include substrate reduction therapy, which cannot cross the blood-brain barrier or reach either bone or cartilage, and can therefore only help manage select symptoms. Additionally, while gene therapy approaches are being explored, they are still in early clinical development, require surgical procedures and are prone to immunological responses from the vectors. Conversely, our STARs in our <font style="font-style: italic;">GLB1</font> program are designed to cross the blood-brain barrier, and STARs in our GM1 program are designed to penetrate bone tissue, which is an important target tissue for treatment of Morquio B.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified novel STARs targeting GLB, and the four most promising compounds have been selected as leads: GT-00413, GT-00493, GT-00513 and GT-00546. Data from our preclinical studies have shown that our STARs do not inhibit the normal activity of GLB in healthy cells, whereas competitive chaperone compounds typically do. Preclinical studies indicate that our STARs help mutated &#946;-galactosidase escape premature degradation and travel to the lysosome where it can perform its catalytic activity. In addition, preclinical studies of these STARs in GM1-affected cells and Morquio B-affected cells show an increase in GLB activity and a reduction in the accumulation of a GM1 ganglioside substrate.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Overview of GM1 Gangliosidosis </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">GM1 is a rare and often life-threatening LSD in infants (type 1), juveniles (type 2) and adults (type 3). It&#160;manifests in a continuum of clinical severity by type. In type 1 or the infantile form, the onset is observed earlier and is a more severe and rapidly progressive disease. Type 2 and 3 are less severe manifestations and have slower progression with a juvenile or adult onset. The infantile form of the disease is characterized by onset in the first year of life with symptoms including hypotonia (reduced muscle tone), progressive CNS dysfunction that can lead to </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">66<br></div></div></div>
<!--End Page 69-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 70-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">deafness, blindness, enlarged liver and spleen rigidity, and progressive skeletal dysplasia that can result in restrictive lung disease and aspiration pneumonia. The disease rapidly progresses, with a life expectancy of two to four years. Juvenile GM1 manifests between 18 months and five years of age with a slower progression compared to infants. The average life expectancy for type 2 GM1 is typically 10&#160;years. Adult GM1 has an onset age between three and 30. While it is less severe and progresses at a slower rate than infantile or juvenile GM1, adult GM1 causes debilitating symptoms, including muscular atrophy, corneal clouding and dystonia.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">GM1 is caused by recessive mutations in the GLB1 gene, which encodes the lysosomal enzyme GLB. This enzyme catalyzes the first step in the natural degradation of GM1 ganglioside. The reduction in GLB activity can result in the accumulation of toxic levels of GM1 ganglioside in neurons throughout the brain and highly variable storage of glycosaminoglycans and glycopeptides in visceral and skeletal tissues, causing progressive damage to both the CNS and the peripheral tissues.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The prevalence of GM1 is approximately 1:100,000 to 200,000 live births worldwide. Currently, there is no effective cure for GM1, and symptomatic treatment options, including substrate reduction therapy, ERT, bone marrow transplantation, stem cell transplantation and gene therapy are limited or still under development. Existing approaches are unable to address both the neuronal and systemic symptoms because current treatment options cannot cross the blood-brain barrier or reach other hard-to-treat organs such as bone.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Overview of Morquio B</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Morquio B is a progressive LSD that results from a defect in the GLB1 gene which leads to the accumulation of keratan sulfate in bones, cartilage and the cornea. Clinical presentation of the disease ranges from a severe, rapidly progressing form (which represents the classical description of this disorder) to a phenotype that evolves more slowly. Onset of disease symptoms commonly occurs before the age of one year in patients with a severe phenotype or as late as the second decade of life in patients with the slowly progressing form of the disease. Patients with Morquio B retain their normal neurological functions but develop severe skeletal changes which may lead to nerve compression, growth retardation, corneal clouding, and impairment of cardiac function. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The prevalence of Morquio B is approximately 1:200,000 to 300,000 live births. Currently, there is no effective cure for Morquio B, and symptomatic treatment options, including substrate reduction therapy, ERT, bone marrow transplantation, stem cell transplantation and gene therapy are limited or still under development. Existing approaches are unable to address both the neuronal and systemic symptoms because current treatment options cannot cross the blood-brain barrier or reach other hard-to-treat organs such as bone. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Preclinical Characterization of GLB STAR Lead Compounds</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Biological Activity</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified novel STAR molecules targeting GLB through our SEE-Tx platform. The four most promising molecules selected as lead compounds were: GT-00413, GT-00493, GT-00513 and GT-00546. We conducted our initial studies on these compounds. After additional studies, we narrowed our lead compounds to: GT-00493 and GT-00513. Binding of these compounds to the GLB target has been confirmed using a biophysical assay. In LSDs, the mutant enzyme is often unstable and is rapidly degraded in the endoplasmic reticulum (ER). Preclinical studies indicate that our STARs help mutated GLB escape premature degradation and travel to the lysosome where it can perform its catalytic activity. These preliminary studies were conducted <font style="font-style: italic;">in vitro</font> using cells that carried the <font style="font-style: italic;">GLB1</font> mutation. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The figure below shows how GT-00513 increases the delivery of &#946;-galactosidase to the lysosome. HEK293 cells were transfected with WT (normal GCase expression), I51T (a prevalent mutation associated with GM1) or W273L (a prevalent mutation associated with Morquio B) GLB1-HaloTag and were treated with the indicated compounds for </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">67<br></div></div></div>
<!--End Page 70-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 71-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">17 hours and a fluorescent Halo ligand. Once the protein reaches the lysosome, the tag is cleaved off &#946;-gal but is resistant to lysosomal hydrolases enabling the detection of a 31 kDa fluorescent fragment that corresponds to the protein that reached the lysosomes. Lysosomal fragment is measured by western blot.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; text-align: center;">Effect on protein maturation and lysosomal delivery of WT and mutant &#946;-galactosidase</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; text-align: center;"><img style="height: 192px; width: 461px;" src="nt10015006x17_graphic9.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The figure below shows that GT-00413 treatment cleared the toxic GM1 ganglioside accumulation (green florescence) in GM1-affected canine cells. In this preclinical study, canine GM1-affected cells were loaded with GM1 ganglioside for two days followed by the addition of GT-00413 for four days. The canine cells were stained to detect GM1 ganglioside which appears green, and cell nuclei were stained to appear blue. The images in the top row below show the cells before GT-00413 treatment. Images in the lower row show the same cells after treatment with GT-00413, showing the reduction of the GM1 ganglioside substrate.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; text-align: center;"><u>GM1 ganglioside depletion in GM1-effected cell lines</u></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; text-align: center;"><img style="height: 317px; width: 580px;" src="nt10015006x17_graphic4.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 0pt; text-align: left;">Toxicology and Safety</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our STAR lead GLB-targeting molecules have been evaluated in an acute toxicity study in mice after oral administration, we treated two mice per dose and monitored the mice for seven days. No abnormal clinical signs were observed in any of the molecules (GT-00413, GT-00493, GT-00513 and GT-00546) and there were no mortalities in mice when dosed at 50, 150 and 400 mg/kg. The maximum tolerable dose in mice was therefore higher than 400 mg/kg.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">68<br></div></div></div>
<!--End Page 71-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 72-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Pharmacokinetics</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our STAR lead GLB-targeting molecules have been tested in pharmacokinetic (PK) studies after intravenous and oral administration in mice. These molecules were initially tested in a neuro-PK study to evaluate their brain penetration (three mice were treated for each of 15 minutes, two hours and eight hours). An intravenous dose of 10 mg/kg was administered to mice, and plasma and brain drug levels were measured at 15 minutes, two and eight hours after dosing. All the tested molecules showed positive brain-penetrating properties.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have also performed oral bioavailability studies in mice to compare oral versus intravenous exposure. In the seven-day PK study, after repeated administration, we used 27 mice in total (nine for each dose group). The animals were observed after the oral administration and they were found normal with no central or peripheral clinical abnormalities. The brain to plasma ratio was greater than one at each dose tested (up to 1.9) while the bone to plasma ratio increased over time (from one hour to eight hours), which equals a ratio of 15.1 at one hour and 44.3 at eight&#160;hours. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The pharmacokinetic profile was completed with PK studies after repeated treatments to obtain safety information and exposure in tissues including some of the most relevant for the GM1 disease: brain and bone. We conducted plasma pharmacokinetics and tissue (brain and left femur bone) distribution analyses of GT-00413 following a single oral (180 mg/kg) and seven day repeated oral (30 and 90 mg/kg) dose administration in mice. GT-00413 was generally well-tolerated after seven days of treatment without showing clinical signs. Comparable plasma exposure was observed at oral doses of 30 and 90 mg/kg and accumulation was not observed after seven days of treatment. Brain concentrations were quantifiable up to eight hours following the last dose showing brain and bone exposure. A single oral dose of 180 mg/kg was quantifiable in plasma, brain and bone up to eight hours after administration. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Typically, therapeutic compounds having a brain to blood ratio from 0.3 to 0.5 have sufficient access across the blood-brain barrier, those with a value greater than 1 freely cross the blood-brain barrier, and those with a ratio less than 0.1 may not have access to the CNS. Results are shown in the graphs below: </div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; text-align: center;"><u>Plasma pharmacokinetics and tissue (brain and left femur bone) </u><br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><u>distribution of GT-00413</u><u> in mice</u></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; text-align: center;"><img style="height: 348px; width: 557px;" src="nt10015006x17_graphic5.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Pharmacology </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are planning to evaluate these lead molecules in pharmacology studies to obtain the proof of concept in relevant animal models. These studies have been planned for the fourth quarter of 2020 and second half of 2021 and </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">69<br></div></div></div>
<!--End Page 72-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 73-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">are expected to be performed with a CRO along with the academic group at the University of Minnesota headed by Professor Chester Whitley, a professor in the Department of Pediatrics and faculty member in the Division of Genetics and Metabolism, the Department of Experimental and Clinical Pharmacology, and Mucopolysaccharidosis Center.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;">GBA1 (GCase) Enzyme-Related Disorders: Neuronopathic Gaucher Disease and GBA1 Parkinson&#8217;s Disease</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are investigating the restoration of GCase enzymatic function as a treatment for neuronopathic Gaucher disease (nGD), a LSD. Unlike other types of Gaucher disease, none of the existing therapeutics are effective in treating nGD. GCase is an enzyme encoded by the GBA1 gene and found in lysosomes that is needed to breakdown the large molecule glucocerebroside (a component of the cell membrane) into sugar and fat. The misfolding of GCase can lead to accumulation of these substrates to toxic levels in the liver, spleen, bone marrow and nervous system and can result in lysosomal storage and neurodegenerative diseases. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The GCase mutation most commonly associated with nGD is also found in the most pathogenic form of Parkinson&#8217;s disease. Reduced GCase activity may enhance the risk for Parkinson&#8217;s disease by facilitating alpha-synuclein accumulation, which is a pathological hallmark of Parkinson&#8217;s disease. As a result, we are also investigating restoration of GCase function in patients with GBA1 Parkinson&#8217;s disease (GBA1+PD). Currently, there is no cure for nGD or for GBA1+PD, and there are very limited treatment options. Current treatments such as ERT cannot address central nervous system symptoms because they cannot cross the blood-brain barrier, unlike our STARs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified novel STARs targeting GCase and are continuing characterization of our most promising compounds. Data from our preclinical studies have shown that in normal cell lysates these STARs do not inhibit the normal activity of GCase in healthy cells, while competitive chaperone compounds typically do. In transfected cells with either normal GCase expression or Case with relevant mutations, STARs increase lysosomal GCase. In addition, preclinical studies of these STARs in healthy and GCase-affected cells show an increase in GCase activity, and preclinical studies in a relevant neuronal model of Gaucher patient-derived fibroblasts show a reduction in the accumulation of toxic GCase substrate. A reduction of alpha-synuclein accumulation was also observed in the same neuronal models as well as two other neuronal <font style="font-style: italic;">in vitro</font> models. A preclinical in vivo animal study, discussed in more detail below, indicated that these STARs enhance GCase wild-type enzyme activities and a rotenone induced Parkinson&#8217;s disease animal demonstrated that oral administration of STARs lead to depletion of alpha-synuclein, increase in tyrosine hydroxylase and improvement in locomotor activity.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Overview of GBA Gaucher Disease</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Gaucher disease is an inherited LSD caused by the misfolding and subsequent dysfunction of beta-glucocerebrosidase (GCase), an enzyme that breaks down fatty chemicals in the body. Gaucher disease is traditionally classified according to one of three types. Type 1 Gaucher disease is traditionally referred to as a non-neuronopathic form of the disease, for which some treatments are available, but evolving science has shown that patients with type&#160;1 Gaucher disease may also manifest neurological symptoms later in life. Current ERT and gene therapy treatments are unable to address the onset of type 1 neurological symptoms because these treatments are unable to cross the blood-brain barrier. Unlike Gaucher disease type 1, Gaucher disease types 2 and 3 have early onset brain degeneration that gets progressively worse over time. For this reason, Gaucher disease types 2 and 3 are known as neuronopathic Gaucher disease (nGD). Currently, there is no effective treatment for the severe brain degeneration associated with Gaucher disease types 2 and 3. In type 2 Gaucher disease, there is neurological impairment that presents before birth through the first months of life, progresses rapidly, and is typically fatal within two years. It is a devastating disorder characterized by neurodegeneration and brainstem dysfunction. Additionally, infants with Gaucher disease may have abnormally large organs, deficiency in growth, seizures and compromised swallow and airway problems. Gaucher disease type 3 (also known as chronic neuronopathic Gaucher disease) is thought to be the most common type worldwide. It has a later and more gradual onset compared with type 2. People with Gaucher disease type 3 may survive into adulthood with a wide variety of signs and symptoms, including seizures, skeletal irregularities, eye movement disorders, cognitive and coordination problems as well as enlarged liver and spleen, respiratory problems and blood disorders.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Gaucher disease is caused by alterations in the GBA1 gene that encodes GCase, an enzyme which catalyzes a key step in breaking down glucosylceramide and glucosylsphingosine. Partial or complete loss of GCase activity can cause the buildup of glucosylceramide and glucosylsphingosine in the lysosomes of macrophages and the accumulation of these lipid substrates within the CNS can result in neurological symptoms.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">70<br></div></div></div>
<!--End Page 73-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 74-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The prevalence of Gaucher disease type 1 (non-neuronopathic Gaucher disease) is reported as 1:57,000 to 75,000 people worldwide. Type 1 is the most common form in Western countries (around 95%). The prevalence of type 2 and type 3 Gaucher disease (so called neuronopathic Gaucher disease) is approximately 1:100,000 people worldwide, and these forms are the most common in non-Western countries, especially in Asian countries where they make up more than 50% of the Gaucher disease patient population. At present there are no available treatment options for neuronopathic Gaucher disease, but ERT is still used to address organ enlargement, hematological manifestation and bone disease, as well as to improve the quality of life for these patients. ERT does not cross the blood-brain barrier and is not efficient in treating neurological manifestations, therefore creating a significant unmet medical need in this patient population.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Overview of GBA1 Parkinson&#8217;s Disease</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mutations in the <font style="font-style: italic;">GBA1</font> gene are also among the most pathogenic risk factors for the development of Parkinson&#8217;s disease and related neurodegenerative disorders characterized by the accumulation of alpha-synuclein in cell bodies of neurons. Studies have shown a link between patients with nGD and people who carry the mutation for Parkinson&#8217;s disease, although the exact mechanism for this association has not been fully elucidated.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">It is widely accepted that GCase deficiency has a biological role as a modifier or facilitator of Parkinson&#8217;s disease pathogenesis in the brain. Brain autopsy studies have shown that even some cases of idiopathic Parkinson&#8217;s disease (without <font style="font-style: italic;">GBA1</font> mutations) exhibit decreased levels of GCase. GCase activity may enhance the risk for Parkinson&#8217;s disease by facilitating a pathological hallmark, namely alpha-synuclein accumulation. Alpha-synuclein accumulation and GCase deficiency are thought to act in a debilitating cycle. GCase deficiency can cause the accumulation of glucosylsphingosine substrate, which has been reported to directly affect the accumulation and aggregation of alpha-synuclein. In addition, increased alpha-synuclein levels can lead to less GCase activity, which in turn can lead to more alpha-synuclein accumulation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Parkinson&#8217;s disease is reported to affect about 1 in 780 people worldwide. Approximately 2.3 to 9.4% of patients with Parkinson&#8217;s disease carry <font style="font-style: italic;">GBA1</font> mutations, making it the major genetic risk factor for the disease and this rate is higher in certain patient populations. At present, there is no effective cure for Parkinson&#8217;s disease associated with <font style="font-style: italic;">GBA1</font> mutations (GBA1+PD). Treatment options or potential treatments, such as ERT, are limited due to their inability to cross the blood-brain barrier and are therefore unable to prevent neurodegeneration. Current approved therapies for Parkinson&#8217;s disease are limited to symptomatic treatments such as levodopa, dopaminergic receptor agonists and inhibitors of enzymes related to dopamine metabolism such as monoamine oxidase inhibitors and catechol-O-methyltransferase inhibitors. These therapies aim to improve overall dopaminergic function. The benefits of these types of treatments diminish over time as the disease progresses, and these therapies do not impact the non-motor symptoms or the progression of the disease. As the disease progresses, the non-motor symptoms, such as dementia and cognitive impairment, can lead to severe morbidity and mortality.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Preclinical Characterization of GBA1 STAR Lead Compounds </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Biological Activity</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified novel STAR molecules targeting GCase and are conducting preclinical screening of the most promising compounds. Biophysical assay results have demonstrated that our STAR compounds can specifically bind to GCase protein and increase its thermal stability. We observed a dose-dependent increase in GCase activity in normal and GCase mutant cells when treated with our STAR molecules. Additionally, selected compounds have shown cell type and mutation specific GCase enzyme enhancement in an extended panel of patient derived cells representative of the most frequent and pathogenic GBA1 mutations related to GBA1 Parkinson&#8217;s and neuronopathic Gaucher&#8217;s disease. The figure below contains results from preclinical screening of one of our promising compounds for Gaucher&#8217;s disease. The Gauchers fibroblast lines shown below represent nearly all of the known mutations in Gaucher's type&#160;III and neuronopathic Gaucher's disease.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">71<br></div></div></div>
<!--End Page 74-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 75-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><u>Compound shows enzyme enhancement in Gaucher patient-derived fibroblasts</u> </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.25pt; text-align: center;"><img style="height: 271px; width: 389px;" src="nt10015006x17_graphic6.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Treatment with GT-2287 of transfected cells both with WT and mutated GBA1 leads to GCase lysosomal delivery. HEK293 were transfected with either GBA WT, GBA L444P and GBA N370S with HaloTag, 30 hours later, compounds and a fluorescent Halo ligand that covalently binds to a pocket in the tag were added for 17 hours. Once the protein reaches the lysosome, the tag is cleaved off GCase but is resistant to lysosomal hydrolases enabling the detection of a 31 kDa fluorescent fragment that corresponds to the protein that reached the lysosome. Full length protein and lysosomal fragment were measured by western blot. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The figures below show the results from our initial lysosomal delivery study of our GT-2287 compound:</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">Compound shows increase in lysosomal GCase delivery</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.25pt; text-indent: 20pt; text-align: center;"><img style="height: 129px; width: 576px;" src="nt10015006x17_graphic12.jpg"><br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">72<br></div></div></div>
<!--End Page 75-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 76-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">As shown in the figures below, treatment with GT-02287 and GT-02329 of cells bearing wild-type and L444P GCase leads to a decrease of glucosylsphingosine. Dopaminergic neurons BE(2)-M17 carrying either wild-type or L444P GBA1 mutation were treated for 10 days with 25 &#956;M of GT-02287 or GT-02329 compounds. Media exchange with compound was performed after 3 days, then after 4 days and finally cells are harvested after 3 additional days. GlcSph (Lyso-Gb1) levels were quantified by LC-MS/MS.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">STAR compounds decrease glucosylsphingosine levels in the neuronal cell model</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.25pt; text-indent: 20pt; text-align: center;"><img style="height: 249px; width: 532px;" src="nt10015006x17_graphic13.jpg"><br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Supported by a grant from the Michael J. Fox Foundation and the Silverstein Foundation, the promising compounds were further evaluated in a neuronal cell model developed by the Vall d&#8217;Hebron Research Institute. These neuronal cell lines express either normal or mutated GCase and display alpha-synuclein accumulation. Since accumulation of alpha-synuclein is the pathological hallmark of Parkinson&#8217;s disease, the use of these cell lines is important to determine the capacity of STAR compounds to decrease accumulation of the most pathogenic form of alpha-synuclein, namely phosphorylated alpha-synuclein (p-synuclein) through enhancement of GCase activity. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">73<br></div></div></div>
<!--End Page 76-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 77-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As shown below, Compound 1 has shown an ability to increase GCase activity in the neuronal model and to decrease the levels of phosphorylated synuclein (green fluorescence) both in the wildtype and in the most pathogenic GBA1 mutations (L444P and N370S).</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><u>Decrease p-synuclein levels in differentiated neuronal cell lines</u></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.25pt; text-align: center;"><img style="height: 339px; width: 600px;" src="nt10015006x17_graphic7.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Toxicology and Safety</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are continuing our medicinal chemistry analysis and other work to optimize our lead series for this indication. GT-002287 was administered in mice after IV (3 mice per dose group) and oral administration (12 mice per dose group). GT-002287 was safe up to 60mg/kg IV and was well tolerated up to 120mg/kg PO BID following sub-chronic twelve days treatment. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Pharmacokinetics</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We examined promising STAR molecules in neuro-PK studies to evaluate their brain penetration properties. Several of the compounds selected showed high brain exposure with a brain-to-plasma ratio level greater than one. A complete PK program, including bioavailability and exposure in tissues, will start as soon as new leads have been generated based on the ongoing medicinal chemistry efforts. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">74<br></div></div></div>
<!--End Page 77-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 78-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Pharmacology </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A preclinical mouse model demonstrated that oral administration of GT-02329 significantly enhances WT GCase activity and the effect is dose-dependent. GT-02329 was administered orally, twice a day for 12 days, to ten mice per group and samples were collected one hour after the final administration. </div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 22.25pt; text-align: center;"><img style="height: 226px; width: 595px;" src="nt10015006x17_graphic14.jpg"><br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A preclinical rotenone-induced Parkinson&#8217;s disease model demonstrated that oral administration of GT-02287 leads to depletion of alpha-synuclein, increase in tyrosine hydroxylase and improvement in locomotor activity. GT-02287 was administered orally, twice a day for 7 days, to ten rats per group and samples were collected one day after final administration. Rearing behavior and locomotion assessment has been performed at day 8. </div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 22.25pt; text-align: center;"><img style="height: 125px; width: 576px;" src="nt10015006x17_trichart1.jpg"><br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, pharmacology studies in mice are planned for the second quarter and fourth quarter of 2021 for GBA1+PD and nGD indications in collaboration with academic groups in Spain. This work will be supported by CROs and by grants from the Michael J. Fox Foundation and the Silverstein Foundation.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; text-align: center;">IDUA Enzyme-Related Disorders: Mucopolysaccharidosis Type 1</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are investigating restoration of IDUA function as a treatment for Mucopolysaccharidosis type 1 (MPS 1). IDUA is an enzyme in lysosomes needed to breakdown large sugar molecules called glycosaminoglycans (GAGs), especially heparan sulfate and dermatan sulfate. The misfolding of IDUA can allow substrate to build up to toxic levels in the bone and cartilage and can result in MPS 1. There is no cure for MPS 1, and treatment options to address symptoms such as ERT, laronidase, and bone marrow transplants are limited.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified a STAR targeting IDUA and are applying medicinal chemistry approaches to generate proprietary compounds. Preclinical studies of this compound have shown that in healthy cells, this STAR can stabilize recombinant IDUA and increase its activity. Additionally, when this STAR is co-administrated with laronidase, there is a dose-dependent increase in IDUA activity levels <font style="font-style: italic;">in vitro</font> and in mice.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">Overview of Mucopolysaccharidosis type 1 (MPS 1)</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mucopolysaccharidosis type 1 (MPS 1) is a rare LSD that presents as a spectrum of symptoms that can include severe impairment of the CNS. Because there is no clear delineation between the syndromes, patients are best described as having one of two subtypes, severe MPS 1 or attenuated MPS 1. Patients with severe MPS 1 typically have earlier onset of symptoms and experience a decline in intellectual function and a more rapid disease progression. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">75<br></div></div></div>
<!--End Page 78-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 79-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Symptoms include abnormal formation of the soft tissue of the face, enlarged vocal cords, enlarged liver and spleen, heart valve defects, short stature, joint deformities, corneal clouding, macrocephaly, hydrocephalus, hearing loss, development delays and regression. Children with severe MPS 1 usually do not live past the age of 10. Patients with attenuated MPS 1 make up approximately 55% of all MPS 1 cases and present a variety of symptoms that tend to be less acute than in those seen in severe MPS 1. Due to their longer life span, attenuated MPS 1 patients also make up a larger fraction of the patient population.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">MPS 1 results from mutations in the gene encoding IDUA, an enzyme responsible for the hydrolysis of glycosidic bonds in terminal &#945;-L-iduronic acid residues of complex glycosaminoglycans (GAGs), such as heparan sulfate and dermatan sulfate. Impaired degradation of these molecules can lead to their accumulation within lysosomes and triggers a complex cascade of intracellular events ultimately leading to multisystem morbidity caused by tissue damage and organ dysfunction.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The prevalence of severe MPS 1 is reported as affecting about 1 in 100,000 live births. Attenuated MPS 1 is less common and occurs in about 1 in 500,000 live births. At present, there is no effective cure for MPS 1 and there are limited treatment options to address symptoms such as ERT, laronidase, and bone marrow transplants. These approaches, however, do not cross the blood-brain barrier or penetrate the hard to treat tissues like cartilage.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Preclinical Characterization of IDUA Compounds </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Biological Activity</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified certain compounds that bind to an allosteric site on IDUA with functional effect. We plan to use this compound as a starting point to generate proprietary compounds. These compounds have been shown to stabilize IDUA and protect the enzyme against denaturation in physiological conditions. Preclinical cell-based studies indicate that stability and cellular uptake of IDUA is enhanced when co-administered with these compounds in MPS-affected fibroblasts. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Toxicology and Safety</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The acute toxicity of these preliminary test compounds was investigated after acute intravenous administration to mice to provide information on the maximum tolerated dose to be used in pharmacology studies (three mice were treated per dose group and monitored for seven days). Intravenous administration of these compounds at doses up to 45 mg/kg was generally well-tolerated. The highest tested dose of 60 mg/kg resulted in 100% mortality (two out of two treated animals died). Consequently, the dose of 45 mg/kg was considered the maximum tolerable dose for intravenous administration in mice.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Pharmacokinetics</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We performed a neuro-PK study in mice after intravenous administration of this compound at 2 mg/kg. We monitored enzymatic activity up to two hours in the plasma and up to six hours in tissues (bone and cartilage) at this dose, the compound was not detected in the brain. However, these compounds showed tissue distribution in bone and cartilage after oral administration in mice (nine mice per dose group). Bioavailability is critical for a potential treatment of MPS 1 as current treatments are ineffective at penetrating bone and cartilage. Additionally, at higher doses limited brain penetration was observed and the low brain penetration of this compound was confirmed from a pharmacology study performed.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Pharmacology </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Combination therapy of STARs with pharmacological chaperones and ERT can improve tissue uptake and reduce ERT&#8217;s immunogenicity by stabilizing the enzyme in its properly folded and active form <font style="font-style: italic;">in vivo</font>. In preclinical studies, one of our STAR compounds was co-administered with laronidase (Aldurazyme), an approved enzyme replacement therapy, intravenously to mice (we monitored enzymatic activity up to 24 hours in 30 mice per group). Data show the combination treatment stabilized the recombinant enzyme, increasing enzymatic activity levels in plasma, liver, bone and cartilage in a dose-dependent manner. Bone and cartilage represent the most critical medical need due to poor ERT uptake in these tissues. The benefit of combination therapy is particularly noticeable at longer times.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">76<br></div></div></div>
<!--End Page 79-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 80-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">GALC Enzyme-Related Disorders: Krabbe Disease</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are investigating the restoration of GALC function as a treatment for Krabbe disease. GALC is an enzyme in lysosomes needed to breakdown galactolipids, which are fats primarily found in the nervous system and kidneys. Among the galactolipids that GALC breaks down are galactosylceramide, which is an essential component of neuronal myelin, and psychosine, which is formed during myelin production and is toxic to cells. The misfolding of GALC can result in the toxic accumulation of galactosylceramide, inhibiting myelin production, and of psychosine, leading to demyelination of cells and ultimately to Krabbe disease. There is no available cure for Krabbe disease. Current developments in invasive procedures such as bone marrow transplants have not been shown to provide significant neurological improvements, and most developments in gene therapy treatments are still in the preclinical stages. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified compounds that bind to allosteric sites on GALC and stabilize the enzyme <font style="font-style: italic;">in vitro</font>. We are continuing our development of these promising molecules.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Overview of Krabbe Disease</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Krabbe disease is a severe neurological condition that is part of a group of disorders which result from the loss of myelin (demyelination) in the CNS. Myelin is the protective covering around neurons that ensures the rapid transmission of neural signals. The most common form of Krabbe disease, the infantile form, usually begins before the age of one. Initial symptoms typically include irritability, muscle weakness, feeding difficulties, episodes of fever without any sign of infection, stiff posture and delayed mental and physical development. As the disease progresses, muscles continue to weaken, affecting the infant&#8217;s ability to move, chew, swallow and breathe. Affected infants also experience vision loss and seizures. Because of the severity of the condition, individuals with the infantile form of Krabbe disease rarely survive beyond the age of two. The less common forms, those that have a later onset, begin in childhood, adolescence, or adulthood. Vision problems and walking difficulties are the most common initial symptoms in these late-onset forms of the disorder, however, signs and symptoms vary considerably among affected individuals. Individuals with late-onset Krabbe disease may survive many years after the condition begins.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Krabbe disease is an inherited LSD caused by mutations in the gene <font style="font-style: italic;">GALC</font>. In affected individuals, GALC substrate psychosine accumulation can trigger a neuroinflammatory response, a loss of myelin forming cells and a progressive demyelination of the central and peripheral nervous systems.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The prevalence of Krabbe disease is reported as about 1 in 100,000 to 1 in 250,000 live births worldwide. At present, there is no effective cure or disease-modifying treatment for Krabbe Disease. Treatment of a child who is symptomatic before six months of age is supportive and focused on improving quality of life and avoiding complications. For older individuals, treatment with HSCT is individualized based on disease burden and manifestations, but it serves to delay disease progression and is not an effective cure.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Preclinical Characterization of GALC STAR Lead Compounds</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;">Biological Activity </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have identified several compounds that bind to allosteric sites on GALC and are able to stabilize GALC against thermal denaturation. We plan to continue our development of these molecules and believe we can develop proprietary compounds with functional effects.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Competition</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The biotechnology and pharmaceutical industries, including the rare disease field, are characterized by rapidly changing technologies, intense competition and a strong emphasis on intellectual property. According to an October 2019 Grand View Research report, the global ERT market size is expected to grow at a compound annual growth rate of 7.7% from $6.74&#160;billion in 2018 to $12.1&#160;billion in 2026. Similarly, according to a June 2019 Fortune report, the global neurodegenerative diseases drug market is expected to grow at a compound annual growth rate of 7.4% from $35.5&#160;billion in 2018 to $62.8&#160;billion in 2026. While we believe that our differentiated platform, scientific expertise and know-how, along with intellectual property provide us with competitive advantages, we face current and future competition. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are not aware of any other companies that are taking the therapeutic approach to protein folding disorders similar to the one we are pursuing. However, we are aware of companies developing gene therapy approaches for our </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">77<br></div></div></div>
<!--End Page 80-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 81-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">target indications. For example, Axovant Gene Therapies, Ltd., recently began clinical trial for its gene therapy treatment for juvenile GM1, and Lysogene, S.A. is expected to initiate a clinical trial for its gene therapy treatment for GM1. Additionally, other companies are developing product candidates for the treatment of Krabbe disease such as Chiesi, Ranedis, Passage Bio, MediciNova and Polaryx, which are in the discovery and preclinical stages, and Magenta which is developing a cell-based approach for various inherited metabolic disorders, including Krabbe disease, which is in clinical trials. Companies such as Prevail Therapeutics and Apollo Therapeutics are developing candidates targeting GCase and <font style="font-style: italic;">GBA1</font> to address type 2 and type 3 Gaucher&#8217;s disease and are in the preclinical and clinical stage for certain candidates. We may also face competition from large pharmaceutical and biotechnology companies, academic research institutions, government agencies and public and private research institutions with genetic medicine and other therapeutic approaches.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Many of our potential competitors, alone or with their strategic partners, may have substantially greater financial, technical and other resources than we do. These may include larger research and development, clinical, marketing and manufacturing organizations and resources. Mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more resources being concentrated among a smaller number of competitors. Our commercial opportunity could be reduced or eliminated if competitors develop and commercialize products that are safer, more effective, more convenient or less expensive than any product candidates that we may develop. Competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. Additionally, new or advanced technologies developed by our competitors may render our current or future product candidates uneconomical or obsolete, and we may not be successful in marketing our product candidates against competitors.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Research Collaboration Agreement with Sumitomo Dainippon Pharma Co.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In September 2020, we entered into a strategic research collaboration agreement with Sumitomo for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. Under the terms of the agreement, we and Sumitomo will collaborate to identify and develop small molecules targeting allosteric sites in lysosomal enzymes for the treatment of rare genetic and demyelinating diseases. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">License Agreement with Minoryx Therapeutics, S.I.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have a License Agreement, dated December&#160;20, 2017 (the &#8220;Minoryx License Agreement&#8221;), with Minoryx Therapeutics, S.I., a company organized under the laws of Spain (&#8220;Minoryx&#8221;), pursuant to which we obtained, among other things, exclusive worldwide license rights from Minoryx to use and exploit its intellectual property (&#8220;IP&#8221;), including its SEE-Tx discovery platform for the identification of non-competitive pharmacological chaperones and exclusive worldwide sublicense rights to certain IP licensed by Minoryx from the University of Barcelona and the Instituci&#243; Catalana de Recerca i Estudis Avan&#231;ats. Under the terms of the Minoryx License Agreement, we have an exclusive, worldwide, royalty-bearing, assignable, transferable license, including the right to license through multiple tiers of sublicense, to Minoryx&#8217;s IP to make, have made, use, import, export, offer to sell, have sold, copy, modify, perform, display, create derivative versions of products in the licensed field or otherwise to exploit Minoryx&#8217;s IP in the field. Minoryx&#8217;s IP includes the Site-Directed Enzyme Enhancement Therapy (SEE-TX&#174;) discovery platform for identification of non-competitive pharmacological chaperones, certain proprietary Minoryx compounds acting as pharmacological chaperones, all patents and pending applications related thereto and Minoryx&#8217;s Know-How and Trademark related to the SEE-TX&#174; platform. We also have an exclusive, worldwide, royalty-bearing, assignable, transferable sublicense, including the right to sublicense through multiple tiers of sublicense, to the IP of Universitat de Barcelona (UB) and Institucio Catalana de Recerca i Estudis Avancats (ICREA) in EP11380102 and know-how and software related thereto, for the purpose of making, having made, using, importing, offering to sell, selling and having sold, copying, modifying, performing, displaying, and creating derivative versions of products in the field. Under the Minoryx License Agreement, products include any product in the field that would infringe the UB/ICREA IP or the Minoryx IP in the absence of the license provided therein. Also, field encompasses any field of use and commercialization of the UB/ICREA IP or the Minoryx IP. Unless earlier terminated, the Minoryx License Agreement expires upon expiration of the royalty term, which occurs ten years after the first product covered by the licensed IP is commercialized. Khalid Islam, the Chairman of our board of directors and one of our founders, is currently the Chairman of the board of directors of Minoryx.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As consideration for the license grant from Minoryx, we have agreed to pay Minoryx royalties on a product-by-product basis based on the licensed IP used by us, ranging from a high single digit to low single digit </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">78<br></div></div></div>
<!--End Page 81-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 82-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">percentage of net revenues of products during the royalty term commencing on the effective date of the Minoryx License Agreement and continuing until the 10th anniversary of the first product commercialization. Upon the expiration of the royalty term for a product or service in a country, the license with respect to the product or service, as the case may be, shall become royalty-free, fully-paid, irrevocable and perpetual.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to royalties, we will pay Minoryx certain milestones payments of 1.25% of any consideration received by us in the event of a sale of our company or substantially all of our assets, including by merger, change of control, or reorganization.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Minoryx License Agreement will terminate upon expiration of the royalty term (which is the 10th anniversary of the commercialization of the first product covered by the licensed IP) or by mutual agreement. In addition, each party has the right to terminate the Minoryx License Agreement upon a material breach by the other party that remains uncured. Minoryx has the right to terminate the Minoryx License Agreement on a country-by-country basis if we abandon the technology or use the technology for purposes in violation of law and we fail to cure such abandonment or unlawful use. We may terminate the Minoryx License Agreement at any time upon 90 days&#8217; written notice.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Intellectual Property</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We strive to protect and enhance the proprietary technologies, inventions and improvements that we believe are important to our business, including seeking, maintaining and defending patent rights, whether developed internally or licensed from third parties. Our policy is to seek to protect our proprietary position by, among other methods, pursuing and obtaining patent protection in the United States and in jurisdictions outside of the United States related to our proprietary technology, inventions, improvements, platforms and our product candidates that are important to the development and implementation of our business. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of November 14, 2020, our patent portfolio consisted of 3 pending European patent applications and related national stage applications. In regards to our SEE-Tx Technology, we in-license a European patent under the Minoryx License Agreement, which is owned by UB/ICREA and has claims directed to a method of binding site and binding energy determination by mixed explicit solvent simulations. This patent is expected to expire in 2032.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In regards to our GLB program, we in-license from Minoryx pursuant to the Minoryx License Agreement, a patent family with a pending European patent application with claims directed to composition of matter and 8 foreign patent applications pending in such jurisdictions such as Canada, Australia, Japan, Europe, and China. These patent applications, if issued, are expected to expire in 2037, not giving effect to any potential patent term extensions and patent term adjustments and assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In regards to our GBA program, we in-license from Minoryx pursuant to the Minoryx License Agreement, a patent family with a pending European patent application with claims directed to composition of matter and 8 foreign patent applications pending in such jurisdictions such as Canada, Australia, Japan, Europe, and China. These patent applications, if issued, are expected to expire in 2037, not giving effect to any potential patent term extensions and patent term adjustments and assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Individual patents extend for varying periods depending on the date of filing of the patent application or the date of patent issuance and the legal term of patents in the countries in which they are obtained. Generally, patents issued for regularly filed applications in the United States are granted a term of 20&#160;years from the earliest effective non-provisional filing date or the filing date of a PCT application that designates the United States. In addition, in certain instances, a patent term can be extended to recapture a portion of the U.S. Patent and Trademark Office, or USPTO, delay in issuing the patent as well as a portion of the term effectively lost as a result of the FDA regulatory review period. However, as to the FDA component, the restoration period cannot be longer than five years and the total patent term including the restoration period must not exceed 14&#160;years following FDA approval. The duration of foreign patents varies in accordance with provisions of applicable local law, but typically is also 20&#160;years from the earliest effective filing date, which is typically the filing date of the PCT application. However, the actual protection afforded by a patent varies on a product-by-product basis, from country to country and depends upon many factors, including the type of patent, the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patent.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">79<br></div></div></div>
<!--End Page 82-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 83-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Furthermore, we rely upon trade secrets and know-how and continuing technological innovation to develop and maintain our competitive position. We seek to protect our proprietary information, in part, using confidentiality agreements with our collaborators, employees and consultants and invention assignment agreements with our employees. We also have confidentiality agreements or invention assignment agreements with our collaborators and selected consultants. These agreements are designed to protect our proprietary information and, in the case of the invention assignment agreements, to grant us ownership of technologies that are developed through a relationship with a third party. These agreements may be breached, and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our collaborators, employees and consultants use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our success will also depend in part on not infringing upon the proprietary rights of third parties. It is uncertain whether the issuance of any third-party patent would require us to alter our development or commercial strategies, or our drugs or processes, obtain licenses or cease certain activities. Our breach of any license agreements or failure to obtain a license to proprietary rights that we may require to develop or commercialize our future drugs may have an adverse impact on us. If third parties have prepared and filed patent applications prior to March&#160;16, 2013 in the United States that also claim technology to which we have rights, we may have to participate in interference proceedings in the USPTO to determine priority of invention. For more information, please see &#8220;Risk Factors&#8212;Risks Related to Our Intellectual Property and Information Technology.&#8221; </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Government Regulation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The FDA and other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting of drugs. We, along with our vendors, contract research organizations and contract manufacturers, will be required to navigate the various preclinical, clinical, manufacturing and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval of our product candidates. The process of obtaining regulatory approvals of drugs and ensuring subsequent compliance with appropriate federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the U.S., the FDA regulates drug products under the Federal Food, Drug, and Cosmetic Act, or FD&amp;C Act, as amended, its implementing regulations and other laws. If we fail to comply with applicable FDA or other requirements at any time with respect to product development, clinical testing, approval or any other legal requirements relating to product manufacture, processing, handling, storage, quality control, safety, marketing, advertising, promotion, packaging, labeling, export, import, distribution, or sale, we may become subject to administrative or judicial sanctions or other legal consequences. These sanctions or consequences could include, among other things, the FDA&#8217;s refusal to approve pending applications, issuance of clinical holds for ongoing studies, withdrawal of approvals, warning or untitled letters, product withdrawals or recalls, product seizures, relabeling or repackaging, total or partial suspensions of manufacturing or distribution, injunctions, fines, civil penalties or criminal prosecution.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The process required by the FDA before our product candidates are approved as drugs for therapeutic indications and may be marketed in the U.S. generally involves the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">completion of extensive preclinical studies in accordance with applicable regulations, including studies conducted in accordance with good laboratory practice, or GLP, requirements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">submission to the FDA of an IND application, which must become effective before clinical trials may begin; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">approval by an institutional review board, or IRB, or independent ethics committee at each clinical trial site before each trial may be initiated; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">performance of adequate and well-controlled clinical trials in accordance with applicable IND regulations, good clinical practice, or GCP, requirements and other clinical trial-related regulations to establish the safety and efficacy of the investigational product for each proposed indication; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">submission to the FDA of an NDA; </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">80<br></div></div></div>
<!--End Page 83-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 84-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a determination by the FDA within 60 days of its receipt of an NDA, to accept the filing for review; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">satisfactory completion of one or more FDA pre-approval inspections of the manufacturing facility or facilities where the drug will be produced to assess compliance with cGMP requirements to assure that the facilities, methods and controls are adequate to preserve the drug&#8217;s identity, strength, quality and purity; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">potential FDA audit of the clinical trial sites that generated the data in support of the NDA; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">payment of user fees for FDA review of the NDA; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">FDA review and approval of the NDA, including consideration of the views of any FDA advisory committee, prior to any commercial marketing or sale of the drug in the U.S.</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Preclinical Studies and Clinical Trials for Drugs</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Before testing any drug in humans, the product candidate must undergo rigorous preclinical testing. Preclinical studies include laboratory evaluations of drug chemistry, formulation and stability, as well as in vitro and animal studies to assess safety and in some cases to establish the rationale for therapeutic use. The conduct of preclinical studies is subject to federal and state regulations and requirements, including GLP requirements for safety/toxicology studies. The results of the preclinical studies, together with manufacturing information and analytical data must be submitted to the FDA as part of an IND. An IND is a request for authorization from the FDA to administer an investigational product to humans and must become effective before clinical trials may begin. Some long-term preclinical testing may continue after the IND is submitted. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the 30-day time period, raises concerns or questions about the conduct of the clinical trial, including concerns that human research patients will be exposed to unreasonable health risks, and imposes a clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. Submission of an IND may result in the FDA not allowing clinical trials to commence or not allowing clinical trials to commence on the terms originally specified in the IND. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The clinical stage of development involves the administration of the product candidate to healthy volunteers or patients under the supervision of qualified investigators, generally physicians not employed by or under the trial sponsor&#8217;s control, in accordance with GCP requirements, which include the requirement that all research patients provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria and the parameters and criteria to be used in monitoring safety and evaluating effectiveness. Each protocol, and any subsequent amendments to the protocol, must be submitted to the FDA as part of the IND. Furthermore, each clinical trial must be reviewed and approved by an IRB for each institution at which the clinical trial will be conducted to ensure that the risks to individuals participating in the clinical trial are minimized and are reasonable related to the anticipated benefits. The IRB also approves the informed consent form that must be provided to each clinical trial subject or his or her legal representative, and must monitor the clinical trial until completed. The FDA, the IRB or the sponsor may suspend or discontinue a clinical trial at any time on various grounds, including a finding that the patients are being exposed to an unacceptable health risk. There also are requirements governing the reporting of ongoing clinical trials and completed clinical trials to public registries. Information about clinical trials, including clinical trials results, must be submitted within specific timeframes for publication on the www.clinicaltrials.gov website.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A sponsor who wishes to conduct a clinical trial outside of the U.S. may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. If a foreign clinical trial is not conducted under an IND, the sponsor can submit data from the clinical trial to the FDA in support of an NDA. The FDA will accept a well-designed and well-conducted foreign clinical trial not conducted under an IND if the trial was conducted in accordance with GCP requirements, and the FDA is able to validate the data through an onsite inspection if deemed necessary.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Clinical trials to evaluate therapeutic indications to support NDAs for marketing approval are typically conducted in three sequential phases, which may overlap. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Phase I</font>&#8212;Phase I clinical trials involve initial introduction of the investigational product into healthy human volunteers or patients with the target disease or condition. These studies are typically designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, excretion the side effects associated with increasing doses, and, if possible, to gain early evidence of effectiveness. </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">81<br></div></div></div>
<!--End Page 84-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 85-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Phase II</font>&#8212;Phase II clinical trials typically involve administration of the investigational product to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Phase III</font>&#8212;Phase III clinical trials typically involve administration of the investigational product to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval and physician labeling.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Post-approval trials, sometimes referred to as Phase IV clinical trials, may be conducted after initial marketing approval. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication and are commonly intended to generate additional safety data regarding use of the product in a clinical setting. In certain instances, the FDA may mandate the performance of Phase IV clinical trials as a condition of approval of an NDA.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Progress reports detailing the results of the clinical trials, among other information, must be submitted at least annually to the FDA. Written IND safety reports must be submitted to the FDA and the investigators fifteen days after the trial sponsor determines the information qualifies for reporting for serious and unexpected suspected adverse events, findings from other studies or animal or in vitro testing that suggest a significant risk for human volunteers and any clinically important increase in the severity or rate of a serious suspected adverse reaction over that listed in the investigator brochure. The sponsor must also notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction as soon as possible but in no case later than seven calendar days after the sponsor&#8217;s initial receipt of the information.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Concurrent with clinical trials, companies usually complete additional animal studies and must also develop additional information about the chemistry and physical characteristics of the product candidate and finalize a process for manufacturing the drug product in commercial quantities in accordance with cGMP requirements.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The manufacturing process must be capable of consistently producing quality batches of the product candidate and manufacturers must develop, among other things, methods for testing the identity, strength, quality and purity of the final drug product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">U.S. Marketing Approval for Drugs</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Assuming successful completion of the required clinical testing, the results of the preclinical studies and clinical trials, together with detailed information relating to the product&#8217;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. An NDA must contain proof of the drug&#8217;s safety and efficacy. The marketing application may include both negative and ambiguous results of preclinical studies and clinical trials, as well as positive findings. Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a product&#8217;s use or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of the FDA. FDA approval of an NDA must be obtained before a drug may be marketed in the U.S.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The FDA reviews all submitted NDAs before it accepts them for filing and may request additional information rather than accepting the NDA for filing. The FDA must make a decision on accepting an NDA for filing within 60 days of receipt, and such decision could include a refusal to file by the FDA. Once the submission is accepted for filing, the FDA begins an in-depth substantive review of the NDA. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective and whether the facility in which it is manufactured, processed, packaged or held meets standards designed to assure the product&#8217;s continued safety, quality and purity. Under the goals and polices agreed to by the FDA under the Prescription Drug User Fee Act, or PDUFA, the FDA targets ten months, from the filing date, in which to complete its initial review of a new molecular entity NDA and respond to the applicant, and six months from the filing date of a new molecular entity NDA for priority review. The FDA does not always meet its PDUFA goal dates for standard or priority NDAs, and the review process is often extended by FDA requests for additional information or clarification.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">82<br></div></div></div>
<!--End Page 85-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 86-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, under PDUFA, as amended, each NDA must be accompanied by a user fee. The FDA adjusts the PDUFA user fees on an annual basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The FDA also may require submission of a Risk Evaluation and Mitigation Strategy, or REMS, program to ensure that the benefits of the drug outweigh its risks. The REMS program could include medication guides, physician communication plans, assessment plans and/or elements to assure safe use, such as restricted distribution methods, patient registries or other risk-minimization tools.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The FDA may refer an application for a novel drug to an advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with GCP and other requirements and the integrity of the clinical data submitted to the FDA.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a complete response letter. A complete response letter generally contains a statement of specific conditions that must be met in order to secure final approval of the NDA and may require additional clinical or preclinical testing in order for the FDA to reconsider the application. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#8217;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Even if the FDA approves a product, depending on the specific risk(s) to be addressed it may limit the approved indications for use of the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase IV clinical trials, be conducted to further assess a drug&#8217;s safety after approval, require testing and surveillance programs to monitor the product after commercialization or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS, which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further testing requirements and FDA review and approval. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Orphan Drug Designation and Exclusivity</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the Orphan Drug Act of 1983, the FDA may grant orphan designation to a drug intended to treat a rare disease or condition, which is a disease or condition that affects fewer than 200,000 individuals in the U.S., or if it affects more than 200,000 individuals in the U.S., there is no reasonable expectation that the cost of developing and making the product available in the U.S. for the disease or condition will be recovered from sales of the product. Orphan designation must be requested before submitting an NDA. Orphan designation does not convey any advantage in or shorten the duration of the regulatory review and approval process, though companies developing orphan products are eligible for certain incentives, including tax credits for qualified clinical testing and waiver of application fees.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If a product that has orphan designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to a seven-year period of marketing exclusivity during which the FDA may not approve any other applications to market the same therapeutic agent for the same indication, except in limited circumstances, such as a subsequent product&#8217;s showing of clinical superiority over the product with orphan exclusivity or where the original applicant cannot produce sufficient quantities of product. Competitors, however, may receive approval of different therapeutic agents for the indication for which the orphan product has exclusivity or obtain approval for the same therapeutic agent for a different indication than that for which the orphan product has </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">83<br></div></div></div>
<!--End Page 86-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 87-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">exclusivity. Orphan product exclusivity could block the approval of one of our products for seven years if a competitor obtains approval for the same therapeutic agent for the same indication before we do, unless we are able to demonstrate that our product is clinically superior. If an orphan designated product receives marketing approval for an indication broader than what is designated, it may not be entitled to orphan exclusivity. Further, orphan drug exclusive marketing rights in the U.S. may be lost if the FDA later determines that the request for designation was materially defective or the manufacturer of the approved product is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Expedited Development and Review Programs for Drugs</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The FDA maintains several programs intended to facilitate and expedite development and review of new drugs to address unmet medical needs in the treatment of serious or life-threatening diseases or conditions. These programs include Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval, and the purpose of these programs is to either expedite the development or review of important new drugs to get them to patients earlier than under standard FDA development and review procedures.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A new drug is eligible for Fast Track designation if it is intended to treat a serious or life-threatening disease or condition and demonstrates the potential to address unmet medical needs for such disease or condition. Fast Track designation provides increased opportunities for sponsor interactions with the FDA during preclinical and clinical development, in addition to the potential for rolling review once a marketing application is filed, meaning that the agency may review portions of the marketing application before the sponsor submits the complete application, as well as Priority Review, discussed below.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, a new drug may be eligible for Breakthrough Therapy designation if it is intended to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Breakthrough Therapy designation provides all the features of Fast Track designation in addition to intensive guidance on an efficient drug development program beginning as early as Phase I, and FDA organizational commitment to expedited development, including involvement of senior managers and experienced review staff in a cross-disciplinary review, where appropriate.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any product submitted to the FDA for approval, including a product with Fast Track or Breakthrough Therapy designation, may also be eligible for additional FDA programs intended to expedite the review and approval process, including Priority Review designation and Accelerated Approval. A product is eligible for Priority Review if it has the potential to provide a significant improvement in safety or effectiveness in the treatment, diagnosis or prevention of a serious disease or condition. Under Priority Review, the FDA must review an application in six months compared to ten months for a standard review.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, products are eligible for Accelerated Approval if they can be shown to have an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or an effect on a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality which is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity or prevalence of the condition and the availability or lack of alternative treatments.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Accelerated Approval is usually contingent on a sponsor&#8217;s agreement to conduct additional post-approval studies to verify and describe the product&#8217;s clinical benefit. The FDA may withdraw approval of a drug or indication approved under Accelerated Approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, unless otherwise informed by the FDA, the FDA currently requires, as a condition for Accelerated Approval, that all advertising and promotional materials that are intended for dissemination or publication within 120 days following marketing approval be submitted to the agency for review during the pre-approval review period, and that after 120 days following marketing approval, all advertising and promotional materials must be submitted at least 30 days prior to the intended time of initial dissemination or publication.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or the time period for FDA review or approval may not be shortened. Furthermore, Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval do not change the scientific or medical standards for approval or the quality of evidence necessary to support approval but may expedite the development or review process. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">84<br></div></div></div>
<!--End Page 87-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 88-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">U.S. Post-Approval Requirements for Drugs</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, reporting of adverse experiences with the product, complying with promotion and advertising requirements, which include restrictions on promoting products for unapproved uses or patient populations (known as &#8220;off-label use&#8221;) and limitations on industry-sponsored scientific and educational activities. Although physicians may prescribe legally available products for off-label uses, manufacturers may not market or promote such uses. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability, including investigation by federal and state authorities. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first use or first publication. Further, if there are any modifications to the drug, including changes in indications, labeling or manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new NDA or NDA supplement, which may require the development of additional data or preclinical studies and clinical trials.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-market testing, including Phase IV clinical trials, and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, drug manufacturers and their subcontractors involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with ongoing regulatory requirements, including cGMP, which impose certain procedural and documentation requirements upon us and our contract manufacturers. Failure to comply with statutory and regulatory requirements can subject a manufacturer to possible legal or regulatory action, such as warning letters, suspension of manufacturing, product seizures, injunctions, civil penalties or criminal prosecution. There is also a continuing, annual prescription drug product program user fee.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, requirements for post-market studies or clinical trials to assess new safety risks, or imposition of distribution or other restrictions under a REMS. Other potential consequences include, among other things: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings or other safety information about the product; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">fines, warning letters or holds on post-approval clinical trials; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">refusal of the FDA to approve applications or supplements to approved applications, or withdrawal of product approvals; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">product seizure or detention, or refusal to permit the import or export of products; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">injunctions or the imposition of civil or criminal penalties; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs; or mandated modification of promotional materials and labeling and issuance of corrective information.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">85<br></div></div></div>
<!--End Page 88-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 89-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Other Regulatory Matters</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Manufacturing, sales, promotion and other activities of product candidates following product approval, where applicable, or commercialization are also subject to regulation by numerous regulatory authorities in the U.S. in addition to the FDA, which may include the Centers for Medicare &amp; Medicaid Services, or CMS, other divisions of the Department of Health and Human Services, the Department of Justice, the Drug Enforcement Administration, the Consumer Product Safety Commission, the Federal Trade Commission, the Occupational Safety &amp; Health Administration, the Environmental Protection Agency and state and local governments and governmental agencies.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Healthcare Reform</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March 2010, Congress passed the Affordable Care Act, or the ACA, a sweeping law intended to broaden access to health insurance, reduce or constrain the growth of health spending, enhance remedies against fraud and abuse, add new transparency requirements for the healthcare and health insurance industries, impose new taxes and fees on the health industry, and impose additional policy reforms. The ACA, for example, contains provisions that subject products to potential competition by lower-cost products and may reduce the profitability of products through increased rebates for drugs reimbursed by Medicaid programs; address a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increase the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program to individuals enrolled in Medicaid managed care organizations; establish annual fees and taxes on manufacturers of certain branded prescription drugs; and create a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 50% (increased to 70% pursuant to the Bipartisan Budget Act of 2018, or BBA, effective as of 2019) point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part D.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Since its enactment, there have been judicial, administrative, executive and Congressional legislative challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. For example, various portions of the ACA are currently undergoing constitutional challenges in the U.S. Supreme Court, the Trump Administration has issued various Executive Orders eliminating cost sharing subsidies and various provisions that would impose a fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices, and Congress has introduced several pieces of legislation aimed at significantly revising or repealing the ACA. It is unclear whether the ACA will be overturned, repealed, replaced, or further amended, and we cannot predict what affect further changes to the ACA would have on our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other federal health reform measures have been proposed and adopted in the U.S. since the ACA was enacted: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. These changes included aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, which went into effect in April 2013 and, due to subsequent legislative amendments to the statute, including the BBA, will remain in effect through 2030, unless additional Congressional action is taken. These Medicare sequester reductions have been suspended from May 1, 2020 through December 31, 2020 due to the COVID-19 pandemic. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The American Taxpayer Relief Act of 2012, among other things, reduced Medicare payments to several providers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The Middle Class Tax Relief and Job Creation Act of 2012 required that CMS reduce the Medicare clinical laboratory fee schedule by 2% in 2013, which served as a base for 2014 and subsequent years. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">In addition, effective January 1, 2014, CMS also began bundling the Medicare payments for certain laboratory tests ordered while a patient received services in a hospital outpatient setting.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">86<br></div></div></div>
<!--End Page 89-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 90-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which have resulted in several recent Congressional inquiries and proposed and enacted bills designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. In addition, the U.S. government, state legislatures, and foreign governments have shown significant interest in implementing cost containment programs, including price-controls, restrictions on reimbursement and requirements for substitution of generic products for branded prescription drugs to limit the growth of government paid healthcare costs. For example, the U.S. government has passed legislation requiring pharmaceutical manufacturers to provide rebates and discounts to certain entities and governmental payors to participate in federal healthcare programs. Further, Congress and the Trump administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs, and the current administration recently released a &#8220;Blueprint,&#8221; or plan, to reduce the cost of drugs. The Blueprint contains certain measures that the U.S. Department of Health and Human Services is already working to implement. Individual states in the U.S. have also increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Congress and the Trump administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. Additionally, we may face competition in the United States for our development candidates and investigational medicines, if approved, from therapies sourced from foreign countries that have placed price controls on pharmaceutical products. In the United States, the Medicare Modernization Act, or MMA, contains provisions that call for the promulgation of regulations that expand pharmacists&#8217; and wholesalers&#8217; ability to import cheaper versions of an approved drug and competing products from Canada, where there are government price controls. Further, the MMA provides that these changes to U.S. importation laws will not take effect, unless and until the Secretary of the HHS certifies that the changes will pose no additional risk to the public&#8217;s health and safety and will result in a significant reduction in the cost of products to consumers. On September 23, 2020, the Secretary of the HHS made such certification to Congress, and on October&#160;1, 2020, the FDA published a final rule that allows for the importation of certain prescription drugs from Canada. Under the final rule, States and Indian Tribes, and in certain future circumstances pharmacists and wholesalers, may submit importation program proposals to the FDA for review and authorization. On September&#160;25, 2020, CMS stated drugs imported by States under this rule will not be eligible for federal rebates under Section&#160;1927 of the Social Security Act and manufacturers would not report these drugs for &#8220;best price&#8221; or Average Manufacturer Price purposes. Since these drugs are not considered covered outpatient drugs, CMS further stated it will not publish a National Average Drug Acquisition Cost for these drugs. Separately, the FDA also issued a final guidance document outlining a pathway for manufacturers to obtain an additional National Drug Code, or NDC, for an FDA-approved drug that was originally intended to be marketed in a foreign country and that was authorized for sale in that foreign country. The market implications of the final rule and guidance are unknown at this time. Proponents of drug reimportation may attempt to pass legislation that would directly allow reimportation under certain circumstances. Legislation or regulations allowing the reimportation of drugs, if enacted, could decrease the price we receive for any products that we may develop and adversely affect our future revenues and prospects for profitability. Individual states in the U.S. have also been increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">From time to time, legislation is drafted, introduced, and passed in Congress that could significantly change the statutory provisions governing the sale, marketing, coverage, and reimbursement of products regulated by CMS or other government agencies. In addition to new legislation, CMS regulations and policies are often revised or interpreted by the agency in ways significantly affecting our business and our products. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Other Healthcare Laws and Regulations</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If we obtain regulatory approval of our products, we may be subject to various federal and state laws targeting fraud and abuse in the healthcare industry. These laws may impact, among other things, our proposed sales and marketing strategies. In addition, we may be subject to patient privacy regulation by both the federal government and the states in which we conduct our business. These laws include, without limitation, state and federal anti-kickback, fraud and abuse, false claims, privacy and security, and physician sunshine laws and regulations.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">87<br></div></div></div>
<!--End Page 90-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 91-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The federal Anti-Kickback Statute prohibits, among other things, any person from knowingly and willfully offering, soliciting, receiving or paying remuneration (a term interpreted broadly to include anything of value, including, for example, gifts, discounts and credits), directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, order or recommendation of, an item or reimbursable, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. Violations of the federal Anti-Kickback Statute can result in significant civil monetary and criminal penalties, per kickback plus three times the amount of remuneration and a prison term per violation. Further, violation of the federal Anti-Kickback Statute can also form the basis for False Claims Act liability (discussed below). A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, many states have adopted laws similar to the federal Anti-Kickback Statute, some of which apply to the referral of patients for healthcare items or services reimbursed by any source, not only government programs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, the civil False Claims Act (the &#8220;FCA&#8221;) prohibits knowingly presenting or causing the presentation of a false, fictitious or fraudulent claim for payment to the U.S. government. Actions under the FCA may be brought by the Attorney General or as a qui tam action by a private individual in the name of the government. Violations of the FCA can result in very significant monetary penalties, for each false claim and treble the amount of the government&#8217;s damages. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims. The federal government continues to use the FCA, and the accompanying threat of significant liability, in its investigations and prosecutions of pharmaceutical and biotechnology companies throughout the U.S. Such investigations and prosecutions frequently involve, for example, the alleged promotion of products for unapproved uses and other sales and marketing practices. The government has obtained multi-million and multi-billion dollar settlements under the FCA in addition to individual criminal convictions under applicable criminal statutes. Given the significant size of actual and potential settlements, it is expected that the government will continue to devote substantial resources to investigating healthcare providers&#8217; and manufacturers&#8217; compliance with the FCA and other applicable fraud and abuse laws.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may be subject to the federal Civil Monetary Penalties Law, which prohibits, among other things, the offering or transferring of remuneration to a Medicare or Medicaid beneficiary that the person knows or should know is likely to influence the beneficiary&#8217;s selection of a particular supplier of Medicare or Medicaid payable items or services. Federal government price reporting laws require manufacturers to calculate and report complex pricing metrics to government programs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The U.S. federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, includes a fraud and abuse provision referred to as the HIPAA All-Payor Fraud Law, which imposes criminal and civil liability for executing a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may also be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and its implementing regulations, including the final omnibus rule published on January 25, 2013, imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#8217;s privacy and security standards directly applicable to &#8220;business associates,&#8221; defined as independent contractors or agents of covered entities that create, receive, maintain or transmit protected health information in connection with providing a service for or on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. Many states also have laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">California recently enacted the California Consumer Privacy Act, or CCPA, which creates new individual privacy rights for California consumers (as defined in the law) and places increased privacy and security obligations on entities handling personal data of consumers or households. The CCPA will require covered companies to provide </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">88<br></div></div></div>
<!--End Page 91-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 92-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">certain disclosures to consumers about its data collection, use and sharing practices, and to provide affected California residents with ways to opt-out of certain sales or transfers of personal information. The CCPA went into effect on January 1, 2020, and the California Attorney General commenced enforcement actions against violators beginning July 1, 2020. While there is currently an exception for protected health information that is subject to HIPAA and clinical trial regulations, as currently written, the CCPA may impact our business activities. The California Attorney General has proposed draft regulations, which have not been finalized to date, that may further impact our business activities if they are adopted. The uncertainty surrounding the implementation of CCPA exemplifies the vulnerability of our business to the evolving regulatory environment related to personal data and protected health information.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may also be subject to federal transparency laws, including the federal Physician Payment Sunshine Act, which was part of the ACA and requires manufacturers of certain drugs and biologics, among others, to track and disclose payments and other transfers of value they make to U.S. physicians and teaching hospitals, as well as physician ownership and investment interests in the manufacturer. Effective January 1, 2022, these reporting obligations will extend to include transfers of value made to certain non-physician providers such as physician assistants and nurse practitioners. This information is subsequently made publicly available in a searchable format on a CMS website. Failure to disclose required information may result in civil monetary penalties for all payments, transfers of value or ownership or investment interests that are not timely, accurately and completely reported in an annual submission. Certain states also mandate implementation of compliance programs, impose restrictions on drug manufacturer marketing practices and/or require the tracking and reporting of gifts, compensation and other remuneration to physicians and/or other healthcare providers.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As noted above, analogous state laws and regulations, such as, state anti-kickback and false claims laws may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers. Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government in addition to requiring drug manufacturers to report information related to payments to physicians and other healthcare providers or marketing expenditures. There are also state and local laws that require the registration of pharmaceutical sales representatives.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, contractual damages, reputational harm, diminished profits and future earnings, imprisonment, exclusion of drugs from government funded healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, any of which could adversely affect our ability to operate our business and our financial results. If any of the physicians or other healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to significant criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs. Ensuring business arrangements comply with applicable healthcare laws, as well as responding to possible investigations by government authorities, can be time- and resource consuming and can divert a company&#8217;s attention from the business. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Government Regulation of Drugs Outside of the United States</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To market any product outside of the U.S., we would need to comply with numerous and varying regulatory requirements of other countries regarding safety and efficacy and governing, among other things, clinical trials, marketing authorization or identification of an alternate regulatory pathway, manufacturing, commercial sales and distribution of our products. For instance, in the United Kingdom and the European Economic Area, or the EEA (comprised of the 27 EU Member States plus Iceland, Liechtenstein and Norway), medicinal products must be authorized for marketing by using either the centralized authorization procedure or national authorization procedures. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">89<br></div></div></div>
<!--End Page 92-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 93-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Centralized procedure</font>&#8212;If pursuing marketing authorization of a product candidate for a therapeutic indication under the centralized procedure, following the opinion of the European Medicines Agency&#8217;s Committee for Medicinal Products for Human Use, or, CHMP, the European Commission issues a single marketing authorization valid across the EEA. The centralized procedure is compulsory for human medicines derived from biotechnology processes or advanced therapy medicinal products (such as gene therapy, somatic cell therapy and tissue engineered products), products that contain a new active substance indicated for the treatment of certain diseases, such as HIV/AIDS, cancer, neurodegenerative disorders, diabetes, autoimmune diseases and other immune dysfunctions, viral diseases, and officially designated orphan medicines. For medicines that do not fall within these categories, an applicant has the option of submitting an application for a centralized marketing authorization to the European Medicines Agency, or EMA, as long as the medicine concerned contains a new active substance not yet authorized in the EEA, is a significant therapeutic, scientific or technical innovation, or if its authorization would be in the interest of public health in the EEA. Under the centralized procedure the maximum timeframe for the evaluation of an MAA by the EMA is 210 days, excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP. Accelerated assessment might be granted by the CHMP in exceptional cases, when a medicinal product is expected to be of a major public health interest, particularly from the point of view of therapeutic innovation. The timeframe for the evaluation of an MAA under the accelerated assessment procedure is 150 days, excluding clock stops. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">National authorization procedures</font>&#8212;There are also two other possible routes to authorize products for therapeutic indications in several countries, which are available for products that fall outside the scope of the centralized procedure: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Decentralized procedure</font>&#8212;Using the decentralized procedure, an applicant may apply for simultaneous authorization in more than one EU country of medicinal products that have not yet been authorized in any EU country and that do not fall within the mandatory scope of the centralized procedure. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Mutual recognition procedure</font>&#8212;In the mutual recognition procedure, a medicine is first authorized in one EU Member State, in accordance with the national procedures of that country. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Following authorization through either procedure, additional marketing authorizations can be sought from other EU countries in a procedure whereby the countries concerned recognize the validity of the original, national marketing authorization.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the EEA, new products for therapeutic indications that are authorized for marketing (i.e., reference products) qualify for eight years of data exclusivity and an additional two years of market exclusivity upon marketing authorization. The data exclusivity period prevents generic or biosimilar applicants from relying on the preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization in the EU during a period of eight years from the date on which the reference product was first authorized in the EU. The market exclusivity period prevents a successful generic or biosimilar applicant from commercializing its product in the EU until ten years have elapsed from the initial authorization of the reference product in the EU. The ten-year market exclusivity period can be extended to a maximum of eleven years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The criteria for designating an &#8220;orphan medicinal product&#8221; in the EEA are similar in principle to those in the U.S. In the EEA a medicinal product may be designated as orphan if (1)&#160;it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition; (2)&#160;either (a)&#160;such condition affects no more than five in 10,000 persons in the EU when the application is made, or (b)&#160;the product, without the benefits derived from orphan status, would not generate sufficient return in the EU to justify investment; and (3)&#160;there exists no satisfactory method of diagnosis, prevention or treatment of such condition authorized for marketing in the EU, or if such a method exists, the product will be of significant benefit to those affected by the condition. Orphan medicinal products are eligible for financial incentives such as reduction of fees or fee waivers and are, upon grant of a marketing authorization, entitled to ten years of market exclusivity for the approved therapeutic indication. During this ten-year orphan market exclusivity period, no marketing authorization application shall be accepted, and no marketing authorization shall be granted for a similar medicinal product for the same indication. An orphan product can also obtain an additional two years of market exclusivity in the EU for pediatric studies. The ten-year market </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">90<br></div></div></div>
<!--End Page 93-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 94-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">exclusivity may be reduced to six years if, at the end of the fifth year, it is established that the product no longer meets the criteria for orphan designation, for example, if the product is sufficiently profitable not to justify maintenance of market exclusivity. Additionally, marketing authorization may be granted to a similar product for the same indication at any time if (i)&#160;the second applicant can establish that its product, although similar, is safer, more effective or otherwise clinically superior; (ii)&#160;the applicant consents to a second orphan medicinal product application; or (iii) the applicant cannot supply enough orphan medicinal product.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Similar to the United States, the various phases of non-clinical and clinical research in the European Union are subject to significant regulatory controls.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Clinical Trials Directive 2001/20/EC, the Directive 2005/28/EC on GCP and the related national implementing provisions of the individual EU Member States govern the system for the approval of clinical trials in the European Union. Under this system, an applicant must obtain prior approval from the competent national authority of the EU Member State in which the clinical trial is to be conducted. Furthermore, the applicant may only start a clinical trial at a specific trial site after the competent ethics committee has issued a favorable opinion. The clinical trial application must be accompanied by, among other documents, an investigational medicinal product dossier (the Common Technical Document) with supporting information prescribed by Directive 2001/20/EC, Directive 2005/28/EC, where relevant the implementing national provisions of the individual EU Member States and further detailed in applicable guidance documents.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In April 2014, the new Clinical Trials Regulation, (EU) No 536/2014 (Clinical Trials Regulation) was adopted. It is expected that the new Clinical Trials Regulation (EU) No 536/2014 will apply following confirmation of full functionality of the Clinical Trials Information System, or CTIS, the centralized European Union portal and database for clinical trials foreseen by the regulation, through an independent audit. The regulation becomes applicable six months after the European Commission publishes notice of this confirmation. The Clinical Trials Regulation will be directly applicable in all the EU Member States, repealing the current Clinical Trials Directive 2001/20/EC. Conduct of all clinical trials performed in the European Union will continue to be bound by currently applicable provisions until the new Clinical Trials Regulation becomes applicable. The extent to which ongoing clinical trials will be governed by the Clinical Trials Regulation will depend on when the Clinical Trials Regulation becomes applicable and on the duration of the individual clinical trial. If a clinical trial continues for more than three years from the day on which the Clinical Trials Regulation becomes applicable the Clinical Trials Regulation will at that time begin to apply to the clinical trial. The new Clinical Trials Regulation aims to simplify and streamline the approval of clinical trials in the European Union. The main characteristics of the regulation include: a streamlined application procedure via a single-entry point, the &#8220;EU portal&#8221;; a single set of documents to be prepared and submitted for the application as well as simplified reporting procedures for clinical trial sponsors; and a harmonized procedure for the assessment of applications for clinical trials, which is divided in two parts. Part I is assessed by the competent authorities of all EU Member States in which an application for authorization of a clinical trial has been submitted (Member States concerned). Part II is assessed separately by each Member State concerned. Strict deadlines have been established for the assessment of clinical trial applications. The role of the relevant ethics committees in the assessment procedure will continue to be governed by the national law of the concerned EU Member State. However, overall related timelines will be defined by the Clinical Trials Regulation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The collection and use of personal health data in the European Union, previously governed by the provisions of the Data Protection Directive, is now governed by the General Data Protection Regulation, or the GDPR, which became effective on May 25, 2018. While the Data Protection Directive did not apply to organizations based outside the EU, the GDPR has expanded its reach to include any business, regardless of its location, that provides goods or services to residents in the EU. This expansion would incorporate any clinical trial activities in EU members states. The GDPR imposes strict requirements on controllers and processors of personal data, including special protections for &#8220;sensitive information&#8221; which includes health and genetic information of data patients residing in the EU. GDPR grants individuals the opportunity to object to the processing of their personal information, allows them to request deletion of personal information in certain circumstances, and provides the individual with an express right to seek legal remedies in the event the individual believes his or her rights have been violated. Further, the GDPR imposes strict rules on the transfer of personal data out of the European Union to the U.S. or other regions that have not been deemed to offer &#8220;adequate&#8221; privacy protections. Failure to comply with the requirements of the GDPR and the related national data protection laws of the European Union Member States, which may deviate slightly from the GDPR, may result in fines of up to 4% of global revenues, or &#8364;20,000,000, whichever is greater. As a result of the implementation of the GDPR, we may be required to put in place additional mechanisms ensuring compliance with the new data protection rules.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">91<br></div></div></div>
<!--End Page 94-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 95-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_110-bus_pg30"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There is significant uncertainty related to the manner in which data protection authorities will seek to enforce compliance with GDPR. For example, it is not clear if the authorities will conduct random audits of companies doing business in the EU, or if the authorities will wait for complaints to be filed by individuals who claim their rights have been violated. Enforcement uncertainty and the costs associated with ensuring GDPR compliance are onerous and may adversely affect our business, financial condition, results of operations and prospects.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Should we utilize third-party distributors, compliance with such foreign governmental regulations would generally be the responsibility of such distributors, who may be independent contractors over whom we have limited control. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">U.S. Patent Term Restoration and Marketing Exclusivity</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Depending upon the timing, duration and specifics of FDA approval of our future product candidates, some of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, commonly referred to as the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit restoration of the patent term of up to five years as compensation for patent term lost during the FDA regulatory review process. Patent-term restoration, however, cannot extend the remaining term of a patent beyond a total of 14 years from the product&#8217;s approval date and only those claims covering such approved drug product, a method for using it or a method for manufacturing it may be extended. The patent-term restoration period is generally one-half the time between the effective date of an IND and the submission date of an NDA plus the time between the submission date of an NDA and the approval of that application, except that the review period is reduced by any time during which the applicant failed to exercise due diligence. Only one patent applicable to an approved drug is eligible for the extension and the application for the extension must be submitted prior to the expiration of the patent. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, we may apply for restoration of patent term for our currently owned or licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant NDA.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Marketing exclusivity provisions under the FD&amp;C Act also can delay the submission or the approval of certain applications. The FD&amp;C Act provides a five-year period of non-patent marketing exclusivity within the United States to the first applicant to gain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review an abbreviated new drug application, or ANDA, or a 505(b)(2) NDA submitted by another company for another version of such drug where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement. The FD&amp;C Act also provides three years of marketing exclusivity for an NDA, 505(b)(2) NDA or supplement to an existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example, new indications, dosages or strengths of an existing drug. This three-year exclusivity covers only the conditions of use associated with the new clinical investigations and does not prohibit the FDA from approving ANDAs for drugs containing the original active agent. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Employees</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2020, we had eleven full-time employees and three part-time employees. Seven employees are based in Barcelona, Spain, six employees are based in Lugano, Switzerland and one employee is based in Potomac, Maryland. Of these fourteen employees, ten are engaged in research and development activities and four are engaged in finance, investor relations and general management. Our employees in Spain are subject to a national collective labor agreement, Convenio General de la Industria Ouimica. National agreements are negotiated collectively between the national associations of companies within a given industry and the respective national unions. We consider our relationship with our employees to be good and have not experienced any work stoppages.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In January 2021, we hired on a full-time basis, an executive assistant and a business development manager, who are both based in the United States. The total number of employees as of January 2021 is 16 employees.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">92<br></div></div></div>
<!--End Page 95-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 96-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_111-management_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tMAN"><!--Anchor--></a>MANAGEMENT</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">Directors and Executive Officers</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table sets forth the names, ages and positions of our directors and executive officers as of the date of this prospectus.</div><table cellspacing="0" cellpadding="0" class="txttab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Age</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 53.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Position</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Eric Richman</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">60</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Executive Officer, Director</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salvatore Calabrese</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">51</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Financial Officer</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Manolo Bellotto</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">50</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">President, General Manager</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Khalid Islam</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">65</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Founder and Chairman</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dov Goldstein</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">53</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Hans Peter Hasler </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">65 </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director </div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Gwen Melincoff </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">69 </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director </div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Claude Nicaise</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">68</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Jeffrey Riley</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">57</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Executive Officers</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Eric I. Richman<font style="font-weight: normal;"> has served as our Chief Executive Officer and as a member of our board of directors since </font><font style="font-weight: normal;">July 2020. Mr.&#160;Richman has over 25&#160;years of experience in the biotechnology and pharmaceutical industries as an </font><font style="font-weight: normal;">investor and in operational roles. He served as a Venture Partner at Brace Pharma Capital, a life science venture </font><font style="font-weight: normal;">capital firm from 2016 to 2018 and Advisor to Broad Oak Capital, a life science private equity firm from 2015 to </font><font style="font-weight: normal;">present. Mr.&#160;Richman also served as Chief Executive Officer of Tyrogenex Inc., a biopharmaceutical company and </font><font style="font-weight: normal;">he served as Chief Executive Officer of PharmAthene, Inc. (&#8220;PharmAthene&#8221;), subsequently acquired by Alt</font><font style="font-weight: normal;">i</font><font style="font-weight: normal;">mmune, </font><font style="font-weight: normal;">Inc, from 2010 to 2015. Prior to PharmAthene, Mr.&#160;Richman held various commercial and strategic positions at </font><font style="font-weight: normal;">MedImmune, Inc. over a 12-year period from its inception. Mr.&#160;Richman currently serves as a director of Neubase </font><font style="font-weight: normal;">Therapeutics, Inc. (Nasdaq:NBSE) and NovelStem International Corp. (OTCMKTS: NSTM), co-founder and </font><font style="font-weight: normal;">Chairman of InFuse Holdings and Chairman of the </font><font style="font-weight: normal;">b</font><font style="font-weight: normal;">oard of LabConnect, Inc. Between 2007 and 2020, he served as </font><font style="font-weight: normal;">a director of Adma Biologics, Inc. (Nasdaq: ADMA), Zyversa Therapeutics, Inc. and LEV Pharma (OTC:LEVP), </font><font style="font-weight: normal;">which was acquired by Viropharma, among others private and public companies. Mr.&#160;Richman received a B.S. in </font><font style="font-weight: normal;">Biomedical Science from the Sophie Davis School of Biomedical Education (CUNY Medical School) and a M.B.A. </font><font style="font-weight: normal;">from the American Graduate School of International Management. Our board of directors believes that Mr.&#160;Richman </font><font style="font-weight: normal;">is qualified to serve as a director based on his role as our Chief Executive Officer and his extensive management </font><font style="font-weight: normal;">experience in the biotechnology industry.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Salvatore Calabrese<font style="font-weight: normal;"> has served as our Chief Financial Officer since </font><font style="font-weight: normal;">November&#160;</font><font style="font-weight: normal;"> 2020. Mr.&#160;Calabrese previously </font><font style="font-weight: normal;">served as the Chief Financial Officer of Molmed S.p.A. (MLMD.MI), a public reporting cell &amp; gene company, from </font><font style="font-weight: normal;">September 2018 to September 2020. Prior to joining Molmed S.p.A, Mr.&#160;Calabrese served as General Manager and </font><font style="font-weight: normal;">Site Leader for the Italian Operation of Jazz Pharmaceuticals (NASDAQ: JAZZ),and from. February 2005 to August </font><font style="font-weight: normal;">2014 he worked at Gentium S.p.A. (NASDAQ: GENT) covering various roles including Chief Operating Officer as </font><font style="font-weight: normal;">of October 2013, Chief Financial Officer as of December 2010, Senior Vice President of Finance as of February 2010, </font><font style="font-weight: normal;">and Vice President of Finance as of February 2005. From December 2003 until February 2005, he was an Accounting </font><font style="font-weight: normal;">and Finance Manager for Novuspharma, S.p.A., a development stage biopharmaceutical company focused on the </font><font style="font-weight: normal;">discovery and development of cancer drugs and a subsidiary of Cell Therapeutics, Inc. (NASDAQ: CTIC), a public </font><font style="font-weight: normal;">reporting company, which then merged into Cell Therapeutics, Inc. From September 1996 until November 2003, </font><font style="font-weight: normal;">Mr.&#160;Calabrese was employed by PricewaterhouseCoopers as an accountant and was a Manager in Assurance Business </font><font style="font-weight: normal;">Advisory Services at the time of his departure. He earned a Bachelors&#8217; Degree in Economics at the University of </font><font style="font-weight: normal;">Messina and a Masters&#8217; Degree in Accounting, Audit and Financial Control at the University of Pavia. He is also </font><font style="font-weight: normal;">listed in the Italian National Audit Register held by the National Justice Department in the Republic of Italy.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dr. Manolo Bellotto, Ph.D.<font style="font-weight: normal;"> has served as the President and General Manager of the company and our subsidiary </font><font style="font-weight: normal;">GT Gain Therapeutics SA since 2018. Dr. Bellotto has over 20&#160;years of experience international pharmaceutical </font><font style="font-weight: normal;">product, medical and advocacy development, commercialization, and international research collaborations in major </font><font style="font-weight: normal;">and rare/orphan disease indications across various continents. Prior to joining Gain, since 2013, Dr. Bellotto has </font><font style="font-weight: normal;">served as Director of Strategic Projects of Mederis, a service provider for pharmaceutical, medical device and </font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">93<br></div></div></div>
<!--End Page 96-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 97-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_111-management_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">medical food companies providing assessment, prioritization, planning and management of product development, medical and market-shaping activities. From 2009 to 2013, Dr. Bellotto served as the Director of Business Development of Aptitude Health, a global healthcare company focusing on oncology insights for the life sciences industry. From 2000 to 2002, Dr. Bellotto served as Global Product Leader at Vifor Pharma, a global specialty pharmaceutical company. Dr. Bellotto has also held various positions, such as Head of International Product Management and Head of Marketing, at Helsinn Healthcare, DKSH Healthcare, ESMO &#8211; European Society for Medical Oncology, and Chemo SA. Dr. Bellotto holds a Ph.D. in Molecular Developmental Genetics from the University of Zurich after having studied molecular biology at the Biocentre of the University of Basel and at the Fredrich Miescher Institute for Biomedical Research (Novartis) in Basel.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Directors</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dr. Khalid Islam, Ph.D.<font style="font-weight: normal;"> cofounded our company in 2017 and has served as Chairman of our board of directors </font><font style="font-weight: normal;">since 2017. Dr. Islam has over 30&#160;years of experience in the biotechnology and pharmaceutical industries. He is </font><font style="font-weight: normal;">currently the Chairman of the board of directors of Fennec Pharmaceuticals and Minoryx Therapeutics S.L as well </font><font style="font-weight: normal;">as a director of Processa Pharmaceuticals. Dr. Islam also served as Chairman and Chief Executive Officer of </font><font style="font-weight: normal;">Gentium&#160;S.p.A. from 2009 to 2014, where, under his leadership, Defitelio was granted marketing authorization and </font><font style="font-weight: normal;">the company went from a $25&#160;million valuation to a $1&#160;billion all-cash merger with Jazz Pharmaceuticals plc. From </font><font style="font-weight: normal;">1999 to 2008, he served as President and Chief Executive Officer of Arpida AG, where he transitioned the early-stage </font><font style="font-weight: normal;">startup to a SWX-listed company and raised $300&#160;million between their initial public offering and follow-ons. From </font><font style="font-weight: normal;">1987 to 1999, Dr. Islam held various positions at HMR &amp; MMD (now Sanofi-Aventis). Prior to HMR &amp; MMD, he </font><font style="font-weight: normal;">worked in academia at Imperial College, University of London and Milan University, where he was a contract </font><font style="font-weight: normal;">professor. He has also previously served as a director of Immunomedics Inc., Karolinska Development, </font><font style="font-weight: normal;">MolMed&#160;S.p.A., OxThera AB, Rheoscience AS, PCovery AS, Adenium AS and C10 Pharma AS. He is an advisor </font><font style="font-weight: normal;">to Kurma Biofund (Paris). Dr. Islam is a graduate of Chelsea College and received his Ph.D. from Imperial College, </font><font style="font-weight: normal;">University of London. Our board of directors believes that Dr. Islam is qualified to serve as a director based on his </font><font style="font-weight: normal;">extensive science background and professional experience.</font><font style="font-weight: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dov Goldstein, M.D.<font style="font-weight: normal;"> </font><font style="font-weight: normal;">has served as a member of our board of directors since January 2021. Dr. Goldstein has </font><font style="font-weight: normal;">over 20 years of experience in the financial management of various biotechnology and pharmaceutical companies. </font><font style="font-weight: normal;">Dr. Goldstein </font><font style="font-weight: normal;">is the Chief Financial and Business Officer of Indapta Therapeutics, a biotechnology </font><font style="font-weight: normal;">company focused </font><font style="font-weight: normal;">on developing and commercializing a proprietary, off-the-shelf, allogeneic FcR&#947;-deficient natural </font><font style="font-weight: normal;">killer (G-NK) cell </font><font style="font-weight: normal;">therapy to treat multiple cancers. Dr. Goldstein previously served as Chief Executive Officer at </font><font style="font-weight: normal;">RIGImmune, and at </font><font style="font-weight: normal;">Aisling Capital, a private investment firm, Managing Partner from 2014 to 2019, Partner from </font><font style="font-weight: normal;">2009 to 2014 and </font><font style="font-weight: normal;">Principal from 2006 to 2009. Dr. Goldstein served as the Chief Financial Officer and Director of Loxo Oncology, Inc. </font><font style="font-weight: normal;">between July 2014 and January 2015, and was its acting Chief Financial Officer from January</font><font style="font-weight: normal;"> </font><font style="font-weight: normal;">2015 to May 2015. </font><font style="font-weight: normal;">From 2000 to 2005, Dr. Goldstein served as Chief Financial Officer of Vicuron Pharmaceuticals, </font><font style="font-weight: normal;">Inc., which was </font><font style="font-weight: normal;">acquired by Pfizer, Inc. in September 2005. Prior to joining Vicuron, Dr. Goldstein was Director of </font><font style="font-weight: normal;">Venture Analysis </font><font style="font-weight: normal;">at HealthCare Ventures. Dr. Goldstein also completed an internship in the Department of Medicine </font><font style="font-weight: normal;">at Columbia-</font><font style="font-weight: normal;">Presbyterian Hospital. Dr. Goldstein served as a director at ADMA Biologics, Inc., Esperion </font><font style="font-weight: normal;">Therapeutics, Inc., and </font><font style="font-weight: normal;">Cempra, Inc. (acquired by Melinta Therapeutics, Inc.). Dr. Goldstein received a B.S. from </font><font style="font-weight: normal;">Stanford University, an </font><font style="font-weight: normal;">M.B.A. from Columbia Business School, and an M.D. from Yale School of Medicine.</font><font style="font-weight: normal;"> Our board of directors believes </font><font style="font-weight: normal;">that Dr. Goldstein is qualified to serve as a director based on his extensive science background and professional </font><font style="font-weight: normal;">experience.</font><font style="font-weight: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Hans Peter Hasler<font style="font-weight: normal;"> </font><font style="font-weight: normal;">has served as a member of our board of directors since January 2021. Mr. Hasler has over </font><font style="font-weight: normal;">20 years of experience in the biotechnology and pharmaceutical industries. Mr. Hasler </font><font style="font-weight: normal;">is the Founder and</font><font style="font-weight: normal;">, until 2020 </font><font style="font-weight: normal;">served as</font><font style="font-weight: normal;"> Chief Executive Officer</font><font style="font-weight: normal;">,</font><font style="font-weight: normal;"> of Vicarius Pharma AG, a privately held company that provides strategic options </font><font style="font-weight: normal;">to non-European bio-pharma companies bringing late-stage assets to the </font><font style="font-weight: normal;">European market. Mr. Hasler is Chairman </font><font style="font-weight: normal;">of the Board of HBM Healthcare Investments AG in Switzerland, Director </font><font style="font-weight: normal;">of the Board of Minerva Neuroscience </font><font style="font-weight: normal;">Inc., Boston, Member of the Board of Shield Therapeutics PLC, London, and </font><font style="font-weight: normal;">Chief Advisor of SBTech Advisory, a </font><font style="font-weight: normal;">small asset scouting company located in Israel, Switzerland, and the USA. Since June</font><font style="font-weight: normal;"> 2009, he has served as a </font><font style="font-weight: normal;">director of HBM Healthcare Investments, an investment company listed on SIX Swiss </font><font style="font-weight: normal;">Exchange, and is Senior </font><font style="font-weight: normal;">Advisor at SBTech Global Advisory. His prior experience includes Elan Corporation, where </font><font style="font-weight: normal;">he was Chief Operating </font><font style="font-weight: normal;">Officer, and Biogen, Inc., where his positions included Chief Operating Officer, Executive </font><font style="font-weight: normal;">Vice President, Head of </font><font style="font-weight: normal;">Global Neurology and International. Previously, Mr. Hasler was at Wyeth Pharmaceuticals </font><font style="font-weight: normal;">as Senior Vice President, </font><font style="font-weight: normal;">Chief Marketing Officer and Managing Director of Wyeth Group Germany and General </font><font style="font-weight: normal;">Manager, Wyeth-Lederle </font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">94<br></div></div></div>
<!--End Page 97-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 98-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_111-management_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Switzerland, Austria and ECE. Mr. Hasler holds a Federal Swiss Commercial Diploma and a Marketing Manager Certificate from the Swiss Institute of Business Economy SIB, Zurich, Switzerland. Our board of directors believes that Mr. Hasler is qualified to serve as a director based on his extensive science background and professional experience. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Gwen Melincoff<font style="font-weight: normal;"> </font><font style="font-weight: normal;">has served as a member of our board of directors since January 2021. Ms. Melincoff </font><font style="font-weight: normal;">is a </font><font style="font-weight: normal;">seasoned business development and venture professional with over 25 years of deal</font><font style="font-weight: normal;"> </font><font style="font-weight: normal;">making </font><font style="font-weight: normal;">and management </font><font style="font-weight: normal;">experience in the biotechnology and pharmaceutical industries. Ms. Melincoff is currently </font><font style="font-weight: normal;">managing director at </font><font style="font-weight: normal;">Gemini Advisors LLC, a biopharmaceutical consultancy (since 2013) and an advisor to Verge </font><font style="font-weight: normal;">Genomics, a startup </font><font style="font-weight: normal;">drug discovery company (since 2016) and Agent Capital (since 2017). Ms. Melincoff serves on the board of Protalix </font><font style="font-weight: normal;">Biotherapeutics, Inc., Collegium Pharmaceutical, Inc., and Soleno Therapeutics, Inc. </font><font style="font-weight: normal;">and in an advisory capacity at </font><font style="font-weight: normal;">a number of pharmaceutical companies. From January 2017 through January 2019, she served on the board of </font><font style="font-weight: normal;">directors of Kamada Ltd.</font><font style="font-weight: normal;">, the board of Photocures ASA from April 2017 - June 2020</font><font style="font-weight: normal;"> and from June 2014 through </font><font style="font-weight: normal;">November 2016 she served on the Board of Directors of Tobira Therapeutics Inc. (acquired by Allergan plc). From </font><font style="font-weight: normal;">August 2014 through September 2016, Ms. Melincoff previously served as Vice President of Business Development </font><font style="font-weight: normal;">at </font><font style="font-weight: normal;">BTG International Inc., a UK-specialist healthcare company. Prior to BTG, Ms. Melincoff was Senior Vice </font><font style="font-weight: normal;">President of </font><font style="font-weight: normal;">Corporate Development at Shire Plc (acquired by Takeda). Additionally, she led the Shire Strategic </font><font style="font-weight: normal;">Investment Group, </font><font style="font-weight: normal;">the venture capital arm of Shire Plc. Ms. Melincoff was Vice President of Business Development </font><font style="font-weight: normal;">at Adolor Corporation </font><font style="font-weight: normal;">and held executive positions at Eastman Kodak for over ten years in a number of their health </font><font style="font-weight: normal;">care companies. Ms. </font><font style="font-weight: normal;">Melincoff holds a B.S. in Biology from The George Washington University and an M.S. in </font><font style="font-weight: normal;">Management and Health </font><font style="font-weight: normal;">Care Administration from Pennsylvania State University. Ms. Melincoff has also attained </font><font style="font-weight: normal;">the designation of Certified </font><font style="font-weight: normal;">Licensing Professional (CLP&#8482;). Ms. Melincoff was named to the &#8220;Top Women in </font><font style="font-weight: normal;">Biotech 2013&#8221; by Fierce Biotech and to the Powerlist 100 of Corporate Venture Capital in 2012 and 2013.</font><font style="font-weight: normal;"> Our board </font><font style="font-weight: normal;">of directors believes that Ms. Melincoff is qualified to serve as a director based on her extensive science background </font><font style="font-weight: normal;">and professional experience.</font><font style="font-weight: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Claude Nicaise, M.D.<font style="font-weight: normal;"> </font><font style="font-weight: normal;">has served as a member of our board of directors since January 2021. Dr. Nicaise has </font><font style="font-weight: normal;">more than 35 years of experience in the development and regulation of biotechnology and pharmaceutical industries. </font><font style="font-weight: normal;">He </font><font style="font-weight: normal;">is the founder of Clinical Regulatory Services, a company providing advice on clinical </font><font style="font-weight: normal;">and regulatory matters to </font><font style="font-weight: normal;">biotechnology companies. Dr. Nicaise serves on the board for Sarepta Therapeutics, Inc., </font><font style="font-weight: normal;">chairs their Compensation </font><font style="font-weight: normal;">committee, and is a member of their Research and Development committee. Since 2015, </font><font style="font-weight: normal;">Dr. Nicaise has served as </font><font style="font-weight: normal;">an Executive Vice President Regulatory at Ovid Therapeutics Inc., a company that develops </font><font style="font-weight: normal;">medicines for orphan </font><font style="font-weight: normal;">diseases of the brain. Dr. Nicaise was a Senior Vice President of Strategic Development and Global Regulatory </font><font style="font-weight: normal;">Affairs at Alexion Pharmaceuticals from 2008 to 2014. From 1983 to 2008, Dr. Nicaise served in </font><font style="font-weight: normal;">various positions </font><font style="font-weight: normal;">of increasing responsibility at Bristol-Myers Squibb, including senior positions such as Vice </font><font style="font-weight: normal;">President of Global </font><font style="font-weight: normal;">Development, Vice-President of Worldwide Regulatory Science and Strategy, and leadership </font><font style="font-weight: normal;">positions in Oncology, </font><font style="font-weight: normal;">Infectious Disease, and Neuroscience development. Dr. Nicaise received his medical degree from the Universit&#233; </font><font style="font-weight: normal;">Libre de Bruxelles in Belgium.</font><font style="font-weight: normal;"> Our board of directors believes that Dr. Nicaise is qualified to serve as a director based </font><font style="font-weight: normal;">on his extensive science background and professional experience.</font><font style="font-weight: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Jeffrey Riley<font style="font-weight: normal;"> has served as a member of our board of directors since May 2019. Mr.&#160;Riley has more than </font><font style="font-weight: normal;">25&#160;years of experience in the biotechnology and pharmaceutical industries, during which he has negotiated numerous </font><font style="font-weight: normal;">worldwide strategic corporate alliances, established joint ventures and assisted in venture financings to support </font><font style="font-weight: normal;">product development. He has raised over $1.5&#160;billion in equity and debt instruments. He has served in big pharma </font><font style="font-weight: normal;">(SmithKline Beecham and Pfizer), venture capital (Queensland Biocapital Fund / QIC) and numerous biotechnology </font><font style="font-weight: normal;">companies in the capacity of business development and general management. From March 2010 until December </font><font style="font-weight: normal;">2017, he served as the President, Chief Executive Officer and a director of Synthetic Biologics, Inc. (NYSE </font><font style="font-weight: normal;">American: SYN), a clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent </font><font style="font-weight: normal;">and treat gastrointestinal diseases. He has served as a member of several public and private boards of directors in the </font><font style="font-weight: normal;">United States and Australia. Mr.&#160;Riley received a BS degree from Boise State University, an MBA/MIM from Arizona </font><font style="font-weight: normal;">State University&#8217;s Thunderbird School of Global Management and has done advanced science work at the University </font><font style="font-weight: normal;">of California, San Francisco and Berkeley. Our board of directors believes that Mr.&#160;Riley is qualified to serve as a </font><font style="font-weight: normal;">director based on his extensive science background and professional experience.</font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">95<br></div></div></div>
<!--End Page 98-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 99-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_111-management_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Election of Officers</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each executive officer serves at the discretion of our board of directors and holds office until his or her successor is duly appointed or until his or her earlier resignation or removal. There are no family relationships among any of our directors or executive officers.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Composition of the Board of Directors</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors is currently composed of 7 directors. Our directors will be elected annually to serve until the next annual meeting of stockholders or until their successors are duly elected and qualified. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The number of members on our board of directors may be fixed by majority vote of the members of our board of directors. Any vacancies or newly created directorships may be filled only by the affirmative vote of a majority of directors then in office, even if less than a quorum, or by a sole remaining director. Each director shall hold office until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Director Independence</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Nasdaq Stock Market LLC, or Nasdaq, Marketplace Rules, or the Nasdaq Listing Rules, require a majority of a listed company&#8217;s board of directors to be comprised of independent directors within one year of listing. In addition, the Nasdaq Listing Rules require that, subject to specified exceptions and phase in periods following the initial public offering, each member of a listed company&#8217;s audit, compensation and nominating and corporate governance committees be independent under the Securities Exchange Act of 1934, as amended, or the Exchange Act. Audit committee members must also satisfy the independence criteria set forth in Rule 10A-3 under the Exchange&#160;Act and compensation committee members must also satisfy the independence criteria set forth in Rule 10C-1 under the Exchange Act. Under the Nasdaq Listing Rules, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of the listed company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In order to be considered independent for purposes of Rule 10A-3, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee: (1) accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries; or (2) otherwise be an affiliated person of the listed company or any of its subsidiaries. In order to be considered independent for purposes of Rule 10C-1, the board must consider, for each member of a compensation committee of a listed company, all factors specifically relevant to determining whether a director has a relationship to such company which is material to that director&#8217;s ability to be independent from management in connection with the duties of a compensation committee member, including, but not limited to: (1) the source of compensation of the director, including any consulting, advisory or other compensatory fee paid by such company to the director; and (2) whether the director is affiliated with the company or any of its subsidiaries or affiliates.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors has determined that Dov Goldstein, Hans Peter Hasler, Gwen Melincoff, Claude Nicaise and Jeffrey Riley are &#8220;independent&#8221; as defined under Nasdaq rules and the Exchange Act rules and regulations.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Background and Experience of Directors</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon completion of this offering, our nominating and corporate governance committee will be responsible for reviewing with our board of directors, on an annual basis, the appropriate characteristics, skills, and experience required for the board of directors as a whole and its individual members. In evaluating the suitability of individual candidates (both new candidates and current members), the nominating and corporate governance committee, in recommending candidates for election, and the board of directors, in approving (and, in the case of vacancies, appointing) such candidates, will take into account many factors, including the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">personal and professional integrity; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">ethics and values; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">experience in corporate management, such as serving as an officer or former officer of a publicly held company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">experience in the industries in which we compete; </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">96<br></div></div></div>
<!--End Page 99-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 100-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_111-management_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">experience as a board member or executive officer of another publicly held company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">diversity of background and expertise and experience in substantive matters pertaining to our business relative to other board members; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">conflicts of interest; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">practical and mature business judgment.</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Board Committees</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee. The composition and responsibilities of each committee are described below. Our board of directors may also establish from time to time any other committees that it deems necessary or desirable. Members serve on these committees until their resignation or until otherwise determined by our board of directors.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Audit Committee</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our audit committee will consist of Hans Peter Hasler, Jeffrey Riley, and Dov Goldstein, with Dov Goldstein serving as chair. Our board of directors has determined, in its best judgment, that Dov Goldstein is an audit committee financial expert as defined by the SEC rules and has the requisite financial experience as defined by the Nasdaq corporate governance rules. Our board of directors has determined that Hans Peter Hasler, Jeffrey Riley, and Dov Goldstein are &#8220;independent&#8221; as defined in the applicable Nasdaq rules. Our audit committee will be responsible for, among other things:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">selecting and hiring our independent auditors, and approving the audit and non-audit services to be performed by our independent auditors;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">assisting the board of directors in evaluating the qualifications, performance, and independence of our independent auditors;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">assisting the board of directors in monitoring the quality and integrity of our financial statements and our accounting and financial reporting;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">assisting the board of directors in monitoring our compliance with legal and regulatory requirements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewing with management and our independent auditors the adequacy and effectiveness of our internal control over financial reporting processes;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">assisting the board of directors in monitoring the performance of our internal audit function;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewing with management and our independent auditors our annual and quarterly financial statements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewing and overseeing all transactions between us and a related person for which review or oversight is required by applicable law or that are required to be disclosed in our financial statements or SEC filings, and developing policies and procedures for the committee&#8217;s review, approval and/or ratification of such transactions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">establishing procedures for the receipt, retention, and treatment of complaints received by us regarding accounting, internal accounting controls, or auditing matters and the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">preparing the audit committee report that the rules and regulations of the SEC require to be included in our annual proxy statement.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The SEC rules and the Nasdaq rules require us to have one independent audit committee member upon the listing of our common stock on the Nasdaq, a majority of independent directors within 90 days of the effective date of the registration statement, and all independent audit committee members within one year of the effective date of the registration statement. Hans Peter Hasler, Jeffrey Riley, and Dov Goldstein qualify as an independent director under the corporate governance standards of the Nasdaq and the independence requirements of Rule 10A-3 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">97<br></div></div></div>
<!--End Page 100-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 101-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_111-management_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Compensation Committee</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon completion of this offering, we expect our compensation committee will consist of Claude Nicaise, Jeffrey Riley, and Gwen Melincoff, with Gwen Melincoff serving as chair. Our board of directors has determined that Clause Nicaise, Jeffrey Riley, and Gwen Melincoff are &#8220;independent&#8221; as defined in the applicable Nasdaq rules. The compensation committee will be responsible for, among other things:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewing and approving corporate goals and objectives relevant to the compensation of our Chief Executive Officer, evaluating our Chief Executive Officer&#8217;s performance in light of those goals and objectives, and, either as a committee or together with the other independent directors (as directed by the board of directors), determining and approving our Chief Executive Officer&#8217;s compensation level based on such evaluation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewing and approving, or making recommendations to the board of directors with respect to, the compensation of our other executive officers, including annual base salary, bonus and equity-based incentives, and other benefits;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewing and recommending to the board of directors the compensation of our directors;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewing and discussing with management our &#8220;Compensation Discussion and Analysis&#8221; disclosure required by SEC rules;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">preparing the compensation committee report required by the SEC to be included in our annual proxy statement; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewing and making recommendations with respect to our equity and equity-based compensation plans.</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Nominating and Corporate Governance Committee</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our nominating and corporate governance committee will consist of Dov Goldstein, Clause Nicaise, and, Hans Peter Hasler, with Hans Peter Hasler serving as chair. Our board of directors has determined that Dov Goldstein, Claude Nicaise, and Hans Peter Hasler are &#8220;independent&#8221; as defined in the applicable Nasdaq rules. The nominating and corporate governance committee will be responsible for, among other things:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">assisting our board of directors in identifying prospective director nominees and recommending nominees to the board of directors;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">overseeing the evaluation of the board of directors and management;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewing developments in corporate governance practices and developing and recommending a set of corporate governance guidelines; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">recommending members for each committee of our board of directors.</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Compensation Committee Interlocks and Insider Participation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">None of our executive officers serves as a member of the board of directors or compensation committee (or other committee performing equivalent functions) of any entity that has one or more executive officers serving on our board of directors or compensation committee.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Code of Ethics</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will adopt a new Code of Business Conduct and Ethics that applies to all of our officers, directors, and employees, including our principal executive officer, principal financial officer, principal accounting officer, and controller, or persons performing similar functions, which will be posted on our website at https://www.gaintherapeutics.com. Our Code of Business Conduct and Ethics is a &#8220;code of ethics,&#8221; as defined in Item&#160;406(b) of Regulation S-K. We will make any legally required disclosures regarding amendments to, or waivers of, provisions of our code of ethics on our website. The information contained in, or that can be accessed through, our website is not incorporated by reference and is not part of this prospectus.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">98<br></div></div></div>
<!--End Page 101-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 102-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_112-executive_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tEAD"><!--Anchor--></a>EXECUTIVE AND DIRECTOR COMPENSATION </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The following section provides compensation information pursuant to the scaled disclosure rules applicable to &#8220;emerging growth companies&#8221; under the rules of the SEC, including reduced narrative and tabular disclosure obligations regarding executive compensation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our named executive officers for the fiscal year ended December 31, 2020, which consist of our current Chief&#160;Executive Officer, all individuals who served as principal executive officer during the fiscal year ended December&#160;31, 2020, and our two other most highly compensated executive officers who were serving as executive officers as of December 31, 2020 (other than our principal executive officers), are as follows:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Eric I. Richman, Chief Executive Officer (employment start date July 20, 2020);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Manolo Bellotto, General Manager and President (and also serving as principal executive officer prior to Mr. Richman&#8217;s commencement as Chief Executive Officer); and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Salvatore Calabrese, Chief Financial Officer (employment start date November 2, 2020; served as a consultant prior to commencement of employment).</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Summary Compensation Table</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table shows the compensation earned by each of our named executive officers for the year ended December&#160;31, 2020 and does not reflect the stock split which will occur prior to this closing of this offering. Our compensation packages for the named executive officers consist primarily of base salary, annual cash bonus and a stock option grant.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;">SUMMARY COMPENSATION TABLE</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 35.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Name and Principal Position</div></td><td class="gutter" style="width: 1.59%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.59%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 4.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year</div></td><td class="gutter" style="width: 1.59%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.59%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.95%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Salary<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Bonus<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($) </div></td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Option Award <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">$<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup> </div></td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">All Other <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Compensation<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total ($)</div></td></tr><tr class="header"><td style="width: 35.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(a)</div></td><td class="gutter" style="width: 1.59%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.59%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 4.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(b)</div></td><td class="gutter" style="width: 1.59%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.59%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.95%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(c)</div></td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(d)</div></td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(f)</div></td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(i)</div></td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(j)</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Eric I. Richman <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><font style="font-style: italic;">Chief Executive Officer</font><font style="padding-left: 4.99pt;"></font></div></td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2020</div></td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.95%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">131,250<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">67,500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.51%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.34pt; text-align: left;"><font style="padding-left: 5pt;">63,843</font></div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.92pt; text-align: left;">14,540<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">277,133</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Manolo Bellotto<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><font style="font-style: italic;">General Manager &amp; President</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup><font style="padding-left: 1.62pt;"></font></div></td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2020</div></td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.95%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">177,494</div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">53,248<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.51%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.34pt; text-align: left;">298,057</div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.92pt; text-align: left;">21,250<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">550,049</div></td></tr><tr><td style="width: 35.9%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salvatore Calabrese <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><font style="font-style: italic;">Chief Financial Officer</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup><font style="padding-left: 1.22pt;"></font></div></td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2020</div></td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.59%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.95%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">41,810</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup></div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">46,181<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup></div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.51%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.34pt; text-align: left;">202,253</div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.92pt; text-align: left;">&#8203;<font style="padding-left: 0.37pt;">29,116</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(11)</sup></div></td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;319,360</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718, of stock option awards granted under the 2020 Omnibus Plan.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Reflects pro-ration based on Mr. Richman&#8217;s July 20, 2020 start date.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Amount consists of a discretionary annual cash bonus of $37,500 (which reflects pro-ration based on Mr. Richman&#8217;s July 20, 2020 start date) and a one-time signing bonus of $30,000.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Amount consists of reimbursement of medical and dental benefits. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Amounts for Mr. Bellotto were paid in Swiss Francs (CHF), and have been reported in this Summary Compensation Table using the 2020 average foreign exchange rate of 0.939.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Amount consists of a discretionary annual cash bonus.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents the Company&#8217;s matching contributions under the Company&#8217;s defined benefit and contribution plans in accordance with local regulations and practices. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Amounts for Mr. Calabrese were paid in Euros (EUR), and have been reported in this Summary Compensation table using the 2020 average foreign exchange rate of 0.877.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(9)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Reflect pro-ration based on Mr. Calabrese&#8217;s November 2, 2020 start date.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(10)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Amount consists of a discretionary annual cash bonus of $25,086 (which reflects pro-ration based on Mr. Calabrese&#8217;s November 2, 2020 start date) and a one-time signing bonus of $21,095.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(11)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Amount consists of compensation paid in 2020 under consulting agreement prior to commencement of employment (see &#8220;Employment Agreement with Named Executive Officers&#8212;Salvatore Calabrese&#8221; for additional information). </div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Employment Agreements with Named Executive Officers</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Eric I. Richman, Chief Executive Officer</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mr.&#160;Richman began employment as our Chief Executive Officer on July&#160;20, 2020. Although Mr.&#160;Richman was not a named executive officer for fiscal year 2019 (and therefore his compensation is not disclosed in the Summary </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">99<br></div></div></div>
<!--End Page 102-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 103-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_112-executive_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Compensation Table included in this filing), we have also described his current compensation arrangements. Under his employment agreement, Mr.&#160;Richman receives an annual base salary of $300,000, and is eligible to receive a discretionary annual bonus determined based upon achievement of Company and personal objectives established and approved by the Board. Mr.&#160;Richman also received a signing bonus of $30,000. Mr.&#160;Richman is eligible to participate in the Company&#8217;s standard health and welfare benefit plans available to the Company&#8217;s U.S. employees, and 401(k) plan.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Manolo Bellotto, General Manager and President</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mr.&#160;Bellotto serves as our General Manager and President. Under his prior employment agreement with the Company, which was in effect during fiscal year ended December&#160;31, 2019, Mr.&#160;Bellotto was entitled to a base salary of CHF 153,600 (USD $154,527, using the 2019 average foreign exchange rate of 0.994).</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under his current employment agreement, effective September 1, 2020, Mr.&#160;Bellotto is entitled to a base salary of CHF 200,000 (USD $201,207, using the average foreign exchange rate of 0.994). Mr.&#160;Bellotto is eligible to receive an annual cash bonus, targeted at 30% of base salary, upon the achievement of objectives to be determined by the Chief Executive Officer. Mr.&#160;Bellotto&#8217;s current employment agreement also entitles Mr.&#160;Bellotto to a grant of a stock option of 1.5% in the Company capital, with anti-dilution protection in the event the Company capital increases. Mr.&#160;Bellotto is entitled to participate in all employee benefit plans and programs available to the Company&#8217;s Swiss employees. Under his current employment agreement, Mr.&#160;Bellotto is subject to a non-solicit of Company employees, consultants, customers and vendors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mr.&#160;Bellotto&#8217;s employment is terminable by either party upon six months&#8217; notice. If Mr.&#160;Bellotto&#8217;s employment is terminated within 24 months following a change in control either by the Company without cause or by Mr.&#160;Bellotto for good reason (each as defined in his employment agreement), Mr.&#160;Bellotto is entitled to severance pay equal to the sum of (i)&#160;two times his base salary, plus (ii)&#160;two times the greater of (x)&#160;the average of the bonuses received in the last 3&#160;years or (y) the target bonus for year of termination, plus (iii)&#160;a prorated target bonus for year of termination. In addition, all unvested stock options will fully vest and be exercisable for 90 days following termination. Mr.&#160;Bellotto would also be entitled to reimbursement of any legal expenses incurred in the curse of enforcing such payments. Severance is in lieu of any notice pay, and is contingent on Mr.&#160;Bellotto&#8217;s execution of a waiver and release. Mr.&#160;Bellotto&#8217;s employment agreement is with Swiss subsidiary GT Gain Therapeutics SA, and is governed by Swiss law.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Salvatore Calabrese, Chief Financial Officer</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mr. Calabrese began employment as our Chief Financial Officer on November 2, 2020. Under his employment agreement with GT Gain Therapeutics SA, Mr. Calabrese is entitled to a base salary of EUR 220,000 (USD $250,855, using the 2020 average foreign exchange rate of 0.877). Mr. Calabrese is eligible to receive an annual cash bonus, targeted at 30% of base salary, upon the achievement of objectives to be determined by the Chief Executive Officer. Mr. Calabrese also received a signing bonus of EUR 18,500 (USD $21,095, using the 2020 average foreign exchange rate of 0.877). Mr. Calabrese&#8217;s employment agreement also entitles Mr. Calabrese to a grant of a stock option of 1%&#160;in the Company capital, with anti-dilution protection in the event the Company&#8217;s capital increases. Mr. Calabrese is entitled to participate in all employee benefit plans and programs available to employees of GT Gain Therapeutics SA. Under his current employment agreement, Mr. Calabrese is subject to a non-solicit of Company employees, consultants, customers and vendors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mr. Calabrese&#8217;s employment is terminable by either party upon six months&#8217; notice. If Mr. Calabrese&#8217;s employment is terminated within 24 months following a change in control either by the Company without cause or by Mr. Calabrese for good reason (each as defined in his employment agreement), Mr. Calabrese is entitled to severance pay equal to the sum of (i) two times his base salary, plus (ii) two times the greater of (x) the average of the bonuses received in the last 3 years or (y) the target bonus for year of termination, plus (iii) a prorated target bonus for year of termination. In addition, all unvested stock options will fully vest and be exercisable for 90 days following termination. Mr. Calabrese would also be entitled to reimbursement of any legal expenses incurred in the course of enforcing such payments. Severance is in lieu of any notice pay, and is contingent on Mr. Calabrese&#8217;s execution of a waiver and release. Mr. Calabrese&#8217;s employment agreement is governed by Swiss law. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to commencement of his employment with us, Mr. Calabrese was serving as a consultant to the Company pursuant to a consulting agreement with GT Gain Therapeutics S.A.. Under his consulting agreement, Mr.&#160;Calabrese received a monthly fee of EUR 4,500 (USD $5,131, using the 2020 average foreign exchange rate of 0.877) assuming an </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">100<br></div></div></div>
<!--End Page 103-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 104-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_112-executive_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">average of 4 days/month of service, with an additional daily fee of EUR 1,500 (USD $1,710, using the 2020 average foreign exchange rate of 0.877) for additional services upon prior Board approval. Mr. Calabrese also received reimbursement for reasonable and necessary expenses incurred in connection with his provision of the consulting services. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Stock Option Grants</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In 2020, we granted stock option awards to key employees, including our named executive officers, under our 2020 Omnibus Plan (described further below). The stock option awards for each of our named executive officers have a three year vesting period, with one third vesting on the first anniversary of the grant date and the remaining two thirds vesting in equal monthly installments thereafter. The stock option awards have an exercise price of $2.97 per share. On a termination of the optionee&#8217;s employment by the Company without cause, or due to the optionee&#8217;s death or disability, the portion of the option that is scheduled to vest during the period that is six (6) months following the termination date shall immediately vest on the termination date, and the remaining unvested portion of the option shall be forfeited. Following a termination of employment, options generally remain exercisable (i) for one year, if termination is due to death or disability, or (ii) ninety (90) days, if termination is by the Company without cause or by optionee for any reason (and are forfeited immediately on a termination for cause). </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Gain Therapeutics Inc. 2020 Omnibus Incentive Plan</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In September 2020, the Board adopted the Gain Therapeutics Inc. 2020 Omnibus Incentive Plan (&#8220;2020 Omnibus Plan&#8221;), which allows us to grant an array of equity-based awards to our named executive officers, other employees, consultants and non-employee directors. The purpose of the 2020 Omnibus Plan is to provide additional incentives to selected employees, consultants and directors whose contributions are essential to the growth and success of the business of the Company. All stock options granted to our named executive officers, as disclosed above, were granted under the 2020 Omnibus Plan.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Plan Term. <font style="font-style: normal;">The 2020 Omnibus Plan expires after ten years, unless terminated prior to that date by the Board.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Authorized Shares; Certain Limitations<font style="font-style: normal;">. Subject to adjustment as described below, </font><font style="font-style: normal;">1,310,000</font><font style="font-style: normal;"> shares of our</font><font style="font-style: normal;"> </font><font style="font-style: normal;">common stock are available for awards to be granted under the 2020 Omnibus Plan. If any shares subject to an award</font><font style="font-style: normal;"> </font><font style="font-style: normal;">are forfeited, cancelled, exchanged or surrendered or if an award otherwise terminates or expires without a</font><font style="font-style: normal;"> </font><font style="font-style: normal;">distribution of shares, such shares shall again be available for awards under the 2020 Omnibus Plan. However, shares</font><font style="font-style: normal;"> </font><font style="font-style: normal;">that are exchanged by a participant or withheld as payment in connection with any award under the 2020 Omnibus</font><font style="font-style: normal;"> </font><font style="font-style: normal;">Plan, as well as any shares exchanged by a participant or withheld to satisfy tax withholding obligations related to</font><font style="font-style: normal;"> </font><font style="font-style: normal;">any award, will not be available for subsequent awards under the 2020 Omnibus Plan. If an award is denominated</font><font style="font-style: normal;"> </font><font style="font-style: normal;">in shares, but settled in cash, the number of shares previously subject to the sward will again be available for grants</font><font style="font-style: normal;"> </font><font style="font-style: normal;">under the 2020 Omnibus Plan. If an Award can only be settled in cash, it will not be counted against the aggregate</font><font style="font-style: normal;"> </font><font style="font-style: normal;">number of shares available for awards under the 2020 Omnibus Plan. Non-employee directors of the Company shall</font><font style="font-style: normal;"> </font><font style="font-style: normal;">not be granted awards during any calendar year that, when aggregated with such director&#8217;s cash fees with respect to</font><font style="font-style: normal;"> </font><font style="font-style: normal;">such calendar year, exceed $500,000 in total value (based on the grant date fair value of such award).</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Administration<font style="font-style: normal;">. The 2020 Omnibus Plan will be administered by our board of directors, or if our board of</font><font style="font-style: normal;"> </font><font style="font-style: normal;">directors does not administer the 2020 Omnibus Plan, a committee of our board of directors that complies with the</font><font style="font-style: normal;"> </font><font style="font-style: normal;">applicable requirements of Section 16 of the Exchange Act and any other applicable legal or stock exchange listing</font><font style="font-style: normal;"> </font><font style="font-style: normal;">requirements (the board or committee referred to above being sometimes referred to as the plan administrator). The</font><font style="font-style: normal;"> </font><font style="font-style: normal;">plan administrator has authority to select individuals to whom awards are granted, determine the types of awards and</font><font style="font-style: normal;"> </font><font style="font-style: normal;">terms and conditions of awards (including exercise price and applicable vesting periods), and construe and interpret</font><font style="font-style: normal;"> </font><font style="font-style: normal;">the 2020 Omnibus Plan and </font><font style="font-style: normal;">granted </font><font style="font-style: normal;">under it.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Types of Awards<font style="font-style: normal;">. The 2020 Omnibus Plan provides for grants of incentive stock options (&#8220;ISOs&#8221;), nonqualified</font><font style="font-style: normal;"> </font><font style="font-style: normal;">stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock, restricted stock units (&#8220;RSUs&#8221;), stock bonuses,</font><font style="font-style: normal;"> </font><font style="font-style: normal;">other stock-based awards and cash awards.</font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Stock Options</font>. The 2020 Omnibus Plan authorizes the issuance of stock options under the 2020 Omnibus Plan. Each option issued under the 2020 Omnibus Plan will indicate whether it is intended to be an ISO or a nonqualified stock option. The exercise price of all stock options granted under the 2020 Omnibus Plan will be determined by the plan administrator, but in no event may the exercise price be less than 100% of the fair market value of the related shares of common stock on the date of grant. The maximum term of all stock options granted under the 2020 Omnibus Plan will be determined by the plan administrator, but </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">101<br></div></div></div>
<!--End Page 104-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 105-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_112-executive_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">may not exceed ten years. Each stock option will vest and become exercisable at such time and subject to such terms and conditions (including treatment upon the optionee&#8217;s termination of employment or service) as determined by the plan administrator in the applicable individual option agreement.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">SARs</font>. SARs may be granted under the 2020 Omnibus Plan either alone (a free-standing SAR) or in conjunction with all or part of any stock option granted under the 2020 Omnibus Plan. A free-standing SAR entitles its holder to receive, at the time of exercise, an amount per share equal to the excess of the fair market value (at the date of exercise) of a share of common stock over the base price of the free-standing SAR. A SAR granted in conjunction with all or part of a stock option entitles its holder to receive, at the time of exercise of the SAR and surrender of the related option, an amount per share equal to the excess of the fair market value (at the date of exercise) of a share of common stock over the exercise price of the related option. Each SAR will be granted with a base price that is not less than 100% of the fair market value of the related shares of common stock on the date of grant. The maximum term of all SARs will be determined by the plan administrator, but may not exceed ten years. Free-standing SARs will vest and be exercisable at such time and subject to such terms and conditions (including treatment upon the optionee&#8217;s termination of employment or service) as determined by the plan administrator in the applicable individual option agreement. SARs granted in conjunction with all or part of a stock option will be exercisable at such times and subject to all of the terms and conditions applicable to the related option. The plan administrator may determine to settle the exercise of a SAR in shares of common stock, cash, or any combination thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Restricted Stock and RSUs</font>. Restricted stock and RSUs may be granted under the 2020 Omnibus Plan. The plan administrator will determine the purchase price, vesting schedule and performance objectives, if any, applicable to the grant of restricted stock and RSUs, as well as any non-transfer periods with respect to restricted stock or the shares of common stock issued with respect to RSUs. If the restrictions, performance objectives or other conditions determined by the plan administrator are not satisfied, the restricted stock and RSUs will be forfeited. The rights of restricted stock and RSU holders upon a termination of employment or service will be set forth in individual award agreements. Unless the applicable award agreement provides otherwise, participants with restricted stock will generally have all of the rights of a stockholder, including the right to vote and receive dividends declared with respect to such stock. During the restricted period, RSUs may also be credited with dividend equivalent rights if the applicable individual award agreement so provides. Notwithstanding the foregoing, any dividends or dividend equivalent awards with respect to restricted stock or RSUs will be subject to the same restrictions, conditions and risks of forfeiture as the underlying restricted stock or RSU.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Other Stock-Based Awards</font>. Other stock-based awards, valued in whole or in part by reference to, or otherwise based on, shares of common stock (including dividend equivalents) may be granted under the 2020 Omnibus Plan. The plan administrator will determine the terms and conditions of such other stock-based awards, including the number of shares of common stock to be granted pursuant to such other stock-based awards, the manner in which such other stock-based awards will be settled, and the conditions to the vesting and payment of such other stock-based awards (including the achievement of performance objectives).</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Stock Bonuses and Cash Awards</font>. Bonuses payable in fully vested shares of common stock and awards that are payable solely in cash may also be granted under the 2020 Omnibus Plan.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Eligibility.<font style="font-style: normal;"> Our employees, consultants and non-employee directors are eligible to receive awards under the 2020</font><font style="font-style: normal;"> </font><font style="font-style: normal;">Omnibus Plan, except that incentive stock options (&#8220;ISOs&#8221;) may only be granted to our employees.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Equitable Adjustments<font style="font-style: normal;">. In the event of any Change in Capitalization (including a Change in Control), the plan</font><font style="font-style: normal;"> </font><font style="font-style: normal;">administrator will made an equitable substitution or proportionate adjustment in (a) the number and kind of shares</font><font style="font-style: normal;"> </font><font style="font-style: normal;">of common stock, other securities or property underlying, or the amount of cash subject to, each outstanding award;</font><font style="font-style: normal;"> </font><font style="font-style: normal;">(b) the exercise price or purchase price of any outstanding award and applicable performance conditions relating to</font><font style="font-style: normal;"> </font><font style="font-style: normal;">any outstanding award; and (c) the aggregate number of shares of common stock reserved for issuance under the 2020</font><font style="font-style: normal;"> </font><font style="font-style: normal;">Omnibus Plan. In addition, in connection with a Change in Capitalization (including a Change in Control), the</font><font style="font-style: normal;"> </font><font style="font-style: normal;">plan </font><font style="font-style: normal;">a</font><font style="font-style: normal;">dministrator may provide for the cancellation of any outstanding award in exchange for payment in cash or other</font><font style="font-style: normal;"> </font><font style="font-style: normal;">property having an aggregate fair market value equal to the fair market value of the shares of common stock, cash</font><font style="font-style: normal;"> </font><font style="font-style: normal;">or other property covered by such award, reduced by the aggregate exercise price or base price thereof (or</font><font style="font-style: normal;"> </font><font style="font-style: normal;">cancellation without payment if the exercise price or base price is equal to or greater than the fair market value of</font><font style="font-style: normal;"> </font><font style="font-style: normal;">the shares of common stock, cash or other property covered by such award).</font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">102<br></div></div></div>
<!--End Page 105-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 106-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_112-executive_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Change in Control<font style="font-style: normal;">. Except as otherwise provided in the applicable award agreement, in the event that (a) a</font><font style="font-style: normal;"> </font><font style="font-style: normal;">Change in Control occurs and (b) either (x)&#160;an outstanding award is not assumed or substituted in connection</font><font style="font-style: normal;"> </font><font style="font-style: normal;">therewith or (y) an outstanding award is assumed or substituted in connection therewith and the participant&#8217;s</font><font style="font-style: normal;"> </font><font style="font-style: normal;">employment or service is terminated without cause or by the participant for good reason (if applicable) within twelve</font><font style="font-style: normal;"> </font><font style="font-style: normal;">months following the Change in Control, then (I) any unvested or unexercisable portion of any award shall become</font><font style="font-style: normal;"> </font><font style="font-style: normal;">fully vested and exercisable; and (II) the restrictions, deferral limitations, payment conditions and forfeiture</font><font style="font-style: normal;"> </font><font style="font-style: normal;">conditions applicable to an award shall lapse and such awards shall be deemed fully vested and any performance</font><font style="font-style: normal;"> </font><font style="font-style: normal;">conditions imposed with respect to such awards shall be deemed to be achieved at target performance levels.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amendment and Termination.<font style="font-style: normal;"> The plan administrator has the right to amend any participant&#8217;s award agreement,</font><font style="font-style: normal;"> </font><font style="font-style: normal;">subject to the participant&#8217;s consent if such amendment is not favorable to the participant. </font><font style="font-style: normal;">Our board of directors</font><font style="font-style: normal;"> may </font><font style="font-style: normal;">amend,</font><font style="font-style: normal;"> </font><font style="font-style: normal;">suspend or terminate the 2020 Omnibus Plan, but no such amendment or termination may be made which </font><font style="font-style: normal;">would</font><font style="font-style: normal;"> </font><font style="font-style: normal;">adversely affect any outstanding awards without the written consent of the affected participants. Unless the </font><font style="font-style: normal;">board of directors</font><font style="font-style: normal;"> </font><font style="font-style: normal;">determines otherwise, the </font><font style="font-style: normal;">board of directors</font><font style="font-style: normal;"> will obtain shareholder approval of any plan </font><font style="font-style: normal;">amendment to the extent such approval</font><font style="font-style: normal;"> </font><font style="font-style: normal;">is required in order to satisfy any rules of the stock exchange on which the </font><font style="font-style: normal;">common stock is traded or other applicable</font><font style="font-style: normal;"> </font><font style="font-style: normal;">law.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Form S-8<font style="font-style: normal;">. We intend to file with the SEC a registration statement on Form S-8 covering the shares of common</font><font style="font-style: normal;"> </font><font style="font-style: normal;">stock issuable under the 2020 Omnibus Plan.</font></div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">United States Federal Income Tax Consequences of Plan Awards.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following is a summary of certain United States federal income tax consequences of awards under the 2020 Omnibus Plan. It does not purport to be a complete description of all applicable rules, and those rules (including those summarized here) are subject to change.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">ISOs<font style="font-style: normal;">. In general, an optionee will not recognize taxable income upon the grant of an ISO. If shares of common</font><font style="font-style: normal;"> </font><font style="font-style: normal;">stock are issued to the optionee pursuant to the exercise of an ISO, then, generally (i)&#160;the optionee will not realize</font><font style="font-style: normal;"> </font><font style="font-style: normal;">ordinary income with respect to the exercise of the option, (ii)&#160;upon sale of the underlying shares acquired upon the</font><font style="font-style: normal;"> </font><font style="font-style: normal;">exercise of an ISO, any amount realized in excess of the exercise price paid for the shares will be taxed to the optionee</font><font style="font-style: normal;"> </font><font style="font-style: normal;">as capital gain and (iii)&#160;we will not be entitled to a deduction. The amount by which the fair market value of a share</font><font style="font-style: normal;"> </font><font style="font-style: normal;">of common stock on the exercise date of an ISO exceeds the purchase price generally will, however, constitute an</font><font style="font-style: normal;"> </font><font style="font-style: normal;">item which increases the optionee&#8217;s income for purposes of the alternative minimum tax. However, if the participant</font><font style="font-style: normal;"> </font><font style="font-style: normal;">disposes of the shares acquired on exercise before the later of the second anniversary of the date of grant or one year</font><font style="font-style: normal;"> </font><font style="font-style: normal;">after the receipt of the shares by the optionee (a &#8220;disqualifying disposition&#8221;), the optionee generally would include</font><font style="font-style: normal;"> </font><font style="font-style: normal;">in ordinary income in the year of the disqualifying disposition an amount equal to the excess of the fair market value</font><font style="font-style: normal;"> </font><font style="font-style: normal;">of the shares at the time of exercise (or, if less, the amount realized on the disposition of the shares), over the exercise</font><font style="font-style: normal;"> </font><font style="font-style: normal;">price paid for the shares. If ordinary income is recognized due to a disqualifying disposition, we would generally be</font><font style="font-style: normal;"> </font><font style="font-style: normal;">entitled to a deduction in the same amount. Subject to certain exceptions, an ISO generally will not be treated as an</font><font style="font-style: normal;"> </font><font style="font-style: normal;">ISO if it is exercised more than three months following termination of employment. If an ISO is exercised at a time</font><font style="font-style: normal;"> </font><font style="font-style: normal;">when it no longer qualifies as an ISO, it will be treated for tax purposes as a nonqualified stock option, as discussed</font><font style="font-style: normal;"> </font><font style="font-style: normal;">below.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Nonqualified Stock Options<font style="font-style: normal;">. An optionee generally will not recognize taxable income upon the grant of a</font><font style="font-style: normal;"> </font><font style="font-style: normal;">nonqualified stock option. Rather, at the time of exercise of the option, the optionee will recognize ordinary income</font><font style="font-style: normal;"> </font><font style="font-style: normal;">for income tax purposes in an amount equal to the excess, if any, of the fair market value of the shares of common</font><font style="font-style: normal;"> </font><font style="font-style: normal;">stock purchased over the exercise price. We generally will be entitled to a tax deduction at such time and in the same</font><font style="font-style: normal;"> </font><font style="font-style: normal;">amount, if any, that the optionee recognizes as ordinary income. The optionee&#8217;s tax basis in any shares of common</font><font style="font-style: normal;"> </font><font style="font-style: normal;">stock received upon exercise of an option will be the fair market value of the share of common stock on the date of</font><font style="font-style: normal;"> </font><font style="font-style: normal;">exercise, and if the shares are later sold or exchanged, then the difference between the amount received upon such</font><font style="font-style: normal;"> </font><font style="font-style: normal;">sale or exchange and the fair market value of such shares on the date of exercise will generally be taxable as</font><font style="font-style: normal;"> </font><font style="font-style: normal;">long-term or short-term capital gain or loss (if the shares are a capital asset of the optionee) depending upon the length</font><font style="font-style: normal;"> </font><font style="font-style: normal;">of time such shares were held by the optionee.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">SARs<font style="font-style: normal;">. A participant who is granted a SAR generally will not recognize ordinary income upon receipt of the SAR.</font><font style="font-style: normal;"> </font><font style="font-style: normal;">Rather, at the time of exercise of such SAR, the participant will recognize ordinary income for income tax purposes</font><font style="font-style: normal;"> </font><font style="font-style: normal;">in an amount equal to the value of any cash received and the fair market value on the date of exercise of any shares</font><font style="font-style: normal;"> </font><font style="font-style: normal;">of common stock received. We generally will be entitled to a tax deduction at such time and in the same amount, if</font><font style="font-style: normal;"> </font><font style="font-style: normal;">any, that the participant recognizes as ordinary income. The participant&#8217;s tax basis in any shares of common stock</font><font style="font-style: normal;"> </font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">103<br></div></div></div>
<!--End Page 106-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 107-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_112-executive_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">received upon exercise of a SAR will be the fair market value of the shares of common stock on the date of exercise, and if the shares are later sold or exchanged, then the difference between the amount received upon such sale or exchange and the fair market value of such shares on the date of exercise will generally be taxable as long-term or short-term capital gain or loss (if the shares are a capital asset of the participant) depending upon the length of time such shares were held by the participant.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Restricted Stock<font style="font-style: normal;">. A participant generally will not be taxed upon the grant of a restricted share of common stock,</font><font style="font-style: normal;"> </font><font style="font-style: normal;">but rather will recognize ordinary income in an amount equal to the fair market value of the shares at the time the</font><font style="font-style: normal;"> </font><font style="font-style: normal;">shares are no longer subject to a &#8220;substantial risk of forfeiture&#8221; (within the meaning of the Internal Revenue Code</font><font style="font-style: normal;"> </font><font style="font-style: normal;">of 1986, as amended (the &#8220;Code&#8221;)</font><font style="font-style: normal;">).</font><font style="font-style: normal;"> </font><font style="font-style: normal;">We generally will be entitled to a deduction at the time when, and in the amount </font><font style="font-style: normal;">that, the participant recognizes</font><font style="font-style: normal;"> </font><font style="font-style: normal;">ordinary income on account of the lapse of the restrictions. A participant&#8217;s tax basis </font><font style="font-style: normal;">in the shares will equal their fair</font><font style="font-style: normal;"> </font><font style="font-style: normal;">market value at the time the restrictions lapse, and the participant&#8217;s holding period </font><font style="font-style: normal;">for capital gains purposes will</font><font style="font-style: normal;"> </font><font style="font-style: normal;">begin at that time. Any cash dividends paid on the restricted stock before the </font><font style="font-style: normal;">restrictions lapse will be taxable to the</font><font style="font-style: normal;"> </font><font style="font-style: normal;">participant as additional compensation (and not as dividend income). Under </font><font style="font-style: normal;">Section 83(b) of the Code, a participant</font><font style="font-style: normal;"> </font><font style="font-style: normal;">may elect to recognize ordinary income at the time the restricted stock is </font><font style="font-style: normal;">awarded in an amount equal to the</font><font style="font-style: normal;">ir</font><font style="font-style: normal;"> fair</font><font style="font-style: normal;"> </font><font style="font-style: normal;">market value at that time, notwithstanding the fact that such restricted stock </font><font style="font-style: normal;">is subject to restrictions and a substantial</font><font style="font-style: normal;"> </font><font style="font-style: normal;">risk of forfeiture. If such an election is made, no additional taxable income </font><font style="font-style: normal;">will be recognized by such participant</font><font style="font-style: normal;"> </font><font style="font-style: normal;">at the time the restrictions lapse, the participant will have a tax basis in the </font><font style="font-style: normal;">shares equal to their fair market value</font><font style="font-style: normal;"> </font><font style="font-style: normal;">on the date of their award, and the participant&#8217;s holding period for capital gains </font><font style="font-style: normal;">purposes will begin at that time. We</font><font style="font-style: normal;"> </font><font style="font-style: normal;">generally will be entitled to a tax deduction at the time when, and to the extent </font><font style="font-style: normal;">that, ordinary income is recognized</font><font style="font-style: normal;"> </font><font style="font-style: normal;">by such participant.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">RSUs<font style="font-style: normal;">. In general, the grant of RSUs will not result in income for the participant or in a tax deduction for us.</font><font style="font-style: normal;"> </font><font style="font-style: normal;">Upon the settlement of such an award, the participant will recognize ordinary income equal to the aggregate value</font><font style="font-style: normal;"> </font><font style="font-style: normal;">of the payment received, and we generally will be entitled to a tax deduction in the same amount.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other Awards<font style="font-style: normal;">. With respect to other awards granted under the 2020 Omnibus Plan, including stock bonuses,</font><font style="font-style: normal;"> </font><font style="font-style: normal;">other stock-based award and cash awards, generally when the participant receives payment with respect to an award,</font><font style="font-style: normal;"> </font><font style="font-style: normal;">the amount of cash and/or the fair market value of any shares of common stock or other property received will be</font><font style="font-style: normal;"> </font><font style="font-style: normal;">ordinary income to the participant, and we generally will be entitled to a tax deduction in the same amount.</font></div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Potential Payments Upon Termination or Change in Control</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other than under Mr.&#160;Bellotto&#8217;s employment agreement and Mr. Calabrese's employment agreement (each described above in &#8220;&#8212;Employment Agreements with Named Executive Officers&#8221;), the Company has no plans, agreements or arrangements that provide for payment to our named executive officers in connection with termination of employment or change in control of the Company.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Retirement and Pension Plans</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In 2020, the Company operated defined benefit pension plans for employees in Switzerland and defined contribution pension plans for employees in Switzerland and Spain in accordance with local regulations and practices. These plans are funded by regular contribution made by the employer and the employees to third-party or local governments based on the characteristics of the plan and local laws and regulations. See Note 2 and Note 10 to our financial statements for more information regarding the Company's pension obligations. Additionally, the Company adopted a 401(k) plan for employees in the United States in 2021.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Director Compensation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our directors did not receive compensation for their services for the fiscal year ended December 31, 2020.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In 2021, Dov Goldstein, Gwen Melincoff, Hans Peter Hasler, Jeff Riley, Claude Nicaise, and Khalid Islam have been appointed as Board members. Mr. Goldstein, Ms. Melincoff, Mr. Hasler, Mr. Claude Nicaise, Mr. Riley were each granted an award of 10,000 stock options, with the grants made on January 22, 2021. These options have one year cliff vesting, subject to the director's continued service with the company through the applicable vesting date, and provided that these options will accelerate and vest in full in the event of a change in control (as defined in the 2020 Omnibus Plan). Dr. Islam was granted an award of 25,000 stock options with one year cliff vesting. The Director will receive post-offering annual compensation pursuant to the terms of such non-employee director compensation policy as may be adopted by us. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">104<br></div></div></div>
<!--End Page 107-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 108-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_113-stockholders_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPS"><!--Anchor--></a>PRINCIPAL STOCKHOLDERS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table sets forth information with respect to the beneficial ownership of our common stock as of February&#160;28, 2021, both before and after giving effect to the closing of the offering, by:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each person known by us to own beneficially more than 5% of any class of our outstanding shares of common stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each of the directors and named executive officers individually; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">all of our directors and named executive officers as a group.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The amounts and percentages of our common stock beneficially owned are reported on the basis of SEC&#160;regulations governing the determination of beneficial ownership of securities. Under SEC rules, a person is deemed to be a &#8220;beneficial&#8221; owner of a security if that person has or shares voting power or investment power, which includes the power to dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within 60 days. Securities&#160;that can be so acquired are not deemed to be outstanding for purposes of computing any other person&#8217;s percentage. Under these rules, more than one person may be deemed to be a beneficial owner of securities as to which such person has no economic interest.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our determination of the percentage of beneficial ownership prior to this offering gives effect to the Preferred Conversion and the 0.88-for-1 forward split of our common stock and is based on 7,694,642  shares of our common stock outstanding as of February&#160;28, 2021. Our determination of beneficial ownership after this offering is based on 11,876,460 shares of our common stock outstanding after closing of the offering and assumes the underwriters exercise their option to purchase up to 545,454 shares of common stock. Unless otherwise indicated, the business address of each such beneficial owner is c/o 4800 Hampden Lane, Suite 200, Bethesda, MD 20814.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each of the stockholders listed has sole voting and investment power with respect to the shares beneficially owned by the stockholder unless noted otherwise, subject to community property laws where applicable.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468.52pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 58.91%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 19.69%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares of Common Stock <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Beneficially Owned Before <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">This Offering</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 18.84%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares of Common Stock <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Beneficially Owned After <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">This Offering</div></td></tr><tr class="header"><td style="width: 58.91%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name of Beneficial Owners</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 11.07%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.34%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">%</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 11.18%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">%</div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Executive Officers and Directors:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;"></div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Eric Richman<font style="padding-left: 2.41pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 7.87pt;">211,898</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 5pt;">2.75%</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 7.87pt;">211,898</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;">1.78%</div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Khalid Islam<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 2.42pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 7.5pt;">880,784</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 0.37pt;">11.45%</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 7.5pt;">880,784</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;">7.42%</div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Manolo Bellotto<font style="padding-left: 1.84pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;"><font style="padding-left: 17.5pt;">*</font></div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dov Goldstein<font style="padding-left: 4.07pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;"><font style="padding-left: 17.5pt;">*</font></div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Hans Peter Hasler<font style="padding-left: 4.66pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;"><font style="padding-left: 17.5pt;">*</font></div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Gwen Melincoff<font style="padding-left: 1.49pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;"><font style="padding-left: 17.5pt;">*</font></div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Claude Nicaise<font style="padding-left: 1.86pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;"><font style="padding-left: 17.5pt;">*</font></div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Jeffrey Riley<font style="padding-left: 0.93pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;"><font style="padding-left: 17.5pt;">*</font></div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">All executive officers and directors as a group (8 persons)<font style="padding-left: 4.36pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;">1,092,683</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;">14.20%</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;">1,092,683</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;">9.20%</div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other 5% Stockholders<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;"></div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3B Future Health Fund S.A<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(b)</sup><font style="padding-left: 1.18pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 7.5pt;">495,388</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 5pt;">6.44%</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 7.5pt;">495,388</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;">4.17%</div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Robert Michael Floyd<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(c)</sup><font style="padding-left: 0.2pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 7.5pt;">440,392</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 5pt;">5.72%</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 7.5pt;">440,392</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;">3.71%</div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Shawn Milemore Titcomb<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(d)</sup><font style="padding-left: 3.09pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 7.5pt;">729,737</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 5pt;">9.48%</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 7.5pt;">729,737</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;">6.14%</div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">VitaTech S.A.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(e)</sup><font style="padding-left: 3.16pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 7.5pt;">496,507</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 5pt;">6.45%</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 7.5pt;">496,507</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;">4.18%</div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">TiVenture S.A.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(f)</sup><font style="padding-left: 0.26pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 7.5pt;">854,572</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 0.37pt;">11.11</font><font style="padding-left: 0.37pt;">%</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 7.5pt;">854,572</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;">7.20%</div></td></tr><tr><td style="width: 58.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1MM &amp; 1PP AG<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(g)</sup><font style="padding-left: 4.58pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.07%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 7.5pt;">880,784</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.34%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 0.37pt;">11.45%</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.18%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.18pt; text-align: left;"><font style="padding-left: 7.5pt;">880,784</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.19pt; text-align: left;">7.42%</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of 880,784 shares of common stock held by 1 MM &amp; 1 PP AG. All shares of our common stock held by 1 MM &amp; 1 PP AG may be deemed to be beneficially owned by Khalid Islam as the ultimate shareholders of 1 MM &amp; 1 PP AG. The address of 1 MM &amp; 1 PP AG and Kahlid Islam is c/o Financial Consulting &amp; Accounting Group GmbH Flurstrasse 1 6332 Hagendorn. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">All shares of our common stock held by 3B Future Health Fund S.A. may be deemed to be beneficially owned by Riccardo Braglia as the ultimate shareholders of 3B Future Health Fund S.A. The address of 3B Future Health Fund S.A. and Riccardo Braglia is 412F, Route d&#8217;Esch Luxembourg, Luxembourg 2086. </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">105<br></div></div></div>
<!--End Page 108-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 109-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_113-stockholders_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.25pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The address for Mr. Floyd is 4800 Hampden Lane, Suite 200, Bethesda, Maryland 20814.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(d)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Following this offering, Mr. Titcomb will beneficially own (i) 729,737 shares of common stock of which 14,829 is wholly owned by the Shawn Milemore Titcomb Revocable Trust, over which he is the trustee. The address of the trustee is c/o Allele Capital Ptners LLC, 900&#160;N&#160;Federal Highway ste 400, Boca Raton, FL 33432.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(e)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The directors of VitaTech S.A. are Jean Pierre Verlaine, Mauro Saponelli, Lorenzo Leoni, Paolo Orsatti and Roberto Barzi or, together, the &#8220;VitaTech S.A. Directors.&#8221; The VitaTech S.A. Directors may be deemed to share voting and dispositive power with regard to the common stock directly held by VitaTech S.A. The address for each of these individuals and VitaTech S.A. is c/o 3/A rue Guillaume Kroll, L-1882 Luxembourg. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(f)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The directors of TiVenture S.A. are Renato Boldini, Sergio Magistri, Fabio Selmoni, or, together, the &#8220;TiVenture S.A. Directors.&#8221; The TiVenture S.A. Directors may be deemed to share voting and dispositive power with regard to the common stock directly held by TiVenture S.A. The address for each of these individuals and TiVenture S.A. is c/o Via Pietro Peri 9D, 69100 Lugano, Switzerland. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(g)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">All shares of our common stock held by 1 MM &amp; 1 PP AG may be deemed to be beneficially owned by Khalid Islam as the ultimate shareholders of 1 MM &amp; 1 PP AG. The address for 1 MM &amp; 1 PP AG and Khalid Islam is c/o Financial Consulting &amp; Accounting Group GmbH, Flurstrasse 1. Hagendorn, Switzerland 6332.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">106<br></div></div></div>
<!--End Page 109-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 110-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_114-certain_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCRA"><!--Anchor--></a>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our policy is to enter into transactions with related parties on terms that, on the whole, are no more favorable, or no less favorable, than those available from unaffiliated third parties. Based on our experience in the business sectors in which we operate and the terms of our transactions with unaffiliated third parties, we believe that all of the transactions described below met this policy standard at the time they occurred. The following is a description of material transactions, or series of related material transactions, since January&#160;1, 2018, to which we were or will be a party and in which the other parties included or will include our directors, executive officers, holders of more than 5% of our voting securities or any member of the immediate family of any of the foregoing persons. Other than as described below, there have not been, nor are there any currently proposed, transactions or series of similar transactions to which we have been or will be a party other than compensation arrangements, which are described where required under the section entitled &#8220;Executive and Director Compensation.&#8221; The figures below do not reflect the stock split which will occur prior to the closing of this offering. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Corporate Reorganization with GT Gain Therapeutics SA</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;20, 2020, we engaged in a series of transactions, which we refer to collectively as the &#8220;Corporate Reorganization&#8221;. Following the Corporate Reorganization, GT Gain Therapeutics SA became a wholly-owned subsidiary of the company. We, GT Gain Therapeutics SA, and the holders of all of the issued and outstanding equity interests of GT Gain Therapeutics SA entered into exchange agreements, dated as of July&#160;20, 2020, pursuant to which the Corporate Reorganization was effected. Following the incorporation of the Company and prior to the Corporate Reorganization, the Company issued an aggregate of 1,772,736 shares of common stock at par value $0.0001. The aggregate gross proceeds from the offering were approximately $117, recorded as an increase of common stock within shareholder&#8217;s equity (deficit).</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the Corporate Reorganization, each holder of GT Gain Therapeutics SA&#8217;s equity interests contributed, transferred, granted, assigned and delivered to us all of its right, title and interest in and to all GT Gain Therapeutics SA equity interests owned by such holder which resulted in us issuing an aggregate of 2,250,000 shares of our common stock and 1,346,390 shares of our Series A Preferred Stock. The common stock and Series A Preferred Stock issued in connection with the Corporate Reorganization reflects a 10:1 forward-stock split. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Corporate Reorganization was treated as a recapitalization by us for financial reporting purposes and the historical financial statements of GT Gain Therapeutics SA, adjusted to give effect to the share exchange transaction for all periods presented, are our historical financial statements. The Corporate Reorganization was treated as a &#8220;plan of reorganization&#8221; under Section 368(a) of the Code. The exchange agreements contained customary representations and warranties and pre- and post-closing covenants of each party and customary closing conditions. A condition to the Corporate Reorganization was the simultaneous closing of the Series&#160;B Private Placement, described below.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The issuance of securities pursuant to the Corporate Reorganization was not registered under the Securities Act, in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act, which exempts transactions by an issuer not involving any public offering, and Rule 506 of Regulation D promulgated by the SEC thereunder. These securities may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Series B Private Placement</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;20, 2020, we sold 3,366,999 shares of Series B Preferred Stock, par value $0.0001 per share (the &#8220;Series&#160;B Preferred Stock&#8221;) pursuant to the initial closing of a private placement (the &#8220;Series B Private Placement&#8221;), at an offering price of $2.97 per share.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The aggregate gross proceeds from the initial closing of the Series B Private Placement were $10&#160;million (before deducting placement agent fees and total expenses in connection with the initial closing of the Series B Private Placement, which were $878,286).</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The initial closing of the Series B Private Placement was exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated by the SEC thereunder. The Series B Preferred Stock in the initial closing of the Series B Private Placement was sold to &#8220;accredited investors,&#8221; as defined in Regulation D, and was conducted on a &#8220;reasonable best efforts&#8221; basis.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">107<br></div></div></div>
<!--End Page 110-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 111-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_114-certain_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The initial closing of the Series B Private Placement was conditioned on the closing of the Corporate Reorganization and a minimum aggregate purchase price of $8.0&#160;million for the Series B Preferred Stock sold in the Series B Private Placement.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the Series B Private Placement, we paid to Tribal Capital Markets, LLC (the &#8220;Placement Agent&#8221;) (i)&#160;a cash fee of $800,000, or 8% of the gross proceeds raised in the Series B Private Placement, and (ii)&#160;reimbursement of expenses of $78,286. In addition, we issued to designees of the Placement Agent, for nominal consideration, warrants to purchase 269,360 shares of our common stock, or 8% of the number of shares of common stock underlying the Series B Preferred Stock sold in the offering (the &#8220;Placement Agent Warrants&#8221;) at an exercise price equal to $4.46, or 150% of the price per share of Series B Preferred Stock paid by investors in the Series B Private Placement, the Placement Agent Warrants. The Placement Agent Warrants provide for a cashless exercise right and are exercisable for a period of five years from July&#160;20, 2020.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to certain customary exceptions, we agreed to indemnify the Placement Agent to the fullest extent permitted by law against certain liabilities that may be incurred in connection with the Series B Private Placement, including certain civil liabilities under the Securities Act, and, where such indemnification is not available, to contribute to the payments the Placement Agents and their sub-agents may be required to make in respect of such liabilities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with our Series B Private Placement, the Company entered into a non-exclusive strategic advisory agreement with Allele Capital Partners LLC (&#8220;Allele&#8221;), a strategic advisory and investment firm, at $10,000 per month. Certain individuals affiliated with Allele are also registered representatives (but non-control persons) of the Placement Agent. The agreement with Allele will terminate upon consummation of this transaction. See Note 18 to our audited consolidated financial statements appearing elsewhere in this prospectus for further details on this agreement.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The descriptions of the Corporate Reorganization and the Placement Agent Warrants entered into in connection with the Series B Private Placement are qualified in their entirety by reference to the terms of such agreements, which are filed as exhibits to the registration statement of which this prospectus forms a part, and are incorporated by reference herein.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 17pt; margin-left: 0pt; text-align: left;">Participation in the Series B Private Placement</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the Series B Private Placement, we entered into a preferred stock purchase agreement and warrant agreement with certain investors, including beneficial owners of greater than 5% of our capital stock, members of our board of directors and affiliates of members of our board of directors, pursuant to which we issued and sold to such investors an aggregate of 33,672 shares of our Series B Preferred Stock at a purchase price of $2.97&#160;per share for aggregate gross proceeds of $100,005.84. Such purchases were made on the same terms as the shares that were sold to other investors in the Series B Private Placement and not pursuant to any pre-existing contractual rights or obligations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The table below sets forth the aggregate number of shares of Series B Preferred Stock and Placement Agent Warrants issued to our related parties in this financing:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.28%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Series B Convertible <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock (#)</div></td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 13.63%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Purchase Price ($)</div></td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 12.43%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Placement Agent <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants (#)</div></td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Strike <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price ($)</div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><u>Participant</u><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><u>(1)</u></sup><br></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.63%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.9pt; text-align: left;"></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.43%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.84pt; text-align: left;"></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.36%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.13pt; text-align: left;"></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Eric I Richman Living Trust<font style="padding-left: 4.84pt;"></font></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.01pt; text-align: left;">16,836</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.9pt; text-align: left;">50,002.92</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.43%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Shawn Milemore Titcomb<font style="padding-left: 4.84pt;"></font></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.01pt; text-align: left;">16,836</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.63%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.9pt; text-align: left;">50,002.92</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.43%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.84pt; text-align: left;">101,599</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.36%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.13pt; text-align: left;">4.46</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 9.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Additional details regarding these stockholders and their equity holdings are provided under the caption &#8220;Principal Stockholders.&#8221;</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">February 2020 Capital Raise</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February 2020, prior to the Corporate Reorganization, GT Gain Therapeutics SA sold 35,295 shares of Series A Preferred Stock, par value CHF 1.0 per share, to certain investors, including beneficial owners of greater than 5% of our capital stock, members of our board of directors and affiliates of members of our board of directors, pursuant to which we issued and sold to such investors an aggregate of 35,295 shares of our Series A Preferred Stock for aggregate gross proceeds of CHF 1,082,500 or USD 1,101,898 (the &#8220;February 2020 Capital Raise&#8221;) and incurred </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">108<br></div></div></div>
<!--End Page 111-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 112-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_114-certain_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">issuance costs of CHF&#160;10,368 or USD 10,553. The closing of the February 2020 Capital Raise was exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated by the SEC thereunder. The Series A Preferred Stock issued in the February 2020 Capital Raise was sold to &#8220;accredited investors,&#8221; as defined in Regulation D.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The table below sets forth the aggregate number of shares of Series A Preferred Stock issued to our related parties in the February 2020 Capital Raise:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.19%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Series A Convertible <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock (#)</div></td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.11%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Purchase <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price (CHF)</div></td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Purchase<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price (USD)</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><u>Participant</u><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><u>(1)</u></sup><br></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.19%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 21.79pt; text-align: left;"></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.92%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.62pt; text-align: left;"></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3B Future Health Fund S.A.<font style="padding-left: 0.42pt;"></font></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.19%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 21.79pt; text-align: left;">18,748</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;">575,000</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.62pt; text-align: left;">585,304</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">VitaTech SA<font style="padding-left: 4.49pt;"></font></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.19%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 21.79pt; text-align: left;"><font style="padding-left: 5pt;">9,374</font></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;">287,500</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.92%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.62pt; text-align: left;">292,652</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">TiVenture SA<font style="padding-left: 0.76pt;"></font></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.19%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 21.79pt; text-align: left;"><font style="padding-left: 5pt;">7,173</font></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;">220,000</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.62pt; text-align: left;">223,942</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 9.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Additional details regarding these stockholders and their equity holdings are provided under the caption &#8220;Principal Stockholders.&#8221;</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">February 2019 Capital Raise</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February 2019, prior to the Corporate Reorganization, GT Gain Therapeutics SA sold 58,119 shares of Series A Preferred Stock par value CHF 1.00 per share, to certain investors, including beneficial owners of greater than 5% of our capital stock, members of our board of directors and affiliates of members of our board of directors, pursuant to which we issued and sold to such investors an aggregate of 58,119 shares of its Series A Preferred Stock for aggregate gross proceeds of CHF 1,782,500 or USD 1,772,089 (the &#8220;February 2019 Capital Raise&#8221;) and incurred issuance costs of CHF 20,730 or USD 20,610. The closing of the February 2019 Capital Raise was exempt from registration under Section&#160;4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated by the SEC thereunder. The Series&#160;A Preferred Stock issued in the February 2019 Capital Raise was sold to &#8220;accredited investors,&#8221; as defined in Regulation D.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The table below sets forth the aggregate number of shares of Series A Preferred Stock issued to our related parties in the February 2019 Capital Raise:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.19%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Series A Convertible <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock (#)</div></td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.11%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Purchase <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price (CHF)</div></td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Purchase<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price (USD)</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><u>Participant</u><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><u>(1)</u></sup><br></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.19%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 21.79pt; text-align: left;"></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.31pt; text-align: left;"></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.92%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">VitaTech SA<font style="padding-left: 4.49pt;"></font></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.19%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 21.79pt; text-align: left;">20,623</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.31pt; text-align: left;"><font style="padding-left: 7.5pt;">632</font>,500</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 7.5pt;">628,808</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3B Future Health Fund S.A.<font style="padding-left: 0.42pt;"></font></div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.19%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 21.79pt; text-align: left;">37,496</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.31pt; text-align: left;">1,150,000</div></td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.73%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.92%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;">1,143,281</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Additional details regarding these stockholders and their equity holdings are provided under the caption &#8220;Principal Stockholders.&#8221;</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Convertible Notes and Conversion</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;4, 2018, pursuant to convertible loan agreements, TiVenture SA and VitaTech SA granted loans to GT Gain Therapeutics SA in the amounts of CHF 350,000 and EUR 550,000, respectively. As part of the February 2019 Capital Raise, TiVenture SA and VitaTech SA converted their notes into 41,225 shares of Series A Preferred Stock, 14,851 to TiVenture SA and 26,374 to VitaTech SA, respectively. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Investors&#8217; Rights Agreement</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the Corporate Reorganization and the Series B Private Placement, we entered into an Investors&#8217; Rights Agreement (the &#8220;IRA&#8221;), dated as of July&#160;20, 2020, which provides, among other things, that certain holders of our capital stock, including TiVenture SA, VitaTech SA, 3B Future Health Fund S.A. (f/k/a Helsinn Investment Fund) and Allele Capital Partners, LLC, have the right to demand that we file a registration statement or request that their shares of our capital stock be covered by a registration statement that we are otherwise filing. Lorenzo Leoni and Marianne Bj&#248;rdal, former members of our board of directors, are affiliated with TiVenture SA and VitaTech SA, and 3B Future Health Fund S.A. (f/k/a Helsinn Investment Fund), respectively. Eric Richman, our </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">109<br></div></div></div>
<!--End Page 112-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 113-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_114-certain_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Chief Executive Officer and member of our board of directors, is party to the IRA and affiliated with Allele Capital Partners, LLC. Khalid Islam, a member of our board of directors, and Lorenzo Leoni, a former member of our board of directors, are party to the IRA. See &#8220;Description of Capital Stock&#8212;Registration Rights&#8221; for additional information regarding these registration rights. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Right of First Refusal</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the Corporate Reorganization and the Series B Private Placement, we entered into certain agreements with certain holders of our capital stock, including a right of first refusal and co-sale agreement, dated as of July&#160;20, 2020. Pursuant to the right of first refusal and co-sale agreement, we or our assignees have a right to purchase shares of our capital stock which stockholders propose to sell to other parties. This right will terminate at the consummation of this offering. Khalid Islam, a member of our board of directors, and Lorenzo Leoni, a former member of our board of directors, are party to the right of first refusal and co-sale agreement. Eric Richman, our Chief Executive Officer and member of our board of directors, is party to the right of first refusal and co-sale agreement and affiliated with Allele Capital Partners, LLC. TiVenture SA, VitaTech SA, 3B Future Health Fund S.A. (f/k/a&#160;Helsinn Investment Fund) and Allele Capital Partners, LLC, are also party to the right of first refusal and co-sale agreement. Lorenzo Leoni and Marianne Bj&#248;rdal, former members of our board of directors, are affiliated with TiVenture SA and VitaTech SA, and 3B Future Health Fund S.A. (f/k/a Helsinn Investment Fund), respectively.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Voting Agreement</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the Corporate Reorganization and the Series B Private Placement, we entered into certain agreements with certain holders of our capital stock, including a voting agreement, dated as of July&#160;20, 2020 (the &#8220;Voting Agreement&#8221;). Pursuant to the Voting Agreement, among other things: (i)&#160;the stockholders prior to the Corporate Reorganization and Series B Private Placement (the &#8220;Gain SA Stockholders&#8221;) have the right to nominate three (3) members to our board of directors (the &#8220;Gain SA Stockholders&#8217; Nominees&#8221;); (ii)&#160;our stockholders prior to the Corporate Reorganization and Series B Private Placement (&#8220;Gain Stockholders&#8221;) shall vote in favor of the election of the Gain SA Stockholders&#8217; Nominees; (iii)&#160;Allele Capital Partners, LLC shall have the right to nominate one (1) member to our board of directors (the &#8220;Allele Director&#8221;), which initially shall be Eric Richman; (iv)&#160;the Gain SA Stockholders shall vote in favor of the election of the Allele Director; and (v)&#160;the Gain SA Stockholders and the Gain Stockholders will vote in favor of one independent candidate to the board of directors acceptable to the Allele Director and the management of the company, which shall initially be Jeffrey Riley. Upon consummation of this offering, the Voting Agreement will terminate and none of our stockholders will have any special rights regarding the election or designation of members of our board of directors. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Khalid Islam, a member of our board of directors, and Lorenzo Leoni, a former member of our board of directors, are party to the Voting Agreement. Eric&#160;Richman, our Chief Executive Officer and member of our board of directors, is party to the Voting Agreement and affiliated with Allele Capital Partners, LLC. TiVenture SA, VitaTech SA, 3B Future Health Fund S.A. (f/k/a Helsinn Investment Fund) and Allele&#160;Capital Partners, LLC, are also party to the Voting Agreement. Lorenzo Leoni and Marianne Bj&#248;rdal, former members of our board of directors, are affiliated with TiVenture SA and VitaTech SA, and 3B Future Health Fund S.A. (f/k/a Helsinn Investment Fund), respectively.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Agreements With Directors and Officers</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;">Relationship with Minoryx</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mr.&#160;Islam, one of our founders and Chairman of our board of directors, is the Chairman of the board of Minoryx, the licensor of our proprietary technology and as such there may be times when there is a conflict of interest between us and Minoryx. As consideration for the license grant under the Minoryx License Agreement, we have agreed to pay Minoryx royalties on a product-by-product basis based on the licensed IP used by us, ranging from a high single digit to low single digit percentage of net revenues of products during the royalty term commencing on the effective date of the Minoryx License Agreement and continuing until the 10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> anniversary of the first product commercialization. Upon the expiration of the royalty term for a product or service in a country, the license with respect to the product or service, as the case may be, shall become royalty-free, fully-paid, irrevocable and perpetual. In addition to royalties, we will pay Minoryx certain milestones payments of 1.25% of any consideration received by us in the event of a sale of our company or substantially all of our assets, including by merger, change of control, or reorganization. No such transactions took place in 2018, 2019 or 2020.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">110<br></div></div></div>
<!--End Page 113-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 114-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_114-certain_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Employment Agreements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have entered into written employment agreements with certain of our executive officers. These agreements provide for notice periods of varying duration for termination of the agreement by us or by the relevant executive officer, during which time the executive officer will continue to receive base salary and benefits. These agreements also contain customary provisions regarding non-competition, confidentiality of information and assignment of inventions. However, the enforceability of the non-competition provisions may be limited under applicable law. See &#8220;Risk Factors&#8212;General Company&#8212;Related Risks&#8212;Under applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors from benefitting from the expertise of some of our former employees&#8221; for a further description of the enforceability of non-competition clauses.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Equity Incentive Plans</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For a description of our equity incentive plans with members of our board of directors and executive officers, see &#8220;Executive and Director Compensation&#8212;Gain Therapeutics Inc. 2020 Omnibus Incentive Plan.&#8221;</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Indemnification Agreements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We intend to enter into indemnification agreements with each of our directors and executive officers. These agreements will require us to indemnify these individuals to the fullest extent permitted under Delaware law against liabilities that may arise by reason of their service to us, and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified. We also intend to enter into indemnification agreements with our future directors and executive officers.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There is no pending litigation or proceeding naming any of our directors or officers to which indemnification is being sought, and we are not aware of any pending or threatened litigation that may result in claims for indemnification by any director or officer.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Policies and Procedures for Related Party Transactions</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors expects to adopt a written related-party transaction policy, to be effective upon the completion of this offering, setting forth the policies and procedures for the review and approval or ratification of transactions involving us and &#8220;related persons.&#8221; For the purposes of this policy, &#8220;related persons&#8221; will include our executive officers, directors, director nominees, and their immediate family members, and stockholders owning five percent or more of our outstanding common stock and their immediate family members.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The policy will cover, with certain exceptions set forth in Item 404 of Regulation S-K under the Securities Act, any transaction, arrangement, or relationship, or any series of similar transactions, arrangements, or relationships in which we were or are to be a participant, where the amount involved exceeds $120,000 and a related person has or will have a direct or indirect material interest, including, without limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness, and employment by us of a related person. In reviewing and approving any such transactions, our audit committee is tasked to consider all relevant facts and circumstances, including, but not limited to, whether the transaction is on terms comparable to those that could be obtained in an arm&#8217;s length transaction with an unrelated party and the extent of the related person&#8217;s interest in the transaction. All related-party transactions may only be consummated if our audit committee has approved or ratified such transaction in accordance with the guidelines set forth in the policy. Any member of the audit committee who is a related person with respect to a transaction under review will not be permitted to participate in the deliberations or vote respecting approval or ratification of the transaction. However, such director may be counted in determining the presence of a quorum at a meeting of the audit committee that considers the transaction. All of the transactions described in this section occurred prior to the adoption of this policy.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">111<br></div></div></div>
<!--End Page 114-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 115-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOC"><!--Anchor--></a>DESCRIPTION OF CAPITAL STOCK</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">General</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of the closing of this offering, after giving effect to the Preferred Conversion, our authorized capital stock will consist of 11,331,006&#160; shares of common stock, par value $0.0001 per share, and no shares of preferred stock, par value $0.0001 per share. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are selling 3,636,364&#160; shares of common stock in this offering (4,181,818  shares if the underwriters exercise their over-allotment option in full). All shares of our common stock outstanding upon consummation of this offering will be fully paid and non-assessable.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based upon the initial public offering price of $11.00 per share, and after giving effect to the Preferred Conversion, as of December&#160;31, 2020, there were 7,694,642&#160;shares of our common stock outstanding held by 58 stockholders of record, and no shares of our preferred stock outstanding.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have adopted an Amended Charter and Amended Bylaws in connection with the completion of this offering. The following description of our capital stock and provisions of our Amended Charter and Amended Bylaws are summaries and are qualified by reference to the Amended Charter and Amended Bylaws. Copies of these documents will be filed with the SEC as exhibits to our registration statement, of which this prospectus forms a part. The description of our capital stock reflects changes to our capital structure that will occur upon the closing of this offering.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Common Stock</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of shares of our common stock are entitled to one vote for each share held of record on all matters on which stockholders are entitled to vote generally, including the election or removal of directors elected by our stockholders generally. The holders of our common stock do not have cumulative voting rights in the election of directors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of shares of our common stock are entitled to receive dividends when, as and if declared by our board of directors out of funds legally available therefor, subject to any statutory or contractual restrictions on the payment of dividends and to any restrictions on the payment of dividends imposed by the terms of any outstanding preferred stock.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon our liquidation, dissolution or winding up and after payment in full of all amounts required to be paid to creditors and to the holders of preferred stock having liquidation preferences, if any, the holders of shares of our common stock will be entitled to receive our remaining assets available for distribution on a pro rata basis.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All shares of our common stock that will be outstanding at the time of the consummation of the offering will be fully paid and non-assessable. The common stock will not be subject to further calls or assessments by us. Holders of shares of our common stock do not have preemptive, subscription, redemption or conversion rights. There will be no redemption or sinking fund provisions applicable to the common stock. The rights powers, preferences and privileges of our common stock will be subject to those of the holders of any shares of our preferred stock or any other series or class of stock we may authorize and issue in the future.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Preferred Stock</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No shares of preferred stock will be issued or outstanding immediately after the offering contemplated by this prospectus. Our Amended Charter authorizes our board of directors to establish one or more series of preferred stock (including convertible preferred stock). Unless required by law or any stock exchange, the authorized shares of preferred stock will be available for issuance without further action by the holders of our common stock. Our board of directors is able to determine, with respect to any series of preferred stock, the powers (including voting powers), preferences and relative, participating, optional or other special rights, and the qualifications, limitations or restrictions thereof, including, without limitation:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the designation of the series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the number of shares of the series, which our board of directors may, except where otherwise provided in the preferred stock designation, increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares then outstanding);</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">112<br></div></div></div>
<!--End Page 115-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 116-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">whether dividends, if any, will be cumulative or non-cumulative and the dividend rate of the series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the dates at which dividends, if any, will be payable;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the redemption or repurchase rights and price or prices, if any, for shares of the series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding-up of our affairs;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">whether the shares of the series will be convertible into shares of any other class or series, or any other security, of us or any other entity, and, if so, the specification of the other class or series or other security, the conversion price or prices or rate or rates, any rate adjustments, the date or dates as of which the shares will be convertible and all other terms and conditions upon which the conversion may be made;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">restrictions on the issuance of shares of the same series or of any other class or series; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the voting rights, if any, of the holders of the series.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or a majority, of the holders of our common stock might believe to be in their best interests or in which the holders of our common stock might receive a premium over the market price of the shares of our common stock. Additionally, the issuance of preferred stock may adversely affect the rights of holders of our common stock by restricting dividends on the common stock, diluting the voting power of the common stock or subordinating the liquidation rights of the common stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of our common stock.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Registration Rights</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The IRA provides that certain holders of our Series B Preferred Stock, including, but not limited to, certain holders of at least 5% of our capital stock and entities affiliated with certain of our directors and officers, have certain registration rights, as set forth below. The registration rights set forth in the IRA will expire one year following the completion of this offering, or, with respect to any particular stockholder, when such stockholder is able to sell all of its shares pursuant to Rule 144 of the Securities Act during any 90-day period. We will pay the registration expenses (other than underwriting discounts and commissions) of the holders of the shares registered pursuant to the registrations described below. The IRA does not provide for any maximum cash penalties or any penalties connected with delays in registering our common stock.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions, to limit the number of shares such holders may include. In connection with this offering, we expect that each stockholder that has registration rights will agree not to sell or otherwise dispose of any securities without the prior written consent of BTIG, LLC and Oppenheimer &amp; Co. Inc. for a period of 180 days after the date of this prospectus, subject to certain terms and conditions and early release of certain holders in specified circumstances. See &#8220;Shares Eligible for Future Sale&#8212;Lock-Up Agreements&#8221; for additional information regarding such restrictions.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Demand Registration Rights</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">After the completion of this offering, the holders of an aggregate of 4,151,479&#160; shares of our common stock will be entitled to certain demand registration rights. At any time beginning on the earlier of July&#160;20, 2023 and six months after the effective date of this registration statement, the holders of at least 50% of our shares of common stock entitled to certain demand registration rights then outstanding may request that we register all or a portion of their shares. Such request for registration must cover securities the aggregate offering price of which, after payment of underwriting discounts and commissions, would exceed $5,000,000. We will not be required to effect more than two registrations on Form S-1 within any 12-month period.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Piggyback Registration Rights</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">After the completion of this offering, in the event that we propose to register any of our securities under the Securities Act, either for our own account or for the account of other security holders, in connection with such offering the holders of an aggregate of 4,151,479 shares of our common stock will be entitled to certain piggyback registration rights allowing the holder to include their shares in such registration, subject to certain marketing and </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">113<br></div></div></div>
<!--End Page 116-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 117-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to (i)&#160;a registration relating to the sale of securities to service providers of the company or a subsidiary pursuant to a stock option, stock purchase or similar plan, (ii)&#160;a registration relating to an SEC Rule 145 transaction, (iii)&#160;a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities or (iv)&#160;a registration in which the only common stock being registered is common stock issuable upon conversion of debt securities that are also being registered, the holders of these shares are entitled to notice of the registration and have the right, subject to certain limitations, to include their shares in the registration.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Form S-3 Registration Rights</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">After the completion of this offering, the holders of an aggregate of 4,151,479&#160; shares of our common stock will be entitled to certain Form S-3 registration rights. The holders of at least 30% of our shares of common stock entitled to certain Form S-3 registration rights can make a request that we register their shares on Form S-3 if we are qualified to file a registration statement on Form S-3 and if the reasonably anticipated aggregate gross proceeds of the shares offered would equal or exceed $3,000,000. We will not be required to effect more than two registrations on Form S-3.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Annual Stockholder Meetings</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Amended Bylaws provide that annual stockholder meetings will be held at a date, time and place, if any, as exclusively selected by our board of directors. To the extent permitted under applicable law, we may conduct meetings by remote communications, including by webcast.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Anti-Takeover Effects of Our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws and Certain Provisions of Delaware Law</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Amended Charter, Amended Bylaws and the DGCL will contain provisions that are intended to enhance the likelihood of continuity and stability in the composition of our board of directors. These provisions are intended to avoid costly takeover battles, reduce our vulnerability to a hostile or abusive change of control and enhance the ability of our board of directors to maximize stockholder value in connection with any unsolicited offer to acquire us. However, these provisions may have an anti-takeover effect and may delay, deter or prevent a merger or acquisition of our company by means of a tender offer, a proxy contest or other takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the prevailing market price for the shares of common stock held by stockholders.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Authorized but Unissued Capital Stock</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval, subject to any limitations imposed by the listing standards of the Nasdaq Global Market. These additional shares may be used for a variety of corporate finance transactions, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could make more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Business Combinations</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are subject to Section 203 of the DGCL, which prohibits persons deemed to be &#8220;interested stockholders&#8221; from engaging in a &#8220;business combination&#8221; with a publicly held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation&#8217;s voting stock. Generally, a &#8220;business combination&#8221; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">No Cumulative Voting</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under Delaware law, the right to vote cumulatively does not exist unless the certificate of incorporation specifically authorizes cumulative voting. Our Amended Charter does not authorize cumulative voting. Therefore, stockholders holding a majority of the shares of our stock entitled to vote generally in the election of directors will be able to elect all our directors.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">114<br></div></div></div>
<!--End Page 117-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 118-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Special Stockholder Meetings</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Amended Charter will provide that special meetings of our stockholders may be called at any time only by or at the direction of the board of directors or the chairman of the board of directors. Our Amended Bylaws prohibit the conduct of any business at a special meeting other than as specified in the notice for such meeting. These provisions may have the effect of deferring, delaying, or discouraging hostile takeovers, or changes in control or management of our company.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Director Nominations and Stockholder Proposals</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our amended and restated bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors. In order for any matter to be &#8220;properly brought&#8221; before a meeting, a stockholder will have to comply with advance notice requirements and provide us with certain information. Generally, to be timely, a stockholder&#8217;s notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the immediately preceding annual meeting of stockholders. Our Amended Bylaws also specify requirements as to the form and content of a stockholder&#8217;s notice. Our Amended Bylaws allow the chairman of the meeting at a meeting of the stockholders to adopt rules and regulations for the conduct of meetings that may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not followed. These provisions may also defer, delay, or discourage a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to influence or obtain control of the company.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Stockholder Action by Written Consent</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to Section 228 of the DGCL, any action required to be taken at any annual or special meeting of the stockholders may be taken without a meeting, without prior notice, and without a vote if a consent or consents in writing, setting forth the action so taken, is or are signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares of our stock entitled to vote thereon were present and voted, unless our amended and restated certificate of incorporation will provide otherwise. Our Amended Charter will preclude stockholder action by written consent at any time. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Amendment of Amended and Restated Certificate of Incorporation or Bylaws </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DGCL provides generally that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation&#8217;s certificate of incorporation or bylaws, unless a corporation&#8217;s certificate of incorporation or bylaws, as the case may be, requires a greater percentage. Upon consummation of this offering, our bylaws may be amended or repealed by a majority vote of our board of directors or by the affirmative vote of the holders of at least 66 2/3% of the votes which all our stockholders would be entitled to cast in any annual election of directors. In addition, the affirmative vote of the holders of at least 66 2/3% of the votes which all our stockholders would be entitled to cast in any election of directors will be required to amend or repeal or to adopt any provisions inconsistent with any of the provisions of our certificate described above.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The foregoing provisions of our Amended Charter and Amended Bylaws could discourage potential acquisition proposals and could delay or prevent a change in control. These provisions are intended to enhance the likelihood of continuity and stability in the composition of our board of directors and in the policies formulated by our board of directors and to discourage certain types of transactions that may involve an actual or threatened change of control. These provisions are designed to reduce our vulnerability to an unsolicited acquisition proposal. The provisions also are intended to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they also may inhibit fluctuations in the market price of our shares of common stock that could result from actual or rumored takeover attempts. Such provisions also may have the effect of preventing changes in our management or delaying or preventing a transaction that might benefit you or other minority stockholders.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Dissenters&#8217; Rights of Appraisal and Payment</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the DGCL, with certain exceptions, our stockholders will have appraisal rights in connection with a merger or consolidation of us. Pursuant to the DGCL, stockholders who properly request and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of Chancery.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">115<br></div></div></div>
<!--End Page 118-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 119-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Stockholders&#8217; Derivative Actions</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the DGCL, any of our stockholders may bring an action in our name to procure a judgment in our favor, also known as a derivative action, provided that the stockholder bringing the action is a holder of our shares at the time of the transaction to which the action relates or such stockholder&#8217;s stock thereafter devolved by operation of law.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Exclusive Forum</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Amended Charter will provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will, to the fullest extent permitted by applicable law, be the sole and exclusive forum for: (1) any derivative action or proceeding brought on our behalf; (2) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees or stockholders to us or our stockholders; (3) any action asserting a claim against us, any director or our officers and employees arising pursuant to any provision of the DGCL, our Amended Charter or our amended and restated bylaws, or as to which the DGCL confers exclusive jurisdiction on the Court of Chancery; or (4) any action asserting a claim against us, any director or our officers or employees that is governed by the internal affairs doctrine; provided that the exclusive forum provisions will not apply to suits brought to enforce any liability or duty created by the Exchange Act, or to any claim for which the federal courts have exclusive jurisdiction. Our Amended Charter will further provide that, unless we consent in writing to the selections of an alternative forum, the federal district courts are the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act, subject to a final adjudication in the State of Delaware of the enforceability of such exclusive forum provision. We note that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Although we believe the provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, the provision may have the effect of discouraging lawsuits against our directors and officers. See &#8220;Risk Factors&#8212; Risks Related to Our Securities and the Offering&#8212;Our Amended Charter will provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for substantially all disputes between us and our stockholders and federal district courts will be the sole and exclusive forum for Securities Act claims, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.&#8221; </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Officers and Directors</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors&#8217; fiduciary duties, subject to certain exceptions. Our Amended Charter includes a provision that eliminates the personal liability of directors for monetary damages to the corporation or its stockholders for any breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL. The effect of these provisions is to eliminate the rights of us and our stockholders, through stockholders&#8217; derivative suits on our behalf, to recover monetary damages from a director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior. However, exculpation does not apply to any breaches of the director&#8217;s duty of loyalty, any acts or omissions not in good faith or that involve intentional misconduct or knowing violation of law, any authorization of dividends or stock redemptions or repurchases paid or made in violation of the DGCL, or for any transaction from which the director derived an improper personal benefit.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Amended Bylaws generally provide that we must indemnify and advance expenses to our directors and officers to the fullest extent authorized by the DGCL. We also are expressly authorized to carry directors&#8217; and officers&#8217; liability insurance providing indemnification for our directors, officers and certain employees for some liabilities. We believe that these indemnification and advancement provisions and insurance are useful to attract and retain qualified directors and executive officers.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The limitation of liability, indemnification and advancement provisions in our Amended Charter and Amended Bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. In addition, your investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There is currently no pending material litigation or proceeding involving any of our directors, officers or employees for which indemnification is sought.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">116<br></div></div></div>
<!--End Page 119-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 120-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Indemnification Agreements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We intend to enter into an indemnification agreement with each of our directors and executive officers as described in &#8220;<font style="font-style: italic;">Certain Relationships and Related Person Transactions&#8212;Indemnification of Officers and Directors</font>.&#8221; Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors or executive officers, we have been informed that in the opinion of the SEC such indemnification is against public policy and is therefore unenforceable. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Transfer Agent and Registrar</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The transfer agent and registrar for shares of our common stock will be &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Listing</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have been approved to list our common stock on the Nasdaq Global Market under the symbol &#8220;GANX.&#8221;</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">117<br></div></div></div>
<!--End Page 120-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 121-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUSF"><!--Anchor--></a>U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following is a summary of U.S. federal income tax considerations generally applicable to the ownership and disposition of our common stock by a Non-U.S. Holder (as defined below) that acquires such stock in this offering and that holds such stock as a capital asset (generally, property held for investment). This summary does not address all aspects of U.S. federal income taxation that may be relevant to a particular Non-U.S. Holder in light of its individual circumstances or the U.S. federal income tax consequences applicable to Non-U.S. Holders that are subject to special rules, such as controlled foreign corporations, passive foreign investment companies, corporations that accumulate earnings to avoid U.S. federal income tax, banks or other financial institutions, tax-exempt organizations (including private foundations), U.S. expatriates, broker-dealers and traders in securities or currencies, or Non-U.S. Holders that hold common stock as part of a &#8220;straddle,&#8221; &#8220;hedge,&#8221; &#8220;conversion transaction,&#8221; or other integrated investment. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary is based on provisions of the Code, U.S. Treasury Regulations promulgated thereunder, and administrative and judicial interpretations thereof, all as in effect on the date hereof, and all of which are subject to change or differing interpretation, possibly with retroactive effect. This summary does not describe any U.S. state, local or Non-U.S. income or other tax consequences (including estate, gift and Medicare contribution tax consequences) of owning and disposing of our common stock.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For purposes of this summary, the term &#8220;Non-U.S. Holder&#8221; means a beneficial owner of our common stock that is, for U.S. federal income tax purposes, neither a partnership nor an entity or arrangement treated as a partnership for U.S. federal income tax purposes nor any of the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a citizen or individual resident of the United States; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a corporation, or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or any political subdivision thereof; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a trust if (a) a United States court is able to exercise primary supervision over the trust&#8217;s administration and one or more U.S. persons have the authority to control all of the trust&#8217;s substantial decisions, or (b) the trust has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If a partnership (including any entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds our common stock, the tax treatment of a partner in such partnership will generally depend upon the status of the partner and the activities of the partnership. Partnerships and their partners should consult their tax advisers as to the U.S. federal income tax consequences to them of an investment in our common stock in their particular circumstances. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS TAX ADVISER REGARDING THE U.S. FEDERAL, STATE, LOCAL, AND NON-U.S. INCOME AND OTHER TAX CONSEQUENCES OF THE OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Distributions </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Distributions on our common stock will generally be treated as dividends to the extent such distributions are paid from our current or accumulated earnings and profits as determined for U.S. federal income tax purposes. Any such distributions in excess of our current and accumulated earnings and profits will be treated first as a return of capital to the extent of the holder&#8217;s adjusted tax basis in our common stock and thereafter as capital gain from the sale or exchange of such common stock.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The gross amount of dividends paid to a Non-U.S. Holder with respect to our common stock will generally be subject to U.S. federal withholding tax at a rate of 30% (or such lower rate as may be prescribed by an applicable income tax treaty), unless the dividends are effectively connected with the Non-U.S. Holder&#8217;s conduct by the Non-U.S. Holder of a trade or business within the United States (and, if required by an applicable income tax treaty, are attributable to a permanent establishment maintained by such Non-U.S. Holder in the United States). Dividends effectively connected with a Non-U.S. Holder&#8217;s conduct of a U.S. trade or business (and, if required by an applicable income tax treaty, attributable to a U.S. permanent establishment) will generally not be subject to U.S. withholding tax if the Non-U.S. Holder complies with applicable certification and disclosure requirements (generally, by providing an Internal Revenue Service (&#8220;IRS&#8221;) Form W-8ECI (or appropriate successor or replacement forms)). </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">118<br></div></div></div>
<!--End Page 121-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 122-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Instead, such dividends generally will be subject to U.S. federal income tax on a net income basis in the same manner in which citizens and residents of the United States are subject to U.S. federal income tax. Corporate Non-U.S. Holders may be subject to an additional &#8220;branch profits tax&#8221; at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty) on its &#8220;effectively connected earnings and profits,&#8221; subject to certain adjustments.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">An eligible Non-U.S. Holder may obtain a reduced rate of withholding under an applicable income tax treaty by providing a properly executed IRS Form W-8BEN or IRS Form W-8BEN-E (or any appropriate successor or replacement forms), as applicable, certifying that it is not a U.S. person as defined under the Code and that it is entitled to benefits under the treaty or, if such Non-U.S. Holder&#8217;s common stock is held through certain foreign intermediaries or foreign partnerships, by satisfying the relevant certification requirements of applicable Treasury regulations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A Non-U.S. Holder eligible for a reduced rate of or exemption from U.S. federal withholding tax may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. Non-U.S. Holders should consult their tax advisers regarding their entitlement to benefits under an applicable income tax treaty and the specific manner of claiming the benefits of the treaty.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Sale, exchange, or other taxable disposition</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A Non-U.S. Holder will generally not be subject to U.S. federal income or withholding tax with respect to gain recognized on the sale, exchange, or other taxable disposition of our common stock unless</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the gain is effectively connected with such Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable tax treaty, is attributable to a permanent establishment maintained by such Non-U.S. Holder in the United States), in which case, the Non-U.S. Holder will be subject to U.S. federal income tax on such gain on a net income basis in the same manner in which citizens or residents of the United States are subject to U.S. federal income tax and, in the case of corporate Non-U.S. Holders, may also be subject to an additional &#8220;branch profits tax&#8221; at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">in the case of a Non-U.S. Holder that is a non-resident alien individual, such Non-U.S. Holder is present in the United States for 183 or more days in the taxable year of disposition and certain other conditions are met, in which case the Non-U.S. Holder will generally be subject to a flat income tax at a rate of 30% (or lower applicable treaty rate) on any capital gain recognized on the disposition of our common stock, which may be offset by certain U.S. source capital losses; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we are or have been a &#8220;United States real property holding corporation&#8221; (&#8220;USRPHC&#8221;) for U.S. federal income tax purposes at any time within the shorter of the five-year period ending on the date of such sale, exchange, or other taxable disposition or the period that such Non-U.S. Holder held our common stock and either (a) our common stock was not treated as regularly traded on an established securities market at any time during the calendar year in which the sale, exchange, or other taxable disposition occurs, or (b) such Non-U.S. Holder owns or owned (actually or constructively) more than 5% of our common stock at any time during the shorter of the two periods mentioned above. We believe it is not, has not been and does not anticipate becoming a USRPHC for U.S. federal income tax purposes.</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Foreign account tax compliance act (&#8220;FATCA&#8221;)</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Provisions of the Code commonly known as &#8220;FATCA&#8221; may require withholding at a rate of 30% on dividends in respect of our common stock held by or through certain foreign financial institutions (including investment funds), unless such institution (i)&#160;enters into, and complies with, an agreement with the Treasury Department to report, on an annual basis, information with respect to interests in, and accounts maintained by, the institution to the extent such interests or accounts are held by certain U.S. persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments or (ii)&#160;complies with an intergovernmental agreement between the United States and an applicable foreign country to report such information to its local tax authority, which will exchange such information with the U.S. authorities. An intergovernmental agreement between the United States and an applicable foreign country may modify these requirements. Accordingly, the entity through which our common stock is held will affect the determination of whether such withholding is required. Similarly, dividends in respect of our common stock held by an investor that is a non-financial non-U.S. entity that does not qualify under certain exemptions will be subject to withholding at a rate of 30%, unless such entity either (i)&#160;certifies that such </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">119<br></div></div></div>
<!--End Page 122-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 123-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">entity does not have any &#8220;substantial United States owners&#8221; or (ii)&#160;provides certain information regarding the entity&#8217;s &#8220;substantial United States owners,&#8221; which we or the applicable withholding agent will in turn provide to the Treasury Department. We will not pay any additional amounts to holders in respect of any amounts withheld. Prospective investors should consult their tax advisors regarding the possible implications of this withholding tax on an investment in our common stock.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">THIS DISCUSSION OF U.S. FEDERAL INCOME TAX CONSIDERATIONS IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSTRUED AS, TAX ADVICE. THE FOREGOING SUMMARY IS NOT A SUBSTITUTE FOR A SPECIFIC ANALYSIS OF THE TAX CONSIDERATIONS APPLICABLE TO A PROSPECTIVE HOLDER OF THE OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK, WHICH ANALYSIS MAY BE COMPLEX AND WILL DEPEND ON THE HOLDER&#8217;S SPECIFIC SITUATION. EACH PROSPECTIVE HOLDER SHOULD CONSULT A TAX ADVISOR REGARDING THE PARTICULAR FEDERAL, STATE, LOCAL, AND NON-U.S. TAX CONSIDERATIONS APPLICABLE TO PROSPECTIVE HOLDERS OF THE OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">120<br></div></div></div>
<!--End Page 123-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 124-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSEF"><!--Anchor--></a>SHARES ELIGIBLE FOR FUTURE SALE</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to this offering, there has been no public market for our common stock. No prediction is made as to the effect, if any, future sales of shares, or the availability for future sales of shares, will have on the market price of our common stock prevailing from time to time. The sale of substantial amounts of our common stock in the public market, or the perception that such sales could occur, could harm the prevailing market price of our common stock.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon consummation of this offering and after giving effect to the use of proceeds therefrom, we will have outstanding 11,331,006&#160; shares of common stock (or 11,876,460  shares of common stock if the underwriters&#8217; option to purchase additional shares of common stock is exercised in full). The shares of common stock sold in this offering (other than any shares sold pursuant to our directed share program that are subject to &#8220;lock-up&#8221; restrictions as described under &#8220;Underwriting&#8221;) will be freely tradable without restriction or further registration under the Securities Act, except for any common stock held by our &#8220;affiliates,&#8221; as defined in Rule 144, which would be subject to the limitations and restrictions described below.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Registration Statement on Form S-8</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We intend to file one or more registration statements on Form S-8 under the Securities Act to register shares of our common stock or securities convertible into or exchangeable for shares of our common stock issued pursuant to our 2020 Omnibus Incentive Plan. Any such registration statement on Form S-8 will automatically become effective upon filing. Accordingly, shares of common stock registered under such registration statement will be available for sale in the open market, subject to any vesting restrictions or the lock-up restrictions and Rule 144 limitations applicable to affiliates described below.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Registration Rights</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to our IRA, after the completion of this offering, the holders of up to 4,151,479&#160; shares of our common stock, or certain transferees, will be entitled to certain rights with respect to the registration of the offer and sale of those shares under the Securities Act. See &#8220;Description of Capital Stock&#8212;Registration Rights&#8221; for a description of these registration rights. If the offer and sale of these shares of our Common Stock are registered, the shares will be freely tradable without restriction under the Securities Act, subject to the Rule 144 limitations applicable to affiliates, and a large number of shares may be sold into the public market. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Lock-Up of Our Common Stock</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to a Lock-Up Agreement (the &#8220;Lock-Up Agreement&#8221;), we, all of our directors and officers, and holders of substantially all of our outstanding common stock, have agreed with the underwriters, subject to certain exceptions, not to (i)&#160;offer, sell, contract to sell, pledge, grant any option to purchase, lend or otherwise dispose of any shares of common stock, or any options or warrants to purchase any shares of common stock or any securities convertible into, exchangeable for or that represent the right to receive shares of common stock (such options, warrants or other securities, collectively, &#8220;Derivative Instruments&#8221;), including without limitation any such shares or Derivative Instruments now owned or hereafter acquired; (ii)&#160;engage in any hedging or other transaction or arrangement (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) which is designed to or which reasonably could be expected to lead to or result in a sale, loan, pledge or other disposition or transfer of any of the economic consequences of ownership, in whole or in part, directly or indirectly, of any shares of common stock or Derivative Instruments, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of common stock or other securities, in cash or otherwise (any such sale, loan, pledge or other disposition, or transfer of economic consequences, a &#8220;Transfer&#8221;) or (iii)&#160;otherwise publicly announce any intention to engage in or cause any action or activity described in clause (i)&#160;above or transaction or arrangement described in clause (ii)&#160;above during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus (the &#8220;Lock-Up Period&#8221;), except with the prior written consent of BTIG, LLC and Oppenheimer &amp; Co. Inc. Currently, the underwriters have no current intention to release the aforementioned holders of our common stock from the lock-up restrictions described above. Our Lock-Up Agreement will provide for certain exceptions. See &#8220;Underwriting.&#8221; </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Rule 144</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In general, under Rule 144 as currently in effect, once we have been subject to the public company reporting requirements of Section 13 or Section 15(d) of the Exchange Act for at least 90 days, a person who is not deemed </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">121<br></div></div></div>
<!--End Page 124-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 125-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_115-description_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">to have been one of our affiliates for purposes of the Securities Act at any time during the 90 days preceding a sale and who has beneficially owned the shares of our common stock proposed to be sold for at least six months is entitled to sell those shares without complying with the manner of sale, volume limitation or notice provisions of Rule 144, subject to compliance with the public information requirements of Rule 144. If such a person has beneficially owned the shares of common stock proposed to be sold for at least one year, including the holding period of any prior owner other than our affiliates, then that person would be entitled to sell those shares of common stock without complying with any of the requirements of Rule 144.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In general, under Rule 144, as currently in effect, our affiliates or persons selling shares of our common stock on behalf of our affiliates are entitled to sell upon expiration of the Lock-Up Agreements described above, within any three-month period, a number of shares of common stock that does not exceed the greater of:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">1% of the number of shares of our common stock then outstanding, which will equal approximately 113,311 shares of our common stock immediately after this offering assuming no exercise of the underwriters&#8217; option to purchase additional shares; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the average weekly trading volume of our common stock on the stock exchange on which our shares our listed during the four calendar weeks preceding the filing of a notice on Form 144 with respect to that sale.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales under Rule 144 by our affiliates or persons selling shares of our common stock on behalf of our affiliates are also subject to certain manner-of-sale provisions and notice requirements and to the availability of current public information about us.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Rule 701</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Rule 701 generally allows a stockholder who purchased shares of our capital stock pursuant to a written compensatory plan or contract and who is not deemed to have been an affiliate of our company during the immediately preceding 90 days to sell these shares in reliance upon Rule 144, but without being required to comply with the public information, holding period, volume limitation or notice provisions of Rule 144. Rule 701 also permits affiliates of our company to sell their Rule 701 shares under Rule 144 without complying with the holding period requirements of Rule 144. All holders of Rule 701 shares, however, are required to wait until 90 days after the date of this prospectus before selling those shares pursuant to Rule 701. Moreover, all Rule 701 shares are subject to Lock-Up Agreements with the underwriters as described above and in the section titled &#8220;Underwriting&#8221; and will not become eligible for sale until the expiration of those agreements.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">122<br></div></div></div>
<!--End Page 125-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 126-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_116-under_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUND"><!--Anchor--></a>UNDERWRITING</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We and the underwriters named below have entered into an underwriting agreement with respect to the shares being offered. Subject to certain conditions, each underwriter has severally agreed to purchase the number of shares indicated in the following table. BTIG, LLC and Oppenheimer &amp; Co. Inc. are the representatives of the underwriters. </div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 85.68%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Underwriters</div></td><td class="gutter" style="width: 2.88%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.88%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td></tr><tr><td style="width: 85.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BTIG, LLC<font style="padding-left: 0.45pt;"></font></div></td><td class="gutter" style="width: 2.88%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.88%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;1,636,364</div></td></tr><tr><td style="width: 85.68%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Oppenheimer &amp; Co. Inc.<font style="padding-left: 1.87pt;"></font></div></td><td class="gutter" style="width: 2.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,454,545</div></td></tr><tr><td style="width: 85.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">National Securities Corporation<font style="padding-left: 4.65pt;"></font></div></td><td class="gutter" style="width: 2.88%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.88%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 40pt;">&#8203;</font><font style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 40pt;">545,455</font></div></td></tr><tr><td style="width: 85.68%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="padding-left: 3.09pt;"></font></div></td><td class="gutter" style="width: 2.88%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 2.88%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 40pt;">3,636,364</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The underwriters are committed to take and pay for all of the shares being offered, if any are taken, other than the shares covered by the option described below unless and until this option is exercised. The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may also be increased or the offering may be terminated. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The underwriters have an option to buy up to an additional 545,454 shares from us to cover sales by the underwriters of a greater number of shares than the total number set forth in the table above. They may exercise that option for 30 days. If any shares are purchased pursuant to this option, the underwriters will severally purchase shares in approximately the same proportion as set forth in the table above. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table shows the per share and total underwriting discounts and commissions to be paid to the underwriters by us. Such amounts are shown assuming both no exercise and full exercise of the underwriters&#8217; option to purchase up to 545,454 additional shares from us. </div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 475pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 73.26%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.63%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 12.11%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">No Exercise </div></td><td class="gutter" style="width: 0.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 12.11%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Full Exercise </div></td></tr><tr><td style="width: 73.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Per Share<font style="padding-left: 1.08pt;"></font></div></td><td class="gutter" style="width: 0.63%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.63%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.11%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 35pt;">&#8203;</font>0.77</div></td><td class="gutter" style="width: 0.63%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.63%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.11%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 35pt;">&#8203;</font>0.77</div></td></tr><tr><td style="width: 73.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 0.09pt;"></font></div></td><td class="gutter" style="width: 0.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2,800,000.28 </div></td><td class="gutter" style="width: 0.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$3,219,999.86</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Shares sold by the underwriters to the public will initially be offered at the initial public offering price set forth on the cover of this prospectus. Any shares sold by the underwriters to securities dealers may be sold at a discount of up to $0.4620 per share from the initial public offering price. After the initial offering of the shares, the representatives may change the offering price and the other selling terms. The offering of the shares by the underwriters is subject to receipt and acceptance and subject to the underwriters&#8217; right to reject any order in whole or in part. Sales of shares made outside of the United States may be made by affiliates of the underwriters. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A prospectus in electronic format may be made available on the web sites maintained by one or more underwriters, or selling group members, if any, participating in the offering. The underwriters may agree to allocate a number of shares to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to underwriters and selling group members that may make internet distributions on the same basis as other allocations. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We and our officers, directors, and holders of substantially all of our common stock and securities convertible into or exchangeable for our common stock have agreed or will agree with the underwriters, subject to certain exceptions, not to dispose of or hedge any of our or their common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus, except with the prior written consent of the representatives. See &#8220;Shares Eligible for Future Sale&#8221; for a discussion of certain transfer restrictions. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The restrictions described in the immediately preceding paragraph do not apply to certain transfers, dispositions or transactions, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">as a <font style="font-style: italic;">bona fide</font> gift or gifts or by will or intestacy upon the death of the holder, <font style="font-style: italic;">provided</font> that any such transfer shall not involve a disposition for value and the donee or donees, beneficiary or beneficiaries, heir or heirs or legal representatives thereof agree to be bound in writing by the restrictions set forth herein and <font style="font-style: italic;">provided</font><font style="font-style: italic;"> </font><font style="font-style: italic;">further</font> that, in the case of any such transfer by <font style="font-style: italic;">bona fide</font> gift or gifts, no filing under Section 16 of the Exchange Act nor any other public filing or disclosure reporting such transfer of the holder&#8217;s shares shall be required or voluntarily made during the Lock-Up Period (other than a filing on </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">123<br></div></div></div>
<!--End Page 126-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 127-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_116-under_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 45pt; text-align: justify;">Form 5) and <font style="font-style: italic;">provided</font><font style="font-style: italic;"> </font><font style="font-style: italic;">further</font> that, in the case of any such transfer by will or intestacy, if the holder is required to file a report under Section 16 of the Exchange Act in connection with such transfer, the holder shall include a statement in such report to the effect that the filing relates to the transfer of securities by will or intestacy;</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to any trust, partnership, limited liability company or other entity created for the direct or indirect benefit of the holder or the immediate family (as defined below) of the holder, <font style="font-style: italic;">provided</font> that the transferee agrees to be bound in writing by the restrictions set forth herein, and <font style="font-style: italic;">provided</font><font style="font-style: italic;"> </font><font style="font-style: italic;">further</font> that any such transfer shall not involve a disposition for value and <font style="font-style: italic;">provided</font><font style="font-style: italic;"> </font><font style="font-style: italic;">further</font> that no filing under Section 16 of the Exchange Act nor any other public filing or disclosure reporting such transfer of the holder&#8217;s shares shall be required or shall be voluntarily made during the Lock-Up Period (other than a filing on Form 5);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to limited partners, members, stockholders, other equity holders or trust beneficiaries of the holder or to any investment fund or other entity that is controlled or managed by or under common control with the holder, or, if the holder is a trust, to a trustor, trustee or beneficiary of the trust or to the estate of a beneficiary of such trust, <font style="font-style: italic;">provided</font> that, in each case, the transferees agree to be bound in writing by the restrictions set forth herein, and <font style="font-style: italic;">provided</font><font style="font-style: italic;"> </font><font style="font-style: italic;">further</font> that any such transfer shall not involve a disposition for value, and <font style="font-style: italic;">provided</font><font style="font-style: italic;"> </font><font style="font-style: italic;">further</font> that no filing under Section 16 of the Exchange Act nor any other public filing or disclosure reporting such transfer of the holder&#8217;s shares, shall be required or shall be voluntarily made during the Lock-Up Period (other than a filing on Form 5); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i)&#160;through (iii)&#160;above; <font style="font-style: italic;">provided</font> that the transferee agrees to be bound in writing by the restrictions set forth herein and <font style="font-style: italic;">provided</font><font style="font-style: italic;"> </font><font style="font-style: italic;">further</font> that, unless permitted under clauses (i)&#160;above, no filing under Section 16 of the Exchange Act nor any other public filing or disclosure reporting such transfer of the holder&#8217;s shares, shall be required or shall be voluntarily made during the Lock-Up Period (other than a filing on Form 5);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(v)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">pursuant to an order of a court or regulatory agency or to comply with any regulations related to the holder&#8217;s ownership of the Shares; <font style="font-style: italic;">provided</font>, if the holder is required to file a report under Section 16 of the Exchange Act in connection with such transfer, the holder shall include a statement in such report to the effect that the filing relates to the transfer of securities pursuant to an order of a court or regulatory agency or to comply with any regulations related to the ownership of the Shares unless such a statement would be prohibited by any applicable law, regulation or order of a court or regulatory authority; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(vi)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to us as the result of a vesting, conversion, exercise or exchange of any security convertible into or exercisable or exchangeable for shares of common stock pursuant to any existing employee benefit plans described in the Registration Statement, the Pricing Disclosure Package and the Prospectus (in each case, as defined in the Underwriting Agreement), including shares of common stock surrendered or transferred to us in connection with a &#8220;cashless&#8221; or &#8220;net exercise&#8221; to cover tax withholding obligations of the holder in connection with such vesting, conversion, exercise or exchange; <font style="font-style: italic;">provided</font>, that any shares of common stock received upon such conversion, exercise or exchange shall be subject to the restrictions set forth herein; and <font style="font-style: italic;">provided</font><font style="font-style: italic;"> </font><font style="font-style: italic;">further</font>, if the holder is required to file a report under Section 16 of the Exchange Act in connection with such transfer, the holder shall include a statement in such report to the effect that the filing relates to the conversion, exercise or exchange of securities convertible into or exercisable or exchangeable for shares of common stock pursuant to existing employee benefit plans and that no securities were sold by the holder and <font style="font-style: italic;">provided</font><font style="font-style: italic;"> </font><font style="font-style: italic;">further</font> that no other public announcement shall be required or shall be made voluntarily in connection with such transfer;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(vii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">pursuant to a change of control (as defined below) of the company that has been approved by the our board of directors; <font style="font-style: italic;">provided</font> that in the event that the change of control is not completed, the holder&#8217;s Shares that are subject to the restrictions contained in this Lock-Up Agreement shall remain so restricted in accordance with the Lock-Up Agreement;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(viii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">in connection with a sale of the holder&#8217;s Shares acquired in the Public Offering (other than any company-directed Shares acquired by an officer or director of the company) or in open market transactions after completion of the Public Offering, provided that no filing under Section 16 of the Exchange Act, or other public announcement shall be required or shall be voluntarily made in connection </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">124<br></div></div></div>
<!--End Page 127-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 128-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_116-under_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 45pt; text-align: justify;">with subsequent sales of Common Stock or other securities acquired in such open market transactions during the Lock-Up Period; </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ix)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to us immediately prior to effectiveness of the Registration Statement in connection with the Preferred Conversion as described in the Registration Statement;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(x)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if the holder is a corporation, partnership, limited liability company or other business entity, (A) to another corporation, partnership, limited liability company or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) of the holder, (B) to any investment fund or other entity controlled or managed by the holder or affiliates of the holder, or (C) as part of a distribution by the holder to its stockholders, partners, members or other equityholders or to the estate of any such stockholders, partners, members or other equityholders, <font style="font-style: italic;">provided</font> in each case that the transferee agrees to be bound in writing by the restrictions set forth herein, any such transfer shall not involve a disposition for value, and provided further that no filing under Section 16 of the Exchange Act, nor any other public filing or disclosure reporting such transfer of the holder&#8217;s shares, shall be required or shall be voluntarily made during the Lock-Up Period (other than a filing on Form 5); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 25pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(xi)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with the prior written consent of the Representatives on behalf of the Underwriters. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, the holder may enter into a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of Common Stock, provided that (i)&#160;such plan does not provide for the transfer of Common Stock during the Lock-Up Period and (ii)&#160;to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the holder or us regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of the holder&#8217;s Common Stock may be made under such plan during the Lock-Up Period.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the offering, there has been no public market for the shares. The initial public offering price will be negotiated among us and the representatives. Among the factors to be considered in determining the initial public offering price of the shares, in addition to prevailing market conditions, will be our historical performance, estimates of our business potential and earnings prospects, an assessment of our management and the consideration of the above factors in relation to market valuation of companies in related businesses. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have been approved to list our common stock on the Nasdaq Global Market under the symbol &#8220;GANX.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the offering, the underwriters may purchase and sell shares of our common stock in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering, and a short position represents the amount of such sales that have not been covered by subsequent purchases. A &#8220;covered short position&#8221; is a short position that is not greater than the amount of additional shares for which the underwriters&#8217; option described above may be exercised. The underwriters may cover any covered short position by either exercising their option to purchase additional shares or purchasing shares in the open market. In determining the source of shares to cover the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase additional shares pursuant to the option described above. &#8220;Naked&#8221; short sales are any short sales that create a short position greater than the amount of additional shares for which the option described above may be exercised. The underwriters must cover any such naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of various bids for or purchases of common stock made by the underwriters in the open market prior to the completion of the offering. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Purchases to cover a short position and stabilizing transactions, as well as other purchases by the underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of our common stock, and together with the imposition of the penalty bid, may stabilize, maintain or otherwise affect the market price of the common stock. As a result, the price of the common stock may be higher than the price that otherwise might </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">125<br></div></div></div>
<!--End Page 128-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 129-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_116-under_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">exist in the open market. The underwriters are not required to engage in these activities and may end any of these activities at any time. These transactions may be effected on the Nasdaq Global Market, in the over-the-counter market or otherwise. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We estimate that our share of the total expenses of the offering, excluding underwriting discounts and commissions, will be approximately $1.80&#160; million. We have agreed to reimburse the underwriters for certain of their expenses in an amount up to $150,000. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include sales and trading, commercial and investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and other financial and non-financial activities and services. Certain of the underwriters and their respective affiliates have provided, and may in the future provide, a variety of these services to the issuer and to persons and entities with relationships with the issuer, for which they received or will receive customary fees and expenses. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the ordinary course of their various business activities, the underwriters and their respective affiliates, officers, directors and employees may purchase, sell or hold a broad array of investments and actively traded securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments for their own account and for the accounts of their customers, and such investment and trading activities may involve or relate to assets, securities and/or instruments of the issuer (directly, as collateral securing other obligations or otherwise) and/or persons and entities with relationships with the issuer. The underwriters and their respective affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such assets, securities or instruments and may at any time hold, or recommend to clients that they should acquire, long and/or short positions in such assets, securities and instruments. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions related to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">European Economic Area and United Kingdom </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In relation to each Member State of the European Economic Area and the United Kingdom, or each a Relevant State, no common shares, or the Shares, have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the Shares which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that offers of Shares may be made to the public in that Relevant State at any time under the following exemptions under the Prospectus Regulation: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to any legal entity which is a qualified investor as defined under the Prospectus Regulation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation); or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">provided that no such offer of Shares shall require us or any representative to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation and each person who initially acquires any shares or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with each of the representatives and us that it is a &#8220;qualified investor&#8221; as defined in the Prospectus Regulation. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">126<br></div></div></div>
<!--End Page 129-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 130-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_116-under_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the case of any shares being offered to a financial intermediary as that term is used in Article 5 of the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares acquired by it in the offer have not been acquired on a nondiscretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer of any shares to the public other than their offer or resale in a Member State to qualified investors as so defined or in circumstances in which the prior consent of the representatives has been obtained to each such proposed offer or resale. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to any Shares in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any Shares to be offered so as to enable an investor to decide to purchase or subscribe for any Shares, and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017/1129. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">United Kingdom </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Each Underwriter has represented and agreed that: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000, as amended, or the FSMA) received by it in connection with the issue or sale of the shares in circumstances in which Section 21(1) of the FSMA does not apply to us; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the shares in, from or otherwise involving the United Kingdom.</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Switzerland </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (SIX) or on any other stock exchange or regulated trading facility in Switzerland. This prospectus has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this prospectus nor any other offering or marketing material relating to the securities or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Neither this prospectus nor any other offering or marketing material relating to the offering, us or the securities have been or will be filed with or approved by any Swiss regulatory authority. In particular, this prospectus will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA and the offer of securities has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (CISA). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of securities.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Canada </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions, and Ongoing Registrant Obligations. Any resale of the securities must be made in accordance with an exemption form, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory of these rights or consult with a legal advisor. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">127<br></div></div></div>
<!--End Page 130-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 131-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_116-under_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Hong Kong </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The shares may not be offered or sold in Hong Kong by means of any document other than (i)&#160;in circumstances which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the Laws of Hong Kong), or Companies (Winding Up and Miscellaneous Provisions) Ordinance, or which do not constitute an invitation to the public within the meaning of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong), or Securities and Futures Ordinance, or (ii)&#160;to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance and any rules made thereunder, or (iii)&#160;in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance, and no advertisement, invitation or document relating to the shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; in Hong Kong as defined in the Securities and Futures Ordinance and any rules made thereunder. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Singapore </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&#160;to an institutional investor (as defined under Section 4A of the Securities and Futures Act, Chapter 289 of Singapore, or the SFA) under Section 274 of the SFA, (ii)&#160;to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of the SFA or (iii)&#160;otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA, in each case subject to conditions set forth in the SFA. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Where the shares are subscribed or purchased under Section 275 of the SFA by a relevant person which is a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor, the securities (as defined in Section 239(1) of the SFA) of that corporation shall not be transferable for 6 months after that corporation has acquired the shares under Section 275 of the SFA except: (i)&#160;to an institutional investor under Section 274 of the SFA or to a relevant person (as defined in Section 275(2) of the SFA), (ii)&#160;where such transfer arises from an offer in that corporation&#8217;s securities pursuant to Section 275(1A) of the SFA, (iii)&#160;where no consideration is or will be given for the transfer, (iv)&#160;where the transfer is by operation of law, (v)&#160;as specified in Section 276(7) of the SFA, or (vi)&#160;as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations 2005 of Singapore, or Regulation 32. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Where the shares are subscribed or purchased under Section 275 of the SFA by a relevant person which is a trust (where the trustee is not an accredited investor (as defined in Section 4A of the SFA)) whose sole purpose is to hold investments and each beneficiary of the trust is an accredited investor, the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferable for 6 months after that trust has acquired the shares under Section 275 of the SFA except: (i)&#160;to an institutional investor under Section 274 of the SFA or to a relevant person (as defined in Section 275(2) of the SFA), (ii)&#160;where such transfer arises from an offer that is made on terms that such rights or interest are acquired at a consideration of not less than $200,000 (or its equivalent in a foreign currency) for each transaction (whether such amount is to be paid for in cash or by exchange of securities or other assets), (iii)&#160;where no consideration is or will be given for the transfer, (iv)&#160;where the transfer is by operation of law, (v)&#160;as specified in Section 276(7) of the SFA, or (vi)&#160;as specified in Regulation 32.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Japan </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The securities have not been and will not be registered under the Financial Instruments and Exchange Act of Japan (Act No. 25 of 1948, as amended), or the FIEA. The securities may not be offered or sold, directly or indirectly, in Japan or to or for the benefit of any resident of Japan (including any person resident in Japan or any corporation or other entity organized under the laws of Japan) or to others for reoffering or resale, directly or indirectly, in Japan or to or for the benefit of any resident of Japan, except pursuant to an exemption from the registration requirements of the FIEA and otherwise in compliance with any relevant laws and regulations of Japan.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">128<br></div></div></div>
<!--End Page 131-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 132-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_116-under_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tLM"><!--Anchor--></a>LEGAL MATTERS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The validity of the issuance of the shares of common stock offered hereby will be passed upon for Gain Therapeutics, Inc. by Skadden, Arps, Slate, Meagher &amp; Flom LLP, New York, New York. DLA Piper LLP (US), New York, New York is representing the underwriters.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tEXP"><!--Anchor--></a>EXPERTS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The consolidated financial statements of Gain Therapeutics Inc. as of December&#160;31, 2020 and 2019 and for each of the three years in the period ended December&#160;31, 2020, appearing in this prospectus and registration statement have been audited by Ernst &amp; Young AG, independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein, and are included in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">129<br></div></div></div>
<!--End Page 132-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 133-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_116-under_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tWYC"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares of common stock offered by this prospectus. This prospectus, filed as part of the registration statement, does not contain all of the information set forth in the registration statement and its exhibits and schedules. You can find further information about us in the registration statement and its exhibits and schedules. Statements in this prospectus about the contents of any contract, agreement or other document are not necessarily complete and, in each instance, we refer you to the copy of such contract, agreement or document filed as an exhibit to the registration statement, with each such statement being qualified in all respects by reference to the document to which it refers. The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. You may inspect these reports and other information without charge at the SEC&#8217;s website (http://www.sec.gov).</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon the completion of this offering, we will become subject to the informational requirements of the Exchange Act, as amended, and will be required to file periodic current reports, proxy statements and other information with the SEC. You will be able to inspect this material without charge at the SEC&#8217;s website. We intend to furnish our stockholders with annual reports containing financial statements audited by an independent accounting firm.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, following the completion of this offering, we will make the information filed with or furnished to the SEC available free of charge through our website (http://www.gaintherapeutics.com) as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information contained in, or that can be accessed through, our website is not incorporated by reference and is not part of this prospectus.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">130<br></div></div></div>
<!--End Page 133-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 134-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_200-fintoc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tITF"><!--Anchor--></a>Index to Consolidated Financial Statements </div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 89.74%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tITF">Index to Consolidated Financial Statements<font style="padding-left: 4.77pt;"></font></a></div></td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#tITF">F-1</a></div></td></tr><tr><td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fREPORT">Report of Independent Registered Public Accounting Firm<font style="padding-left: 3.68pt;"></font></a></div></td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fREPORT">F-2</a></div></td></tr><tr><td style="width: 89.74%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fBS">Consolidated Balance Sheets<font style="padding-left: 4.76pt;"></font></a></div></td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fBS">F-3</a></div></td></tr><tr><td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fSOO">Consolidated Statement of Operations<font style="padding-left: 2.55pt;"></font></a></div></td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fSOO">F-4</a></div></td></tr><tr><td style="width: 89.74%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fSOCL">Consolidated Statement of Comprehensive Loss<font style="padding-left: 1.45pt;"></font></a></div></td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fSOCL">F-5</a></div></td></tr><tr><td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fSOCI">Consolidated Statement of Changes in Stockholders&#8217; Equity (Deficit)<font style="padding-left: 5pt;"></font></a></div></td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fSOCI">F-6</a></div></td></tr><tr><td style="width: 89.74%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fSOCF">Consolidated Statement of Cash Flows<font style="padding-left: 3.66pt;"></font></a></div></td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fSOCF">F-7</a></div></td></tr><tr><td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#f2NOTES">Notes to the Consolidated Financial Statements<font style="padding-left: 3.67pt;"></font></a></div></td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#f2NOTES">F-8</a></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-1<br></div></div></div>
<!--End Page 134-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 135-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_200-fintoc_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="fREPORT"><!--Anchor--></a>Report of Independent Registered Public Accounting Firm</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">To the Stockholders and the Board of Directors of Gain Therapeutics, Inc.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Opinion on the Financial Statements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have audited the accompanying consolidated balance sheets of Gain Therapeutics, Inc. (the &#8220;Company&#8221;) as of December&#160;31, 2020 and 2019, and the related consolidated statements of operations, comprehensive loss, changes in stockholders&#8217; equity (deficit) and cash flows for each of the three years in the period ended December&#160;31, 2020, and the related notes<font style="font-weight: bold;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup></font>(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2020, in conformity with U.S. generally accepted accounting principles. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Basis for Opinion</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 26.5pt; margin-left: 0pt; text-align: left;">/s/ Ernst &amp; Young AG </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">We have served as the Company&#8217;s auditor since 2020. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">Lancy - Geneva, Switzerland</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">February&#160;19, 2021</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-2<br></div></div></div>
<!--End Page 135-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 136-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_201-fintab_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="fBS"><!--Anchor--></a>Gain Therapeutics, Inc<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Consolidated Balance Sheets</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.86%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of December&#160;31,</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.86%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.86%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.86%; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current assets:<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 2.77pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;(Note 4)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">7,492,910</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">303,320</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Restricted cash <font style="padding-left: 0.53pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Note 4) </div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.87pt;">11,371 </font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font> </div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts receivable<font style="padding-left: 3.32pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">8,548</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">8,352</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other current assets <font style="padding-left: 1.11pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Note 5) </div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.87pt;">257,011</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 11.2pt;">117,853</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred offering costs<font style="padding-left: 1.29pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt;">1,217,988</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total current assets<font style="font-weight: normal; padding-left: 0.53pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt;">8,987,828</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">429,525</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-current assets:<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net<font style="padding-left: 4.7pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;(Note 6)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 17.5pt;">29,633</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">18,398</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease - right of use assets<font style="padding-left: 3.36pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Note 7)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">523,080</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">200,950</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Restricted cash<font style="padding-left: 3.86pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;(Note 4)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 35pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">10,380</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Long-term deposits<font style="padding-left: 1.63pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">1</font>2,152</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">1,033</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current assets<font style="padding-left: 1.11pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">51,665</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total non-current assets<font style="font-weight: normal; padding-left: 1.09pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">6</font>16,530</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">230,761</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Assets<font style="font-weight: normal; padding-left: 4.21pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="font-weight: normal;">&#8203;</font><font style="padding-left: 5pt;">9,604,358</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 10.83pt;">660,286</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current liabilities:<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable<font style="padding-left: 3.31pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Note 8)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">9</font>61,516</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">154,441</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease liability - current<font style="padding-left: 4.45pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;(Note 7)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 12.5pt;">122</font>,756</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">102,107</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other current liabilities<font style="padding-left: 0.54pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Note 9)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">767</font>,380</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">250,005</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Tax provision<font style="padding-left: 4.55pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 22.5pt;">1</font>,070</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">3,702</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred income<font style="padding-left: 2.2pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Note 9)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">23</font>9,483</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">368,797</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Loans-short term<font style="padding-left: 1.08pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Note 11)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">22,626</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total current liabilities<font style="font-weight: normal; padding-left: 1.07pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5.55pt;">2,114</font>,831</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">879,052</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-current liabilities:<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Defined benefit pension plan<font style="padding-left: 2.21pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;(Note 10)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 12.5pt;">171,558</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">126,629</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease liability &#8211; non-current<font style="padding-left: 4.45pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Note 7)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">4</font>00,324</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">98,843</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">&#8203;Loans &#8212; long-term<font style="padding-left: 4.97pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;(Note 11)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 12.5pt;">715</font>,656</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Long-term deposits<font style="padding-left: 1.63pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">5,618</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total non-current liabilities<font style="font-weight: normal; padding-left: 1.63pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt;">1,2</font>87,538</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;<font style="padding-left: 10.83pt;">231,090</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholders&#8217; equity (deficit)<br></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Series A Preferred Stock, USD 0.0001 par value; 1,346,390 and 993,440 shares authorized, issued and outstanding as of December&#160;31, 2020 and 2019, respectively<font style="padding-left: 0.01pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 30pt;">135</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">99</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Series B Preferred Stock, USD 0.0001 par value: 3,366,999 and nil issued and outstanding as of December 31, 2020 and 2019, respectively<font style="padding-left: 2.19pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 30pt;">337</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Common Stock, USD 0.0001 par value: 4,022,736 and 2,250,000 issued and outstanding as of December&#160;31, 2020 and 2019, respectively<font style="padding-left: 2.19pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 30pt;">402</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.33pt;">225</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Additional paid-in capital<font style="padding-left: 1.09pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">&#8203;13,388,666</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">3,088,154</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated other comprehensive loss<font style="padding-left: 0.56pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.17pt;">(152,698)</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(81,163)</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated deficit<font style="padding-left: 3.31pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 1.67pt;">(</font>3,457,171)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">(1,263,726)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss of the period<font style="padding-left: 0.53pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 1.67pt;">(</font>3,577,682)</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">(2,193,445)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Stockholders&#8217; equity (deficit)<font style="font-weight: normal; padding-left: 0.55pt;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="font-weight: normal;">&#8203;</font><font style="padding-left: 5pt;">6,201,989</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">(449,856)</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Liabilities and Stockholders&#8217; equity (deficit)<font style="font-weight: normal;"></font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.43%; text-align: center; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt;">9,604,358</font></div></td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.86%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">660,286</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0.5pt; margin-left: 0pt; text-align: justify;"> </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-3<br></div></div></div>
<!--End Page 136-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 137-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_201-fintab_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="fSOO"><!--Anchor--></a>Gain Therapeutics, Inc<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Consolidated Statement of Operations</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 34.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Years Ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenues:<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other income<font style="padding-left: 1.97pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">28,881</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">41,301</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">20,609</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total revenues<font style="font-weight: normal; padding-left: 4.73pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 15.83pt;">28,881</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 15.83pt;">41,301</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 15.83pt;">20,609</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Research and development<font style="padding-left: 3.1pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(2,259,204)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(1,586,245)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(826,880)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 2.55pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(1,249,126)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(555,165)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(222,047)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total operating expenses<font style="font-weight: normal; padding-left: 0.67pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(3,508,330)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(2,141,410)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(1,048,927)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss from operations<font style="font-weight: normal; padding-left: 0.49pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(3,479,449)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(2,100,109)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(1,028,318)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other income (expense):<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest income/(expenses), net<font style="padding-left: 1.17pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.82pt;">3,637</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(20,540)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(52,477)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Foreign exchange expense, net<font style="padding-left: 1.72pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(96,484)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(65,682)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(14,964)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before income tax<font style="font-weight: normal; padding-left: 2.17pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(3,572,296)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(2,186,331)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(1,095,759)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Income tax<font style="padding-left: 1.96pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(5,386)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.86pt;">(7,114)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(9,781)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net Loss<font style="font-weight: normal; padding-left: 4.74pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(3,577,682)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(2,193,445)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(1,105,540)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss per ordinary share:<br></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss per share attributable to common stockholders&#8212;basic and diluted<font style="padding-left: 4.72pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 22.5pt;">(1.17)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 22.5pt;">(0.97)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 22.5pt;">(0.49)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average common shares outstanding&#8212;basic and diluted<font style="padding-left: 3.95pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt;">3,046,355</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt;">2,250,000</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt;">2,250,000</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro-forma net loss per share attributable to common stockholders, basic and diluted<font style="padding-left: 1.95pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">(0.61)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro-forma weighted average number of common shares used in computing pro forma net loss per share attributable to common stockholders &#8211; basic and diluted<font style="padding-left: 0.88pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt;">5,860,140</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-4<br></div></div></div>
<!--End Page 137-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 138-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_201-fintab_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="fSOCL"><!--Anchor--></a>Gain Therapeutics, Inc<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Consolidated Statement of Comprehensive Loss</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 35.97%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Years Ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 1.63pt;"></font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(3,577,682)</div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(2,193,445)</div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(1,105,540)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other comprehensive loss:<br></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Foreign currency translation<font style="padding-left: 0.55pt;"></font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(35,317)</font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.82pt;">33,564</font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.82pt;">6,607</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Defined benefit pension plan<font style="padding-left: 2.21pt;"></font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(36,218)</font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.87pt;">(117,803)</font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other comprehensive loss<font style="font-weight: normal; padding-left: 4.24pt;"></font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(71,535)</font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(84,239)</font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.82pt;">6,607</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Comprehensive loss<font style="font-weight: normal; padding-left: 0.15pt;"></font></div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(3,649,217)</div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(2,277,684)</div></td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 0.55pt;">(1,112,147)</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-5<br></div></div></div>
<!--End Page 138-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 139-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 528pt;"><a name="nt10015006x17_424b4_201-fintab_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 30pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="fSOCI"><!--Anchor--></a>Gain Therapeutics, Inc<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Consolidated Statement of Changes in Stockholders&#8217; Equity (Deficit)</div></div><div class="block-main" style="width: 528pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 529.99pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 12.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Series A<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 12.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Series B<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 12.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Paid in <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Capital</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Other<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Comprehensive <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gain/(Loss)</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deficit</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stockholders&#8217; <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Deficit)</div></td></tr><tr class="header"><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.28%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.28%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.28%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">$</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">$</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">$</div></td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.57%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">$</div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Balance as of December&#160;31, 2017<font style="font-weight: normal; padding-left: 2pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 32pt;">2,250,000</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 12pt;">225</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 36pt;">309,517</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 8pt; border-bottom: 1pt solid #000000; min-width: 28.66pt;">(3,531</font><font style="min-width: 28.66pt;">)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"><font style="padding-left: 6pt; border-bottom: 1pt solid #000000; min-width: 34.66pt;">(158,186</font><font style="min-width: 34.66pt;">)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 8.66pt; border-bottom: 1pt solid #000000; min-width: 34.66pt;">148,025</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Foreign currency translation <font style="padding-left: 1.38pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 10.66pt;">6,607</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 16.66pt;">6,607</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 4.34pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 28pt; border-bottom: 1pt solid #000000; min-width: 36pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 20.66pt; border-bottom: 1pt solid #000000; min-width: 28.66pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 34.66pt;">(1,105,540</font><font style="min-width: 34.66pt;">)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 34.66pt;">(1,105,540</font><font style="min-width: 34.66pt;">)</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Balance as of December&#160;31, 2018<font style="font-weight: normal; padding-left: 2pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 3pt double #000000; min-width: 32pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 3pt double #000000; min-width: 12pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 3pt double #000000; min-width: 32pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 3pt double #000000; min-width: 12pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 32pt;">2,250,000</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 12pt;">225</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 36pt;">309,517</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 10.66pt; border-bottom: 3pt double #000000; min-width: 28.66pt;">3,076</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 34.66pt;">(1,263,726</font><font style="min-width: 34.66pt;">)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 6pt; border-bottom: 3pt double #000000; min-width: 34.66pt;">(950,908</font><font style="min-width: 34.66pt;">)</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Issuance of Series&#160;A Preferred Stock for conversion of loans and accrued interest<font style="padding-left: 2.71pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6pt;">412,250</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt;">41</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">1,027,216</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 2.66pt;">1,027,257</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Issuance of Series&#160;A Preferred Stock, net of issuance costs<font style="padding-left: 2.6pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6pt;">581,190</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt;">58</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">1,751,421</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 2.66pt;">1,751,479</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Defined pension plan obligation</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 0.3pt;">(117,803)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 6.29pt;">(117,803)</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Foreign currency translation <font style="padding-left: 1.38pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 6.66pt;">33,564</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 12.66pt;">33,564</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 4.34pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 28pt; border-bottom: 1pt solid #000000; min-width: 36pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 20.66pt; border-bottom: 1pt solid #000000; min-width: 28.66pt;">&#8195;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 34.66pt;">(2,193,445</font><font style="min-width: 34.66pt;">)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; min-width: 34.66pt;">(2,193,445</font><font style="min-width: 34.66pt;">)</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Balance as of December&#160;31, 2019<font style="font-weight: normal; padding-left: 2pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6pt; border-bottom: 3pt double #000000; min-width: 32pt;">993,440</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 3pt double #000000; min-width: 12pt;">99</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24pt; border-bottom: 3pt double #000000; min-width: 32pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 3pt double #000000; min-width: 12pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 32pt;">2,250,000</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 12pt;">225</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 3pt double #000000; min-width: 36pt;">3,088,154</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 4pt; border-bottom: 3pt double #000000; min-width: 28.66pt;">(81,163</font><font style="min-width: 28.66pt;">)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"><font style="border-bottom: 3pt double #000000; min-width: 34.66pt;">(3,457,171</font><font style="min-width: 34.66pt;">)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 6pt; border-bottom: 3pt double #000000; min-width: 34.66pt;">(449,856</font><font style="min-width: 34.66pt;">)</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Issuance of Series A Preferred Stock, net of issuance costs<font style="padding-left: 2.6pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6pt;">352,950</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 4pt;">36</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">1,091,309</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 2.66pt;">1,091,345</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Issuance of Series B Preferred Stock, net of issuance costs<font style="padding-left: 2.6pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3,366,999</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;">337</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">8,713,676</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 2.66pt;">8,714,013</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Issuance of Common Stock<font style="padding-left: 0.81pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,772,736</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;">177</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 22.66pt;">177</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Issuance of Warrants<font style="padding-left: 2.95pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 10pt;">413,887</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 8.66pt;">413,887</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Based Compensation<font style="padding-left: 1.68pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 14pt;">81,640</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 12.66pt;">81,640</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Defined pension plan obligation</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 4pt;">(36,218)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 10pt;">(36,218)</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Foreign currency translation <font style="padding-left: 1.38pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 12.25pt; text-align: left;"><font style="padding-left: 4pt;">(35,317)</font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.33pt; text-align: left;"></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 10pt;">(35,317)</font></div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 4.34pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.33pt; text-align: left;">(3,577,682)</div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;">(3,577,682) </div></td></tr><tr><td style="width: 20.38%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Balance as of December 31, 2020<font style="font-weight: normal;"> </font><font style="font-weight: normal; padding-left: 4.34pt;"></font></div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,346,390 </div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;">135 </div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">3,366,999 </div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;">337 </div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.04%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">4,022,736 </div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.28%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 7.99pt; text-align: left;">402 </div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0.22pt; text-align: left;">&#8203;13,388,666 </div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 12.25pt; text-align: left;">(152,698) </div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 5.33pt; text-align: left;">(7,034,853) </div></td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.57%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.89%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 2.66pt;">6,201,989</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-6<br></div></div></div>
<!--End Page 139-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 140-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_201-fintab_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="fSOCF"><!--Anchor--></a>Gain Therapeutics, Inc<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Consolidated Statement of Cash Flows</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.85pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.85pt;">&#8203;</td><td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.85pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 34.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.85pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Years Ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.85pt; padding-bottom: 2.85pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.85pt; padding-bottom: 2.85pt;">&#8203;</td><td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 2.85pt; padding-bottom: 2.85pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.85pt; padding-bottom: 2.85pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 2.85pt; padding-bottom: 2.85pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 2.85pt; padding-bottom: 2.85pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.85pt; padding-bottom: 2.85pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 2.85pt; padding-bottom: 2.85pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 2.85pt; padding-bottom: 2.85pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.85pt; padding-bottom: 2.85pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.85pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating activities:<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.85pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.85pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.85pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.85pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.85pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.85pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.85pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.85pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.85pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 3.63pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 1.67pt;">(3,577,682)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(2,193,445)</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(1,105,540)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjustments to reconcile net loss to net cash used in operating activities:<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Depreciation<font style="padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">9,592</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">2,571</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">741</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Non-cash interest expense<font style="padding-left: 0.89pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">1,278</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">41,051</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Stock based compensation<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">81,640</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Defined benefit pension expense<font style="padding-left: 4.22pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">8,709</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">8,826</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes in operating assets and liabilities:<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Account receivables<font style="padding-left: 0.32pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 31.67pt;">(196)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(8,352)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other current assets<font style="padding-left: 1.44pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 14.17pt;">(139,158)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(23,909)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(87,277)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current assets<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 19.17pt;">(51,665)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Account payables<font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">395,543</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">5,108</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">117,686</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deposit<font style="padding-left: 1.4pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 19.54pt;">(11,430)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 30pt;">(377)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">4,962</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Tax payable<font style="padding-left: 3.22pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 24.17pt;">(2,632)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(6,002)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">9,704</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other current liabilities<font style="padding-left: 2.54pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">176,357</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">126,805</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">124,350</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred income<font style="padding-left: 4.2pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 14.17pt;">(129,315)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">218,988</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">149,809</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total changes in operating assets and liabilities<font style="padding-left: 4.39pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">237,504</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">312,261</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">319,234</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net cash used in operating activities<font style="font-weight: normal; padding-left: 0.34pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 1.67pt;">(3,240,237)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(1,868,509)</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 7.5pt;">(744,514)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from investing activities:<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Purchase of computers and office equipment<font style="padding-left: 4.98pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 19.17pt;">(20,826)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(13,723)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(7,987)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash used in investing activities<font style="font-weight: normal; padding-left: 3.12pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 14.17pt;">(20,826)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 12.5pt;">(13,723)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 17.5pt;">(7,987)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flow from financing activities:<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from convertible notes<font style="padding-left: 0.89pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">983,778</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from long-term debts<font style="padding-left: 1.44pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">738,282</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Proceeds from issuance of Series A Preferred Stock, net of issuance costs<font style="padding-left: 2.51pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">1,091,345</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1,751,479</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Proceeds from issuance of Series B Preferred Stock, net of issuance costs<font style="padding-left: 2.51pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">9,127,902</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from issuance of common stock<font style="padding-left: 2.02pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 35pt;">177</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Payment of offering costs<font style="padding-left: 2.17pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 14.17pt;">(470,745)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash provided by financing activities<font style="font-weight: normal; padding-left: 0.51pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$10,486,961</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">1,751,479</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 10.83pt;">983,778</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Effect of exchange rate changes<font style="padding-left: 1.64pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 19.17pt;">(35,317)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 15.83pt;">33,564</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 20.83pt;">6,607</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net increase (decrease) in cash, cash equivalents and restricted cash<font style="padding-left: 3.5pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 5pt;">7,190,581</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 12.5pt;">(97,189)</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 10.83pt;">237,884</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash, cash equivalents and restricted cash at beginning of period<font style="padding-left: 1.23pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">313,700</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">410,889</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">173,005</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash, cash equivalents and restricted cash at end of period<font style="padding-left: 1.78pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 5pt;">7,504,280</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 10.83pt;">313,700</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 10.83pt;">410,889</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Supplementary disclosure of cash information:<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash paid during the year for income taxes<font style="padding-left: 4.8pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 22.5pt;">4,569</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 20.83pt;">&#8203;</font>9,437</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Significant non-cash balance sheet activities:<br></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Conversion of long-term debt to Series A Preferred Stock<font style="padding-left: 1.47pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(1,006,823)</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Issuance of warrants in connection with Series B convertible preferred stock<font style="padding-left: 1.39pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">413,887</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred offering costs in account payable and accrued expenses<font style="padding-left: 1.71pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">747,243</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 2.6pt; padding-bottom: 2.6pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 2.6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred offering costs<font style="padding-left: 3.29pt;"></font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">1,217,988</font></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-7<br></div></div></div>
<!--End Page 140-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 141-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="f2NOTES"><!--Anchor--></a>Notes to the Consolidated Financial Statements</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">1. Nature of the business and basis of presentation</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Operations and business</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Gain Therapeutics, Inc. (and together with its subsidiary, the &#8220;Company&#8221;), was incorporated under the laws of the state of Delaware (U.S.) on June 26 2020. On July 20, 2020, the Company consummated the Corporate Reorganization pursuant to which all of the issued and outstanding common and preferred stock of GT Gain Therapeutics SA, a Swiss company formed in 2017, were exchanged for common stock or preferred stock, as applicable, of Gain Therapeutics, Inc., reflecting a 10:1 stock split. The Corporate Reorganization is accounted for as a recapitalization for accounting purposes, with GT Gain Therapeutics SA resulting in the predecessor entity. As a result of the Corporate Reorganization, GT Gain Therapeutics SA became a wholly-owned subsidiary of Gain Therapeutics, Inc. For periods and at dates prior to the Corporate Reorganization, the consolidated financial statements presented were prepared based on the historical financial statements of GT Gain Therapeutics SA, adjusted to give retroactive effect to the share exchange transactions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company is a biotechnology company developing novel therapies to treat diseases caused by protein misfolding, with an initial focus on rare genetic diseases and neurological disorders. We use our licensed platform, SEE-Tx, to discover novel allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, potentially restoring protein folding and treating disease. These small molecule binding sites, away from the protein&#8217;s active areas, are called allosteric sites. Targeting the allosteric binding site instead of the active binding site provides superior regulation of misfolded enzymes implicated by disease, is non-competitive with the natural substrate, provides superior drug-like properties and ultimately enhances both safety and efficacy. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Through GT Gain Therapeutics SA, the Company has a representative branch office and lab in Barcelona, Spain, Gain Therapeutics Sucursal en Espa&#241;a (the &#8220;Branch&#8221;). As of December&#160;31, 2020, the Branch had seven employees. The employees in Spain are subject to a national collective labor agreement, Convenio General de la Industria Quimica. National agreements are negotiated collectively between the national associations of companies within a given industry and the respective national unions. As of December&#160;31, 2020, GT Gain Therapeutics SA had six employees in Switzerland and the Company had one employee in the U.S. None of our employees in Switzerland or in the U.S. are represented by labor unions or covered by collective labor agreements. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Risks and uncertainties</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including, but not limited to, those related to the ability to secure additional capital to fund operations, completion and success of clinical testing, compliance with applicable governmental regulations, development by competitors of new technological innovations, dependence on key personnel and protection of proprietary technology. Drug candidates currently under development will require extensive clinical testing prior to regulatory approval and commercialization. These efforts require significant amounts of additional capital, adequate personnel, and infrastructure and extensive compliance-reporting capabilities. Even if the Company&#8217;s drug development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from product sales.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Going concern</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has evaluated whether there are conditions and events considered in the aggregate that raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s business model, typical of biotechnology companies developing new therapeutic products that have not reached a balanced income and financial position yet, features negative cash flows. This is due to the fact that, at this stage, costs must be borne in relation to services and personnel, costs are directly connected to research and development activities, and return for these activities is not certain and, in any case, it is expected in forthcoming years. Based on the accounting policies adopted, requiring full recognition of research and development costs in the statement of operations in the year they are incurred, the Company has always reported a loss since its incorporation, and expects to continue to incur significant costs for research and development in the foreseeable future. There is no certainty that the Company will become profitable in the long run.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-8<br></div></div></div>
<!--End Page 141-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 142-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Through December&#160;31, 2020, the Company has primarily funded its operations with proceeds from a number of capital increases and long-term loans. Therefore, management and the Board of Directors believe that the Company has adequate financial resources to guarantee business operations in the foreseeable future and for at least 12 months from the date of this report. Accordingly, the consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event that adequate funds will not be available in the future, the Company may be forced to delay, reorganize or cancel research and development programs, or to enter into financing, licensing or collaboration agreements with unfavorable conditions or waive rights to certain products which otherwise it would not have waived, resulting in negative effects on the activity and on the economic, patrimonial and /or financial situation of the Company.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Basis of presentation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The consolidated financial statements reflect the accounts of the Company, GT Gain Therapeutics SA and its wholly owned branch, Gain Therapeutics Sucursal en Espa&#241;a. All intercompany transactions and balances have been eliminated in the preparation of the consolidated financial statements. The consolidated financial statements as of December&#160;31, 2020, represented by the Consolidated Balance Sheet, the Consolidated Statement of Operations, the Consolidated Statements of Changes in Shareholders&#8217; Equity (deficit), the Consolidated Statement of Comprehensive Loss, the Consolidated Statements of Cash Flows and the accompanying Notes, have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;), and reflect within the Consolidated Stockholders&#8217; Equity (deficit) the retroactive application of the share exchange transactions that occurred in July 2020 for the period ended December&#160;31, 2019 (refer to Note 13 <font style="font-style: italic;">Common and Preferred Stock</font> for more details). All amounts in the consolidated financial statements are expressed in United States Dollars (USD/$) and disclosed within these explanatory notes in United States Dollars (USD/$) or Swiss Franc (CHF), which are the functional currencies of the Company and its operating subsidiary, GT Gain Therapeutics SA, respectively.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except for the impacts of consolidation adjustments and the inclusion in the consolidation perimeter of the Company, the consolidated financial statements have been prepared on the same basis as the audited annual financial statements of GT Gain Therapeutics SA (accounting predecessor) as of and for the years ended December&#160;31, 2019 and 2018, and, in the opinion of management, reflect all adjustments, consisting of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial position as of December&#160;31, 2020 and 2019, and the results of its operations and its cash flows for the years ended December 31, 2020, 2019 and 2018.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Segment information</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Operating segments are defined as components of an enterprise for which separate discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company&#8217;s chief operating decision-maker, the Chief Executive Officer, oversees the Company&#8217;s operations and manages the business as a single operating segment, which is research and development in the pharmaceutical sector with a focus on developing novel therapeutics to treat diseases caused by protein misfolding, such as rare genetic diseases and neurological disorders. Geographically, the research and development activities are mainly performed in Switzerland and Spain. The Company does not consider these geographies to be separate segments.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">2. Summary of significant accounting policies</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Foreign currency transactions</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company is incorporated in the United States of America and has operations in Switzerland and Spain. The Company&#8217;s functional currency is the USD. The functional currencies of the Company's foreign operations are the local currencies (Swiss Franc in Switzerland and Euro in Spain). Assets and liabilities reported in the Consolidated Balance Sheets are translated into U.S. dollars (the currency in which these financial statements are presented) at the exchange rates applicable at the balance sheet dates and for the Consolidated Statement of Operations accounts at the average exchange rates for the years ended December&#160;31, 2020 and 2019 and 2018. Items representing the share capital and additional paid-in capital are presented at the historical exchange rates. Adjustments resulting from the translation of the financial statements of the Company&#8217;s foreign operations into U.S. dollars are excluded from the determination of net income and are recorded in accumulated other comprehensive income/(loss), a separate component of shareholders&#8217; equity (deficit).</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Use of estimates</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The preparation of the Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-9<br></div></div></div>
<!--End Page 142-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 143-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates and judgments, including those related to recognition of grant funds, accrued expenses, defined benefit pension liability, warrants and stock-based compensation. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent that material differences arise between the estimates and actual results, the Company&#8217;s future results of operations will be affected. The COVID-19 pandemic did not have a significant impact on the Company&#8217;s estimates. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Unaudited Pro Forma Information</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the accompanying consolidated statements of operations, the unaudited pro-forma basic and diluted net loss per share attributable to common stockholders for the periods ended December&#160;31, 2020 has been computed using the weighted-average number of common shares outstanding after giving pro-forma effect to the conversion of all outstanding shares of convertible preferred stock into 5,860,140 shares of common stock, as if such conversion had occurred at the beginning of the period presented or the date of original issuance of such convertible preferred stock, whichever is later (please refer to Note 16 <font style="font-style: italic;">Net Loss per common share</font>).</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company considers money market, certificates of deposit, time deposit, and other short-term liquid securities with original maturities of three months or less, as cash and cash equivalents. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Concentrations of credit risk</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents. Management believes that the Company is not exposed to significant credit risk as the Company&#8217;s deposits are held at financial institutions that management believes to be of high credit quality, and historically the Company has not experienced any losses on these deposits.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Accounts Receivable</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company evaluates the collectability of accounts receivable on a case-by-case basis and makes adjustments to the bad debt reserve for losses incurred as of the balance sheet date. The Company considers factors such as ability to pay, bankruptcy, credit ratings and payments history. If circumstances related to a counterparty change, estimates of recoverability are further adjusted. There have been no losses incurred on accounts receivable for the period ended December&#160;31, 2020 and 2019, and no allowances recorded as of such periods. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Deferred Issuance Costs</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings as deferred issuance costs until such financings are consummated. After consummation of the equity financing, these costs are recorded as a reduction of the proceeds generated as a result of the offering. Should the planned equity financing be abandoned, the deferred issuance costs will be expensed immediately as a charge to operating expenses in the consolidated statements of operations. There were USD&#160;1,217,988 deferred issuance costs as of December&#160;31, 2020.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Property and equipment</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Property and equipment are stated at cost, including any accessory and direct costs that are necessary to make the assets fit for use, and adjusted by the corresponding accumulated depreciation. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-10<br></div></div></div>
<!--End Page 143-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 144-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The depreciation rates recorded in the consolidated financial statements of operations have been calculated by taking into consideration the use, purpose and financial-technical duration of the assets, on the basis of their estimated useful economic lives. The Company believes the above criteria to be represented by the following depreciation rates: </div><table cellspacing="0" cellpadding="0" class="txttab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 48.72%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">-&#8195; Equipment &amp; Furniture</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">12.5%</div></td></tr><tr><td style="width: 48.72%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">-&#8195; Electronic office equipment:</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">20%</div></td></tr><tr><td style="width: 48.72%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">-&#8195; Leasehold Improvements</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">based on the terms of the lease</div></td></tr><tr><td style="width: 48.72%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">-&#8195; Laboratory equipment: </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">15%</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Ordinary maintenance costs are entirely attributed to the consolidated statements of operations in the year in which they are incurred. Extraordinary maintenance costs, the purpose of which is to extend the useful economic life of the asset, to technologically upgrade it and/or to increase its productivity or safety for the purposes of the economic productivity of the Company, are attributed to the asset to which they refer and depreciated on the basis of its estimated useful economic life. Amortization of leasehold improvements is computed using the straight-line method based upon the terms of the applicable lease or estimated useful life of the improvements, whichever is less.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Impairment of long-lived assets</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In accordance with ASC Topic 360-10-20, &#8220;Property, Plant and Equipment,&#8221; the Company performs an impairment test whenever events or circumstances indicate that the carrying value of long-lived assets with finite lives may be impaired. Impairment is measured by comparing the carrying value of the long-lived assets to the estimated undiscounted pre-tax cash flows expected to result from the use of such assets and their ultimate disposition. In circumstances where impairment is determined to exist, the Company will write down the asset to its fair value based on the present value of estimated cash flows. To date, no impairments have been identified by management for the years ended December&#160;31, 2020 and 2019.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Patents</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Patent-related costs, refer to legal fees incurred in connection with filing and prosecuting patent applications and are expensed as incurred due to uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Leases</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016 02, &#8220;Leases&#8221; (&#8220;ASC 842&#8221;) to enhance the transparency and comparability of financial reporting related to leasing arrangements. For non-public entities, ASU 2016-02 is effective for annual reporting periods beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Under this new lease standard, most leases are required to be recognized on the balance sheet as right-of-use assets and lease liabilities. Disclosure requirements have been enhanced with the objective of enabling financial statement users to assess the amount, timing, and uncertainty of cash flows arising from leases. Prior to January&#160;1, 2019, US GAAP did not require lessees to recognize assets and liabilities related to operating leases on the balance sheets. The new standard establishes a right-of-use (&#8220;ROU&#8221;) model that requires a lessee to recognize an ROU asset and corresponding lease liability on the balance sheet for all leases with a term longer than 12 months. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement as well as the depreciation of the right of use asset.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Effective January&#160;1, 2018, the Company adopted ASC 842, using the additional transition method option provided by ASU 2018-11. Under this transition method, we applied the new accounting guidance as of the date of adoption. Upon adoption, a cumulative effect adjustment was not required.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subsequent to the adoption, the Company determines if an arrangement contains a lease at inception based on whether or not the Company has the right to control the asset during the contract period and other facts and circumstances. The Company is the lessee in a lease contract when it obtains the right to control the asset. Operating lease right of use ("ROU") assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease, which are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-11<br></div></div></div>
<!--End Page 144-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 145-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Leases with a term of 12 months or less at inception are expensed on a straight-line basis over the lease term in the statement of operations. The Company determines the lease term by assuming the exercise of renewal options that are reasonably certain. Please refer to Note 7 <font style="font-style: italic;">Operating lease. Right of use (&#8220;ROU&#8221;) assets</font> for further details.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, the Company subleases portions of its office premises in Lugano. Any impairment to the associated right-of-use assets, leasehold improvements, or other assets as a result of a sublease is recognized in the period the sublease is executed and recorded in the statements of operations. The Company recognizes sublease income on a straight-line basis over the sublease terms, reported within other income. Further details around subleases entered into by the Company are included in Note 18 <font style="font-style: italic;">Related Parties.</font></div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Accounts Payable</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Accounts payable are reported at their nominal amounts due to their short-term maturities. Trade accounts payable are recorded net of trade discounts; cash discounts are recorded at the time of payment.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Payables for Social Securities</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Social Security charges are reported in compliance with rules and laws applicable in the countries where our employees work. Charges are accrued in accordance with the policies stipulated and in connection with salaries due for the period.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Accrued expenses </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As part of the process of preparing our consolidated financial statements, we are required to estimate our accrued expenses as of each balance sheet date. This process involves reviewing open contracts and purchase orders, communicating with our personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of the actual cost. We make estimates of our accrued expenses as of each balance sheet date based on facts and circumstances known to us at that time at the date of the preparation of the consolidated financial statements. There may be instances in which payments made to our vendors exceed the level of services provided, and result in prepayment reported under other current assets, which are subsequently expenses in the consolidated statement of operations when the related activity has been performed rather than when the payment is made. To date, there have been no material differences between our estimates of accrued expenses reported at each balance sheet date and the amounts actually incurred.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Pension obligations </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company operates a defined benefit pension plan (in Switzerland) and defined contribution pension plans (in US, Switzerland and Spain), in accordance with local regulations and practices. These plans are funded by regular contributions made by the employer and the employees to third-party or local governments based on the characteristics of the plan and local laws and regulations. For the defined benefit pension plan, the liability recognized on the consolidated balance sheet is the present value of the defined benefit obligation at the balance sheet date less the fair value of the related plan assets. The overfunded or underfunded status of the defined benefit plans is calculated as the difference between plan assets and the projected benefit obligations. Estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. Actuarial gains and losses arising from changes in actuarial assumptions are recognized in the consolidated statement of comprehensive income/(loss) and accumulated in the consolidated statements of shareholders&#8217; equity (deficit). The measurement date used for the Company&#8217;s defined benefit pension plan is December 31. For defined contribution pension plans, the Company pays contributions to public pension administrators according to local laws and regulations. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized in the consolidated statement of operations on an accrual basis. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Equity-based Compensation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2020, the Company has an equity-based compensation plan, which is described more fully in Note 15, <font style="font-style: italic;">Equity Incentive Plan</font>. The Company applies the fair value method of measuring equity-based compensation, which requires an entity to measure the cost of services received in exchange for an award of equity </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-12<br></div></div></div>
<!--End Page 145-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 146-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">instruments based on the grant-date fair value of the award. The Company issues stock-based awards with only service-based vesting conditions and records the expense for these awards using the straight-line method. The Company has not issued any stock-based awards with performance-or market- based vesting conditions. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company recognizes the related costs in the consolidated statement of operations and as additional paid-in capital in the consolidated statement of shareholders&#8217; equity, in accordance with the vesting period during which the award recipients are required to provide services in exchange for the award. The Company accounts for forfeitures as they occur.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Given the absence of an active market for the Company&#8217;s common stock, the Company and the Board of Directors estimated the fair value of the Company&#8217;s common stock at the grant date determining the estimated fair value of the Company&#8217;s equity instruments based on a number of factors, including prices paid for the Company&#8217;s convertible preferred stock sold to outside investors in arm&#8217;s-length transactions; the Company&#8217;s stage of development; the fact that the grants of stock-based awards involve illiquid securities in a private company.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The fair value of each stock option award is estimated on the grant date using the Black-Scholes option pricing model. As there is no public market for its common stock, the Company determined the volatility and the expected term of exercise of the awards granted based on an analysis of data reported by a peer group of similar biopharmaceuticals companies. The Company expects to continue to do so until such time when reliable historical data will be available regarding stock price volatility and term of exercise patterns. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected contractual term of the award. The Company has not paid, and does not anticipate paying, cash dividends on its common stock; therefore, the expected dividend yield is assumed to be zero.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The assumptions used in calculating the fair value of share-based awards represent management&#8217;s best estimates and involve inherent uncertainties and the application of management&#8217;s judgment. If factors change and management uses different assumptions, share-based compensation expense for stock-based awards granted in the future could be materially different.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Revenue recognition</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Since our inception in 2017, we have devoted substantially all of our resources to identifying and developing next-generation brain-penetrant non-competitive small molecules for the treatment of devastating LSDs and CNS indications using our licensed SEE-Tx technology. To date, we do not have any product candidate approved for sale and have not generated any revenue from product sales. We have primarily financed our operations through a combination of sales of our securities and research grants.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On January&#160;1, 2019, the Company adopted Accounting Standards Codification (ASC) 606, Revenue for Contracts with Customers and all the related amendments, and applied it to all contracts that were not completed as of January&#160;1, 2019 using the modified retrospective method. ASC 606 requires entities to recognize revenue as performance obligations are satisfied and when control of promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. In determining when performance obligations are satisfied, the Company considers factors such as contract terms, payment terms and whether there is an alternative future use of the product or service. The adoption of the new standard did not have any impact on the financial statements. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Grants</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In 2018 and 2019, our wholly owned subsidiary GT Gain Therapeutics SA received research and development grants from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The Silverstein Foundation for Parkinson&#8217;s and from Innosuisse &#8211; Swiss Innovation Agency. Under the terms of the research and development grants awarded, we are entitled to receive reimbursement of our allowable direct expenses. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 5.5pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Contributions from research and development activities under the grants are recorded based on management&#8217;s best estimate of the periods in which the related expenditures are incurred and activities performed, and are classified in the consolidated statement of operations as a reduction to research and development expenses, measured according to the time periods during which the research and development activities are carried out and related costs sustained (Please refer to Note 3. <font style="font-style: italic;">Research Grants</font>). </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-13<br></div></div></div>
<!--End Page 146-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 147-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Research and development expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company expenses all costs incurred in performing research and development activities. Research and development expenses include salaries and other related costs, materials and supplies, preclinical expenses, manufacturing expenses, contract services and other third-party expenses. As part of the process of preparing the consolidated financial statements, the Company is required to estimate accruals for research and development expenses incurred, but not yet invoiced. The Company makes estimates of the accrued expenses as of each balance sheet date in the consolidated financial statements based on facts and circumstances known at that time. In addition, there may be instances in which payments made to the Company's vendors will exceed the level of services provided and result in a prepayment of the expense, in which case such amounts are reflected as prepaid expenses and other current assets. In accruing service fees, the Company estimates the time period over which services will be performed and the costs to be recognized in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company adjusts the accrual or the amount of prepaid expenses accordingly. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">General and administrative expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expenses consist primarily of salaries, benefits and other related costs, for personnel and consultants in the Company's executive and finance functions. General and administrative expenses also include professional fees for legal, finance, accounting, intellectual property, auditing, tax and consulting services, travel expenses and facility-related expenses, which include allocated expenses for rent and maintenance of facilities and other operating costs not otherwise included in research and development expenses.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Income taxes</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company accounts for income taxes under the liability method. Under this method deferred income tax liabilities and assets are determined based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities and for operating losses and tax credit carry forwards, using enacted tax rates in effect in the years in which the differences are expected to reverse. A valuation allowance is recorded if it is &#8220;more likely than not&#8221; that a portion or all of a deferred tax asset will not be realized. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">As of each reporting date, the Company considers existing evidence, both positive and negative, that could impact its view with regards to future realization of deferred tax assets. In consideration of the start-up status of the Company, a full valuation allowance has been established to offset the deferred tax assets, as the related realization is currently uncertain. In the future, should management conclude that it is more likely than not that the deferred tax assets are partially or fully realizable, the valuation allowance will be reduced to the extent of such expected realization, and the corresponding amount will be recognized as income tax benefit in the Company&#8217;s consolidated statement of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company recognizes tax liabilities from an uncertain tax position if it is more likely than not that the tax position will not be sustained upon examination by the taxing authorities, based on the technical merits of the tax position. There are no uncertain tax positions that have been recognized in the accompanying consolidated financial statements. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Fair value measurements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels based on their observability in the market and degree of judgment involved:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Level 1 &#8211; Quoted prices in active markets for identical assets or liabilities.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Level 2 &#8211; Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Level 3 &#8211; Inputs that are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-14<br></div></div></div>
<!--End Page 147-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 148-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Net loss per share</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Basic net loss per share is computed by dividing the reported net loss by the weighted average number of shares of common stock outstanding during the period. The Company gives consideration to all potentially dilutive impacts, except where the effect of including such securities would be antidilutive. As of December&#160;31, 2020, common stock equivalents consisted of the Series A Preferred Stock, Series B Preferred Stock, Stock Options and Warrants, while as of December&#160;31, 2019, common stock equivalents consisted of the Series A Preferred Stock. Because the Company has reported net losses since inception, these potential impacts would be anti-dilutive, and therefore common stock equivalents have been excluded from the computation, resulting in basic and diluted net loss per share being the same for all periods presented. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Recently issued accounting pronouncements </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (&#8220;ASU 2017-11&#8221;). Part I applies to entities that issue financial instruments such as warrants, convertible debt or convertible preferred stock that contain down-round features. Part II replaces the indefinite deferral for certain mandatorily redeemable noncontrolling interests and mandatorily redeemable financial instruments of non-public entities contained within ASC Topic 480 with a scope exception and does not impact the accounting for these mandatorily redeemable instruments. For non-public entities, ASU 2017-11 is effective for annual reporting periods beginning after December&#160;15, 2019, including interim periods within those fiscal years. The adoption of No. ASU 2017-11 in the first quarter of 2020 did not have a significant impact on the Company's consolidated financial statements. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In August 2018, the FASB issued No. ASU 2018-13, Fair Value Measurement (Topic 820)&#8212;Disclosure Framework (&#8220;ASU 2018-13&#8221;), which improves the disclosure requirements for fair value measurements. For non-public entities, ASU 2018-13 is effective for annual reporting periods beginning after December&#160;15, 2019, including interim periods within those fiscal years. Early adoption is permitted for any removed or modified disclosures. The adoption of No. ASU 2018-13 in the first quarter of 2020 did not have a significant impact on the Company's consolidated financial statements. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December 2019, the FASB issued ASU 2019-12, Income Taxes: Simplifying the Accounting for Income Taxes. The new standard is intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. For non-public entities, the standard is effective for annual periods beginning after December&#160;15, 2021, with early adoption permitted. Adoption of the standard requires certain changes to primarily be made prospectively, with some changes to be made retrospectively. The Company is currently evaluating the impact that the adoption of ASU 2019-12 will have on its consolidated financial statements.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The FASB issued authoritative guidance that amends guidance on reporting credit losses for financial assets, including available-for-sale marketable securities and any other financial assets not excluded from the scope that result in a contractual right to receive cash. For available-for-sale marketable securities, credit losses should be measured in a manner similar to current generally accepted accounting standards; however, ASU 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, will require that credit losses be presented as an allowance rather than as a write-down. For non-public entities, the standard is effective for annual periods beginning after December&#160;15, 2022, with early adoption permitted. The Company is currently evaluating the impact that the adoption of ASU 2016-13 will have on its consolidated financial statements.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">3. Research Grants </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December 2018 and in February 2019, our wholly owned subsidiary, GT Gain Therapeutics SA, obtained a research grants for a total amount of USD 186,956 from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The Silverstein Foundation for Parkinson&#8217;s with GBA to advance its proprietary non-competitive molecular chaperones for Parkinson&#8217;s disease and research project &#8220;therapeutic target of GCase enzyme in Parkinson&#8217;s disease with novel pharmacological chaperones&#8221;. Under the terms of the research and development </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-15<br></div></div></div>
<!--End Page 148-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 149-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">grants awarded, we are entitled to receive reimbursement of our allowable direct expenses. As of December&#160;31, 2020, 2019 and 2018, we recorded as reductions to research and development expenses of USD 98,317, USD 82,986 and nil, respectively. The unrecognized portions of the grants are reported as deferred income on the consolidated balance sheet.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July 2019, our wholly owned subsidiary, GT Gain Therapeutics SA, announced that, in a consortium with the Institute for Research in Biomedicine, Bellinzone (Switzerland) and Neuro-Sys SAS in Gardanne (France), it obtained a research grant of approximately USD 1,500,000 from Eurostars-2 joint programme, with co-funding from the European Union Horizon 2020 research and Innosuisse &#8211; Swiss Innovation Agency. The contribution attributed to our subsidiary is CHF 386,218, of which CHF 286,787 was already received as of December&#160;31, 2019. The funding will support the development of the drugs portfolio for the treatment of Gaucher Disease, GM1 Gangliosidosis, Mucopolysaccharidosis type 1 and Krabbe. Under the terms of the research and development grants awarded, we are entitled to receive reimbursement of our allowable direct expenses. As of December&#160;31, 2020, 2019 and 2018, we recorded as reductions to research and development expenses of USD 151,230, USD&#160;23,437 and nil, respectively. The unrecognized portions of the grants are reported as deferred income on the consolidated balance sheet.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">4. Cash, cash equivalents and restricted cash</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company considers all short-term, highly liquid investments, with an original maturity of three months or less, to be cash equivalents. The Company&#8217;s cash and cash equivalents include short-term highly liquid investments which are readily convertible into cash. These investments relate to money market securities with maturities of three months or less. The Company&#8217;s institutional money market accounts permit daily redemption and the fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions, which are considered Level 1 inputs in the fair value hierarchy. Given the high liquidity of these securities, their nominal amount approximates the related fair value. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has not experienced any losses in these accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Cash, cash equivalents and restricted cash are broken down as follows:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash<font style="padding-left: 3.51pt;"></font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 7.5pt;">&#8203;</font>907,255</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$303,320</div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money Market<font style="padding-left: 2.97pt;"></font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$6,585,655</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash<font style="padding-left: 1.86pt;"></font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 12.87pt;">1</font>1,371</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 5pt;">10,380</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Restricted cash refers to an amount required under our Lugano office lease agreement and deposited into a restricted bank account as a guarantee for expenses to be incurred in case of damage to the premises noted at the termination of the lease. The lease expires in August 2021, and the deposit has been classified as current asset as of December 31, 2020. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Details of the cash balances as of December 31, 2020 and 2019, broken down by currency in which the funds are denominated, are reported in the following table:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 3.18%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 3.18%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 3.18%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.18%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.95%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019 </div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash in CHF<font style="padding-left: 4.63pt;"></font></div></td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">128,074</font></div></td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.95%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">95,880</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash in EUR<font style="padding-left: 4.07pt;"></font></div></td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">145,726</font></div></td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.95%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">179,904</div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash in USD<font style="padding-left: 4.07pt;"></font></div></td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">7,149,386</div></td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.18%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.95%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-16<br></div></div></div>
<!--End Page 149-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 150-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">5. Other Current Assets </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Other current assets consist of the following:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 3.07%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 3.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 3.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.07%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Advance to Suppliers<font style="padding-left: 0.75pt;"></font></div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">&#8203;</font>70,985</div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.9%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 4.45pt;">49,812</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">VAT Credits<font style="padding-left: 3.32pt;"></font></div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">47</font>,350</div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.45pt;">36,563</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tax Credit<font style="padding-left: 0.32pt;"></font></div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">10,667</font></div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.9%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 26.95pt;">&#8212;</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred Expenses<font style="padding-left: 1.88pt;"></font></div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">128</font>,009</div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.45pt;">31,478</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Other current assets<font style="font-weight: normal; padding-left: 4.83pt;"></font></div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 0.55pt;">&#8203;</font>257,011</div></td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.07%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.9%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$117,853</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Advance to suppliers refers to pre-payments made to vendors for future services.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Value added tax (&#8220;VAT&#8221;) is an indirect tax applicable in Switzerland and Spain. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Tax credit refers to an advance payment on withholding taxes.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Deferred expenses refer to research and collaboration agreements entered into with third parties for research projects that will be recognized as expenses throughout the research period.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">6. Property and Equipment, net</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Property and equipment consist of the following:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 3.4%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 3.4%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 3.4%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.4%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computer<font style="padding-left: 3.51pt;"></font></div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 3.33pt;">&#8203;</font>25,436</div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">8,735</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture and fixtures<font style="padding-left: 4.64pt;"></font></div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">4</font>,865</div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">4,489</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements<font style="padding-left: 1.86pt;"></font></div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">8,</font>889</div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">8,487</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Laboratory equipment<font style="padding-left: 3.53pt;"></font></div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">3,348</font></div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total property and equipment<font style="font-weight: normal; padding-left: 2.41pt;"></font></div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 3.33pt;">&#8203;</font>42,538</div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 0.55pt;">21,711</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: accumulated depreciation<font style="padding-left: 0.78pt;"></font></div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(1</font>2,905)</div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt;">(3,313)</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Property and equipment, net<font style="font-weight: normal; padding-left: 2.89pt;"></font></div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 3.33pt;">&#8203;</font>29,633</div></td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.4%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">$18,398</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Property and equipment mainly consist of computers and set-up of a conference room in our Spanish office. No disposals, nor impairments occurred during the periods. Depreciation has been calculated by taking into consideration the use, purpose and financial-technical duration of the assets, based on their estimated economic lives.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Depreciation expense for the year ended December&#160;31, 2020, 2019 and 2018 was USD 9,592, USD 2,571 and USD 741, respectively.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">7. Operating lease. Right of use (&#8220;ROU&#8221;) assets</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our leased assets include offices in Lugano and Barcelona and a lab in Barcelona. Our current lease portfolio consists of leases with remaining terms ranging from less than one year to three years. These leases contain options under which we can extend the term from two to five years. Renewal options are excluded from our calculation of lease liabilities unless we are reasonably certain that we will exercise the renewal option. Our lease agreements do not contain residual value guarantees or material restrictive covenants. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Operating leases are reflected on our balance sheet as operating lease ROU assets and the related current and non-current operating lease liabilities. ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease agreement. Operating lease ROU assets and liabilities are recognized at the commencement date, or the date on which the lessor makes the underlying asset available for use, based upon the present value of the lease payments over the respective lease term. Lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectations regarding the terms. Variable lease costs such as common area maintenance, property taxes and insurance are expensed as incurred.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-17<br></div></div></div>
<!--End Page 150-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 151-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of October 1, 2020, the Company entered into a five-years operating lease agreement with Parc Cientific de Barcelona to lease office space. In connection with the lease, the Company paid a security deposit of EUR&#160;2,544 or USD 3,113 classified as deposit in non-current assets. The Company is required to pay for operating costs, including general services, utilities, and taxes, which are billed monthly based on the Company&#8217;s share of the total rentable square footage. These additional charges are considered variable lease costs and are recognized in the period in which the costs are incurred. The first year of the lease agreement is mandatory for both parties. After the first year of the term elapsed, the Company may withdraw giving three months&#8217; written notice. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On December 24, 2020, the Company renewed a five-years operating lease term with Parc Cientific de Barcelona to lease lab and office space. In connection with the lease, the Company paid a security deposit of EUR 6,469 or USD 7,916 classified as deposit in non-current assets. The Company is required to pay for operating costs, including general services, scientific services, utilities, waste management services and taxes, which are billed monthly based on the Company&#8217;s share of the total rentable square footage. These additional charges are considered variable lease costs and are recognized in the period in which the costs are incurred. The first two years of the lease agreement are mandatory for both parties. After the first two years of the term has elapsed, the Company may withdraw giving three months&#8217; written notice. The Company accounted for the renewal as a modification of the original agreement and recorded an additional right-of-use asset and corresponding lease liability based on the incremental borrowing rate determined as of the effective date of the modified lease.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Balance Sheet</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The breakdown of the significant components of ROU assets and lease liabilities as of December&#160;31, 2020 and 2019 is reported in the table below, together with the discount rate used in order to calculate the net present value of the lease liabilities as of those periods.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 24.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.71%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.71%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.71%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease<br></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease- right of use assets<font style="padding-left: 4.69pt;"></font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$523,080</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$200,950</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liability &#8211; current<font style="padding-left: 0.78pt;"></font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$122,756</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$102,107</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liability &#8211; non current<font style="padding-left: 2.45pt;"></font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$400,324</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">98,843</font> </div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average remaining lease term<font style="padding-left: 2.15pt;"></font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;5 years</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">&#8203;2 years</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average discount rate<font style="padding-left: 0.47pt;"></font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 32.5pt;">3</font>.61</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 32.5pt;">5.13</font></div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Statement of operations</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The components of lease expense were as follows:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 25.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.87%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amortization of right of use assets<font style="padding-left: 1.34pt;"></font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.87%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;117,587</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">97,590</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">76,010</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest of operating lease liability<font style="padding-left: 3.01pt;"></font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 9.63pt;">4</font>,213</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 0.37pt;">11,940</font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">10,792</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Maturities</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Future minimum lease payments required under lease agreements with remaining non-cancelable lease terms are disclosed in Note. 19 <font style="font-style: italic;">Other Information.</font></div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">8. Accounts Payable</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Accounts payable are reported at their nominal value. Accounts payable refer to amounts due to third parties on outstanding invoices received before year-end for services already provided. As of December&#160;31, 2020 and 2019, accounts payable amounted to USD 961,516 and USD 154,441, respectively. All accounts payable are due in less than </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-18<br></div></div></div>
<!--End Page 151-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 152-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">12 months. Details of the vendor outstanding payables as of December&#160;31, 2020 and 2019, broken down by currencies in which they are denominated, are reported in the following table:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.85%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.85%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 3.85%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.85%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vendors Payables in CHF<font style="padding-left: 2.98pt;"></font></div></td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">29</font>,423</div></td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">33,822</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vendors Payables in EUR<font style="padding-left: 2.43pt;"></font></div></td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">202,223</div></td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">54,850</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vendors Payables in USD<font style="padding-left: 2.43pt;"></font></div></td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;673,600</div></td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.85%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">53,221</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">9. Other current liabilities and deferred income </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Other current liabilities and deferred income consist of the following as of December&#160;31, 2020 and 2019:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 2.64%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.64%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.64%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Payable for social securities<font style="padding-left: 4.11pt;"></font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8203;</font>88,334</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 5pt;">38,508</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued payroll<font style="padding-left: 2.97pt;"></font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">294</font>,469</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">145,883</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued expenses<font style="padding-left: 0.21pt;"></font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">3</font>79,270</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">65,614</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred income<font style="padding-left: 0.2pt;"></font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">2</font>39,483</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">368,797</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deposit<font style="padding-left: 2.4pt;"></font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">5,307</font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other Current Liabilities and Deferred Income<font style="padding-left: 3.03pt;"></font></div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$1,006,863</div></td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$618,802</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Payables for social securities as of December&#160;31, 2020 and 2019 amounted to USD 88,334 and USD 38,508, respectively, and refer to amounts due to social securities and employees withholding tax.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Accrued payroll as of December&#160;31, 2020 and 2019 amounted to USD 294,469 and USD 145,883, respectively, and refers to accruals on year-end bonuses, accrued vacations and extra-hours including social security charges, to be paid to employees.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Accrued expenses as of December&#160;31, 2020 and 2019 amounted to USD 379,270 and USD 65,614, respectively, and refer to invoices to be received from vendors for services performed and not yet billed.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Deferred income for the period ended December&#160;31, 2020 and 2019 amounted to USD 239,483 and USD 368,797, respectively, and mainly refers to research grants received from The Michael J Fox Foundation for Parkinson&#8217;s Research (MJFF) and Eurostar. Deferred income will be recognized in the consolidated statement of operations in accordance with the costs sustained. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">10. Pension obligations</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net pension obligations related to the Company&#8217;s defined pension plan refer only to Swiss employees and as of December 31, 2020 and 2019, can be summarized as follows:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.22%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 71.8%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assumption used for the PBO</div></td><td class="gutter" style="width: 3.22%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.22%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 3.22%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.22%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">End of year funded status:<br></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Fair value of plan assets <font style="padding-left: 0.22pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">477,288 </font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">370,190 </font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">(Projected benefit obligation)<font style="padding-left: 4.1pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(648,846) </div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(496,818) </div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Funded status<font style="padding-left: 2.4pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(171,558)</div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(126,629) </div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Reconciliation of funded status:<br></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Funded status beginning of the year<font style="padding-left: 1.33pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(126,629)</div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Expenses<font style="padding-left: 0.74pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(</font>44,474)</div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(42,244)</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Employer contribution<font style="padding-left: 1.85pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">36,762</font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">33,418</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Change in AOCI over the year<font style="padding-left: 2.44pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">(36,218)</font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 0.36pt;">(117,803)</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Funded status at December&#160;31, 2020<font style="padding-left: 3.28pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(171,558)</div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(126,629)</div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Component of net periodic pension cost:<br></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Services cost<font style="padding-left: 0.19pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 8.33pt;">36,597</font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.32pt;">43,083</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest cost<font style="padding-left: 4.08pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">947</font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">742</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Expected return on plan asset<font style="padding-left: 2.44pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(</font>3,564)</div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(1,581)</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Amortization of (gains)/losses <font style="padding-left: 2.44pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">10,494 </font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 71.8%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Expenses<font style="font-weight: normal; padding-left: 4.07pt;"></font></div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="font-weight: normal;">&#8203;</font><font style="padding-left: 5pt;">(</font>44,474)</div></td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.22%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(42,244)</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-19<br></div></div></div>
<!--End Page 152-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 153-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.05%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December 31,</div></td></tr><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 3.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Reconciliation of projected benefit obligation:<br></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Projected benefit obligation at January 1<font style="padding-left: 2.45pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">496,819</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Service cost<font style="padding-left: 4.08pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">39,013</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">43,083</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Employee contribution<font style="padding-left: 0.74pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">25,770</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">22,280</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest Cost<font style="padding-left: 1.86pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">1,009</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">742</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Benefit payments<font style="padding-left: 2.41pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">48,365</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">323,742</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Gain)/loss on financial assumption<font style="padding-left: 3.55pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">4,378</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">20,557</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Gain)/loss on experience<font style="padding-left: 4.11pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">33,491</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">86,415</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Projected benefit obligation at December 31<font style="padding-left: 2.46pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">648,846</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">496,819</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Reconciliation of fair value of plan assets:<br></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value at January 1<font style="padding-left: 4.1pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">370,190</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected return on plan assets<font style="padding-left: 3.56pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">3,800</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">1,581</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Gain/(loss) on plan assets<font style="padding-left: 3.55pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt;">(9,495)</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 1.67pt;">(10,831)</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Employer contribution<font style="padding-left: 1.85pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">38,658</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">33,418</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Employee contribution<font style="padding-left: 0.74pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">25,770</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">22,280</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Benefit payments<font style="padding-left: 2.41pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">48,365</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">323,742</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value at December 31<font style="padding-left: 4.11pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">477,288</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">370,190</div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.58%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.05%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December 31,</div></td></tr><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 3.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 3.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.58%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Change in net(gain)/loss:<br></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Gain)/loss at beginning of year<font style="padding-left: 3pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 0.37pt;">117,803</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Gain)/loss on PBO during year<font style="padding-left: 2.99pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">37,902</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">106,972</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Gain)/loss on assets during year<font style="padding-left: 4.12pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">9,454</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">10,831</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amortization of gain/(loss)<font style="padding-left: 2.98pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 2.04pt;">(11,138)</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Gain)/loss at end of year<font style="padding-left: 3.56pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">154,021</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 0.37pt;">117,803</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Change in accumulated other comprehensive income (AOCI):<br></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">AOCI at beginning of year<font style="padding-left: 2.99pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 0.37pt;">117,803</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net gain/(loss) amortized<font style="padding-left: 0.21pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 2.04pt;">(11,138)</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Gain)/loss on PBO during the year<font style="padding-left: 2.45pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">37,902</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">106,972</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Gain)/loss on assets during the year<font style="padding-left: 3.57pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">9,454</font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">10,831</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total AOCI at end of year<font style="padding-left: 0.36pt;"></font></div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">154,021</div></td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.58%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 0.37pt;">117,803</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The assumptions used in the determination of the benefit obligation and the plan assets for the pension plans and the pension obligation were as follows:</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 35.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, </div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 16.67%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020 </div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 16.67%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial Assumptions (%pa)<br></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.75pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.01pt; text-align: left;"></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Discount rate <font style="padding-left: 2.75pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">0.15% </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">0.20%</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest credit rate / ERoA <font style="padding-left: 3.89pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">1,00% </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">1,00%</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salary increases <font style="padding-left: 1.65pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">1,00% </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">1,00%</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pension increases <font style="padding-left: 0.54pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">0,00% </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">0,00%</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Demographic Assumptions<br></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Lump-sum option <font style="padding-left: 4.4pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">25% </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">25%</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Retirement age <font style="padding-left: 0.53pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">65/64 </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">65/64</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Proportion married <font style="padding-left: 4.97pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">.80% </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">.80%</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: top; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Allowance for child pensions <font style="padding-left: 2.22pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">5% loading on<br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">risk benefits </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">5% loading on<br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">risk benefits</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Mortality base table <font style="padding-left: 0.54pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">. BVG 2015 </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">. BVG 2015</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Mortality improvement <font style="padding-left: 2.75pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">CMI 2016 (1.25%) </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">CMI 2016 (1.25%)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Turnover <font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">. BVG 2015 </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">. BVG 2015</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Disability <font style="padding-left: 2.73pt;"></font></div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">80% BVG 2015 </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 16.67%; text-align: right; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">80% BVG 2015</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-20<br></div></div></div>
<!--End Page 153-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 154-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">11. Loans</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March 2020, the Company obtained a CHF 14,600 (USD 16,516) five-year loan. The loan has zero interest and is due at maturity on March&#160;31, 2025. The loan is guaranteed through joint and several sureties by the Swiss government. The loan is part of the infrastructure put in place by the Federal Council and Swiss Parliament in view of the economic consequences of the coronavirus.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In August 2020, the Company obtained a CHF 638,000 (USD 699,139) nine-year loan. The loan has zero interest. The loan is due in quarterly installments of CHF 20,000, with payments commencing on December&#160;31, 2021 and ending on September&#160;30, 2029. The loan is part of the infrastructure put in place by the Federal Council and Swiss Parliament in view of the economic consequences of the coronavirus. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Loans granted do not bear interest and no issuance costs have been borne. As such they have been accounted for at face value, which is deemed to approximate the related fair value.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">12. Fair value measurement</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The carrying amounts of the Company&#8217;s cash and cash equivalents, including money market funds, restricted cash and financial liabilities are considered to be representative of their respective fair values because of the short-term nature and the contractual terms of those instruments. The fair values of money market funds are based upon the quoted prices in active markets provided by the holding financial institution, which are considered Level 1 inputs in the fair value hierarchy according to ASC820. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There have been no changes to the valuation methods utilized by the Company, nor were there transfers between levels of the fair value hierarchy. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For financial instruments represented by short-term receivables and payables, for which the present value of future cash flows does not differ significantly from the carrying value, the Company assumes that carrying value is a reasonable approximation of the fair value.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">13. Common and Preferred Stock </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2019, prior to the retrospective application of the Corporate Reorganization, the authorized capital stock of our wholly-owned subsidiary, GT Gain Therapeutics SA, consisted of 225,000 shares of common stock, par value CHF 1.00 per share, and 99,344 shares of Series A Preferred Stock, par value CHF 1.00 per share. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On February&#160;17, 2020, prior to the Corporate Reorganization, our wholly-owned subsidiary, GT Gain Therapeutics SA, concluded a capital increase, amounting to CHF 1,082,500 or USD 1,101,898 through the issuance of 35,295 shares of Series A Preferred Stock, par value CHF 0.0001 per share to our current shareholders and incurred issuance costs of CHF 10,368 or USD 10,553. The capital increase was recorded in the company&#8217;s consolidated statement of shareholders&#8217; equity, with USD 36 as Series A Preferred Stock and USD 1,091,309 as additional paid-in capital. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following the incorporation of the Company and prior to the Corporate Reorganization, the Company issued an aggregate of 1,772,736 shares of common stock at par value USD 0.0001. The aggregate gross proceeds from the offering were USD 177, recorded as an increase of common stock within shareholder&#8217;s equity (deficit). </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;20, 2020, in connection with the Corporate Reorganization, each holder of GT Gain Therapeutics SA&#8217;s equity interests contributed, transferred, granted, assigned and delivered to Gain Therapeutics, Inc. all of its right, title and interest in and to all GT Gain Therapeutics SA&#8217;s equity interests owned by such holder, which resulted in exchanging 225,000 shares of common stock and 134,639 shares of Series A Preferred Stock in GT Gain Therapeutics SA with an aggregate of 2,250,000 shares of common stock and 1,346,390 shares of Series A Preferred Stock issued by Gain Therapeutics, Inc. The amounts of common stock and Series A Preferred Stock disclosed for the period ended December&#160;31, 2019 have been retrospectively adjusted to reflect the share split. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;20, 2020, the Company completed a private placement of 3,366,999 shares of Series B Preferred Stock, par value USD 0.0001, at a purchase price of USD 2.97 per share. The aggregate gross proceeds from the offering were USD 9.9&#160;million. The private placement offering costs amounted to USD 878 thousand. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-21<br></div></div></div>
<!--End Page 154-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 155-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2020 the Company is authorized to issue 50&#160;million shares of common stock and 10&#160;million shares of Preferred Stock, and there were 4,022,736 shares of common stock, par value USD 0.0001 per share, 1,346,390 shares of Series A Preferred Stock, par value USD 0.0001 per share and 3,366,999 shares of Series B Preferred Stock, par value USD 0.0001 per share, issued and outstanding. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Series A Preferred Stock have the following characteristics:</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Voting</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Series A Preferred Stock votes together with the Series B Preferred Stock and the Common Stock on an as-converted basis, and not as a separate class, except as required by law.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Dividends</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dividends will be paid on the Series A Preferred Stock on an as-converted basis when and if declared by the Board of Directors in its discretion, after the Series B Preferred Stock is paid its dividend and prior to any payment to the holders of Common Stock.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Conversion Rights</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Series A Preferred Stock, at the option of the holder, at any time and from time to time, converts on a 1:1 basis to common stock, subject to adjustments for stock splits, stock dividends and other similar events and is subject to anti-dilution price protection upon the issuance of additional securities under certain circumstances.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each share of Series A Preferred Stock will automatically convert into common stock upon the (i)&#160;closing of a Qualifying IPO (an underwritten public offering of not less than $20,000,000 with a pre-transaction valuation of at least $50,000,000) or a Qualifying Reverse Merger (a merger that results in the surviving company being listed on the Nasdaq or the NYSE and holding unencumbered net cash of not less than $15,000,000 at the closing) or (ii)&#160;the date and time , or upon occurrence of an event, specified by vote or written consent by holders of a majority of the outstanding shares of Series B Preferred Stock and a majority of the outstanding shares of Series A Preferred Stock.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Liquidation Preference</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event of any (i)&#160;liquidation, dissolution or winding up of the Company or (ii)&#160;a Liquidation Event (defined as (x)&#160;a merger or consolidation (other than one in which stockholders of Holdings own a majority by voting power of the outstanding shares of the surviving or acquiring corporation and other than a reincorporation merger) or (y) a sale, lease, transfer, exclusive license or other disposition of all or substantially all of the assets of Holdings), the holders of Series A Preferred Stock then outstanding after the payment in full of the Series B Preferred Stock and before any payment shall be made to the holders of the common stock shall be entitled to be paid in an amount equal to their initial investment, plus accrued dividends on each share of Series A Preferred Stock (or, if greater, the amount that the Series A Preferred would have received on an as-converted basis) and any remaining proceeds will be distributed next to holders of common stock.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Series B Preferred Stock have the following characteristics:</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Voting </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Series B Preferred Stock votes together with the Series A Preferred Stock and the Common Stock, on an as converted basis.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Dividends</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dividends will be paid on the Series B Preferred Stock on an as-converted basis when and if declared by the Board of Directors in its discretion, prior to dividends being paid on the Common Stock or Series A Preferred Stock</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Conversion Rights</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Series B Preferred Stock, at the option of the holder, at any time and from time to time, converts on a 1:1 basis to Common Stock, subject to adjustments for stock splits, stock dividends and other similar events and is subject to anti-dilution price protection upon the issuance of additional securities under certain circumstances.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-22<br></div></div></div>
<!--End Page 155-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 156-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each share of Series B Preferred Stock will automatically convert into common stock upon (i)&#160;the closing of a Qualifying IPO (an underwritten public offering of not less than $20,000,000 with a pre-transaction valuation of at least $50,000,000) or a Qualifying Reverse Merger (a merger that results in the surviving company being listed on the Nasdaq or the NYSE and holding unencumbered net cash of not less than $15,000,000 at the closing) or (ii)&#160;the date and time, or upon occurrence of an event, specified by vote or written consent by holders of a majority of the outstanding shares of Series B Preferred Stock and a majority of the outstanding shares of Series A Preferred Stock. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Liquidation Preference</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event of any (i)&#160;liquidation, dissolution or winding up of the Company or (ii)&#160;a Liquidation Event (defined as (x)&#160;a merger or consolidation (other than one in which stockholders of Holdings own a majority by voting power of the outstanding shares of the surviving or acquiring corporation and other than a reincorporation merger) or (y) a sale, lease, transfer, exclusive license or other disposition of all or substantially all of the assets of Holdings), the proceeds will be paid first to each Series B Preferred stockholder in an amount equal to their initial investment, plus accrued dividends on each share of Series B Preferred Stock (or, if greater, the amount that the Series B Preferred would have received on an as-converted basis). The balance of any proceeds will be next distributed to holders of the Series A Preferred Stock in an amount equal to their initial investment, plus accrued dividends on each share of Series A Preferred Stock (or, if greater, the amount that the Series A Preferred would have received on an as-converted basis) and any remaining proceeds will be distributed next to holders of common stock.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">14. Warrants </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the issuance of the Series B Preferred Stock through a private placement, the Company issued equity-classified warrants to designees of the placement agent to purchase an aggregate of 269,360 shares of our common stock at an exercise price of $4.46 per share, valued in the aggregate at USD 413,887 and included in the issuance costs of the Series B Preferred Stock. The warrants vested immediately upon issuance, provide for a cashless exercise right and are exercisable for a period of five years from July 20, 2020. As of December&#160;31, 2020, no warrants were exercised or exchanged. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The fair value of the warrants is estimated using the Black-Scholes option pricing model with the following assumptions:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Volatility<font style="padding-left: 2.46pt;"></font></div></td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.74%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">75%</font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term (years)<font style="padding-left: 4.55pt;"></font></div></td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.74%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">5</font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate<font style="padding-left: 1.22pt;"></font></div></td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.74%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">0.28</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected dividend yield<font style="padding-left: 0.64pt;"></font></div></td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.74%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">15. Equity Incentive Plan</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s Equity Incentive Plan, adopted by the Board in September 2020, consists of the 2020 Omnibus Incentive Plan (the &#8220;2020 Omnibus Plan&#8221;). The 2020 Omnibus Plan provides for the granting of equity-based awards to our named executive officers, other employees, consultants and non-employee directors at a price to be determined by the Board of Directors. The 2020 Omnibus Plan is intended to encourage ownership of stock by employees and consultants of the Company and to provide additional incentives for them to promote the success of the Company&#8217;s business. The maximum number of shares to be issued under the 2020 Omnibus Plan is to 1,310,000. The 2020 Omnibus Plan expires after ten years, unless terminated prior to that date by the Board of Directors. The Board of Directors is responsible for determining the individuals to be granted options, the number of options each individual will receive, the option price per share, and the exercise period of each option. No option will have a term in excess of 10&#160;years. The exercise price for a stock option awarded under the 2020 Omnibus Plan shall not be less than the fair market value of the Company&#8217;s common stock on the date of the grant. The vesting schedule for options granted pursuant to the 2020 Omnibus Plan generally consists of one-third of the options vesting on the first-year anniversary of the date of grant, with the remaining two-thirds vesting in equal installments on a monthly basis thereafter for the next two years. The options may be exercised in whole or in part for 100% of the shares vested at any time after the date of grant. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-23<br></div></div></div>
<!--End Page 156-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 157-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Stock Option Grants</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following tables summarize stock option activity under the 2020 Omnibus Plan: </div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 58.97%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div></td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.97%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average<br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining<br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years</div></td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.47%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate<br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic<br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div></td></tr><tr><td style="width: 58.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Options outstanding at December&#160;31, 2019<font style="padding-left: 2.72pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.93%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.97%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.41pt; text-align: left;"><font style="padding-left: 2.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.47%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.47pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 58.97%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 1.29pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">488,000</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;">2.97</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.97%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.41pt; text-align: left;">9.7</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.47%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.47pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 58.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised<font style="padding-left: 4.07pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.93%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.97%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.41pt; text-align: left;"><font style="padding-left: 2.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.47%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.47pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 58.97%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cancelled/Forfeited<font style="padding-left: 4.08pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.97%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.41pt; text-align: left;"><font style="padding-left: 2.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.47%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.47pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 58.97%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Options outstanding at December&#160;31, 2020<font style="padding-left: 2.72pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">488,000</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.93%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;">2.97</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.97%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.41pt; text-align: left;">9.7</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.47%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.47pt; text-align: left;">&#8212;</div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 15.6%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 49.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options Outstanding</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 32.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options Exercisable</div></td></tr><tr class="header"><td style="width: 15.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Outstanding</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted- <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average Years <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining on <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual Life</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercisable</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise Price</div></td></tr><tr><td style="width: 15.6%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">$2.97</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.6%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.25pt; text-align: left;">488,000</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.6%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30.25pt; text-align: left;">9.7</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.6%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 25.25pt; text-align: left;">$2.97</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.6%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 31.5pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.6%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 31.5pt; text-align: left;">&#8212;</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2020, the total unrecognized compensation cost related to non-vested stock options granted was USD 957,250, and is expected to be recognized over 4&#160;years.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company uses the Black-Scholes option pricing model to estimate the fair value of stock options on the date of grant. The Black-Scholes option pricing model takes into account variables such as volatility, dividend yield rate, and risk-free interest rate. The computation of expected volatility is based on the volatility of a representative group of companies with similar characteristics, including stage of product development and life science industry focus. In estimating the expected term of an award, we use the simplified method as allowed by the SEC Staff Accounting Bulletin No. 107,<font style="font-style: italic;"> Share-Based Payment</font>, as we do not have sufficient historical exercise data to provide a reasonable basis, and also consider relevant peer group data that we believe is a representative sample of similar companies as a comparative measure. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as we have never paid dividends and have no current plans to pay any dividends on our common stock. The Company&#8217;s policy is to account for forfeitures when they occur.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Because there is no public market for our common stock, the Board of Directors determined the fair value of the common stock at the grant date based on prices paid for the Company&#8217;s Series B Preferred Stock, which the Company sold to outside investors in an arm&#8217;s-length transaction, pursuant to which 3,366,999 shares of Series B Preferred Stock were issued at a price per share of USD 2.97 and gross proceeds amounted to USD 9.9&#160;million.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The weighted average fair value and assumptions used to determine the fair value of stock options granted is as follows:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Volatility<font style="padding-left: 2.46pt;"></font></div></td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.74%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">80%</font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term (years)<font style="padding-left: 4.55pt;"></font></div></td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.74%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">7</font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate<font style="padding-left: 1.22pt;"></font></div></td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.74%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">0.67</div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected dividend yield<font style="padding-left: 0.64pt;"></font></div></td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.74%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each of these inputs is subjective and generally requires significant judgment to determine. The weighted average grant-date fair value per share of options granted during 2020 was USD 2.13.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Total stock-based compensation expense is recognized for stock options granted to employees and non-employees and has been reported in the Company&#8217;s consolidated statements of operations and comprehensive loss as follows (in USD):</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 31.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Year Ended December&#160;31, </div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.23%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.77%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.77%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development<font style="padding-left: 3.1pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.23%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.84pt; text-align: left;">&#8203;57,049</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.77%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">n/a</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.77%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">n/a</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 2.55pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.23%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.84pt; text-align: left;">24,591</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.77%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">n/a</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.77%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">n/a</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total stock-based compensation<font style="padding-left: 2.69pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.23%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.84pt; text-align: left;">&#8203;81,640</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.77%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">n/a</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.77%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">n/a</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-24<br></div></div></div>
<!--End Page 157-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 158-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">16. Income taxes</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company is subject to taxation in the U.S., Switzerland and in Spain. Taxes are recorded on an accrual basis and represent the allowances for taxes paid or to be paid for the year, calculated according to the current enacted rates and applicable laws. The Company has accumulated net losses since inception in Switzerland and in the U.S. and has not recorded an income tax provision or benefit for federal and cantonal tax in Switzerland and for the United States (U.S.) federal and state income taxes during the year ended December 31, 2020 and 2019. The Company report a tax provision for corporation taxes due to the Spanish tax authorities pertaining to our branch Gain Therapeutics Sucursal en Espa&#241;a. Spanish corporate income taxes have been computed based on an effective tax rate of 25%, which represents the statutory tax rate, as no discrete items were noted in the computation of income taxes.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For financial reporting purposes, loss before income taxes provision includes the following components:</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3pt; margin-left: 0pt; text-indent: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.05pt;">&#8203;</td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 34.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Year Ended December&#160;31, </div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt;">&#8203;</td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020 </div></td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.82%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Domestic<font style="padding-left: 4.18pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 7.5pt;">(623,667)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 33.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 33.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Foreign<font style="padding-left: 1.39pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(2</font>,948,629)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(2,186,331)</font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(1,095,759)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 2.09pt;"></font></div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(3,572,296)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(2,186,331)</div></td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.82%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.33%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(1,095,759)</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following were the components of income tax expense provision for the years ended December 31, 2020, 2019 and 2018:</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3pt; margin-left: 0pt; text-indent: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.05pt;">&#8203;</td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 31.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Year Ended December&#160;31, </div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt;">&#8203;</td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020 </div></td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.53%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.19%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current:<br></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.53%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Federal<font style="padding-left: 2.51pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;">$<font style="padding-left: 12.13pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State<font style="padding-left: 2.51pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.53%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 17.13pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Foreign<font style="padding-left: 1.39pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 5pt;">5,386</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 5pt;">7,114</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 5pt;">9,</font>781</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred:<br></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.53%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Federal<font style="padding-left: 2.51pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;">$<font style="padding-left: 12.13pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State<font style="padding-left: 2.51pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.53%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 17.13pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Foreign<font style="padding-left: 1.39pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 17.13pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 2.09pt;"></font></div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;">$5,386</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.53%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;">$7,114</div></td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.19%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.61%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.07pt; text-align: left;"><font style="padding-left: 5pt;">9,781</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The breakdown of domestic and foreign NOLs and related DTAs are reported in the following table:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.05pt;">&#8203;</td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 36.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Year Ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt;">&#8203;</td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt;">&#8203;</td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">USD</div></td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">USD</div></td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.21%; font-size: 2pt; padding-top: 3.05pt; padding-bottom: 3.05pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.05pt; padding-bottom: 3.05pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">USD </div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total NOLs (foreign) &#8211; GT Gain Therapeutics SA<font style="padding-left: 2.98pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(6,076,187)</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(3,660,197)</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.05pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.05pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(1,369,510)</div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">NOLs (domestic) &#8211; Gain Therapeutics, Inc.<font style="padding-left: 0.98pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">(532,209)</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total NOLs<font style="padding-left: 0.33pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(6,608,396)</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(3,660,197)</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(1,369,510)</div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax assets related to:<font style="padding-left: 1.35pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net operating losses carried forward (foreign)<font style="padding-left: 0.83pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4.06pt;">1,111,942</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.82pt;">669,816</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.82pt;">250,620</font></div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net operating losses carried forward (domestic)<font style="padding-left: 3.6pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">146,451</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other temporary differences<font style="padding-left: 3.74pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.82pt;">22,465</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.32pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.32pt;">&#8212;</font></div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total deferred tax assets<font style="padding-left: 4.26pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">1,280,85</font>8</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">&#8212;</font></div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax liabilities<font style="padding-left: 1.88pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(2,682)</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.32pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.32pt;">&#8212;</font></div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Valuation allowance<font style="padding-left: 1.31pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(1,278,176)</div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">(669,816)</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; padding-top: 2.8pt; padding-bottom: 2.8pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 2.8pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">(250,620)</font></div></td></tr><tr><td style="width: 58.98%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net Deferred tax assets<font style="padding-left: 3.01pt;"></font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.32pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.32pt;">&#8212;</font></div></td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.21%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 2.8pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 2.8pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.32pt;">&#8212;</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">According to Swiss tax law, the NOLs can be carried forward for seven years and will begin to expire commencing from 2025 for the NOLs generated in 2017.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">According to the Coronavirus Aid, Relief and Economic Security Act (also known as the CARES Act), U.S. NOLs generated in a taxable year beginning after December 31, 2017 can be carried forward for an indefinite period and are subject to an 80% limitation on taxable income in any tax period.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Due to uncertainty regarding the realization of our deferred tax assets, full valuation allowance has been posted as of December 31, 2020, 2019 and 2018. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-25<br></div></div></div>
<!--End Page 158-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 159-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Deferred tax assets require an assessment of both positive and negative evidence when determining whether it is more likely than not that they can be recovered. Such assessment is made on a jurisdiction-by-jurisdiction basis. The Company&#8217;s assessment includes an evaluation of cumulative losses, future sources of taxable income, exclusive of reversing temporary differences, and risks and uncertainties related to our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2020 and 2019, the Company has determined that there is not sufficient evidence that the Company will be able to realize the benefits of the domestic and foreign deferred tax assets. Accordingly, the Company continues to maintain a full valuation allowance on the Company&#8217;s domestic and foreign deferred tax assets until sufficient positive evidence will exist to support the reversal of the valuation allowance.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2020, and 2019, the Company had no uncertain tax positions and, therefore, had no accrued interest or penalties related to such uncertain tax positions. There are no changes expected to occur in the next 12 months with respect to the status of the Company&#8217;s uncertain tax positions. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company files income tax returns in Switzerland, Spain and in the United States. The foreign, federal and state income tax returns are subject to tax examinations for the tax years ended 2018 through 2020. The Company is currently not under examination by any tax authorities. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">17. Net loss per common share</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Basic net loss per common share is computed by dividing the net loss available to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The other outstanding qualifying securities had no impact on the computations for the years ended December&#160;31, 2020, 2019 and 2018 since such instruments would have resulted in antidilutive impacts given the net losses reported for those periods.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company elected to report pro-forma net loss per share figures assuming the conversion of all of its preferred stock into common stock, which will occur upon the occurrence of certain events (refer to Note 13 <font style="font-style: italic;">Common </font><font style="font-style: italic;">and Preferred Stock</font> for details). The accompanying consolidated financial statements and notes to the consolidated financial statements give retroactive effect to the stock split for the period ended December&#160;31, 2019.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 33.19%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Numerator:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss attributable to common stockholders<font style="padding-left: 2.01pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(3,577,682)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(2,193,445)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(1,105,540)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Denominator:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted-average number of common shares used in computing net loss per share attributable to common stockholders - basic and diluted<font style="padding-left: 3.72pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 3.33pt;">3</font>,046,355</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.32pt;">2,250,000</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.32pt;">2,250,000</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma adjustment to reflect assumed conversion of convertible preferred stock into common stock<font style="padding-left: 4.78pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">2,</font>813,785</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma weighted-average number of common shares used in computing pro forma net loss per share attributable to common stockholders - basic and diluted<font style="padding-left: 2.55pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 3.33pt;">5</font>,860,140</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma net loss per share attributable to common stockholders - basic and diluted<font style="padding-left: 1.95pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(0.</font>61)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">18. Related Parties</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Related Parties</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In September 2018, we entered into a sublease with TiVenture, one of our current shareholders, to sublease 28 square meters of our office spaced located in Lugano in Via Pietro Peri 9D plus access to the conference room and services. The sublease ends on August&#160;31, 2021. The annual rental fee and additional expenses for USD 17,858 is recorded as other income in the consolidated statements of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In September 2018, we entered into a sublease with VitaTech, one of our current shareholders, to sublease 20 square meters of our office spaced located in Lugano in Via Pietro Peri 9D plus access to the conference room and services. The annual rental fee and additional expenses for USD 8,023 and it is recorded as other income in the consolidated statements of operations. The sublease ended as of December&#160;31, 2020.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-26<br></div></div></div>
<!--End Page 159-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 160-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dr. Khalid Islam, the Chairman of our Board of Directors, shareholders and founder of the Company, is currently the Chairman of the board of directors of Minoryx, and therefore Minoryx is considered a related party. In December 2017, the Company entered into an exclusive worldwide, royalty-bearing, assignable, transferable license agreement with Minoryx Therapeutics SL to use and exploit Minoryx&#8217;s IP and into an exclusive worldwide, royalty-bearing, assignable, transferable sublicense agreement with Universitat de Barcelona and Institucio Catalana Recerca Estudis Avancats in order to be able to develop its business, directly or indirectly, through sub-licensing to third parties or any other way of operation. According to the Minoryx License Agreement, the Company shall pay to Minoryx as royalties:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">an amount equal to 8% of (i)&#160;net revenues with regard to products that would infringe (a) at least one composition of matter claim or (b) Minoryx molecules and (ii)&#160;sublicensing revenues;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">an amount equal to 3% of net revenues with regard to products that would infringe at least (a) one method of claim or (b) Minoryx know-how.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to royalties, the Company shall pay Minoryx certain milestones payments of 1.25% of any consideration received in the event of a sale of the Company or substantially all of the assets, including by merger, change of control, or reorganization.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2020 and 2019, there were no receivables outstanding versus Minoryx. As of December 31, 2020 and 2019 there were USD 7,915 and nil payable to Minoryx as reimbursement of a deposit. For the year ended December 31, 2020, 2019, and 2018, there were no expenditures and nil, nil and USD 11,655 income from Minoryx. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">TiVenture is one of our current shareholders and owns 750,000 shares of common stock and 220,240 shares of Series A Preferred Stock. Lorenzo Leoni, a Managing Partner in TiVenture, is a former Board of Directors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">VitaTech is one of our current shareholders and owns 563,710 shares of Series A Preferred Stock. Lorenzo Leoni, a Managing Partner in VitaTech, is a former Board of Directors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with our Series B Private Placement, the Company entered into a non-exclusive strategic advisory agreement with Allele Capital Partners LLC (&#8220;Allele&#8221;), a strategic advisory and investment firm, at USD 10,000 per month. Certain individuals affiliated with Allele are also registered representatives (but non-controlling persons) of Placement Agent, and own 1,772,736 shares of the Company&#8217;s common stock and 269,360 warrants (see Note 14 <font style="font-style: italic;">Warrants</font>). Mr. Eric Richman, our Chief Executive Officer, member of our board of director and owner of 223,743 shares of common stock and 16,386 shares of Series B Preferred Stock of the Company, is also affiliated with Allele. As of December 31, 2020 we recorded strategic advisory expenses for USD 50,000 and no outstanding liabilities exist with respect to Allele. The agreement with Allele will terminate upon the successful completion of this transaction.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 4.11%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 19.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div></td></tr><tr class="header"><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 4.11%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020 </div></td><td class="gutter" style="width: 4.11%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 4.11%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounts Receivable<br></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">From TiVenture<font style="padding-left: 4.05pt;"></font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$6,556</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$4,696</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">From VitaTech<font style="padding-left: 2.78pt;"></font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">1,992</font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">2,417</font></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current liabilities<br></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred income<br></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Due to TiVenture<font style="padding-left: 2.94pt;"></font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$4,584</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$3,006</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Due to VitaTech<font style="padding-left: 1.67pt;"></font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">272</font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">1,373</font> </div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other current liabilities<br></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deposit due to TiVenture<font style="padding-left: 0.73pt;"></font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$3,294</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8203;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deposit due to VitaTech<font style="padding-left: 4.46pt;"></font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">1</font>,504</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non Current Liabilities<br></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deposit due to TiVenture<font style="padding-left: 0.73pt;"></font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$3,158</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deposit due to VitaTech<font style="padding-left: 4.46pt;"></font></div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">1,4</font>42</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-27<br></div></div></div>
<!--End Page 160-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 161-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10015006x17_424b4_203-fins2_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 29.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Years Ended December&#160;31</div></td></tr><tr class="header"><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.72%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.72%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.72%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.72%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.72%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.91%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other Income<br></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"></div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">TiVenture<font style="padding-left: 4.86pt;"></font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;">$17,858</div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.91%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"><font style="padding-left: 17.13pt;">&#8212;</font></div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">VitaTech<font style="padding-left: 3.59pt;"></font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"><font style="padding-left: 10pt;">8,023</font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;">$13,734</div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"></div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Minoryx<font style="padding-left: 4.51pt;"></font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.91%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;">11,655</div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Expenses<br></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.91%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"></div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Allele Capital Partners<font style="padding-left: 1.76pt;"></font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"><font style="padding-left: 5pt;">50,000</font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212; </font></div></td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.72%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.91%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.61pt; text-align: left;"><font style="padding-left: 17.13pt;">&#8212;</font></div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 21.25pt; margin-left: 0pt; text-align: left;">19. Other Information</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Own Shares</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company does not hold, either directly or indirectly, its own shares and in these periods has not purchased or alienated its own shares</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">Commitments</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes our obligations by contractual maturity as of December&#160;31, 2020:</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">In thousand /USD</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div></td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.95%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2026 and <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">thereafter</div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loans<font style="padding-left: 2.06pt;"></font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.81%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 7.5pt;">738</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 5pt;">2</font>3</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">90</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">90</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">91</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">107</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">337</div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease commitments<font style="padding-left: 0.43pt;"></font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">612</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">155</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;"><font style="padding-left: 0.37pt;">116</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 0.37pt;">116</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 0.37pt;">116</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">109</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Collaborative agreements<font style="padding-left: 3.2pt;"></font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.81%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8203;<font style="padding-left: 7.5pt;">509</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">&#8203;<font style="padding-left: 0.37pt;">411</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">84</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">&#8203;<font style="padding-left: 5pt;">14</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; background-color: #CCEEFF; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 1.09pt;"></font></div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">1,859</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">589</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">290</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">220</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">207</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.51pt; text-align: left;">216</div></td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.95%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">337</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">20. Significant events after the balance sheet date</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subsequent events have been evaluated through February 19, 2021, the date these consolidated financial statements were available for issuance. No significant events have occurred after December 31, 2020. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-28<br></div></div></div>
<!--End Page 161-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 162-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 456pt;"><a name="nt10015006x17_424b4_300-bcv_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="block-frill" style="width: 456pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="page-content"><div class="block-main" style="width: 456pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 82.75pt; text-align: center;">3,636,364 Shares</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 36.75pt; text-align: center;"><img style="height: 125px; width: 261px;" src="logo_gainthera.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 24pt; text-align: center;">Common Stock<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 0pt; text-align: center;">$11.00 per share</div><div><div class="rule-partial" style="height: 0pt; width: 192pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 90.75pt;"> </div></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 14pt; text-align: center;">PROSPECTUS</div><div><div class="rule-partial" style="height: 0pt; width: 192pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 12.75pt;"> </div></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 68pt; margin-left: 0pt; text-align: left;">&#8195;</div><table cellspacing="0" cellpadding="0" class="txttab" style="margin-top: 4pt; border-collapse: collapse; width: 456pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 48.68%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 4.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 20pt; font-weight: bold; margin-top: 0pt; text-align: center;">BTIG</div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.5pt;">&#8203;</td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.5pt;">&#8203;</td><td style="width: 48.68%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 20pt; font-weight: bold; margin-top: 0pt; text-align: center;">Oppenheimer &amp; Co.</div></td></tr><tr><td style="width: 48.68%; text-align: left; vertical-align: top; padding-top: 4.5pt; padding-bottom: 4.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 4.5pt; padding-bottom: 4.5pt;">&#8203;</td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 4.5pt; padding-bottom: 4.5pt;">&#8203;</td><td style="width: 48.68%; text-align: left; vertical-align: bottom; padding-top: 4.5pt; padding-bottom: 4.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td></tr><tr><td colspan="4" style="width: 100%; text-align: center; vertical-align: top; padding-top: 4.5pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 18pt; font-weight: bold; margin-top: 0pt; text-align: center;">National Securities Corporation</div></td></tr></table><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 60pt; text-align: center;">March 17, 2021</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 36pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Through and including April 11, 2021 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer&#8217;s obligation to deliver a prospectus when acting as an underwriter and with respect to any unsold allotment or subscription.</div></div></div><div class="block-frill" style="width: 456pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 162-->
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo_gainthera.jpg
<TEXT>
begin 644 logo_gainthera.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M^S;XGTCX:S:GIH1+C5/A[J=_X0L$D\3>'=P\R2RE<!]=T=G^SW\;M=6ZP:C
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MW4JC)E7QN4E<&O<_"W[)O[2GC<D>#_@'\9O$N#UT7X;>+M0!'=@UMH\BL@.
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M"[_U;G^XRM]<L5Q^N:J.C@^TO_D3*?\ R\\H?K%'^89\<8(O^%U_&#=+AO\
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M>A[8K\COL:?\]/U'^%?L)_P6VMS)_P %!/B0P0'/A/X=C//;PM9U^2WV0_\
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MM;&Q_;]^(I5PH/A/X>'&U3S_ ,(Q:9Y()Y].E?D[Y<G_ #T'_?"?_$U^O/\
MP6BMEE_;W^(;E02?"?P^&3[>&;4>HK\IOL2?W!_G_@5?N.1U;9/EBY4[8/#K
MITIQ\O)_?Y'\'<>V_P!=.)M6O^%C&;+_ *>OS79'/^7)_P ]!_WPG_Q-/:WN
M$;:Y9&VHVUH@K;9%#QM@H#M="'0]&4AER"#6[]B3^X/\_P# J_IF\;_\$O\
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MZ:M::MKH?+U*;I59T:]*O2G3FZ=:A5BZ56,H/EJ0EK>#NFHNU[<LK=#]._\
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M]2+E3PM&$L3BI15O>="C&=2$7>T9348R=TFVK']/C&3/#X]B@_Q_SZ4W,O\
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M8G'0IU+2>"A57LZ-:*U]G7G%RL[74-GTYD63* JH J@!0 ,!0, #GH!P!V
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MI?\ 00_/S?WL]-_9QM''[0?P.)7 'Q<^'1)P.@\7:0?7VK_0MA_U47_7-/\
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M\T?8TJ</9OEY%)J33LU9)1227,?8S_<_5O\ &C[&?[GZM_C73_9T]7_[Z_\
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M9#OATFV>.3Q-JD *+M74-1BT[3+>9&9GBTO4(I=T+Q*O[]19\SYGR_EG*?\
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M_,W_ ().+L_8]\%IV'BCQP!CH1_PDM[@CU^M?IE#V_W/_9WK\6S=WS7']?\
M:)V].:5OP/\ 0O@?_DCN&/\ L2X)_-X>BW^)/3)#@#W;'Z$_TI]1R=%_WO\
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M37<T40R'W#LO$'B+2_#6E:EKFN:G;Z3H^DVD]]J.HWTD5O:6=I;HTDUQ-.X
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M0"V%!R0#\[?'#]JKX,? ;2+B[\;^*K8:N8F-AX4TI[>_\3:G(%=EBM]+$ZO
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M]<I:F]O+4:MX>NYE9GL?$&CR->Z3(I2(N$>=!:S!7'F6UY<Q,-F _P!+U3N
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M_KJ?Z%Y%F^'S[)\NS?"U(U*6.PM*O>+349RBO:4VU=<U.:<)+I)/;8*_"/\
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MI>RO:Z[M=?+HS]6^CVDLTXCERN-\OP4$]-93JUK;-Z:-_P!-'T%#]W_@,?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% "9'J/S%&1ZC\Q7Q<W_!
M0?\ 8V1F5OCYX*5E+JP,M^"I1MC C[%V;BF_\/"?V,_^B_>"?^_U_P#_ "#7
M7]1QG_0+7_\ !<O\O-?>>7_;>3?]#7+_ /PKH?\ R9]IY'J/S%&1ZC\Q7Q9_
MP\)_8S_Z+]X)_P"_U_\ _(-'_#PG]C/_ *+]X)_[_7__ ,@T?4<9_P! M?\
M\%R_R\U]X?VWDW_0UR__ ,*Z'_R9]I[E]1^8HR!U('XUXA\)?VA/@Q\=EUM_
MA#\0- \=CPW+I\>OG1)I9&TN75$O6TY+L2Q0NC7:Z??F+ 8'[+-G!0UZ[?7D
M5C!-<W)"00027$TA'RQ0Q(TDDC #.U%&6P"1@X!/7FE3JTY<E2G*%1/WH23B
MTG;ET:3UNK^M[V5SOIUZ%:DJ]*M3JT9)N%6G.,X.V]I1;32:DFT[:6[VT\@]
M"#17R=X7_;<_9:\7>*-+\$^'OC%X6U/Q5K&K0Z)IFBVIOWN[S59I/+CLH@]D
MJ&8ON!PX4;'); )'UC55*56ER^TIS@IJ\7*+2DENXMZ-:K57,\-C,+C(RGA<
M10Q$82Y9.A5A54)6ORS<')1EOH]1,CU'YT9&<9&?3/-1NF[.2,' QD]<#@XZ
M?_J]:\<^*WQ[^$7P.L]*U'XK^-]'\$6>M7,UAI-QK,CHM]=6T*SSV\"0I/([
MPPLDDGR;0&4[B32A3G4:C3BYS;LH+5N]K623;;U7F[)%UL11P\)5,15IT*,%
M>56I.,(15TO>E)J*2;LVVK?,]HHKR3X5?'3X5?&[3-1UCX4^,M)\;:7I%XFG
M:E?:.\K0VEZ\*7"V\HGBA<2&!Q-@(08PV"2"*];!! (Z$9'T-*4*E.3C4BX3
M6\6FFM$]4]5\T52JTZT%4HSC4IR2<:D)*4))]8RBVFO03('4@?C1D>H_,5X-
M\7/VF/@7\#-4TK1OBQ\1]!\$ZGK>GRZII=IJ[W*R7MA!.]M+<Q>3;S+L6>-X
MSN*G<IP#7DO_  \)_8S_ .B^^"?^_P!?_P#R#6T,)BJD5.G0JSA+X91A)IZV
MT:6NNGJ<=;-<LP]25&OF&#HU8-*=*KB:,*D&TI)2A*:DKIIJZU33V9]IY'J/
MS%&1ZC\Z^+/^'A/[&?\ T7[P3_W^O_\ Y!I&_P""A7[&WRJOQ[\$-N.!NN;Y
M%7)QDL]DJ*,GEG94 !+, ":IX'&)-O#5DEN_9R22[MM62MKZ&3SS)EJ\UR_=
M+_?*&[=E_P O#[4R#T(/XTI('4@?6LK2]3L]4LK/4K&5+BRU"WBN[*XC96CN
M+:>,2P3Q,#\T<L;*ZG )5@<<5B^-/&WAGP#X;UGQ?XOU2UT+PWX>L9]2UK6+
M^3RK/3M/M5WW%W._)\N$<MM4G. ,YKF46W:VM[6VU[:GHRJPC!U92BJ<8\SF
MVE%1:34F]E%)W;>QUV1ZC\Q1D>H_,5\6?\/"?V,_^B_>"?\ O]?_ /R#1_P\
M)_8S_P"B_>"?^_U__P#(-=7U'&?] M?_ ,%R_P O-?>>?_;>3?\ 0UR__P *
MZ'_R9]IY'J/S%&1ZC\Z^;? G[6O[-WQ.U!-&\"?&7P%X@UN9S'!H=OXATZWU
MZ=@-S^1H=]/:ZM.J+EG:&R=54%B< U]"PRK*JL""K#(/!R.O."0?0?X<UA4H
MU:+M5ISIW6G.G'\UMYW.S#8O"XR+GA,11Q,8NSE0J0JQ3TTO"35]=O0O44@Z
M#'H*6LSH#IUI,CU'YTV0[8W8#.%)QQS[<\<].:^2_%/[<7[*7@OQ7JG@OQ1\
M;O!&C^)M#O9=-U32KO4=D]K?Q,\<UJ=J&-I89HWMYHU8O#.ACD53@G2G1JUG
M)4J<ZCA%SER1<N6*WD[+1+NSFQ.,PF#C">+Q6'PL*E14H2Q%6%)3J/:,7-I-
M]DFV^W?ZWHJEIM];:GI]GJ-E-'<6=];0W=I<1,'BGMKA!+!-&ZEE:.2)E=&4
ME64@@D$5=K/\/)[KU.A--)IIIJZ:V:>S7D]T%)D>H_.EKQ_XJ?'3X4?!#3--
MUCXK^,](\$:9K%_)IFF7VL22I%>:A##)<26L @CFD:1((VF.8PFS!W$\"HQE
M.2A",IREM&*;;^[MOZ7(JU:=&$JE6<:=.*O*<VHQBN\I/1+S;L>OY ZD#\:"
MRCDLH'J2!U.!^9X^M?%G_#PK]C0]?C[X*XXYFO\ _P"0J#_P4(_8P;B3]H#P
M(B$C+3W5Y%$IS\I>26S6-1NP 68 D@9YKI^HXR^N%K[ZVIR;Z;*V^NB\T>?_
M &WD[^'-<N;>W^V4+7Z:\_<^T\CU'YTO7I7EW@/XO?"_XHV3:E\.?'?A;QO9
M*B-+/X8UW2]92W$@RBW26-S-):,P&5CN(XW/4)C)'IT?W$P,#8N!Z<#BN><)
MTVXU(3A)/:47':U]^NNUCOI5J5>$9T:M*M"2NITIJ<'Z.-TUYIM#R0.I ^M&
M1ZBH)Y!&%9@2,A>,<%F51G)'!+ =:^2=>_;N_9*\,ZUJWAW7?C?X/TO6]"U.
M_P!&UC39YKT3V&IZ9=2V5_9SA+1T\ZVNH)8)0CL Z$9S3I4:U9N-*E.HUNH1
M<OR_K1D8G%X7!Q4\7B:&&A)V4Z]6%*+?92FTK_,^O,CU'YBC(]1^8KXL_P"'
MA/[&?_1?O!/_ '^O_P#Y!H_X>$_L9_\ 1?O!/_?Z_P#_ )!K?ZCC/^@6O_X+
ME_EYK[SC_MO)O^AKE_\ X5T/_DS[3R/4?F*6OF/X=_MA?LU?%?Q58^"/AW\6
MO#'BSQ5J45Y/8Z)IDUT;RXAL+:2]O)(Q-;0HRV]K#+/( ^X1HS $*<?2WG(5
MR!D# (.,<@,,=0>""*PJ4JE&2C5A*G*R?+)6=GL[.SUZ=SLP^*P^+A[3"UZ.
M(A=QYZ-2-2',K7CS0<E=76E[JZT)<CU'YBER#T.:^=?BQ^U-\!?@?K&FZ!\5
M/B1X;\%ZOJEF-0L+#6;F6*>ZLC/-;K<Q)%#*3%YMO+'OX^9&'7&?5/AW\0_!
MOQ4\)Z9XX\ ZY9^)/"FLBX.EZWI[.]E?+:W4UG.]N\BH[K'<V\L+%D4[XV&.
M*'1JJE"NZ4U1J7Y*CBU%V\]M?)OS)IXW"5<15PE/$T*F*H?QJ$*L)5:>B=YT
MTW.*U5N9*]T=M11169U 2!U('UI,CU'YBODWQE^W!^ROX#\5:WX)\6?&;PCH
MOBCP]J4VD:UH]_<7<5QINHP2>5/:W!%JT*O')\KDR",8R7QDU]0V5Y;W]K;W
MMLXDM[J"*YMIE(*2P3+OBE1O[KH5=3@':PR!GC2=*K2474IS@II.#E%QYDTF
MFK]'?3OT.7#XW"8J=:EAL30KU,/+DKPHU85)4IW<>6I&,FX2YDTXR2:::MH:
M)90<%@#Z$C/Y49'J/S%>&?%O]HCX)_ M]#'Q>\?^'_ LGB8W_P#8']MS21-J
MG]E"S.H&T6**4R?9!?6GG94%?M$?7<!7C_\ P\)_8S_Z+]X)_P"_U_\ _(-:
M0PF)J14Z="K.+VE&$FGTT:6NNGKH95LTR[#5'1Q./P="K&S=.KB:5.:32:;C
M.:DK]+K;[S[3R/4?F*,CU'YU\6?\/"?V,_\ HOW@G_O]?_\ R#0/^"A/[&G;
MX_>"?^_U^/\ VRJ_J.,_Z!:__@N7^7FOO,O[;R?_ *&N7_\ A70_^3/M/(]1
MQUYZ4M?'6C_M\?LB:]J=CHFE_'+P7=:GJM_9Z7IUE%<7AFO=0OYEMK*TA5[-
M09;FX=8H1D!G.T'.*^PT8,JL.C*K#C'! (X[?2LJM"M1Y?:TJE/FOR\\7%.U
MMKI7:OKZKN=.%QV#QT95,'BL/BJ<7RRGAZT*RC+^63IN23T>E^@ZDR/4?G7A
M?Q@_:3^"'P'N='L_BW\0]#\$76OV]U=Z/!K#W*'4(+-UCN)(3!!,"(G958,5
M.2, C-=/\+_BU\/?C'X=B\7_  U\3:9XN\,S7EU8Q:QI$QFLVO+-Q'<VQ9UC
MD6:!R%D1D#*3\P4Y ET:L:<:LJ<U3E\,W%J,M>71]==&T..-P<\3/!PQ5"6+
MII2GAHU8.O"+2:<Z2?/%-2BTVDFI*VZ/3J3(&<D#'7GI]:6J\C+B0%<@-STY
MP ?IWZD]>>.M9]_+_-+]3IZI+=O3MY_AL3!T/1E..N&!Q^M.R!U.*X#Q=\0_
M /P[TN;7?'7B_P ,^#='@0R7&K>)=;TO0M.A3<JYEOM5NK2U52S( ?..794^
M\P4_+EW_ ,%'/V*[2>6UD^/GA%Y+>1HF>"WUZ[@<HQ&^"ZM-(GM;J!L9BGMI
MI8)D^>&5T8,=Z6&Q-97C0JN-[7C"4E]Z5KOM^9QXG,L!A)<F(QN$H3ZQK8BE
M3=N]IR3\MM^Y]Q49!Z'->+_#?X_?!?XO6AN_AE\3_!?CA$6-I[?P[X@TS4-1
MLC(F](]2TJ&Y.IZ9/LRS0:C9VLT8#%T4 X]B@D256*$D*Y4YX(( /3.1E2I&
M<$@AAE2I.=2G4I2Y:E.<)6VG%Q?I9ZW_ $.BC7H5X1J4:U*M"2NI4IQG%KO&
M46TUYILFI-R_WA^8J.<G9QU+*/3@L ?TJE-+%;AG?"*B[FD;: !P22Q.!CJ2
M2% Y.#TC5M1BKR>R1JNM[*,5=R>R_3SW-+(]129'J/S%?+OC[]LW]ESX67O]
MF>.?C=X#T?5E<13:/%K,&KZO;LP8C[9I6AG4M1LHSM($MW:P19PI<,0#R_AS
M]O\ _8Y\4ZBFEZ9\?_ ,-S+M$;ZUJ,WAJR>1V"1P#4O$UOI&G?:9F(6WM1=F
MYN&RL$4A5L=2P6*<7+ZO6V35J<VFN^VUNIYLLXRN%14I9C@8S;Y>26*HJ?-T
M7*YWO?2V]W;3K]EY'J.>GO16%INN:9J\,%WI=Y;ZA:3MB&ZM)X;FWE4/M,D4
MT+R1R1[L .K$$LN.HK=KF:<6TTTUNFFG]S/1BXR2E&49Q>SB[JUEO]_W'\OU
MU_P0[^.US=W5P?C#\,@MQ-(X58_%(*AFWD ?V)@$N3T[9]Z\C^-__!)#XN_
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M%&?^3,/C]_V)!_\ 3UI%8Y=_O^"_["J'_IV)Z7$'_(ASO_L58[_U'F?SX?\
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M,\T6IO9VECJ=H@O$U5)A<R6UH8I2S2;G)WG]#O\ @N[_ ,E;^!G_ &3K7?\
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M^1\WXZ457RWA+#N4H1K<3X6BYP=IQ52E*#G!])*[E%]';L?0A^$7_!40;/\
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MV_X+D6MS'\=OA#?/$1:R_#"ZB@D /[R:Q\2Z]-.G?[IOK'H!\LK<YY7];_\
M@E#=6UQ^PU\(TMY1(;.X\;6LX'6*4>-_$%PL;\#YQ;7%N[< 9?(P,"O@[_@N
M1\,=0U'PS\&/BO9QW,EKX?UC6?!>KM"K%+>/6OL^MZ6SM&KM')?7&@WMG&9$
M$#C?:B1;BYMHINM_X(F?'#1]2^%'CSX&:A>VUMXB\'>*I/%FD6;3&,W_ (?\
M3P!+R>T260R7']FZYI<IOO(06UI!JVG[]K22!?K\0OK/"&"5*2G4P5>U:"O=
M1G.24MNG-=^2?E?\2R9_V5XW<14\8G2IYUE/UO UIM*-25:CDU*5%)_$Z;RN
ML[IZJ<%9<K;_ '>I#G(Z8P<YZ]L8_7-49'545G9UV8PJLWS \8 W?,0"#Z\>
MQKA/B)XZ\._#GPAXC\=^*-3ATGP]X4T34-=U2]N;D11+:6-NTS#9+(D;O* 4
M@C9D+W+01CEL'XV%.4Y0C!.4IR4(I*[<FTK)+5[K[_4_=JE6-*G4JU)0A3I0
ME5J2E-1C&E%7E-MV244FWKLKW/XR_P!N]XI?VT_VC)$8D)\5O$2-TP)5O3"5
MZ=.A]<]\<5_:EX)_Y%;PS_V+>B_^DBU_#]X8@U_]JS]K/1AY$MYK/QF^+T5]
M>6TWFRA+37-<?4K]KR6VA1OLFE:*ER]Y>+$BP06DTC%60FO[F-(LHM.LX+*!
M=D%K;PV\"9+;(8$$:+N)/3:<  #:1GYLU]EQ9RT\-DV&<KUZ&$BJU.VM.U.E
M!<VO5IOT[GX7X,.6(S'Q S&G%O XKB&JL'B=HXF,J^(Q'/!6T2A7IIW<KM[I
M61JTR3[I^C?^@-3Z9)]T_1O_ $!J^*/W@_D#_P""PW_)[?BK_L3/ G_IH-?T
M>?L#_P#)G_[.W_9,/#W_ *1Q5_.'_P %AO\ D]OQ5_V)G@3_ --!K^CS]@?_
M ),__9V_[)AX>_\ 2.*ON,]_Y)G(/^O=+_TW3/P+P[_Y.CXF_P#8?4_]29'V
M'1117PY^^G\W/_!=W_D<?@#_ -BOXO\ _3SI-?;_ /P1R_Y,WTW_ +*#XT_]
M+%KX@_X+N_\ (X_ '_L5_%__ *>=)K[B_P""-P!_8ZTL$9'_  L+QGP?^OQ:
M^VQ?_)&X'_L(E_Z>F?AF2_\ )\>)/^Q10_\ 43*S]4+X-]GG*MM.+C!P#\Q0
M;#@@YPV/3'\OX8OA1'%#^US\-(KX1+!%^T/X+CNEND"0)!'\2M/66.=9MW^C
MQQ!D<S%MT2EI68EB?[JY8@Y3(Z%N@_O \D$@$<#@AN<<<5_&+_P4<^#>I? #
M]KKQS<VUI)8^'?'/B"3XH>#KI%6WMA!KE_)J%[86TL15+=M"\3/>6*V\'EK#
M;S6"1H($B8<O"M2#JX["3DH2Q6%<:<GJN=3@E&W5M-O=:*UF;^-.'E3R[AO.
MI<\J&2YYAZN(IPIN=Z<G&ISRFFE3@I4/9N4DU>I'Y_V96G4#)($2L&/1MS$$
M#G^ (,]LOE<*0*O5\;?L4_M*:!^TO\"O"/C:TU.SE\7V6F0:)\1=&CEB2ZT3
MQ9I@:RU,7%HA#6]EJ<MNVJZ-(55+C2KNVD3E7CC^O_D,>5<XX;)<D=">#D\<
M_3IUKYG$4:E"M5HU8N$Z<Y1:::O9[Z]&M5Y6[G[#@,9A\PP>$QV%J0JX;%T:
M=:G4A)27+.$96=MVKV:T:M9I--%JBN"\<_$#PQ\//"6M^-O&.LV.A^&_#EC/
MJ6KZG?7$=O:VEG;(7F:29W1?,( 2&,,7FG>.&-6D=5/SG^S'^V[\ _VH['_B
M@/%36GBF.-+F_P# ?B54TGQ?8PF&&3SQI;W5PE]:CS%,DVDS7<-N9$CN!!+(
MHD<<-B)498B%&<J4&HRFD^52:NE>W7^K7%5S# T,73P-;%T*>,K0E4HX>52*
MJU8P<5)P@VI22YE>R;\M';[$F0.F"2,,C C_ &7!QSQ@@%3GL3CG%?F3^W%_
MP3D\$_M8^7XPT75U\"?%JPL1I\'B5;2*^TOQ!8(&\FQ\1Z=YUK*[VJYBL-5L
M[A+RT1DB>.ZMH8H%_362:-8][[@O&?E8D9(Y*@$C&03QA1DM@!B.$TSXE?#[
MQ!XH\2^!-(\5Z)J/C'PBM@_B?PS;W\#ZSHL6J6PO-/EO[-6$\$-W;XDBE8>4
M?FC+"0%1>#Q.)PM=5L+.<*E)*3E"+=HW2]^V\7;9NVG3<Y\XRS*\YP-7*\VH
MT<1A<=&5!T:THQE.3B_X,G[T*R5W&=/WX[K8_CT^*'_!.7]LOX+WLE_)\.M<
M\2V5C<2S6WBOX<W-MXLLY&M4$Z7ZVUG*/$5@R2,D4?VS0["]8ATTYM0'S5QG
MP^_;8_;#^!FHG2].^+OCV--*N8[:3PGX\EO_ !!8V"6*3PC36T+QBEU<Z-%#
M)=7!>TMXM)O)&6W-]&4MK,#^VZ-+?Y<(&)"K@Y?/'R@C+8&,X)  _2O%OC9^
MSS\&?CQHS:!\4/A_X=\3PO;W$,%]=:=%#K6GH^PLVF:Y:BWU;3G#*'5K.Z56
M=5+H^ *^JH\6^V<:>98#"8JG)<LYJC&-1*R2:;YKRON]/+0_&L7X*SR]O$\'
M<4YWDN(I/GI8:MC:U?"32LY0GR3I-0Y4TG)5;63:?7\JOV-_^"O^D?%3Q/X>
M^%_Q[T+1_!7BGQ!J5CHGA_QEH;WR^%=6U:_N(X+*QUBVOFF;P[=7S21P6L\&
MHZKIUQ=$BY_L5G6S7]SE8,JL,88!A@Y&",C!'!'H1UK^#S]I'X667P.^/7Q,
M^&V@:I/?Z?X'\3WFG:'J5SY?VU;'SPUK'=O#'A[F&-TCE;RRTC1^8RER:_M;
M_9N\1:MXP_9V^ GBW7W,FN^*/@M\+?$6M.0%+ZMK?@;0M3U%RH  +7EU,2
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M(E5]'U)'4.CV%XK(P#*RF!E(93D$%2000002#P37SM/^)3_Z^0?W23/TNO\
MP:MM+TYJ_:\6K_*Y_$U^R"3_ ,-I_! 8P/\ A=.B<GT_M1SGG _BQ^N.Q_N
MK^='X&?#WP#8?M"?#N_L? _@^ROK;XAZ9/;WMIX:T6WNX)UO)V6:&YALDFBE
M5@&$B.K@@$'(K^BZOJ^+*WM:F7+D4>3"6T;=[\CN[_<?D_A#EW]G9=GE/V\J
M[JYM*JY2@H6;C+W4HRDK+N598P[$DXPZ-T[A37X-_P#!=,9^&7P1;N/'7B(
M?]P%!S]?\YK]Z6ZM]5_D:_-+_@HYX;\.^(_"/P]A\0Z!HNO16WB/59;>+6=+
ML=4CMY'TQ%>2%+Z"=8G=?E9T"LR\$D5Y60U'2S;!U+<W).]F[75M8WL[)WLS
MZOC_  BQW!_$.$E-TU7P-6/M$N9PDHQ<9I-J_*XIVND[:GR[_P $-LGX'?&
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*2E:4VY65TE__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>nt10015006x11_logo.jpg
<TEXT>
begin 644 nt10015006x11_logo.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M)?.W?3H=N(Q%#"T*N)Q-6-'#X>G*M6JR=HPITUS3E)](J*;;\CYZ_P""A?\
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M+=-=T]&?V'2JTZ]*G6I24Z=6$:E.<6G&<)J\91DM)1DM4T]4%%%%0:!1110
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M\23ZC%8EHY!HVBVGEV>@:#;M$D41AT?1[2QTQW"N;MK5KJ21Y9G=O#?LL?\
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M^#O%FG6VK>']?TFX6YL-1L+C($D;HQ:.:)UDM[BVE"7%K=PSVMQ%'/#)&O\
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M37N2BGUNU^1KD^=XO),WPF:85I8K 5K<C=E*TH^UH3<7=0J*\)I:\KEUO?\
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M?^19E;_Z@J'_ *9CYI=/ZZ_PIQS7E'C+B=:)+.\P7G;ZS+7_ (?97M<^RO\
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MX4#Y7BT'7;C0;3)QD&.STF($#J[L<C:I/R6+%AG]T#DD\KG&>V2*^WOV[O#
MT']LW]I>R+N[77QA\7ZX2PQN_P"$GU&?Q0FT*>D*ZZ(%) +A#G[JY^3OLB_[
M7Y&OT'+_ &:P&"]E_#^K4G"S;5G"+E9_XM^S['\M\1.O'/\ .HXAR5:.>9JZ
MBDDY+$2Q+]MS-_:<8PT>B5G'XFS]1O\ @BMHGG_MDMJ#((_[(^%_C"Y4@ 9:
MZN]"T_:5P-P*W3'.05( '#&OZ][?*[1W*)G/!&4W8^HZ5_(]_P $;;Y=,_;%
MM[,LJKK?PW\8:>PD=4,GD2Z1J:QQ;B"\Q>Q5PB MY23/C:C5_7'$"2K=B%^H
M^0C'^3VK\TXQ4O[8;DM/J]+E;[<MM/GS+L?UKX'R4N!*24DVLUQRGM=/FBXJ
M5MM.1KOIW+-%%%?+'["%%%,+@,5(;A0Q..,$D8SZ\=,=Q1:_RU$VEOU=OF))
M((U+'  !))[ =3VX&>3VK\+?V[/^"O.F_"'6]:^$O[/&F:-XS\=:<\MCKOCG
M51=W7A'PS?PRE+G3=,L[66R?Q%K5MM!N9Q>0Z38S;(B-5*7$,?U!_P %3_VE
M=0^ 7[.4^F^$[^73_'7Q5U&7P3HE];Y^UZ1I$ME//XIUJV*$M'/;::J:;;3X
M7['>:S:WR%Y+00O_ !V"S\V22XE\UY927+.6E=F8LQ:21OFDD)>1FD?+EW=F
M.YFS]IPQP_3QZEC\99X>G)QIT9<T?;R3M>+BTW&$K)ZI='?8_!O%WQ(QW#TZ
M/#O#U2-/-,32E4Q^-O%RR[#."E&$%*,E'$XBG)NB[.2?(X6DU)?17CK]N/\
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M@?C#&$78NWQ]XE'R]<-B_#,<@89F)QD?1_\ PUM^U?\ ]'"_&/\ \+_Q/_\
M+&O'?L8]'_$$?S(I38@#.&(]0#CCL3TS_P#JZT_J>%:3^JX>SV;H4M=MO=]/
MZ1<.(>(TGR9[G<5'5J.98V*CLV^55U:^^ROOZ>RQ?M>?M;0MNA_:,^-$)XR8
MOB'XI4G'J#J;1'ZF(M_M$  ?M+_P1<_:,^,GQ0^+_P 6_!GQ/^)'C7XA6D?P
M\TWQ'H\GBWQ!JNM+I=QHGB*WTF]-C%J-U,MHVJ1Z_:R3E(U:1+.W7>1&V[^?
M/[(O^U^1K]S_ /@A3X:ED^,OQN\4LV!I7PZT707&%Q(_B#Q&M\) <[LK_P (
MSM92H"AT )S@>%Q)0PU+)\7*%##TY>XHRC1IQDI.6B344TVDUHUYW2L?H'A;
MGF>XKCC(\-7S?,\70K5JT:U'$XS$8BFZ<<'B:DO=JU)J-G!2<DD_=6O1?T[I
M]T?C_,TZFI]T?Y[FG5^26MIVT/[43NDWNTFR.5V1"RKO(SQ]%9OY@#\:_,;_
M (*I?M*O\ OV7_$>FZ1?I9^/?BXL_P /?"B03A+^SM=1A!\4:U #G8=+T1Y8
MK:X$<C0ZEJ%A@ /N7],[N0Q1A@< ,=QQG \N0_\ H07WZXZ5_'!_P5(_:"D^
M/_[3_B"RT:^%UX"^%D!\">&A#)YEG>ZC97>_Q5K$84E7>^UA7M4N(CY<]GHF
MB,H BF:;WN'<N>8YC1@U^YH25:M+[*4&G&$GTYVK+O<_.O%'B=\,<*8VM1DX
MX[,;Y;@5!1=2$Z\'[7%133]VA1Y[R::C-PTNTU^6ALG+ES'_ 'MORX*J79D7
M( !$:L(UX!VJ,\FG+8N\B1B%"\APH(1=S$X7+M\J@D\LQ"@<D@#-=5]D7_:_
M(U]&?LF_ &]_:-^/_P /_A=9"4:9K.J1W?B>^MPV_3O"6F*FI:_?QML80SK8
M*L-C)*GD_P!IWFGP2',X0_K];$QP\)UZK3IX?#U)<C]U-4XIP2M;X;:=V]==
M3^)LMPN(S3,L%EV'<ZF+S/'X:A%)*4Y>UJ*-6K9IKE@FI3;LDFG=7/Z-/^".
M'[,W_"G?V=$^*&MV?V;QG\<+N#Q"QEB\NYLO ^F"XMO"-EL<"2".^>74_$ 1
MMLC1:[ D\:R1*%_8)(=O\1)VA<D?[.,GD\GK69X>TC3-!T/2M$T:SM]/TG2+
M&WT[3;&UAB@M;.RLHU@MK:VAA58HH(8HT2&.-0B(JJHP!6S7X;C<74QF+KXJ
M<FY5JLJBOTC=^SBM%I"%HKR6NI_H1D.3X?(,FRW)\+%1I8#"4Z%U>]2II/$5
MI7;;E7KN=:712FU%1C:*\_\ BAX!T#XG> ?%WP^\4VHO_#GC3P[JWAG6;1@"
M7T_5]/N+*Y>,MPEQ''*9+>4#=%.L<J_,BD?P._&OX0Z]\%OBSX_^%OB2 _VO
MX*\2:EHTTSHZ"^MHY//TS5(5D)=K;5],EL]3M7?<9+6[B<D[B3_H.S8V?,NX
M9Y& >QSP?;(_&OYN_P#@MM^S>D.L>!_VD_#>G+%#JAM/ ?C\V\953?6UMJ%U
MX8UJ[$0 S/80WFB7%Q,=KS6/AFU5MZ1QR?2<'8]8?'SPD[<F,BHJ3=E"I!J4
M?*\OAL]VUMN?EWC9PY+,^&89QAH2EB\AJ>W<:<7*=7"U;4ZL6M;JCS*M>WNQ
MC/O=?SJ?8F_YXK_WP/\ XFOV?_X(N_M)S_"[XZZS\$?$-_%'X4^,MM!'HS73
MN8+/QYHD$\^E"!P5CMFU^Q>_TRY4J6OM271(4*.H5_R,-H!V?)Z#!SUQZUK>
M'M3U3PGKVA>*/#UW-INO>'-7T_7=&OX'>.:QU72;N'4+"]A:/$BRV=S;1W:-
M 1*C0AU/!-?H^88.GC\!B\'52O4I7IMMIPJPUA*+3WZ6U3ZIV/Y;X5XAQ'#'
M$&79U2JSY<OQ$)XO#PC!RQF"JVP^(PJ33UG&:JJ4>6<?8WC.*;3_ -"V!S)$
MK$8R6X^CL!^8&:EKYV_99^.FB_M"_ CX<?%/2ML<WB30(AKMG&-HTOQ3ILCZ
M9XFTID<1S*+/6K6]2W,L2/-:""YY2:-W^B P;.,\>M?AE6G.A5J4*B<:M&<J
M=2,E:2E"3C*ZTUNFGYG^@F$Q5#'83#8W"U85L-BZ%+$4*U.2E3J4JU.-2G.$
MEO&4)1E%]4[BT445!T!1110!_'1_P6?M3)^W)XG<1AMW@3X<\D=2/#]TN.^1
MQT]>QK\HOL3?\\5_[X'_ ,37Z]_\%CH$?]M[Q0Q#9/@+X>= <9&@W('?T]!^
MHK\L/LB_[7Y&OVW)6_[(RW7_ )@L-_Z:C_DON/X X^G)<;<5+FLEGN8VM&/_
M $%2>NFNWW:>9]4?\$ZK8Q_MM?LZ.8PF/'T)R% Y&E:F0,X'7%?W(PC"HPZ@
MN<?60+_+]:_B1_X)ZVP3]M']GI@#QX[BZC_J%:GZU_;?#_JQ_P "_P#1RU\+
MQK_R,,,^OU6WRYY+]3^BO !N7"V;*3O;.TM4E_S#83M_7H7J:PR,>Z_^A"G4
MAZ?BO\Q7QA^ZG\;'_!8^V,O[<GC-Q&'SX,^'XR5#=-!C&.AQ]/Q[U^6?V)O^
M>*_]\#_XFOUK_P""O]N)/VV_&+'//@[P%T![:$@K\P/LB_[7Y&OVS)&_[(RW
M7_F#H?\ I$?\D?P'XA3DN..*4I-6SK&Z6B_^7J[J_3^KZ?67_!-VV:+]N']G
M5_*"@>-Y02%QC.@:R.H [X%?W#J"4P#M)0@$=02T6#^'6OXG/^"<]NJ?ML?L
M]L >/&DW4''_ " =8_#KC_\ 7BO[9(^@_P!W_P!GAKX7C3_D94?^P.'_ *>F
M?T7X!2<N$<PNVW_K#55]%HL%E_;U_70P?%_@GPYX]\,ZOX.\8:58^(?#>OZ?
M<:7K.D:I:QW5EJ%E=)LF@GADR"KC:0RE9(W2.2)XY45Q_(!_P44_X)Q^(?V4
M_$E[X[^'T%]XB^ VN:A,=/O)-U[J'@.^NKC;'X?\2W+-N>P7;##H>OW]P%N!
MY]C=LE^(3<_V5URGBKPAH7C;P]K7A7Q3HNFZ[X>\06=WINKZ1J4,5U8ZAI]X
MK1SP7$,T<B,LL;'<"K;6^="KA67Q<GSG$Y1B%.F^?#SDO;T7M)7MS0VY9QO=
M-=+IIJY][QKP3EO&>6RPN)2P^8482_L[,(K]YAJEE[L_^?E&=E&<)WTUBXS2
M9_G;FS_NP="RMN10=RLRL"H!VLA&QUW-B17PS+@TGV(D$& <^@QC\E_GT[5^
MMO\ P4._X)U:W^ROXDF\?^ 8K_7_ (&>(+\-#<LLEYJGP_U.[=F@T37KE \[
M:;=2B;^Q->D> 7,X33=4:XU&4WM]^7_V( ;B".=O!##( +*60LJO&2%>-F$B
MD@[=I#']<P6,P^/PU.OAZKJTY65[VG&<;2Y)J-N64;*ZLDTMFC^(^(,BS;AS
M-,5EF:8=T*U'F::IIX>M0;5.-?#RJ1?M*4].62;E&3^S)7C][?\ !/?]OGQE
M^QSXQBT/Q U]XC^!OB/43-XJ\,^;*\_AVYGA-NWBGPO$TJP0WD $,VJV&PC6
M[>%H]\=XMG+#_8QX!^(GA/XH>$-#\=^ ]:L/$?A?Q%86VHZ1JMC*[07%O<1J
MX5TDCCGMKB(MY=Q:7,4-W:7"R6UW!#<Q2PI_GX?8XVX;>!UR,@@CE2#[, :_
M1+]@7]NSQC^R'XNCT/59+_Q'\%O$FH6W_"3^%=TLTVAS.QB?Q+X6CWA+;488
MV!U#3UC,&MPQ0PG[+=0PWB?.<1\.QQZGC<'%1QD%S5:27+#$QO\ 9M9*JO>N
ME:\5$_5O"OQ1J9!/#\/9_6E5R2K)4L%C9SYZN6348KV=5N\G@Y67)*;DX5)5
M+6BK+^S:H'Z-]7_D*X_P!\1O!OQ0\):%XY\":Y9^(_"WB.QBU'2=6L)4E@N+
M>7(*L%8O#<02!X+JVF5)[:XCD@F1)(W4=>3N3< 0#N.#P>0.M?F+C*+J1DG&
M4'RRBU9QE=:-/6Y_6T9PJ*E4IRC.G4CSPG%J49QDDXRC)73BUJFG9G\?O_!:
M:V,O[:4[",/_ ,6J\!C)4'&)==XS@^N?QK\E?L3?\\5_[X'_ ,37[#?\%E(!
M+^V7<L<\?"_P*. >SZT?ZU^4OV1?]K\C7[/D3?\ 8^7Z_P#,/'\W_DC^"?$2
M<EQOQ,E)I+-*VEHOI3[KR_J^GU-_P3JM2G[;G[.#F)5V_$.V.=H&/^)9J7?'
MX5_=%7\0'_!/>V"?MI?LZL-W'Q"M#R#C_D'Z@*_M_KX?C;_D98;_ + 8?^G\
M0?T)]']M\*9LV[_\9!66R6V6Y9V_K\C^03_@K/X%?PG^VEXWU&.!(+;QQHOA
M3Q=:O%\XF^T:1%HM])<EHTVS_P!J:%?@('E412PDX/ _-7[,V6P\8Y/!V@CI
MQCMCTK^C#_@M9\)VU'3/A5\:-/M ?[$OM:\ ^(YE"EFBU-8=9\-._P X*+;3
M6&OJQV.S?VE!C"@E?Y^5L2 "8\[P'^7D8('MUXK[#AS%PQ.38+5^THQG1:77
ME<$VUIK:VVBOHGH?@WBKEE;*>.\]A.G&-/'XF&;X7ETOAL72IP=1:[RQ=.O3
M??V<7W/>/V*?'\7PF_:J^"/C>\N8(-/L/&=MINISN8Q'!I7B2VN?#.J3RL\U
MO''';Z=K%W.9I)@D$D<<Y5C&"G]O<6 (]I#+M&&7I@ID$8[&OX#!:,DL,JHZ
M&&02*RL4=6'&Y6!!#!2X4@C8Y5^J@'^S;]ACX]P?M _L\>!?%,]P)O$NDV,'
MA'QG&2OFQ^*/#]C;07UR\:E_+CU:!K76;96;(M]012S.K5\UQK@Y.6%Q\;NG
MR>PJNVD9\UZ:Z_$FWK]_?]9^CYG\)8?.^':LDJT<53S3"0;?-.C.A0H8G1Z6
MA.G%KEWYFVO=9]BT445\$?TL%0R99MN&X7.0#CDD8!'\0ZXX[&IJ*!._1VU^
M]=C\H?\ @HK^PO\ $_\ ;#U;X7W/@CQ/X4\/:=X%L?%27D/B7^UA-<7OB.;0
MW$ELMA9W*;(8M("L92&20[HB-SY_-H_\$1?VA2<GXE?"_/U\2?\ RHZ^IZD\
MG)-?U!T5[6#S_,\!0AAL-6C"E!R<8N$9/WI<SU>KN_\ +8_/L\\+^$.(LRKY
MMFF$Q=;&XE4E5G3S#%T(-4:<*5-*G2J1A%*$(QT6NK=V[G\O?_#D7]H3_HI7
MPO\ S\2?_*FC_AR+^T)_T4KX7_GXD_\ E37]0E%=7^M>=_\ 03'_ ,%Q_KI^
M?=GD?\03X _Z ,?_ .';'^7_ $^\OQ?<_E[_ .'(O[0G_12OA?\ GXD_^5-)
M_P .1OV@QU^)?PN'X^)/_E37]0M1.?FQTX!SVY)_PH_UKSO_ *"8_P#@N/\
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MZ6875URI4CCE2"">3U'I7\'GP\\6Z]\,_'/A3XA>&)?L>O>"?$&F^(M+N"6
M%WITPFCAE"Y+VLZ-/!=0E76>&=T92.#_ &Y_!+XG:#\9?A?X-^)OAILZ1XPT
M.RU:",E#):321F.^TZX\MGC%UIE_'=:?<JA*I-;.JE@ Q^#XORUX;%T\?&%J
M..Y]=KUZ?*ZCZWOS7WT;=]3^FO [BN.;9'5X>Q%92QF21I3PJE+]Y4RRHO9:
MI[QPN*C4PT6O^7<:5]7KZK1117QY^Z!1110!_)!_P6 MS)^VMXG<%1_Q0GP^
M],@_V'=@ Y]2.F1QUXK\N3:N.KQ#Z[?\*_6#_@KI%O\ VS?$I\L-N\#?#T!B
M3_T![L>F/;'4GFOS)%DPZQ'VQS7[/DM5_P!F9;&RM]3H*^K>E./^7];/_/KC
M^HUQQQ4K/_D?9EJGVQ4[:=_GNCZ;_P""?MNR_ME?L_L2C;?'$1PN,C_B6:CS
MQV )SVQR:_M1@_U2YZX;_P!'+7\:7[ ]KY?[87P%;8RX\:IR1Q_R"]1X[?K7
M]ET/^K7W!/YRJ?ZU\5QJ[X_"O_J&]/ML_H[Z/LK\+9MO_P CQ6OV6&PFWEJ7
MJ0]/Q7^8I::W0?[R?^AK7QI^[G\B/_!7*%G_ &U/&#!D _X1#P(,-C/&AIZ]
MOZYK\ROLS?WXOS6OU3_X*QVWF_ME^+7V%L^$? XR!Z:*E?FO]B_Z9-^7_P!:
MOVK))?\ "1EW_8)06S_DBN_G_P #9/\ S_\ $.=N.>*E9_\ ([QNW_7W^OP[
MZ?4G_!/* I^VC^S^Q9"!XSEX7&?^0%J_/'8=3VK^T>/I^''_ 'U#_7-?QL_\
M$_K79^V/\!6V%=OC"4Y/_8#U?^?2O[)HCQ] 1_X_"?ZU\-QF[YC0??!P\O\
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MLR*5:>^B@N_$VJP-(208+(Z5I]M+$,E;_5+>0^?$\2?T'8& ,#  &.W%>*?
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MU)RQ&7*&6X^4$W)8>O64L/6FDK>QH5I5(U:DG>*K0LGL?E^;-G;:&=5)Y/+
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M2JJJ@[54#J?(B8A?F&SD*1D(2Q/!(/)9F8D=69CG)-*8(@,[V/.#@=. >>,
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ME/#Y%=8F,'%TZN.Q-.-5U5)?$L-3OAII^["O*I&RG%27+&P;IY0&[C( /O\
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MC/J?R/\ A7ZWD[_X2\!K_P PU'K_ '8?\'\?,_S[\1&_]>N*M?\ F=X[HO\
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MK^FMX>\,V\>HZ5X=U;4K.22"P*RHES9V<\)>-CAT$A9"?F )KXP_X4=\6_\
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MQ@9/!/!.,\#UH =130ZDX!). >AZ'H>E.I75[75^W4/UV\PHHIN]?7]#_A3
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MMK;<YVG&#_/E)_P7<MHYI8#^SA*7AD:)MOQ1C.YUDE0[1_P@.<?NS_+MD_T
M>)/^1=U__L"ZK_Z0SU_&1_P3D^'?@SXK?MD^!? WC_P[I/BKPIJT/Q"?5-!U
MNSBOM/O5L_"OB:ZM/-BD!82P7\=K<1-&\; PE26SBNOAW 9=B<-FF)S"C.K#
M!4Z=6*A4<'\-:4H:;N?(K;6LSA\2<_XERS..#<HX<S##9?4X@Q.886M5Q.%I
MXFGSTIY;&A)\Z<H\JQ%;W8*\[^2/TR/_  7BLP<']G*4$=0?BE$"/P_X0*FG
M_@O%:' 3]G&8DD\K\4HO;C_D0NOIR"<\=Z_4Y?\ @G[^QF54_P##/'PY'
MT>50 !@ !+E5  '\( J1?^"?O[&H.1^SS\.,#D[M*G'UX^UC/3\??'!]=X6L
M_P#A)QO-RNS^L+E4K1L]]KN_S\A?V!XO.7+_ *[Y!%)ZO^QHN5DU=6Y;7:OY
M)OR/=/@G\2O^%N?"CX;_ !.736T9?B#X)\->,!I#S_:GTI/$6C6FKK8R7)@M
M3</:K=I"TQMH=[+N,:[MH\G_ &P_VF#^RG\'+[XM/X3D\:I8:WHFD'0XM5.B
M&4ZS=BU\]]1_LS5EA%H 965K-EE!$896()^@O#'AK0O!>@Z3X0\+Z39Z#X<\
M-Z39Z-H6C:=#Y%AI>DZ;!#9Z?8VD9RR6]K:PPPPJ7?:B  D 5^:__!8<X_8P
M\1'_ *GKP/\ ^G5L?K7CY?1HXO,L)0=.:HU\5"#@]9^SE5@N5:_$XR:33\[G
MV_$&+QN5\*YKC:>)@\PP&4U,1]9A34X?6J-'6HJ<U&+7M(N?)))->ZU8^.Q_
MP7?M6.%_9PG8DD #XH1DDC&1QX!ZC(R.V1ZTJ?\ !>+3A(@G_9RNEB9U#M%\
M38))$3J[JDG@BW1BJ9(5I4R<?,!DUQ?_  1__9S^!_QK^&/Q;U7XJ_#+POXY
MU'1O'>D:?IE[KMC]KN;*SN-#CNGMK=BR[8C<+YI7.69V))Q@_KQ>_P#!//\
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M&97SNA3J/!8KF;?+B*:AS3;=[<[E*T;:62OJ?E/AEQCQ+F^/QV5<7*%/&XS
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M:70&F&M7OV3[0-1;3-7"&W)#^5]B<RYV[X_O5X_^PG^V\G[:.A>/==7P!-X
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MX=Q"PM?$2RFE.%64Y3A&K2IJ"FH)TW)*=N:Z5K;<)^P[_P %)8?VR?B+XA\
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M_#VG6?B[6]#CEATS5=8M81'=7]K'-!9NJW)42RC[):Q_:7F,,$<!CC3\H/\
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M_B)^V'X7\7>)O!7C/P=X:M?".O6^@WEIXD.M&ZN9[RRBOUFM?[,TK4(A L1
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M5*>1XI4\.XNI62C-49OGC3;?O2YG[T4U_=;; K"H+%SER6)))S(Q[YX&< =
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M7E53$65][+HMD>G!0O0 5P/Q8_Y);\2O^Q \9?\ J.ZE7?UP'Q8_Y);\2O\
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MY%N7+>$O%9CMIY964;G6Q\0V>@+#;2,D<BZA> 2^;(L,W[>UX#^TWIFFZS\
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M**ITCP=I$.GF\,"6\^J:@\IN]5UB\C0E5O-6OY;J^N(U=UBDN/(C8Q1)C/\
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MY51PH K]P?AM%'#X#\%Q0QI%%%X2\.Q11QHJ1QQII5HJ1QHH"HB+PJ* JC@
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I56+K9CF&=8B./S',,1",*U>HZ=H4^6,IJ-*DYU9PCS.TZU66G-8__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>nt10015006x17_graphic1.jpg
<TEXT>
begin 644 nt10015006x17_graphic1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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MZ:V4M+[Z26JNM;;IH.5V3MHU?OI=K6VVJ>]CI:*^0?VU_P!L3P=^Q3\(]/\
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M%8B%3'TW_:,%"CC(UXT?9S5%0C)(Y9YY3C3P]&A34X4\Q>-K2J8'+J,I1=+
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MPZ@60>H-#^QWH_B/]A.;_@FIK?A>_P#BEK/P ^,3?M@K\)?$%QK.IWOP.?\
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M24HIZ\TN:I=U'9M1::2FDE)JUG9V=E^E'PH^.?PG^./_  LG_A5/C33O&?\
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MHY2K.]1*2<G%5;Q;EI**Z/2EBK)IJ6MK-2LXI*G=1=M%)T[2TU3=]5K^1_\
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M[;)D3KJ4Z<^5^XK--[]++2VG>ROU/X]-:^"OP]T'P1\<?VM=,T>:W_:(\/\
M_!QCXB\+^'/BDFI:D/$OA_P2?VR;7PO>> ='N?M6S3_!.KV7B+7+K7O#=K'%
MIVOZA?BZUB&^-E8+:_MI_P %E?\ DVKX)_\ 9^'[#W_K0O@ZOU$;P5X->TGL
M'\)>&6L;KQ"WBVYLFT'2FM+CQ6VH+JS>)I[8VAAE\0MJJ)J;:U(C:D=05;TW
M)N5$@T]6T31M>MX;37-(TS6;6WOK'4[>VU:PM=1MX-2TRYCO=-U"&&\BFCBO
MM/O(HKNQNT5;BTN8HYX)(Y45P1PG+3JTU-+VD8)M1M[T6W*;5]7.ZN]]-WH)
MU[RIR:;]FY;RW344DNUK.WKT/XU_B&_[-]U^S?\ MV>)?C7KNGP?\%@=/_;(
M^+%K\'8$\0:I;_M26'Q L?BIIL7[.6C_  "T5;V'Q_)\%IM$30/[#D\'V$GA
M:\T$W-U)++J%G8FW\Y^-.M>$_AQ^T=\2OBOXQO?@)^T#\7-+_;)^#.H>-OAC
MXVU7XB?!'_@I=X!^)L$/P\L7\._LI:SI6IW@^)'[/5OJD4M_H-C8Z!%H.MVS
M:I+,\C012U_:==_#CX>ZAXJM/'5_X#\&WOC:PC6*Q\8W?AC1+GQ3911X"1VG
MB":Q?5K=$"J$2&[14  4"H[WX9_#?4O%EGX]U'X?^"=0\=:<D46G^,[WPIH5
MUXKL8X?]2EGXBGL)-7MDAR?*6"\01Y.P#)K*6 G+:K!6<4G[-W?+SOVLTYN,
MZKYVKN-G:^C?NZK%17V9V=VUS;-J"Y8NUU#W>]]=;G\<O@;6?A9\.OVXOA]X
MTT:\^!7[0_B+Q7_P5"UG0)Q+J7Q"^#'_  5.^%WBCQWX^UO3-7T_XF^$?[1O
M[7XE?LS?#Z.>=]2M[_2M%\-WFG16SQK8)-<PV7[S?\%GKW5[/]DSP:+J^\4Z
M9\&+W]J#]G;3?VK-1\(RZW;ZG9_LN7WCJ&#XL2WESX?!U*U\.O;MI4'BBX0H
MD?A^;4229#&C_II'\,_AO#XOD^(,/P_\$Q>/9HS%+XWC\*:$GBZ6)HC T<GB
M1; :RZ-"3"RM>D&(^604^6NMO;*RU*SNM.U&TM=0T^^MYK2]L;VWBNK.\M;B
M-HI[:ZMITD@N+>>)FCFAF1XY8V9'5E)!UIX1PI5Z7/&U5MIQAI&Z2O*\N:?-
M9<R<]KI25[F<\0I3I3Y7^[W][5^2TLFNCMJ]6M#^-#]LCP-^R'KVH?M[:)^P
M[I7PQ\7_ +)7A[_@FXGCCXJ6WPDN+3Q9^SYX;_:HT?XL:7'\(/$7AFZT:?4_
M EA\7XOAM>^,7UB[T.XCUF.PE>:]<:G<ZV7_ 'N^,?@GPA\-/^",WQU\+?#W
MPSH?@GPYIW_!.KXS:A8:'X7TVUT32[._UC]GCQ1K>JWEM9:?%!!#=:CK%_>Z
MI>SH@EN;^ZN+J5FFE=S^B>C_  Q^&OA[P]J/A'0/A[X'T/PIK#3MJ_AG2/">
M@Z;X>U5KH!;EM2T:SL(=.OFN% 6<W5M*95 $A8 "N8^/'P@TWXY? /XS? 2Y
MU27PMI'Q@^$'Q#^$,^LZ98V]U/X<TWX@>#-8\&RZGI^FR26UK<2Z1;:LUW:6
M+RV\$SV\=NTD4;%E(85P]M).#E4I3@HPAR1CS2E)*-V[1NU==97EI>P.NI>S
MB^;EA4C)RE+F;45&-W9;JS:WLG;7=_RV_LVO^Q?I]Y_P1NU+]@#7M!N_VMO$
M'C7P7:?M06G@+7[G4OB9JGP8D^%FO7'[0DW[4.EV=W=:U"=/\91:&_AZ3QY:
MV\$(5CX78:/!9O%RGPF_9HT+P;_P1D_:#_:R^#G@_79?VGO&FK_&WPQXX^+/
MAZ[\3ZE\3M,^ LG[1_\ 9OQ.\->#Y+"[FETG1;3P'X:O;Z[@TVVMDM[3^W+V
MXN8K>YOG;^J?X&_L\?#3X#^#_!?A_P +>%_"W_"2>%OA_P"$_ &I_$*U\):#
MHOB_Q?9^%M%TW1TOM?U33K1;ZZEU!M-BOKBWGOKF);@C#.8T>O7],T#0M$TW
M^QM&T72=(TC==-_96F:=9V&F[KZ:6XOF^PVD,5KNO+B>>>Z/E9N)II99B[R.
MQSA@-+S=.+]E4@E3IJ,:<ZE.A!5()R=II4I7::;YDDURW=O%)/W5-KGC)N<[
MN:C.<G&5DO=?,DDT]FVNA_)#\;_ '[#OBOXI67@G_@G'IOPX^('PHUS_ ()V
M?M>:M^U;X<^$EQ'XU^&]SIF@_"B]UK]GG7_BM::;+J>BQ?'RT^,-CI%YI4WB
M9(?B6EQ#-<:BB2+"]?/=Y_PK'5?#'_!)_P .^$];_8;TS]DE_P!D'7=5\4I^
MTE+JD_[(UW^VO;:;X+3X@Z=\:E^'^OZ!X<M_CA8^&9HY]+T_XCZFD\>IR:]#
MJ.GMK#Z6C?VC>%_AS\/O Z:G'X*\">#?"$>MS-<:S'X7\,:)H":M<,'#3ZFN
ME6-HM_*PD<&2Z$KD.^3\S9S)?@_\)9_#$G@B?X7?#N;P9+?2ZI+X1E\%>&I/
M#,FIS$F;47T%M,.EO?2EF,EVUJ;A\G=(<FB6!<KM2I1<FFXQIM07+.E)0BN:
MZA+V3<UK[TW);6;6*223C-J*:3<DY2NI)REI9M<RM_=5KG\BO[.HUS3]1_8.
ML;;XF:'\1?ANG[7W_!1U?A)>^ ](^)>C_"_0_ C_ +.TMV?"OPGNOB;<7>N>
M(OA9HOBB;Q!_PA>M6U]J.F3V$Q5+ZXOH[V2NB_9X_9N^$'P>_8Q_X(8?M1?#
M[PLOA_\ :$^(_P"UM\!?"OC[XMVFH:D/&?C+P?\ $WPW\7+KQ'X.\1:J;LRZ
MIX52V\-:%I6DZ!<[M+TK3+%K:SM8_ME\US_7/!X*\&VUOH%G;>$O#-O:>%(I
MX/"UK#H.E16_AN&YM7L;F'0(4M%CT>*XL7>SGCTY;=);5WMY T+%"Z/P;X0B
MTW0M&B\*^&X]'\+W5G?>&=*CT/2TTWP[>Z?'-%87FA6*VHM=(NK&*XN(K.XT
M^*WFMHYYDA=%E<,1P'*[N<6THJ/N/W'&.%5X\TI-?[N[6=XJ:2>CO+Q3=K*2
M5WS6E\2;J-IV2WY[OI=7ML?CQ_P6U^%OPV^(?PM_8^N/'?@7PKXOGA_;_P#V
M6?"44WB+0]/U:6/PQXW\;_8/&'AY'O()6&C^)[&SM;77=.!^RZG;VT$=W%*D
M2!?@CXG?M ? /]EZW_X+_?!'X@^.?"7PD\3^,O#5A;? 7X8:I?6?AO5O&/AO
MQ3^Q;X?^&WA.+X2^%Y)+:[\0Z5IGB&P?3[V+PI97=OX>M;8W5\MI:1-*G]1^
MJZ)HNNQ6L.MZ1I>L0V.H66KV,.JV%IJ$5GJNG2B?3]3M8[N*9+?4+"<":RO8
M0ES:R@202QN,UR^O?"[X9>*M;M_$WBCX=>!?$GB.TL)]+M?$&O>$M UC6[;3
M+E)8KC3H-5U#3[B^BL9XIYXYK2.=;>1)ID>,K(X;6KAG.<JD)0C.5E>4&]/9
M5*3NTXO:IS)7WC;K=13K1C&,)*32;>C2UYZ<U9--6]QI_P")M>?\N7[)W[)O
MP&_:K^/GQ_B_: \!V'Q-T_P=_P $S?V"HO"VD^))KN[TKP_JWB;X%ZC)=>+-
M)L3.+:S\86!T6W&B^)(X_P"U-(\Z\:QN(6N96;QG]CO7_@/\1+[]B5_^"HOB
M'PEJGP N?^"8_AJ3]GJ^_:*\2-:?!C5?B/IOQ!UO1_B7=76I>+[VU\(7OQAL
M/"UEX>@TQKB\F\26^@VV@7>FA-073)A_8AIWA7PQI$]S=:3X<T'2[F\T_3])
MN[C3M'T^RGNM*TB&2WTK3+F:VMXI)]/TRWEE@T^RE9K:RAEDBMHHD=E.!J_P
MJ^&&O^']*\)Z[\./ >M>%M":)M$\-:MX0\/ZCH&CM <PMI6CW>GS:=I[1$ Q
MFTMX2G\.*R6 MRM2@Y*524U*%XU>>M&I%5%=.2A%-1OM*TELT]'BKW5I).,(
MIJ5I0Y8<K<-+)R>KMNKI]S^7C0/#7[")_:._X(N_$FP\+ZCI/[/NIVO[7OA#
MX?>.OVQH/#T'BC6YO"[B^^!&GR>)_%5W<+>:19^.;NYD_9XM-3U :F-/NO#T
M/ARU2:YL(I/ ?V9YOA!K&O?L0:)^W-JGAJW_ &)+K6/^"C5Y8+\7-732_@-J
MG[25G^TIKT6B6?Q8U#Q!<VO@E[BU\ R:A+\/[+Q7=K:7&J/J\=M'+<F"&3^Q
MC5_ O@CQ!:Z)8Z]X.\*ZW9>&KJTOO#EIJ_A[2=2M= O;!42QO-$M[RTFBTJZ
MLDC1;2XL4@EMU15A= H I:G\,_AQK7AU_!^L?#_P3JOA*2\GU%_"^I>%="OO
M#KZA=7$UY<W[:+<V$NFM>7%W<W%U/=&V\^6XN)YY)&EED9CZB[W4J:5HOE5.
MT)2BL*G&4>;6G)X:Z2U7/]KE]Y+$JS34[NZOS>]%7J6E%M?':I9O3X=+7T_C
MU^'GPQ\!?''XT_LG?".*'7?%W[!FM_\ !4C]JFV_9ET?4]5\22^%/%'P3T3X
M#1^(=7\/^%[J_NM^L?!N[^)>G^)K#2K.SN)M$U72)=3M9?-DNM05_P!K/^"8
MG@'PI\$_VH/^"JGP#^&&EIX2^#GPT_:+^"VH_#SX=Z;+.OA?P0WQ$_9S\#^,
MO%=CX6TMY'MM$TJ_\07T]XFF6$<%G;Y2.&)$10/URM_!_A*TC\/0VOA;PY;0
M^$C(WA6*WT33(8_#+36TEE,WAZ..U5=%,MG--:2'31;&2VED@;,4C(="RT31
MM-O=6U/3M(TRPU+7KBWN]<U"RL+6UO=:NK.TBL+2YU:[@BCGU&XM;"""RMYK
MR2:2"TABMHF6&-$72E@U2G&?-%R53G;4+/D=#V7LXZMQA&7O0C=J,4HZM<Q-
M3$<\7&S47&R5[^][13YWHO><4TWNVV^I_$?_ ,%4_'/PP\5_$C_@IIKT'AO]
MFKP=\4/AQXN\%>#M.\2_M*^/_&?B_P#;,U;7O#?AKPI=:-JG[%'PQT6?1(_A
M5\-&M-U^_BVSU'5=-U*W75]=\0VDEHTUI:_I+\-_V:?@7^V__P % /VH]7_:
M/\(Z;\8].@_X)]_L4:QHMIX@N;B]T2VUWXB^!_%U[J?CG3+.*X6SB\60_8%D
MT#Q)$AO]'-]>SZ;/!+<M(?Z(=6^%7POU[Q!+XLUSX<> M:\4S:=-I$WB75O"
M'A[4=?FTJXMI+*?3)=8O-.FU&33Y[.66TFLWN#;2VTDD#QM$[(>AT[PQX:T>
MYFO=)\/:'I=Y<Z=INCW%WIVDV%E<SZ3HT<L6D:7-/;6\4LNG:5%//'IMB[M;
M6,<TJ6L42R.#$<"_:NI.<)P=3GE!TTE*WUCENK\K?[_5\NO)=MMZ6\4O9\L8
MRC)048RYOA?[I.SM=*U/:^SMTU_C=_8QUKX$_$.7]A&?_@J%XF\(ZE^SQ<?\
M$U7'[/M_^T7XG:Q^#NI_%32OBSJ^C?$.6?5_%]_:>$[GXLZ5X*T_PW#I!FO)
M/$=MHUMH%SIIBOXM'<?K;_P0(TSP'?\ [!_Q$T?P@+S7/AE??M5_M+Z;X;3Q
M-%/=7>K>";KQ):VVEQZS%J8>YN?MNB20I<KJ"M/<12$72F1Y!7[(ZM\)_A9K
M^@Z/X6UWX:^ -9\,>'I4GT#PYJO@[P[J&@Z'-$6,<VCZ1=Z=-I^FR1EF*/96
M\+*6;!&3GJM'T'0_#MK+9>']&TG0K*:[N+^:TT?3K/3+66^O'\R[O9;>RA@B
MDN[J0![BX9#-.XW2NS<U5#".C.$W.,N2$H<W(U4FY1I)\T^9WC%T_<5G:+4;
MZ-N:F(4X3BHRCS.+MS7C'EDY7BK*TI7]Y]UYZ?Q7>!M#^ O@+]F?Q)X!CM?!
MO@7X7Z=_P5ZN/"__  4-T3P)(OA[Q=X=_9CL?B%XO3X.:?\ &BS\*M;>(= ^
M"/\ ;LEU9Z7=>(ELO#BDSVNDS/.+F&O8_C%)^PYI/B+_ (*3:!\%+^RO/V#I
M_P!GCX$KH-E^S=JUMJG@B#_@H)=^+)4^#EA^RG<^&+J[\+-\3[BP%E<^,;3X
M;S221"WG_P"$EA6VM[V-?ZTU^'7P_2;Q1<IX%\')<>.!&/&LZ^&-$6;Q>(5D
M6$>*)18A]?$2S3+&-6:[""64+@2/FKIGPM^&6BZ/IWA[1_AUX$TG0-'U:+7M
M)T/3?"/A^QTC2]<MR3!K6G:;:Z?%9V6K0%F,.HVT,5Y&6)29<FLU@)**CST]
M(\J;IMM)0J0Y5[^D)*?-4CIS2YM;2]VOK2O?EGNG92M?WJ<FWIK).#47T33W
MC9_QXP7_ (IM/^"?'_!0+3OVJ[[Q<G_!3BW_ &A?V#9/VH_^$[N]-_M:;X<M
M^U/^S];_  +F^&ITOR[1_A@/![R07SZ-YEH?&DVMG4I";G3$KV_49?V!KBU_
MX*):_P#\%(;O63^VGX>_:X\3#PG8^'=?FL?VPK7X=PZEX13]G>V_8UTS6]2T
M[Q5-HUYHDMD=-_X0"(Z3>:6?M&O2-H\6G31_U7:IX"\"ZW?7NIZUX+\)ZOJ6
MI6NG6.HZAJGAS1[^^O[+1]1@UC2+.]N[NSEGNK72]6M;75-.MYY)(K'4;:"]
MMDBN88Y5@U/X<_#W6_$NF>,]9\">#=7\8:*%&C^*]3\,:)?^)-)"'*#3=<NK
M&75+$(>5%K=1!3RN#3^HR5OWD)J-/V:]K3=3F]ZN_:37,N:K^^NY_:ESNRY_
M=/K,;M\LHWDI/DDHM-*DN6#MI%^S:M9V36_+K\0?\%-X]$U;_@F_^TG!XL\:
M?$KX5Z%JOPDL[?6O&?A'PQ?^+OB%X2M=0U7P_#<7-[X:\,WD-YJ-O&9OLGCJ
M/2K^-+;PY+XANTNA;VS2U_++KGBOPOX5^!_[?_@;P+X+_9@U>WT3X=_L*?&'
MQ9\8O^"<WC+QSKG[,>J>%O ?[8/PBNKM/%GPMO+K6=+\!?&J#PI+XA\4>)GT
MW5)[^[T'2_$5[J4>S[;,G]TMS;6U[;SV=Y;P7=I=0R6]U:W,4<]O<V\R-'-!
M/!*KQ30RQLR212*R2(S*RE217%>'?A9\,?"&C:MX=\)_#GP)X8\/Z]YPUS0_
M#WA'P_HNCZT+A)(IQJVF:;I]M9:B)HII8Y1>0S>9'+(CY5V!TQ&$=>?.IJ#]
ME.DVX\SM*%2/5I6?M&W91DK-*34O=BC75*#BXN7OJ6DN5:2@^U[^YUNM=M-?
MY0?^"FO[2?P2_:/^,?[:.J_ ;XJ^#OBWX5\+?\$9_B3HNL>)/A]XCT_Q5X33
M7;WXR:9KPTZ#7-%N;S1[O4K/3-3L#J=M;W,ESI=Q-]AOTM[N*2!.]^%]E^Q?
MX>^.7_!,B;_@F[XAM+CQ[??#+XR3_M>7/P/U2Y\3?$2Y^#</[.^KW6J:G^T7
MH^A3ZI?CXNVGQ331$^'=CXXM(]>;QZD6D:?;OIUK9VT/].NE?!OX0Z%IUQH^
MB?"OX<:/I-WIMYH]UI>E^!_#-AIUSI&HS)<ZAI5Q96NEQ6T^G7UQ''/>6,L;
M6UU-&DL\3NJL-?P[\._A_P"$-2U?6O"?@;P=X7UCQ!()=>U;P[X9T71=2UN4
M-O$FKWVFV5M=:DX?YPUY+,P;YL[CFH6"DZKJRG3;E*$G:F^:/)6]K:G)S;CS
M:0EH[K7^Z5]8BHJ,8SM%223DK/F@H>^K-.SO)=+Z6ZG\0?[,GASX()XH^$OP
MJTO0/V6?VK;#XQ?LZ?MA>&K3XC?!&[\<>%OVGH5T+X7^)/&D-]_P41^ 6M:C
MXETK7-;;Q%I.FZ3X!U77IK6^TWQ3':7NDB6:UT[[3]%?LU? C]D7]I+3/^"#
MOP?70OAWXS^&VI_#+]N+5OCYX#\$ZM9VVE>(?C!X=^&O[/-[JFD_%VS\)7UK
M=3^*+6X@\-ZCK>C>(GBU*9+'0_[2@DL3#')_79H/PR^&_A77=6\4>&/A]X(\
M.>)M?\PZ[XBT'PIH6D:YK7FR":7^UM6T^PM[_4?-F599/M=Q-OE D;+C-+H?
MPU^'/AB:SN/#7@#P5X>N-.N=7O=/GT/PKH6DS6-YKZ6L>NW=G+86%N]K<ZU'
M8V4>K3P,DNHI9VJ7C3+;PA)AE_*HJ4J<HIQ3BZ>CA&IAY\NK;ES>PE?G<G^\
MLW+ENZGB^;5*479V:EJFX58WTM:W.K<MOAV1_%7_ ,%-+GX$V7C'_@HGX5\(
M^ ?V7?AIX@^ G@WX6?"KP+<?M)>.?&WB;]IY5\)?#?0(O D'[!'PBT*YT=_A
MMX1LK*UMI)/&=EK&K6E[(EYXF\56L^FW&JVD7USK$/A*V_;.\8?%;PIIOP[M
MOVL?BY_P1E\%?$S]FWQ/=VNBV?Q#^(G[26I^$]4MM9\1_"JY$:ZWXH^+%UX+
M^WQ$^%1?^))]#@F0QOIUO<&/^I;5_A;\,O$'B$>+=>^'7@76_%2Z?-I*^)M7
M\(Z!J7B!=*N();6?31K-YI\VHBPFM9YK:6S%S]GDMYI87C,<CJUYO '@1]1\
M-ZP_@KPDVK>#;0Z?X0U1O#FCG4?"M@;?[(;+PY>FS^TZ':&U)MC;:9+:P_9S
MY.SR_EI_49<\Y^T@E*HIQ4::5K3JR3T:2FHU6E)*Z<5)M\S2/K4>51Y).T.5
MWE>[Y8)[INS</>[IM6T/XT?V!M,TJ'XU?\$PM9^%/Q@_8PTGXLZCXC>X^*V@
M?LYZ%\;O$'[57Q!\.W_@VYD^,N@_MJ-=>)-=LM*N+.X^V7D6O_$/2])TK3?%
MUG:/X0>/0-L:_K;_ ,%R;7X(7NL_\$T+3]I*_ATSX%7'[<NG1?$R]O+ZXTS2
M8O#;?"/XB^<OB+4;6:WEL/"<]S]FM_%UY]H@AMO#,NK37$L=NDKC]N=$^&OP
MZ\->(-5\6>'/ /@K0/%.NAUUOQ+HOA;0]*U_6%DD$KKJFLV-C!J.H!Y565Q=
MW,H:0!VRP!K6\0>$_"WBR"WMO%7AK0/$MM:27$MK;^(-&T[68+:6[LKG3+J6
MWBU&VN8X9+G3KV\T^X>-5::RN[FTD+03RQO<,'RT)T>:#YY4Y? W#]W[-6E!
MS=^=4[2M)*S2W3;B6(4JL*C4K14ENN:TK[.UO=OHVGKK9+1?Q^?M"P?"_2/A
MY_P5R7]B&33=2_8<\*^'?V O%HA^#EQ-X@^"ND?&OP[^T'X5\0?&:Z^#LGAF
M6^\*G3M)^&FE:/J_Q*C\*3/86%];1O,L,-O*L?=_\%%OVG?@I^T5\:OVI=7_
M &?_ (M^$OBKX?\ "O\ P1,_:)LM8\1_#OQ+8^)?#EEKNI>-]&UF#3?[:T2Z
MNM-.N6.G75J^IV"7!U#1Y;B.UU"*UN=T(_J[T3P%X&\->')?!WASP9X4T#PC
M/'<PS>%M%\.Z1I?AR:&]3R[R*71+&S@TV2.[C/EW2/;,LZ?+*'7BL/2?@Y\(
MM T^YTG0OA7\.-%TN\T[4=(N]-TGP/X9TZPNM)U=XI-6TNYL[32X;>?3M3D@
M@DU&REC>VO7AB:YBE:-"(E@IM2C&K",9I<R5-^ZU4KU$J=IJT4Z_+9WTBK6O
M9-8F*:;A)\K=KR5VG"E!N?NZM^S3TMO;6Q_(-\8IY5^)/[2Z>,KS7++]FN\_
M: _X(R6_[8%_I%SK=K;P?L^3?LH^"O\ A)'\77FALMS;>!WUW^P!XGN;F6.V
M2(VQ+FY:V5I?BCX6_9,F_: _X*U:#_P3W/@S7? %]_P1W\6>;I?P%O;+Q!\,
M(OB ?&%A-J=E\.)O"EQ?: \S:2NC7&OV/A69["UUZ2\29(M7.IPQ_P!BS^"O
M!LD.NV\GA+PS);^*+2UL/$L#Z#I3P^(K"QL5TNRLM=B:T*:M:6>F(FG6MM?K
M<0V]BBVD2);J(QG>&?AG\./!42P^#?A_X)\)PKI\VDK%X:\*Z%H4:Z7<7)O)
M]-":786JBPGNR;J:SQ]GDN29WC:4[J3P#;=ZD'S2G)R=.]2/-*L^6$N;2-JU
MVFG>2?\ -[K^M*R]R5U&,;*247RJEK)6U=Z;2?:2[:_R_P#[0'[6GP%_:&^(
M?_!/+0O@=\7O"GQ)U/P3_P $_?VZM4\>6W@SQ#9ZV_A&]\0_LF^%+/2]"\6_
MV9<W"Z%XNM;WPMK0O_#6K-;:[I1ACEN[*!+F%Y/FK]EV3]C6S^ /_!(C6_V,
M=>\/7/\ P4&U3]H?X):=\5[;PKXBNKSXWZGX(FEU"/\ :$L_CQI&G7EQXE3X
M-V7A=)6TN7Q991^'K'PP+*X\-2)'-=22?UI^*OV;OA%K?P^\>^ _#G@+P+X
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M7Q1DO([,!X=91E^,P^-I8S,9U,/452$:D\,X.232YE'#1E;5NRDGMKW^;/\
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M^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\
MQVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_
M  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\
M$W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_
MGJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_
MSYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/Y
MP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\
MCM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^
M$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?
MV=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^
MV\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H
M$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?S
MA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$
M^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__
M "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI
M.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_
MB;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0
M(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??
M'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_
M^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\
MQVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_
M  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\
M$W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_
MGJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_
MSYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/Y
MP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\
MCM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^
M$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?
MV=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^
MV\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H
M$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?S
MA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$
M^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__
M "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI
M.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_
MB;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0
M(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??
M'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_
M^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\
MQVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_
M  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\
M$W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_
MGJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_
MSYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/Y
MP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\
MCM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^
M$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?
MV=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^
MV\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H
M$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?S
MA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$
M^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__
M "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI
M.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0(N?SA_\ CM'_  A_
MB;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??'_Y$^;/^$/\ $W_0
M(N?SA_\ CM'_  A_B;_H$7/YP_\ QVOI.BC^V\1_SYH_^3__ "8?V=2_GJ??
M'_Y$^;/^$/\ $W_0(N?SA_\ CM?0>DQ20:5ID$R&.6'3[**5#C*21VT:.AP2
M,JP(."1D<&M"BN/&8^IC(PC4A"*@VUR<VMTD[W;[&]##0H.3C*3YDD^:W1]+
M)!1117"=(4444 %%%% !1110 4444 %%%% !7\_?_!=/_@H;>?L[_#.W_9=^
M$VLR6/QF^-GAVZG\6ZU87'E7G@'X0ZE_:6BW]U:W$#BYLO$OC&ZM[O1M#FC,
M,UAIMMK.JQ317,>G/)^Y/Q1^(OAGX0_#;Q[\5/&=['IWA3X=>#_$7C7Q#>2.
MJ"'2?#6E76K7HCW$;[B6&U:&UA7=)<7,D4$2/+(B-_FH?M(?'WQI^U%\<_B5
M\>O'UPSZ_P#$7Q)>ZO!IX>1K7PWX=61H?#'A+35EEG>+3?#6B)9Z7;*TLLDA
M@DN;B:>ZN)YY?VCP6X*I\39_/-<PI*IE.0NE6E3FKT\5F$VY86A)/2=.CR/$
M5HZIN-&$TX59(^)XWSR65Y='"X>?+C,PYZ<91?O4</&RK5%U4I\RI0?>4Y)W
M@>'HJHJHHPJ@ #V'OU)]2>2>3S2LRJ"S$*J@DL2  !U))X HYRJJKN[ND<<<
M:-)+++(P2.**- SRRRNRI'&BL[NRJJEB!7]4'_!*_P#X(AP:A;>&/VC_ -M7
MP]YT%U'IOB/X;_L_ZFC+"+>01WVGZ_\ %_3[BV222YD'D3V?@%Y/L\,1'_"5
M)/+)-HEM_5W%O&&3<&99+,<VK6<N:&#P=+EEBL;62NJ6'IMQ5EHZE63C2I1:
M<Y*\4_R3)LEQN=XJ.&PD/=5I5J\[JC0IWLY3DD]7]B"O.;T2LFU^9'[ /_!(
M7]H3]MBXTCQOKUO?_!C]GN6>">Y^(_B+398O$'C'3MUM))%\,?#E[%&^KI=V
ML[-:>+-02+PO$Z.T$VK30M9-_8]^R3_P3^_9<_8LT-+'X*_#JQM_%%Q:):Z[
M\3?$HA\0?$GQ'B.%9O[0\3W,"365E<20K</HF@P:1H$<Y>:'2XY7=V^R;*RL
M].L[33]/M;:QL+"V@LK&QLX(K:TL[.UB2"VM;6VA5(;>VMX42&""%$BBB18X
MU5% %FOXNXT\3>(^,ZU2G7Q$LORAR:I91@ZDXT'!/W7BZBY9XRKLY.K:DI*]
M*C3UO^W9)POEF20C*G36(QEESXRM%.IS=?8Q=U0AV4/>:^.<@HHHK\Z/HPHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#9Q17\8_\ P^N_;O\ ^AM^'_\ X;C0:/\ A]=^W?\ ]#;\/_\ PW&@T?\
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M[?\ _P!''^(O_"5^'7_S'4?\2Z<7?]#GAS_P=F?_ ,[ _P"(HY'_ - .;?\
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MCD?_ $ YM_X*P?\ \V^O]/3^YJBOX9?^'J?[?_\ T<?XB_\ "5^'7_S'4?\
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M7\,O_#U/]O\ _P"CC_$7_A*_#K_YCJ/^'J?[?_\ T<?XB_\ "5^'7_S'4?\
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M_D_7^GI_?[17\ 7_  V_^V5_T=5^T+_X>#Q[_P#+VC_AM_\ ;*_Z.J_:%_\
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M3Q!?VUM%=23W,6E)J=@UTEO'),!=1;(GR<>'>!?A7\1?B8/%3^ _!^M>)XO
M_AG4?&/B^?3;;?;>&_#&E;/[0UG5[J5HK>SL[;>"QEE61@LACC<12E/K[6/C
MYX$^ WQA^$/Q6_9;^,_QW^)=WX,U*ZU/Q#:_&[3;32;62W>:S@N_#MK;:=XA
MUI+W2/$^CF_T[6Q(+:5(S \#^:L<D7UK^WU\3?AC\%?A5H/PV_9M\+:CX&M_
MVY/#'A7]K?XIZC<&".\M_ _CY-0_X1?X1Z0UIM%EX8L=<TS7=5O]+0O#$[16
ML$\MA>R6T7L+B#B"GBLJP%3 4*];.U_L6+>#QF64L)+!XB<LU698'&8FMBZ:
MIY=[*O@.2I?%XCGI3]C3<*CX'E>52I8S$0Q5:G3RY_[11]OAL7.NJ]&*P3PF
M)P]*%"?-BN>EB>:+]C3M*//)2BOQ-HHHK[P^9"BBB@ HHHH **** "BBB@ H
MHHH _KD_X('_ /)GWQ(_[.4\8?\ JK_@Y7[>5^(?_! __DS[XD?]G*>,/_57
M_!ROV\K_ #U\4O\ DX/%?_8TG_Z:I'].<'_\DSDW_8''_P!+F%%%%? GT@44
M44 %%%% !1110 4444 %?PJ?\%/_ /D_;]I/_L<]-_\ 40\-U_=77\*G_!3_
M /Y/V_:3_P"QSTW_ -1#PW7]!_1S_P"2KSK_ +)ZI_ZLLO/S3Q1_Y$>!_P"Q
MK3_]1,8?!5%%%?V*?A04444 %%%% !7KOP7^!7Q0_:!\5S>#?A7X:?Q!J]EI
M5UKNK3SW^G:-HN@Z'9/%%=:SX@U_6;JQT?1=,AEN((6O-1O;>)IIHH49I'53
MY%7W]^Q/XI\2^"O"7[2^M7WPD7XR_ ;5/AUH?A7X_>&]-\3GPUXPTCPYJ_B.
M&7P_XJ\+W5HTNI"YT36+1I+F0V-WI"PR?\381QB*1?)SW&8O 97B<3@8X>>,
MB\/3P\,3.G"G.KB,51P\8I5<3@Z=2M+VK6&P\\7A8XG$>RP[Q%'VOM(]^68>
MCBL=1HXEU8T)>UG5E2C.4XPI4:E5M\E*O.%-<B=:K&C5=&ESU52J<G(_!/C!
M^R[\:O@=>>#K;QSX7MI;7XA*_P#P@VM^$-?T'QWX=\5SQ74=E+8Z)KOA#4=8
MTV^U**YF@BDTZ.X^VAKB$>0?,%>MZE_P3L_:RTK0-2UJY^'NF2ZCHOAV3Q7K
M'@.Q\=>!]1^*.EZ!!:F]GO[[X:6/B"?QG#Y%L&>:U.CF]1AY7V;S6C1_TA_9
MP\'_  H?5_V-OBU\*?''Q,TWX ?\-7^(O!>E?!CXZKX?N&\(?'O6?AI<:]H'
MBGPAK^FVMM;Z]X9N+FP\/:9%/.J3V7BA8)$C6^O[IE_,CPKX<_:MU/\ ;(U3
M2?A_)XWL?VF6^)OB=9]4>[N+#6M/US^U+^+7=3\0:KJ9-K:Z%'#]J;6+W69&
MT5]),BW9ELI-C_(X3B3-\<\50AC,FP-7*L#7QN85\RP.,P].K*GC\?AOJ]2C
M+'P>71PE'!*68XJ&(S.C&>*HU,/[2CR^U]VOE& PRHU98?,,3#'8FGA\+2PF
M)H59TXRPN&K.K"HL-+ZVZU3$-82C.GA)RC2G&LHU$^6?X<?L!?M-_%7P%X<^
M)?A'PGX8/A/Q:-1/ARZU[XD_#[PO?ZO_ &5?S:9>BST?Q#XDTW5)#'?026X7
M[("[[=@(="U/P=^P7^U%XV\3?$;PCI_P\M]&UWX3W>D67CJV\9>*_"?@N#1Y
M]?$[Z*8[_P 3ZUIECJ,&J16\D]C=:=<75M<P-%-#*Z31EOT(UGP]^RMK'P#_
M &#/#/[77B+XQZ%J-[-\7=(MO$WPQO\ P9<^&+-Y?BV]KK^H>,+O5-.U74;C
M3_[0,,O]I^&G=DL#=7<*7#^21[?\6O$'AJZTC_@H99?M _#OQ6O@+P5KO[+G
M@/0O#WPV\3V[>(M<\$>%/MVE_#KQ7:^+-=TV]@U8>(-*CT[7[^\EL-TD-V]D
MI2:W9Z\>KQIQ"JU>E2HX22J8W$X?"R>4UE&-.CQ;@N'Z4L+4J9W1AG525#$5
M:E>-)9=##8A8=U9QIXBFI]\.'<JY*<ISK)TZ%&I67UV%YSJ9)6S.:Q$88"H\
MOC&I"$:;E+%2K4G5<(.5.7+^3 _X)_?M-2?$;3/A5:^&_!NH>,M4\&Z_\0(K
M72_BG\-M2TVS\)^&;JVL]9U;5M<LO%$^D:/':SWEN%CU*\MIIT9Y8$DBAF>-
MGB;]@+]I;PIK'@#0-1\/>"[S6?B=XVT[X?>#M-T#XJ_#7Q)>:AXFU2UO;VT@
MN(-#\4W\NFV M]/N6N-7U!;?2[5Q%%<W<4MS;I+]:_L9W?[/,WQM_: N?AUX
M(^+VA_"U/V#?VAAXV\/>,/$F@:GXUU7R[&W?Q"/"^JZ?H=CIU@;SP\UK::7]
MNLKW[/JZS7,_F6SI .3_ &7+S]FR[_;0_9$/P)\!_&?P?J,?QGT8>()_BAXH
M\/>(+"\LF0_8HM*BT;0-)FM[R.=9GGDGGEB>$JJQ!@7'I5N(^)*%7,XRAAW3
MRK)?[0K.62RIJ>(E@\PQ488B<>(ZKP4;X:A35.E2S!RO)NM#G2I<E/*<IJPP
MK7.I8S,%A8<N8\[C2]OA*+E1B\K@L0_WU23E.6&Y=%R-1O+X*T/X ?%GQ#\6
M]3^!=AX2NHOBCHU[XFT[5/"VI7-CI=Q97?A&SO[_ %Z*:ZO[FWL0+6TTR[FA
ME6Y:*]18C9/.+B R>7Z)HFK^)-;TGPWH.G7>KZ]KVJ6&B:-I-A ]S?ZGJ^J7
M<5AIVG65O$&DN+N]O)X;:WAC5GEFD1$!9@*_HF_9\GT?]JSXT:7^TC8-8VGQ
MR^!UM\3OAC^T)HT*Q6]QXU\'CP7XQT?X>_&B.% %N-1>7[-X/\7&)4;[5!I]
MZT45ML:3\B_V$?AS=?$;]J/X>_9?$M[X4/P[O+WXS3ZMI&E)KOB P?".(^.V
ML?#>BRYBU77[^318[73+.2.>-II/,DMKI(VMY?1P/%E6M0SV>.HT,)6R#)\%
MBL?0M6G[',*JS:5>/-!3J5<%6I8/"8K RIT?;5,+B8SDG4FJ=/DQ61TZ=7+8
M8:I4KPS/,,31P]6]./M,)#ZBJ3M+EC"O3G7Q%'$*4^2-:DXJT8\TN+^.G[)/
MQU_9RTW0]9^*GA2RTO1_$&I7^A6FJZ+XE\.>*].L_$FE1+-J?A;6;OPUJFJ0
MZ+XFL(6\VZT/4GMM0C1)6,)$,NSBO@O\"OBA^T#XKF\&_"OPT_B#5[+2KK7=
M6GGO].T;1=!T.R>**ZUGQ!K^LW5CH^BZ9#+<00M>:C>V\33310HS2.JG]F?V
MIM$\&?M5?LH^,/CQ\";[3/A-^SQX)\2^.?BW\0_AC-X:U.]^(FM?M9^)-;TK
M1[^;Q)<_VE/I_P#8NK>#=<BN-/UG2I(-,\.V\$NFOI<\0A&G_ _[$_BGQ+X*
M\)?M+ZU??"1?C+\!M4^'6A^%?C]X;TWQ.?#7C#2/#FK^(X9?#_BKPO=6C2ZD
M+G1-8M&DN9#8W>D+#)_Q-A'&(I%Y\MXHS7&\,8[&SI8.&?X#'?V=B,%5I2P<
M,/BZF+H4J6%JT<5CHT)8YX?$TI4</3S9X?%UJF'IQQM&.(4J>N+R;!4,YPV'
MC*N\LQ.'^M4J\)^WE5HPH5*DZT*E+#NHL-[2G)5*LL'[2C3C5FZ%1TK2\P\3
M?L3_ +17A3QW\+OA[?\ @[3=0UCXTZ@FE?#+5?#OB_PGXE\(>+-0:Z6TEM;#
MQCH>LWWAN.:SE>-KZ.ZU&![2&19IPD9+#H/B-^P+^TC\*O"VK^,?&.B^ [71
M]#DM(=033?B[\+]<U99[W4+?2[>WM]$T?Q9>ZM>7!O;J*-X+6SEEB7S)9$6.
M*1E_2/\ 9Z\$^"+K7_V'?BM\!_&GQ;LO@-_PVD?!TGP3^,*Z+<ZAX5^)VJ^#
M(_$6I^)?!>OZ+:6R:_X4NM TVSTNZFG"26>KK([1BZU"\(^"_C;?_LFW'BSQ
M#!\-/AK\?- ^)*_%)2==\8>,/"^I^#?,3QB1K3/I=AX;M-1\JZ3SQIRK?H\$
MC0&:255=7PP/$V>8[,J6"A]7<,-24\RE#)J_M(5%FF8825'$0KYWAWETXX?"
M4^>=%9Q2=:52K1G5H^RC/;$9-EN'PE3$R51.K4Y<*IYA3Y7#ZGA:ZG0E3P%7
MZVI5:\U!55@IJ"C"I&%3G:^/?B=\,_&7P>\<Z]\./B!I2Z+XO\,S6D&LZ8E[
M9:@MK+>Z?::G;J+S3I[JSFWV=[;R$P3R!&<QL1(C*/KFS_X)J?M97>C:+KLG
MA;P)IMEK_A_2/%&G1:Y\8OA5H>HMHNNZ;!JVF75QI>J^+K2_LS<6%S#-Y5U;
MQ2Q[BCHKJP#/^"E=G=G]M;XZ3BUN#!_:GAI_.$$IBV+X'\,[F\P+LVC!RV<#
M!R>*^NOVW=0_9.A\>>#+?XH_#;X]>(?B*?V</@2!KG@7QAX8TGPGM?X6:&-&
MVZ;JGAS4[WS+5?+&H$W3+,ZOY2(I"UU5^(<YK87A.6!AAU7SS*)YCC73R^6/
M]G4AA\KJ.-&A/-\L5.CSX^?-*>)KU(J-.*A-N4C"CE67QKYXL0YNEEV/AA<.
MJF+^JJ<)UL9!.=6."Q;G4Y,/"T8TH1ES3ES*T4?G9\)?V0OCM\:=(U_Q+X,\
M-:1;^$/#.L2>'M5\;^+_ !AX4\#^"EU^+RB^B67BCQ7K&DZ/JFJ+'-#,;/3;
MNZF$$T,Q41RQLW9:?^P)^U!?_$/7/A;)X)T71_%^A:'I'B8V_B/Q[X&\.Z7K
MGAW7KJXL](USPEKVL>(+/1O%VEWMS:SPQWGAV^U&))(RDK1OA3[#^U?'K5S^
MQQ^P5/X1%[)\);?P)XWM-;BT\RR:3;?&A/&6JMXD.O+;?Z&OB&729K7^SWND
M6].G&[$6V)Y5/@_C'P_^T'I&F_LI7GQFO-;/@S4]/M7^!VD>(=3@FU#2_ <7
MBZV:1[31I'&KZ7H5_>3+<:'/J$*VU_IJVXTF5]/M88H>G#YIG6.A+$4LPR+!
M4\1CLXR_"8/$X/$U<93J95B,514KQS.A'&UZD,#6K8C"0IX3ZO1K*I'$5/JK
M6*RJX'+L-.-*IA,RQ$J6'P&)K8BE7I4\/...IT)V=\)-X>E"6)A"E7YZSK5*
M?*Z<%63HP?'K]BWX_?LTZ%!XA^+V@^%]!LY]?M?#(M-.^(?@3Q)K<.KWFGW^
MJ0176@>'O$&I:Q:P&STVYDDO+BRCM8F-O')*LEU;K)\I5]T?\%+O^3Y_VB/^
MQLTG_P!0_P -U\+U[7#F*QV/R/*\PS&KAJF*S# X3'R^J8:IA:%..+PU+$1H
MQIU<5C)R=+VC@ZKK+VEN;V=/X3S,VHX;#9CC,+A8584<+B:^&7MJT:U2;H59
MTG4<XT:,5S\O-R*#Y+VYI;A1117MGG!1110 4444 ?JQ_P $7O\ D_CX>?\
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M64YCB,?Q?_;>A?\ 0?\ #_\ X/=(_P#DRC^V]"_Z#_A__P 'ND?_ "97.J'
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M <9_X35__D#6HK)_X2#P[_T,GAO_ ,*#1O\ Y.H_X2#P[_T,GAO_ ,*'1O\
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M*3_@JSX%E^'W_!0W]HJSDMY;>V\<7'@KXI::TD;)'>6WBKPAIFFW]U:L21+
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M 7BK0](T_P 0:OX=UC3M#U;RAI6I7=C-!9WYN+=KJV%M.Z*DAGME:YAVD^9
MK2(612:X:2)AQM],J#T]P,Y![XR1G)]*\O$8*=-ZTY0?+%VFG'223V:3Z)[6
MZWLSVLNSJABX>TH8BCB:<9RIRJ4*D*T%4@U&I!R@W'GA+2<4^:+7*U>YANTP
MSF24CI]]@1G'OP>.#[]1VSYA,O*RR$=2!(^1S]>G;M]*WI(^Y(]<X.0?<=1G
MZ 'VXJC)$.0>.G8\YQC&,X_+FO+JT;7M??5;]$KV>NG7OJCZC"XQ*SA+33K9
M[KU?RWUWZ&$TDXY\Z7CMYC^G)'/'?CTS]*@:27KYLA]O,;GKZMP1SQCZ=:T[
MB %25R2#SP<GZ<>OMUX]:SW7J>F.P'^>G/\ D5X^)PJ?,TFO)WTVOITMIMTO
M=V29]1@L=K%/5:6[=.MGOIK:^MNY4=Y6&?-E[])'[8Z<\'I]>]4G>;D>;)[?
M.WK_ +P!_'H:T7'<=.X_K]?7K^E59(\@G\?Y\]??I7@5Z4HZ7?SOHU;?7_@;
M'U6'KQDEMK:UK.VV_9:[.Z7?6RS&EFY7S91Z'>QYP>.OKZ\_A51I9LG,LG_?
MQC^N1G_/>M%TSG(Y'(_#I^N:H."<YY(/.!SC@9'3KZ=\>I!'GU8-WU];^JV7
MG\K[GKT:BT5EOY>6WZ>9$TLQQB63(/\ ST;!^O-,,\K GS9,@#C>_KSWQCD>
M_%.([]O7!Q^&?_UU'A5//<\>@^OT/K[=\UYE6+6J;\K-M^C_ *_4].C);.SZ
MZVM;O?\ J^GR3S9?^>LG_?QO\:B>248(DD'_  -L?S_S^=2..XZ'_#C'X5&P
MR"*Y)WM>[NO-]SK5DU=*RT^7]?D,,LA_Y:2?C(WZ<C_&D\R3_GH__?;?XTRD
M/ )]C_\ K_S^-9.3W;;LGU?^?D;I)[6UM;\%V[?UT/ZQ/^#0IW;]OWXZAF9@
M/V4O$I +$@'_ (6E\*N0">M?Z*M?YTW_  :#G/[?OQU.?^;4O$N?_#I_"K^E
M?Z+-<&9/FGAGKKA5OO\ [QB$;X;:M_U]_P#<5(****\TZ0HHHH **** "BBB
M@ HHHH *_D:_X.F--L-5T_\ 9&M=1CGEM_-^*\NVW>-)/,0^!]IW2JZ[0"V1
M@'D8/&#_ %RU_+W_ ,'$^A^'/$/BK]D+3?%+;=+>P^,LO_'[%8;KE'^'XA43
MSR11Y(=SL+@MC(!VFOK^ Z'UKBO*,/>G'VU>I"]76DN:A5LYZ/W4]]'Z'Y?X
MU9G')O"KCK-90Q%2. R'$8IPPG^\S5*=*7+0]Z'[V6T/?CJUJMS^)Y/!/A('
MYM/U8XZGS[3Z\#R&SP/3'.2<=+Z>#?!04%]/U;<2<JT]KPI^Z=PMMISD  $^
MXZY_1/3O@Q\(9]'ABN=4MCKG_"1J\D\7B6P%FWALZB9)+9=]\J_;_P"S2L )
M&WSP6,P(W#W'P_\ L[_LLZAXD\0RWVJ7$'AN?1+&/PQ;OXRT*&^M]<VW0OYM
M0W:P2UH7-HT0C>7"K(&C3:/,_IQ\-J,>:3RN2Y=E2E.S7+K[E&6^RZM)O6S/
M\J8^*^$Q%14X?ZRTVJDHJ4J[HTY\JNI>TGBU%4Y1NU-V]Y*/NRE&+_)"U\(?
M#G!-QI&LL5P"!>VJ[L],9L6!QP3Z\ <G%=-I_ACX.+)&UWH&O21HR^8%O; L
MR$_,JE[':I8=&9&P>Q[??OA_]AL:K-']I^*WPML+>0[F,OC+2_.0<%5R6\MC
MR 6W$ DD9KUC2O\ @FRVHI)%'\;/@T!,ZM')-XOL3)&JY"@F-67)&-W7!48]
M*Q>5QHVE*A@>73WI4%*-E:VSVLTDW%6T=EL=;XL68_N\/C^)YRDZ=HTL7B:$
MU&3BI.+O&>BYI64M;M7TT_.^VTO]FMW42>"_$D$$0)"_VKI;S2#(X=WTO:SC
MD+M6/.<$GJ?2=%M/V*D,?]K^ _'<@&W>+?6=$3=T)P/[#D8="3AN.0.H(_0.
MQ_X)*3WB!O\ AH/X(PLRABLOC:W4Y(.<@6N!SP!P2!V-%Y_P21U"U25XOV@?
M@G.(8R\GD^,H9<*,99L6ORJ">23CVXK-/!\W)[/*DU;X:+BKO1;0>NR5W;YI
ML;P6:.,JT,9QS[-V:Y\=.K'W;-JU2=25G:\M+O5,^:-'7_@G%:1V]UJ7PP^(
M]R'#L%B\2Z(LJF+A]Z+8Q21^BABK2<[0>,]_;>(/^"4@AB^U_ WXHS2?O SQ
M^);!96YSYC[@1_'M0C&<$D=*D\2_\$W[O1+=F7XU?!JXE1E4F3QI9P*%(R3A
MHE9SS@9'/7Z^6W/[$M[9Q[I/BG\*6^?;^Z\9:<^X9'[P9/W<$'EMV!]WI73]
M0A6BE##X>,$E9QJ5*:NN7WKQJ1UOK:W7IL>;'/?[.G/VV9YHZCG=QKY;@L8U
M%7:3]K0KRLE;5I:K5N]ST#5?%'_!)N"%2OP6^*5I)*YCB5_$EA(Y.W)=<0L,
M*!@DY8D@$8Q7GNLW/_!-V9I$T[X8?$ZU;&X)-KFE%@"!C*OI;XP#V/0\]*XK
MQ/\ LG1Z/J)LIOB%\-M46 JZW=CXGTVZ@VRJI!5?,\P.JG:ZLJL""%+ 9KSW
M4_@;):S2)%XJ\'W:KN4/'KUCE@.%.&<,-WI@$#@D&KIY4H13^JT:BLFY.I.;
M=O.<Y;[WZ;6[Q6XMRJMRJIG694:D.=3=' 4<+RR<HJ*BL)@Z=N57YDVV_BNE
MH^GU71?V,IV!T?P'XV4SMLB%QK>BL%W A21_8<;#!["1CR,9[\)=_#WX 7[F
MTTKPMXD7460S)$VI:.;<VV2-XE.FB0RAL?)M4 ;B&RNUDN?AS-;VL< UCPLL
M\<AD^TKKUNTC#'RIM1R@49R&QN]",FLV+P5J0N%:W\1Z&)U4H&77(XVVC)*^
M80,<C/WAW_#I6 PL='E]&6D4W&,6X^ZMG)._O:)WU71WNO+CG'M)2G1XQSJA
M9S4(UL?C:*GRRBZ;<:<HI0E%)-.*E%NR<>N#_P *@\ 7Z:K+IOAK56CTN>6*
MZ\S5M-B,;11&9P";-]^(QNR@ 8X&/FS6+/\ !318]"AUR'0]0CTN_DL88G76
M-/)D;4+F.WM,Q_8@"#+-$&P<H I< <UVL7A[6[8W"VOBK2HOM1)N1'KX3SF8
M;6\U< 2';E26#$CY=Q'-*-!\1M;1V(\4Z=+:AXQ;VJZ\3&)8G62%8HB"@:.4
M(R  ;7 88(!&;RW+Y*3EE<_:.G-<T%0<5/:#UHRLMKJ[O>Z=M#U*/$&;TY4U
M1XL<Z+K8:<EB<1F%6K+#PIOZS",W5?[V=;D=&4FU"FIJ46[-<E<_LP7$6N:9
MX<?1)EU/6;:\N[%!K.G&%X;%4-PTDOV<[&3>I56R6R ,D8K7\.?LA:SXAUOQ
M)H-KX=N;N^\*"R.LQ#7]-@2#^T[1[VS,4[63I)O@C9G55W!QL.&S77V&@>/M
M2O+?4+?Q:INK-9HK;43XDD)M?.PMS%#<!R8MX 62-67S 5!!'-=6GA[QGX<N
M;G6E\8:OJ;:A)9QZM)I&M7&^::&,QVT>L7%M=2W$<4<1,5HTH+RJ'B@4LCQK
MT1R?)>9RGE6)E35;VLW_ +&E[-4E%*,?81G)JHW)6=K)IZVOQ8GC3BRA3="E
MQ;EDL5+!QITXJGG+?]H+'1DY^T6,Y(47@&Z,*53]Y+%M554]G^Z?RCI7P(;Q
M6\\7A6RNKF^LY)([O3)PDLPCB9P]S:2QJJ7,2"*5IHPHEAC03A9(M[)UUK^S
M1<V]L+F:SN+Y9$_>QVH*6V58$XEVJ[8(P?+&%*D9&01]I_"9-'TSQ'I+ZC(\
M#PWD$T=IICK#+!()%(99O,5X9E+%DGE9Y'GVL3&,J/W&\:ZA^R9K_P #&EAA
MLH_B5>PQRZG/I\-E:VC2H9&DES;S*7OYQY2W!:)!<3*SO"LCONX99)E]%86I
M+ XG$JO7>'YL)252-%ODY*E6*<>2"C)JI)<R<K*,(<SMT0\0N)LQJ9Y0I<19
M/D\,ERV.9T:>>8RI@ZN;0BJBJX/+<7)5?K6)C5A"-&"ITY-2;G7E[-2G_)]J
M_P *M#TZ9HKVRAM6CS^XA+O/A>0&6-Y'Y'4%D..HQTR[?P[H,7^BV6G-L?#%
MIU,<9V\@DC=+G!/)=2>G>OM+XH:)83ZS<P:+$9"9F\N#2K8SRR_*B;GG4/)C
MYF#9?9N!"C:H"^4-\/\ Q##.MN= GMI9".)H2\P4X(8J2H0 '(SC.&QG:<9U
M\@IPJRC2I*T)N+<8N2E9Q2:>J3[WMRO35JYZ.4^(F(Q>7T:^88[$1G4IPJPI
MU<7&E&+>G-*#C"<N5QT:YT_)-'A!\,6[<I#;(, YBM!*V">/GD$Q)S[9_"F?
M\(D3R//4' ^5(H3CICY53'3TYP.1FOJ@?"R1!$]Q?73Q,6+%($M8\A>D;F20
MG:W# H,_I4+> M A9EFNH7P>%EOA(ZXZAE0*S$L"2,#'KCFLWP]%<K='EOUE
M)Q73;W9)K1;-*^]M3:'B50G>-'%^VE%^]&BE6:2Y5K[U.2;TM=+36VS?RVW@
M]6P?])SP?]> >, @'?\ CGMGTR*3_A$0""#>$\C!:*7UYP^_T /IU^OT_%X-
MTRV5EBO[=V9V?Y[6XVD_+QD%^% ."%QR.:5/"-O)(6^VZ0Z,/]6?*@8':RC$
MCP.XP"&V[<AN^1FC^P*2M:"N[72:>NBT;2?EMV?<N7B)B;M^_P D=G.%2FW;
MEOHVXQZ_::LGZ'S%_P (O;PG]ZD&"3Q<6<8/3D!T6(@DCKG(&<=C6+K?A*VN
M?L\<5G;AAN=F@#'<255<[RY7@<!21R0?0?5^J> F^S27(L(9H($DEGDBN\B.
M-5R9%?,:_=R7_P!'/ 554D$UD>&OA_<:Y*E[806[V<4PBDM;J]19SC)<Q I&
M) L9+[5Q)C&%/4YU,CUA3]E?GM+52YG%-*]K/3WMUU[&^&\1L/&C/&/%\OU>
M\9R5:BJ/M9JT*?M(UKQD]DJBWLKJ]GY;X;^$1U*SALHK97D\@.8+RT"JP<\O
M%YD9C<;S\I656..,]M.\_9FU"1UMX="N;:X,0D,Z@_94B3'FW=SYI @MHL^9
M-*#Y<8(.[D _KS^Q_H7PKL/%.G_\+.MGM],"Q0E-2CQ#-:A@%6&6XV94QY"%
MF\MWY)W)#CZQ_;(N_@!-:V'@SX)WMAX=T#7=0@_M)[Z.UM[:>>X98X)=7OH)
MI6_LVR,I>"!?)AA5'N#%+<*9E[ED. 5?#8:I@L3*5:A4JSQ,*?\ LE)4HPFX
M5*[D_9U)JR@E!WFTG9;?*OQ$XDJY;FW$&&X@R;"4<OS*C@*635L=&>?XZMB)
M04*^%R^$*<*N!IN4O:U)XE2ITJ<ZJC-I)_S)ZO\ "CP_H<ABF^UZFB,(I+[3
MYK:.TDG(^=8DG@DF\M&RJO(,R8+A$5@*[?P-^S->^/[*\U+0=%OTL+218I+C
M4KZTM899&3S"D#"Q8RE(R'<JH10R@MFOZ';S]A_]GK3] TFQU3PY;>(-<%K#
M)<^(I+^_C34[R5=\ES;BUNTM88&+$6T7EE1;K$I=W+2/\X:_-X,^"UYJGPUU
MO58(M.TU/[3\-26EBDEY#9:I-*ZZ/J[PD$75K+\MO<2J\EQ9-;@2?($;T,MX
M8RBM74\9*$<%RZ4H4H\\GHHR=>M"H^37FM[M1_:VL/BWQ)XXR7*H4<#2KXC.
MJE2#E4GB9XBA#W?;.$L'@Z\.;%>SA)3C3:H1;E*DZD(IR_%SQO\  -/ ,UG'
MKVD:@D=^CM;75IJ%M<VCO&P$D)E%JNR90RMY3*#L96' K@QX)\+$$BRU<@#)
M(N+7&/7)A%?J_K)\-_&&^O="LXO/T/P]'!J>K"]"V6H2RRR-;6D5A%*4N1;A
MIO,N+BUW%E*1_+$7<^4>//@;X8TW3+Q=)@6PO(8O.2X-ZUS;ED"NT<D@GD@\
MN5756=<E&^;)VF-M,;P91<ZU;*_JU;!+^"ZRA4G)Q2;IJI&,82=FES-1NV]&
MN63YN'O&S%RI8+ <42S/!Y]-0>,CAJU=4:-.I44*-2K2JXAUZ/-3<)NG'VR5
M-QGS)R=.'Y[CP7X6R-MEJV[JN9[7&1T)_<\@'KUK_3V_X)@@#_@GW^R6!T'P
M;\-@?0?:!7^;]+X&UZ*"&Z?39UAEA,L4@57+1D<$JC,Z!@,C>JY4@C-?Z0G_
M  3%&W_@G_\ LG+Z?![PZ/R-R*_"/%7 RP>"RCGH*A*IB:]XJFH7<:,;ZK25
MKZ=KOHT?Z ?15SRGG6(XU]GC9XQ8:CD:O+$3Q'L_:5<UBTG*4N1MTK22M=QU
MV/NVBBBOQ0_L4**** "BBB@ HHHH **** "BBB@#^7[_ (."_@I>6/C#]GS]
MIFRLT;2]1TS4?V??%EZDCF6&^^T:Y\0_A^)K<1E%MVV^/;<71D4"XNH+:0%I
M;8'^>S2]7U[PWK>@>+/">L7GASQAX0US3/%/A'Q'ITAAO]!\2:)=)?:3JEK(
MO.^VNHD,D1S'<0-+;3*T4KJ?[S_V^/V:HOVLOV4_BO\ !VWV1>*;W1#XF^'5
MY(45+'XD^$2==\%S2NZL$M+G6;2#3-18 /\ V9?WBHRLP(_@<MVNMDD&H6DV
MGZI8W%SINKZ;<+LN=,UC3;B2RU73;E#REQ87\%Q:S*>CQ-7]J>!.?T<ZX-JY
M#B7"KB,CK5<+4H5$I>TRW'.I6P\IQE=2IN4L5AVFN51I1BU9J_X-XC9;5R_/
M*6:4>:G3Q\(5(U87BX8O#*$)V:^&3BJ55.]W)R?1M_W'?\$WOV^/#'[;WPA6
MXU+[#X>^.?P^@L=%^+O@B.4)C4EM8%B\;^&[>1O/G\%^*I&>YTV;]XVF7HN]
M#O)6N;$37'Z-5_G3_!KXQ_$W]G;XH^&OC1\&O$3^&?'_ (7<Q)(X>71_$^@3
MW%O<:MX+\6V",@U7POKOV6&.]MB5N+6:.WU+3IK;4;.VN$_ME_82_;_^$G[<
M7@!-2\.3Q>%/BQX<LK:/XF_"34[I#KOAC4Q%;)=:EI!D$<GB'P5>7<X71?$U
MI%Y$RNMI?QV6IQ3VB?BOBOX6XGA+&5<YRBC.OPUBZKDN12G+**U27^[8C=K"
MRD[83$/1)JA5:J1A*M]]P=Q?1SS#PP>,J0IYM1@E*,FHK&0BDO;4D]ZEM:U-
M:IWJ17(VH?>=%%%?BI]V%%%% !1110 4444 ?G5_P5N_Y1L?MD?]D8UW_P!*
M]/K_ !]Y/]9)_OM_Z$:_V"/^"MW_ "C8_;(_[(QKO_I7I]?X^\G^LD_WV_\
M0C7MX/\ W&G_ -A>*_\ 3.#.*M_'E_UZI_\ I=891116I 4444 %%%% !111
M0 4444 %%%% !12X)_\ UCMR:_6+_@F!_P $@?VG?^"G7CH6_P /-,;P-\$]
M U."U^(?QR\264P\-:'&)+9[S2O#ENQA;Q;XM^QW(GM]%T^9(808Y=5OM.@>
M.212:BG)M**U;;22U2UOI;7]%JRXQOKYZ*U[]_N^[OU/R[\,>%O$GC77M+\+
M>#_#^M>*/$NMWD&GZ/H'A[3+S6-8U2]N9%AM[2PTVPAGN[JXFE=$2.&-V9F
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M=ZEK6H.[K]FL3&AN=7U&ZG:2"V2T#,"S1:3#:6<8O5^$?B5XVU'XG>'KW2_
MVN_\(?X:NH(M0>STFXM)A%HTCPM)J7Q7\8I,+73+R_5KMK#P9HDDM[;7"^7J
M]O(\L%T>?!XF%>3G1I-0T7*Y2C%RY8MN48IJFYMW]FI7:=ZDJ7-&_I<19!+*
ML-2H9ACZ4J\%.7MW"&*Q-.FZDER8:O4IQ=:-*2E2^N*@KSI..&_M.5&O.'D'
MBZY\$?#ZPNS9VRZE<6<D-G>6G@V&2[MK>\F,I@M]7\7RF6 W4SQ2!H8);D[H
MYT:VA9&5?+-9O/$.K:3+<:#+!H7FI#+'/!8Q65A'YCPEUN-9UMH;F>X"--%*
M-/L8T%S'M4O&Z..^@EN_$,D.D>%+1/$YTE(XY/%VIV4&D^'-%@MXXEN)M&T)
M1:Z1;!)"))=1U&)[B>9OM-RT+W$KMB:WXU^&'AVXCM M[X]\4F(&XN;N8MHM
MK<,6E:&VF\E8)(X%;9MM(/(<Q*\,_E.%'K.S5I5HQIRC[JC'EY;./.X3C\7+
MS)2:OI[W/=-KX'"X6K3JQEA\#6Q6)C4J-SQ%?ZU*JE)1INMAJRA1P\9**FJE
M2I3K1;2=%TY14O+M.T"\FA\JYN[OQ'?!G9[NUT^[ORSL69$>YO'A4;?NJZ!\
MQ@-M&W!VCX,\0NH,.D7$:D# N[ZQMC@;B,)$A*G:8R1G)^;/)P-A/$_Q$\62
M+;Z0MCHL,H98;;3[7;(0^5'E2,EQ*-XP%P\/R@;05R3R'C'PM\0] $4WB=M9
M\F=PJSS7$Y"*0-K/'\HB#9"AT!4<*6#'%?"4>/N JV</A["\2Y5B<YC5]A+
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MX,^"]$^'_P ./ ^DVNC>&_#&@6JVME9VMM$D1EE;+3WNH7;)]HU'4[V6XO\
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ME]/$5Z.'P^!I3C@LJPN#P-']QAJ:4:&&@YNG.M7E4K2JU:GGOPL^%7BCXO\
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M^26SNH9#_%OBIX:8C@G,'C\OA4K\-X^M+ZK5=YSR^M*\OJ&*EJ[)7^JUI/\
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MO<[WEU'Q#KTFH:Q?RO(\CW-Y)\^ ,?EU^U]_P4R^+7P8_:6\3?#?P%9>%?\
MA%O!%E;:?-_:]H=7L->U2^L;6\O;J_O;"[ANM-N-'FE^Q0VEK,%203IJ5N)E
M55\F=6KBJLHTK*$7HK**DHNS<^5*Z;N[6M:U[O5[WIX>"E-N[:5TY/5VVNV]
MNUD];GS=\;?VY_VS?"4OC_X#_%.^\-:/XIN/MEGXQM_#DFG7&M:#IWB;28M0
M2Q\/:EHDPB2TT[2;G=^[N+F\CD$\3ZC=0,)3TO[*'_!0CQI'>>!/@9\3CHOB
M?P)JWB:=/$&O>-M,U;Q/K4G@J]@2P@\+6NEP0ZE)?W#2E'M)Y[>[BECFELW2
M..&26OS)^+?Q"UCXQ_&+Q?\ %#Q3&MAXG\0ZK]NE07T=_IS1W\!A5=+NVTV.
M1=,L;.V$-C:S0M=VVG1F!M3N)7:XK@4OKC04AU#3M)N#<VLCW^G7(U%K"XM-
M0TYVBNQ93+.]S$D16\DM)8U69I$C#,<Q-7<\/!TDITX*=D[P48\LK)+56O;K
M?7\SSW7FJJE&4W%25E)O6*WTZ?.VB22/UW_X*9_\&X_[(O[8GA+Q!\0?V;O"
M_AW]FO\ :.^PWFJZ-J/A73I-*^&?CW5#!<7=MH_C?P;9R6UAHC:G=/';/XI\
M/6=KJ.F"3S[W3=9C@6T'^<E\<O@=\4?V;_BSXZ^"'QB\":CX-^)/PX\07WAO
MQ1H%\9)/L][92E%N;*[MY)+74])U"'9?:3JMA+<6&IZ?<6]Y93RP31R-_K5_
M\$W?CFGQD^ T-K>ZCXIU;Q)X(OX]%UN\\5ZQ'XAOIFGL;6ZMO+UJ'3-,@>(9
MGCCL'-Y>V421_:KRX\^*1_YA_P#@[W_90\-Q6W[,_P"V/H%C%8>+-:UVY_9\
M\;R6=K(USX@@&EZYXU\"W5PMOS<7>F_8?$^F),Z/<2P7=E;AO*M(T&&$K5%6
M>&J6GJU&4E3<M-6G*I%]+M-M=F[-<O944)T_;1;2LG)WJ\J5UKRP:Z+6VRZ]
M_P"'<*QS_P 2N0_^!/?T^?\ J:]%^&GPF\??%WQ!%X:\!>"[_7+]]KW$T8N8
M=/TVW+JC7>IZA,Z6EE:H7&Z2>56;[L2.Y"G]*_V4_P#@E'\2OBG9Z7\0?C9=
MZE\,OAU<)%J%CHCVKIXW\3VC&*6(16$Y T#3KV)G5-1U"-[K 22VTZ=)!(/V
M)T_X4_#SX->%;?P5\.M#L?"^@6A#&ULXKB2ZO;H0K#)?:IJ$SR7FH7TRQ@RW
M%Q,[Y.R$11 1U]QE?#F(Q<E/%KZK13NH.%%UJBLF[+D:A%V^)W=[6AU/YV\0
M?'SA_AJ57*^')4>(,[4I49SA4Q2RK 5%[O[_ !$)J6*JQDM*&%;@]54Q$&K/
M\E/AQ^QEX4^$UG!K/C'3[;QGXU6(3;I(KTZ'HLVQ&\O3K4S$W]Q#(KJ-0ND"
MG<WDVL10.?Z]?^#=3]F#3['2/BW^UCK>A16NK:OJ,_PF\"331W'FP:/8+IFM
M>*+^U%S(WEK?7LNFZ=OC13ML+B(':76OYW?B"L/[\_V@R_?'$5R2"0V.<GG.
M .>I&!P37]VG_!,7X9V_PJ_85_9P\/P1A)M4^'NE>,M1;:RM-J'C6,^)9YG#
M_/OVZC%%\QSLC7[H^47Q;['*\IA@\+3C16+K<DU%*+<:<5*4FU9MSBXQ;=VU
M=/8^?\%\?FG''%U?B#/L;/'ULKPE;$4E.59TL/6Q,X4*,,+1G-TJ-&,'6GR4
MX12J*$FE*]OO0# ZD^YZTM%%?EI_6YYQ\7OBGX4^"7PS\:?%?QO/=6_A;P+H
M=UKNL/96TEY>200;$BMK2VCP9;F[N98;6 ,T<(EF5IYH85DE3^;_ /:<_;^\
M8_M ?$KPWK/P?\2>+_ _@7POX*O!J'@IM3MHQJ7B:>^EO+76'OO#VI?O)[G2
M9[:R6*Z)_LF2VE\M'DN)-OZF?\%:-9^*6@?LI:AJGP^UC2=-\-KXHTS3_BYI
M]_<Z=9W_ (F^'6LV.IZ5>>'=&FU*"YB>[U+6+O28IK.UC34;RU\U;291'-%/
M_)OX>\6:MH&K:W8^'O"B0QZL OV0HLM[%;*5DS;/Y1<, H#21[-REE/#&O2P
M5&#3JS7,TVDNST_KY^>OGXNM-/V4$]E+2[;6FB2O?9O9O>RMJ?N?X+_X+%^.
MOA[\-_#'AOQC\*8O$GBFUCCTH>,-;\7W,(OXUN91!>ZGIUMH,DTLD-AY,#-'
MJ7G74T9N9G7>]9O[2/[;W[.?[;7P;3X2_&*X\9_"C5]%\0Z/XQTWQI\/EL/%
M^EZ?K5C%?6$+7/A_4;W1K[5+,6VIW1NM/5FG5D62UO%E1=_Y):7XGLM3L+C7
MM<TNZ'V*1-/M-/NR+JW@<A59I6:)<?/EL[3M!VY. QO>)O!.CS>'Y+[2/#D%
M]J=[ ;N6:QN'A6(.I<#&[AD&,#C)[<YKK^J4KJ<5+F;YHN*=[JUW;3S?O=[Z
MVUY5BZWPRLXM)._;37;MO>UM5)IF'XA\-+H_B+Q+X4\%>,?$GQ2\$/%;WVE:
M_J&A1^%=1U.*2UA?4;J[\/1WVI?V<D=V]U%$ANYF:"(2.^YBB<UX;\)_#N]U
M9]+FU&^\,D6[S7=Y+%<GS+J,9%K$B.@8._RAMS!1EBI'-<-HNI:AHOB+2FTL
M>(K6><+9:E:3':92799HK63>XEM\*@4MM)^?C !/O_BF7PGK5K::?JEW)X<N
MHPLRJ]LLEXS!2NYI$3<=Q)).XY8>_'3!.Z33]VTKM.,FXZV:MK*326G?32Y@
M_BB]H\UWI)QM>UTX^\U%ZJS]YKE3YK%CXE?V3!X8T#P_;ZM<2:+>>'-#AL[J
M. B2&:PNIA+=_:-I"R17J"6=),JS<,2K<9-IXM^(7PV\%>(;#33IGC*QU:W(
MA\6H\X\0:7#/;"%K80/NB46\?SKY,A0RJ NTDUU]NWAK6?AO%X;C\26L][IN
MHR3:5<RV-PRVQ4!C%J+JA5-/OWD(G<'S()$68DH"!R&OMXXNEM+JX\(VUGX>
MLS!#J6G:3,G]GZM#"H!GMKN%Y8YA=*/,+HY.6)VJ#BO>CC,90E+%X-\U"K3H
M>WBFYJE5ITJ49QE37PQO3]QNRDG;6S/Q"KP5PCG5.'#?%%!8;/,MJYE#+,:L
M0\-4S++,=C<9BL/7P4Y>Y7A3>.2QN&3GB*.)A)SG3A4@YP?#KXI1S6ND_#_Q
M;XM=O!2VAU,ZI9Z'<P:A'J8F\PZ1=S0VL\QFD;<&EX,GF8WH!S=T_P")7@Z7
MQSXMT+5?";>(] OX5L/"=N;M+*"TD.(H[R[@F_>B>4#S&ZR D80GY1YS:#Q9
MX;\075_9Z>WA[1/$<IM["SE9+@P07)15C$DOS,R@#YF )(SG&*?<_!3Q9I'B
M2TU+6;K[!X7N'BUB?7;MTM'7SY#)&-.56\^]NI"/W-O!D[B';"\C26<XC%2C
M&G@</[3I*IR.*BHM-S=H\J]_5W:;Y5LSQ:/A)D?"E*IBLQX[SZE0O3="AA*\
MLOJUZOM:;A2IX:G.J\16J4X^SPM&&'<Y3LTYN$(K];_V0OV7?AIXRT[31X[^
M.ECX#TF\\0V_B"_\-6%]8Z9<MY;I91>";C4O$ZV4T>H:C]GN;R^ET:WO(X(H
M[<6MR\WFR1_TVZ9%!!IUA!9NKV<-G:PVCK()E>VB@2.%EE#/YH,:H1)O;>/F
MW-G)_BST'5-0.M&ZEMM<MK2PT>73?"\S-!>SW!N6 FU/5#<N5CGU /)-<$$M
M"1&%'REE_IU_8,^-7A;XD?"/3_ NC1ZW#K/PETO1?#6N_P!MW5KJ,UVSVK&"
M_BOK("V,<\L-U&MD 'LHX8X07C"2-\KGD5*M&5.HZM.A"EAKZ6;I4H1E.+LF
MX.5XP>SC%-;W/W3@>E/#Y7*6(PD\#7S'&X_,Y8:M4G.O"&-Q,JF'6(YYU.3%
M2H<E7%TXSE&GB:E6*;=V?<U>5_'+X0>#OC_\'/B?\$OB!IL&K>#/BIX&\3>!
M/$5C<)YB/IWB72;K2Y9X\$-'=69N%O+.XC9)K:[@AGA=)(U8>J45X2;BU);Q
M:DO6+37XI'VSU37<_P 7/]I#X(^)/V<OC]\9O@-XJ\)N->^$/Q+\9?#^_EC_
M +5:"\;POKU]I=OJ-LYF;S+34K6V@O[24,PDMKB*0,=V:\<MHG\X?\4K(>N0
MRZJ<C\),^I]>#QUK^A'_ (.??@SIOPK_ ."I_C#Q#9:DVF6GQL^%7PY^*S6\
M=K=>6NI3+K'@;5Y \(,<CW-]X*DOIF^]YMVP;'&?YZ+6.T\X9\1R+E2=PMK_
M "#V' '/&/3KWQ7VN!G&<\-4Y:2YG":O++8M7Y6ERU(J:>K^+5Z.^MSYO%KE
MIUXN5?135XK,IJZ2NTZ3Y6FNL&UT-DV\F/\ D4I"?IJWX9S+P/Y4OD-_T*9'
M_@V_K,:@\NR P?$TH/\ UZ7^2/;&?P[TGE6/_0SR_P#@+J'^>_\ G%?4.R2U
MI:?]/,LUO:WE?;[FGY_-*_?$?.EG7EY^7X>A_H._\&DJ[?V0OV@E-E]@Q\8=
M%_T8^?E?^*>NOF/VAFD^?KR<>G%?UC5_)O\ \&D8C7]D']H$17;7R?\ "X=%
MQ<,DL9;_ (IZZRNV7Y_EZ G@CD5_617YQGW_ "-L7MO1V<&O]WH[.G[C7^'W
M>VA]SE7_ "+\-N_<EJU43^.>ZJ_O$^ZG[]_BUN?F-^TG_P %:OV4OV5_C#XB
M^!WQ,M_BQ=^./"^G^'M3U=?!_@!O$.CPV_B?2(-;TI4U(:O9^9*]A<QM,GD
M12;H]S%2:\*_X?W_ +#'_0*_:"_\-(__ ,T-?AE_P6%_Y22_'S_L5/@A_P"J
MTTNOS:K^H.$_!+@W.^&<AS?&3SA8K,LJP6,Q"HXVE"DJV(H0J5/9P>%DXPYI
M/EBY2:6EV?E.>\?YUEN<9C@*%/ RHX7$U*5-U*-1S<(M6YFJT4WT;25_R_KR
M_P"']_[#'_0*_:"_\-(__P T-'_#^_\ 88_Z!7[07_AI'_\ FAK^0VBOH?\
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MZW6I?V7OMIMK(;F(MCRKX9_\$L_VAK+QCX>O?B7X?\)6'@OPMJ>C7^LR:O\
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MB?=3;X%T)3&!DGY&#+@G(*D-SFO\Z;5/&'@CQ_H,?B?PCXCM]<T2^C+0WEC
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M)%<PZTJV]W+:_:S)/;V*7@:V6S97>_MV4F^V2I'YC,C1]<WB+3_#GAB3X?\
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M(9'C:>#IYJ\HRZA0H95@\9FCS#%Y?BJV8?6,6Y8?$X;"8?"0Q5?FCC:V$RW
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M+5K;0O%W@[Q?KVAZO>ZW?23SV5UXCL;S5Y-):WTZ22);;^R[6W*PIY<]O=$
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ML)6ITDJ53V2A0GB*,U4HUY4J=*U6E43C&<;.!I4C3<S *H)8X. !UP  > .
M:SM<\7,DFG7S70,EL4B+%MKC8V^$D9R#PW.#DC.>]3LS%"&0NA!4\''(Z>AS
MSP,$^YKS[QSX<.J:8TVF21VVHVZLT*2/Y45VIQBWD9R!&^5S%)@@,2K *Q*^
MQ4Q52E3FX1NHI2E!/WGR.+BHO75M7;N[WL[[/Y;)\LP,L73C7_=N<_8^VE/V
ME"G3JQ]G)5D[5++FNU)-QCK>*/3$\<3PZQ]KM[WRUU*)I"R2XAD9[>2)-T8;
M9((RSB-9 VUFR >0?LSPE\:[K1M*\&OIWB"^@U"PT_3YI& M4MX+J(XMTM9%
MGE:6#[,+=IC+ DB3M=0I"\,"2'\)+_XD:EI%S+IFIP7%I=V4K)Y=PQC=&4_-
M@'[R,>59,J00RD@BO7O"'[3=K9Z9I>FM>6VG7VG_ &VSWZG"-1T^>PU'[09;
MI)2KS6%Y:&18X%MX)-QD^T(ZRPJI\:7%&48FG7P>81IRHXB-6E7P^(47&?M8
MNE5HS4G[L9QDTW+W4DF[W/O\3X4<5X">69YPU]8PF.R^KA<5@<RRN=:G6I2P
ME2GB<%CZ-6E!JI6HU:5.5.251-NTDX^\?T(>,O\ @I!\1=7^#GBGX5W-WHWF
MWTMM9WEQ!&;R_>R$TC7]QIDXMSIL6TV\-K)*ES+<-'=/<VJF.%Y%_-2^^,.M
M>(I9-,NI]8UCPY+?VC:OIEO<RO--(PFMH&LUF2:,:MLFN+>PE2SF\F6<K(C*
MQ1_TC_X)!^)?V-O'7A6_U+Q=9:9KWQ2U+5M5L/$^GZ[>)=WNCZ*EUNTBVTRS
MN0D8L;N."&^>[@MVD>Y)MYI_]&0-]!_MR_MP_LC_ /!-3Q/9^,_AEX#^#OQ
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M"]AJOB?2;'3[#Q;I.B7#Q@BZU#1K:WUB'3YW\X1Z/?&)YR&K^$?/&/<'^?\
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M/'8.DI.KBL/3Y/B4JU--.Z5K<UVVVE%)-R;2BFW8_P! _P#X-&/^3._V@/\
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MB?\ A?\ Q=_^>!7Y]?\ !43_ ()K?L2? +]B[XF_%7X0_ S3_!7C_P -:KX
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M?#WA7PQHEL]YK'B'7M3E$&GZ5IMLG+SW$I^>61H[:U@66[NYH+6":9/[$O\
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ML1Y&!F>1&D\PJRYXN.R\0W4@CAU;2$WL &N=<TBU&'("J7FN$3'3)( 4<L0
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M92GEDA@[ONECAU3Q%+9Z);CQ#J&Z>*&SLY-3A-O%+,RPQ)#%-M@@!9A&I7:
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M6\B&TMAU)P4+D;@.H;'0<C!.?R!%8.K:T;!?W+>6)$<19 F"R*?E3:75@C9
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MV$NHP1-?6UE?);Z@+0K+<VT#,JG8^+'QNUGPYHWB'XNW/AH7'Q6\<>&9M/\
M!WA#4-7TO0]1\,_#?3-FOSSZ[J^IB/3=%UGQ+$UKXBU^&](DL[>/POX0V2ZI
MJ(6X^$O VG:7\.H=+\3>-].FN_$3W3ZOX'^&][<17&JZAXA2,7L7C3X@7=PP
MM/[0MWCBO+32-4=-.T-_LU]KK"XBTW2D_.OXZ_M-_$7QMK_Q#TF_\7Z5J6C^
M(-9C2YO_  _%=I#<:%IT\\]GHT&IWMKI^K7>D7=[,=5O;6\MHUU#5T7498^(
M(U_.<L\.\JP&.=3!/%U<-3<8UZ^+JR<*L>>,GAZ$8*'/3YX)SJ<T)55#V<*T
M(>TF_P"D.(_I)<89WP]'#9__ &=1S7%*H\#E^38.-*O@9.DO9YAF<L75Q-.C
MC(T:T88?#_5G#!.O]:Q.#K5YX?"TY?VGOV@$_:#^)0\86'A=/!7AC1]$TSPS
MX3\*K<Q7L]E:64(>^O\ 5-0A@MO[2UC6-2DNK_4-1>(33>9'&SL(5)\!LY46
MXB>1"\5NRS2*2!YC@[HX2<' E=/FV@E4R<8X'*VMQ<7MQ'!!!)->3DI:VT>Y
MY"N"2S;06' +NV"0H"KRV#N3VUU 4LW26U=N9;FXADC$0/WIF5AD[S\D" $]
MR"JJ*_7LOIQP^'I87"4Y1PU",:<(KWFVN5)2G+64I.TZE23;:UFW*7,?Q_Q'
M6Q6<YCB<QS/$4ZN:9G5>)Q6(<:=-4[MOFHX:E[.,:4+SIX>AAZ480G/EHT^2
MEREW6M61;:_F,$44EZK+$ VY47+R7!4ON8&1P O'^K&S.,-7]ZO_  3)Y_8"
M_91/K\(?#_\ Z'=5_G[^(;JWCVR3,[111^6RJ2%:,#,F%4;0[#^(8(P.XK_0
M(_X)DX/[ 7[*)7[O_"H?#^W/7&^ZQG\*_%O'A3^I\/2E;E>)QO+;NJ&'YKVT
MW:M:^FFN[_O+Z!^"A@GXBQ2_>5:'"]2H_P#N)G_(M=;Q@US:13DW)1BI<J^Z
MJ***_FX_T0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH _.K_@K=_P HV/VR/^R,:[_Z5Z?7^/O)_K)/]]O_ $(U_L$?\%;O
M^4;'[9'_ &1C7?\ TKT^O\?>3_62?[[?^A&O;P?^XT_^PO%?^F<&<5;^/+_K
MU3_]+K#****U("BBB@ HHHH **** "BBB@ IRD G/H?K^'O3:* /TC_X)A_\
M%+OC3_P3(_:#T_XM_#::37_ ^O\ V'0_C!\++R[,&B?$+P:M_!<W-NLCPW*Z
M3XDTY8WN/#OB""!KG3[EI()EN--N[ZRN/]3[]B7]N/\ 9\_;]^"6A?'#]GSQ
MA;:_HM[%;6OB;PY<,+?Q5X!\3M9V]U?^%/%FDOMGL=3L&G"+.BR:?J4.R]TV
MZNK65)#_ (SU?7/[&W[<'[2'[!GQ<TSXR?LW?$&^\&^(8#%:Z]HTBKJ'A+QI
MH@GCFN?#WB_P]<[[#5]+NO+4!V2.^LI=MWIE[97D,5PG/7P\:VM^6:3M+H]K
M*7E?:SNG)NTMC:G4DG;=:;IWMUUOOZK7:Y_K^_'O]GWX5_M,?#^?X:_%WP\?
M$/AF34;36K-8+V[TS4=)UO3X[F&QUC2=2L98;JRO[:*\NX5D1S')!<SV\\<L
M,KQM_*]^WC^PEXA^"OQ>U?3OA+\#_'8^$NF^%M)O=%\9:?>:QXIT?6H[>"YO
M?%&L^.?$-W>26_AN^TVY$ML\%TFG:;;Z/:6U\9'\^60?:'_!,K_@Y _9(_;4
ML] ^''QVOM*_9A_:)N(K#3SH?BO5G_X5KX[U9TAMYKGP3XWN[:VL-,FO;UF:
MW\,>*;BSU&(2Q6MAJ&NNDDP_7+]ON?7)_P!BW]H6Y\(MH%W-+\,->FGDUJ>+
M^RI_#CVF_79()V8V[7CZ(;M](=V,3WQM2"V5SQ4I5\-4C%II2DH[RY&VU=QE
M%J_3S6S2=T55A"M!MZ.*O>RYDTKV=T]T?QS>!M#T:\NKV#Q7H>JZ>9+)TT(V
MJFZBDNU"_9VBN!(JM:3E6<7"O)N 5TW*:]+_ .$6BT7PA<:>;Q4N]9NO(62_
M8N;4R$",[ED++M)7)R, $DYQG.\$:?XN-OI4R"TDTG6=.2UTB2]OT+6A"(D8
MA\QP (2"%!8* "B$@9KH],\.7MS=Z;I^HWEQKZV]^;J2U\-Z;=>(-6#1NH#_
M -G6*S7$L2R%8Y#M\M"Z\-N"U[=Y12;G9:.3LDW=*VL4GY7;NG^'AS2J.4)4
MXS3T<>2/-):))MQ;LE=1ZI;]S@=6D\3?;= ^'L TFYNM'FBSK&C$R-)%OSYT
ML[L0[Y<@,-G"X;@J*[?5/A[X?N+J_F@N-1U"_L;5+I]0U&..,QW\,0+QNRR2
M*T8F#*J[B2.64=#^G>@?\$O?CGXR^&<7QT\$>.M/\,_$7Q-H&J7\/P@\8^"+
M?2/MFFJ=_A[3O[<DU,-X<U?5H(!)*^H:1&EG]MMX;H6A@N7/S_XP_81_;<_X
M5_>^*I?@3?::-%U"P@\1>%++QAX5U_QAXALPC_VIK.@:?H>H7L=[9V[*NVT-
MS'J$J2K]CM+M8YFCP6)H-V]HKIV;=KW=OM/5^MV]DW;0V6#J025*BJ<;+EC2
M7LTDK?9I\L>9IVYG'F:YM>_YD:WXS\66U]%?:M'>:4=-<6VFW-G;F."\@A?:
M,2!1&Q8#[R[LD>HKVO2M8U/Q#I5E<:-:/9+;O9ZO>ZCJR+MFN+.2.YVH[*K
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M\9Q*Y:VKL?A)\;_"MG^S-\8/A!<^ O@'XMO/$WC73X[OXH^)W!^,<%QK$-O
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M $*%5]HVEG(4C&?E R>!U['K7/+-*3:7LI;:IU*"U5K:O 1MYIR?5K>Z[?\
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M9<JA2:CM=INFY?.39:>WMR2/[0M?P2Z[8QP8.A Y]:A:UMAS_:-MZ#]W<_\
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MCJCE4PF&Q.)K0@[XNK&O+E2G=\^)QU>KB*%KKEJX9VC)7C3:DX/ZKT#PU?\
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M'C]=O+W[*([J]$LOE@.JP(H!*#JRX+$=VV\YW'CBO]$S_@F+S_P3_P#V3O\
MLCWAW^=S7^;#>>+7O@3*H\PJ WS##9Z$+M.W)).,@<=LYK_2=_X)AG/_  3]
M_9,/K\'?#A_/[37\_P#C7C<-B\%D2P]1U%2Q>,Y[J2M.5"A=1YMXKELFM[7;
M>A_HY]#;*<7EE;CYXNE[*=>EP[RQO&3M3GG/VHMW2YT^FK>FA]W4445_/A_<
MX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MYU?\%;O^4;'[9'_9&-=_]*]/K_'WD_UDG^^W_H1K_82_X*PV-YJ7_!.']L.R
MT^UN+V[F^#'B#RK:UA>>>01SV,LK+'&K,5BBCDEE;&V.)'D<JB,P_P E&3]G
MGXY&1R/A1XZ(WM@CP]?D'D\@B+!'N*]_ 4:U; Q]E2J5>7%XCF]G3E/EYJ.#
MY;\J=KV=K[V=MCS\14A"N^><(7I4[<TE&]IU;VNU>QXQ17LG_#//QS_Z)1XZ
M_P#">O\ _P"-4?\ #//QS_Z)1XZ_\)Z__P#C5=7U/%_] N)_\$5?_D?-?>9>
MWH?\_J7_ (,A_F>-T5[)_P ,\_'/_HE'CK_PGK__ .-4?\,\_'/_ *)1XZ_\
M)Z__ /C5'U/%_P#0+B?_  15_P#D?-?>'MZ'_/ZE_P"#(?YGC=%>R?\ #//Q
MS_Z)1XZ_\)Z__P#C5'_#//QS_P"B4>.O_">O_P#XU1]3Q?\ T"XG_P $5?\
MY'S7WA[>A_S^I?\ @R'^9XW17LG_  SS\<_^B4>.O_">O_\ XU1_PSS\<_\
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M3W3=!G?]XL/F6]K<RPR3IYC&1U+U_EW#]GKXYC_FD_CK_P )Z_\ K_SR]?\
MZV*#^SS\<CU^$WCD^Q\.ZA@?3]U_^KMBL9Y7B9IKZMC$NT:=51=^77E<)1^Z
M*WVZNHXK#IW]I0OU?/!OIUO?O??YG^T-X4^)/P[\=V4&H^"O'G@WQ?8W,:RP
M7GAGQ-HVN6TL;J&5XY=-O;E&5@P(YZ$>M=K7^*UIGP8_:/T202Z+X!^*&D2C
MD2Z78:Y82 YSD/:M$P/ []A7<PZ/^VU;H(K>7]H>"(# CAUOQS&BC&,!5U
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MLSRZE>^OU%R5VTW)I8]7UNVM&W?76Y^%)\":ZT0BBU_PG]J;:4\[Q=X9BA1
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MJT<=UY:6<:[4@BBL8(8?LUM:*%6"V2-H80N8$C+,6_2[_B%[^)7_ $=%X/\
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MUC!=VA!.[YI[B20XR,$J%52>GR@]\X.#6C8^+%D?-M))(%.=MM"(HP>P,KD
M#C/,G8\=*_H1C_X-D?BE%GR_VGO T6>\7A76$;_OK[&S=AT(H;_@V3^*[\/^
MU+X/9?[I\.Z\WIW:W8C@8^7 ]JI<44E>TG%Z6<9..UF^][^GGMH9R\!<_G%P
MG#!RC9+W\1"2>W,N2SMHM/>U\NGXT_#_ ./^N>!'CN--UD:7)%P)8Y3+<18!
M(!E1A$A + "27.&< X)4^B>)_P!K_P 1^*=(FT[Q#J5UK^AF22[+:K?QRRV-
MVZG=J6CW5Q /LET$<^;' )[>]CV17D<C1Q,GZC-_P;"_$Z21WE_:B\'R@@A$
M?P[KQ6/.?N@VW;.1[_4@PR?\&O\ \3I H?\ :E\(L$X56\.ZZ54>@7[+@#Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R/$'_(!UO\
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M8'H/R%&!Z#\A7Y-2?\%(_A;\6-2_9DUWX8?%'Q?\*M/\2?M.^/O@-\5_A/\
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M_2*PKT6OB\P_WW$?]?'^2/H<-_N]+_ @HHHKC-PHHHH **** "BBB@ HHHH
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M.=P4444 %%%% !1110 4444 %>6_%'_CRTG_ *^KC_T2E>I5Y;\4?^/+2?\
MKZN/_1*5W9;_ +]A_P#%+_TW,YL9_NU7TC_Z7$\9KD;WX@> ]-\3V'@G4?&W
MA'3_ !EJL7VC3/"5[XDT:U\3ZE!S^^L-!GO8]5O(OE;]Y;VDB?*?FX->=_M/
M_$#Q!\)OV:OVAOBGX2MDO/%7PT^!OQ:^('AFTDC\Y+KQ!X-\ Z_XBT:V>'#>
M:D^HZ;;1-'M8R*Q4 YP?YMO"/[*G[$=K_P $RO@C\;/C[^SA\>_VI?C?^UY\
M.X_BQ\1?VF/@GX#U?XI_'/PI\4/%GAY?&3?$/_A(CXAT*Y\%Z;X*O[NWMO"]
MI \.B,=!6SU/3+B-[_S_ *FO7E3ERQC%M4Y59.<Y0BHQE&*2<85&Y2E)+:T4
MKN^B?C4J2FKR<DG-0BHQ3;DTW?6459)=VW>R1_5W5*?4M.MKRQTZYU"RM]0U
M/[3_ &;83W4$5YJ'V.+S[O[#:R2+/=_982)KGR$D\B+]Y+M3FOYVOB1_P49\
M9>%/@E^Q,?@M^U/\*OA;\+_BC^SA'XUL_CE^U%\/M?\ C'^TA\5M=\.RCPUH
MOA^S_9J^$6KP^(9;S74TJ[U?Q3XYL;C5M-BNYI;>RAGO;"X@U#F_#O\ P4$\
M5?'+2?\ @EO^TGKWPK^%S_%#QU\*O^"D&NS:]<Z-XD:X\&>+_@%\(_B-IEQ?
M> X]0U+3K[1-(\?7?@=6U_1]>LKS4;?1=4DT836MY:M=M'UVE?E7Q6I2W33C
M4J4877*W+1UX6<HQ4]7%N*DU2PTVKZ6]]:;IQC.2O>RUY'=)MI;I.R?]*U%?
MSQ_ ']O'_@H'C_@FY\:_C]-^SSK_ ,$/^"@.N^'_  !+\.?A]X.\3^'O&_PN
MUCQAX/O]>\%>*_\ A,M5\4:O9>(SJ[:>-0U_1%T*QM=(BFGTJRN)Y#!J,'TQ
M_P %-OVXOVAO@5\5/V2OV1OV0?"W@#5?VC_VP/$OBVS\.^+_ (J27\O@/X?^
M%O EMI5QKVL:GI6G&"YU6ZN!JZS1+'=.UM8Z5J"Q:9J-[>60@I8NDZ4JK51*
M+IKE<??DZJ@Z2C%-W=3GBHIM--M24;.TNA/GC"\6Y<WO7]U<E^?F;2MRV=]/
M2]T?L)17\F?Q5_X+8_MJ_ ?]G3]LOPC\4? OP83]LO\ 8J^/WP-^&GB/6_#]
MMJ]_\*/B3X+^,-SK<MKKNDZ-)>VU_HFHV]GH]N6,^H8:UUW3I#IEK?6FHV\7
MO,/[=_\ P5$\"_M+WO[%7[0&D_LO:1\7_P!IC]EWQU\</V6_%'@9?%[>%OAI
MXD\):'XC\0ZIX*^(+NUQJ7B"33]%\*>)H)-3T^-(UUBRTNZL+_4+"YF01]?H
M72Y:NO*G^[?NSG.I2C3EKI-U*<J:6J<K._*^8OZK4U]ZGU:][>*46Y+2SBE)
M.^^ZM=6/Z/=3U_0M%%JVL:UI.DK>WT.F6;:GJ5G8"[U*XQ]GTZU-U-$+B^GR
M/)M(M]Q+D;(VS6M7\"7[/OQ)^,Y_X)M?L%^-?V@-#^%WQQ\$>/\ _@IOX!;X
M1W?BC5?BE_PL?0_$>H_$CQH_Q)\9>-M9T'Q;X9BUS79?$LVGWGA47MUK>EFT
M2]76]+G<P"OTX_:;_P""K/\ P4H\,_%3_@I\OP*TC]FN+X-_\$YO%GP[O/$,
M_CO0/%%QXT\1>%O&<DMC9^'-*33]773KW4[Z6RUC5+_5+K^S%L;32UM[)FNK
MJ&"7.&94W!3G3J14H4YJ,4YSM.E.LVU:*48PA*2DF^:-FU%NQ3PDD[1G%ZR3
M;O%:2A!+3F=W*:332L]$WU_JREECACDFFD2*&)'EEEE=8XXHXU+/)([$*B(H
M+.[$*J@DD $U1TG6-(U_3[?5M"U33M:TJ[\W[+J>DWUMJ.GW/D326\WV>]LY
M9K:;R;B*6"7RY&\N:*2)\.C*/YB_A9_P4X_;>\5?'[P=\$?VJ? 7P _X5E^V
M5^P7\5_VG_A9X5^'0\7MJ_@#0]-^'_CK7]-\+^,_$5Y?6<^N3ZSIOA+4K;6/
M[.6V,"ZE8SZ9J=M/%/ GSY\(/VS?VDOV7?\ @B%^R-^T_P#LV77[)/P!^$VB
M6'[0=IXR^'?Q$M_BKXIOM>\7W'[1'CS3_ _A;X06^H^(/%GB75=5U^>T\1ZC
MK,&N^(KB*SFNWO4GTWP]ITB6-K'TFI22GR0A5G.ZY9KV4\.F^65ER\N(C-MR
M345\-[V7U6:LG**E*48QU;B^:,W\23=[PY;<MFWN?V$45_)5\8/^"SG[>7[-
M_P"R1^R/JG[1GA7X'_!?]I+]M#QMXXUCPWXJ\:>&/'$W@7X*_ 7PE#X*CL?%
MOC_X?^$XO$OBR^\2>(KOQ7'?V>D::E[J%CH(_P!+T.35I%M+5GA'_@O?^TOX
MM_8-_:R^*/@SX:?#CXM?'/\ 9<^,'PJ^'^J?$SX>^'/B&_PAUCX7?%:X\7)I
MWQS_ .$"URPT?QQ:Z9ILG@;5=,FTO4/[*>*YUK0K_5+'3H;:]L+E?VEAN9Q;
MJ1DJ7M7&4&I)>S]MRN-VU+V=I/3E5[.5[I+ZI5M=<K7/R73=K\RC>]MN9VM\
M7:)_6Q5+4=2T[1[*?4M7U"RTO3K55>ZO]1NH+&RMD=UB5I[JYDB@A5I'2-6D
MD4%W5 2S '\7?^"-7_!07XF_MT>&?C:OQ,^*G[./Q=G^&VL>#U\-^+?@;IOC
M_P #Z[=Z9XGM-=DOH?'OPK^(^B:1K?A?[!>:5%::'K%C+J&EZ^R:LL4Y73X+
MJ^_)7]L2#]HP?"W_ (.))?B#\5_"/C/PQX<\4_LX:3+X>T[P%K.BWDFHWWAC
MX#:[X$/AW4;WQYK=OX;T3P]X2O4T77M%33KX>)/$SW_BF&\T=;UM+2Y8R/L:
M=>$)3A4]K;WHJWLZ=6HTVG).[I.*<>9;R3>BDE0?M)4Y22<>2]DW?GE"*MHM
ME-;VULK6;:_L1N[RTT^UN+Z_NK>RLK2&2XN[R[GBMK6UMXE+RSW%Q,R10PQ(
M"\DLCJB*"S, ":?!/#<PPW-M-%<6]Q%'/;W$$B2PSPRH)(IH98RT<L4J,KQR
M(S(Z,&4D$&OYU/VB_P!JC]M?X):C\;_V>?VQ-/\ V;/C-H/Q=_8,^//Q]\%V
M/@7P9XL\-Z#X1UWX965E:>+?A9XNM]3\6ZE?>.?#$T.OVT$>OQW&@7VI)Y4T
M<=@5NK9O%/''_!4?]I'X.:Q\-/ VDZY^SC^R[X T#]G_ /9 UOX'>#_C;\*?
MBS;_  Q_:C7XB?!_P3XE\?Z!X8_:)T:ZOO!/P-TSX9W^J77@?0[7Q-;:Q=7M
MUI,8NKD*99XE+'4H-J49QY7RR4DE*,K<UFFU&W+9IJ;<FXPC&4Y1BVL+.25I
M1=]4TVXN.BT:5[J3::<;))R;Y4V?U-T5\V?M8?%WQ%\%_P!E'X[_ !N\&1Z1
M<^*/AU\'/&7C[PY%J*G4]$EU;1/#EWJVG"Z6UGMC?Z>UQ%&7\BXA%S#RDBAP
M1^6GPO\ VU/VZ?AI>_L(?$[]K*?X >)?@M^WIK'A/P='X;^%GA/Q3X:\6? /
MQ3\1? [>+?AA/-XAU3Q/X@M?B-IGB0K#9>*$.CZ!+X<N[MOL,E_:VGFW&]2O
M"G.,)*5VDVTKQBI34$Y.ZLN9I:)M7NURIM9PI2G%R3CNXJ+=I2:CS-)6MM?=
MK:V[5_W>HK^>#3/^"C'[<2?LW>#_ /@IKK>C_ <?L8^+OB9X<TBY_9[M-&\2
MK\9?#?P7\9_%VT^#?AGXD2?%:36FT75/&G]M:MI&LZGX-A\$Q:;'I<S+#J G
M,\-GH>+?^"@_[<^M?!;]HS]O_P"%>D? :#]DK]G'XG?$;PK:? CQ+HOB6[^+
M?Q=^'GP6\7_\(1\3O'2?%&VURRT7P3KTFI:5XCO_  GX:;P;JMM+:6L=KJ%Y
M-+%;W.L9?7*5KVJ?![5+EU=&S?MDK_P[)Z?'?3DNTG7U>=[<T/BY+\VGM+I>
MSV^*[7]WKS6U/Z K74M.OI[ZULM0LKRYTRX6UU*WM;J"XGTZZ>&.X2VOHHI'
MDM+A[>6*=8;A8Y&ADCE"E'5C=K\:_P#@F)XETWQG^TY_P53\8:-(\NC^*OVD
M?A%XDTF21'C=],US]GWP9JE@[QR*KQLUK=1,R.BLA)5E4@@<7\0OVQ?V[/B7
MKG[;GQ)_9=C^ 7A?X)_L'^+?%G@6]\(?%/PYXG\1>,OVA/%/PP\*0>+?BC#%
MXGT;Q%HEG\+=)T^TN%LO"EPFB^*+G5KI8Y+\V<,\@L[^LQ]FIN,GS3JQC&'O
M-JE*:E*[Y4ERP<G=]5%<TFDQT)<[@I)<L:;;E[J3J1BTM+OXI<O;2[LC]HM7
M\:^#?#^L:%X=U[Q;X8T3Q!XHF>W\,Z%J^O:5INL>(KB,HLD&A:9>W<-[J\T;
M2(KQ:?!<.I= R@L,]-7\R'[(MGKO[:7_  5MU/\ :D\93?"?Q'X-L?V,OV7/
MCG\/O"OB?X5W>L>*_AMH/Q)U#XEZIX2\,^#/%5[XP>RT#QYX)\66+S^*OB+9
M^'VB\96]C:0:;X>\.@"[/T%_P4O_ ."AW[1?[+O[0=G\.?#?C+X3?LW?"F#X
M/V'COPE\9/CM\&_BG\2OAS\:_BG=^(;_ $ZY^#-[XY\ 3PZ1\%H=-TRTL[NY
M\6>)(;V/?JD1$7EO$8X6+BJ4Z\XN--594X6<6Y1B^7G;;48J34K)R3T2U;BI
M-X=\\:<9)RY%.5[VC?HDDY-I-;)[WLDG;][:*_G@^(/[=?\ P4,\??$G]IK1
M?V?M4_99\*>$/V8/V1/@%^U%XDOM:TGQ#\5+'QCK'Q$^&FN>.=<^'O@SQ9HG
MB+P[87_AO5G\.^('T;QX^FF2"PL='9-*9M5GD@Z'X'_M]?MSR_$7]BSQ=\<=
M(_9_N_A%^W]\)_C'X^^'GPP\'V^N^&O$OP<O_AO\-[3XG>&;3Q-\4]?U:]TG
MQ'8>+M#O;%-6U:?PYI5MX=DN;MVMFBL8Y+A_7*7,H\M2SDH\W+[NM14;[WLJ
MCC%Z7]Y-)Q4G%?5YVOS0O:_+S6?P\]M4E?EN][:/6]D_W^K$L_$OAS49;2#3
M]?T2^GOUOVL8;/5;&YEO5TJ?[+JC6D<,[O<KIMS_ */?F%7%G/\ N;@QR?+7
M\Y/[+W_!5[XZ^-/VM/V8OA/X\^-'[,_QJT?]I7Q7\2O!'C+X=_ 7X9_$FWT[
M]G3Q%X6\'^(?&/AZWT_]HK4-2U7X<?&:6['ARZT;7+#1VL[[3I&>Z@AN[5&O
M8?FO_@F,S']IG_@FN"S$'3/^"M>02<''[1/B3&>><8&,],"H6.IS<?9Q<E*:
M@[M)Q<JF'@G[O.G[N(4K733CRR47>U_59+GYI).$'-63::4:CMJHM:P2O9II
MW3:M?^N6BBBNTY0KZDT/_D"Z/_V"]/\ _22&OENOJ30_^0+H_P#V"]/_ /22
M&O"SS^'A_P#'/_TF)Z66_'5_PQ_-FI1117SAZP4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% &1X@_P"0#K?_ &"-2_\ 2*:O
MEZOJ'Q!_R =;_P"P1J7_ *135\O5])D?\*O_ -?(_P#I)Y.9?'2_PR_-'XD>
M.O#/[97['?[>G[2W[0_P2_90UG]K_P""G[6O@GX1W.IZ;X!^)_PU^'GCCX:?
M%#X6Z+?>$XK'5;#XDZWI%OK?AC7=,E?4CK.DRLVF27\=O/:RFRD:X^6]3_85
M_:@U7]CWXE:_\8OV4_#OQA^*W[0__!2'Q+^V[\2?V=_"GQK'@?XG?!;P?XF\
M+VWA'05^"'QMT'QEX0\+_P#"[/AGINAZ=+8WUYK4GAS6[;6];L)&FD$<<G]+
M=%>D\)!\R<ZG(W4E&FU3<(2JR<JCBI4VY7DV^6HYQ7,THVLER*O)6?+#F2@G
M+WKR4(\L4_>LK+=QLW9:G\O/PI_8M_X*'ZS=?LSZA\2?"GQ3U/X=?"K]M[XB
M?$3X>>$/CG\7OA5\0_C9\'_V>M6_9MUSP5I!^(?CW1/$XTWQ;<:IX^U,VVFZ
M!H=SK^N:!!+)-?I%9W#"R]^\'_L0_M*Z9_P3U_X)>? ^_P#A>]I\3OV>_P!O
M+]GSXS?&+PU'XM\!F;P7\._!O[0'C[QGXM\5#6K?Q/)H>LR:9X6UVQU-M/\
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MC*ZFW.*YDD[35OB?P\KV['X3?&GX>?M__%'P%^S#\>?$_P"RSX<N/B/\(/\
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MZGX?U_1M0B6>PU;1=9LI].U73+Z!OEFL[^QN9[6YB;Y9(970\-5?PEX4\-^
M_"OAGP/X.T:P\.>$?!OA_1O"GA7P]I4(MM,T'PWX=TVVTC0]&TZW7*V]AI>F
M6=K8V<*DB*W@C0<+3JT/:U%)SE&"ARRC'E]^U2,TI<T9>[[MGRN,M7J$*O)!
MI13ES<R;O[ONN-U:2N]7HTUMZ/\ #+P7_P $^_CWXE_X)7?M:_LH>(="T[X<
M_%_XI_'G]HKXF^!;'5];T#5=(UJ'5/C[+\5OAP=;U/PMJVL6-IIGC>PTC2].
MO!=7/]H:):ZD)-4TV*:R>RJEXL^#?[:G[;WQ7^ _B'XG_LJ7/[)OA_\ 9B^
MW[1N@7%_XG^*WPQ\87'Q/^+7QC^$=O\ "_3O#'@>W^&GB#Q!-8_#K3;D'6Y=
M>\5+HIO-/5[ Z/%=A0G[\LRJI9B%5069F("JH&223P !R2> .356PU"PU6S@
MU#2[ZSU*PNE+VU]87,-Y9W"!F0O!<V[R0RJ'5D+1NP#*RDY! EX2F^5<TTE&
MG%J\/?5&HZE/FO!OW)R;]QQO>TKK0:Q$TV^6%^:33:E[KG%0E;WK:QBEK?JU
M8_E.F_81_:VUGX:?\$[/B/X]_9,^,]YK?[&WP!U7]C_XI_ CX9?M2>!?A5\5
M?$FAZ5X3\&C1_CY\*_B3X&^)^F^'+WP[J>N:'?Z3>^ -?\6:)XEO[)8GN-(=
M%L;N/T?X8?\ !.W]H[14_9F\8Z5^S;>_"UO^&_/C1^T9\1?!&L_M!?\ "W_&
M_A#X>^)_V=M2^&'A+Q9\4_&WCCXB:W9^)OB=X@U*UTNQ\4V?PTNM3TVWC.E2
MO!)]FU"^C_IUHJ(X&E%WYIM^YNJ5VX*"4N94E*[5.*:YN75VBM+5]:G9)1@K
M-_SVL[NUN>VEWK:^UWH?S[^#OV)/VF-)_P"">W_!+SX)77PO6U^*?[/'[>?[
M/?QI^+OAI_%/@.<>"_A]X+_: \?>-?%7BJ75;?Q2=#UX:9X8URPU*;2O"^KZ
MMK]_'>/8Z?87-\EQ;1>%_L]_L@?MN?"[]K?X5ZM\+/V<_B-^R?HNG_M)>)/%
M/[3FL>$/VD_#'C7]AGXL_ _4-0\5WFI77PS^!/BCQGXI^)7A/X@>.#>Z$;*R
MM-(T'3?"5W;WE\]AIKRV2VW]/E%/ZE2O2:E47LE3C&SA>U)1C'WO9\T;J*4G
M!P;3:T6@EB9I37+!J;FVGS6O-MO12LTKNUT[:>=RBBBNPYSW/X9?\@&[_P"P
MO<?^D5A7HM>=?#+_ ) -W_V%[C_TBL*]%KXO,/\ ?<1_U\?Y(^APW^[TO\""
MBBBN,W"BBB@ HHHH **** "BBB@ KYM\9?\ (S:O_P!?"?\ HB&OI*OFWQE_
MR,VK_P#7PG_HB&O9R3_>:O\ UXE_Z<IGGYC_  H?]?%_Z3(_$KQ5_P $YOVJ
M_ ?Q0_:/\5?L6_MT6/[//P\_:O\ B!K7Q6^*/PX\9?L^Z+\7Y?#/Q0\7:19:
M/XT^(7PQ\37/CGPM/H>L^(+?3=/EDT_4--OK&*[MK>Y::8V=I'';O?\ @E-<
M^"O@W^PK\/\ ]G?X]-\.O'7[#WC[6?'FC_$/Q[\-H/B=9?$K4O'6C:SIWQ-G
M\3^$[;QAX*-C?>)=0UNYU;2I[+Q!+#H*HFF_9[^()=1?I=\<?C3\/_V=?A-X
MY^-OQ4U2ZT;X>_#G16U_Q5JEEIE]K%W9Z:MS;V?F0:9IL-Q?7DAN+J",16\+
MO\Y<@(K,/1-&U>PU_1]*U[2Y6GTS6M-L=7TZ=HY(6FL-2M8KRTE:&54EB:2W
MFC<QR(LB%MKJK @>]]6P_-)6;DU?E]K4O",JBJ7A'G_=IU*:DG!1]Z.CTLO-
M]M623O97WY(*[4>6TGR^^U&5K2OH_,_'NR_X)*W-MX[T_P ;R_'Z&9[/]I3_
M (*#_M"RZ>GPM>)9C^W9HXTL>$TN3\1)#%_PK!A]H;6S!+_PF0/E#2?"Q'FG
MQ+P;_P $>?VH?AAX_P#V=/'_ ,//V]/A\UW^RW^S?X._9W^#FC_$?]CV3Q]H
M7@>#2-%LK'QIX\\,Z5%^T;X:L+'QAX^U&"[GN]9U&VUG7-'T.YA\,66MRZ=9
MQ.W[9?!KXP>#OCO\/M)^)G@(>(%\,:U=:U9V(\4>&=;\(:UYV@ZS?:%?_:=!
M\166GZM:1_;].N/LLEQ:QI=VWE74!>&:-SZC26$PTK3C!ZN,XRA5JQO:,%!I
MQFM$J<&NEXQE\6H_;UHWBY6M>+3A!VU=UK%]VGY-K;0_&7QU_P $IO&WQ2\9
M_$'XD?$']IC2-3\<_%#XB_L$_$_Q?J.C?!%]#TFX\2?L7OH]SKPT[1O^%JW_
M /9UE\6K_3;BYL[<7LX\ 17B6Q/C 6WFS)_P4C_85TSXH7'[3G[4.K1_$/XC
MIK/[$G@CX!Z5\&?A%X;TQ_BEINO?"[X\^)/CGI7Q;\#:_K7B2WTWQ#KOA^Z\
M11W-O\-Y= @G\00^&;G3[/6KV]U^VTJ']FZ*IX6BX3@H651R<FY2E>4G4;D^
M:33UJ3=G=.]FK)))5ZBE"7-?D2222C[JY?=]U*VD8JZUTWW/YEOV$=/^/O[1
MW_!2[X6_M$^*_C5\4_VAOAU\"_V2/B%X'UGXD^./V2O$7[(WAGP[XU\;^)/#
M%KI?PTT[PKXJGN=4\9_$:XLHM:\2^/O&.G7%QX7>/2],L=$^S6ZPQS?7W_!3
MGX-_'3XM_M??\$OY/@-XQUCX6^*/!OCC]I37C\68?AZ_Q(\)^#+F+X<^$;C3
MK+QYX>>_T6RO/#?B_P"P7OAZ[LI_$&A7=Y!<W']E:E;W\$4B?M714QPJ5&5*
M4Y2<ZM.K.5YW;A4I3LG*I.HKJE&-W4E)7;3T23=>]2,U!)1@X1C[MK.,E=I0
M47K)MKE2>S[GXNM_P2?\8^,?#/CW7_C+^TO;^./VBOB[^U/^S1^T=\2OBGIG
MPECT#PDV@?LP^(]%UCP1\(?!GP\C\>SR^']&&G:=?Z4?$]YXHU?4/.U&+4+W
M2]0&GP6<GT[^TY^QQ\3OB/\ 'GX=_M6?LU?'S3_V?OV@? WPS\3?!/5M3\5_
M"^T^+_@#Q_\ "/Q/XAT[QC+X5\1>$W\5>"=1L[W2/%^E67B#1=>TSQ%'-;3I
M-:S6<]M<S*?T%HJUAJ*BXJ+2DXR;YZG,Y1DYJ7/S<ZES2E)R4N:3;YF[LAUJ
MC:;DG9-)<L;6:46N7EY;6225K)+2Q_,U\:_^">'QR^%'QU_X)WZ!\'/CIXLN
MOCAXH_:4_;._:8^-/[5-]\(;+7_"L_Q@^('P\^'\VH7OBOX9:=J]EH6@^ /%
M-AX6LO ]CX2B\7:?+!I%J8='UR._@BEC^PV_X)/^,?&/AGQ[K_QE_:7M_''[
M17Q=_:G_ &:/VCOB5\4],^$L>@>$FT#]F'Q'HNL>"/A#X,^'D?CV>7P_HPT[
M3K_2CXGO/%&KZAYVHQ:A>Z7J T^"SD_:*BH6#H)S;BY*4E)1<ZG+&U&%&]N>
MTIN,6W4:YWSR3E9ZV\14:BDTFDTY<L;RO-S2ORW45I:*?+HFDC\YOVK?^"=O
M@_\ :Y^,P^(?Q!\;7-IX*O\ ]D;X[?LI>(/ =AX>5]4O+;XU:YX0UN/Q[I7C
M"76UATC5/!MQX4AGTO3)?"^IQW>HR6M[)J%M'9M:77D7P._X)S_'[PCXS\!7
M?QP_;"TSXE?#;X1_#SQ#\/O _@?X8_ #P]\#-3\7-KGAB+PA;>+/C9XGTCQC
MXF;Q]K6B:*KFSL++3- T>;6R==DMXGN+O3YON?\ :6_:N^#'[)/A_P"'/B?X
MV:WJVA:1\5?B]X0^!O@V?2/#FL^)9;SXA^.;+7;_ ,/:==VVBVMW/86-Q;>'
M-5>?5;F-+*U:&..:57GB5OH^J]A0E4E*UZBDIS2J36NCCSP4TFO=3C&2<=&T
MM7=*K5C!*_NM.,6XQTM:_*VKIV:3:=[.S/Y^-*_X(Q_&GP]X-_9;TJQ_:U^%
MGBCQ/^QUK_Q-T[X*7'Q+_9-M/&O@"#X6_$:ULS;Z5XK^'E_\8Q9:Y\3/!NN1
MWFOZ#\2+;4M++F2RTR30K<Z?!JE>T?"/_@DUXI^'OA3X;:'XK_:>_P"%B:]X
M'_X*<W7_  4EUGQ9/\'+#PQ=>+]:UKX=>(O"/B7X;2Z1H_CQ]'T)=4\2>*-4
M\4V7BG2[;[!I%@8/#5OX*EC@35*_9^BE'!X>+3C"2MRVO5JM>ZH1CHYM-I4X
M)-J]HI7M<'7JM6<ENW\,$[MM[J/=M^K9^ W_  5I^!GA7]MG]I/]B;]ESPKH
M/Q.D^)WA[XGV?C7XV>-/#_A+Q-I_@+P]^QGXBT[6(?C!X:\1?$6XTV#PC=ZO
MX\U+PSX8T'0?#ECJU_J]G=3R37UC;VNIQ0:K^S'QE^%%U\3/@CXZ^#W@_P =
M>*/@O?>)?!-[X4\*?$#X=7+Z7XE^'=ZMDL&@:YX>-O-:@_V)<06CMIGVBWM]
M2L(I]*FFBM[J1U]AHJXT8QG6F[.5=QYFDXOEC!0C&Z=VTK^]=/71*R)=63C3
MBKI4KN-W?WF[M[))72LK.W=W/P%?_@B=XE^)-Q^T!XI_:'_:4\'^(_B5\8_V
M:%_9MTOQC\%/V<M!^"4=JMC\3/"/Q;TWXO?$O3+3QSXF/Q5^)4OC+P+X:FU6
MYU"\T6VGTF+4-+@EB>[@OK+E_P!HO_@G;^U39?"_]J?]I/XZ_M6:?^TI\1O#
M'_!+C]L?]EOP+\-?A_\ L[)\-K74;3QM\.9]4T;4K!K'XB^,M5U7QIJVK:"]
MOJ\#6%TFN7.I:39Z/#HZ:2R:M_0)XJ\4>'_!'ACQ'XT\6ZM9Z!X5\(:#K'BC
MQ-KNHR&+3]%\/Z!I]QJVLZM?2@,8K/3M-M+F\N9 K%(87;!QBO#_  ]^UA\#
M?%GQ%^#WPN\-^++C6/%'QZ^".H?M$_"W[/H6MQ:9XC^$NG2>%(W\2-J%Y86T
M>F27"^-/#\UKI.JK9ZK)%=2%[.)[>5%QEA<,KKX)25DW5J-R;D^5R4JG[QJ<
MGRJ?-J[+<T5:L[OXH[NT(I))+F2:C[B<8I/EMHE\_P P?V7?^">'[0/C+PS^
MP[KO[6?[40^+7P=_9E\"^!_'?PB^!2?!*S^''BK3O'LWPK7PCX=?XQ>-8O&&
MJMXTOOACX7\0ZWX8L%@\)^&KK4[J675-9$>H->)=:WPT_P""4'Q?^%EWX%^%
MOA;]L*UTO]D?X>?%MOB;H'P[T?X">'=%^/5SX=C\97WC*U^#6M?M$6'B]+N]
M\ F^OI+;4M2MO!-CXEU+3,Z6UW;VP1D_;:BK6$H)1]V3E'[3JU7)W4$TY.HY
M.#]G#W)-P]U:$^WJ:V:2Z)0A9.[=TN6REJ[R6NKUVM^=_@W_ ()Z^$+#]G?]
MM']F[XA^,[GQQX._;*^.7[4_Q?UV^TW0%\+:EX+L?VEO$E]XBBT#2S+K7B&/
M4=9^'T]U!+I?BF3[!%JFI6-MJ#^'M.0&SKR?X<_\$]/VA+_4?!VA_M4_MKZK
M\=?@U\,_A!XX^#/A+X7^"/A5%\%$\8Z+XY\&1_#Z\\1_&W6--\?>*[?XAZ]I
MOA(SV>G6L&B:'H\>M'_A(_LPGN+K3W_0#P[^T!\,?%7QQ^)'[.NBZS=W'Q5^
M%'A/P5XU\:Z+)I&I066G^'_B =1'AFYM]9FMUTR_ENO[,NC/;6EQ+-:#R_/1
M2Y"]7\5?B5X2^#'PO^)'QA\?7L^F^!?A1X"\8?$KQIJ-K97.I75AX3\"^'M1
M\4>([VVTZS26[OY[71]+O)X;*UCDN;J2-8($>5U4OV.':4DE:DN2ZJ2Y4H2Y
MG&I:5I*$DVU4YN5WVNP52JO=O9RM)7C&]Y124HMJ\>:-E>+5UOT/RH^&?_!,
M'XU:3<?LO?#KXS_MD'XN_LN_L8^._ WQ"^ _PFL_@?HW@?QS=ZU\(K*YTSX)
MV_Q2^*EMXTUL^+=/^%MA+;164.E>$_#A\2W%E9W^N'[5:0,.L\&_\$OI?"?[
M-'[('[/!^-T=^W[*G[8_@G]K)_%P^'+6J^.D\'_$/QKX\_X0)=!_X3JY/AIM
M1'B\:7_PDYUC7Q:'3S>_\(_<BZ^R6_ZA^"_%NA^/_!WA/QWX9N9+SPWXU\-:
M%XM\/7<UO-:2W6A^)-+M=9TFYEM;A([BVDGL+VWE>WG1)H68QRHKJP'2T1PU
M!).,6_=<4W4J3?)+V;LG*;?+^ZIV5[*SY;<TKIUJO\UM;V48Q][76RBM?>=W
MN^NRM_.O_P %2/V#_'MUHGQ\^*'P[\;^)]5\2_M<_M<_\$Z1:Z=X-\!7%YKW
MP5M?A%XNT[P;>>.(K^'6=43Q+'8+J0\6R3W.C>'K'15TX6]Y+>0NUVGU?IG_
M  31^*'Q0\3?'/Q[^VA^T_8_'CQO\4/V1OB5^Q3X,O/A_P#!VP^#F@?#KX3_
M !85I/'7B=- 'C+QH-:^)/B2^BTZZN=7-]IUAI]K8_V18V9L9AY7Z\T4OJE'
MGE-J34G?DYY\G,YU)RDX\W+)N5637,GR/X+*UFZ]3DC&Z]U6YN6+?+:"23<;
MI)02=G[RWOK?\2OAG_P2X_:0A^)7[+7C#]H7]MW1_B_X3_9'\ >//A3\./!'
MAK]G6P^'4^J^$/&7PT'PR76/$GBE?B=XCN;CQO'I-KI,^H:FNERZ5=C31##I
M5O<W5QJ3<]X4_P""0GQ8\%_";]G3P[HG[67@^7XO_L>>+OB''^SM\1]6_9JT
MK5O"H^"OQ%TK[)K7PA^+GPZU/XEWT?CNXEU)[C4H/'6D>(O">H:<)EAM='::
M%+MOW6HH6#PZ^Q)M[MU:SE_RZL^9U'*\?8TG%W]UP3C9WN?6*KM>2LMER02M
M[W112UYI7[W=S\C_  [_ ,$S_B#<:9\$M5^*O[4,WQ!^)/PV_;J\&?MJ^)]:
ML_A7:>%? E_;^"_AQX]^'NE_!3X:?#S3/&;V7PR\*6T7CB758/$$FI>+-2GO
M+:[;4M.OI-0AETW]<***UITH4DU!-7LW>4I-M))-N3;;LM7?7=W9G*<IZR=[
M7MHEOZ)=MNG0[;X??\C-:_\ 7O>?^B&KZ"KY]^'W_(S6O_7O>?\ HAJ^@J^:
MSK_>X?\ 7B'_ *74/8R_^ _^ODO_ $F(4445Y!W!1110 4444 %%%% !1110
M 5Y;\4?^/+2?^OJX_P#1*5ZE7EOQ1_X\M)_Z^KC_ -$I7=EO^_8?_%+_ --S
M.;&?[M5](_\ I<3PW4-/LM6L+[2]3M8+[3=2L[G3]0LKJ-9K:\LKR%[:[M;B
M)P4E@N())(98V!5XW96!!-?CIHG_  25\8?#'P_XE^#O[.W[??[2OP$_96\3
M:IK=^?V?/#FA_"_Q.GA.P\2W=Q>:[X:^'GQ4\8>%]6^(W@KPW=2WEXL&G:7J
MY:W6X>26:[NI+BYN/V7HKZZI2IU+.:;<;I.,I0DE*W-'FA*+<967-%OEE973
MLCPX5)PORNR;3::4E=;.TDU==':ZUL]3\A]:_P""2'A'PMX@^#?B']EK]H7X
MK?LMWOPF_9SB_92FN/#FB> OB7J7B;X,P^(=0\4+9IJOQ.T#7[KPMXP?6M7U
M2Z?QGX=^RZA$;F%+&&RCLX4*?#C_ ()!_#/X<^!_V;/ 5I\9/B1K>D_LQZ1^
MUUH'@^\U>P\.2:KK6D_M=>&_%_AWQ*GB*\BM8Q<W_A3_ (3/4]3TF_ABB?4K
MU8QJ,7D$QC]>:^>/VDOVE? O[+OA7P-XO\?V.OW^F>/OC'\+_@EI$?AVTMKR
MZ@\4_%?Q)#X8\/WE['=7EDD>D6M],LNI3Q/+<16X+0VT[X2LY8?#QO.4%%)*
M_O24(J,J<U:/-RQ7-2IMV2NX*]RU6K.T8R;;=EI'F;:E&U[7>DY)7>EW:Q\\
MV/\ P3O\"6/PK_8*^%:_$'Q;)IW[!'B_X>>,/!>J&QT=;WQW=_#SPG?^%+*T
M\3Q"(P6-OJ$-\UY=-I6R6*6,11-M8L%_;Y_X)W> ?VZ[+X3Z[<_$7X@? WXV
M? 7Q1=^*_@Q\<_A?>I;^,/ U]JJV*:Y:0VMS(EC?V&K#2],ED$A@O+2[TZUG
ML[R%#=P7?Z&453H47"5-P3A-04E=ZJ"2AK>Z<5&/*TTTTFG?4E5:BE&2D^:+
MDT[+1R;<NEGS7=T[IIVM;0_E(_X*"_\ !'?Q'\(_^";?QU\"?L_#XT_M=_M/
M_M"?M&?!OXF_&KXD:X#KGQ.^((\+:WKGDWQTRTF:VL=,\+VWB#4[@_93/=/+
MJ5W>7MS-$EO%9_IE^RM_P2$\'? 7X^G]I3XI_M'?'7]J?XE:!\+[_P"#/PHO
MOC-JEC<?\*J^&FJVEUI]YH&E/IP#:M=G2KZ^TM=0OA'&L.H:G.++[9?27"?L
M+7SOI/[2W@36/VH_%O[)=M8^(%^(W@[X/>'_ (UZEJ,MI:KX9E\+>(O$UQX6
ML[2UO5O&O'U>+4+<R3V\EA' +9U=+EW#(,5A,-3JQJ-).U.G2BV^6,H.I--*
M_OSE*<I7GS/F7,GS79I[>M*$HIO7FE.2M=Q:@K;>ZH\J5HVT=FK(_'SX<_\
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MO]FN\^$%K?1^$-5;4?#0M]4;6;O19_$VH:E-:^(8=52PCNS/^@W[/OP9UO\
M:0_X*1?'5O'7QU^/ND_#K]F+X=?L">/OAU\(O OQ2\0^$/A_<^-+[X0>'?$M
MU>^)]%TR81:WH>H-H]S8ZQX;9K?3=7@UG4Y+Y);F6*:']1/B7_P38_80^,7Q
M(\0_%WXG?LN?"CQG\1?%MG)9^)?$^L:%))=:WYMI]A>^U"UANH=.GUK[)B!-
M>:S_ +;C54:._61$=?I'PA\&/A9X!\8>,/B!X-\#:#X=\9^/]+\':+XR\1:;
M;-#J/B'2OA_H_P#PC_@NPU"0R,DEOX<T7_B6Z<B)'Y=L CER 1ZL,'/VT)U'
M!QC*#G:4W*MR+$>]--)*4I58-Q3DER-\SM%''+$Q<'&*FGRR4;J*C#F=+W8Z
MM\J5.5G9/5;:G\J_P"_;#^+7['?P<_9<_;L^+'Q$^(7Q$^#/Q5^$?[7G[/'Q
M!T7Q/XE\0>)-.M?C=\/?B)\6/C#^SYK=M9WMY>;?$_C6T\,^)/A-:3QQPI<:
M<UA9W%RLMGI,$MCQ-:?MDS>.OV#OV1?'[?%_XV77Q1_92\??MH?%KP+HW[65
MY^RWXB\=_';QY\1HK_4O X^+3I>>(;O0/@AX;\06]I;?#;PM=Z1!?+YWB.TA
MM=)T?4;,?TL:A^QQ^R[JOP>T;]G[4_@?X"O_ (+^'O%-MXUT3X<7>E-/X:TW
MQ79^(+KQ5;:[:VDDS.E]'K][>:EO,I5Y+JXBD1K>9X6T?VA/V3_V<?VK?#NC
M^%?VB/@]X,^*^B^'KZ74O#\'B;3V>[T&]G@%M<S:-JMC-9ZMI?VJ!8X[N*RO
M8(;M8;?[3'*;> QI8*O[-1=;FY844H\SLY)4O;QDY0FG&;I)P<J<VN>HG&TF
MF_K-/FNJ=KN5Y67-;7V;24EK'F:DE*-[1:DI*Y_,G\*M9_:0^/\ X@_8"_9W
M^+?[1GQ#TOPQ>_M@_M\?"?Q!>_"#]HU/%_C'Q%\%OACX$^'7B7PU\*_B/\9?
MA\NC'Q+XL\+7.J:[X$UOQ1;QVFNM9V[:KI%UI;ZC:2V_Z_?\$J9O%/A+7/V_
M/V=]4^(/CWXB^!_V;OVR=8\!_"34?B;XIU3QMXPT#P#KGPJ^&OC.V\)7?BO6
MY[G6=:L-%U77-3;3[G5;JZOB+R=IKB3>H3[O\)?LG_LW^ K?X-6O@OX,^!?#
M%O\ L]1^(X_@O#HNCQV"?#T^,-.BTGQ5/H:P.@^V>(K"&.'6;Z\^UWFH.IN+
MF>2Y=YF]"\%?"?X<?#G6_B)XD\#^#]&\,Z[\6O%J^._B1JFEP/%=>,/%Z:+I
M?AU=?UAVD<37XT31=+TX/&L:>19Q_)YA=WUH86I2G&<IJ33LVW)R=/ZO2I\F
MJ2TJP<]DFK2=I:**E>,X.*BTFM+I:2]HY-[MZQ=GYM[[G\/O_!0/]H']H/X9
M_M\_M-_&#Q)^T#\:_'?P4^%/QX\(:'H?B7]E3]JGPMX=U#]FK3+;6)+*?X;>
M,OV===M+T^*=89[&ZTS4H[K3M,TRXU6WFFD\3SM?S69]D\6?&6S_ &L/VD/^
M"A_Q._:;_P""F?QI_87A_90\7_#72_V8=/\ #NN7>E:;:_#Z[OIIH/&VI_!7
MPN]IK'Q-U;7K./2+Z^TK0H9+^TOO%$=Y?FZTW3?L!_J%^(?_  3=_83^+'QA
M3X_?$;]ESX2^+OBZ+_3M5N/&6K^'A+=:GJFDS13Z?J.N:='/'HNO7UO)#$3=
M:SIM]-.B+'<O-&-E6_C+_P $[/V'_P!H3XF:1\8_C1^S+\*_B'\2]$ATFWL_
M%FO:#OOI[?075]'@U:"UGMK#7H=."1PVT>N6FH*EI%!9$&S@A@3E> Q/-4?M
M:<HRK.HJ<YUN65U52<Y0Y9KDYXRC&\FY07[Q)1Y=5BJ5H+DG%Q@H\\53NK<E
MTDTXM/E=V[;_  O4_GG\/?#[XG_M]_\ !6[XL_!:Z_;E_:,TCX"^%/V+_P!E
MKX\V6J?"3Q'KOPQB^*FOZA\/?@X=)\5#PI.\4?@G2_&$_C#5_&NM^'X-.MKQ
M;R^@TVY6)XI7C_*7XO?MA?MX>.OBY^UO\>=-^)'Q2^'_ ,3?@7^U7J_PL^&L
MNH?MM?!#X.?"7X/>&O WBM+'1_AGXM_9Q^)-]INN_%4WUK9_8]6\9Q:C#HNL
MW4>K-JW]JW"ZXB?WL^&_V=/@=X/^,'BGX_>%OACX5T'XQ^-?"&B> ?%/Q TR
MQ:UUS6?!GAN/2X="\-W+1RBT72]*AT32(K.W@M81%%IUK&"4B45XA\0?^"<'
M["OQ5^,$/Q]^(G[+?PC\6_%V+4K+6)?&FK^&XYKS4M6TYHWLM2UNP26/1]>O
M86BC/VG6M.OY90@6=I5&*JI@*TXOEK<LY5ZM2;4YV<9.3I6<E-QE13]V*2U;
M:FI6F*&*A%^]!RBJ<(Q3C'222YM$XJTK+[DN6VA_(Y^W=^UM^V9\<_VR/BGX
M,U[7/BCX*L/@9^RG\,/'O@;PE\*/VR/@Y^RCX:\'>-_%/PY\/>,]9^+OB#6?
M&=S<:-\;M+M_$.N7L9\*^&-3%[>Z';:=%IFKVEC;QW%S[9'\2OVL/VPOBC_P
M12^$OQ9_:7^*/PYN_CU\#OCII'QM\6_L^?%K0X)/B7I?@OQ%J>E6OB"W\2>
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MJ/Q>\:7MYJ'BGXBI<BX2_P!/\5ZW=ZA?27NJZ9=V<[)>7-NA2WFDB95_8?\
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M75AX.U(W_P#Q*])A:VMA#^_?PH_8/_8[^!NA^-/#7PI_9V^&7@S0?B/X/C\
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MUK_U[WG_ *(:OH*OGWX??\C-:_\ 7O>?^B&KZ"KY;.O][A_UXA_Z74/:R_\
M@/\ Z^2_])B%%%%>0=P4444 %%%% !1110 4444 %>6_%'_CRTG_ *^KC_T2
ME>I5Y;\4?^/+2?\ KZN/_1*5W9;_ +]A_P#%+_TW,YL9_NU7TC_Z7$^)?VH)
M9(/V:/VB)H9'AFA^!?Q;EBEB=HY(I(_ 'B!XY(Y$(9'1@&1U(96 8$$ U_*7
M\'/V%_@??Z+_ ,$/996\?K??MH?#?Q1!^U9J$7Q-^($4_P <_#>B_!73OBYI
MW@WQGY?B55?PO9:YI=GI5EI>G?88K7P]"FEQ_N0V[^QW4-/L-6L+W2]4LK34
MM,U*TN=/U'3M0MH;RPU"PO(7MKRRO;.Y22WNK2ZMY)(+FVGCDAGAD>*5'1F4
M\?9_"WX9:>G@..P^'7@2QC^%EO-:?#!+/PCX?MD^'%I<:4="N+;P&L.GHOA"
MWGT0G1YH?#PTZ.72B=/=6M#Y-?48C#*O*$I<MH<NDE?15J52=NW/"G*F[;J3
M3TNGX]*LZ46ES:MMV=KWA**3[VDU+7MW/Y%+"U\.>!;R']DGQ]XR\4^ /^"=
MOAS_ (+#?M!_!SX@V4GC;Q+I?AGP[X T;P'I7B3X-_"'Q+XW?58];T+X8ZUX
M_N9[6^M[SQ#::=<)N?4KAFC,]4_BM_P@WA'X@_&GX.?LN>)$\4?L5_#_ /X*
M&?\ !*J_^'5II/C"_P#&WP]\!_%WQ+XRU&X^)G@[X:>(+R]UB*;1IXK31=2U
M[2M.UF]T[P_J"V$-K!:C4&1_ZZ-1^#'P?U?0O&7A;5OA3\-M3\,_$76;GQ'\
M0/#U_P"!O#%WHGCGQ#>FV:\U[QAI4^ER6/B76KIK.S:XU768+V_F:TMFDN&,
M$12AHWP$^!GAWP?H_P /M!^#7PJT;P'X>U_3O%>@^"],^'WA.R\*Z-XJTB\C
MU'2O$^EZ!;Z3'I5CXBTW4(H[^QURVM8]4M+V-+N"Z2X42#G^HRV4X):M/D?/
M&+IRIJBGS65%753E2^-;;2CLL7'=PD]KKF]UR4HR=1K=U/=<5*_POU3_ (C-
M6U#XF^)=-^/G[0?Q!^+'[-7PF_;"T#]L'7-%C^+WCSXS_'J/]KGX;:YH7Q/T
MW1_!'PT\(?L_^"?"_B73=8^'&H^'UTO2+#PQH7@[6M UC0]5NKR]C2YMB]E^
MA.O6?[&7Q'\1?\%)_BE_P4=^+7BCP'^TW\%/VD?$NG?#6YT3XD>(_#GQ8^$/
MP@T*VT*7X&S_ +,?@I[[2H=93Q3;2-<B_P!-\+:A+XHN[MY?$[1,7:#^F34O
MV?/@+K/Q'L?C%J_P5^$^J?%K3&A?3OB;J'P]\)WGCZRDMX5MK:6V\77&DR:]
M#-:VRBWM9DOQ+;09A@>.-F4R>*_@#\"O'GC30OB1XW^#'PJ\8_$+PN;=O#GC
MGQ1\/O">O^+]":SE\^S.D>(]5TFZU?3S97'^D61M;N(VDY,]MY4I+THX"<4U
MSTZEY)VJ0E*,FE->TFE)7JWG?FUEI9S=X^S'BHNWNSC9+6,DI+6#Y8MK2%HM
M6VV]W1\WX#V7[3OPJ^#?QT_X++-\7OC"O@B?Q9^RE^RMXM^&MC\6=:LO"/CG
MQA:M^S'\1--N[O1_#=VVEF?QA=:]J>C6NN:+X>TZ&Z@\07\-L+"#8J0_DAK'
MC[XR>#_V>_$7BWX3Z[KNF>,IO^",O[#^G>(_%FFW^JQ:YHGP_P#$/[1WA?1/
MB9KJZGIMO?:U:QVO@B_ULZIJNGHVHZ9I3WVIV;&YLXD?^V3QQ^S[\!_B;XIT
M/QQ\1_@K\*/'WC/PS;_9/#WBOQI\/?"?B?Q%HEH))9EM=+UG6M)O=0LK=)YI
MIXH+>XCBBGEDGC1)79SKZ)\'/A%X:8/X<^%?PX\/N/!MI\.0VB>!_#.E,/A[
M8-(]CX$#6&EVY_X0VR>65[3POG^Q+9I9&AL4+L2ZF"J5+Q=:,8IUG&2C+G7M
MIRFV_>M>+E96:TBG>[LE#$PC9^S;?[N\;KE?)&,---+J-]4]6?QX>']%L/A1
MKOQ]\)?#+]IS]F7]F'X5^,?V"_B%JOQ*T?\ 8V^(7[3/[3ND:6+;6=)M_!GQ
MV\2RQ>$O$<?A?Q;'=ZM=>'/$$MKXIT7Q;JOAW6K_ %L:=<W%C<377V__ ,$9
M]2\#_#+]K;XA? W1?"'PVTSQ!XF_9G\(?$27QA^R?^T1KWQ?_9@^(6BZ1XF3
M1[;QKXI\ ^+8-2\4?#/XU:M+>[KRXU3Q+'<ZMIEQ.MWX:TV:>.YO?Z&/A_\
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M:P))^Q-^SK\&?C!\3O\ @C7KWQ-\#V?C35_'.@?\%9W\6W^M:EK<\^NGX/\
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M?M,JTL:L/VBOCCE6=589^)_BDC@D'D=*_=/ _P#Y&F>_]@&%_P#4B1\-QO\
M[I@O^O\ 4_\ 2(GB=%-5T?E65AZJP/\ (FG5_1Y^;!3'C20;9$5QG.& .#V(
MST([$8(I]% 'WY^RO_P4W_;(_9#N=+L_AQ\5=2\1^ -. @E^%/Q&>;Q?X(FL
M-\;M::8FH2MJ_A9U\L?9[GPWJ6G&'F-XI[62>VE_JM_8C_X+A?LS?M27FA^
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M5+C1?A[\,_#=_P"+/%VJVFG7NK7-CHNFH'NIX--TZ&>]O95#*$@MH9)')X&
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M>#;7PKK+:G9VUE)X<N[?4%OXC<3ZG>P-#&M@9)/1OV:OVJ/C7KUGX7E_;1\
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M/A]K?C/1;'Q??>)O',,$_@_1;?0);H:E)?>(X;FVDTF,6^+M;FW\MB9X@[/
M/[8'[+/Q4^)VO?!?X;_M!_"/QQ\5_#!U :[\/_#'CG0-8\4Z>=)E,.J*^E6=
M[+<3-ILBNM\MLLS6GER-.(UC<K^/W[#/[+NG6G[:_P"UKXE^,7PAU+QKXX\
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M4W=Y I>:19(9;GC/VQ=+OM&_X*>^(?[/T+7-%\2?M#_\$H_BG^S[\!/'^G^
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M33;F>2U\[RY1;S2*(+DQ3""60Q2!?Y6/VDOASI?[4/CO]I#XU? KX->,;?\
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MG[2'QE^&?PE_X*+_ +('QO\ !'B7QS^SKX5\!_MK_%?X9>!-$U&+XH:YX^\
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MY'Q#IWCKX@?LQ_\ !0?]J[XZ>+/V&/VH?C1X'^-G[,7[(_@[P)XY^&'P7O\
MQG>KXG\*?#_6&\3_  UU:TU 6=[I-IK5_J-E:>*+QD:PT36M M-.\50I=2:9
M&GQE:?L*?M6?#SX0_LO^#-5^#'CC4M>T3_@GQ_P4DTKQ%H_A;1[WQ3IGP^\8
M?'75]1\8?#KX.2ZKH\-U8_\ "0P6.O6OAK1M(CGEN+^[TVYM;#[6;=W-RQ&(
M2J)>]:=2UJ=12II8F$(*4[\L^:G-RCRQ248>]S)L4*-)N+>BY(WO*#C-^R;E
M:-E*+4DD[MN\M+71^POPC_X*8>$;72[_ ,:_M(_$GX7>%?"P^ /[&OQ&?POX
M!\%?&?Q3\0O!OC/]HOX8ZOXWU>#QE8:)X1\1Z;+X7UJ[TV<^ YO#UUJMQ8V&
MG7L7BN:RNY]/%U[CX;_X*E?L#^+/AO\ $_XN:+^T5X>/P_\ @UK.@>'/B/K>
MJ^%OB'X=N/#_ (D\4M.OAWPY'H/B'P?I?B/7?$.L-;S+8Z%X=TC5M5F9,"T!
M9=WX8:=<_MT?L=Z#^T'XV^#'[)OQX\7?%7XD_L4?\$L_@;\/-4T7X1>)O%EM
MX(\8>$?@9XOT3XI^*+_0K?399=;OOA!.K6>K^'D7=9^++W0M.UL007+139GC
MC]FK7?%/[)/[./AC]G+]G;]O[PA>?LG_ +5'@K]H?]HO7?&OP;@^&7[1WQ^U
M_P 9Z-XLTSQM\8OA;;>-CKUG\0/B#X3\175MX@A\/R07C:7I']E:9:"66"VO
M+=+%UU%)*,I1A-RC.E4YVU.48.,E-*=HQ=2HE&-HQY4[S3BO84FTVW%2<$G&
M<.5+EBY-KE?+[SY(MR;<G=JT7S?TN?L\_M5_L_\ [5GA[6_$WP#^)&G>/=.\
M,ZJFA^)[0:5XC\+^(_#&K36R7L%AXE\'^,]&\.^+?#]Q<VDBW-HFL:)9?:X=
M\EL95CD*_0E?AW_P2N^$/BBS^/W[67[16K>#/VQ]*TCXGZ#\(O!6G_$C]L_4
M/"?AWXD_%NX\"6>MM+J ^$6A> O#FK^%=/\ !L.HQ>'M*\3:YK^IMXFL9Q%:
M64,.G*8/W$KOH3G4I1G-)2;ELG%-*32DDVVE))/XI+6\92BU)\M6,85'&#;B
ME'5M-ZQ3:NK)V;:O9;:I/0****V,PK7E_8^_9/\ %EO'K/B7]FCX#:WK.MQ1
MZKK.KZC\)O MSJNK:IJ,?VG4-2U'47T,WE[J%]<SS75Y>7$TES<W,LEQ/(\S
MLYR*^I-#_P"0+H__ &"]/_\ 22&O*S7%XK"1HRPN)Q&&E*4U*6'K5*,I))-*
M3IRBVD]4F]&=^!ITZDJBJ4X5$HQLIQC)+5]))H^)/%?_  3#_P""?OC0EM=_
M9,^#7F%643:/X6A\-S*&4*2DOAV32W1L $,I#*P#*0V37R%\1_\ @@/_ ,$\
M?&R22>&/"7Q%^$U^_FL+GP'\2?$%W:F1U4(7TGQS)XQT^.*-ER(+"&P5@S@M
MRI3]K**QP?&7%F7RC+!\29W1Y=HK,L7.GZ.E4JSI27E*#7D;U\FRG$IJOEN!
MJ7ZRPM'F^4U!27R9_);\9O\ @VL\5V4=UJ'[/O[2>EZWY<4KV_A;XN>%)=)N
M)I!*S1PIXP\)SWEN/W!2-1<>$T#3(7ENDCEQ#^+_ .T/_P $U_VV?V7WGN?B
MA\"?%%UX:@A%P_CKX?QGX@^"TCVJ7^V:MX<CN;C2'C+%7CUNPTUF*N\/G0J9
M:_T<J1E5U*LH96!#*P#*P/4$'((/<$8K]%R/QVXTRR4(YD\'GN'6DHXJC'"X
MKE72&)PD:<4^\JN'K-]>Y\UCN <CQ2D\-&M@*CU4J-1U*5_.E6<]/*$Z?J?Y
M4J21RC=&ZN 2"5(.""00>X((((."*?7^A)^UI_P23_8S_:X&J:WXC^'L7PX^
M)E^L\R?%#X6+;>%?$,NH2_:)/M?B#3;>W;P]XK\VYG,]ZVMZ7/J-SM BU.U?
M$J_RC_ML_P#!&W]JG]C]-7\8:+IS_'CX+:='=WUQ\0_ FES)K7AK2[=6F,_C
MCP0+B]U32XK>W61[O6=(EUC0XEA::[N]/\V*"OZ X1\8.%.*9TL)4K2R7-*G
M+&."S&<(TJU1V7)A<:K4*S<G:$*GL*\_LT6?GF<<%YOE2E6A!8_"QNW6PT9.
MI"*M[U6@[U(K=MP]I"*3<II:GY)U]Q_L(?M[?&+]@SXI1>,O -Y/KOP_U^YM
M(?B?\*KZZ==!\8Z1'/"9KNQ602PZ)XPL[>,KI'B*UA\] 38WPNM-GN+9_AI'
M215>-E=&&592""#W!%.K]'S/+,!G.!Q&6YGA:6,P6+ING6H5HJ4)Q=FFGO"<
M))3IU(.,Z<XQG"2E%-?,X7%8C!8BGB<+5G0KT9<T*D'9IK=-;2BUI*,DXR3:
MDFFT?Z;O[-'[27PL_:Q^#WA;XU_"#78]9\*^)(/+N;9V1=5\-:_;PP/J_A3Q
M%9HS-I^O:++<1Q7MJYP\<EO>VSS65W:W$OO=?YYG_!,;_@H!XI_8.^.UAJM]
M>W]_\!_B#J&G:-\9?",;--!;Z?+<16\'Q!T:SV2%/$GA.-VN9%M5CEUO1TN]
M(F9G>SEMO]!?PQXFT#QGX<T+Q=X5U:QU[PSXGTC3]>T#6M-G2YT_5='U6UBO
M=.U"SG0E9;>ZM9HIHG'57&0#D#^%/$G@'$\#9S[&#J8C)L<YU<JQDEKR1:=3
M!XB27+]9PW-%-JRK4G"M%)RG3I_OG#7$%+/L%[1J-/&T.6&+H)Z*37NUJ:W]
ME5LVKZPDI0;?*I2W****_.3Z0**** "BBB@ HHHH **** "BBB@ HHHH R/$
M'_(!UO\ [!&I?^D4U?+U?4/B#_D ZW_V"-2_](IJ^7J^DR/^%7_Z^1_])/)S
M+XZ7^&7YH^1/VA_V"?V.OVK]?T;Q7^T+^S[\/OB=XIT&QCTO3/$VLZ?=6GB&
M/28;F6[AT>YUK1KS3-1U#2(+FXN9[?2]1N;JQMY;N[>""-KNX,ECXB?L)?L?
M_%?X0^ O@'X__9\^'.O?!KX7ZG::U\/_ (=#29-)\-^%=7LM-U/2(-2TJTT2
MYTUHKTV&M:M%<W,DLDMY+J%W=WC3W<SSGP#1_P#@IY\!="_:4_:=_9^^/7CK
MX5? 8_ _QK\+?!O@36_'?Q(TC1+SXIW/Q"\%3>*KZ2STO6ETT69T&X2"QE:V
MN;ZW9;R"2YFMG9$D^A?%G[3>B^"/CI)X*\5ZU\)_#WP<L/V9M8_: UGXE:S\
M4]"T_P 1Z8NF^/\ 0?"D,TG@B?;.WPUETG6'U";XD_;QI$&M"RT$HT]]%(?4
M3PL^>2C2DY2=.J^1.3<9.-JBY>:RE'1S7+9*2?+9G'RUX\JO-62G!*3MJDUR
M6=KVEM'5:K?0\P\+_P#!+7_@GWX*\*?$7P/X7_99^&VD>$_BUHVE>'OB-H<$
M>NRV?BS1=#UJV\1:3I^I?:=:GE6"QUNSM=2A^RRV\GVF"-G=E4+6O\%O^":?
M["?[.WQ"T?XK?!3]FKP!\//B)H$&HVVC>*]#_MTZEIT&KV$^EZE';_;M9O+9
M1=Z?=7%I*6@9O*E<*5)S7L/PL_:S_9A^.'BSQ/X$^#OQ^^$?Q.\9>"[274/%
M7AGP/X\\.^)-9T/3X+FWLY]0O[+2[^YFCT^"[N[2VGOE5K6&>ZMHI9DDN(5?
MY3^)_P#P4^_9[T?XI_LZ_"7X)_$?X1?';Q9\7_VHO#?[/'CK1?!WQ+T34];^
M&=CKO@CX@>*)_%USIFC/J<UZMAJ/@VQT9X)1;61EUA1)?QSB&*6>7!PY)\N'
M5I)4Y1A3NI*5TH<JO=3E?W=F[NVK'S8B7-'FK.ZO-.4[--)7E=VLXI*[T:LN
MQ^CFN:)I7B71=8\.:]8P:IH>OZ7J&B:SIETI:VU'2M5M)K'4;&X52K-!=V<\
MUO,H928Y& ()S7ANK?LG?LY:[\*?AG\#-9^$7A+4_A!\'=5\$ZU\-_AU>V]U
M/X6\,ZC\.0P\$R1:9)=F+4H- W%K6QUG^T;"9PDEY;7,D:,OC/@;]N_X06'P
M]O?&7[1_Q1_9\^"5V/'7QC\/:/;Q_'#PGXBT35?#GPJ\8W/AR?5H]=>338?[
M;AM3ILOBGPY%%->>&]4O#I=R6F7:/9+C]KG]EZT^#$'[15S^T!\(X/@3<RI;
MV_Q:D\=^'E\!SW;S/;K8Q>(C??V?)?F:*6(V"S&\5XI T \M]NKE1FFY.F_<
MN^;ENJ;L[R4M5'9ZI+9]B.6K&R2FO>TY>:SEM[K6C=M%;6QV>C? _P"$OAWX
MM>+?CMH7@/0=(^+GCSPSHW@[QGXZTZ"6UUCQ1X=\.SF?0]/UL0S+9:@VEL1'
M9WUQ:OJ,-JJ6:W?V2-(%S$_9V^"*?&W6?VCA\-?#3?&_Q%\-S\(==^(TEM-+
MKNJ_#0ZI8ZTW@V^$L[V$^COJFF6%V\3V9E=K6*-Y3"#&9?A%^T-\"?C];:K>
M?!'XO?#OXL6NAP:+<ZU<?#_Q9HWBF+28?$=M<7FA/J3Z1=W0LCJMK:74UFEQ
MY;S);3X7,3A?CSQK_P %+/@I\'OVP/B[^S7\??%OPU^"GA+X=?"7X0_$+0?B
M;X_^(&F^'D\7Z[\3]6\7:?-X5M=*U6*SA632;?PU'=K<6M]=R2K<2&>"!!&Q
M)2H1C&4G3493O&5ER^T?-+FYDK*6DGS-K6^MV"C5E*27/S**NKM2Y5RI*SU:
MUC:*Z;+0VO#?_!)__@G+X0\9V7Q"\,_LB?"+1O&FE_$30_BOI'B&QTF^BO\
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MCCM7Y=>)_P#@JM\)I)?A3IWP*^#WQW_:A\2?%#]GWPK^U/-X8^#'AG0;K5O
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MFVFHR?,DXVBW>R;#ZO6NE[.5VK]-M-W>R>J5G9W:5C]HJ0      #  & !Z
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M7E9QDFXW47&5VN5V:HU7;W'KJM4NSUN_=^*-E*S=U;<_4       #  X  Z
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M]7U#X@_Y .M_]@C4O_2*:OEZOI,C_A5_^OD?_23R<R^.E_AE^:/Y<?&7C_\
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MK\OAV"&]T+2SX<%TNGF<G5^!?A&3X ?$7_@GO\>OBK\'/'7P]_9[\0_MA?\
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MM]%C5J>TGS<O+I%6NG\*2OHHK6VRBDM@HHHK8S"BBB@ HHHH **** "BBB@
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M>+KO6O@2?A=;3?#\S^'H#=V\6NXOIF\1KX=E72OWL<3W@^Q'];^G6N-?XB^
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M%WC@RW6HP0>*;8^'= U2*&PTF>PL;V]O1['XJ_X)F_&/7?V /V]?V3;7QO\
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MI;X:?"./X%Z]\/M%^*GP._:.^$O[0OA.V^*;>(8/ ?B.\^&FH:A<2>'=>O\
MPK8ZGKVF07T6HF9+NPTV]=Y+06;+;+=F_M/OJBKCAJ<83@G-J:BFW-N24$E!
M1;V44M-[O5W;)=:;E&5HIQ;DDHI)N3O*ZZWZ_A8_"_Q-^PK^W_X2?]JWP5\
M/B5^R_I7PJ_;GO\ 4?&WQ;/Q M/B3>>*_@C\2OB1X+M/"OQLNOA+'HVCIIOC
MOPUKC0SW7A&'QE-X=O\ 3L6<-XD/ESW4GWWXK_9)2S_8 U[]BCX8ZQ96[0_L
MTWOP%\(^(O%/VBVLI+S_ (09_"EGK_B'^RK2_N+=+V])U351IUE=O$T\XM;:
M7:D9^U:*<</3CS6YGSQE#WI-\L9MRE&/2*<FWIY)6221*M.7+=17*U+2-KN*
M23EWLDETZO=MGX]_M-_\$T_$OQU_8_\ V+OA+9ZK\)=1^,W[&%M\&M5\/6?Q
M/\/:EXN^ _Q%UOP#\.+'X=>,_"?C72AIZZ])X*\6:;_:#6>H0:0VK6,L>G7?
M]F17*G[-X'X=_P""9'[55C\+?C]>Z5'^P#\(OB/\5M?^%)T3X#_#S]G'PQK7
M[-E_\._AU>7E[XD^'OQ1\5>)_AVWQ/\ $\7Q-O;R/4KW5([*>3P1?:59GPJJ
M?;+J>'^@"BI>$HN7/:2ER*#<9N+:4/9IMJSOR>[O9V3:;2::KU(KE35N;FLX
MI_:4[:].97[K6S5V?S5>$?\ @CS^T]X/^&_CG6_!6O?LQ_"SXE7O[7O[./[5
M'PR_9Y\&7WQ<N_V6O MU\!;*YM-2TF+6-9L;OQO8:E\1KJ^DUGQ!+H_AYM/M
M;C3K33;$K9W$,^D?1'B/]AK_ (* ^#[G]JCPQ^S_ /$C]ES2_AO^W1/<^-/C
M%'\0+7XEWGB+X)?%3Q_X&L_!_P 9M2^$*Z-HZV/COPQK0MFNO"=OXT?P[?V3
MQV45[%"$N;F3]S:*E8*C%)1YXV5O=FUOS\UK;*2G)-*T4K<J7+&U/$U&VWR/
M6^L>W+;[G!--W=[W;NS\OOV+/^"?5]^R'\</B_XGL?$?A[7_ (4>*_V;_P!D
MOX$>"[ '45\8O<?L]^$O%GASQ1KOBZR?3(=$MD\57.O0ZG91Z3JVHDRS:A'<
MP6*QVXG_ #H\ ?\ !%CXQ?#.^\-_!WPSH_[!MQ\#O#7Q=/C:S_:*\4_ RV\;
M?M=3?#8>+9/%2_#;4-'\6^#]8^&>HZXJ2MX<A\=76I275OI*0WT5FM[ MG)_
M2Q152P="481<6E!S<;2::522E.*?1-I;:I)6:UO*Q%1.3NFY**=TOL*T7ZV;
MWNG=Z;#418T2- %2-515 "@*H"J % 4    *  .  .*=11728A7U)H?_ "!=
M'_[!>G_^DD-?+=?4FA_\@71_^P7I_P#Z20UX6>?P\/\ XY_^DQ/2RWXZO^&/
MYLU****^</6"BBB@ HHHH **** /Q?\ ^"Q?_!-^Q_;(^$$WQ0^&6@V2_M*_
M"72;B\\-7-M"D6H?$?P?8K>W^H_#.^GWQ1SW,TL\^H^$)[QF6PUQI+-9;>TU
MF_>OX2I89[>:>UN[>>TN[6>:TO+.ZB>"YM+NVD:"YM+J"55DAN+>9'AGAD57
MCD1D=0017^JK7\1W_!>;]B.V_9]^/VG_ +1W@/3#9_#']HW5=1F\26UO;,EE
MX>^-*K=ZKKT:RQ(+>"#QSIL<OB6SMG*SRZM8^*)H_,@4"#^F/ GCRK"O_J7F
M=9SHU54K9'5J2;=*K%.I7R^\F_W=2"G7P\=%"<*U-7]I3C'\PX^R",Z?]MX6
M"52GRPQ\8I)3IMJ-/$62^.$FH5']J#C)VY&W^W/_  0(^.=Y\6?V$;'P7K$[
MS:O\ OB!XB^%<)EE2263PLUGI7C#PG,%!,D=O;6/B:XT*W63(QH;B-O+41QE
M?F[_ ,&T?CNZ@\=?M5?#!I&^PZCX7^'?Q!@BXV"\TO4];\-7L@RV5=H-3T]6
MVKAPJ[FRB"BORCQ4RR&4\?<18:E!0I5L7#'4XI62684*6,J66R2K5JJ26EEI
MV/K>%,5+&</Y;5G)RG"B\/)O=O#5)T%?N^2G'5ZO=ZL_K:HHHK\^/H@HHHH
M**** "BBB@ HHHH **** ,CQ!_R =;_[!&I?^D4U?+U?4/B#_D ZW_V"-2_]
M(IJ^7J^DR/\ A5_^OD?_ $D\G,OCI?X9?F@HHHKW#S0HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#W/X9?\@&[_P"PO<?^D5A7HM>=?#+_ ) -W_V%[C_TBL*]%KXO,/\ ?<1_
MU\?Y(^APW^[TO\""BBBN,W"BBB@ HHHH **** "BBB@ KYM\9?\ (S:O_P!?
M"?\ HB&OI*OFWQE_R,VK_P#7PG_HB&O9R3_>:O\ UXE_Z<IGGYC_  H?]?%_
MZ3(_"/X>_M9_\%&/VEX_'7[0G[,'@C]G#7?V>/!/[1/B[X/^&O@MXN?Q3IOQ
MB^+?@/X<^.E\$^,/B/:?%!]?L_!7@;4[YK75=7\-^&M0\+:K&MC;JNHWCW4<
M5KJ7S=^W%_P5F_:$_9C^+?QD_L_X@?L@Z+X=^#7C3P=H^B_LRW=EX]^*_P ?
M_BSX-U"\T"'Q#XO\0^,?AOK,GA#X#32#5M1&AZ1X[TIIBNC2F^D26ZTT:I]C
M>)/^"31U'6?B+X,\)_M9?&3X?_LE?&+XTWWQZ^)W[+WAS1/!B66J>-=<\46?
MC/Q7I/A?XKOIZ^/_  /X&\5^)K*+4M4\*Z)<BVA:2ZCL)[8W+2)YY\7_ /@B
M[%\2&_:?\'^%OVN?B;\+O@5^U9\3-9^-OQ#^$_A[X<_#'5-1D^*NK0:'*+N3
MXGZMI3^.[WP!:ZWX9T+64^'9U&TTMOL)LXKRV:>:]?U*D<:Z;4%4]I?XO:4W
M%R2G[T(\T7&DWR:.=U;6A+WN;EC+#<UVX<ME9>SG=*\-)2L^:5E)-\JOK:HK
MJV;\4?VRO^"@/CW]HO\ ;'^&'[+=O^S7X9^'_P"RS\&/A!\9[76_B_X9\=>(
M?$GBZ?Q]\*HOB)-\/5A\->*='L+"74_+U1(O%,R-'HJVMC;'2=3-W<W=KF?"
MW_@H;^V!^V]K_P +O!/['VA_ ;X;:[!^QA\%/VJ?C3KWQJTKQGXOT<^-?C'%
M=2:'\%_!NG>&-=\/WEA8O#IEWJ-YXZU.XU%[#3KVQ$>BW5Y#+!/^@7@#]A[0
M/ OQ!_:>^(?_  L'7=8U+]I_X3_";X5>(K6?1].M(/#EO\*OA=<_#&#7-+>&
M>1KN[URUN6UBYM+E8[>SNA]FA>6$[Q\M:'_P2;U7X4Z9\$+W]FG]KGXE_ 'X
ME?#+]FGPA^R?X^^(.B> OA_XM3XP?"KP5>76I>'[G5_"?BZTU+1_#?C?1=1U
M'5)=#\7:1)+J>EVE\UA&[P0QFJ<,6GS7J2C*=24X1J04E!5G[*--N48P?LVG
M+WE>*:<N:R(4L/:UH)J,%&4H2:YN2//*:46Y+F4DM-W=*Q^2/[&O[18^"/P>
M_8)\??%/X9^$]:U>P^+O_!63XC^+-1O)==N/$?P[N/ACH6M>-_%NF^ +Z'5K
M73T;51;7FAWDWB#2=:5K&VMFM(;.X\R9O;/CC\6/V^?C/HG_  22^._QTL_V
M?M.^ O[0O_!0']BKXF^%?!/PVTWQG9?$OX3)XO\ [9\4_#K2/%WB/6=?U#0O
M&]MK?@_5+Q?$LVG:/HC:+XCCL;*".\M999A^A_PF_P""/GPI^&?A;]FGP5J7
MQ3\:_$#PS^SKX@_:HU1[3Q1I6E+>?$K2_P!JK19_#_BK1O%>H6$\#VSZ3IEQ
M*BZGIL23:M/-//+!8^8B1<IX>_X)#>*]/U/]F+0/$W[<GQJ\;? ?]C+XU?#?
MXM_LX_!#6O!/P\M]/\,VGPOU-G\*^$?%WC/3+*R\4>/(-$\,/+X-\.ZMK$Z2
M>'M(GG.GV"K(MM'A'#XM4_9RC+E:II*%2FK2C2PL92J-M<\+PJQ25W?:*3A*
M.LJU!SYTXW3D[RC-OE<JC2A96C+6+=TE;=W3B?*/QL_X*]?'CX,?M%SZ1K?Q
M!_9(O_!^F_M<>&_@+J'[,'@K3/'OQ)^.%C\*-<^(%KX(_P"%G>+/C-X1UV[^
M%G@/QV+:Y_MIOAAXBTNWN;&4#2;F_DU!/L=QR&F?MA_M#_L:_%'_ (+1?M$_
M%#Q9X%^*7AKX7_$KX8^"/!/@)='\8:5/)\0_&.A^&[#X-6]EK%[XJU^+0/AW
MX:\/ZSJK>._#VF:1/J6O:V]QJ^@WFEF0V$WU-X@_X(AQZIHOB;X9:+^V-\4O
M"O[/]Y^T)<?M.>$?A'I?PU^&$EQHGQ1N/'MOX]C;Q7\1I=.3QQ\1/#.F7WV^
M'2-!US4[9;>6;3=0N;J[GT:%+GZ*^(G_  2O\&_$[XA?MAZMXE^,OCC_ (5#
M^VCX>\-3_$/X/6.@^&+9_#?Q>\$V_AZV\$?&7P5\0S;2>*-+UGPJ- $UEX9E
M6X\-:A/?S_V[::K!!:016Z6.E>3YE*,I2IWJ1:4I4:\.9^^U*$9NGHXPT;<:
M2?-%KGPR22Y;.*52T9)M1G3E;X5:32GLY:JSG9IGY_?"_P#X+"_M##6OBA\/
MWLOA/^V#XU3]E/XI?'/X7ZC^SQ\(_CK\--.TWXN_#G3SJT_P/\6Z)\3H9=0\
M3VEYHQN=9T;Q3X8N;+4]?BT6]TJV\/V^JW]E#']7_P#!+_\ ;\^+/[6GQ$\>
M^"_'_P 5_P!F'XK:=HGPR\/^.W'PET'X@_"+XK?#3QG?ZO;:;XC^%WC_ ."_
MQ5O[WQ7?Z9X<6\MO*^*&E"'PUJ-]);V" 75ZD%OZ3X?_ ."9_CS7?^%A77[0
MW[=/[1_QGUCQ)\$]<^!'@+4O#4FB? >+X9>'=;N;2]?QM:Z9\*QI5AXM^*UK
M>:=I[P>./%45_=26T=W87UM?6M_(D?7_ +*O_!/+6_@7\?K_ /:<^,/[27B_
M]I3XPP? Z']G+PGX@USX??#_ .&\.A_"I/%>E^,[FWUV#P-I]O<^.O%M]K>B
M:9-<>,/$][=ZJT27<<C3->&2'2G#&*I2<W-P4GS*3@G&-OMM5JCD[W<?XK:L
MKTK/FB<L.X345%2<8V:4G>7NWY?W<$NM](+1W4[JWY0?M4:C^TO=_M)?\%SM
M/UWXF^#-1^%OA/\ X)B>-9XO":>'O%BZIIWA#7?@)\:]0\":9X4O+GQE<Z/X
M?\0:=K<TNI>.M8CT::T\4NS-8:;HL[+-'[Y^S=^U=^W1\ [C]@GX>?'S2/V=
M?%WPK_:A_9;U_4?A9H/@(^*_"/C7X;>(?@]\#_#WCO0=%\?^./%VKWWAK7X-
M>T&;2=-\1Z]!I.@Z?HVL7NI7=OY^EZ1'-J?VS\>_^";B_&7XS_M(_%/0OC_X
MP^'&A_M9?LI^(OV7/C;\.[+P9X2\3:3X@L-0\"^.? WAGQKIFMZNL6NZ!J?A
M.V\:)J::5I5S;VVM7FC0PZC=_8KVXMTZ7XP?\$Y?A]\:M%_97\->*O'GBJWT
M']F3X0?%3X,QVNE6=A:WOCKPY\6?@EIWP0UR\O=0+R/X?U.RT6P.K6$VGPW:
M+J$[1LOE1HU)4,1&<YP<U)5;Q;J1M*$\2ISNFY6BJ,I+E<4U)-QBWRMKVM)J
M*ERM>S2?N.\91I.*V4=742U3M:UWO;\QOV=_^"KO[1OQ!_:<^"7P,\1?%G]C
MOXEWW[2.D?%?15\/? KP?\4==L?V9_B9X:\*7?B'PCI/B?XMW'B.;X>?&^PM
M[Z Z/XKMO!&H:1=J]G?36ES#:2:;J-[]6?\ !#/4_COX@_90\:^)/C3X^\.^
M/$UC]H#XX'P_=V.D^(K?Q/!JEE\4O&-MXTN?$NN:_P")M>_MJTU/5UMIO#%M
M;6]A)H6DPFPO)]3D:.>(^"__  2*U_X9?$#]DGQGXK_;'^(?Q&T;]BB<Z/\
M WX>M\*?A9X(\):?\/Y/!MQX+N]!U^/P?IVGZCXA\6:AIT6@&]^(6JWMWK-R
MFB-%<VMS-J,MY!]D_L6?L=WO[&>D_%3P3H_QE\2_$3X6>,OB;XL^(WP[\"^)
M/"WAC2Y?A/\ \)MXEUWQ3XCT.S\4:-!%K/C"WOM1UJ/;=^(6+VD>G0K8P6RW
M%RCO#T\3[6$ZRG:/M4DYQ]U3IT+.256?,O:0JVLY-.49*$(^[!U9T.2<:?+=
MJ&T7K:4FTFX1LTG&^BNE;FD[N7X^_$[_ (*9?\%&O"'A#]IG]I'PQX-_9AUG
MX#?LX_\ !0#XI?L<VGPWU72_B!9?$[XDZ'X8^,+_  ZTCQ<GBVUU^X\/^&Y[
M!-4\/Z=/&NAZH^KZC!KFIFRL+:"RL;[Z"N/VY_VY_@CXD_;#^"OQYT_]E#Q9
M\7O@]^S=\-/VE?AAXVT;7=<^#?P=T[0_B5XR\0?#^\T/XEZEX_U_49/L_@76
MO#NI:G_:%EJFEW7BVRMH-/M(--O]7@%A]->)O^"8G@SQ-^S]\=_@!<?%3Q/;
M:7\=OVS/&G[9&J>(H=!TI[_0-?\ &GQ@T_XNW/@FPLGNOL]WH]C=V"Z)!JEQ
M+'>RV\C7DEN)5$!A_:Y_X);_  Z_:\\=_&_Q[XL^)?B_POJ/QA^ 7PF^"MI;
M:#I>CW,'@_4O@U\5?$_Q;\*>.(EU(SP>(3/KWB*.PU?POJEK'IM[I5B\:W<5
MQ=K/:)T\8DY1G4E+DBU%U()<[C651*Z:2O['ENFD]5]M@IX=\JDHI7?,U"5[
M)TN7:SO_ !+V=VM_LGY^?!/_ (*D?M5?$V[_ &O/A3X!\>?LP_M-?$_X0_L?
MG]J[X2?$3X4_"[XP^!?AUK^K^'_%,NC^+?@W>:-XYUS[;XQN+VTMX4\(_$#P
MAK3>'-1N-;T^6<K<6NJ:1I_W?\"_^"@FN?M1_M#_ ++'P]^"5EX2O?AMXY_8
MSM_VNOV@]<O([Z_U7P?'XXO++PA\-OAGHT]I?Q6FD>,#XUM_%LGB"QU>WO9X
MM'\*ZDOE6LXMY+FA\+_V)O$W[*/QB^)'[=OQ6^/WQG_:V^(UM^S!K7P8UOP!
MX<^#'@K3Y=5\&Z'XNTCQ_P"&O#_PC^&/PTLM.AL]1L[K3-8T^T\,6=O>+XDU
M3Q5J&IWEW;7!(/(_\$:_V.)/V<?AS\?_ (O:_P##;Q5\)_$?[4'Q[\=_$+P9
M\,_'K-_PFOPE_9ZAUW4G^"GPMU^QDDG?0M4T73M4UK6M4T4R_:+"XUZ'3=0#
M7FELP=)8I3I4YRFDW.4U*SE&G3G&5/53JIN?-[.:=64FDVFT@FZ#C4E&*T45
M!I:.4H\LU9J#]U+GBU"R;>S=WY1\?8_VN-3_ ."T^L:%^R9K/P<\+:W=?\$O
M_A?>^+_%_P ;=$\5^*_#6BZ/9?M3?',Z?IVC^%O">M>'[V_U[Q'JSVEJU]<Z
MI!::3H]EJ=X8KZ[2SL9_+W_;\\6_%7QM^Q5XJ\?_  5^&5C\>/AK\3O^"DOP
M7^(MP\_B/5K#P-\7_P!ESX:16?B;4/AC=VVNZ?%_PC?C:[MK3[9!XAMM<N8=
M)D6SL[FWNHCJ$GZ(?M$_L!?$#XI_M76_[8OP4_:Y^(?[-/Q7@_9[T#]FZ:#P
MWX \!?$#POJO@73/B!XZ^(6HSZSH7CFWO;*^U6\U7QA9'2;I88)?#\WAZ*ZM
M9;AM3N8X>0T/_@DW\*O#.B_LY:7HWQ,\=O?? J?]IOQ#XC\2ZY!IVM>(_C%\
M0_VKO";Z!\3/'_B^^D:VCL=6EU2:XU^TMM.MWMB6ATZ9F2%KN53I8GFJ>S4D
MI5E/WITW!KV]&:<(MMQE&$:DI-J+U27-+EY"%2BE!R<;J'*[1FII\DT^:6B:
M=XI)7\[)7?QI\&?^"BW[?5CX'_X)]?M/?M&:)^S3_P ,Z?MO>,?"OPNNO!/P
M\T3QWI_Q-^'NK^,?A_XV\<>%?'\OB+6/$6IZ%JVGZ[I_P_UG4;[PQ!I*-HEK
M>Z?8+JM]=/+/;?*'[:/[2/[=/[4W[!W@O]J+5-,^ V@_LG?&+]ICX2VWA3X9
MZ)8>,C\;?!G@/2OV@K;2/!GCK7_'D^MGPKX@OM8N] MK37_#=EX7TN*TMM5@
MU.QOI0)K&U_;VV_X)T>#8?@!^P-^S_/\0]>O-$_8.^)_PA^)F@ZS/H6F&Z^)
M5S\)?AUX\^'EKHOB&Q^U&VT>PUZU\=W6H7TMA)>2VTEC#:Q++'/)*OR=XK_X
M(NW_ (A\&VOP'T_]M;XR^'_V1_"WQ>L/C1\,_P!G2W\%?#^_M/!/B"Q\=-X[
M@\-7'Q&NK1?'7B;P'8:C>:NNC^&=4U)8;*YO;/5+F>_O]+66[SJ4,9*E*FW4
MJ*=.S7M()JK*G13<FY1O24E63@KZR7+%JSA5.IAU-3]R$HU$[\DK>S4I?"DG
M:;3BT[+1.[OH_H+_ (+1:O\ %/0/^":_[3>M_";Q?8^"M:T[PE:-K^K7%OK,
MFI7'@Z]U>QTO7M*\.WVB:UHMSHVMZB+^U@74YY+ZS73/[3LI].G-\DMOX'X6
M_:,_;T\:_$7P=^QG\"-;_9GM_B?\&/V5?AG\:?CO\9/B'X)^(-SX*UC5_B'J
M.IV?PX^%W@KP+H_C)-9TJZG\):39ZCXJ\8ZIXCU:"WENGN=/TAI572Y/U'_:
MG_9\\.?M6?L[_%[]G;Q9K&J^'M!^+7@S4O"=UX@T-;=]6T*XN#%=:9K-E#=*
MUM=2Z7JMK97QL[C;#>QP/:221+,94^$=1_X)I?%>TUKP)\5/AY^W-\3?AQ^T
M?I/P2L/V>/BA\9='^$_PGU"R^,/POT'Q'JWB#PA#K7PVU+2Y?"GA[QAX,&KS
MZ9H/C30_+UA+%%6Z>:1Y9&Z:U.LZ_M*?M'!TZ<9*%2,6U&I-RC'GE%1D^>,N
M:Z3A&<>9-Q4LJ4Z?L^6;BI*<G'FC)I-Q@E*7+%N45:2<=[N+M9.WH/P!_:H^
M)O[7/[ ?Q!^*^AZ;X<^$G[0'AW1_C7\,/%-G<+JOB;P;X4^-/PBN]=\(^)[W
M3%M+_0]:OO#LFM:1)J>D1+J<&H6,%U;VTNH7TMF]W=?@5\$-2_;)U+X;_P#!
M"+4/"_C3X5^*?C!XU\3_ +8-S\/O$OC;1_&CZ#X;\$:OX&\-0ZOJ_P 3X8_%
M%YKGQ#\8:/J'_":>(1/IVI>';77!>Z'I,PT][>_U6X_J%_9R_91^&W[,_P"S
MMI'[-_@J?7M3\+VVE>(H/$7B3Q!?B\\6>,_$7C6:^O\ QOXRU_4!&L3Z]XGU
MC5-1U2Z-O!':6LEPEM:6\=K;Q1CXS_9Z_P""6J_ V_\ V3FU;]H_QG\2M"_8
MR\9_&_5_@MHFL^!/!V@OIW@?XR^%-*\.GX>ZMJN@F"ZU>W\+7UEJ6OV7B/4(
M[K6=0N-:GTV<V^F6.G06V=6A7FL/S<TI*G3C5E&:BE..)PM64VKQ3?)3J-.,
M7[R5HK0N%6E'VG+9+GDX*46VXNG.*6B=KR:NFU9-Z[GPEX[_ ."PO[0?P2^&
MGC;X5?%^W^!.G?M6>&?VY[_]CN/XHV/AWXCS_ FS\)6?PQT'XKWWQUU/P#HU
MSK_Q#O%T?0-<M]/E\":/?W-[=ZG>Z<8[[R4O /N7_@FA^W]XP_:P\7_'_P"$
M'Q"O_ WCW7?@I/X.U;PU\<?A1X%^)/PX^'7Q6\'>,=+),D'@KXH0R>(_#7B;
MPSKUCJ&G:W9?VOJEC<)<6K6,ABM6O-0T?B%_P2F\#^-M7^,?C?2_C)X[\#_%
M;QW^UQH'[9?PQ^)/AW1O#DVJ_!CXH>'OAGHWPNBTVPTO5X=0TGQKX2U;0=.O
M5\0:'XAMXK75XM2%M<1@6,$S_2?[)_[*GBS]G[4/B=XV^*/[17Q+_:3^+/Q<
MU31KSQ/XN\8VVD^$/"FC:7X<L#I^B:!X#^%?A$6_@GP990QR3W&I7.E62WFL
M74J2W<H6&..JI0QBK0]I)NG&Z=W%IP2FDI/VEW-RY)\RIM\NCJ+6#526'=.7
M)%*;L]FFI7@W;W;*-N=6Y[::1U4E]ET445WG(%%%% ';?#[_ )&:U_Z][S_T
M0U?05?/OP^_Y&:U_Z][S_P!$-7T%7RV=?[W#_KQ#_P!+J'M9?_ ?_7R7_I,0
MHHHKR#N"BBB@ HHHH **** "BBB@ KRWXH_\>6D_]?5Q_P"B4KU*O+?BC_QY
M:3_U]7'_ *)2N[+?]^P_^*7_ *;F<V,_W:KZ1_\ 2XGQ1^TSI7BO6OV>_C1I
MG@?QE)\/_%5S\-O%IT?QA%H>F^))-$F@T>ZN9IDT75R-/O6N+2&XL@+@@6YN
M?M47[Z".OY4_V>? 7[2^J^%?^#?G1?A]^T+IF@?$/QG\*OVD-5\"_$'7_A9X
M:UR+X1_#Z\_9ZTV34_#=EX;^T0:=XYUK3=$MM:BT37O%AG>YU;4[6;6;:XM+
M,HW]A>LZ38Z_I&JZ%JD/VC3-:TV^TG4;?>T?GV.HVLMG=P[T(=/-MYI$WH0R
M[LJ00#7YT_L__P#!+SX*_L\ZS^S?K'A_XH?M ^-4_9-N_BF/@;I'Q'\;>&/$
M&D^$O#GQ8\#0?#[5O!"I9>!-'U"X\)Z!HD#7/A>S748;ZRU:YNKJ_P!1U.WE
M6SC^EQ.'G5J4Y1O9<BDU4E"RCB</5;236O)3G9KWE)1UT37D4JL80FG:[NXI
MP4KMPG&S;6UVKIZ6OW=_R$\;_P#!4/\ ;4^%WA;6/V8?$/C2#Q=^T+IG[?'Q
M"_94?]I7P#\ (?&OB.3X6> ? 7A3XGW?C;1_V?/#4+>'M<^)=]HGBJUTFUTF
MWMQX=LO(NKJZT^\%LU])/J?[<O[5/B'X<W'@[XT^#-4\<V7@+]OG]A+PS\+O
MC;\?OV3(/A1??$[P-\5O'4]KXF-[\+?%>@OX4\,_$KX=ZII0CTOQ=X-6UNH8
M=8T[6=)CTF\MVD?]>/'7_!+/]G#QXGQ5OKK7?B[X>\:?$W]I)?VK]-^)?A#Q
MGIWA[X@_";XQKX8T'PB=4^%&O6?AH+HFD3Z)X>M;>\T;Q!:>*(;[[3=_;)9D
M%DEEAZ)_P2>_9_L_"^J:7XK^(GQ_^)?C;Q-\>O@Q^T5XW^,7Q!^(.F>(/B;X
MT\;? /41J/PUT75]1F\*KH-GX'T<-<6+>'M!\/:1/+9W=T1JD=](MZF'U?&<
MS_>MPM)1O5EI'EDH1DG=2ES<LW.W-9).IHXSV5;#))\B4KQ;:@E[UXN335K1
MM>*AM?[.K:\@_P""='Q+_;C_ &F_B7\8OC-\4OVBO":_L^_"_P#:+_:(^!>A
M? ;0_@WX2LM8\36?@G6YM.\-^(M?^)2"/7+"XT"2_M(;6RTF&.+5K;2]VM/=
M7-Y-./,/VT/!_P ??'?_  6%_93\-_L\_%_1/@3XHO?V(OCH_B+XE:IX%T7X
MD:GHOA&W^*/@^>\M_"OA'Q+(/#M]X@U/5X]%L?M.N075AI^D2ZM=K;RWT=DC
M?K3^S?\ LT?#[]ESPOXY\)?#F]\47VF?$#XN_$/XTZW)XKU'3]2O(?%GQ,U6
M/5_$%KITNFZ1HT4&AV]S$D>E6<\%U>6\ *W.HWLA\VO"?VG_ /@GI\./VG?C
M-\//VA;KXN_M!_!?XR?"GP)XA^'W@3QK\"_'ND>#;O2M$\4ZM!JFN-=V^I>$
M_$46K2WZ12:9-;7[2Z6=/NI773UU2"PU*SWE1J?5HP;G.I[2G.?[Z:;Y:D92
M4:C=X+EC9*/*K[6;<C)58*M*2Y8P<)0C^[BTKQM=PM[RNW?F3;6CNM#\F;K]
MN'XZ:CXA^ ?PY^.5G\+/B)\3/V?/^"K&H_LP^/?B3!\+?#\]GXY\.Z'\/=7\
M7:-X\\$:/J5KK ^''CZ;1M3M+'4;WP9<VM]INHVUS:VCVJW%S9'8T/\ ;:_;
M[TK]E?X+?\%1/%/Q>^&.M? ?XL?%7X=6FN_L?:?\*M(M3X3^#7Q:^+]K\)O#
M=SX:^+EI<7'CC7?BGH1UO1==U:SU%3H5Y*E_IUOIL4MJ(;O],_"?_!+_ /9L
M\&^&/@AX<TV^^)][=?!']H6\_:C3Q=KWBZRU[QI\5/C-JEOJ5MK'B;XOZ]J?
MA^YD\4#5XM2=+RWTF#PYLCM+*"SEM+>%X9?/_#7_  2#_9N\,^*_"T\/Q _:
M'U7X*^ _B<?C'X#_ &3M:^*$5]^S7X0^(<>M7OB2PU;2/!8\.PZ\=.T7Q)?3
M>(M$\/7WBR[T:QUAGN&M+B"0VPR]AB]^=N\;1M6DG"=J:A.;27M8TU&:G&2:
MJ-W<7>\='5P[^RM'JG33O&[YHQ5UR.3=XM-<JTNMC\J/V1_C?^T*GBN/]C3]
MFWQUX<^#7BS]HS]O7_@I#X^\7?&SQ!X,T[X@WO@KP+\$]2\ 7-WI?@SP=K[Q
M>&M9\5>)M6\7Z=;I-K(O+32-.L[J]EL)0Z&O8KW]O7]N7_A;%Q_P3B_X61\.
M++]J&+]KS2_@2?VO;;X<::WAX?"34O@9#^T7;^+D^%=\)_!8^+$WA1V\*2>'
MGFD\/1ZL$ECL'6YMKT_H;K/_  2=_9WO/#]K:^&O''QU^'?CW0?CU\6OVBO
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MCZH**** "BBB@ HHHH **** "BBB@#(\0?\ (!UO_L$:E_Z135\O5]0^(/\
MD ZW_P!@C4O_ $BFKY>KZ3(_X5?_ *^1_P#23R<R^.E_AE^:"BBBO</-"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBGQ=X,DU"?3-1TB1?$'@?7[WPSXCM/LFJ6UK=%+35M/N88[@1>3<QJLT+NC
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M\M^*/_'EI/\ U]7'_HE*[LM_W[#_ .*7_IN9S8S_ ':KZ1_]+B>,T445]D>
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M4H)*[O*<HQ7FR*M2%&G4K5)*%.E"52I)Z*,(1<I2?DDFV?B=^R3\2+3XJ?\
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M*^KJ*/[=E_T#1_\ !K_^5^O]+4_LU?\ /Y_^ +_Y(^4?L-[_ ,^=U_X#R_\
MQ%'V&]_Y\[K_ ,!Y?_B*^KJ*/[=E_P! T?\ P:__ )7Z_P!+4_LU?\_G_P"
M+_Y(^4?L-[_SYW7_ (#R_P#Q%'V&]_Y\[K_P'E_^(KZNHH_MV7_0-'_P:_\
MY7Z_TM3^S5_S^?\ X O_ )(^4?L-[_SYW7_@/+_\11]AO?\ GSNO_ >7_P"(
MKZNHH_MV7_0-'_P:_P#Y7Z_TM3^S5_S^?_@"_P#DCY1^PWO_ #YW7_@/+_\
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MK*73_P"RM?UO7+S4M>NM/M+2>9-+M%U2.#2)I'O-+2TO7>X;SCQ+_P $E/V
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M /$5]744?V[+_H&C_P"#7_\ *_7^EJ?V:O\ G\__  !?_)'RC]AO?^?.Z_\
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M  !?_)'RC]AO?^?.Z_\  >7_ .(H^PWO_/G=?^ \O_Q%?5U%']NR_P"@:/\
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M /$5]744?V[+_H&C_P"#7_\ *_7^EJ?V:O\ G\__  !?_)'RC]AO?^?.Z_\
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M2J498F2>_P#M-6=:-]?Y)PMMI;2Y^\=%%%?FI]2%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*,]I4ZU2I6K8NO[;&5Y7;A0BU*M-](QC#W:<=$FX0C;1'].W[-/P7T;]G;X
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MY;_A-?"__06B_P"_%W_\CT?\)KX7_P"@M%_WXN__ )'H^JXK_H&Q'_@FI_\
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M?\_-?>=317+?\)KX7_Z"T7_?B[_^1Z/^$U\+_P#06B_[\7?_ ,CT?5<5_P!
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M=317+?\ ":^%_P#H+1?]^+O_ .1Z/^$U\+_]!:+_ +\7?_R/1]5Q7_0-B/\
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M /06B_[\7?\ \CT?\)KX7_Z"T7_?B[_^1Z/JN*_Z!L1_X)J?_(^:^\/;4?\
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MKE[(<M/J.JWTDMS*J\);VR-':6D02"TMX($2-:=%=?\ #?X;_$3XU?$3PO\
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MZ>:C_P $[O"7@W2?B1X@^*W[5/@;X>Z#\,_BEH'P5UG53X"\6>)K>X^)>I^
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M\/75VNF7[:3/I]Q\_P#ACX7_ +1?Q#^('_!1?Q;#X$_;L^*.C?$[_@BI\?\
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M1X@U#2M!O]5T*TF@NK(6]Q<13I\&?#+]D?XA>(8/@7X_B^#'[7'B3P?\0_\
M@M?\#?COXFB_:7\%Z*OC;4_!G@?X#_&;1=<_:+\:_"7P;\,/"4'P;\(:]XDU
M#PQ87][XT%VU]J&GZ'?ZC-I<^HVB:E57$UXUITX4XN*<8Q<HR;:<:;=1N,M8
M*4I0MRJSBWSW]PF%&DZ<9RF[O5I-)+WFG'5:2LKW;=U]FUI'[NZ9_P %.OV#
M]:^%FJ_&G2OVC?"5]\.=!\=V7PRU[6+?1_&;ZEH/CG4M*U'7--\/ZYX2_P"$
M9'C'1Y]2TC2=2U'3KO4M MM.O[6RN)+2\F"&KGPF_P""E?[#'QS\3Z#X,^%7
M[1G@SQ;XG\3^+;SP%H6D06/BG2[C4?&FGZ+<>(KOPO$^N>'],@36XM%M+F_&
MGSS17$L<+I"DDP\JOR'_ &I/%'[4W[*'[0__  4]^(O[.'[*7QI^(&O_ +0L
M_P"R!\.OA'XI^'_P)\?>/_"&@ZW??!SQ3%X^^-KZ=X/\-ZF?%5I\+Y[2Z75F
MT>#4I/\ A.-3\/Z)K"[]4DMY>6UKX1^!="_X)A^)M;^ 'PG_ &E_AI\;/V!_
MB)X0_;[U#XG?M8_ WQQ\"_%OQU^./P\35/&?Q=\:7&I?$#3[&Z\7-X[\)V?C
M30]8L(+J:WM;#4?#OAF^NDMY+>ZJ/K5?F<;4VZ:K.I'V52+G[*K."]DW4LW4
MIPE42]Y0]U.4N9%>PI<J=Y^\X*+YX-+GA!WFN2Z49S46T]=796/W*^*'[>_[
M'?P6U+Q?I/Q3^/\ X%\$WO@'QAX7^'WC$:S-J<=MX>\;^-?!?B?XA>%?"VH7
M\&G3V$>M:WX.\&^)=:L[%+EYC'I;VDBQZA<6=I<>.I_P5W_X)LOI7AW6O^&N
M/AFECXF\0W'A>S$Z>)[>_P!*UBTN;"TN(_&6D3^'H]6^']A%<:G8(VM^.[+P
MYHFVZBD&HF(EQ^3_ (-_9A^)WQ'_ &=O^"=GQQ\;_"?6_&?Q%_:I_P""O/PT
M_P""@W[0FD:;X4U'Q5;_  Z\"^.?A?\ &F\\##Q?Y%C?/H7@+X:^$&^&/A]9
MO$1@TGP[J>H0:7>31ZA?L+KM_B3^REXPO-!_X.&[S3OV>/%%YK7QN\!V=O\
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MHEAK?B9;YO#NC:+=W&BPKXSU;6VTS4(=+TWP4/$-Y?75E<VEO#)=0O"/Q?\
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MC9J'B?PY#K/AS3Y/&'A^&Y>VM9-;\'QZ_IL<MY9[IRMU;F7\_P#X._!/XI^
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M\E&M[-N*O)J^CDK-X2I152$;M4YRA'F;3Y6XPE.+:LFZ?.DVDEZ:I==\,/\
M@HY^Q!\9K7XCW?PT_:-\!^)X_A+X,UGXC>/(H_[<TN\TKX?>'K.YO];\<V&G
MZWI&FW_B;PCIMK:327/B/PM;:UI"$P1"\,UW:QS4/"7_  4O_8/\<^$/B?\
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M0+%)+XQ\'VD:B6*[L=1LXI5MQ':3_(_CCX$?&+X[_L5?#K3?@[\.?%'Q&O\
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M[K5:Z'ZJ5\S>)_V2/@SXU_:/\%?M3>+[#Q3XF^)WPV\/2Z#\/;'6O&OB:_\
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M_'3XB:[K7A#XN_ +1+#0/%^F_#C7/"MY>>._$?PAU&'Q)JFD2>!8A=ZWX/\
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M'OPU^$VA_"7X-R?L4M\*?AA\3X/".J>$/C)XH\1^)=.^)\?Q/\0Z7;7W]O\
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MP:GK^2/]M#]MC]HWP/?_ +2OQ"^"O[2'[3/B)OV7#\,M&\,^$?V??@?X/?\
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M+;6WC+P!XB_LY(K;Q#X4UB6"=[*ZC+!;RSD2;3=6M=UEJ=I=6S[ VOJ30_\
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MTZ^@\%>)->DGTVPEOYKZP:WU)[2!K^VN#&*^Y_BK\#/#_P ;?AKXW^$/Q0\
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M>_\ QFOJ&BC^W*O_ #XI_P#@4@_LZ'_/R?W+^N_]+7Y>_P"$?U[_ * FK_\
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M:O\ ^"V]_P#C-'_"/Z]_T!-7_P#!;>__ !FOJ&BC^W*O_/BG_P"!2#^SH?\
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MRC))QE%III---'3*,91<914HR34HR2<9)Z--.Z::T:>C./\ A[X%\._"_P
M^!_AIX0MIK+PG\._!_AKP+X7L[BXDO+BT\.^$M%LM T2VGNYB9KJ:#3=/MHI
M;B4F2=T:60EF-=A112G.=6<ZE24IU*DI3G.3<I3G-N4I2;U<I2;;;U;;;!)1
B2C%)1BDDDK))*R271):)!1114C"BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>nt10015006x17_graphic2.jpg
<TEXT>
begin 644 nt10015006x17_graphic2.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M=WFG3W6K7U[J-]8W.M>&=+UV.VOKNY2VU=%GM1"D%K%#\^_\$_\ ]DOX-_\
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M*_#7B=M&NSI^L#P]KNEZT=)OQOS9:D--NKDV-V/+DS;77E3#RW^3Y6Q^3?\
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M/-<V5EXF\6064D-[JE[J5Y;7,>@^&[:\L7NXK.ZU"_O+2SCM(M2_C_\ C?\
M\%$/VR/VI=?T3Q'\:OB[)XI'AN:[G\.^'X?"_A?1?"FC'47B>Z2ST32=*M(I
M&D2"&W-W?2WFI&V3RFOV5G+;7_!:_4O$LO\ P56_:M_X2IKHO:^*/"-GH2W*
MX1/"T/PZ\)'0UM1R#:M \DBE3AIGE+!79Z^+--UOP\?#MK!#"RZLL@\R7)VL
MN.<<8QWX^G? _G?C3BG/WFV,IX/,,3EU'!5:E.A3P]:=!OV,U'GDX6<ZTK<^
MK:BM(6/]A?HJ^!/A%4X/RC&\4</9%Q%F6>99A<PQV.SG"4<RYGCZ%.J\-@H5
MU*G0P]*-54U[&,:E1Q=2I*4[G[5?L3_M(>#O'-SJ'AKQ[H5G!XMTW2Y+F"TM
M7D73];MD,<+ZAIRRM));W%K++&+VPDFEV*Z75M(\7G1VW)_M ?'WX+Z%J^HZ
M _BRSDUB">2*XTK1[6]UJ;3I0<-;ZA+I\%Q;6<\9!$EM-="Y4_+)&I)Q^0.G
M^)=9T._CU3P]JEYI.IQP7MO!J.FS>1=PPZC:SV%Y''*%)036ES-$SKM==X>)
MDE5'7G].TORKA% #R22?/(Y):220YR222S,QW.Q))8EB2:]#!>,F=8;)*&%J
MX7#XO-X2G"IC<53YX5L/&,/9.5*+CSXERO[2I+XDH>ZY7;X.)/V?? &=>)N8
MYKE6:YAD_ ..I8>>$X>RF45B,!F5>4X8RG3QV*AB+99&$:53 X>$)2IRG5A*
MK3ITZ49?HEX1\:^&_$-\MQX?UB&\==L[VK+-:7J0[B/,>RNTBG"9_C17C4<&
M0$A:_2GX%_&C1_">DWEG?V$%Y)=6YBC:0@F(D'G)!)ZYQG) Y'I^ ]Y8ZIX0
MO+&^AN/L=_"$O+*ZMV!>)P=P'!PZ,#LEC<%)$9T<,N0?T \$^*9-8T+P]XAB
M_<+K&GVEX\2D[8[AU"7<:[L';'=),B9^8JJ[_F)!_3?#SCZIQ9];P.886.#S
M/!*G6?LW+V.(P\Y1@G&,VW&K";5XQ]WDES+1,_C[Z6_T4J?T>JN09WP_G>)S
MWA+B.O6PD'F'LWF65YI1H*L\)BIT.6EBJ->E&I6PU5TH3IRI5*52/,HSG^C]
MQXO35)I)K9=H8LRJO0 G@#N0.O"^WI7EOC3Q#=I"Z;7 SP<8(Z__ %QU[=^V
MW\&;!/%5[8:8;J""6Z95$MPX6-02 ,ME0.3@@#@#!!'3K?B%X+@M+V\T_?#-
M);2-%YD+AXG.2,QG(!7)X.>?I7ZFNCM\MOD?Q*T]+JR\KN]DO79+K;N?%>K:
MQ>&1VW/M+$\$D8'?U)SU[YQ7H7P\UZ'SX_M#9Y!.X_7)R2/J>."<YK7U?X>L
M\$LL<9 "DYVGK[8..._MZ'FO%+RRU+0+X^4&PKX!^;D#H01G&006&.,9ZM@E
MW\O^&^7])ZZEQ::7>VO?I?\ 3^D?H=J7B'PI-HNGIIT)BNXX"+Z1Y 4DD/=!
M@;5ZY]\<X-?/'BO58IY2D3!@2V &XP.F0#UZ^I&3VZ>)#QQ?Q1"%W<<9Q\W3
MKGD'KSV&<\>E;6A37.O741+.0Q4XZ$YYQV)!QD'!QTQUH5M')VT3?_ ]>CV$
MX]](WOO9[)=GZ:]=3VCP/HJW,RS'!&X'IV^4\'IZ=_7KU'MUQ9/';+$.,+G'
M3/'<>HYX^O?&>>\*>'[O2=/BNIH'CB*Y5V7@_*C=<D#G.>>P!]J'B'QI%9/L
M=QE20V1@\''8$=LCZ9YH(C=:K;\]5HUOY:+=]BW<^%H9T>9U&2,X/!!ZDY(Z
M@$XYZ=!Z^0^(-*M?/:VV*><8"C/7.??N?8CUZ]R?B) ]LZ"56R>#D@?JHY[=
M._7)X\<U'Q3%/J@.X$>9Z'.0<G.!DY)(&.1ZCN+R_ $FVNFVR:Z*^R\_3KI?
M7M]%^'*SA+IH6V-N.XID<$$X)( [8XQSTQ7U;X/TCP%I'@^__M!_+UE WV=2
M5 (V#&001]X9/)&,C(Z5P.G_ !3\-#X?V^CQZ6D>JH0S7?&Y@<DCUZ#NPXY
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M/[0B;4M0U#2)M.NBZ^^W1]=%^(C^B*BH&NK9-Q>X@0(&+EIHUV!02Q;+#:%
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MUV]I PFN%CC(:OY\OBK_ ,%5_P#@IIJ=K^T?\;_V:?\ @G)X-N?V2/V6=?\
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M\60^+'5?AAI7C"R\5V__  J>P\9->LNAV^F6]_)??V='K;BQ&EOXI$H.FMK
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MDIXJDJ%>A-4DVE.M2]LJD(<R<XJI&"E4<(R_.7X;?$S1)=#MU:YA4B% 5+@
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M[I]Y8"YM[ZWDD_I#HI<O2[M=/IO%IK\M0;O^'X*Q_%);?\$[OVDXO^"LT?\
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M8I&MII51B/*_^"M6I>//@/\ \%,O^"5O[:X^!'QX^,_P5^">C?M-^"_B._P
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M=?/07]?U]WRUM:Y^$?Q8_P""2G[2C_'CP9^VE^S!^W[<_ O]M:_^"W@KX/\
M[3_Q)U/]GKP?XP^%G[5$OA#1M+TH>-/$?P:;Q/I^@> =:NY-+M[F"UT*YUBT
MTJ"TTZST@V$UK/J%Y]8?\$]/^"?&L_L8WOQ[^)WQ8_:(\9?M4?M+_M0^+]&\
M8_&KXQ>)= M/ NBWLGAJSOK#PUX?\$_#?2]7UO1_!F@:+::E=VT5M8ZA,;BW
M2PM52UL-+TZQM?TLHHLE_3^_U\]P_K\O\C\]/^"@/[!I_;HB_99C'Q4_X5?_
M ,,U?M3?#/\ :5+'P1_PFO\ PF@^'<]S.?!>/^$N\)_\(Z=8^T!1XBSK@L-A
M/]AWN["YW_!2/_@G5X5_X*$_#GX=:9'\3/%'P&^-_P "OB)IWQ9_9]^/W@JQ
MCU;Q'\,?'FFJJ_:6T6?4=(AU[0]1\FRDU32&U33)9[C3--FAU" 6\L=Q^CE%
M%EKY_P!?H!^(/P;_ ."6'[2?B/\ :<^%_P"U)_P4,_;SU3]K[Q#\!_"_B?PW
M\&?ASX&^"V@?LZ_#G1+[Q7;#3]:\9^+M/\'>)M2_X3#Q!J5@TGFVLEGIMK;7
M46G%;BZL=+M+)?E/1/\ @@G^TUX/^!OQ8_8C\ _\%/==\$_L$_$WQ+X_\1O\
M)=+_ &8?!$_Q:BL/B!J%[JNI>!=6^-+>.;;4]1\+R:C)93:]/9Z1IEYXEL(K
MW0T@T'3K^<-_3511RKS^]];>?DAW?W?UKWV6_9'\]VJ_\$+_ !%I'P0_8/MO
M@[^V+J_PD_;._P""?GA76/ WPM_:O\/_  >L+C1_&G@?6=5U*_NO!?Q"^"^K
M^/\ 5M/U3P^]IJ-SIWV:7QE?6Y&H:U-=65];:D--MO6OA%_P2'\7:IX[_:,^
M/'[<O[66N_M8?M%?M"_LX^+_ -E>#Q=X>^%_A_X*^!O@Y\'O'6@:AH7B/0_A
MQX$TC6?$ML=7N5U"2Y?Q%?7EO)=S/>37FFRW>HW5R?VWHH22V_-]K;;!=]_Z
MO?\ 1?)6V/YQ;?\ X(9?'O7O^"?5E_P3T^*G_!0BT\?_  X^'GQ4^"?C+X">
M(E_93\/^'M1^&'@CX1:[K^N7O@/5+71OB[:WWCR;Q=+JNG1P^(];\017/A==
M*9+:TU>VOA;6?OW[0'_!*?X\P?M>_$;]MK_@GK^VS<?L9?%CXZ^&-(\,?M >
M$_$GP4\-?'CX8_$RXT2.WMM*\9Q^'O$^O:5;>'/%^G6MC8"._@LM1DGDANXX
M[JPL]8UFUU#]O**++^F^E_/S87_K[O\ )'\\EU_P0+T;5/V(?VIOV<?$7[4W
MB7Q?^TA^VA\5O"?QC_:&_:^\7_#2UU74O%'BCPKXJTWQ-9Z9I/PKT[QWH.FZ
M%X8MGMM4M]+TRU\8-)83:W<SR7-U86>E:18?=_[??_!/#_AN/X*_L]_!\?%[
M_A6/_"B/CC\&_C-_PD)\ _\ "9_\)4/A+'/&?#?]D_\ ":>%/[#.O^=N_MC^
MTM8_LK9C^R]1W97]+**+*UK:6M_7WA=WOU"BBBF(**** "BBB@ HHHH ****
M "N0\?6.O:EX.\067A@PC7Y[!QI:W$GDP2W*.DBV\LIXB2X5&@9VRJB0[OES
M77T4; ?FA\,_B#XI^%7Q)U?7?CAI"_"+0;[P_=/JD.LWFEG1KYK1XY)?$=GJ
MMA?3Z9'IVB16TJ:@LTD=T(+R.Z$0MX&9_L#X/_M*_ #]H ZNOP4^,'@#XG2:
M X36H/!_B/3]7NM-#2&));JU@E-S';2R*4ANS$;69AB*9Z^%O^"ROP$^+W[0
MG[$OBKPO\$-%/B?QSX>\5^%_&1\*0&VCU'Q5X?T6:Z&M:'IL]S+"BW3Q7,.H
MBU$JG45TXV&'-P$;^>C_ ((\_L<?MKM^VA:?$K4? 'CO]GSP=\/M&\2:3\0-
M=\4Z#J7AZS\0C4-/^QP>"=*AD^R#Q!--J4EKJ%Q/9M<:?IG]E-)-<+>QVT$O
MZ;P_P3D>;\%9[Q)B^)L-@,RRQ8IX?*YSPZE/ZM2I5*<*U&=18JI+,)U50PT\
M/#DIU+<WMI.4(<E2O5AB*5*-&4X3Y>:HD[1O>[TNERVN[O9Z'])O_!0C]I+]
MB+PE\-O%_P"SY^U?XMMI[/XD^%&74O NG:;XIU?66TB:X\RPU>[F\)Z=?7/A
MR&'4+)+BQU6ZGL72>U$EM(7537QO_P $X_\ @D/^R5\*-<T']K/PEXSUGXQV
MGB[1KG7OA;I6L7%E>>$_ >G^)8IDF;3)K1VNM9U*WL9YM,CFUA_/TD-/;/";
MZ)[FOA/_ (*^?L7?MKZG^T#;?%_X1_"+3OBG\/M;^&.G^%/%WBWPA/:0^)'U
M:VU&]9[OQQI.KZDER(]+T][&UL-<M#=6O]F1!+R6U-LL(_<K_@EG\!/&?[-W
M[%/PI^&GQ!U"*[\7HWB#Q-K5C;7B7]GX=N/%&L7.K#PW:7<>89XM)CG2*66!
MGMGNWN7MI'MVB8_F7Z?\!_HO1_,[=4M]'TO]^F_:_JM[GYR?M0_\$*/A3XS^
M/?C']K.'XI>/];TF?5K+QKXF^!6J);75AK=IH[V\M]X<T7QS>:@^H:+HWV*V
M9=.TB72KR."&(:5;W5O;S)+;LMO^"7'[,?Q\_:@3X[KXY^)_@RQ\7^)/#'CW
M6O@]ICZ=_P (?)JVA1LLUI'XAM;BXU+3X]7U;3K&XAMA<6]S8,MQ;6ZR_:8V
MM/Z)+FVM[RWGM+J&.XM;J&2WN()E#Q303(8Y8I$8$,DB,RLI&"I(->%^$_V:
M_A-X&\16'B3PKHVIZ3<Z<;MX+!/$.M7.D/-=2F;SIK"\O;A)9+>5G:V!81Q;
MMNQE5%5K^O\ @;:^N@KOOZ;;::?AOOY[6[KX;?#C1/A?X>'AW0[O6-0@-U-=
MS7VNW[:CJ5Q+,Q.)KDI$"D2XCB58U"H!G)R3Y+8_#GXFVGQPU+Q9-=^&W\#W
MLIO4U!))SXI:-4"PZ#)";18UL$)V,5O#"T<<<OE>>"H^FJBF8K&[ $E4<@>I
M"EL<'(SMQD \&E>VKUMWOT]-1;V7=I=%N[==#\.O^"G7_!;+X4_L#^(3\'/
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MFW8B:=WPX\0U3_@D/_P3.UOXOS?'?5?V+O@=>_$^YU\>*KK7)O"Y.FW?B,7
MNCK5WX26Z7P==7\ER/M$TUQH$GGSL\LPD>1V;]'**5EV0KON-CC2)$BB1(XX
MT6...-0B1H@"HB(H"JBJ JJH 4    4ZBBF 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%<!\5?B?X+^"OPU\<_%OXBZQ#H'@7X=>%]8\7^*M7F&Y;+1M$LY;V\>.,$
M-/<R)%Y-I;1_O;JZDAMX@TDJ _PE?M;?\%[/VQ/VF_%VIZ?\"_$^H?LT_!ZP
MUF:3PI:>![B6P^)>L:=;RR):7WC/QE'<SR"YNX2)I]$T!+#2+4N+:5M5EMUU
M"3YKB/BK*^&:$*N/E4G5JINEAJ$8RJSC%I.<G*4(4Z:;MS2DG)IJ$9N,DOV+
MP?\  _C;QJSBIE?"E'"4,/AITX8W-<RJSHX'#U*J<H48^RIU:V(Q$HIS]E1I
MN-./+*O4HJI2<_[]**_C$_X)W_\ !>/XS^ O&/A#X5?MCZW#\2_A3J]Y9Z$W
MQ:OK=H_B/X(GNW:WMM9\2:D+F.T\6^'8[J2!M:EOK2+7K"R^TZC;7^H"V32I
MO[-XI8IXHIX)(YH)HTEAFB=9(I8I%#QR1R(2CQNC!D=2592&4D$&JX;XIRGB
MG"5,5EE6;="4:>)PU:*AB,/.:;@JD5*47":C+V=2$I0ERR5U.,XQ?C1X%>(/
M@/Q#A>'^/,NHT/[2P]3&9-FN!K/$Y7F^%HSC3K3PM=PIU(5\-*I2CB\)7I4L
M10=6C-PE1KT*M62BCZ5_*7_P4"_;R_X+^_\ !/GX>Z1\8OB7X;_X).Z_\._%
M_P :?"WP<\*6O@[0?VK-9\60ZCX]N]77PM>Z];:MX_\ "NEQV<%II;?VW<V%
MY--%<.OV+3KB-B(_HF['XX?U:45^2O[,_P </^"@'PJ\:^)+/_@K!\4?^"8G
MPU\(ZKX*OM9^%5O^S[XO^*OA'Q?J6J^&[J&\\8:EK\?QU\0#3KOPEH?AV0W%
MY=:&GVC3[MX)+Z5+1S7VTW[8O[)B?"FV^.K_ +3'P'C^"][J-SH]E\5I/BOX
M'C^'UWJ]G(T5WI5KXM?6UT2XU.V=66>PAO7NXMI+PJ!FF!](45Y;\)?CC\&?
MCWX7;QM\$/BO\.OB]X/2Z>QD\3_#;QEX?\:Z%%>Q1I+)9S:IX>O]0LX;I(I(
MY6MY94E$4B2;-CJQ_-G_ (*%_P#!53X.?LZ_LE_M3_$?]FGX[_LQ?%3]I/X"
M^#$U_2_A-J'Q!T+QM*-2A\4Z%HVIV_B3P5X+\;Z%XNG@T^PU"_N+F&QU339[
M66V$UQ,L,,T;JZM?H"U:7<_7BBORF\,_MB_'*[^)7[&_B'QKXM_8_P# /[-G
MQ6_8T_X7Y^T _C'QG<>$OC5HWCJX\)1>((=1^&.A:UX\6S3X1Z7/=0'Q#JNM
MZ/KTFE6D%\MSXB@FB21O!/V:/^"MNL_MN_L$_M)?M"_ .X_9M^''[0WPXU?X
MM6_@#X9?&CXHV<WA#P_X9\'>*(-!\&>-/C3>6>O^$]4T7PWXDMWDEN-9@O-!
MT9[N2"&QU'RR6<33_3S6G^86_JZ]/Z^_8_=2BOF6P_:,\#_#']GGX3_%O]JK
MXN_ CX6WOB;X?> ]2\8>+F\?Z'X=^$-]XXUOPIIFJ>($^'OB/Q/KKQ:MX5N-
M4GOKCPM-_:^IW5WX?^QW;W=WN>Y?O/!_[0/P*^(7PZU#XO> _C+\+_&7PKTB
MVO[S5OB/X7\=^&=<\$:5::7";G4[C4_$^FZG<Z/I\6GVX-Q>O=WD(MH,33;(
MR&+ ]>HKYH3]M#]D*3QIX<^'$?[47[/TGC_QA;Z7=^%?!:?%_P  OXG\16VN
M6]K=:+-HNB+KQU#44U>UOK*XTLVL$IOX+RUEM!*EQ$S]=\9?VD/V??V=M.T_
M5_CY\;OA1\%],U>26'2K[XH>/_"_@:WU.2 *9TT^3Q)J>G"], =/.^S>8(MZ
M>9MWKD ]IHK\H?\ @IC_ ,%#+W]F7_@G+\1OVV/V3=>^#7QEN?#]]X%@\'ZU
M?7L_Q!^%VMV_B/QWH?A;5G>Z\!>+O#\^H26MIJ-UY/V'Q+;?9K^.,W*3)');
MO^G'@K6;KQ'X-\)>(;Y((KW7O#.@ZS>1VJ21VL=UJFE6E]<);)++/*D"33NL
M*2S32+&%#RR,"Y/Z_K[@.FHKR?XO?'GX)?L_>'[?Q9\=/B[\-?@[X9O+O[#9
MZ]\3/&OAWP1I-Y>A0YM+2^\1ZCIUO=7*HRN\$#R2(C!V4*0:_,KX.?\ !2S5
M_B__ ,%3/C)^R7X9USX'^*?V5O O['OA#]HKPI\6_"%Y=:OK>J:YJWB2UT;Q
M ;WQY9^-=0\"7OA'2XCJ"M'8^&[.\L;JSE%[K$GD314?J'?R_P TOU/V-HKY
MGL/VT?V0=5\0Z-X2TO\ :B_9^U+Q1XB\/7WBW0?#]A\7O 5WK&L^%],L[K4-
M1\0Z;I]OKTES>:-96%E>7UUJ,$;VL%I:W%S)*L,,CKZI!\7OA3<_#9OC);?$
MKP)/\)%T:X\1-\3H?%FA2> %T"TDEBNM:/BY+XZ"-*MI89HY[\W_ -EBDBD1
MY59&  /1**\7^(7[1W[/WPE\!Z'\4OBC\;OA1\//AMXGM]/N_#7CWQI\0/"W
MAKPCXAM=6L8]3TNXT/Q!J^J6FEZM!J&FRQZA9RZ?<W"7%C(EW$6@82&Q\/OV
MA/@-\6=1M='^%OQH^%?Q&U:^\,#QK9Z9X&\?>%O%5_=>$#JCZ'_PE$%IHFJ7
MUQ+H UJ.32#JR1FQ74HWL6F%RC1  ]@HKYR\.?M@_LG^+_B7-\&?"G[2WP'\
M2?%NWN9K*;X::%\5_ ^J^.4O;;S?M%G_ ,(Q9:Y-K#7D!@G$UJMH9XS#*'C7
MRWV^_:M=26&EZE?1*C2V>GWEU$L@)C:2WMY)D5PK*Q0L@#!64E2<,#S0!?HK
M\/\ _@FO_P %?OAY^T-^R]H'Q4_;.^,W[+7P%^+/BGXO?%7P)X>\&KXVT[X9
MVNM:!X,\7W7ASP_?Z9X?^(OC_7]?N[J^6SN(KR^AU%["ZOK>=;2WM?*DA7[E
M_:H^,GQQ\!^+OV/K;X$Z]^S1%X0^+?[0GA#P=\7I_C=XMET?7-<^$FM6_P!I
MU"/]GM;+Q7X?M_%/Q5O(BK^'=,:V\3VUXDD4@T6YB9I%5T]?Z_K\AV=TMKVW
MT6J3_)H^VZ*^;/&_[97[(_PTBU.?XA_M.? /P/%HOB>[\%:NWBKXM^!="_LS
MQ?8"T:_\,7RZEKENUKKUBM_9->:5,J7MJMY;-/#&)XBWK#_%'X:1_#__ (6Q
M)\0O!,?PN&C+XC/Q'?Q3HB>!?[ <*4UK_A*VOAH7]EON4+??;OLS,RJ)"Q I
MB.[HK\0OVM/^"MOASP=\8/\ @GKX,_8]^)O[-7Q^\'?M0?M8V/P&^,VL:)XF
MA^)=YX/\.7UA!<0S^';SP#X]TZR\.>);B87ZVUSXFLM=L)DLY5CTJ0P3-7[0
M>)O$_AOP5X>UGQ;XPU_1O"WA;P[I]SJ^O^(_$.I6>CZ'HFE649FN]2U75=0F
MM[+3[&UB5I+BZNIXH(4!>1U4$T?YV_!/]4!NT5^67_!+;_@ISX$_X*3?##X@
M^.M/C\$>"/%7A7XL_$SPQ8_"O3O'6F>)?&EG\,_!^MV.B^&_'GB2PB>"]M[?
MQ'+<LW]HP:=#H;RM%!97$Q!=_KCPK^V9^R+XZ^(TOP@\%_M/? 'Q9\5(KF6R
M?X=>'/BYX$UGQI]L@,BS6:>'-/UVXU66ZB:*426T5J\RF.3*#8V%=??M_7S
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M*W7##('&<<9Y'Z8SSQVQ7F[>#[ZPO"\<;*-_!VX_+C.1GKS^'6O4-&TN^>!
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M@T?QG\.;=A%_:O@WQYX=ECT?4]06X/E7&G2VEM&FRY-K?7S:=JL=A\&>%_\
M@Y8\"^,_A-%^TKX9_P""??[9FM?LI>$-5'A_X\_M :;I7@N[\-?"'7[C5(--
MMK*VTY-;$_CJRL5O-/N?%.KZ?>:/8^'#J>FV1?4;Z\B@*NK7_K[M].O;J.S[
M>7]?>?TTT5^2_P"UA_P5Z^"'[/\ I_[-VB?!SX?_ !'_ &Q_C5^U_P"&4\;?
MLZ?!3X"VVG7'B+QGX%?3X]2/CO7=2UN>UM_!_@]+=Y8WU34+*ZNEN++54;3E
MAT76KC3H/V4?^"N7PV^./BOX\?"+]H/X,?%#]B#]H7]FOX:WWQH^+'PC^.LF
MAW26WP=TRT2^U7XG^$?&7AZXETOQ9X/T>"6#^UM2BLM/^S/<0F"*[MV-PI=?
MU_GL(_6^BOYS5_X.&=%?P;<?M*I_P3V_;'/_  3^M_$BZ W[9[:9X.CT%[!O
M$2>&#X[C^&<FKKXHE^'7]I,5'B:'499 X73Y=,BUIGTN/C_CO^V#\(/ O[;O
M[;7QA_9F^&_[2GQL_:>M?^"67@'XHZ-J7@WQ[X%E^"%_\&O%NN>&;WPGXZ\%
M^$-=GTF]M/$/A-=8T?QWXBUJ?5YH=3\+:=JMKI6GM?W$0G+K?[[Z:=UIKY=^
MXTKNWEII_737\KG]+45Y:3S3V\-U;S7%L5%S!%/%)-;EAE1/$C%XBPY42*I(
MY%6*_P ]']A/PE^S#H'['_[)W[5O[4?[/W[=FF_%7XK_ +6GP3\+Z=^T)HO[
M0.D-H/[0_CKQE\4/'&O:?XDM]&U[7?$4X\"^"M2\)Z=I?C:ROM)T+Q/J\]U'
M]@U&=9[Z:OZA?CS_ ,%C#X6_:3^)W[*W[(W[%W[0O[>'Q,^ 4>DR?M":E\&[
MOPEX>\!?"FZUBU:^M_#%UXO\2WDEMK7CI+:&\63PK;VMF[ZC97FCP:A-JFG:
MM:::7TN]+VZW>OE9?K^ ^5V76_R[;:^9^U-%?S2?'K_@HY^Q'^VU\)/^"<_Q
MQOO#'[3D%S<?\%*?A;\*O#_PW\+:[X;^&WCGX6_M,:#<3"W\+?'C1]4;5[36
M_!EA)=VTNKZ-H6H)<:M9WEO):ZC;.MS;IXY^P_\ \%-OVP/$7_!0'_@JTGQ%
M_9<_:G\<>"?AS%H&H>'_ (9WGC'X?R:9^S/IOPT^$_C?QAIWP_N]&'BI]'@\
M0?&S5(&&BZGX6@U-KR^O=-/B>\"6D:VA=:>>UM>E]?Z\_16]==-OFOO6WX>7
M]7U%?EUX4_X*Q?L\>*/^"9>K_P#!4(Z=XCTCX1Z!X"\0^*M;\#:A<:+_ ,)S
MIWB?P]KT_A)_AK*8[YM&_P"$LU/Q:MGH.EH]['!//JNG2S&!9F2/[G^ 'Q4N
M/CG\$/A/\9KGP3XA^&[_ !4\ >%_'\/@7Q9)9R>)O#%EXLTFVUK3]+UXZ?)+
M:1ZK#87ELU[;QOOM9W>VG6.>&5%=_P#,1ZM<W=I91^=>7-O:0[E3S;F:."/>
MYPB>9*R+N<\*N<L> ":G!! ((((!!!R"#R""."".01UK^,C_ (*^>-O'?[3'
M_!93]EO]D3XG?LG?M2_%G]G_ , ?"7XD>(]'^$'PM^)WA[P%)\>=4URV NOC
M=X=O+/QMHB_\(Q\/9+.WTJ]M_$=UI?B"*Y\,:Y'I=L]CJDZ7GZ07G_!8_P -
M?#'7/'?[/'["/[ W[4W[:OPD_8FM=.^%7Q>^*_PIO- B\&^#G\#Z1'I]UH'A
M/4_$EWJ&M?%?Q'HECI=S'J<< TZ[U.[LKF]L[G4;&9-4EGF6ODVO-VMLDOU^
M2';\[/RT3Z_XEY>9_0Q17X7_ !<_X+]?LA_#;]C_ /9Q_;4\.>$?BO\ %+X8
M?M$?%F7X,6WAGPCI.BK\3/ /CNQTG6=1U?PWXK\)WFL*K^(].N](72AHNF:E
M=-?3ZEIUW9WDNGW45T_W?^PC^UI\3_VP/ASXR\>?$_\ 8[^.W[&E[X=\>7/A
M30?!GQ]M(-.\2^,M!71-'URR\9Z58BSTZZATR>+68].N@UI<6%OK-EJ6F66L
MZI<:;J(M'=?U_7_#B/N&BOY@=2_X*!?M<P?\' ^I? 2+]GO]I37_ (,:!^S!
M;>%=-^$FF>+O MKX5M[37OC;::9J/[95SHK^*;?3;_P9-ING6NAVIO\ SO'>
MGVD%Y;VFDVD%[<)=?)O["_\ P40^,7[.?[2/_!73X?\ PK_8S_:C_;D\7VG[
M='Q$\<:U8?"B;3H?"OPR\!6TEWI=I#J'B3Q-=72GQ#KTNG:P_A7P-X<TB^U/
M6TT&^,:VRQQNRYM;6>[7W)/;=[C2O^GF]--_/\#^S"BOQ@O/^"YW['UM^P+\
M-OV][;2?BAJ^C?%SQG-\)_A[\!-&\/Z;J/QW\1_&FUUF\T*]^&%GX:@UEM*.
MK65S9-J-SJ7]L'3DT.[TR[1WU#5-/TFX/V<_^"P$WCS]H[X>?LJ_M:?L8_M
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MNNS17'AG6+B"198)]"U":&5"&22*73YGCD1APRNC!E(X((-?AKX7_P"#=O\
M8=\/:IX3T;4O'_[5GCC]GSP#XR;QUX)_9&\<_'C6=>_9PT'6O[0FU:WMF\'2
M:;%JVJ:)I^IRB^LM,U+Q#<,\Z-_:EUJD=U?1W7[O7=I#>6=S8R@B"ZMIK201
MD(PAGB:%PAP0I",=IVD*<<$#%4E;TTM_5EY6Z]Q/I^/]>7YW/XX?^"%7_!.'
M]@#]H/\ X)O?M&?$KX]_"7X8?%#QG\0OC'^T7X8\??$#QMHNFZSXE^$^@^%[
MBXATVS\%ZWJ<<][\.KG1M,OI/%[ZKX<GTJ]O+K4H[V\N;B"&VCB^)OV;/'7C
MKQM^Q]_P;YV_C36]7\1Z?X!_X+61_#3X;ZSK5U/?7EU\+?!WBT67@^"*]N"T
MMSIVEPRW>CZ60[PP:=I]M:6VRVMX8H_WP@_X-MOV)M"T#7_!_P /OC5^VO\
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MDL=/:U$FK)I>M]4[)?\  TZ>>X[/7KI^EWU_X.KTV?\ .I^U1\*_AC\-O^"
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ML"#_ +((/Z'FJNTFE;:ROMT_R)B[/R?3?T?]>>FQPG@[69HE2)X9!NP,D'#
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M74]1A\6>)-:\.:=X6CO;W5K*#P%X>C\/ZKJ/V^T\02^=]A9A:2?KQIUI"_\
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M]_/_ #3_ $/\V>W^#OB[6/\ @F_^S3^T@@^,=G\%/V7_ /@KI^U7KGQY\2?
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MC:?>QQOIT]W'/<3R7ES^G=4M4GW$%%%% !1110 4444 %%%% !1110 4444
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M%DQVFEZ19PV%C;J6)9A%;01IN8EF(+,2S$G^2/X6_$/Q[\!/$5GXR\$Z]?\
MAK7K25)[JV$LXTG6(48%]-U[36DCMM2T^Y4['AG021L1-:RV]RD<Z?T,:?\
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MAMX[\36&DW^NRVRJUVNA:*7DUK6ELU>,WLFF:?=QV8EA^U-%YT6_Z-K^+?\
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MEMKRSN)K>>-@\4C*0:VZ_!+_ (-T/!/BWX;?L$:UX"UGXR?!CXS^$/#/Q_\
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MU&G?:]+TVX"3"S%G%:V-J*_5FBBA:)+L(**** "BBB@ HHHH **** "BBB@
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M5X[J>_FO8UMH[:Z?_ 7WZ(#[>HK.N]8TBP266^U33K**!HDFDN[ZVMTA>?\
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M<\379-.RLWYJVO\ P';?4PUOKZ)DS(V01CGT]0<GZ\D]<9KJ8?%=W!$J!]I
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M\D*F[Y^,@YV\G/('/!Q7I'C#6O"GAZ[CMO#U\+J#R4)<-D*PP6!).0!T[YZ
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M&.F76M:?:>!K+0(9(=9O;#1[2;4M<%S<Z=9Z3:;7N+S>VP,1^K]%?F9\#/\
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MD74Y(3*]_+=S16UC]KN;F2RMY(_ /V0/^"2G[/WQM_X(=Z3^VIXW^)/QBO\
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M;:^AUW4--9)-=+_#VZ6NM_+T8[KJ^D59>25]=/-=WZ'YR?\ !(SPM\>/@/\
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M.!G (')SVZ8'6O&O GBH6URIE.W]YUS[^QP,]>>.0><BOHZ7X@69LE4NA8*
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M3_9[MECDPI;LPP!NQV)QCUQS@<YY%OPE>66I(3<E6W<#(4GKU&<D8SV(S^'
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MT$ZK-;ZGJ3W=_;R*KP7$; $/E^Y7LKM:.W5=G?N%VG?=^>JZ=/EOOVL>"?\
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M@592000:9;6UM9P16MI;P6MM"H2&WMHHX((D&2$BBB58XU!)(5% Y/%?RO\
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MAFS:+4[1KNYU3Q7J*&#3_$6@QW%W;7!LEUY<RU\O\[==K/O8+/MV_&UOOO\
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MY4TFK;I:;:MWZ:?IDU?>_P ]6KV_+?SZNU[^N^&?"-MJQ\R6('=SRHY/( Y
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MQ:US2('NM3T7X=?$SP=XQU>QLTE6%KZYTS0=8OKV*P$SI$+YH/LC2,J+,68
M]E\4_C)\)?@;X8/C7XS?$SP'\*?"(O8--'B7XA>*]$\(:+)J-RLCVVGPZCKM
M[8VL]_<)#-)#9PR27,L<,KI$R1.R@'I-%?,FH_MJ_L>Z0W@1-4_:E_9[L&^*
M%G!J'PY^U_&#P# /&^GW6H3Z3;7_ (8:37@NLV5SJUM<Z5;W=B9K>?4[:XT^
M*1[R&6%?IN@ HHHH **** "BN-T_XB_#[5O&FO?#?2O'?@W4_B)X5TW3]8\3
M^ M/\3Z)>^-/#FD:L%.E:KKWA:VOI-<T?3=3#H=/OM0L;>UO ZFVEDW#/94
M%%%% !1110 45QWC/XB?#_X<6NBWWQ#\=>#O =EXE\2:5X-\.WGC/Q/HGA>U
MU_Q?KOVC^Q/"FBW&N7UC%JOB36/LEU_96AV+SZIJ'V:X^R6LWDR;>QH ****
M "BHIIX;=0\\T4"-)%$KS2)&IEGD6&&,,Y4&2:5TBB0'=)(ZH@+, >3_ .%B
M_#[_ (3H?"[_ (3KP=_PLP^'CXM'P[_X2?1/^$Z/A1;M=/;Q,/"/V[^WSX>%
M^RV1UK^S_P"S1=LML;GSB$H [&BBB@ HHHH **** "BBB@ HHJ$W$ E> SPB
M>.);B2$R)YL<#LZ),\>[>L3O%(JR, C-&ZAB48  FHKCO _Q$^'_ ,3M%D\2
M?#7QUX.^(7AV'4M0T677O _B;1/%FBQ:QI,WV?5=)DU30+[4+%-2TRX_<:A8
M-.+JSF_=7,4;_+78T %%%% !163KVOZ%X5T75?$OB?6M)\.>'="L+K5=<U_7
MM1L]'T71M+L87N+W4M5U74)K>QTZPL[>-Y[J\NYX;>WA1Y9I$12PA\->)O#?
MC/0-(\5^#_$.A^+/"WB"PM]5T'Q+X:U:PUW0-;TR[026NI:1K.EW%UIVI6%S
M&1);WEE<S6\R$/'(RD&@#<HHK'\0^(= \):#K7BKQ7KFC^&?#'AO2K_7?$7B
M/Q#J=EHN@Z#HFE6LM]JFL:UK&I3VVGZ7I6FV4$]Y?ZA?7$%I9VL,MQ<31PQN
MX -BBL;P[XC\/>+]!T?Q5X3UW1O%'ACQ%IMGK/A_Q'X=U2QUO0==T?48$NM/
MU71]8TV>YT_4]-OK:2.XL[ZRN)[6Z@D2:"5XW5CLT %%%% !1110 4444 %%
M%% !7\R_PX^#/_!43_@EO\?OVT/"_P"R1^R!X,_;6_9A_:[^/WCC]J'X77__
M  O7P3\&M7^"/Q7^)Z6D/B?POX[LO&<AOM7\)6L6D:)!%?:0A5M-T2SEAU%-
M5U*]LK?^FBBDU_PX?U_7_ /XX/ O_!%']N;XR?\ !-G]M;X+?M%V'@'P-^UO
MX_\ ^"AGB+]MKX4WTWB+POXK^&/Q"\1M8^'KNX_M%O#]_KC:'X2\8WMQXMTN
MST[Q%8Z?J^G[-.?6-$MM/>0-ZWX3_9:_;\_:&\<_LX^ [G_@DE^Q#_P3UT'P
M+XWT'7_VH/V@[KP_^RA\<D\?Z!X>MT_M'PK\(/ 5KX-U_4]'_P"$ONTEO;?4
MYIY;G097L;;_ (2J 6-S-JG]8E%%O-]%OO;O_P "P[]M/^'O\_G?\K?S4^&O
M@7_P4A_X)B?MC?MI>-/V3?V4- _;B_9:_;8^)'_"]=(T*Q^-/@3X->/?@Q\8
MM3M##KNE:[)XZF2UU7P?J=Y=W,,5[IMO>"VTC3='N[F\L+^._M-0X?XD?L(_
M\%5OC=\-OV%/%_[2&JZ3\7OC3X7_ ."JOPZ_:Z^)_@/0_&7P_LO"7[+_ .S_
M *9?-<2> /"NN:K>>'&\<6W@M#/))::%<^*=5N'NX[+0EU&UM1(W]1U%%O-[
MW_%/\UZZL+_E;^OZ_#0_#+_@M3_P3V^,'[7%E^RO^T#^SAX.^&7Q7^./[&_Q
M7N_'MA\!_C*NCCX;?'CP%KUI9Q>+OAUK5UX@QH=G?W[Z/IT.FRZS+9:6;>^U
M5YM0L[R'3IE^;_V:_P!F#]LSXS?M??"3XIZW_P $Y_V5/^"7?[//P>\-^(M0
M\4:?I'AG]F+XR?&GXK_%2^L9;3PY>^#O%?A#P/\ VS\.=)\%:DUOJMAK-A?^
M&[V]6WN=TNJ?;X(-*_I=HHMYO6U_E_GU]!=+>OXV_P C^%?P#_P2E_X*"?#C
M]F;]H_\ 9&M?^"7/[//Q%_:/^*>O?%Y[_P#X*7_$GXV_"CQ5)X@\*^,=1UC4
MM.UOPSX<\4'4/'VD>.KS2F'A;PU"3X?ATC5-2M_$_BP:?_Q,KF;[SLOV6O\
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M;2(8;Y0H)!<8')R >&'/4\Y/)/.3SQPO@GQ 4ACC!(#C !.,<$G*9Z8R<=<
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MP&\">(_VN?ACX+^#G[0&H6VI_P#"??#SX?>*8_&7A30KFVUB_M--;3->AO\
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M?@C\8_V3[/XQ^++_ .'?C2YC,'B?X=>/?"_PG\;>#)+5=1NY;YK'4-:FO+F
M:;H4>D6<UCJ^H7=B]5;>S:NWII9;NU]^MF_.XEJ[_E;RL[:+>U_+[S]*==_X
M+V>)O#/[ O[6_P"T'XK_ &;]+\'?M7_L-_&+PA\%OV@OV<M3\=2:OX7M]9\2
M>*]+T"W\4^$?'VC:<T>L^%]<LYM7O=!>&*X,=QIOESWE[IUS8:KJ/Z"_\$[_
M -I#_@HC^TE>>,O''[7G['OP\_9:^"GB+PAX-\9_L^MI/Q3M?'/Q+URS\4&\
MNYM)^(6BV=Y,-$U/3]#72]4O?M>C^%I;*YU:#2$T_4;FVU.73OYHO'O[$_Q
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M@'XM?M8_$7_@F'HWAG5_A]>_$VX\.?!OX=:O<?$"7Q!XU\5^(?']QHHU;4?
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M#_#OP$^.?_!._P +Z%XW^(6A?";Q9<^./!?Q2\+^,;0CP3<_#NZU2-;ZRO\
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MZQ#XINW?2[&/^V= ,,\9=)+QCY ^IJ/T **** "BBB@ HHHH **** "BBB@
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MS'[O!SN8\E>_0@Y/'UQ0Y<J<M]+-+5VTZ?UU*BK-:_9_'2_WZ?U8_0?X)?M
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M?S%>B^%/&=K%IL4;,I(C ^;CC9P"",=?4^O!SBN(\92Q:[*PAPP;C@<<GCC
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MQ^R:A+";>[<P&:.-M\+!EPWV_110']?U]P4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!^.7_!>[PYX^\2_\$N?VB8? 4TRMI'_  @_B/QC
M:6T7G3ZAX"T+QIHM]XCA11'(RQ68CM-9O95,?E:?I=W))((ED5O\Z_P=K,,*
M(K,OR@#KCC_$>G_UZ_UQ?$/A_1/%F@ZUX7\2Z59:YX=\1:5?Z'KNC:E EUI^
MK:1JEK+9:CIU];2 QSVEY:3RV]Q$X*R12,IX-?Q]_M5_\&N_B'4/B)K?BO\
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MWE\6_P#@CQ\2G\=_LY_M'_LG_MFZM^S'^V#\$?V?/!O[-OCGXL6GP=T+QWX
M^/\ \/O!WA^PT&S3QU\)?$?BJ;3M/U!19+=V5T-:U\Z=Y6GQVX^W:7IVK6W8
M?L"?\$EO'?['W[7WQU_;2^+/[9?BS]JSXM_M%?#32O!OQ&O/%7PIT7X?E_$=
MAXBLM:D\0:&V@>,M7TC1?#4-CIMAH.A> ].\/6MEH-C;(;?5YX]MK&N5W5U=
M\R;>FUE^7I^8VTWIM]V_EMHM/57W/1_^"WWP;\$?&/\ X);?MGQ^-X=>F7X9
M_ #XN_&#PI_8/BOQ)X5,?C7P#\-/%VH^'9=7/AO5-,_X2'0DN97.I>%M=_M#
MPYK46V'5=,NXT15_GV\8^%M9_9T_X)5?\$?_ -ES]EOXB_$KX&7O_!5OXK?L
MQ>$_CW\6+3XB>,M?\1>'K#QU\.O"3>,(O E_XEUZ_?X?6.LW-YIICT7P9<>'
M]+M].T^_T^TMHK:^NHY/Z_?VD?@CH'[2W[/GQN_9X\5:E?Z-X;^./PI\>_"C
M7=7TI(I-2TO2O'WAC4_#%[J-A'.1#)=V4&I/<V\<I6.26)4=E5BP_&>W_P""
M(/C3QU^PAH/[%/[2'[;OB;XK7WP1\5^ O%'[&_QP\&_!;PW\(O&W[,LOPST2
M30/"=M:6VA^,=7;X@I'8N8[R?7-8T[5#"Y@AU9)X;.^MJ=^G9]O)VOOKJM-K
MW)2L[WZ)>>COOY_IZ'PG^UA^R;X4_P"")'[1/_!/#X]_L1?$;XT:'X6^-/[3
M7A7]G#]HWX*^//BWXO\ B3X7^-'A_P =VOV5_%LVD^+=3U)K7QAIK'4KYKS2
MH8[*PU"YTW4M,LM*%C-;ZC_1-_P4(\-?M(>,?V*/VE?#'[(>J2Z/^TCK?PMU
M^P^$U];:I9:'J"^(YEA\RVTC6]1GM;#1M<O]+&H6&AZK=W=G!I^K7-G=/>V0
MB^UP_G/\-O\ @D5^T/X\_:1^ /[0W_!1?]O[7/VU8/V4M5NO$WP#^%>D_ SP
M=\"_ ^E^/);6*UMOB+XV7PCKE_+XN\0VLMGIFJ6UK-;V\$&I:9;I+>W>CS7V
MD7GZJ_M;?LT>"/VQ/V<?BW^S5\1-0UW1_"?Q:\*7/AN_UOPQ>FP\0:%<B>WU
M#2=<TBYY3[9I&K65CJ"6\ZO:WBV[6=TC6\\JD2^+I?9:*VF^EQ]O6^NW33TT
M;LN_=L_C"_8'U#]GKX$?ME?L0Z-X^M_^"CG_  3._:[U+Q%I7@KXO:9^T+<?
M$#XN_!3]MWQOJ]MIVB7WA34?$?B?Q*;'PY>>+O$%Q+%X?U&R\+'2=/.HZ9O-
MC>6UEK%WR][\1-._X*!_M@?M]?$G]L7]FK_@II^UMX/^%7[27Q'_ &>/V</!
M_P"R!)XUTOX5_L_>'_AMJ4]EI^HW4W@WQ1X;2;XN/;W6FZU=Q:O8WE@TETVH
MZK::O%J-I::9^[G@[_@B_P#M+>,/%7[+&D?MH?\ !2+Q'^T]^SS^QC\0/ _Q
M+^"_P;T[]GCP3\*M7UKQ?\,(EA^&^L?$?XDZ5XIUW7]=/A>UCCTVXLV@N?[?
ML1,UY?6UU=W<TW:>/_\ @D3^T/\ #S]I7X^_M#?\$[/V_P#7/V,K3]J[7+CQ
M?\?OA7K?P,\)?'7P3JGQ&U*2\EU?XG^"X_%'B'1V\+>)KVXOKK4)+:&VD2;4
M+FXWZFNF&VTRU%'3ROMY66ZV>OY-[ZLO\O+OMV2ZZ_E:R/Y]OBOXL_:[O?\
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M*WOM:N59F83ZE/<R@L2'R377444 %%%% !1110 4444 %%%% !1110 4444
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MBY<RDHW;W6FG357[[7MMV_/'18!+IV6&1M!P#D@8 R>,CZGG\\U7TG3+>?5
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M-;]EKM?]3V_P[XYO+>T7YG   YW9QWR=W3(SGD''3H2R]\<7<D^]78@G.#G
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M]#CV-?'_ ,"_#EUXFU:UTNV9%FE?:"S8 'R@@@D9(ZY&0,]1DX^B/B%X5N=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]:CVETTN;6ST5ETMO:^K^[IWI66B6WIOIOTO_P /M8^DM82QU&P!C4%B@!X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "OY#?^"V?[-7C'X7_M)2_M*Z7I=]>_#+XP66APZO
MK=M;3/:>'/'VB:9!HUQI&KSI"(;$:WI.F66I:-/<28O9DU2V4^;:(LO]>5<]
MXJ\)>%_'7A_5/"?C3P[HOBOPQK=I+8ZQX?\ $6F6>L:/J=G,I26WO=.OX9[6
MXC92>)(FVG#*0P!&M&JZ-13M>VZO:ZNF_P C.K352$HM;[/L^Y_GA6_BZ*YL
MA&\Q!*X +?*<C .-W&>.,G X)/6L"2\U:T6VU-;>\33[RYN[>QU#R)XK2[N+
M'R7OK>WNF7R+BXLENK4W4,,KR6_GPM.$\V,'^TV?_@D%_P $_P"?Q$?$0^!Z
MV[&8SG1+3QEXUMO#9<RB7:-%BUY;5( 1Y:VL>RU6$^4L(3 'XE?\%7?BO\-]
M9^*GA']D#X._#OP5X2\!?LX3.9KCP[H=CIEPWC#Q%IEE+J^B:9]A2*.WTBQL
M_L2:O^Z:[U?Q'%)<WDSMIL#S>G'%NO4IQA%Q=FVV]$DO1Z6\K+OL>;4PWLH.
M4YJZ?NI*]WIN[Z.S>R?K8_) >)]:G@6*6YG9 H(1V;IP>A;C)'_UP"*L:99Z
MA=2B?<Y&=PY8]_0<>WU[<\=;J7AA--C"SP-%(JY(D5E?;GY20RC&>W<]V)!S
MK^'I;*"$JQ08 P#CW/'/09YX!Y!Y'3L49Q:;DG=*Z2O==6WI9IZ_/5;M\B3Z
MN_RL<W-)>H?(9W(SMQGCDXZ'&#SU'O\ 6B'P[?,ZW,0?ABV5SECU ?C)(_,9
MXKI9D@NM201;2"PSZ<-D]L<\8/7GMQ7TOX/\#MJ>GF2.V:8*GS%4!VC:,DX!
MXY'<8]1TK2R26ROV[7_6UM.B0I-JR2NW_P "_P"!\NOK>J:/'L=Y%Q@$,Q &
M"!@D_,>WK]?3L_!VJ76K72^8[$$CDGZG.3D_0]Q@<&N@\?>$EAE>.&)0VX<,
MI7J_/*K_ '>G8GGH>)_ ?A>:!DD$9 SP3GH#D$YSW. ,\^G6H5^:UKI+XM;I
MM+^M[_BVFURV6C=M//3;RMUV>]]3T'7/#"W6CN[@$M%GIG<3UXZ=B?Y8XKY)
MN/#PM]>8850MQD;>.K#:3G&""22 /3/?/V=XDU1K'3FA^Z?+90,<#CMTY!(!
MXP!D@D5\>ZW?W(U9IU#<.#DCC(()Z ^F?RZ$U3W_ $^:UO9[?UL$=&XV6FM[
M^G1_?Y?B?9W@CX8ZM<^$CK0MF^PB,*90OR\1YY]">,=?S%>/^,=/&CWCN,<.
M<@=0<GJ<<\#M_.NE\'_''6=.\,CPX;IUL2 /+8G&<!03C&/ES^=>0>/?%C:@
MY,3!W>3!R2" S,6.1W]/?@GO2YGHFKW5_1=5;7;?U8^1:6=K6];Z7_SUZ6^?
MH6@^.XX+9XA)G@+R1C !'J#U&.1SCKQ7G/BV]77+IE*;][$D !N#TYY.>"3G
MM^--\#>'+[79DBMT>1Y2 J+DDD[2,@ ]=P ZY/3M7K=[\,-0TV9/MEM)%* .
M'0AN0"1R5' (.!Z]>:O1/:Z[7Z[_ (?+7T)T@U97OIY]/OV_$^<;KPJD<6]8
MP,\D@$\?0 <=B?H*]1^'6FVD=Q$LZ( &4'(ZCWR,C],=>>17IR>"4GMRK(-R
MCGC!SGGMWP#T''Z^;ZTC^&)GD#&,*6.X#G@\8QCI[ DY_ 2DDK;Z^5ON20[W
MT^'KJM6]-%9]MUOLK'NVOPZ7!I9DC$*L(SC:5)^X2> .Y&/3H>,YKYP;Q)%8
M:J1N4!9#T/\ =;@8YSC."0"">W4C,O?B0]VC6QN>OR $DG)R"/8Y)'?@]NE<
M;=V4UVQN48L?O$\D98Y&.O!]21[GG@NNFO\ 2_S6CW$HZNZ235K)^G]?UK]9
MZ/X^MI[!(@XR4 P6'4CKP>N3U_$]<55C!U*[5V&0S\X&1CH.>>,'!/'7L*^=
M?"<MP+E8))&"A@,9]P#W]Z^M]#TR&*Q$[, P0,6/?(X(XYZ#].!TIZ]?+\O5
MZ_UW!QLU=Z;O2VUDKVWWM?I=ON37FBZ:NF,TB1 ^7R2H)R >F3UX&<_B>E?+
M6NZ9:OK6R#RB"Y&3T&&!!X'')]\].,U[/XO\02Q));0/N RN%R < @DDX[YZ
M<=^V3\XR:I<IJHEF!"B0 Y/JWO[>P(/0 T+?T3?ST6ODKWUTTUW0XI:M>GDW
MH]--%\O\C[6^%_PYUG5]!N=1T^$R164!>5EX V(I/8$X7/ //?UKY]^)-W=:
M=J$D4A93%)L;)Z$,<DYSD #TX'3)KU[X<_&"_P!!T>?3;2\,4-U#Y4L:G 8E
M IW<D9."?7GK7CGQ)E_MEI[E6#L[,[D<DD[F/(ZGGN,8&,^JU3OOV5NOK_P.
MH+EM:VUVT[Z;>6OYVTZLZ/X?>+;2%5$CH<'!!()&%?G.0#SW/? ]JF^*^I6F
MO>&-<L+1D%S=Z9=10;<9\TQ%HU)YSN90".X;IW/ROI^J7FG7@C65]N_ 4$CJ
MV.,'G)Y/H!P>378VFJW/B#6(]%MY&Q$R)=S*V&$C[6,$9!."-RB5CSO/EC !
M6NC T*V,Q%*%&*E)5(-MZ1BXN+=Y;VOIL]SY3C;B#)N&N'\?C,[K2AA:^'K8
M>-&A>6*Q$JU&I%TJ$%R^\HRE-OF2@DY2=MN<^#_C.X\-ZA!+(K)Y,ZAT?((V
M.I*/G&&P-S< $G&..?U"3]J32=0\(6FBI%''=QPHA92JNS%0#_$3M)([$\X'
M (KR3PO^S1H^K:1]K=!#<SQEQ(%P[.5+%V)"YY)R2",\ X/'F=U\&+SPMXNB
MM[B1Y;/[0KHH)(*!P!\H&.PR .@/3-?I$:4G&,)*+E%IJ*?PNZN[I>\DW>^B
M5T?YVU\?*A4QE?!/%8;#XY58<\XPM7IN?,HZR?L9RC:Z3E9M\KE'67I&@?"#
MQK\>_'FB:58ZO;>'=/UN\876MZH95L--LH8I+FXNI43YI#'%&0D:G,DC(I*?
M,P^DO&'PV;]DC7M%M'\86'BG2=0E>"WOU5+::2>WC69Y4@$SI):.)6$<@ERA
M4"0992=?PQ=:3I?AZ.V@;[&\=L8Q+$S6\J%D*DK(I5E8C(^4@GD<BOFWX]_&
M"W\.?L_^/I_'7AZ#QW'J7C73/!7PP\1SZJECXD\/^,YM'NM;@C-_/:RL?"UG
MIMG++JD,+/+/)-!"80]U'<+RU<-G>)SC+*.70CB</BJM+!U<%'DC6K5:LI)U
M5.IRP4*=.U64U5@J<*<Y23CS,_3?#S(>$N)LDS#AR5+$?\1 Q4:V:<-YNJM5
M8'"PP%&C76"K*G5Y:3JSA7ISJU\-5A/VT/WU*5."?LGBWXSS_$_7?"GAKP]
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M]]%N5K#Q"MIJ0?*E ^?O8 YSUZ]>,D[>0?0CZ T_XA9L4A20;F P,MG@$XR
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M476;(NR!BRY&!DY(X.?F '.. .W3G%OI9M6:>A":OIJM-_E=V[NVG7;T/&?
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MX.O.C.I1E*,W3DX--KGC&<7\4)QC.+4DFO\ 3F=.%16G&,XW32DDU=;/^O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC$6E>)-(AE33[RWO%M!J!MO[0T_S[61MGC/@_P"(_BGQOJ.F^%_#.FZYXO\
M$FJ2)9:3H.@6E[K6K7T[?*L%EI]DEQ=3NP )6.)B I)(P<?Z NH:=I^K6DVG
MZK86>IV%RACN++4+6"\M)T((*36URDD,J$$@JZ,""017*>&?AG\-_!4\UUX-
M^'_@CPE=7./M%SX9\*:#H,\^,X\Z;2K"TDEQDXWLW4^IKKACYJ-I1YI6LI7L
MEHM&EO?[M/OYI8*#E>,G&/6.]]5HG?1;]-['\=O[5/\ P3C_ &C_ ($? /P?
M^T-XGMHM1@F@EN/BMX/TUOM6I_"J*]O8H/#\^I36SRQ:K:2P31)XBNK$^3H.
MINL+37%B9+^W^0?@S\;[WP)<K=6<ZK)L5&#<Y#  @_=QQWQ],5_?SJ>F:=K6
MG7VD:O86>J:5J=I/8:CINH6T-Y8W]E=1M#<VEY:7"207-M<0N\4T,R/')&S*
MZLI(/X\?%#_@AS^QWX[\27/B/PC=_$;X0B_N7N;[P_X(US3KGPP7E??*--TS
MQ+I.M2Z-&V6$=KI][%IT"G;!8(JJHJCC;/\ >W=KVMLMK:;Z6ZWOU[DU,&F[
MTGR[:/OW3Z?UMU_G4\2?&LZ_<SW=W<1F:X=G<*PP&8YSM+'^\>,<# XSD^C?
M![X@>';77K6ZUN)+FR#(9$P"6!!R,?='."0".F#UKE/^"GW[+7A_]C#]H;PY
M\.? (\22^ ]?^&/ASQ1HNM>)=0&IZAJ^K'4];TGQ+)/>06EC8Q7$-[IT#-I]
ME:6T%K;75FZP 7&YOB30/%M]9%&CD)! YR2/Y]_7(^N,"N^G54XQD]FKQD]$
MWIIM=/K=^?J>?5I^SFTY)25F[.RZ;K\--+_C^L_CGQ+X6\0ZR\NA0I;VS[1'
M&-O4J ?NGN2>A[8KG-3TBYMM,>4PM&KQEE8A@&&2,KQVXZ>W3-?#OA;XH2P7
MUN]Q)E8Y%)&\D,%QD<D9[Y!/';M7VKKGQVT_Q?X=TW38+.WM6M;<1-+$ &<
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M&/I_B^_TF2]B,W]E>(-&T2[N=5TK5K92#=Q/9M:PRLL$6H32H0/[-/#WP\\
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MH!;+ ;0>A;)X![9QGM0 ZBBB@ HHHH ***3(R!D9() SR0,9('4@9&?3(]:
M%HHHH **0,K#*D,,D9!!&1P1QW!ZCM1D9 R,G) R,D#J0.IQWH 6BBB@ HIN
M].NY<%MH.X?>SC;U^]GC'7/&*=0 4444 %%%(2%Y) !( )(&23@#GN3P!W-
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M'M%'X?:<JY[=.7FO;R/^>#&+#+&8I8)S>#6)KK".KI4>&]K+V#J=INER.?\
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M-J>LI?6E[X>@L&\,Z5'906=E7N?[,O[#_P"WQX,^*7_!"OQ)^T19:[\2M?\
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MMT>.;G]J']EWXI?MZ?L?>,/V/M6\._ [_@H#\0_AUJ3_ !YT_P 8Z7IOP=\
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M_P!H+X_?&SQ9\0? #P?#PV=QJ$_[-?A_P1\>3J>I>,/%&O6HU?PEJWBC1I]
M\-(T-GJ^DZQ9BZN0DY:7O_3U6STMMJEYZ6&K6=_PU=EZO3HD]>UMS^R&BBBK
M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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<4 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>nt10015006x17_graphic3.jpg
<TEXT>
begin 644 nt10015006x17_graphic3.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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MNXS_ *"\5_X45?\ Y/R7W'Z+?\/:_P#@HW_T=?\ $3_P%\)__,Y1_P /:_\
M@HW_ -'7_$3_ ,!?"?\ \SE?G311_9V7_P#0#@__  FH?_(!]=QG_07BO_"B
MK_\ )^2^X_1;_A[7_P %&_\ HZ_XB?\ @+X3_P#F<H_X>U_\%&_^CK_B)_X"
M^$__ )G*_.FBC^SLO_Z <'_X34/_ ) /KN,_Z"\5_P"%%7_Y/R7W'Z+?\/:_
M^"C?_1U_Q$_\!?"?_P SE'_#VO\ X*-_]'7_ !$_\!?"?_S.5^=-%']G9?\
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M]K_X*-_]'7_$3_P%\)__ #.5^=-%']G9?_T X/\ \)J'_P @'UW&?]!>*_\
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M#_Y /KN,_P"@O%?^%%7_ .3\E]Q^BW_#VO\ X*-_]'7_ !$_\!?"?_S.4?\
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MCK_B)_X"^$__ )G*/^'M?_!1O_HZ_P"(G_@+X3_^9ROSIHH_L[+_ /H!P?\
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M%']G9?\ ] .#_P#":A_\@'UW&?\ 07BO_"BK_P#)^2^X_1;_ (>U_P#!1O\
MZ.O^(G_@+X3_ /F<H_X>U_\ !1O_ *.O^(G_ ("^$_\ YG*_.FBC^SLO_P"@
M'!_^$U#_ .0#Z[C/^@O%?^%%7_Y/R7W'Z+?\/:_^"C?_ $=?\1/_  %\)_\
MS.4?\/:_^"C?_1U_Q$_\!?"?_P SE?G311_9V7_] .#_ /":A_\ (!]=QG_0
M7BO_  HJ_P#R?DON/T6_X>U_\%&_^CK_ (B?^ OA/_YG*/\ A[7_ ,%&_P#H
MZ_XB?^ OA/\ ^9ROSIHH_L[+_P#H!P?_ (34/_D ^NXS_H+Q7_A15_\ D_)?
M<?HM_P /:_\ @HW_ -'7_$3_ ,!?"?\ \SE'_#VO_@HW_P!'7_$3_P !?"?_
M ,SE?G311_9V7_\ 0#@__":A_P#(!]=QG_07BO\ PHJ__)^2^X_1;_A[7_P4
M;_Z.O^(G_@+X3_\ F<H_X>U_\%&_^CK_ (B?^ OA/_YG*_.FBC^SLO\ ^@'!
M_P#A-0_^0#Z[C/\ H+Q7_A15_P#D_)?<?HM_P]K_ ."C?_1U_P 1/_ 7PG_\
MSE'_  ]K_P""C?\ T=?\1/\ P%\)_P#S.5^=-%']G9?_ - .#_\ ":A_\@'U
MW&?]!>*_\**O_P GY+[C]%O^'M?_  4;_P"CK_B)_P" OA/_ .9RC_A[7_P4
M;_Z.O^(G_@+X3_\ F<K\Z:*/[.R__H!P?_A-0_\ D ^NXS_H+Q7_ (45?_D_
M)?<?HM_P]K_X*-_]'7_$3_P%\)__ #.4?\/:_P#@HW_T=?\ $3_P%\)__,Y7
MYTT4?V=E_P#T X/_ ,)J'_R ?7<9_P!!>*_\**O_ ,GY+[C]%O\ A[7_ ,%&
M_P#HZ_XB?^ OA/\ ^9RC_A[7_P %&_\ HZ_XB?\ @+X3_P#F<K\Z:*/[.R__
M * <'_X34/\ Y /KN,_Z"\5_X45?_D_)?<?HM_P]K_X*-_\ 1U_Q$_\  7PG
M_P#,Y1_P]K_X*-_]'7_$3_P%\)__ #.5^=-%']G9?_T X/\ \)J'_P @'UW&
M?]!>*_\ "BK_ /)^2^X_1;_A[7_P4;_Z.O\ B)_X"^$__F<H_P"'M?\ P4;_
M .CK_B)_X"^$_P#YG*_.FBC^SLO_ .@'!_\ A-0_^0#Z[C/^@O%?^%%7_P"3
M\E]Q^BW_  ]K_P""C?\ T=?\1/\ P%\)_P#S.4?\/:_^"C?_ $=?\1/_  %\
M)_\ S.5^=-%']G9?_P! .#_\)J'_ ,@'UW&?]!>*_P#"BK_\GY+[C]%O^'M?
M_!1O_HZ_XB?^ OA/_P"9RC_A[7_P4;_Z.O\ B)_X"^$__F<K\Z:*/[.R_P#Z
M <'_ .$U#_Y /KN,_P"@O%?^%%7_ .3\E]Q^BW_#VO\ X*-_]'7_ !$_\!?"
M?_S.4?\ #VO_ (*-_P#1U_Q$_P# 7PG_ /,Y7YTT4?V=E_\ T X/_P )J'_R
M ?7<9_T%XK_PHJ__ "?DON/T6_X>U_\ !1O_ *.O^(G_ ("^$_\ YG*/^'M?
M_!1O_HZ_XB?^ OA/_P"9ROSIHH_L[+_^@'!_^$U#_P"0#Z[C/^@O%?\ A15_
M^3\E]Q^BW_#VO_@HW_T=?\1/_ 7PG_\ ,Y1_P]K_ ."C?_1U_P 1/_ 7PG_\
MSE?G311_9V7_ /0#@_\ PFH?_(!]=QG_ $%XK_PHJ_\ R?DON/T6_P"'M?\
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M )/R7W'Z+?\ #VO_ (*-_P#1U_Q$_P# 7PG_ /,Y1_P]K_X*-_\ 1U_Q$_\
M 7PG_P#,Y7YTT4?V=E__ $ X/_PFH?\ R ?7<9_T%XK_ ,**O_R?DON/T6_X
M>U_\%&_^CK_B)_X"^$__ )G*/^'M?_!1O_HZ_P"(G_@+X3_^9ROSIHH_L[+_
M /H!P?\ X34/_D ^NXS_ *"\5_X45?\ Y/R7W'Z+?\/:_P#@HW_T=?\ $3_P
M%\)__,Y1_P /:_\ @HW_ -'7_$3_ ,!?"?\ \SE?G311_9V7_P#0#@__  FH
M?_(!]=QG_07BO_"BK_\ )^2^X_1;_A[7_P %&_\ HZ_XB?\ @+X3_P#F<H_X
M>U_\%&_^CK_B)_X"^$__ )G*_.FBC^SLO_Z <'_X34/_ ) /KN,_Z"\5_P"%
M%7_Y/R7W'Z+?\/:_^"C?_1U_Q$_\!?"?_P SE'_#VO\ X*-_]'7_ !$_\!?"
M?_S.5^=-%']G9?\ ] .#_P#":A_\@'UW&?\ 07BO_"BK_P#)^2^X_I:_X(\_
MM_\ [9'[07[<'@KX;?&3X^^,O'O@:^\'^/M2O?#>KPZ!'875[I>@2W&GS2M8
M:-9W)-K<$31A9U4R*I<,H*DKX]_X(*_\I&/ '_8@_$W_ -1N2BOSOBRC1H9C
M2A1I4Z,'A*<G&E3C3BY.K63;C!)7:25[7T1]=D=6I5P4I5:DZDO;S7-4G*<K
M*%.RO)MV5W97LC^]"BBBOESV0HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *_@S_X+V?\I$_&_P#V3WX;?^F:6O[S*_@S_P""]G_*1/QO_P!D]^&W
M_IFEKZS@[_D9U?\ L#J?^G:)X?$'^XQ_Z_0_*1^,=%%%?IA\6%%%% !1110
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MJ:=K.RW9\ 4445Z9PA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^6,>7FMS;62O*]S^:[XS?L[?&+]GUO :_%WP;<^$#\3?!6F_$3P0+C4-)O\
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M_P#<O7^GI_89]OL?^?VT_P# F'_XNC[?8_\ /[:?^!,/_P 77\>?_"1^(?\
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M-_\ @[_[EZ_T]/[#/M]C_P _MI_X$P__ !='V^Q_Y_;3_P "8?\ XNOX\_\
MA(_$/_0=UG_P:7W_ ,?H_P"$C\0_]!W6?_!I??\ Q^C_ %&?_0R7_A+_ /=_
M7^EJ?ZSK_H#?_@[_ .Y>O]/3^PS[?8_\_MI_X$P__%T?;['_ )_;3_P)A_\
MBZ_CS_X2/Q#_ -!W6?\ P:7W_P ?H_X2/Q#_ -!W6?\ P:7W_P ?H_U&?_0R
M7_A+_P#=_7^EJ?ZSK_H#?_@[_P"Y>O\ 3T_L,^WV/_/[:?\ @3#_ /%T?;['
M_G]M/_ F'_XNOX\_^$C\0_\ 0=UG_P &E]_\?H_X2/Q#_P!!W6?_  :7W_Q^
MC_49_P#0R7_A+_\ =_7^EJ?ZSK_H#?\ X._^Y>O]/3^PS[?8_P#/[:?^!,/_
M ,77\'O_  7J(?\ X*(>-)$(>.3X=_#=HY%(9)%&D3H61QE74.K(2I(#*RGD
M$#ZV_P"$C\0_]!W6?_!I??\ Q^M[X@*NH#P5=7ZK>W,G@;2_,N;L"YG?;J>M
M!=\TP>1L#@;F.!P.*]3)^&WE&,]O];5?VE&I2Y?8^SM=TY\U_:3OK"UK=?(X
M\?G*Q^&E2^KNDX2A4O[3FOKRVMR1ZRW\O/3^9"BOZ+?L%C_SY6G_ (#0_P#Q
M%'V"Q_Y\K3_P&A_^(KZCV?G^'_!/#]IY?C_P#^=*BOZ+?L%C_P ^5I_X#0__
M !%'V"Q_Y\K3_P !H?\ XBCV?G^'_!#VGE^/_ /YTJ*_HM^P6/\ SY6G_@-#
M_P#$4?8+'_GRM/\ P&A_^(H]GY_A_P $/:>7X_\  /YTJ*_HM^P6/_/E:?\
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M5I_X#0__ !%'V"Q_Y\K3_P !H?\ XBCV?G^'_!#VGE^/_ /YTJ*_HM^P6/\
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MTJ*_HM^P6/\ SY6G_@-#_P#$4?8+'_GRM/\ P&A_^(H]GY_A_P $/:>7X_\
M /YTJ*_HM^P6/_/E:?\ @-#_ /$4?8+'_GRM/_ :'_XBCV?G^'_!#VGE^/\
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MH]GY_A_P0]IY?C_P#^=*BOZ+?L%C_P ^5I_X#0__ !%'V"Q_Y\K3_P !H?\
MXBCV?G^'_!#VGE^/_ /YTJ*_HM^P6/\ SY6G_@-#_P#$4?8+'_GRM/\ P&A_
M^(H]GY_A_P $/:>7X_\  /YTJ*_HM^P6/_/E:?\ @-#_ /$4?8+'_GRM/_ :
M'_XBCV?G^'_!#VGE^/\ P#^=*BOZ+?L%C_SY6G_@-#_\11]@L?\ GRM/_ :'
M_P"(H]GY_A_P0]IY?C_P#^=*BOZ+?L%C_P ^5I_X#0__ !%'V"Q_Y\K3_P !
MH?\ XBCV?G^'_!#VGE^/_ /YTJ*_HM^P6/\ SY6G_@-#_P#$4?8+'_GRM/\
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M_GRM/_ :'_XBCV?G^'_!#VGE^/\ P#^=*BOZ+?L%C_SY6G_@-#_\11]@L?\
MGRM/_ :'_P"(H]GY_A_P0]IY?C_P#YJ_X(*_\I&/ '_8@_$W_P!1N2BOV#_X
M)OVEK#^U1X4>*VMXG'A_Q6 \<,:-@Z3)D;E4'![C/-%?F'&2MFE)?]0=+_T[
M6/MN'7S8"3M;_::B_P#)*1[A_P %6_\ DJOPX_[$B\_]/,E?E97ZI_\ !5O_
M )*K\./^Q(O/_3S)7Y65]SP[_P B7+_^O+_].U#YC.?^1GB_\</_ $U ****
M]H\P***^DO@%\#-(^)UEXY\<^//%4G@CX4_#'3K2_P#%^OVUFM_JEU=:D\T6
MD:!H=I(Z12ZGJ<T+QQO)YD<3&)6B=IX\8UZ]/#4I5JLG&$7%:1<I2E.2A"$(
MQ3E*<YRC"$8IN4FDC2E2G6FJ=-7D[O5J*48IRE*4FTHQC%.4FVDDCYMHKZ^\
M5?"O]GOQ1\-?%GCOX*?$+Q)::WX$>PEUKP+\38]%T_4]<TJ^G^S_ -H^&+NQ
MFCBO+BV<-)-IRI<7!B5LK"WE>?X_9_ 'XTZAX*;XBV7PS\77/@E;.34?^$BB
MTF9K%M/B#-+J$8XGEL(U1W>\BA>V5%+F4(,UE3QN'G%RG-T&JJHN&)7U>?M7
M&,XP2J\O.Y1E&47!R4D]&VFEI/"UH22C'VJ</:*5!^UBX7<7)N%[*,DU+F2L
MUV:;\AHKV?PI^SM\<O'&E6.N^$OA;XRU[1=2LKC4=/U:PTB>33[VSM;J:RN)
M;6\;9!.8[NWGM_*C=IGFB=$C8J161X-^"OQ8^(.L:UH'@SX?^)O$&L>')'AU
M^PLM-E$VC3QRR0/;ZF9_)CLKD30RQ"WG=)FDCD149D8#1XK#+VE\107L?XMZ
MU->RNW%>T][W+R37O6U36Y"P]=\EJ-5^T_AVIS?/IS>Y[OO::^[?378\OHK:
M\1>'->\(ZUJ'ASQ/I&H:#KNE3FVU'2=4MI;.^LYPH;RY[>95="4974XVNC*Z
M%E8$XM;)J24HM2C))QDFFFFKIIK1IK5-:-&;33::::;335FFM&FGJFGHT]@H
MHHIB"N[C_P"297G_ &/>F_\ J/ZK7"5W<?\ R3*\_P"Q[TW_ -1_5:SJ;1_Z
M^4__ $M&E/[?_7N7Z'"4445H9A1110 4444 %%%% !17MG[.?PRTKXR?&GP+
M\--;O[[3-*\4WNI6UY?::(#?6Z66A:IJJ&W%S'+#N>:PCC?>C#RW?&&P1](:
M#^SU^SA\7M7UKX?_  :^)WCZQ^*MG;ZQ)X>T'X@^']+@T7Q5=Z)'//>:9::I
MIDJ_8[IX+6>2*2X8*L2/-Y$RQR*O%B,PP^&J2IU?:KDI0K5*D*-2I3I4ISG"
M,ZLX*7)&].;;:M&,7*344V=5'!UJ\%.FZ?O5)4J<95(PG4J1C"3A3C)KFE:I
M&ROJW97>A\!T5[IJ7PAOKGPI\'7\)^&?B'JGCKXAW7CVQOM+N/#[?V/J5YX5
MU\:;;0>"9[=6NM7>SM%F'B42H!IM]&8CM17(YSQ=\%/BUX#US1/#?B[X?>*-
M"UWQ)((?#^FW>F3-<:U,7AC,.E^0)DOIDDN($DAMWDDB>6-9%4L =H8K#S:B
MJM-3;J\L)3C&<E0J3IU)1@WS.$94Y>\E:RN[&<J%:*;=.;BE3;E&,G&+JPA.
M$922LI-3BN5N]W;<\NHKU3QW\$/BY\,8]*E\??#WQ/X7BUN;[-I,NIZ=(D5]
M=85OL<$D1E0WF'4_8V9;GG_5<'%WQ?\ L_?&OP#X;C\7^,_AGXM\.>&I&@0Z
MQJ>ERP6D#73I';+>'+26)N))$C@%['!YLCJB;G(%"Q6&E[-QQ%"2K-QI-5J;
M]K).SC3M+WVFTFHW:>C$Z%=<]Z-5>S2E4O3FN2+5TYZ>ZFM4Y631X]17KE_\
M!/C/I?@M/B)J/PT\7V?@E[6*^'B*?2+A+!;&?9Y-])D>=%92B1#'=RQ);L&!
M$A&33M/^ /QIU;P6_P 1--^&?BZ]\$I:37Y\10:3,]B]A!O\^^B'^OFLHA'(
M9+N&%[=%1G:0*,T?6L+;F^LT+>T]E?VU.WM?^?5^:WM/[GQ>0?5Z][>PK7Y/
M:6]G._)_/;E^#^]MYGD-%%%;F04444 %%%% !1110 5W/C7_ (]_ _\ V(VF
M?^G36JX:NY\:_P#'OX'_ .Q&TS_TZ:U6<OXE/_M__P!)1I#X*O\ AC_Z<B<-
M1116AF%%%:&D:=<:QJNFZ3:07-U=:G?V=A;VUG";F[GGO+B.WBAM;=<-/<2/
M(J0PJ09)"J Y-#:2;>B2NWV2!)MI+5MV2[MF?17TKXC_ &=/&NM>-_$FC?!O
MX>_%#Q1X>\/ZQ:^&[B?6?#AM]9L?$*Z;;W6I:=K,%J/LNG30SM.\:32)Y=H(
MI)G!8D^'^+O!WBGP%KU[X7\9Z#J7AOQ#IQC%[I.K6SVMY )HUFA=HWX:*:)U
MDAEC9XI48/&[*<UA2Q-"MRJG5@YRIQJ>RYX^UC"2BTY4[\T;<T;W5DVM=4;5
M*%6E=SIR4%)P]IRR]G*2;5HSLHRV=K/6S.:HKNI_AC\0K;Q7I/@6?P=X@B\8
MZ[#IUQHWAMM.G_M?4H-6@^U:;-9V84RS17EM^_@D0%&B!DR%5B/I'X<_LF:[
M\1D^'GAFWT?X@:#XY\3>+/$L'BG4=5\,@^"_#G@CPW=Q:1J&M6]TLT5SJ&H6
M&MN-/OH3-;VT=W-;V?F"2425%;&X7#P52K6A&#7-S*2DE!0G/VGNMMPY:<K2
M2=VK*[=BJ6%Q%:3A"E-R3Y;--7ES0CR*Z2Y[SC>+M9.[LM3XTHKZ(N_V7OC5
M>>,/%WAKPA\-/''B&W\,^)]1\/F[_L.6WD A#7FG/J(9A;V%S?:.]IJ)ADF"
MJES&JNVY-V'9_LW_ !XO]"U#Q+9?"?QM<Z'I<M[#?:A%HERT43Z=+-!?[(\>
M?<):3031W$MM%-%&T;;G YIK&X-I/ZUAU=0=G6IIKVJO333DFG-?"FDY=+B^
MJXF[7L*SMS;4IM>Z[2::C9I.R;V5U?<\3HI2""0000<$'@@CJ".Q%)728!11
M10 4444 %%%% !117M6G?#!=>^&/AOQ!X?T7QWJOC7Q%\0[CP=8P6VBI+X2U
M"/\ LZ.XM;#3-23_ $BY\2/<-^\T\ J+8B0<UG4JPI*+F^52DH)O9-J4KR>R
M246VWHBX4Y5')05W&/,UU:O&-HK=MN2LEJSQ6BO7O%/P!^-/@GPT?&'BWX9>
M,/#WAE9DMY-8U31[BUM8)9)?)B%SO'FVJS3$10R7$<44SD+&[$@'A=-\'^*=
M8T#7_%.E:#J>H>'?"K:>OB/6;6UDFL-%.JRO!IW]HSH"ML+R:-XX"^ [(PSQ
M2A7H3CSPK4IPYU3YX5(2C[1M14.92:YW*48J-^9N25KM#E2JQERRI5(R<>=1
ME"2DX)-N=FD^6R;YK6LF[V3.;HKWGX8?!O4/$ROK/BOPQ\0U\(ZEX/\ &^L^
M&=8\): -2.IZMX4LQ*[,;@"(Z'I]PP&NWL1+641!'S<5Y_=_#/X@6'B71/!U
MYX/U^W\4^)8-,N= T&33YQJ>L6^LKNTJ?3[;:7N8K]<M;21AED )!^4XE8FA
M*I.FJD.:G'FE>4;63DI6=]?9N+53^1VYK7&Z%50A-TY<LW:/NRNVU%QTM]M2
M3A_/]FYPU%>R>%OV>OC=XV.OCPI\,?%VN?\ "+ZC=Z/KQLM+D9=-U:P8I>Z9
M*TAC5]0MF&V:S@,MPA(S'\PSY+?6-[IE[=Z;J-I<6&H6%S/9WUE=PR6]U:7=
MM(T-Q;7,$JK)#/#*CQRQ2*KHZLK $$5<*U&I*4*=6G.<+<\(3C*4.97CS1BV
MX\RU5TKK5$RIU(1C*=.<8RNHRE"48R:W46TD[=;/0JT445H0%%%% !1110 4
M45[]\%?A+H_Q,\.?''6=5U+4+"?X7?"K5O'FDQ6(MS%J&HV%U;PQVE^9XW86
MCK*Q?R#'+G&'&*RK5H4*;JU&U!2A%M)MWJ5(TXZ+O*<4^RUZ&E*G*K-4X).3
M4FKNRM",IRU\HQ;\]CP&BM'2-(U37]3L-%T33[S5M7U2ZBLM.TW3[>2ZO;V[
MG8)#;VUO"KRS2R,0%1%)/T!KT+QU\$?BW\,Y-(C\>?#[Q/X8;7YA;:+_ &CI
MTBIJ5T0A^QVLD/FQR7G[Q/\ 0PWVD9YBX.'*M2A.-.=6G&I--PIRG&,YJ*O)
MQBVI245JVD[+<2IU)1E.,)RA%I2FHR<8MNR4I)63;:23>K>AY917K_C+X _&
MCX>^'X/%?C;X:^*_#7AVX>&)-6U/3)(;2.2Y_P"/>.Z8%WLGG) A2\2!I&^5
M 6XKU7X$_LE?$OXG^*/A_/XA\$^-M'^%_B[4TM[OQM9Z7M@M]/DMKB2&_A>Y
M1U6VFN(XH8KR: VCF4!)&)%8U,=A*=&6(EB:+I1Y_?C5A)2E"+E*G"TO?J63
MM"-Y-Z6-887$U*L:,:-55)<ONRIS3BIM*,Y77NPN_B?NVUN?)=%=DG@[4=4\
M?-X"\.0RZEJEYXKE\+Z-"Y1);RZ;57TVS$C#$:&1@C2O@(@+-PHK[%USX+?L
ME_#?Q2OPH^(WQ7^(5UX^M9+?3?%/BKPOH6F?\()X4URX1&DLY([UGU/4+;39
M)4CO[F L$*RLPA=)8(56QM&A*$&JU2I4IRJQIT*-2M-4HN*E4E&";C%.44KZ
MRD^6"E)-!2PM2JIR3IPA"2@YU:D:<>>5[03DU=M)MVT2UDTFCX(HK[_T']D#
MPSX6\;?'30?C)XEU^/P[\(O VE>/M/UWP/;6$LGBGP]K%RJV6HV=MJ)F15E@
M8HUOYX,-Y#<1>?*D:R/Y_P#$+X&_">[^#6I_&_X'^./%6N:%X7\4:;X6\7^'
M?'&AVFF:OIUQK*Q_V;>V-YI\S6EU \DD:2Q"-VQ/N\V(P-'+C'-<'.<(0E4G
M&I*C"-:-&HZ'/B(0J4(.JH\L95(U()*5K2DHRM)V-98#$1A*<E!.*JRE3=2"
MJJ-&3A5DH-IR47%M\M[I75T?(%%%%>B<04444 %%>Y_LW?"W2/C/\8O"OPYU
MS4+_ $O3->BUZ2XO=,$!O83I/A[5-8A$(N8Y8<236$<4F]#^[=]N&P1[CX3_
M &0?^$]_9K\4_%_PGJVHWOC?POXH\16I\).MJT&K^&O#30?VI/IZJJ7;:K:V
MUP+YD4RQ2QPO;I$LLT+#BQ&887#5%3KS<).6'C=Q?*GB9U84FY+1)RHS4F[*
M"2<FD[G31PE>O!SI0YTE6=DUS/V$:4JEH[MI5H62UE=I:H^&Z*^ROA7^S=X8
M\>^$_@7X@U#7-:L[GXI_&36?ASJ\-HMF8=/TO3=/CNXKVP\V%G-[([%7\]I(
M=OW4!KO[/]G;]F/Q[XUUOX1?#SXJ?$+0_BG9WNM:1H-OXY\.Z6WACQ!KNBO<
M))I2ZAI4BSVK7;6DPMKB;8"HW+#--Y=K+G/-<)3E4B_;/V7M'6G"A5J0I1I5
M94ISJ.$9<L%.$O>LURQ<ME<UCE^(G&$E[)>UY/9QE5A&51U(1J0C!2:3DXSB
M[7W=M]#\]J*T=8TJ_P!!U;4]$U2!K74M'O[S3-0MF(+07MC<26US$2.#Y<T3
MKD<'&1P:^X-7^#'[,'P\\#_"'6_B=XL^+<7B#XG?#K1_'AM?"VF>'KW3;1-1
MW136Z27GD3J([F.58U?S&,05F<L2*WKXNEA_8J4:M25=M4HT:<JLI<L'.3M%
M.R4$W=Z=M3"CAIUO:6=.FJ23J.K-4U&\E!)N77F:5MSX.HKV>U^$'B/XC>(O
M$I^!/@_QWXY\&Z;K-OI^GWS:.)]4@BU!)9--37%T_?9V=U<K;73CYUA$<+.S
MJ%)K-F^!OQ?M_'$7PUF^'/BQ/'DUL+Z'PQ_9-PVIRV!+*-0CC56C?3]R.IOE
MD-H&5E,P((%K$X>[BZU.$XP]I.G.I"%2G#E4FZD')2@HJ2YG))*^K%]7K:-4
MJDHN7)&<82E"<KM)0DE:5VG:S=^AY517T_\ #_\ 9G\87'QS^'OPB^+GAWQ1
M\/U\:W5R%EN+..&\ELH+&_N#<Z9+,MQ8W0%Q:+!*4:41[B'"L5SQ'Q#^ /Q9
M^&MG)K_BKX?>+-"\)3:K+8:;K^K:7+;VEPCSS+8--(!_HTE[!&)8%N4@\\',
M(8$9B.-PDJL:,:])SG3A4IVJ0<:L:DJD(^RES6J2O2G>,;M)7ZC>%Q"IRJNE
M4Y83E"?N2O3<8PD_:*UX*U2-G*R>MMCQ>BOLCXI_L\>$?A]JGQ<TNSF\?ZTW
M@;P+\-?$VBZC9:59WFE6]]XRM[*XU%?&%Y#'$-+TY!<O!I,T*;Y[E1%(6.37
ME,_[,_Q_MM%U+Q%<?"+QU#HNDVHO=0U"70[I(H+/[*MZ;H*RB6:W2T=;B2:W
MCECBC8-(RY%33Q^$JPC4]M"G&?L^1UI1I.?M*=.K'E4VFVXU8)I:J3Y=RJF#
MQ%.3C[.4W'FYO9IU.7DG.#YN5.WO0E9O=*YX;17K?A'X"_&;Q[X<F\6^#/AK
MXM\2>&X)I8'U?2=)GNK5YH"%N([<J/,NS;L<3_94F$)R)2I!QYYK_A_6_"NL
MZCX=\1Z7>Z+KND7+6>IZ5J,#VU[8W2 %X+F"0!XI%#*2K#."#T-=$:U&<Y4X
M5:4ZD+\].-2,IPM9/F@FY1LVKW2M==T8RI5(QC.5.<82MRSE"2C*ZNN6323N
MDVK-W2N8]%%%:$!1110 45]+_LS?"+P3\6=:^( \?ZOX@T?P[X#^'6L^/+J;
MPU%93:G.FCW=A'-;QQ7R/"^ZWN9F1<QEI50%U4FO5XOV<O@G\1/!=YX^^"OQ
M \;7NG^$_&7@3P[X[\/>-=!L+#5+73?'/B.P\.V.J:-?V$CVDKI=7A)@FCG+
M!'9_)$:B?@K9CAJ%65*I[5.$J4)S5&I*E"=>WL82J13C&51RC&-[+F:3:NCK
MIX*O5IQJ0]FU/VCA!U(QJ25+^)*,&TY*"O)VN^5-V/A&BOJ/XW_LK_$SX7:]
MX]OM-\$>,[WX8>%-=OM/L?&U_I9%K<Z9;3+!'J5S) B*ML\C;#>) EF6X$G!
MK@+7]GKXWWO@T_$*U^%_C"?P8+)M2_M^/29C:-IJ*7?4(T.+F6Q6-6D:[C@>
MW$8+F3:,UK3QV#JTJ=:.)H>SJ.,8MU:<??G%25-IRTJV:O3?OKJC.>%Q$)RI
MRHU>:"DVE3F_=BW%S32UA=:37NON>-T5ZYX5^ GQF\<>&9_&7A'X:>+O$/A>
MW^T;M:TS29[BSE^R.T=T+1@ ]\;:1'2<623F%T99 I4@1^ _@5\8?B?I]]JO
M@#X=^)_%6F:;,UM>W^EZ>\EI#=(GF/:B>1HHY;I$(9K:%I)U#+F,%E!N6*PT
M54<L10BJ4E"JY5::5.<G90J-R]R3>BC*S;V1*H5WR)4:K=1.5-*G-\\59N4+
M+WDDTVU=*Z[GD]%7=2TW4-'U"^TG5;*ZT[4]-N[BQU#3[V&2VO+*\M96AN;6
MYMY566&>"9'CEBD571U*L 17U_\ #W]DJ]U_X(^/?C1XO\0V>B6NE?#W6O&?
M@7PQ87MA=Z]X@ATF[2S?6=3M \LFG>'ENDEL%+(EY<W;J1]G2(?:%B,70PT(
M5*U11C4J0IT[>\ZDZC2@H)7<KWNVM%%.3:BFQT</5KRE"G!MPA*<[Z*,8*\G
M)O;LENVTDKGQG111708A1110 4444 %%%6["W6[OK*T=F1+J[MK=F7&Y5GF2
M-F7.1N4,2,C&1SQ1L&Y4HK]+_$?[,'[+&F?&1_V??^%F?%;1_B+/?:1H^GZG
M>>&]%U7PP=7U[2++5=+@G-I):WC02KJ%M!(X^SJLQ*O/%$&G7RSQ%^Q;X\C\
M ^%-4\"Z)XE\=^-KKQO\4/"GBW3=#M([G1]+M_ >LQZ38ZA;3F.&2!-3(F=5
MO9]TKXB@3>I2O+AG&!E[/FJ3HJLJ<Z;Q%*=",J=6G4J0JJ=11@Z<HTIKFYM)
M<L6DY1OWRRW%1Y^6,:OL^935&:JRC*$H0E!QA>7.G4B[6U5Y)VBV?$=%>K>&
M/@9\8/&7B+7/"?ACX<^*]7\1>&91!XBTJWTN9+C0YF:14BU4W ABL9)&BD$2
M7,D;3;&,0< U#9_!3XM7_CB[^&MG\//%<_CNQC,U[X732;G^U;2W$:3?:KF%
ME"PVABECD6[D=;9D=&64A@3W/$X=.47B**E""JS3JTTXTVDU4DN:\8---3=H
MM-.^J.7V%:R?L:MI3=.+]G.TIIM."=K.:::<5K=-6/+Z*]/O/@K\6;#QQ;?#
M6\^'OBF#QW>H)K/PNVE7!U6Z@,;R_:;>%%99K01Q22-=QNULJ1NS2@(V,WQ_
M\+OB'\+-2M=)^(GA#6_".H7L#75E!K-FUN+VW1E22:TF!>"Y2-V5)6@ED\IV
M59-K$ N.(H2E"$:U*4ZD/:4XQJ0<IP_GA%2;E#^]%->8I4:L8RE*E4C&$N24
MI0DHQGI[LFU92U7NNSU6FIP5%?17PE^&7PNUGP3XK^)7Q<\?7WAOP]X>UC2_
M#NF>&/"EOINI>-O$NK:E$UR\MI8ZA=1)::186R[[G4)H7A>0M"DBRQ[)*W[0
M'P;TCX3:CX(U#PIXDN_%/@?XE^"].\<^$=2U33UTK6H]-OI);>2RU>Q222..
M\MYH2WFP[(98I4V+N22LEC*#Q#PUYJI>44W2J*G*<81JRIQJN/)*<:<E-Q4M
MKVNXR2T>&JJC[>T>2T9-*<'-0E)PC.4$^91E-.*;6]NC3?S]11174<X4444
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M1_#&K&6]TPWEM&TD5OIUA;-;[(YKB>Y5"K?A+-<7%P[23SS3R, &>:5Y'8
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MT%\.O^B5>+__  [&D_\ SIZ]GVS_ .?57[Z7_P M_JS\K_/?\1.X$_Z'\/\
MPV9W_P#.S^K/ROZ+17G7_#07PZ_Z)5XO_P##L:3_ /.GH_X:"^'7_1*O%_\
MX=C2?_G3T>V?_/JK]]+_ .6_U9^5S_B)W G_ $/X?^&S._\ YV?U9^5_1:*\
MZ_X:"^'7_1*O%_\ X=C2?_G3T?\ #07PZ_Z)5XO_ /#L:3_\Z>CVS_Y]5?OI
M?_+?ZL_*Y_Q$[@3_ *'\/_#9G?\ \[/ZL_*_HM%>=?\ #07PZ_Z)5XO_ /#L
M:3_\Z>C_ (:"^'7_ $2KQ?\ ^'8TG_YT]'MG_P ^JOWTO_EO]6?E<_XB=P)_
MT/X?^&S._P#YV?U9^5_1:*\Z_P"&@OAU_P!$J\7_ /AV-)_^=/1_PT%\.O\
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M_!7HW^-'_#J#X:?]%0\:?^"O1O\ &C_6W)/^@BK_ .$];_Y#^K/RN?V!F?\
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M_P!%*^(__?'AG_Y34?ZVY)_T$5?_  GK?_(A_8&9?\^Z?_@Z'^9^$%%?N_\
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M.A_F?A!17[O_ /#J'X1?]%*^(_\ WQX9_P#E-1_PZA^$7_12OB/_ -\>&?\
MY34?ZVY)_P!!%7_PGK?_ "(?V!F7_/NG_P"#H?YGX045^[__  ZA^$7_ $4K
MXC_]\>&?_E-1_P .H?A%_P!%*^(__?'AG_Y34?ZVY)_T$5?_  GK?_(A_8&9
M?\^Z?_@Z'^9^$%%?N_\ \.H?A%_T4KXC_P#?'AG_ .4U'_#J'X1?]%*^(_\
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M_P!%*^(__?'AG_Y34?ZVY)_T$5?_  GK?_(A_8&9?\^Z?_@Z'^9^$%%?N_\
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M.A_F?A!17[O_ /#J'X1?]%*^(_\ WQX9_P#E-1_PZA^$7_12OB/_ -\>&?\
MY34?ZVY)_P!!%7_PGK?_ "(?V!F7_/NG_P"#H?YGX045^[__  ZA^$7_ $4K
MXC_]\>&?_E-1_P .H?A%_P!%*^(__?'AG_Y34?ZVY)_T$5?_  GK?_(A_8&9
M?\^Z?_@Z'^9^$%%?N_\ \.H?A%_T4KXC_P#?'AG_ .4U'_#J'X1?]%*^(_\
MWQX9_P#E-1_K;DG_ $$5?_">M_\ (A_8&9?\^Z?_ (.A_F?A!17[O_\ #J'X
M1?\ 12OB/_WQX9_^4U'_  ZA^$7_ $4KXC_]\>&?_E-1_K;DG_015_\ ">M_
M\B']@9E_S[I_^#H?YGX045^[_P#PZA^$7_12OB/_ -\>&?\ Y34?\.H?A%_T
M4KXC_P#?'AG_ .4U'^MN2?\ 015_\)ZW_P B']@9E_S[I_\ @Z'^9^$%%?N_
M_P .H?A%_P!%*^(__?'AG_Y34?\ #J'X1?\ 12OB/_WQX9_^4U'^MN2?]!%7
M_P )ZW_R(?V!F7_/NG_X.A_F?A!17[O_ /#J'X1?]%*^(_\ WQX9_P#E-1_P
MZA^$7_12OB/_ -\>&?\ Y34?ZVY)_P!!%7_PGK?_ "(?V!F7_/NG_P"#H?YG
MX045^[__  ZA^$7_ $4KXC_]\>&?_E-1_P .H?A%_P!%*^(__?'AG_Y34?ZV
MY)_T$5?_  GK?_(A_8&9?\^Z?_@Z'^9^$%%?N_\ \.H?A%_T4KXC_P#?'AG_
M .4U'_#J'X1?]%*^(_\ WQX9_P#E-1_K;DG_ $$5?_">M_\ (A_8&9?\^Z?_
M (.A_F?A!17[O_\ #J'X1?\ 12OB/_WQX9_^4U'_  ZA^$7_ $4KXC_]\>&?
M_E-1_K;DG_015_\ ">M_\B']@9E_S[I_^#H?YGX045^[_P#PZA^$7_12OB/_
M -\>&?\ Y34?\.H?A%_T4KXC_P#?'AG_ .4U'^MN2?\ 015_\)ZW_P B']@9
ME_S[I_\ @Z'^9^$%%?N__P .H?A%_P!%*^(__?'AG_Y34?\ #J'X1?\ 12OB
M/_WQX9_^4U'^MN2?]!%7_P )ZW_R(?V!F7_/NG_X.A_F?A!17[O_ /#J'X1?
M]%*^(_\ WQX9_P#E-1_PZA^$7_12OB/_ -\>&?\ Y34?ZVY)_P!!%7_PGK?_
M "(?V!F7_/NG_P"#H?YGX045^[__  ZA^$7_ $4KXC_]\>&?_E-1_P .H?A%
M_P!%*^(__?'AG_Y34?ZVY)_T$5?_  GK?_(A_8&9?\^Z?_@Z'^9^$%%?N_\
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M.A_F?A!17[O_ /#J'X1?]%*^(_\ WQX9_P#E-1_PZA^$7_12OB/_ -\>&?\
MY34?ZVY)_P!!%7_PGK?_ "(?V!F7_/NG_P"#H?YGX045^[__  ZA^$7_ $4K
MXC_]\>&?_E-1_P .H?A%_P!%*^(__?'AG_Y34?ZVY)_T$5?_  GK?_(A_8&9
M?\^Z?_@Z'^9^$%%?N_\ \.H?A%_T4KXC_P#?'AG_ .4U'_#J'X1?]%*^(_\
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M?_P0VBUGP1^TM_P5(^&7QG^$FB_LS_M1:Q\7OA+\8?'W[-'PZM= N/@=\/\
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MN?V5O^A$^.W_ (37@7_YXU?RRT5]E_JAE/\ -B__  =#_P"5'\W?\3"\>?\
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M'_\ PWXK_P">!_4U_P /N?V5O^A$^.W_ (37@7_YXU'_  ^Y_96_Z$3X[?\
MA->!?_GC5_++11_JAE/\V+_\'0_^5!_Q,+QY_P ^.'__  WXK_YX']37_#[G
M]E;_ *$3X[?^$UX%_P#GC4?\/N?V5O\ H1/CM_X37@7_ .>-7\LM%'^J&4_S
M8O\ \'0_^5!_Q,+QY_SXX?\ _#?BO_G@?U-?\/N?V5O^A$^.W_A->!?_ )XU
M'_#[G]E;_H1/CM_X37@7_P">-7\LM%'^J&4_S8O_ ,'0_P#E0?\ $PO'G_/C
MA_\ \-^*_P#G@?U-?\/N?V5O^A$^.W_A->!?_GC4?\/N?V5O^A$^.W_A->!?
M_GC5_++11_JAE/\ -B__  =#_P"5!_Q,+QY_SXX?_P##?BO_ )X']37_  ^Y
M_96_Z$3X[?\ A->!?_GC4?\ #[G]E;_H1/CM_P"$UX%_^>-7\LM%'^J&4_S8
MO_P=#_Y4'_$PO'G_ #XX?_\ #?BO_G@?U-?\/N?V5O\ H1/CM_X37@7_ .>-
M1_P^Y_96_P"A$^.W_A->!?\ YXU?RRT4?ZH93_-B_P#P=#_Y4'_$PO'G_/CA
M_P#\-^*_^>!_4U_P^Y_96_Z$3X[?^$UX%_\ GC4?\/N?V5O^A$^.W_A->!?_
M )XU?RRT4?ZH93_-B_\ P=#_ .5!_P 3"\>?\^.'_P#PWXK_ .>!_4U_P^Y_
M96_Z$3X[?^$UX%_^>-1_P^Y_96_Z$3X[?^$UX%_^>-7\LM%'^J&4_P V+_\
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M[G]E;_H1/CM_X37@7_YXU?RRT4?ZH93_ #8O_P '0_\ E0?\3"\>?\^.'_\
MPWXK_P">!_4U_P /N?V5O^A$^.W_ (37@7_YXU'_  ^Y_96_Z$3X[?\ A->!
M?_GC5_++11_JAE/\V+_\'0_^5!_Q,+QY_P ^.'__  WXK_YX']37_#[G]E;_
M *$3X[?^$UX%_P#GC4?\/N?V5O\ H1/CM_X37@7_ .>-7\LM%'^J&4_S8O\
M\'0_^5!_Q,+QY_SXX?\ _#?BO_G@?WC_  '^.GP]_:.^&/A[XL?#+4I=0\,Z
M^D\9@O8H[;6-$U6QE:WU30==L8I[E;'6-+N5:&Z@6>>%U,5U9W%U97-M<S>P
MU_&W_P $\OVT]2_9&^+"P>(KNZN?@G\0;NQL/B-I@:2=?#\\8>WT[Q]I-MAR
MMYH_FB'7;>V$;ZMH.\.+B\TO2D3^Q;2]3T[6]-T_6=(OK74])U:RM=2TS4;&
M>.YLK_3[Z!+FSO;2XB9HI[:ZMY8YH)HV9)(G5U)4@U\/G.55,JQ<J3O*A4O/
M#U7]N%_ADUI[2%^6:TOI))*2/Z=\.>.L'QWD-/'0]G0S3"\F'S? P?\  Q/+
M=5J49-S>$Q23J8>3<N5JI1E.52C-EZBBBO(/OPHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#+U+_6:5_V%(O\ TDO**-2_UFE?
M]A2+_P!)+RBJ?PQ_[>_,2WEZ_HC^:K_@N/\ \EJ^#O\ V3C5/_4ADK\]OV'_
M (%:!^T3^T?X)^'7B^>>W\&"WU[Q1XP:VF:WN9_#_A71[O6+FQAG3#P'4[B"
MUTZ2XC99+:"ZFN(CYD2 _H3_ ,%Q_P#DM7P=_P"R<:I_ZD,E?FA^R5\?)?V9
M_CUX(^+C:9)K>EZ+)J>F^(]%B=(YM4\-^(-+N]&U>"W>3$8NX+>\^W6(D98V
MO;2W65A$SY_5,K5>7#5%89M8AX.NJ+BTI>T<JO+RMZ*5[<K>BE9]#^%N/*F6
M4O&K&U,ZC&>4PS[))YC&I%SIO!QP>6NO[6$;RG1]FFZT(IRG2YXQ3;2/O?X>
M?';P)\9_%&O>%Q^P#H7B']E\7.I>'8[OX/?"K6]9^*/@N!K.1]"U=/%^ENQG
M\3LR6=[?V]U>6AF2XF8321J1<>"_$7X<>#_#W[!V@>([7PDFG>+H/VIO'7A.
M77M=T"WTKQV?#^F:+(;'1=??8;RUEMF57N]*>9X;6^$BJ"4#5]&_"KXA?L>?
M +XAO\3OA?\ ME?&71OABWB6+QM_PSOH/P]\7V&K:Q>V\9>W\)^(-6EOX/"U
M]:0%4L&U.[$D<^GHMN+DL1>-S-W\8_V5OV@_@+XA\!_%'XU:Q\#==U+]I;XB
M?&6RLA\,?%GQ#F_L7Q0CQZ=97$_A^&#38[@+<.96COI71X&4P!9$>N://2K4
MY4,+CH86%?"5*G[K'3J-QC64_:4:D)3G4]Z/MJE%2IR?)S-R5SV*T<)C<JQN
M'S7/.%\3G]?*L^PN$:Q_"U#"<M;$934PSPN983$TL/AL(U2JK+\)F+P^,H*6
M*5&G"E*4#._X)T^ G\5?"/\ :NU_PW\%_A[\:_B=X5M_A0W@'P]\0="TO6M/
M275-8\16^N+"VIW-BML'TN&2YD$=_;>=)96X;S"B1G:_;C^$6F^'OV=_A#\0
MOB5\!_ 7[._QU\1_$36M!O-&^%UJ$\.:SX$L[$3'6-:L=+O]3T:PUFWNY+?[
M/!]N;4;F$S'"Q#RK?,^#WB+]CKX9> /VE_@BG[5^O#P]\8]!^%+Z'\3K7X+?
M$*SO;#5?"_B'Q#JFMZ:OANV$E]MAMSID?VR;4+*&Y74Y!!YQM)TKA_C3\;?@
M9X3_ &3;W]F3X5?%OQY^T'J?B?XF:3X]U#QMXQ\)ZMX2T3P=8Z-9"%=(\+:7
MXBO;O5H9[^=5-S*F+=XYM1+;#<1H&UB:F:>WI4\5&$L;AY1YL-C*+>&EA*-.
MJY59\N&C2A/GE.A4I.I*I!I-.2,54R;"<"_V7C<7D53$T.&LUI3]CG?#68Q6
M=0S_ !N)PE.GE^$]KG-?&8C#+#TJ.:87'K!4<-6C*=.I"E-2W_V@OAY^RWHG
M[#OAKQ%^SY%J7BR\T_X^KX2\1?%SQ5H*Z-XC\7WL7@JXU*_72[2=1?Z-X3CD
MFM8]/TB9('\VV>ZN8Y[F1KJ;X7^ 'P.\5?M#_$W2/AIX3NM,TRZO;74M7U?7
MM:G-OHWAOPYHEH]_K>O:I*H+BTT^TC9S'&#)/,\,"8:0,/5I_BQX%?\ 8;L/
M@LNK3'XBP?M#WGCZ71?[-U(0KX6E\&1Z1'J']K&U_LEI&U &'[$MX;T >:;<
M18<]5_P3N\27NB?M%+HL/A+7?&FE?$/X<_$3X>>*]'\,?96\21>$_$'A^676
M]6T2"[GMUO+[1X-/34/L4$HO+RW@GM[19+B2.-_0A]9PF S&2E5E5I5L5.C4
MQ+3E.*47&I>2A"4=&XI*--VY8I1T/DL2LFXAXMX/HSH8&A@,?@,@PN/P62QE
M3H4:TY2IUL&HT98G$TJG,X4Z\ZDJV,BI.K5E4JWD]3QQ^PYI^G?"#Q#\:?A/
M\?/ ?QL\,Z!XR\*> &T_POHVOZ9KL_BKQ1JT&CQ:>]EJR(+:-9KRQN+&Z9Y(
M=5MKDO;$>4Q;J-?_ ."<^L:5!XI\):5\:_A_XC^/W@;P9<>-_%?P/TZQUM-3
MM+#3].AU;6-)TSQ7/"OA_5_$.E6,PGGTNV=99%4^60"K'ZF;P]\)/V9?V(OB
M1XI^%OC#QI\0)3^TW\$M:CU3QY\.]9^&,.IZOX"\1VWB2S\+:/H?B0"_U&?2
MK#3]0E\0:E';"T:XN#;1JPLI8XN[\<?M\_##4+[QU\6=,_:P^)4^F>)_!^H-
MX7_9NTCX3^'M(\1>'_&6JZ3'9KI&J_$O4/"-]8W'AG3+O[0\]PEU=7%W;2A(
MKJZ\E8;KR_K^:SYOJTJM>G#$5:<*E3"\M6HX0P<J=*M3IX6:IQDZM:\I1PS=
MFW6AR<K^Y_U4X PRI?VY1P&5XS$Y-EN+Q&#PF?1Q&%PD,1B<_IXK'Y=B\9GN
M'^MU81PF6J%&C5SEP<U"&68I5Y5H?%OA7_@G-;:W9?!JWUS]I+X8>$O&O[0'
MP[\-^//A;X$U/2O$4^LZNWB/2TU&WTO4+BWA-EIB)*YTV#4)99(]0O8;F.S@
M<V\BUP?@K]A:\E\*3^,OC7\7O!WP*T>\^(&O_#+PFNO:9K7B2^\4>)?#&H2Z
M3KES#::#%(^F^'=/U.&2SGUN_,<*-')+)''"89)^XUK]H[X37WQ\_P""?_CJ
M'Q)<R>&O@3\'OV?O"7Q-OCH6N(^@:]X%U;4KOQ1:6]DVGK=ZO'817,<B7&BP
M7UK>%BMC+<,"!]9Z#^W1\._&/@V]\&6'[2^O?LVW?@_XR_%#7K#6XOA)!\0M
M)^)7PW\:>,M7\3:=<06E[X>U'4- \26"Z@T26U['9^8D@\])V.RSVJU\ZIQ@
MXNK)5>6527U57PR]KB(<M-4\-6E+FC&AS<]"M)*3FE",DX^=E^5>&F+K5HUH
MY?0J8%3HX6C'/'*EG-26 R:LZ^*GC<\RVC2]C6KYI[+V&9Y?0G.A'#N5:O1]
ME7_'3XW?!SQ9\!/B9XF^%WC064FL^'+F()?Z9.+K2]8TN^@CO=(UO3)QAGL=
M5T^>WO+=94CGB67R;B*.>.1%\GKZ=_;!^,&B_'#X\^*_'/AK6_%GB3PX;?2=
M"T+7_&T6E6_B+5].T*PBL8M0O+31],TFSLHKJ1)9;.R-H+FVM&ABN7,JLB?,
M5?0X65:>&H3Q$5&O*C3E5BDXVJ.*<ERM)Q=]XM)Q>CV/R'/:.78?.LUH915E
M6RNCC\53P%652-5SPL*TXT9>U@W&JG!+EJQ;52-IIOFN%?T._P#!"O\ X\_V
M@/\ KY\&?^BM6K^>*OZ'?^"%?_'G^T!_U\^#/_16K5Y'$W_(EQ?_ '!_]/4S
M]%\#_P#DY&2?]><T_P#59BS]NOCA\*='^.OP9^+'P4\0ZCJ6CZ#\7/AQXU^&
MNM:MHWV4:OIFE>-_#NH^&[^_TO[;!=6?]H6EKJ4L]G]KMKBW^T1Q^=#+'N0_
MG)KG_!'+]FKQ+XV_X)N>/M<U[QS?^(/^":?P^\!_#CX<2O+H20?%#1?AAH/A
M:P\ R?$^%-("W,WAGQ'X4L?'%A'H/]D6P\1S3.\+6D=M!#^GGQ#\?>$OA5X"
M\:_$[Q[K%OX>\$?#SPKK_C7Q?KMWO-MH_AKPQI5UK6MZE.(U:1H[+3K*XN&2
M-6D<1[(U9V53^$>D_P#!6']OSXC?!S5/VRO@S_P2_E\4?L56=EK'C#0=8\5_
MM":-X/\ VD?'WPAT,SW5S\4?"GP8;P9J6G_V??:):7&LZ)H-WXM;5=<LS'/I
M!O[*6SO+[\D;6E_EHWV_X'X'][J_3J[?/^K>FA]:^+_^"17[._CWX=?M9?#S
MQ5XH^(]ZG[4_[3,G[6T?BRQU33-%\7_!3XT6NF:!8^&_$GPHU?2],MFL9O"\
M_A^&\TUM;CU>2?[9>VE\]Q;RJ%\ZL?\ @C9X3\4V7Q\UG]I+]JO]H3]J/XP?
M&[]F[Q;^RCI?QB^):?#W2M:^$'P=\:65U;:_IOPX\*^#O">A^#+;7M5N+B.^
MUCQ+K.C:IJNJSV^RXF6&\U)+SR#]JK_@N[X!_9Y\6?\ !.6_T'X0:CXR^!_[
M=VCZ#XOU_P"(^MZ]?>$O$'P3\#ZSXB\(^'KS6]:\&_\ "-:O_:MWX:F\4DZ[
M83:QI,27.GRVEK>3">&X/T!_P5M_X*LZ3_P3$\%_ 35=/^&$/QH\;?'CXHP^
M#='\(#Q7-X5ATKP;81V \6>/[K5+7P]XE+V.AWVO>%-+BMGLX(KV\\0VV+R-
M89,GNZO16M?TZ;;^6_9 ^;;7T^2_2U_Q/9_CW_P3>^&'QV_9K_9W^ 3_ !!^
M)7P[\3_LG'X7:K^SU\?/ M_I-A\5/AUXS^%'A6V\&Z)XPLVNM,N?#FH76JZ'
M#/:>(-)OM&DT;48[R9!:0B.#R_R]^#/_  2^\>:5_P %+/VQ-'_:%\9?'[]I
MWX-?M/\ _!-BR^%7Q)_:.^+$/A[2SXI\8>)/BF-*U3X>^&'\$Z!X>\)>%6\-
M^!-,L+S2?#NB:/'#IZB35)EGDO93)]M_\%*O^"PGP/\ ^"=VB^%?#M[H.J_%
MC]H+QU#X+U;P[\&O#HU*V32/!WBKQ;I_A6;Q]\0/%UMHNK:=X+\)6EW<W5CI
MMW>V\UYKVOQVFD6-EMN)[RT_7*SN/M=I:W6W9]IMH+C9G=L\Z)9-N[ W;=V,
MX&<9P.E%D_56^75>7ZVOM?4U7X_BOPTZ]3\2/@U_P10T7X;_ !/_ &2OB5X]
M_;:_:N^/$?[$&MR3_LX^!OB->_#>'P7X*\)2>#=4\%'P?-8>'O!.EWVKJ-+N
MM'C'B._U"3Q!'9>&M(T>WNX-*C:UKH++_@BK\'_"O[/O[+WPF^%OQV^-_P *
MOBQ^QSXF^)'B3X"?M0>$I_!Z_%7PXOQ:\1:KK_C[PUK6DWWARX\">*O"/B)=
M333-0T#6O#EQ;36FGVIW*\U_]LS?$7_!37]J#XV_'7XZ?![_ ()Q?L9^'_VE
M?#'[,GB:3X?_ !@^-WQ:^-]I\#/AK>_%.RB$^L_#/X93_P#"(^+K_P 8Z[H.
M&LM;U.2+3M(TJ_,;7LD5A=Z3>ZM]4_L8?\% O"7[3?P1^)'Q+^*W@N^_95\9
M_ 'Q]XF^%G[1G@/XMZ_I%CI7PN\:^$V@.I2CX@73:9X:UOPC=V]U;W6F>)DD
ML[:4--!-'&T*R3KW=O*W576FSZ[+7RN%I;ZO;K=ZVMY]OR.E_8M_87\(?L=K
M\6_%,OQ*^(_QY^.G[0'BO3?&/QQ^/OQ;O-*G\<_$'4?#^F'1/"FFMIWAS3M&
M\,>'?#?A+1C)IWA[0=!TBSM+&WGFC!>%;:&V\#_:E_X);3_M!_M3P?M>?#K]
MLK]IC]E/XJGX/6'P0U.Y^!4WPY@MM9\%6'B2X\4BUOI/&/@OQ-=[KC5I+6>=
M(9XHBVGVC*BLK;OO/P;^TO\ LX_$;P/XC^)WP^^/_P $_'7PV\'+<OXN^(/@
M[XJ>!?$W@CPLEE";F\?Q'XKT77KW0=#6TMP;BY;4[^U$$ \Z4K'\U3>#?VC_
M -GGXB^-=4^&OP^^/'P9\=?$70[)=2UKP#X.^*'@CQ/XTTC3F6)UO]4\+:)K
ME]KEA9%)X'%U=6,4!6>%M^)4+5;_ #_&_P"8:^?3RVM;]/P/G']BK_@GY\-O
MV+M3^+WCK3OB+\8/CK\</C]?^$[WXR_'CX\>,7\9?$7QM!X"TV^TGP5HTL\-
MKIVDZ5H7ABRU34XM*TW2].MUC6]>*666WMK""T]'^"W[*^E?"']H?]KG]H^;
MQCJ7B[QC^UEXC^$]]JEK?:5:Z;9^!?"/P9^'D7@+P7X'T26"ZN9=0T^WEN/$
M?B:ZO;A;22?6?$^IO]E7)DDZK4OVM_V4]&\5^)? FL?M-_L^:5XX\&&W'C#P
M;J7QG^'%CXJ\*&\N[.PM!XE\/77B2+5]"-U?:AI]G;C5+.U,UU?65O&&ENH$
MD^'/B!_P4>\?:/\ $/\ X*2_##P!\$O OB/Q/^P9K'[&FF^'YO'OQY\)_![P
MO\5(OVIM \+^)=;GUSQKX_L=)\(_#J3P)I>N7ZZ-;W^MZJ_C?5+&PT33_LFL
M:U8V3I62TZ?U]_4+/MO;?Y)6O\MOR/UGHKQCXH?M'_L\_!#4M T?XT?'CX,_
M"'5_%;.GA?2_B?\ %#P1X!U'Q(\<J0NN@V7BO7-)N=7*32Q0L-/BN"LTL<1P
M\B*9_B?^T-\ ?@C9:%J7QG^./P?^$6G>*)#%X9O_ (G?$OP7X"LO$4H6%S'H
M5UXJUK2H-7=4N+=V73WN"J3PL0%D0EBL^Q[!17R^_P =_%5Q^U/X1^"FB^%?
MA_K'PH\4? 2_^+@^*=O\:/ __"9_V_!XL_L.PT'1_@NMU)XUU_P;>Z0T6JO\
M3]-BD\*6]],FB27/VX;6^6_VM?\ @J5\"_@%!\+=/^%'C/X,_M#>.?&?[5WP
M9_9G\;^ ?!?QL\(7GBCX91_%75=9TF\\5>(=&\-OXIU>SN?#MSI(@.B:MI^D
M+=W4_P!GEU&SDCVNK_G8=FW:W2_R_0_42BO$_&O[2W[.7PV\;Z'\,_B+\?O@
MIX!^)'B;[-_PC?P_\:?%3P+X6\;>(/MLOD6?]B>%=<UVQUW5?MDX,-K]AL)_
MM$H,<.]_EJ;XC?M&_L]?!W7?#WA?XN?'?X-?"WQ-XM=(_"OAWXC?$_P3X(UW
MQ,\LXMHT\/Z3XFUS3+_66DN2MN@TZWN"]PRPKF1@I8K/L>S45\L:'^T!XDN/
MVD?C3\*?%'AKX<^&OA+\+OA=X%^(.F?%8_&WP)?^)M4N/$HOY=?M_%WPFANT
M\6?#OPSH5O9^?IOC7Q,MOH/B.,7#:9<.+>;R_3OA5\>_@7\=K35[_P""'QH^
M$_QCL?#]XNGZ]>_"OXB^$/B%::)?N&9++5[CPEK&KPZ;=NJ,R6UX\,SJI94*
M@FB_]?U^8[/\+_)GK-%%% @HHHH *_C=_P""IG_)]/QN_P"NG@7_ -5QX2K^
MR*OXW?\ @J9_R?3\;O\ KIX%_P#5<>$J^JX0_P"1K/\ [!:O_I5,_#OI!?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!\+O_#?^$_\ Y4U]/_KM'_H72_\ "I?_ "CU_I:_A_\ Q+1/_HL8_P#AB?\
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M_?Z/_P"*K^]__A1_P5_Z)!\+O_#?^$__ )4T?\*/^"O_ $2#X7?^&_\ "?\
M\J:/]=H_]"Z7_A4O_E'K_2U/^):)_P#18Q_\,3_^>Q_!!]KM/^?FW_[_ $?_
M ,51]KM/^?FW_P"_T?\ \57][_\ PH_X*_\ 1(/A=_X;_P )_P#RIH_X4?\
M!7_HD'PN_P##?^$__E31_KM'_H72_P#"I?\ RCU_I:G_ !+1/_HL8_\ AB?_
M ,]C^"#[7:?\_-O_ -_H_P#XJC[7:?\ /S;_ /?Z/_XJO[W_ /A1_P %?^B0
M?"[_ ,-_X3_^5-'_  H_X*_]$@^%W_AO_"?_ ,J:/]=H_P#0NE_X5+_Y1Z_T
MM3_B6B?_ $6,?_#$_P#Y['\$'VNT_P"?FW_[_1__ !5'VNT_Y^;?_O\ 1_\
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MUVG_ #\V_P#W^C_^*H^UVG_/S;_]_H__ (JO[W_^%'_!7_HD'PN_\-_X3_\
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M8R:C[?%UDF[2J-*,(<TE1HQIT8MQ@FRBBBN$^G"BBB@ HHHH **** "BBB@
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M\_6G?^"VX_\ EI1]OUK_ )^M._\ !;<?_+2F44<D/Y8_^ K_ ""[[R_\"?\
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M $5&6?\ @R?_ ,K\OS[L_2[^U)_^><7Y/_\ %T?VI/\ \\XOR?\ ^+K\T?\
MAYC\'_\ HG?Q=_\  #P%_P#-_1_P\Q^#_P#T3OXN_P#@!X"_^;^C^Q,?_P!
M%?\ \!?^?E^?=A_Q$O@;_HJ,L_\ !D__ )7Y?GW9^EW]J3_\\XOR?_XNC^U)
M_P#GG%^3_P#Q=?FC_P /,?@__P!$[^+O_@!X"_\ F_H_X>8_!_\ Z)W\7?\
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ML/\ B)? W_1499_X,G_\K\OS[L_2[^U)_P#GG%^3_P#Q=']J3_\ /.+\G_\
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M_P _+\^[#_B)? W_ $5&6?\ @R?_ ,K\OS[L_2[^U)_^><7Y/_\ %T?VI/\
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MEG_@R?\ \K\OS[L_2[^U)_\ GG%^3_\ Q=']J3_\\XOR?_XNOS1_X>8_!_\
MZ)W\7?\ P \!?_-_1_P\Q^#_ /T3OXN_^ '@+_YOZ/[$Q_\ T 5__ 7_ )^7
MY]V'_$2^!O\ HJ,L_P#!D_\ Y7Y?GW9^EW]J3_\ /.+\G_\ BZ/[4G_YYQ?D
M_P#\77YH_P##S'X/_P#1._B[_P" '@+_ .;^D/\ P4Q^$ !/_"NOB\< G L/
M .3CL,_$ #)Z#) ]2*/[$Q__ $ 5_P#P%_Y^7Y]V'_$2^!O^BHRS_P &3_\
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M%^3_ /Q=']J3_P#/.+\G_P#BZS**/90_E7WO_/R_/NPYI=W_ %_PWY]V:?\
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M4>RA_*OO?^?E^?=AS2[O^O\ AOS[LT_[4G_YYQ?D_P#\71_:D_\ SSB_)_\
MXNLRBCV4/Y5][_S\OS[L.:7=_P!?\-^?=FG_ &I/_P \XOR?_P"+H_M2?_GG
M%^3_ /Q=9E%'LH?RK[W_ )^7Y]V'-+N_Z_X;\^[-/^U)_P#GG%^3_P#Q=']J
M3_\ /.+\G_\ BZS**/90_E7WO_/R_/NPYI=W_7_#?GW9I_VI/_SSB_)__BZ/
M[4G_ .><7Y/_ /%UF44>RA_*OO?^?E^?=AS2[O\ K_AOS[LT_P"U)_\ GG%^
M3_\ Q=']J3_\\XOR?_XNLRBCV4/Y5][_ ,_+\^[#FEW?]?\ #?GW9I_VI/\
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M+_Z17M%!_P"/[1_^PDO_ *17M%<^(WA_A?\ Z4S2GM+_ !?^VQ/R"_X*>?\
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MYMMUS-O33HWI^HN9\W-I>R7W*W]>9_/5\6_@)_P4Y_X*:>)?@]\*?VL?@/\
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M /(U?>>TI_\ /R'_ (%'_,_D;ZCC?^@/%?\ A/5_^0*E%6_[.U/_ *!.K_\
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M7_A/5_\ D"I15O\ L[4_^@3J_P#X*=1_^1J/[.U/_H$ZO_X*=1_^1J/:4_\
MGY#_ ,"C_F'U'&_] >*_\)ZO_P @5**M_P!G:G_T"=7_ /!3J/\ \C4?V=J?
M_0)U?_P4ZC_\C4>TI_\ /R'_ (%'_,/J.-_Z \5_X3U?_D"I15O^SM3_ .@3
MJ_\ X*=1_P#D:C^SM3_Z!.K_ /@IU'_Y&H]I3_Y^0_\  H_YA]1QO_0'BO\
MPGJ__(%2BK?]G:G_ - G5_\ P4ZC_P#(U']G:G_T"=7_ /!3J/\ \C4>TI_\
M_(?^!1_S#ZCC?^@/%?\ A/5_^0*E%6_[.U/_ *!.K_\ @IU'_P"1J/[.U/\
MZ!.K_P#@IU'_ .1J/:4_^?D/_ H_YA]1QO\ T!XK_P )ZO\ \@5**M_V=J?_
M $"=7_\ !3J/_P C4?V=J?\ T"=7_P#!3J/_ ,C4>TI_\_(?^!1_S#ZCC?\
MH#Q7_A/5_P#D"I15O^SM3_Z!.K_^"G4?_D:C^SM3_P"@3J__ (*=1_\ D:CV
ME/\ Y^0_\"C_ )A]1QO_ $!XK_PGJ_\ R!4HJW_9VI_] G5__!3J/_R-1_9V
MI_\ 0)U?_P %.H__ "-1[2G_ ,_(?^!1_P P^HXW_H#Q7_A/5_\ D"I15O\
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MW:=&@X4+0G+$QD4445\V?MX4444 %%%% !1110 4444 %%%% !1110 4444
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M "51_85__P!!=/\ P7)_\E4>TI_SK_P&?_R(<LOY7]Z_S_JS\KUJ*L_V%?\
M_073_P %R?\ R51_85__ -!=/_!<G_R51[2G_.O_  &?_P B'++^5_>O\_ZL
M_*]:BK/]A7__ $%T_P#!<G_R51_85_\ ]!=/_!<G_P E4>TI_P Z_P# 9_\
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M=_P?ZL_*YR2\OO\ Z_I/RO@45O\ ]F6_]Z7_ +Z7_P"(H_LRW_O2_P#?2_\
MQ%'MH?WON_X/]6?E<Y)>7W_U_2?E? HK?_LRW_O2_P#?2_\ Q%']F6_]Z7_O
MI?\ XBCVT/[WW?\ !_JS\KG)+R^_^OZ3\KX%%;_]F6_]Z7_OI?\ XBC^S+?^
M]+_WTO\ \11[:'][[O\ @_U9^5SDEY??_7])^5\"BM_^S+?^]+_WTO\ \11_
M9EO_ 'I?^^E_^(H]M#^]]W_!_JS\KG)+R^_^OZ3\KX%%;_\ 9EO_ 'I?^^E_
M^(H_LRW_ +TO_?2__$4>VA_>^[_@_P!6?E<Y)>7W_P!?TGY7P**W_P"S+?\
MO2_]]+_\11_9EO\ WI?^^E_^(H]M#^]]W_!_JS\KG)+R^_\ K^D_*^!16_\
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M_P#Q%']F6_\ >E_[Z7_XBCVT/[WW?\'^K/RN<DO+[_Z_I/RO@45O_P!F6_\
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MUS\\"BBB@ HHHH **** "BBB@ HHHH *_77_ ()<]/BQ]?#W\KVOR*K]=?\
M@EST^+'U\/?RO:\/B/\ Y$^+_P"X7_IZ!^H^#7_)P<F_Z]9E_P"J[%'ZYT44
M5^5G]OA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#E(?\ $>>-O^@?(/\ P@Q?E_U,?)_?Y'[T_P##R?\ 9R_YY_$/_P (\_\
MRQH_X>3_ +.7_//XA_\ A'G_ .6-?@M11_JEE?\ /B__  ;3_P#E(?\ $>>-
MO^@?(/\ P@Q?E_U,?)_?Y'[T_P##R?\ 9R_YY_$/_P (\_\ RQH_X>3_ +.7
M_//XA_\ A'G_ .6-?@M11_JEE?\ /B__  ;3_P#E(?\ $>>-O^@?(/\ P@Q?
ME_U,?)_?Y'[T_P##R?\ 9R_YY_$/_P (\_\ RQH_X>3_ +.7_//XA_\ A'G_
M .6-?@M11_JEE?\ /B__  ;3_P#E(?\ $>>-O^@?(/\ P@Q?E_U,?)_?Y'[T
M_P##R?\ 9R_YY_$/_P (\_\ RQH_X>3_ +.7_//XA_\ A'G_ .6-?@M11_JE
ME?\ /B__  ;3_P#E(?\ $>>-O^@?(/\ P@Q?E_U,?)_?Y'[T_P##R?\ 9R_Y
MY_$/_P (\_\ RQH_X>3_ +.7_//XA_\ A'G_ .6-?@M11_JEE?\ /B__  ;3
M_P#E(?\ $>>-O^@?(/\ P@Q?E_U,?)_?Y'[T_P##R?\ 9R_YY_$/_P (\_\
MRQH_X>3_ +.7_//XA_\ A'G_ .6-?@M11_JEE?\ /B__  ;3_P#E(?\ $>>-
MO^@?(/\ P@Q?E_U,?)_?Y'[T_P##R?\ 9R_YY_$/_P (\_\ RQH_X>3_ +.7
M_//XA_\ A'G_ .6-?@M11_JEE?\ /B__  ;3_P#E(?\ $>>-O^@?(/\ P@Q?
ME_U,?)_?Y'[T_P##R?\ 9R_YY_$/_P (\_\ RQH_X>3_ +.7_//XA_\ A'G_
M .6-?@M11_JEE?\ /B__  ;3_P#E(?\ $>>-O^@?(/\ P@Q?E_U,?)_?Y'[T
M_P##R?\ 9R_YY_$/_P (\_\ RQH_X>3_ +.7_//XA_\ A'G_ .6-?@M11_JE
ME?\ /B__  ;3_P#E(?\ $>>-O^@?(/\ P@Q?E_U,?)_?Y'[T_P##R?\ 9R_Y
MY_$/_P (\_\ RQH_X>3_ +.7_//XA_\ A'G_ .6-?@M11_JEE?\ /B__  ;3
M_P#E(?\ $>>-O^@?(/\ P@Q?E_U,?)_?Y'[T_P##R?\ 9R_YY_$/_P (\_\
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M;3S?#$7^GVS2 R%?+D*)<VGHM]NGS;M>^N_3:Y[MWM:_?S5_16O;YGO&J_\
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M_L$J?^G:)^*>//\ R16'_P"Q[@?_ %%QY\H4445^CG\=!1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV>=%_P ]8_\ OM?\:/.B_P">L?\ WVO^-?U)_P#"@_@7_P!$6^$W_AN?!_\
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M_ O_ *(M\)O_  W/@_\ ^4U'^N5'_H!J_P#@^/\ \K]?Z>A_Q+QF'_148/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_1#?AO\ ^#[QM_\ +BOR/HK]!_XASP3_ -$_A?\ P;B__FD_/O[4Q7\F _\
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M&9_X@M"Z7+"^Z7+&[2MK:WI?_@L_M/WM[RMWN_+S]/Z;/H#[5J__ $$E_P#
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M;2PS2'+"]N6%][<L;V5KO;II?UUWU/>M>\K;7N[7[;^7Y]V>N_:M7_Z"2_\
M@%!_C1]JU?\ Z"2_^ 4'^-%>-_&3]H'X0_L_Q?#2?XN^+T\(1?&#XM^#_@7\
M.7?1/$FM_P#"1_%7Q[%JT_A+PHH\-Z/K#:6VK1:'JCC6=;&F^'K+[*1J.K6;
M36XE.6"WC!>L8^7EZ?TV%WT<OO?^?E^?=GLGVK5_^@DO_@%!_C1]JU?_ *"2
M_P#@%!_C113Y8_R0_P# 8_Y>7Y]V*[[R_P# G_GY?GW8?:M7_P"@DO\ X!0?
MXU#I-_>1C45DD29SJ4[-(8@FXF&W_A4[1@8''UJ:OQZ_:B_X+4?LA?L:_&_Q
ME\!/BUI?Q?NO&_ADZ-J6HS>$O!VCZOH;6_B/0M-UG3Q;WUYXJTN>61;.[B%P
MK6<8CFW(K. &/J91D6:9]B9X')LLQ.9XN-&5>6&P5"5:LJ-.=.,ZCA33ER1E
M."D]DY*^K//S+-LNR>A'%YKC\-E^%YU26(QE>%"C[6:O"G[2K*,>>2A)J-[R
ML]]3]E?[3N?^F?\ WP?_ (JC^T[G_IG_ -\'_P"*K^>G_B)-_P""?'_0#_:$
M_P##>>'?_F[H_P"(DW_@GQ_T _VA/_#>>'?_ )NZ^B_XAAQ[_P!$9G__ (;<
M1_\ ('A_Z_\ !?\ T5F0?^'3!_\ RWR_/NS^A;^T[G_IG_WP?_BJ/[3N?^F?
M_?!_^*K^>G_B)-_X)\?] /\ :$_\-YX=_P#F[H_XB3?^"?'_ $ _VA/_  WG
MAW_YNZ/^(8<>_P#1&9__ .&W$?\ R ?Z_P#!?_169!_X=,'_ /+?+\^[/Z%O
M[3N?^F?_ 'P?_BJ/[3N?^F?_ 'P?_BJ_GI_XB3?^"?'_ $ _VA/_  WGAW_Y
MNZ/^(DW_ ()\?] /]H3_ ,-YX=_^;NC_ (AAQ[_T1F?_ /AMQ'_R ?Z_\%_]
M%9D'_ATP?_RWR_/NS^A;^T[G_IG_ -\'_P"*H_M.Y_Z9_P#?!_\ BJ_GI_XB
M3?\ @GQ_T _VA/\ PWGAW_YNZ/\ B)-_X)\?] /]H3_PWGAW_P";NC_B&''O
M_1&9_P#^&W$?_(!_K_P7_P!%9D'_ (=,'_\ +?+\^[/Z%O[3N?\ IG_WP?\
MXJC^T[G_ *9_]\'_ .*K^>G_ (B3?^"?'_0#_:$_\-YX=_\ F[H_XB3?^"?'
M_0#_ &A/_#>>'?\ YNZ/^(8<>_\ 1&9__P"&W$?_ " ?Z_\ !?\ T5F0?^'3
M!_\ RWR_/NS^A;^T[G_IG_WP?_BJ/[3N?^F?_?!_^*K^>G_B)-_X)\?] /\
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M *9_]\'_ .*K/HH]G#^5!S2[O^O^&_/NS0_M.Y_Z9_\ ?!_^*H_M.Y_Z9_\
M?!_^*K/HH]G#^5!S2[O^O^&_/NS0_M.Y_P"F?_?!_P#BJ/[3N?\ IG_WP?\
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M []@?X%ZE^SA\/\ ]H_]K?\ :OF_9J\/?'+QMX@\#? S1=#^$.K?%O5/$?\
MPBUS%IOB+QIXG72O$N@GP]X3T?6)1I\^V*[O)P&N8W3]W!-[57B;**.59;G,
MJ]:I@\WCA99<L)@\7C\5BWB\-+&4H4,%@*&)Q5::PM.K7JQIT9>RI4:M2HXP
MIRDO!I\.9M5S/,<IC1I0Q>52Q$<>\1BL+@L-AHX;$1PM2I5Q>-JX;#PIRQ%2
MG2I2G4BZLZM.--2<TC\L**_=:]_X(M_V%^TO\<OA;KO[0T\WP,_9Q^$/@#XL
M_$KXW>&/A!K'B?7]27XBZ3'?^&_"G@/X4Z!XHU75?$FJ:M<"Z@L;U=;BA%E;
MG4KJTAWK9F[HW_!%K2O'7QJ_9R\.> /VB]:'P$_:7\'_ !@UOPU\5O'GP.US
MP3XW\$>*?@UX6U?Q-XC\%>.OA/KGBO3[^W=HM.ME@\066NFTN+*YN-1L[&ZB
MMK>/4/(EXB\'Q@JKS:2HO +,O;?V=FKHK#O+9YPH2JK!.$<;+*X2QRRZ36/=
M!*2PUY04O9CX><7SFZ4<J3JK%O!^R6/RWVKJK&PRZ52-/ZWSRPL<;..&EC4G
MA%4NO;6C)K\'**_9C7O^"67PW^)7PM\&?$G]A_\ :J3]ILZE^TCX,_9<\::1
MXB^$FL?!Y_#WCCQU'))H7BO3)M8\1Z[-JG@:X413->M:131V327(DEN;74-/
ML>T^-?\ P2 \%^$? /[1$_P6_:+\:_%+XO?LG>%]6\9?&/P=XM_9Q\9_"CP)
MK?AOPE,;;XAZG\*?B9KNMWVE>+1X)N%D$MN;2,^(+*)]2TJ9;?REEU7'O"WM
M*-&6/Q%*M5Q#PTZ.(RG-\/6PE55\/AD\RI5\#3J992J5L5AXTJ^81PU&LJJJ
M4JDZ49SCS_ZC<3.G5JQP-&K2IT5B(U:.9Y77I8JG[&M7:P-2CC9PQ]2%+#UY
M5*6#=>K3=-PJ0C4<(R_#.BBBOL3Y(*_L#_X-;/\ D _M<?\ 87^&/_I%XGK^
M/RO[ _\ @UL_Y /[7'_87^&/_I%XGK\D\<O^38\0_P"/*?\ U<X _4O!K_DX
M.3_]><R_]5^)/Z$_^"A?_)A?[:?_ &:K\?O_ %5GBFOY*?V2OCOXG_X)W?L9
M_'#]DKPF]P?%7[9'[#G[%'[37[%.E19\_5?C!^V/\+?AE^SQ\4[71Q##,[WO
MASXK76F^,)]),\<TUG;_ &RUCAEUB65/[5OBW\,_#GQH^%GQ(^$'C%M13PE\
M4O OBOX>^)WT>ZCL=670/&.AWWA_5VTR\FM[N*TOQ8:A<&TN9+6YCAG\N1X)
M54HWQ)J7_!*_]DS6?%7[!7C35]#\5ZEXC_X)R^$/#G@C]GS4;O7;)Y+K1?!_
MAC0?#/A7_A80715'B:[\/GP[8>(-+FL/[!2W\2M<:EY+1O':Q?YZSA*4DXV3
M46K_ .)V?1WLM>UTC^X8R25GJM7;S5FOQ5O\MS^9_P"!#^._^">W['_[5'PU
M^!?C_7/ %]\-_P#@M'^SG\"M8\3Z)>):WNN^&)/#7PE\/^.8-3N9UF1[3QC)
M;7=WKB'$=Q]LG3*PN4K]4/\ @I_^WG\=_P!D']K?XL:E\-_%&IZEX<^&O_!*
M#XR?''2?A=,!J/A"3XN6GQJ\*>#O"7CW7M"4!KK_ (1^VU26:\DDD2,Z':ZE
M&V(FE:OT/\;_ /!+#]E+XB_"W]JOX1>+M.\<ZIX7_:]^-<O[0OQ$N1XM^Q:]
MX8^*ZVWAZ'2_$GPVU?3]-M)O#+:%<>&=,O\ 2[>\76HS<&\M]1_M#3+R:P/G
MGP@_X(X?LJ_#'XA^+OBKXL\4_'[]HGQY\1/@;XK_ &<_B+K7[1WQ9OOB</&O
MPE\77&D277A?58+K3+ VEKI=KHZ:=HJZ)-I<=K:W^I2W$=Y?SPWMO/)-)1CH
MO=UO;EY6^BWO=>6GR*<XO7KK=6WNH_Y6[?(^?_A7\'/VE?V6+W]FK]I#QK_P
M5#\;?%W1?B-X7U+5/CW\%OVA]4\)7?A?XX:[KGPVOO&^E:/^RAH\%GI]QX \
M4:;K-LUQH7A;PY+?)J_AN!K>;,$,MG=_G-/\5OVXK7_@FG_P^Y?]NWXMS?%"
M'7K3XKS_ ++<4'AY/V5+GX4W/QFMOADOP*M_AP]M+-#KC:#<A;;QPVI2^*[O
MQ 8D1K?5+I-9@_:/]GS_ ((_?LQ_L_?$SX8_$N'QM^T5\7V^ =MKME^S?X&^
M.7QDUGX@?#G]GJU\0V T>^7X7^%9;33[>QFBT$MX?L)];GUMK'23&L"K?P0:
MA'QMO_P1 _8XMO&D5[%KOQ]7X'6_Q1_X7/;_ +'8^+^LC]E"#XCC4O[<76H_
MA:MJK_8%\0@:\/#QULZ&U_FWDLGT=FTLS[.=E[MM[+VDG:7NVGYV:D[7ZOJV
M'-&^_75\J=UVL_NU[??^=GP8\/?MC_MZ_'#_ (*C:@O_  47_:(_9\\-_LU_
M'._T;X _#_X;ZEX:TO1_!&KZCX%MO$]K<_$4W^DS:CXF\ Z?]BL["V\"ZA>0
M:,-OB'4)9#=7ESYF+^SK^US^U9_P5;\8_L4?L_:I^T+\0_V4=%UC]B'Q%^U+
M\??&'P BT_P-\2/C'XWT'XO7GP3TG2/"WBR\M[]O!WA>2XL/^$ZU&R\.V12^
M>YO-/F7^S8[%+/V?X:?\$7[[XM_M(_\ !2?XD_'OQ+^TE\ /#W[0?[2.M3>%
MV^!'QZL?!VA_'W]G[4_#]A&ND>/O#GAZ[\2QC28M3;5K:TM=5T_PSXBB@U34
M8;F.XMGM/LOZ1_&/_@E+^RS\3M!^ 5AX)/Q*_9I\5_LP>%9O 7P/^*'[-7CN
M_P#AG\1_!O@"\LC9:GX';Q"D&JG7/#FJ@M>WL&MV]]?-JDMYJ4.H0W6IZL]^
MH0FXZIK5\R<I)S7/=:7]VR5M=TUT'*4;Z6\K*ZCHNOKT2TV/Y_K_ .-'QM\3
M?M+?L??LN_'3XG:I\=];_8K_ ."VWA?X.>%OCMKEE86'BKX@^!=7^#/BSQ-X
M>M_&DVC)#87_ (V\)P7,FB:_JT2K?7DR02:D\VH+-=W'LEY^VK^UOH'PH^(_
M_!+%_C+XZO/^"A#?\% ]#_9<\!?&NYNXI?B5'^S3\1+]_C]I/QTFNX[.6">X
MT3X"Z?XAT!]5=(/L>EI8ZM+/'JEG-!7[+^!/^"3/[)7PZ\._L^Z%X<M/B+]M
M_9Z_:*NOVK-+\8:MXVDUOQM\3/CEJ.FZGI6J^,OC!XDU?3;R]\82ZE;:FZS6
MMJ=$AMTM+"VT_P"QV5N;63YE_9Y_90^(OQN_X*O_ !5_X*1?'#]F2^_9QLOA
MG\'K+]GOX%V'BGQ9X/\ %/C/XK:N=6\1V'B?XSZK;>"O$>MZ?X9TNT\&26OA
M3PKINIHNK7^E^()[B5X3IS1S"IU%RZOF;L[7=H-+FO+:Z223;U:LMPYXM;*R
MN]7;WKQM;KK9WMM?6UC\OOVAOVB_VQO@/^U-\5OB'^TE^T[^V?\ L[_#?PE^
MTUH>B?!;XY?##P7X'_:,_P"">FF? 2/5M#T*+P9\>?AYX0UG3O$-AXYU.RN;
MBR\4ZWXNU0>.-%\0ZOIVJG2_EL[EN!_X*#_MG?M!:+XA_;L^-OP%_;$_;F^)
MGBW]FGQVZ> A^S?\+-/\%_L#_L\Z9X/O-%_M'X;?'S6/'*+I_P 9?%4ZMJ-K
MXFU.S37+:\U'4;2WT>:Y1K?0]-_<SXA?\$3/V0OB/\1/B-XHU+Q-^T+H?PP^
M,WQ&T_XM_&;]E_PI\9M=T+]F[XJ?$.PU/3=;D\0>+OA_!;/=R_VIK6DV.K:M
M8:;KVG64U[!&;2&QMU%O6)\5?^"%_P"QY\7=4^-=IKWC?]I_0?A)\?O%NM?$
MCXA_LZ>"OCMKWAKX$WOQ1UZT@2]^(EOX+M[&:;^WH]8M++Q5:6=_JE_X=@U^
MRLU;1)= M;?08ATZKYET<G;WW?K9WT6FBNTY:/39B4H_.UMK6V_X.E[?@>%W
M&O\ [0O_  4>_;A^-'P)L/VK/C1^R#\(/V7OV;/V6?B1:>'OV=M4TSPEXW^*
M'Q*_:E\&Z[XV?Q-KOC/4=.U"_P!4\$?#:'PVOAY/#=M;0Z9J.HZDS7IBN59V
M\[UKXA?M:?%SXH_L!?\ !.+4_P!OV+4K[QQX"_:B^(G[1O[8G[+$7A?P]XS^
M+5M\!?%NF:'X+^&/A'Q%8PZCI/P]\=:;;ZS:'XQG0[5M2,VE<QP0ZG=1S_HG
M\8?^"3_P!^*WB#X7>/=%^)7[1WP/^+?PQ^$>C? E_C+\!?BU<?#CXD_$3X4Z
M%I^G:?I_A;XFZI8Z/<Z5XG2W73_M4-\FC:?>17=Y=E9#:?9K2V;XO_X)#_L?
M:W\#OV?/@AX'T_XD?!$?LJZEXAUO]G_XL_!WXBZWX7^-7PZUOQM=3WOQ#U2R
M^(-V=6OM4N/B/>75S=>-5UFWOXM4FE#6Z6/V>T%O3A-\VFKW?._?CS1?+;:/
MNWCII\I,7-'3\-%[OGYW>MOU/QE_X*0_#7]H;P-^S3\./V=M=_;OTK]H?QMX
M/_X*U_LB:3\(?B/JEIX1\0_'_P" OAWQOX=\9ZIX9TKX[V"1/IOB?Q?HUW=7
M7B#PKJ7B;3$?Q3H<=K)>+]A:.PT_TCXC?%7]HW_@GQ^T%^V5^SYXA_X*,?$+
M4?A==_L"Z3^TUX&^.O[4_AR#XT:]\ OB7>?%A/A5=7VCZ9X<T)-5\46.LRO*
MVA>"K72;O28-<O\ 1$BT*\6TNTU']3?#_P#P2&_9+\/_  U\/_#SS_BWKFHZ
M?^U!X+_;#\7_ !3\4?$2X\2_%GXL_'7P$=1CT'Q%\3?%VM:;>KK.G1V.I2:9
M+HVE:;H=J+*"%K=K>_EO[Z]]'_:6_P"":7[,'[6OCKXC>/\ XU:5XPUW4OBA
M^SI!^S)XCTW3O$[:-HT/@.Q\?_\ "SM(UG2(K.P&HV'C31O&4=IJFG:S_:<U
MBHL;:WNM'NH/M"3GLYZM:2NK>\]K:Q;W[+=[::;M2CHG:VM[QO=W6MMN[^>I
M^%'[#/[4/[17@_\ ;V^"'P@;XH_\%"?&OP9_:,_9:^/7C'5[S]OOP_X>\.WG
MB?XB_";0='\2:;\3O@5X<6;4?$W@OP?<KJ<UC<Z!=2VFFR0ZAIZ++JEQITB:
M?\[^$O&?[>6A?\$<O#'_  4V\7_\%$?VE?%?Q5^)EY\*?!6B_#O^U-$TWX=^
M#O#=[^V%X-^'+:JEM::<;O7/&>K>%]!UBWUGQ'J#)<W5EXPU+2)5DM[*UD;^
M@#X0_P#!'[]GSX4_'CX>?M.:A\7_ -JWXP?'3X;^&O''@;1_'OQL^-][\0;J
M^\ ^./"5YX.N/ ^HZ=J.B1Z9!X>T*SU"]U704T.UT;48]?N7O]4U'58(K6RM
M_2I?^"8/[-4W["GA#_@GB]S\2/\ A0/@F_\ #&HZ-<#Q3IP\?/<>$_BK%\8=
M-^V^(_\ A'OL$\<GBV(1WBQZ% 9=(9K.)H)MMVI&G.UI7T4^5<VS:AR[/NI;
MWW\PYUS75K-QOIT5^;IUW_!:'YKZII?[5/[?_P"T!_P4QU/0OVV/C5^ROX8_
M8H\?W'P#^!'PP^%L/ARR\(WVO:+\+=)\<ZY\2OC?H6MV-XOQ1\/^,=4UM+73
M-!U9[.PB\-6UR+*[03L%^"?^"=GCCXY?'#]G[_@D/_P3L^'7[0/CW]F7P+X[
M_91_:/\ VFOC+\3/@]+IND_%/QI8^!?VB/%G@WPW\-_ ?C6]M[L>%H;C5M4O
M?$7B2_TFSFOI])M+: #[)+*C?OE^T-_P28_9O_:&^,'CCXSW7C7]H/X0Z[\8
M_#VC^$_VA/#_ ,!_C!K7PR\(?M#^'=!LY-+TO3OBSH^FVUP^KF'1)9/#\M[I
M-WHM]<:))):R7'V@K=IA:G_P1R_9.?X$?LV?!#PCK7QL^&.H?LB-XG7]GSXY
M?#CXE3^%?CSX!LO&FK:OK'BS2(/'.GZ5':ZAHVOS:S/;:AI][H<B-:V]H('@
MN$FN)QTYN3=OYDWS/WTYQ:5OLWBFG;>UGIN<\>5*_6+6FD;1MUT>OW[[GXV?
M$?XX_P#!2?PUI/[6'[$?PT^-GQH_:"D_9(_:]^ .DZ_\6? &M_#/PU^V=X]_
M93^+WPO\8>/=9^&O@C6_$\<&G>*_C'X+U?0]+@N-6T*UO/B1KNBWT=Q968MV
MN;2"M\._VW?BU9_"[X">"?!'[8O[3OC3Q-H__!9/]E7X)_$'P#^TS\+A\,/V
MG?A1\&?BGX4^)6K7?P4^,WB5=4U6S^+_ (?\57WAJXU72/%\-GI-W+9Z=)IE
MY%$MK;V=G^QT_P#P1;_8UG^""_"(R_&1/%P^-$?[1TG[3"?%+61^T[<?'F*!
M[)?B?<_%-H&EFUG^RI#HXTUM)_X1Y+!8Y(](35(H]273\'?\$>/V5/"FEZ"=
M0\0?'+Q[X]T_]J?X4_MA>*/C%\0_B;-XM^*?Q+^+_P %M%\0>'?AXGCWQ'JF
MD2P7_@_0M'\3ZQ9P^'-)T[1B5N7G.H?:I;BXG7LZEUZ:^]>RO=1Z:I63W3M?
M?4:G#KT:Z;VLF_GKV/Q0^(7[3'[7WP6_; \1>/OVK?VF_P!L7]G;PL/VTY?#
M_P ,_BCX-\$^!_V@?^":>O?LXWGC5M#\+_"KQIX7\":WI6I>"_&>KZ)MT?7?
M&'B34I/'WA+6[F+5-:TVUN8S>0_V#@@@$$$$9!'((/0@]P:_'[7/^")'['NN
M_$?Q'XHG\0_M V7PI\9?&*+X_>,/V4M+^,6M6/[,'B;XN1ZQ:^(9?%.J?#6*
MT\YHKS7K2'5[S1+;7+;1I+A!:16<.C#^RZ_8'ITK2G&47+FV;5M;][N_GI:Z
M3[]")N+M;?KI;32WZA7^=U_P7Q_Y2>?'+_L!?"S_ -5QX;K_ $1:_P [K_@O
MC_RD\^.7_8"^%G_JN/#=?T!]'/\ Y+[$?]D]F'_J5EY^*^.W_)$0_P"QS@/_
M $WBC\;****_N4_C8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%'!<7O\ ;=NVA6$;76K7(BN)+6SLX4^_?V9?A;X7_:U_X)Y_LS^&OVA/@?\
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M2BDD4445XAZX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 0G_ (_M'_["2_\
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MI\0T5]O?VO\ !_\ Z-T^'O\ X5/Q<_\ GA4?VO\ !_\ Z-T^'O\ X5/Q<_\
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M?Z>GQ#7]@?\ P:V?\@']KC_L+_#'_P!(O$]?SM?VO\'_ /HW3X>_^%3\7/\
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MCOH_"MU8OJ]KJM];ZG]H46Q@^^?^$??_ *"]_P#]^M/_ /D.C_A'W_Z"]_\
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M;B>WM;:">[=9+N:&"**6ZD5=JO<2(BO,ZK\JM(S,%X! JS5W_A'W_P"@O?\
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MY?W?-_=YARR_E?WK_/\ JS\KTJ*N_P#"/O\ ]!>__P"_6G__ "'1_P (^_\
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M+=76JOT3L3*GSM*<$T[Z249*^CO;7;7]#P3_ (9A_9J_Z-Y^!O\ X:7P#_\
M,_1_PS#^S5_T;S\#?_#2^ ?_ )GZ^D_[-M?1_P#OL_X4?V;:^C_]]G_"K_M3
M%?\ 07B__!]7R_O_ -6]!?5J?_/FE_X!#R\OZMZ'S9_PS#^S5_T;S\#?_#2^
M ?\ YGZ/^&8?V:O^C>?@;_X:7P#_ /,_7TG_ &;:^C_]]G_"C^S;7T?_ +[/
M^%']J8K_ *"\7_X/J^7]_P#JWH'U:G_SYI?^ 0\O+^K>A\V?\,P_LU?]&\_
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M&E\ _P#S/U])_P!FVOH__?9_PH_LVU]'_P"^S_A1_:F*_P"@O%_^#ZOE_?\
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MV,1W 8FHU5G8*BL['HJ@LQ[\  D\5[!YPVBG*K,VU59FY^502W'7@#/'>FT
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MR9_39_P_9_X)L_\ 18?$_P#X:CXC_P#S.4?\/V?^";/_ $6'Q/\ ^&H^(_\
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MA.$E9QE%V::_J^ZT/K(3C4C&<)*4)Q4HR3NI1:NFGV:"BBBH*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M77;G7;WP5:WQ1;2 Z9/J2VBI;3Q26NZS'$_%7_@J5K^F?!CP3X-_9+UKXH?
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MP[_X)]_!7]BB]^'GQ^\;^/? 'B3QQ<_#3Q!J^M7?C<:IX)^'GBC2O#NH"_\
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MM,^)&CZ!X"^*7C7X=QV_C"'XWVWAY-6D;PKJVGBX<Z7K5]"Z3I(DC&%W#&!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ,@444)+31=.B_Z=@NGR_P#<8?8)_P#H+:E_Y3__ ) H^P3_ /06U+_RG_\
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M -QA]@G_ .@MJ7_E/_\ D"C[!/\ ]!;4O_*?_P#(%%%"2TT73HO^G8+I\O\
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M .@MJ7_E/_\ D"C[!/\ ]!;4O_*?_P#(%%%"2TT73HO^G8+I\O\ W&'V"?\
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M ) H^P3_ /06U+_RG_\ R!110DM-%TZ+_IV"Z?+_ -QA]@G_ .@MJ7_E/_\
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M /06U+_RG_\ R!110DM-%TZ+_IV"Z?+_ -QA]@G_ .@MJ7_E/_\ D"C[!/\
M]!;4O_*?_P#(%%%"2TT73HO^G8+I\O\ W&'V"?\ Z"VI?^4__P"0*/L$_P#T
M%M2_\I__ ,@444)+31=.B_Z=@NGR_P#<8?8)_P#H+:E_Y3__ ) H^P3_ /06
MU+_RG_\ R!110DM-%TZ+_IV"Z?+_ -QA]@G_ .@MJ7_E/_\ D"C[!/\ ]!;4
MO_*?_P#(%%%"2TT73HO^G8+I\O\ W&'V"?\ Z"VI?^4__P"0*/L$_P#T%M2_
M\I__ ,@444)+31=.B_Z=@NGR_P#<8?8)_P#H+:E_Y3__ ) H^P3_ /06U+_R
MG_\ R!110DM-%TZ+_IV"Z?+_ -QA]@G_ .@MJ7_E/_\ D"C[!/\ ]!;4O_*?
M_P#(%%%"2TT73HO^G8+I\O\ W&'V"?\ Z"VI?^4__P"0*/L$_P#T%M2_\I__
M ,@444)+31=.B_Z=@NGR_P#<8?8)_P#H+:E_Y3__ ) H^P3_ /06U+_RG_\
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97YL$D@$$HHK&KO%=.1:?-E1V^[_TF)__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>nt10015006x17_graphic4.jpg
<TEXT>
begin 644 nt10015006x17_graphic4.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
M                                                          !8
M65H@        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($AE=VQE='0@
M4&%C:V%R9"P@,C P- !S9C,R       !#$0   7?___S)@  !Y0  /V/___[
MH?___:(   /;  # =?_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( GH$B ,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG]EO++[;IUV"T$_V2_@M;VW+@',5S;PRJ1AD%?RB?\% / ?[>/[8'[+WQ?\
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M> /%7A6>ST#X51_#/PCK7A:>]D6QL=)\"/X8TZ[\/^?)<.JVT-KH362$2OE
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MI17+*[]G_P""+497_@F7\5Q\OS_$_P#:29>21AK"V^_D YSG/7C%>9?\$O\
MX@77P?\ ^"1O[4/Q&T666'5?"/Q$_:2UC2YXX50V&L_V'H$6FW,"!W$J6-[/
M;78+F/>8G1@BC>?4_P#@BX/^-9GQ1QA@_P 2OVC64AE(97T^V*DD$A>#C!((
M R>M<-_P2>^'LGQL_P""4_[1_P +;("*^\<?$W]I/PEI\DJE(GU;4-%T2'29
M69PH: WSV8DD4E=BOAB5-=&*E04\U51ITWG.$DTOM4T\1SM/7[+?FKG!DD:T
M,'PK1HTIQQ3X&S"&&E9J%#$Q63*G&HNC<K**>ONNST9Z]_P1%_9Y\&Z7^RGI
M_P"T'XGT+3/$?Q6^/.OZYXRUWQ?JT,>K7LFFRWKQV%G8SW\#2V<"W'VZ29(R
M"\CA"[)$E>8?\%S_ ( ^$_!OPE\"?MK_  U\/0>'OC;\"_B1X6==;\/QKICZ
MOX5U"6[FOK'4H;%(Q=W"ZG8Z2MK<."R0SWD,V^.<M'8_X([_ +6_PQ^%7P/N
MOV/?C]XQTCX1_&3X'^+?$'A^U\/?$*]3PQ%K'A<W"R6.H:7J6KFVTZ01W*WC
M3VS722)%<VDT(F260Q<9_P %?_VI?AY^TUX9^&W["O[-?B.U^+WQ1^*7Q,\,
MZAXG?P#=Q:WH7AGPAI\>J6=Q-J>NV+RZ=+,UWJ$.IB'3YKYK:WT2[-\+5I;3
MS]*D<32XDQ%6BIK#K$UG&I43G167S4DN:<KPE2>&DHK6SNDK.R,85,IJ>'N%
MPBJ826+67X;#T</*=*IB8\0TG!P@Z2?M7C:>:152I&WM>>,I2LKR+/\ P51T
M?XK_ !6^"O[ ?[5.A> /$/Q9\!?#J32_'OQC^%>@0?VC=ZP_BKP[X.UJVU.X
MTM5?[='H5SHFNVFX+B*74T60I#/*R^J:;_P46_X)4_MJ_#:]^"/Q3O+3X7?\
M)5IMKHEYX,^(7@JX\):SHURTMN6BT[Q#8:3JNAZ--87T$<8NYM3MXE=(Q,N&
MV5[E^TM^U[J?_!.K2?V/?AQXP^&$'B;X'>)])TGX8_$+XL+JTXB\#ZGX;T'0
M]-MQ?Z&=&FM;N#79);N]AEDU."1H--U#;;.8U#<O^VW:?\$LOB7^SMX]\8>/
MM7_9\U)SX-UF^\*:QX-UCPS'XW_M^XL'FT5])TSPW.-:FOY=3%D)HKO39/)5
MF-XL #.OGX>2J1P]&I0Q4H>VG]5Q&$J6=-SJQLW2Y)QDXM)VO"=DES*RMW8R
MG5H8[/,7@,TRN=>6$P']M9/G>'G##2=+"PA&K1Q:E"K2HU\*I4TE3Q.%^L*3
M=JBK1? ?\%,/A'X ^"O_  2)\6?"_P"%.IZAKGP\\.6>AIX6O]7UBW\4376E
M:CK-YJ@E75;=+2VOK<SWTT]J\*")4*(GR*"OE?\ P41^*/B+P+_P2*_92\$^
M%M6N=(O_ (S?#[]F_P"'5WJ4>;>5]$U#X=>'%U"TE$,A:W^V&:V=VBDE,30^
M6!(C%E^2;:W^)EK_ ,&]NO/\1CJSP7'BB]G\!1ZLMU_;L'@$>(I(M,%ZMTS.
MSRZK#K$]D4=H'TFXLGA9HF0'[D_;Q^!/BOXY?\$BOV<=5\ :5<ZMXI^$OPQ_
M9U^*MCHMG"\M]J&FZ%\.M"?4;*SA53*UUB2UD5 N1'#*64[<5VT,/A\)F&%6
M,JJM1HYS7I5:JEI-4XTGSMJZUGRW>NJ=]#BS*IBL=@<^EE^"Q&$Q&(X(RFI0
MHTU*-2G3JSS)U,'14;6KTJ"E"GR6E%RA9)\J/U"_9'_98^%G[.'[/?PX^%GA
MGPCHX6P\):._B6^O]/LKS4->\17]A#=:]?ZE<RVY>X-QJ,]R(HWW+#;"* ;A
M'N;\'_C5^R]X%_9[_P""Y'[+.O?#K1O[#\.?&**P\?7NCV12'1M+\4'7=7TC
M6HM+L(TCBM(;R32EUNYCC!476J3LF 0B_KQ^QC_P4-_9R^//[//@KQ?JOQ8\
M#>"_%_A_PSINC?$CPKXT\5Z-X=UOP[XGT*QBL-:^T6VLW=E)<VES<6TE]9W=
MLLJ26US$DHANUFMHOQ?\<_M7^'/VL?\ @MA^ROKGPR@U?4OA?\-S!\/?#_C+
M[%<C0/&&HZ=XBUJ[\2ZMHUT(S;RV5MJ-_<Z=!<B4B[M[**Y0!90BYY92QCQ6
M9RK*M&,<OQ]2NZG/&,OW<G3OS64FYN+@M;J[6ES?B#$9!4R;A=X)8/$Q6><.
M_P!CPP\J55TTL70IU*E/V;DU&CA75C6D](OW9-5'%&3^TK^T=\ -8_X+%>+=
M1_; UV;_ (4G^SYX=T/0? OA<:)XA\3Z?-XG&B6&H$ZII6C:5J*(&\37-]J1
M>1"EQ;SQVKR (0/NKX\_\%&/^"3OQ[^#_C'X2>,M=EF\.^(=#O\ 2H38?!SQ
MK:76CW4EO)':WNDW$/@]/[/N[.?8\$R!8TD0;U(7%?.WQLG\*_L/_P#!83Q)
M\9/CGX2L+[]G/]J3PGX<M'\8ZWX=LM;\/>'->LM%T_1[B;4Y+^&XM[62PUZP
MN[^Z6*(W:Z5+;SQ+,S^4OZF_'K]JW_@G]\#O@[K_ ,69=1_9W\:QVNCW%]X=
M\,^#(?A_XEU[Q;J+0-+8Z7IVFZ);W]XKWLK)')<W%O';VI<O=RPJK$;XE7J9
M)*EA,76IK+\+"@\)B5!NLI2YTG'#5?9UHUW-U5.\FG%Z0<3#+E7HPXK^N9OD
MN&C3SC-*^<0Q^63K5H82I&,\(ZU1YEAXU,.\O5&-%QH\OLX^RC>I&3/F7_@@
MC\3-8\9?L93^"M:O]0OY_A/XUU3PO8MJL$T-[;:)>R3ZEHUHXE9R8K>P:**W
M 92D2JK11,-@_;^OAK_@GM\8/%'Q^_9WT+XP^*?@#H'[.]QXVN[J^TWPAHLU
MO)/JFCP2/;Z=XBU%+;P_H$<)U6V6.ZL(VCNI/L4T9DEC8F,?<M>!F,G/'8N;
MIJBY5ZC=)5(U?9RYG>/M(I1G9W3DDDWJ?<</QA#(\IC2Q$\72CE^%5+$U,-4
MP<Z]+V,?95)86M^]H.5/E;I5/?AM))W04445Q'L!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% &9K&BZ/XBTV\T;7]*T[6M(U"%[>^TO5;.
MWU#3[R"12LD-S9W4<L$\;J2K))&RD$@BOSH\;?\ !(;_ ()\>/-:U#7]6_9[
M\/V6HZO=F]U9M%U+6M/MM0N&;<S360OYK2%">!%9PVL:+\L:( ,?I516U'$X
MC#2<L/7JT)-6;I5)0;79\K5_F<F*P&"QT5#&X3#8J,7>,<10IUE%KJO:1E9^
MECY!^!_[!'[(7[.6H-K'P@^!?@SPMKC.LIUMK>ZUC5$E0826VN=:NK_[#(G&
MUK%+8A@&^\ U?3/C+P?X:^('A'Q-X$\8Z3;Z[X1\9:#JWA?Q-HET\\=KJ^@:
MY8SZ;JVFW#VLL%RD-[8W,]M(UO/#,J2$QR(X##I:*B=6I5FZE2I.I4;NYSE*
M4VU9)N4FVVDDEKHDNQ=#"87#45A\/AJ%##I.*H4:-.G2Y7=->SA%0L[NZMK=
MWW/./A-\(OAO\"_ NB_#/X3>%+#P5X%\/1O%HOAS3);V:SL(Y"&=8I=1NKV\
M?<P!)FN9&)[UR6G_ +,_P(TOXU:A^T5I_P -- M?C5JNEOHU_P#$"-M0.KW&
MG2Q^3+#Y#WK:7%)+%F*6ZAL([N2)GC>=D=U;W2BA5)IR:G-.:<9M2:<XO5QE
M9^\FTFT[IVU+="@XTH.C2<:#C*A%TX<M&4%RPE27+:FX1TBX).*T5D>6?&3X
M)_"O]H+P)J/PR^,O@S3/'O@35[C3KO4?#>KR7T5E=7.DW]MJFG2O)IUW97:M
M:W]I;7,?EW" O$H<,A93Z#H^D:;X?TG3-"T:TCL-)T>PM=,TRQA+F*SL+&!+
M:TMHS(SR&.""-(T+NS;5&YB<FM*BES2<5!RER)N2C=\JE)).2CLFU%)M*[22
M>R+4(*;J*$5.45&4U%<[C%MQBY6NXQ<I-)NR<FTM6<#\4?A=X ^-7@+Q'\+_
M (H^&K+QAX"\76MO9>(_#6H2WD%GJMM:7]IJEM%/+I]S9WB"*_L;2Y4P7,3>
M9 @+%"RML^#O!_AKX?\ A;0O!7@W2+?0?"WAG3;?2-!T:T:=[;3=-M5V6]K"
M]S+/<-'$O :::20_Q.372T4KNW+=\MV[7=KM)-VVNTDF][)!RQYN?ECSN*BY
MV7,XIMJ/-:_*FVTKV3;=KL*^>?VK/BQXM^!OP"^(OQ7\%_#4_%S6?!>C'57\
M )J;Z3/KNF+-'#J<=O<KI6L[Y(+262X>W>Q=)8(Y@S+@!OH:HYH8;B&6WN(H
MY[>>.2&>":-989H95*2Q2Q.&22.1&9)(W4JZDJP()%.#49QE*//&,DY1;:YD
MFFXW335UI=--$5X5*E&M3I570JSISA3KJ$*CHU)1:A44)IPGR2:ER33C*W+)
M6;/Y_P#X;ZU_P16_:O\ #.B?'WX@^"/@IX(^(-] NL>-O"?B[4]9\.ZGH'B6
MU+P7]A=6:7&DZ9K0MIHG:UN=*LV6\MY(GFMX;DRVL'F/[,3^ /VNO^"K&E_%
M_P#9V\*6^E_LS_LE?!@_"G0-=L-!U#1= U;5Y]<U[7[>30DNK6UAF8ZQKNLQ
MS.DES<M:16=[<E/MJ1I^O7BS_@G'^P[XX\1R>+/$_P"S9\.M1UV:Y-W)=):Z
MGI\#7+8W2_V;I>IV6E@L1N95L@K,6<J69B?J#X??#3P!\*?#MKX2^&_A#0/!
M?ARS+M!I/A_3H+"VWNQ9Y9C$HEN9F)P9[F2:;8$3?L1%7U5C\/2IU_9+%U*M
M?#RP\?K%6+IX>%1I3Y.5MU;PO"'.H**DV^8^4IY#CZV(PWUR.38?#X;&X?'5
MZV7864,9FE?").A+$\].%/#+VRA6J1A/$R?)&G&I&+<CR']H/]C[]G#]J:VT
MR#XZ?"S0/',^B),FC:I=F\L=8TM9RK2+:ZEIMS:7)CW*'2&X:>"-RSI$K.Y;
MC?A-_P $_OV0/@E;:U#\/?@EX8TRX\1Z5/HNOZI>R:IK&J:KIMRC17-M->:G
M?7+6RSQNT<QT];-I%P&)P#7V117 L5B516'6(KJ@G=455FJ:>]U#FY=]=M]=
MSZ1Y?@)8B6+E@L)+%224L2\/2=>2BN6/-5<.=\L?=5Y74=%IH?-FE?L@?LV:
M)\#KS]FS2OA1H=G\#K]M2:[^':7VO/I$K:O?7&I:B?M,NKR:M']JOKNXN7\K
M44"/*1%L4*J^T^!?!'A7X:>#/"OP\\#:-;^'?!G@CP_I7A;PKH-I)<S6VC:!
MH=E#IVE:;;RWD]S=R0V5E;PV\;W-Q/.RH#+*[DL>JHK*52<[\TYRO)R?-)N\
MGO)W;O)]6]7W.F-.G"W)"$.6*A'EC&-H1^&"LE:,>D5HNB/&]9_9]^#7B#XP
M^&/C]K/@+2;_ .,7@S1KWP_X7\=S3:D-5T?1]1CGAO;&V@CODTUH[B*YG1WF
ML99@LC!9%XQ^?_\ P4!_:\^%7P3^)OPG^"G[4OP-TKQ9^S+\9H;BR\0?%K6)
M;W4])\$ZSO>VM(=1T*U\.W,L9>Y\EVO;'7;74+6R\V]MHIIH8[>3]9*X3XB?
M##X>?%OPY=>$?B9X-\/>./#=XKB;2/$6FV^HVP9U*-+ 9D,MI<!20MS:20W"
M=4E4@&M:%:,*U*=;VM2G332C"K*G4BK/E]G/7D<9/F22LWH]VS@S#!UZV$KT
M\NJX?!8FM5I595:N%AB*-9PG3]K3Q-%N'M(XFA3^KSJ<WM(0DI0?-"*/Q!\3
M>)O^",7['O@O7?CW\'_#WP8USXAV&DWNI_#_ $;PK?:QXL\1ZOXH2UDDT"RL
M-(U*^U!+":34OLN+V^M$NK,9FA,EQ&D3>U?\$6O@'XK^'/[%!G^*V@G3=9^-
M?B'Q)XQO_#]Y:S6EPGA;Q 9UTRTU&&1Q<QS3V%[<)-'+Y<T:, =IQCZV\$_\
M$XOV'/AWK\7BCPA^S7\.=,UV&[COH;VXM-3U@0W<3B6.:*TUS4M2LHRD@#*J
M6P0$#"\"OM6***"*.&"..&&)%CBBB18XHXT 5$CC0!$10 %50%4   "NNOC*
M/U66%P_UB7M:M.K6K8F<>9^QC-4Z<(0<DHQ=24G-R;D^BZ>5EV2UZ6/I8_%T
M<LPBP=#%8?!X/*:<XT(_7)4)8C$5IU*-"4JLUAX0C"--0C&[<IR=UY'\+?@#
M\'?@GX$U/X9?"OP'I/@SP'K.HZ[JVI^&M,EU"2PN]1\31I%KMR[7U[=W*-J,
M<:),D4Z1J%'DI'S5CX-_ SX3?L^^%;SP1\&O!.F> O"FH>(=5\5W>B:3-J$U
MI-XAUP6PU74\ZE>WTT<MX+.V\R**5+=/*'E0QY;=ZQ17G.<WS7E)\SO*\F^9
MK9RN]6KO5ZZGT<:5*/)RTZ<?9P=.GRPBN2#M>$+)<L'RQO&-D^5::(^-OV@/
M^"?W[(W[3NKQ>)/C'\&O#_B+Q1#!);1>)[66_P!%UP02[?,22[TJZM4N2Y1"
M9;J&>8;1MD R#J_L_?L,?LJ_LO7,VI?!3X/^&_"6MW$*V\WB BZU37'A7.$3
M4-3N+J2VR2Q=K1;=Y-["1G! 'UI16WUO%>Q^K_6:_L-%[+VL_9V3NER<W+9/
M5*UD]3E669<L2\8L!@UBVW+ZTL-16(YFN5R]MR>TYG'1RYKM:-V.!^)?PM^'
MGQC\(:EX"^*'A#1?&_A#5U"W^A:[:"ZM)6575)HF!2>UN8UD=8KJUE@N8U=P
MDJAV!^&- _X)%_\ !/GP[X@LO$=I^SSH%U=Z7=1WVDVFIZOXBOM,TR[C.5FM
MK*75=LF> \5X]U!(%4/$P'/Z2T5-+$XB@I1HUZM*,TU-4ZDX*2>C346KW6C[
MK0K$Y=@,9.G4Q>"PF)G2E&5*>(P]*M*G*$E*+A*I"3BXR2E&STDE):JYY/\
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M_"CX]^$+SP'\8? N@^/O"E\&$^D:[;-*BEAM,EM<P207MG*1C,MI<PN<#+$
M"OC#P9_P22_8!\"^*=/\7Z-\ M$GU?1Y(Y-&35M5US4=-TIH@!&+73)M0%FR
MIM!VW45R&QA]XXK](:*FGB,12BXTJU6G&2:<85)133WT32UZE5L!@<34C5Q&
M#PM>K%)1J5J%*I-)--)2G%NR:32O9-76I6L[.TT^UM[&PM;>QLK.&.VM+.T@
MCMK6UMX5"106]O"J10PQ(H2.*-%1% 55  %6:**Q.O;8**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCKO]YRU.)XPBY1P<ZJ6ZI5>9].OLU&^^C=_)]?\ 9'I,CU'YBO\ &U?]IO\
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M /#R?$7T_P"QCIR?M7_M2G.?VE?C_P!O^:R?$7W_ .ICH]A/O#[W_P#(^O\
M3TKZW32O:=M/LQZV_O\ K_2U_P!IZBO\63_AJ[]J3_HY7X__ /AY/B-_\TE'
M_#5W[4G_ $<K\?\ _P /)\1O_FDH]A/O#[W_ /(^O]/2?KM+^6I_X#'_ .3]
M?Z6O^TW17^+&W[5W[4F#_P 9*_'_ *'_ )K)\1O3_L9*K_\ #5G[4G_1RO[0
M'_AYOB/_ /-)1[&?]WY-^7DOZ7R*6+IM7M/_ ,!CY?W_ %_I:_[4E%?XKW_#
M6'[4W_1ROQ__ /#R?$7_ .:.C_AK#]J;_HY7X_\ _AY/B+_\T='L)]X?>_\
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M-U'HGA+PYJ<+NW[NVU6.)$7:[R?RG X7;^OTQV_SUHA*UG+2*2MUZ;V5^O\
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M_B.<4U"/Y;_U]^AT+#4U;?\ 3==NEE:VOD2-*[=3_//\_P#/XU'116MJ??\
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MA2!#W/Y=Z801U&/KQ4JE3;NZD4G:R;72RVNM/ZL*E1HROS./1JUG;;T?1/\
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MGS_W-.G44&L-GZ_HC_9DHHHKSSTPHHHH **** "BBB@ HHHH **** "BBB@
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MND[*2DWTUNM].[.3P2V&)&><9S_];].WTI<E2%'3(Z]>?_UUL7-BUOCCTR"
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MP^(K3?/5@Y*E^YC34JE:*N^54E'9ZMW;T/ I]%WLRZ= ;B#JT_E[MAYX+$8
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M_E2 D@9X-+M8\@9'?@G'XCUXZUI*UM79::[=5;7U-9*-VY-*.EM4M=+???\
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MG3]K5Y*>%I49TH.HI*E6GB*U=?NZ=*JDG*FI)I<T592M^N?_  :N>%+C2O\
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M^$0C+=&/'O\ _6J3R^  >0.<D?\ ZS_^NK5K:75WL6W@EFDD?9&B1N7=B>
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M1^K>RIXJ@DITHMJBE4G&+4IQE%_G_P"-/V.O&6@:(FMV22WULRN\^S[.5M@
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MN;>IW'.]+&RHS<XTZ<G+!5L$U/F:4:^'GAY5%:2:J1C4<H:N*DES1:O%\O\
M94/93I^UE[^;4\UO;:<,92Q7LDDU[K]GR7N]V[6]T_*O]OQ?^,MO^"9DF4 7
M]H/4P0SHK'=I-JH\M&(>0Y8;M@8H#N;"\UP'P0\1^*_!G[57_!4KQ9X*\*-X
M]\5^'#IFM>'?!9G-A_PD^KV/AF&\L= AOFCD6*;4YXH[2.0QF.-I1N88-?LG
M>Z-I&I7.GWNHZ5IM_>:3.UUI5W>V-K=7.F7++M:XT^>>*26RG9?E:6V>.0KP
M6QQ3K;2-*LKN]U"STS3[2_U)E?4;VVLK:"[OW0!4>]N8HDFNF10%5IWD*@
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M]U\]3:CTR[DA$JPL5W! ^Y#R1G!&[.3UX%7([*[<$6P59%.W#G:'/=$8@+N
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MEJCRN "^D,=B6\^=BT5LNY2R@[F(9L(,+R=S D=.:[[3?#U]+$;<Z-*\\D9
ME=X55"RXWY9PKA3\V%8D@<#M7"VL]M::A;1(Q@U!B8XV(P 6^4C!(//(^G7-
M>LZMJVL:/:VFGW=W''<2[#&T87?M;&TD9!'I@\'DXJ<<JT53IT(QE":4^>7/
M[1/9KF@XQ<$HIVLVVW?=)<6<U\='$8-85TXSJMP5.K*M!6IVDZJ5*TJL(QW3
MJ)MMZ6N<C:0W6C27>E36:".Y+!Y7A!"9R>&&[IZK_6H-3L;;0-5DNK*$SQS(
M PC4R",-C)&T'H2<E<^_OU%EON7$FL7\30,>2I0R $?Q*&W ]#R1SVR*SHD7
M4]7BL8KH16DC@22(#*RQ@G<^Q,G 4;C_ #XQ7/#%RM4A52DE!.I*/.H:?%:\
M;J35KQMJTK/1LSCB\15QE1V7LJ>&OF,H>V6'JJR2=.4HJ4:FCO"*DM(W<6W>
MA91.D4VHHZB&XW#!*[T+J1@Q$^<",GDH,'KCK7"3>&[B6\N+F1XF21\QJ9(R
MY9B=N8PY<+V!*CCKT%>CW\NB>&_$5Y:?:)-3TZ*&0QR(IQ-*$.UMI8@-N(^4
MX/'(ZUE6UL;_ .TZE9 E#@QVSHXF#*V21\A7//3.>#D<5TT*\\.JE63Y:=2"
M5.<H_:ERJ$9=-+>]+31]-+]CK8FBW6H^T4*RPLE.M22IRI-J*IQE%1E3JQ6L
MIR?+RK6*Z]CH6D_$'P+;Z1K]W;S6&BW#,EO.5C9)HB4#N-K,V(P5^8KCYLG.
M*[O5(K#6Q]OMIEN+B,)<R3>655)^BYW!=V=S$A<C\!7%6?B[5]1CMM'\1WUW
M+I%JNV"SGB8)$7(!$1;"Y)4;O]WOWZ_4-$T[2K.WN-+U!V-XGF)9X;A^ROC=
M_"2!V^F*^>Q3JNJY8E4XUGS*,L/&2ISAO&[E?]XHZ2E=J5^RL_E,XG%9EET^
M3ZEFDZLX4JV!PLW@L91G%3E2Q%1PE-SIIN4Y\W)K><E'0ZJXLKW2M$L-9DU*
MRU*X;+16%G.KW$87 (FA7YHSM8D;NO')Q2^'O$=[XG>^5+>6U-G@3RLI$<:*
M/F)< KP!TR6.#@5QUOI(CL)KV?5A9WSK^ZM&G7<X4AF"([ 990P/RYQTZ<6+
M*$/:I+I,ES:7%R6CN[4D"&4C@SM+D*<Y/RYSVYS7)&,>67+K)M6DT[1^%N]D
MDXVNE9JS1\CFN595BL-BGCOJ]7'NNJ.#S*.'GAJ6#<JL:M2+I<]2C5HR<:L8
MUU"5)U>:554XM-_TX?\ !N%K7@B?]MW6],TJQE/B1/@AXL>]U3<?(G1=5T4L
MH1PK@[< -SG!SC()_N<K^ ;_ (-F=)O;/_@H5XEFG:1X_P#A1?C-=Y#%,G4M
M$"C=C;ZXYP>W3!_OYK]&X6@H95&,92E^_K2;E)R=Y.+:3?17LEM%*RT2/Z"\
M*LMPN4\&X+!8/&U<PH4\5CIQQ=:493JRJXB52>L(4XJ,)2<(I05E&WDOR1_X
M+M_\HE?VV_\ LDY_]2/0J_R5S]U?^!?SK_6H_P""[?\ RB5_;;_[).?_ %(]
M"K_)7/W5_P"!?SKZ,^MS+^-2_P ,OR18/W5_X%_.FTXD%5P<_>_G3:#R._KI
M]R%'!'U%3 @]*@J5.A^O^%!,U>V^B?YK_@C</[_G_P#7J= ^!@'IW(Z=SUXS
M^OUQ3,CU'YBI%#'  //U]^XY]>/6J7PSU@O=M[][:M;6:U)3U5UH]'J[V=N[
M=NCO;H:%JJO)&"4(9]KKM)<+NP3R,'KD8)/'2O7/$/A?P=:^&-/N](U)KG7+
MI@;BT,%R/*( R%=XA%CDDXD!XP<YQ7CUG:74DR""*25F8 B-))".>NU%8@#(
M'/&/7&1]-?#OPI8V;1W_ (EDFEMI=ODVT43R$9X)=64^6P8K@,!QE@<"OG<Y
MQ%/+U2Q#K2G92?U>FU>I.222VDTHNTGM9)IOJO*S;'+ T7459MTDJBH4(2G7
MQ/(XR]C"":NY)))M62=WIJ<G9_!S4M0\-Q:Y:7$<US\NZQ#QK(JE7.\M(Z)P
MP"D!CC<.!VQ]%^'6J:C=O;7J&"6'YE@WQ.\JCE@NR1E.!S@'.U6..U??'@_X
M?>(KNWN=0T#2DGT,QD8N)8HD\L-&Q5!*RAI H^Z@9MNX[< X[_3OA[X;O;Z&
M34)TT&=%_>S80P*P7$BB;Y4RR[E WL2Q R1G/Q-;B^K%5US8=NFG=4E.K6H-
MJ+7/3IU)SYDG=)15VMK:/^><W\>\/DF.Q>!QE#ZW&HY/!5,$DJV':2_V3&TZ
MM32HJC]E.</=@TVH-JQ\@>"_!^@Z5-+9:G9QR7%WA(PT2NQSA QV;]N"Q)W;
M<]^^-GQ_\#AI-C%J.G"VSJ,8D2*":UE=5)/^MB29GB//215) /IS[9XF\ 6V
MK>-=/TGX<7$VJW21DS3.I5',?[R4Q$_*44*2') R,#=D$T=1M;/0O$5MIWB/
M5C (F$6H\B18'!821H-Q4D< C@@C!!ZUY,,VQ4ZU+$QQ56-25-8FK1G&I[:5
M/:#E0<DZ=Y*VL&VUR)<QQ1X\Q^,S7+<UX?S+$5Z^/P-3%XWAFO1JXF4_JZBJ
M<(QI12PT:D(\].LZDHSYU-J,))/YB@L] \+:<D&O:!<+<,AVWC ';N4#> F_
MAC\PYR<\UY!KWB#;(UKHTDD-O()-TP#AG#,Q"GY=Q #;<D  #&<#CZ8^-NE/
M)$TMA>?VA9$,;9X8F8FW&?*R45AD)MW \@YR.M?)FGVMQ/=M$R*J(3C>".1R
MW7G@D@YYR,=N/L<FY,32^NXB7M&YISI2;4;74DU"24HM<S5F]-=%9G[-P5FM
M//\ *GFTG4C7J^UE7PU2K.I1HUH5)1<5&K2C*+A+F7+[RT=F[)FSX;\9W&CB
M.$6RB:.1MU[(=S8;!X&&8J!TR"<DCCO;\2%-=O(;Z*[6]DG!\U%1XPF,=1,D
M6>20,9SM].O#ZC93I+,Z@A8Y"I(W8X(/W@I'<<$^F.O/8^%;-YV/F$KM52H8
MLNX$9R,CD'.<C&?PK];X"X8R[B'B6C+D:]FDU33BG:\+1GS1EIU:5NVFZ^DJ
M892G1JTI*C4JZU7!I\\9)2:4G&6S6RLEI==[%GX>MHPKS$ C(.45L9/;!(ZG
MC\^IKH+;2+% &C5"0,C$8!..>_ Z?_JQSJW6G,D&Y3DY4 #<QQZX K',DL)P
M0<CC!!.?7KC\??%?U=3R; 9+.-.>748I0BU/D][MOLDK7V779-'8H1B[OF;C
MI&3UELM+R5UIW>NN_6V]JBGB,8]<+R>G^?I^%-U/3K5XV"1H3M_N#]<D<]/?
M\,U&DTCXR/0\*1Q^?_UJDGO-Z%\' !.["A>,YZ'';/7ZUVMY?4P^(C*C!JI"
M+A[2*;C&"?/RV4;/6+;=UL]DS10C4:27/>+=GKHN6_WW[_)HXFW\,W^K:M!I
M]K&[W%PY2WACPSOD$A5 )Z=B>,#CO75:!X6O=+\5VNB73"VO9)8ED6;:0%E;
M"_,I*L?4*2WK@5[/\';6QLY)_%LYCDNK1,0;R#Y:$8\Q$;^,#C*DY/.<U]"P
M^!_!T\UOXETJ^&N7.KP^9<SW,9M5T:XCYDS),2A,;9 8-M8#/7 /\)>)^>X&
MAQ%C,)EU*:HJ,Z=2J_>MBGKHX)4Z=.$$Y6DKRDE&,K^Z_P /SKQ5P658C.\)
M/ XV>$PU"I@L,Z.'55ULSE94Z3E)QIQI1@Y5+-<\DDHRE:SRM/\ @M<>$=6T
MK5+^\M9(+V*.5Y+1U#6\<C(0) VPJS @@8P%')&,5UGC72H?"E_;S:%=31W=
MU$LD=U+/#*TD<BG*(UO))Y;$X;,OE@!6&<XJ"'QEX!:0Z;XJ\2RP?889566*
M:&59RF#&H)F!01[=J_* 0PY  KPCXA_%SPMO,6CRSW-O$&@MY6:)WR <,P64
ME00IP1GK@=@/QRA2Q^+Q-.G4CB,0XPG&JWAIQPU:,Y+V34Y2<6XI>\E?1^\H
MMV?XUE.5^(_&F>8'-,UPF+P]&E!4:48X.6%P\L'"%2I0=2%:+A7A.<TVJD5)
MJ*M>:O'I)O&FI^$-7@O#+<7\C2&XF<R&6.%MI)) W ^X4-R>_2MW4OVBTUBU
MN6O;VUMHDC91(%D1Q(B': GDB0MD# 5>6'&3S7QY9?%N:UNKXWEH+^*971$E
M*\!@0#][ VD@]< C.<5Y-XAUQKVZEDC18(YG,GEHZ%02<X(5SWQVSW(KZ[#\
M)TZ^(H+$45%J$7"O%4^:/,USP2G%M)-1:<5RV337VC]RI>$&29_4CBN)LMIS
MS.A"C2AC,-6]E2Q-.')+]YAJ;C3=2$5[*[7(XJSA*2;/:?%'QR\67=W<B'6+
MB:S0D6JB212XSQ@/&-HP!@,!W/.:\<U_QEKGB,;M5U"ZF '$32;E'MT ]L\_
MTKCY+AFR=P[>Q_+)SSR1QWZ4W.%!*MDXR%&,C'H?0U]QA<GP^7\KHT*#<+6D
MJ<6UI'O=7=WO_DE^M9?PMDN4*A_9V4Y?@9T(QC3J87"T:4TE&"=Y0A&[E:\V
M]9/5V&L>I"G'.03R/Q_/I4>UB.0<Y SR3^&,]/USZXJRD;2L-B/R, [23QQC
MC.?_ -==%9>&M5O$WV]K,Z#[Q$,[8]R5BP%]_;'7FO3J8BC02E6JPBVEHURV
M=HNS2:5TVEVOLGH>[4KQI*]244W9_P L=;:.^SN[6NO)Z'*A)& PG09XX)SW
MP3DYQZ5-;V5U=2>5;P/(^<;>%R?0%RJD^P->G:#X)OY[P0W48AC<#YY28NF<
M[?,5=Q&1P!Z9Y(KZO^'7P4T";PYK/B";58GU#3"L\=A+M4RHN"64L!G;@<;6
M)_ 5\[FG$^$RZ#D[5')PC2Y(RE&4IRC!7Y;\JYI)-W23:;=F?.9UQAE63495
M<343G[BA"FI23E-J,$[)J*;W;DEVZ)_#5SX=UC3HUEO]/N+:,H)%:5 %<$9#
M!@2".GOBH8+*1W5C&2HP6Q@_*?;G/&>G;OBOM+XHWDGB;0M*L8K*PMA8)]F=
MHO*2:6-6P&DXW,2/XL$]\"N3\0>"? .@_#[1M<TS6Y+SQ7>.R7NE2J-EOL;'
M)W<*<9&0.F:G"<3RKX)1JX:$*V(J24.3FE:,6HWNY=6F]WMKLSGRWBEXW#4J
M>(P\<-B*^)J8>I0A-UITITG&W/--1A%K5-IW6VB=G^%/#7ABV\+VWB%IK>TU
M:PE65+.1"99&3D$#;MQD9R6[CK7T'X3^.GA_2K2[UNX\@>)DM@VF*;:4E)RN
M-VY(6A5@"<98*#QGU^!)]7O'!6:>5<#_ %<88H??Y3M.?H<^E5>L:R+,X+J&
M(W/P2 <8)XY..#QW%>-BN'?K\)2QN*K3IUZEU23NHQ;3E2<;?PY6LV[WC==3
MY?B#@?+.)5['.GB\93HXU8O#<E>5)4(Z<^&C*/-&M1J)M252%[-\LT[-?=J?
M&?3/$3W6J>.=0U"^U21E2""!Y! L8;" G9T2/MC!8'!ZUZYI?Q<^$7A_3;2?
MPW!)#K_E;KFXNEF"S9P&0-Y:KWQU^;IG-?E@F68AII, 9'SMU'/'.?8?G5N"
M^GB+PQLQ!&XO(^"/0!G8=1SQQGW-85.!<+7A!0KUE2IVMA*$W1A*'*HJFZ:3
MA[-+5P:::6R;3/G,Y\(N&LVP\\%">8X'#U)1E4PF&Q%.A@/9J<)Q@\-1HTD_
M9N+=-^T4U-\TI5;**_3\?&W6?&%W#:QW$>H$.(;*%0SK;K(?*55!3)'S\'GN
M<]<^M7'A#QMK6GSZ%JGB$64UE:K?6=DLP,,[,5*Q-/&PA4J.,2,VQNN%&1^>
M_P "/&NGZ1X@TT7J!'6[B'F,8V7.\9(R^>!E@,'D# Z8_0[PMXTEU?Q-J.E6
M=N=6TIXI)WO9MJ7,$2Q_/MRQ#)N.P*.1O!!]/S_.\!6RJI*CA,+AZ-/#0G75
M2="DK.,X*].Z5*#Y95>=7C.KSOEG"<;R_F3Q8X+AP/G.#CPQETJ&$P>'H9BL
MQK?[1*K6I5HP3IO$2JT9.%14HJBX3YYS]Z$D]/*?#NK^*]&UA_#GB-=3NM&B
M:47-IIM[#,"J\[PT,S0DA1O.'Y (/.:ZWXC>#;;3_!#ZX;J;2[N]8_V;"R1B
M46Y1G!NWC<J&50"V26)X(/:'Q#K\*ZT^F^%[>2W4RXNI7A+W,S[L/&A +LC9
M*A<$N>Q'%6KKP/\ $#QIX<UN;496N=*TRR>80SNT<L$8PN?*8 Q* <%G$?4#
M'&!S5INF\+BZE>CEM*<Z3Q$:K495_:/EA&-.5Z=.I4JSC&3E*I4<%&',G:WR
M.$S*.*XFX<SS$X;+<EE]:R[$XW#8&A4A]>A3Q-+VU>6$FZM-^WI1=2=*/LJ4
MX1G+[2;_ " \9:G?W&K7D-V3((Y9%,ID#!L.WS 8SSU&,YSUY.>%8*#P<CZ?
MCGG'7KG [5ZW\2]#32M8OHE*,RRL,*^_A25/0<\J.3ZGK7DTF#EAC;@''TV@
M_CGIG]*_H'*,1AJF64W0HTZ<YJ"NN>UN6.RE.5OQMT=C_37!5J$\#AW0BHQJ
M4Z,X.-XQ=.48RB^6_*G9VLE9;[ZD;&,'@YXY)4]>X''05$Q4XQCOGC'I2'MU
MY'.?7O\ K25WJ/(E'716UW_ ]"SC9/=6OVZ7_#;U"BBBF/U"BBE )Z GZ TF
MTMW;^O\ @@?7?[ /_)[G[*7_ &7KX9_^I3IU%+^P"#_PV[^REP?^2]?#/M_U
M-.G44N>/]?U_7KH=>'7-"5FM)?FD?[+=%%%8GNA17YM_M^_M[:C^Q/J?P3M;
M+X77WQ0/Q=\4:AX/M-*TC4_L6LMX@N-'U'_A%+&Q@:RNDFBU;Q*FDZ;J%TTD
M;:;I]U=:C'!?26JV5Q\N>/O^"E_[5G[+FI>"/%'[8'[)FE^&/A1\4]1GT'PG
M>?"OX@2>./&&B>*9M%U'5- \,:SHFH>&/#,-]JFN7%FEM_H-\8;*W%W=M)-+
M;QVEQZ=+*,;6HT:].%)QQ'-]7C*O1C5KN$I1G&G2E-3DXN+O[JT:UNTCQ*_$
M.5X:OC,/6K58SR_V7U^:PV)G1PD:U&->E.O6A2E2A"=.::ES-74D[.,K?N/1
M7XPZ]^WM^VC\()_ 7Q-^/_[)GA;PK^SOX]\2^'_#]WK7ACXG2Z]XU^'MKXNU
M"VT[P[K'BS2+SPEHU@R7$][9K>6MEJDPLQ,P-Q+,J12?8.M_M;7^G?MH_"_]
MEVQ\(6U]X=^(OP<\2_%)/')U9X[BTDT;4O#5I::;'I*V$D<\=Y;ZX\[7)U&,
MQF%%$+ARRXU,OQ--KW:<XN%::G2JTZM-JA%2K)3A)QYJ:DN:-[NZ:NFF]_[8
MP*BI3G5I-XC"X90JX>O3J>TQU6-#"OV<Z:G[.M4DHQJVY$U/FE'DE;[=KGIO
M%OABW\2V7@R?Q!I$?BW4=,O-9L?#;7]O_;5SI-A+;07FI1Z<)#=&QMY[NVB>
MY,8B\R54#E@P'RM^VE^U'J/[*OA;X-^(=-\)P>+G^*/[0/@#X+W-M/J;:6-)
MM/&>G^);R77(W%E>_:I;%M!1%LRL"RK.S&XC* -^2'Q"\<?MAP_\%E]"G\-_
M"'X?ZKKFE_LS:YI>@Z/?_$W6-/T6\^&E_P#$#3S?>+;JZB\#WGV?Q-'/:0P)
MH4=I<0M"?,.L*%V-K@\LK8N,YJ4*5..&Q.(A.I.$546%4?:07-*-FG.-WT3V
M9PYKQ)@\LJTZ'L\1B:[S'*L!6IT,/B*KH?VM5=.A5DZ=.2<;1F]'9-)2:;2?
M]'-%?F5^T3^V9\=O#_QA\-_LS_LR? 2'XI_&>Z\%6OC;QQK?BG7[SPI\+_ E
MC=2M9Q6DWB*+0=7NM8O3=PW<DUO;Z=;R1V:VDT NGGN8K+,^ G[9_P"T"_[0
M-Q^R;^U9\%?"_P /_C#J_P /=2^(_P ._$G@'QJOB7X=^,M)TV>6QN;-[C5=
M)\.^(=,NTU!4M8Q'H>I&3;<RS"VB2W:ZR67XB5%5X^RDG3G6]E&M2E75&G=S
MJNBI.HH))RNTFXIR2<5<ZI9Y@88V.!DL6ISK+#+$?4L5]1^LN,91PSQOLOJR
MK24DE%U.5S3I<WM;0?Z36OB[PM?>)-3\'67B'1KOQ7HNGV.JZQX=MM1M9]9T
MO3=3EN(=.O=0T^.5KFS@O9+2Y6U>XCC$WDNT>Y1D\)\/OCK\,/BEXL^)/@?P
M1XD76?$WPDUZW\->/=.&GZE:'1-8NM-LM5AM3<7MI;VU[NLM0M93+8S7,*F3
M8T@=65?P=_9M\=_MHC_@JM^V+,?@Y\,;K4-2T7X):9\0-.D^*.M1VG@_P1;:
M=??V%K7ARX/@&4^(-0U2WDN+F^TZ>'0XK*Z#6Z7-TO\ I3?I-\!/VIO!>K?$
MK]M^/7O /AKX8Z-^SWX[M[+Q/XVT^YCGNO&=G'X,\/ZU+X@UM$TVQ:&\MX[U
M=.CC>YO=T=K#FX12%3?$994P]UI6_P!CP>+O3G!^S6+5%QC.*;;:E5C!)6D[
MQG;E:./+^(:.81A4Y*N#C_:N:9<X8O"XBFZRRV>+A*=.I.-.--2AAO;RG-.$
M$IX>259:?HS17XS>&_VZ/V[OCKH-Y\7_ -FS]C;P;K7P,MKW6'\,WGQ&^+U[
MX3\=_$WP]I]]<V]IK7AW0;'P!KVGZ7_:%M;BYMH;_67AF62,PW4L3I,W:7/_
M  5%T+5/V'_BG^U1X;^&^JV?C_X+3W?AWXG?!7Q3=3Z9JWA/QWI+&+6/#LNJ
MV^FWPOK=)$:73=0MK#?=6KP-=V>GW336<&']GXN]O9IM5:=&:C.G)TZM5\L(
MU$I-PYI+EO)**E[K:EH=$.(\JG*JO:UX1I82KCH5:N#Q=*CB\)1IJK5K8&M.
MC&GC8TX24I1PTJD^5QFHN$HR?ZRT5^)TW[>_[>7CGX8S?M'_  ;_ &,_"US\
M!K+39O$ME:^/?BC>^'_BEXS\'P1FY&O:+X7T_P #ZWIUA]LLE^V6EE=Z])+)
M"R;7+.!7Z8_LN_M"^%?VI_@9X"^.'@ZWGL=)\:Z3'=S:7<NDMQH^JQ 1:KI$
MT\8$=Q)IMZ);5IXPJ3&/S$4*P%95<+6HQE*<8VC4=*?+.,G3J)7Y9J+;BVD[
M7T=GU1TX+-\%F$U3P\JZE.BL32]OA<1AE7P[<5[;#NO3IJM33G!2E"]N>$FN
M6<)2]OU?5],T#2M2US6[^UTO1]'L;K4]4U*]F2WL[#3[*%[B[O+J>0A(;>V@
MC>::5R%2-&9B #7Y[Z!_P52_8[\2:M)8Z=XP\6?V0=9TK0;#QE<?#SQE#X,U
MG5-;URS\.Z9;:3K[:0;>[>ZU6_M;< *AC60S2[(4>1;/_!4?Q'\9?#G[&7QT
ME^$GA'P[XEM+SX2_%6V^(FH:WXEN] O_  GX*_X0'7&O_$/ANTMM#U9/$.N6
M8#/:Z-=76B07+JJMJD 8LOYH? #]H'XF_ K_ ()_?LPZW\4_V:_A%KG@?6-?
M_9^\$_#?4(/%4MWJGB*Q\9>)M&TG_A-_$.ER>!4M]%\0::]Y%JB646IZP'O(
M5C.JJRK/7;@L%2KTH2DIU*M;$2H4J=.O2I-<D(3E*2J0DY<WM$H^]!*TFW+9
M>1G&>5L'F"P-&<</&CEM;,L1B:^68W&T'"%:E1C2C4PU6C&$O?E)J]2<K*,8
MIWO^\G_"\OAE_P +;TWX&_\ "1K_ ,+,U;P=<^/;#P[]@U'=/X7M9[.VGU$7
M_P!D_LY0DM_;+]G>Z6X/F9$1"MCUNOY^OVL?VB-6^ ?_  4W^&NN^$/AEK7Q
M3^(GC7]F/6O"'PT\ Z*T-A;ZWXLU;5O#EY:6&L>(Y)+@Z!HUO;VMQ<WNHIH>
MHK;V]NTTJI&K8]YA_;R_:N^ _P 0?AW8_MM?LZ>$/AU\)_BOXGT[PEI'Q'^'
M/CV]\8P>!_$6O13+H6C^+[*]\+: 6^TZBL&G7&I6\Z6D#7'FQ^>RK"^4\NQ"
MA0G!1DL105>E%S@JE1*4XR4(.7--IPDERK6S2NTS:EQ)@UBL;A:[J\V%S)8"
M=6A@\54P^'<\/A*]+Z[B80G1P[G]95IU9TXJ#A*2@I)O]C**_)G]LC_@HWXZ
M_9U_:#^&O[.WPM^!,_QN\:_&3P+J6L?#RTT[Q*NAI<^)K;4-&,4&M7$ND7\>
MF>'8O#UQK>L7&K1B]F$^G6ME]@$5Y+>V;?$7[>GQV_9^^"<.N_M.? ?3+/\
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M<K_*D_X.)AC_ (*R?M*<CFY\.''/_0)C]L?K[5K25W+5+W>O^*)Y^8_PH?\
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M[WVT^9NB64<NQQ[Y(S^.!^M*)MQQN!SVP/\ XHUCKJ"DXPOYD?U-2I?*6 .
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MO_E$K^VW_P!DG/\ ZD>A5_DK'HOT_J:_UJ_^"['_ "B7_;:_[).?_4CT*O\
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M_L,$?7L1SZGI50O)74.5]'>Z2=KI/TZ_GL'-%? E%]TK6?GUO^&V@Y+,2<#
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MS7,$$FJZSJ,]NFBV6G&7=Y]\]ZL5U!% DDQ2VDEC0B,L/R#\.7VE> /VMO\
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MODE\4N:,F[V5E-I*5MU>[T9WWB#58]6N(5L;9+:&.+"PQ D2N<;W.XD_*5&
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M.:]ZA7J5'*<IP;Y8\L8M+ENYK0P)?B)J=Y)#IA$J7\<G[M][!B0=H;.SC)'
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M^;).. ,$\DD  9&2.:SV4>85[9'3TQGMCK5QOE+!N"&(/L<D<_CU/'.>E1'
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M<NZU2.WU_P <:MK=P9O,-HK1")TAQ\^&=BS, #SNP>V ..M<>+F<*R;E;?\
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M"6P\,>*-"\46%UI>M,9?/BMHM8L;.[EGTJ>1'FAN4CDMBDZ1FOE3]J_X ?\
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MSV&Q#'/:W$9>)_#?!/\ P3F_:D\'_L6?MR? K5;OPSXR^)OQI^*OB/Q3\/\
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MP6H#C=P..QZ>GISQV/'2MJ:>.SMG5 H)3ALXP01T/8]?4]<YJFLJQAG<?P'
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M7?;3\$(6/(Y/U)P?\]!ZG@=*D3:3\_Y9_KD<_P">:B;..,8')SGMS_2A6)Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?T-1/A.!CIP._L,=?_K5W7B;P^="O7M1*LJHS!9%VE6 ]UX/;]>O?B98_F+
M].O XQ]03QT_7IT>&JK%1YZ,FX-72UT6EW]YQTJT*D(3NI*:YHR2Z/5;ZK?;
MY)%;;D/N!Z-SV_#O].U1;%'4'\2>GZ5LV5H]Y(L,: R2D(@QU9L*,Y]21STY
MS[U8UG0;_17CBO8@DDJAHT)ZJ>0<CG!!XZ#)_&MX8FG[14VHMVV:U]6OU5_T
M-858P:BY)2>JC=7:T;=GVV;Z6.=CC+-@C@''!QD]OPS_ )ZU&RE78=@2 /0
MX_'W.:U8D /( YX[GGMQT'^&#VJ.: -N;IDGGC(QG@<'CCVHYW&K)W?+;3M>
MZ>V]K&\:JE_6J6W_  ;Z]K=L\ $>X[#J1ZCK^/M^J-CC'I_G\?45*T13E23C
MOCG]./T&>G-1'KTQZCW_ *?2NN,E*&VO>R\KZ_EON:*2:LK?JOZ^:$HZ\#O1
M3E^\.WO^%&GVKVZVWMUMYV'^/IO\@V,2%'5C@<9ZG';O^=>E^$/AQJGB::)$
M@E:-RN7$<HX8C&"O'K^&/Q\Y1@)5/H>."?FSVQW]"/Q]*^Q_@SX_T'1[2"&[
MBMVO(MH ?<-Y!P<X' ]AV. :\#/<?BL-A^? 0E)MV<E%N4=%[V^U[7O:U]VD
M?+\;YKFV3Y!B<9D67?VECZ=)^QP\;*<JDDK3E)+F<8.SE%/7O;;C/'G[/>N^
M%-+LM4CCDDBFB\QHC'*SE0%)9>2<#<!SQSG(Z5\X75K);3/')&T<D;'(8,""
M/8]STP>GX5^KNL_$K1?%QM+*3[(Q:#R$@DW+$F5 W*6/&,<9)XSDG)KX5^-/
M@Z+PYK,DZ2P/%>MYJBV:-@@9 0/W9X&3WYSSD]O"X:S_ !E6K'"YBH^UJ<TH
MR@M5[_PW6ND;:MI-II,^#\*^.N),\IRP'&>4ULJSA.<\/ST9T8XJAS.SA%IJ
M,Z=GO+WX)2[L\$51@@^IQV],D=*CJ5!("_F+@$YCYR2A P3Z$G(P., 5%7Z)
M)KV<91;::NI/5M-K=O<_<9PBH[)NT?>:NW>W5W;"BBBHBDU=ZN_7Y?U]_<RL
MELK!1114S25K*V_Z":3W2?J%-!.XCM@'^7\\TZDP,D]S_P#6_P *@++LON0'
MZD?E_4&C'N3^7] /UI:*"9)*+LDGW25UJ*#CIU]?S_"EW-Z_H/\ "FT4&-O[
MTOO7^7E^?=A3MS>OZ#_"FT4"M_>E^'^7E^?=B[CDGN?\]Z7>W^13:*!W6U_Z
MT_S0\.>^3^5.WCT/Z?XU%CW ^O\ ];-+@>H/TS_4"M8Q32;7]7_X']78U#FU
M2O?6_?;OZ6^_S)"X/&#^..G?OZ=/>FY3^Z?\_C3**KECV7W&M*$4GS+JMUZ>
MG3?SOU5A,CU'YBC(]1^8INP>I_3_  HV#U/Z?X4679?<C3EI]ETZ>G_!_'LK
MOHI ,#%+19=E]R)M'LON04A /!I:*.6/9?<%EV7W(;L7T_4_XT;%]/U/^-.H
MHY8]E_7_  WY]V,*3'U_,_XU*$! //('I_A3&&"16ZBK+1;+]/Z^_NS>R6R2
M^2_KHAFT'J,_B?\ &C8OI^I_QIU%/ECV7]?\-^?=C(V4 $@=*CJ9_NG\/YBH
M:RDK-I>7Y( HHHJ0/KS]@'_D]S]E+_LO7PS_ /4ITZBE_8!!_P"&W/V4N#_R
M7KX9]O\ J:=.HH-8;/U_1'^S'1117GGIA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7^55_P<1<?\%9/VDR><77APC\=)C/<<=3^/?T_U5:_RJO\ @XD_
MY2Q_M)_]?/AS_P!-$==6%2<IW6T/_;XG'C7^ZBN\_P#VV7^9^(SD-TR.,<_C
MZ8_G31\N<LWMSP/S_#]:*0_3([]/;'4_6NFK!.#26NEDM-;Q].QXTZ<+-\JO
MWZ[J^OGU-6RU*2+:I&4'S#@;MP(P<GH/Z'\:Z/[7%=)(TH.6CPH!  <8 8Y/
M(ZY'/J.M<."00>F.W']#T[8JW%<NA )(&>2,]!VQU/->?4P5.<N>4+35G=2<
M6G=/HU?YWV?0\VOA9.;J4XM246DU&ZMH^N]TM?NO;0WY"V1Y9 P ,DD]O8>O
M8?TQ4BN4D1B, )LE"\%AQG8>G3ID#DYX[YT4_F$ $\]_KGG!Z^^?Y]+Y5SVY
M)[G@=/?^O;M7-5C*$;*$=OB<8N?9^^[N^SW['FM3@E&34>7FMI9^^ES6>F_3
MM;3=HW;#Q%=:7M;2Y9[*X0",3QOM;:!M&2I!S@<DG\^_;>'=7\0>)-0M[./4
M9[B^DD5(Y)W+,KN1@J2Q. Q Z^U>0.V"R_Q;B,<@9S_+\?\ &M#3]2N]/<3V
MTSPSHRM&R,0>#GJ,XQUY/X5PXK 86M1;ITH_6'%?O*EYRNTKI7OI?IMTML<N
M)P,G&3H0P\*DDTIU*4*B;G&,5[31SG!7;<6TFG=]CZ!\<Z+XJ\-WMO8^)1/=
M7=Q:O/;NNZ4O;HX5V !<@!CUS@\C/8<K'X5M]0T-]:_M;3[<^:T"VDPE%V75
M6? 0(0!\O!)QW..!6)IWQ+\0V]ZVH_:A?7*PM:@WRM.(XW'(3S <#.2<?Q<Y
M]>;NM0:YGEN'N&$DSM,ZQ[UBWL2=H3;@8R><8QT]*\FAAL3AXQC/EC52]^48
MW4G_ (&O=]VVNS=[)IJW%3P%>4(0KRI49QC!RJX:#5.;5^>"PS25)6Y;23WN
MXIIZ:]B7MYEC@B,URDB[!A2KX8!L9Z@+N(XXQBNIUN)[LPK-%Y+@(6'08/7I
MZX/'?\<#SH:E,N'5S%(C*5<9/< ]!G) ZX'!]>:Z;2_%,,5_9SZD/MEM#/!)
M/%M?=+#'(K21C('+JK)GH"W.!S5UZ=?DC4A3YYPDW=)ZZ1:BD[1U:>^FO1'1
M/!1]M"M>RITIQY8U)QG)M:)2;46G>Z5[J7,7X]"O86D>RC:XA@B,\TD:,5C4
M'!SWSS]/2J<&M2PD^<DR[>F1R>?S!P. <=>V*[#Q5\1=*O=52X\*0'1M/^R+
M#/:O'(?.?:-RML0C!/<C'(//2N1\+W&DZWK,4>LRI:VKS9DD$<DH +98[8T+
M'CH I/MC-2Y5ZN%>)QV#DW"#<U&+34=+*T$HMZ:J*?Z'E86GB(K$5*U-+#QI
M0J*$8NMBH-.2E"HG&TJDN6\?9MQY;1<5),['3-6LY;*6YD<QS @1!BJD ]<[
MCCM_7J>=*WTRX\2F1;%H]Z1$NSNNT[>H!!/.#WP>G K)\;^'].M[J0^%Y;F[
MTR-L&[BL[J&(+L4Y9I(DVG>6&&P>,]*P?#!O?MEM!=3W-M837&V28;TP#M!.
M\X!'3'4'!]<5YBI86IAYX[#3="K"TE3J7G)+=^X]6[13Y=4VT];G'/!U:U&I
MB,/5E356+J1A6I<U2A&,$W3]DG&;F[-JGS*[E=;INU<^%=15[E#"TTD)'RPH
MSY!W!F! ("C:,Y(SVS@U6TK5)M*N9XS;,S1QF(JZ@AMQ!)0,,@KMZ]BP^M?=
M.D_":QFT.*^\ >*++7=9NK&9]2TEMUO<VL*1J=QDO5AAD9M\F$BE:1]OR(P.
M1\B>,?"=]H]\99XW68SR0ON58^6(+G&<X# 8(&W!ZUQ8'/:&8U)X6O*+E&T5
M%J5&:;LDYQDHRC&3C+ED_=DDW%NQY60<29=G5?'9=2K4HRHI4Y4*D9TL7.4*
M4'5E]5JMN,'+X91G.ZD[M234>%OY#J,WF>68VR<(RXR2 ,8 [\=._(S77>%_
MA0^J6-YKFL&6RT^ /Y<K1S&.1PA95#*I7GC@GUSQS7*7]G=Q3PQ18D9PK$),
MIV@G.20V!@CN<YSZ5[+X1UGQQK&BWOA.RGMO[*3,KF>YABPRH=P!F= 6V@@8
M)W'& 3@5Z&.Q6(P="G/!U,-"*<>>52<9*-/1-P3YE)ZVLT[]-CW<=/%T\!3G
M@\5A</#VE'V];$/V:I89U()NDTI0E.;;45.,KNUM;6^:M0A^S7[B/A5;(].#
MCKWY'3O].G=^ ?!^K^.M:BTK0Y8GU.3+A)3D%>2%0 \[1D'D  =<&N8\3VLU
ME>7&(2Y5V4E,2 'ODKD 9/5CCGT%4-$UG5O#DD.H6-Y<6ET9#F>!W5HP6_U8
M9<'Y>F5XXX) R?:=.MC,N=3#SHPJ<FKE&,EKRM2<7TL]E^MW[5;"UXX>K+"3
M3Q4J*AA*LI2E!5'%24JL8/WZ:>]DV]-':QW_ (MLO%G@W4+W0M2NBEQ9RA9H
MU!PH(#!1V/RD8[=^YK@9M1NM2<)<N7B\P$,<B1,  JN#MP>O)SDGKWOZUXBO
M=5GEEO97N)Y<-)-,YDEDW $$O\V>,=3GH#@YK"#1(%97.3RPVL,-V[<],]Q[
MDT\#1C2I1E5I8=U>6+]I[&G:3LO>U5WS6O:^UCEI5,="AAX5X4HXM1A'$SPT
M.2+J\L55E%*\DG--Q3;:5D[V8^YMGACSN5T:1F1CDR8(/!)&,8[ D9]*HX^8
MKW'?MW_PJ[<723($#;MI/0,,9!'\0 _*J)X8MGTQCKR3CWYR/ZUZ<*E2HE*J
MTY-/:*BK1LHI):6L=T')I7YKM?:NWHHI;V;_ *MH,9MI"D9W$#/&,DX_&FM&
MK<X(ZCT_'']#CZ<T]@",^@X]O?C_ #Q2*R]V.<8Z$_Y/O_+I1+GNN2UNMS2[
M23C%\R>ZOY?U_P #9GE; "G&..<D_P"..>?Z]J[YW'<<G/..E7"0?NL<XZ8Q
MG]?Y$'\JIOP[#OFE#VEWS--6TT5[Z=OG_P #8TI2E+>#3\X]-'V^6@Y&&,$C
M/7'M_P#KHD_AP0>O3/MZ@4P1AB&)Z=OI_P#KI[J% P<]<]?PZX]^PK0VTNM7
M>ZNONTVMIV\O(@',A^G?\*=+\@P#DD?0>X/7M^M0N3NRN<Y'MQCGKTITC;@N
M.P ].,CKGVS5<MVM-+*_;X5I\S75--6M=W7IJG^FY6:4 \9X(QTQQ@]/Q]>:
MM+<),,2*3SV('<XQDGTY[50=&ST]^H] /Z&FY>/^$^N!U^H/^>XZUHH1C\-]
ME^E_Q7SU+:C)*W+S?)7?;[UIZ$L@C+$ 8Y;'3.,\<#T_'I]:IN-IW'U&?;'_
M .H<_P!.:G4MN)8CG/.0<Y.1QG(QGN/YTR8,V-H!'8YXR/\ ]9_*J-HI*R=M
MDK]GI_PSV]2>-5*X; )YR>@[#\?Y>W-6/[):7YEDC/<J,DCKU[?ASGO642ZC
MJ5P,#!'IUZ^V.<=/QIT=W=1G*NP!XSTSZ9Q^!/4#.>]5[*<M5)+KMLK=7]_^
M;-'1J."E3DE+=;-[VZ._?;?HT:PT9QV7/J,CO]..OO[]:K/9M V2O*\@DY7V
M)]J8VHW(C(\YL\<9([\X_F<>E4FO+ACDR,1R<$Y!SSSTS35*44KM-Z6MHK=U
M85+#XQZRE%I-?9WM:^MMFMFKZWU=[FAOD]$_\>_QJ'[9(AP&SCC&<<^F.GI_
MAQBJ?VJ7^Z/R'_Q50$GD]3^6:J--O=::;>?]6^_5;G1'#3NO:)>5O=Z1O=]K
M_P!6)YI9)W/.WDGUSZY_/_&H-H3@<]S]?_U8I03P<X/?].N.H_H/I2D%B>_?
MC@>G>NA4J:2LGS==7M_P?\]M#JBH*"C'[/9V[:NVN_R5[>0S'?C.,#_Z_M_]
M?UI5^4Y ))]#G/.><GG^?;.,TI!'44!BO(&>W^>151BHM-;K77^OZOZ&D9-:
M7T[-Z??_ ,/W Y)^ZP'J<>WO^O.>,T D'KQW^E!<G@C&?I_B:2BWO<RNGY-I
M?=L2TE+F5DVNCTUM?T_K<_J%_P"#363/_!2/Q2I[_ 7QQC@< 7VCGGW-?Z2=
M?YL__!II_P I)?$__9!?'/\ Z6Z/7^DQ7)5OSRNV]M6[O9'KX76DO5_DC\G/
M^"YH+?\ !*#]M10Q4M\*L97J,^(]#'^>M?Y2E@\K72C[4T0. 7!VN-OR@!L\
M_=XSC [<<_ZMW_!<@9_X)2?MH#U^%@'_ )<>AU_E+16(D;>C%3SP,#N3GK@G
M)[X[\=Z^PX>X5H9_E]>K.'-6IXF5&+NU[JITI):=+SD_/Y7/F.(Z-:M7A[+=
M8:23TNI2E>^O3W5][[BZXRJ$7SC.0Q)).7' .6).3GJ#[@CK7(.@=B,8)_'U
M/;L?U_ET5U;ONVDY;UR 2.F.._!QS^6.<B2%T;+#VSD=<GT/?Z"OGL;D.,R&
MM6I35H*34963BXRLXI.UD^5V=M=-;ZGBX=NG"G3JM^T@DIMNS;=G>UU9/?1)
M;6T'6,S6D@V M-N!C*D##@_+G.,'IW_QKT3Q?X*\41:=IFL:JIGCN[>-[9HL
ML8T< JLG)Z @$C]2,CR]P1N)R ,DD<D =P!D\#TKZ=^$,%[XS:VTN_\ -U.V
MMU2*"W)$K#!"JHC8[NX P!G!X[U\7FM:670^NJ"=I+FYF]FTFE?1>FEM[V,,
M\Q[RK /-O:T(8/+E/$9@ZMO:?5*=)RFJ,G)*$D[.\G%-7YF]GXS9_#/Q;=V/
M]IQ:;.; 9(N3%+Y;$9( .S W8[D8YXX-<G=Z;>V=Q+:36\@EBW>8NT_*1G.<
M@'@]?3(]>/U,F^'NO^%?#Z+J,4ECH=Z?+6,".58V89#O'"SO'M7)^=5/'8'%
M?(_C7P,8]9NI=,D2[ADD=6N/DC\T'^(+*4<@C./ESQ]:\3 \4QQE24JDZ+I6
M?)4IM.FI0DE*,IQ<H\RV:O=25K'Y]P;XK9?Q+F./P].K@EAJ=2<,#7I2JI58
M1Y7RU95795$G]E*,G\'NVO\ +#1$':RD$\D$$8XXSZ?A^=4WM]S?*P&.O![_
M )8^G^-?3,?P_P!-AT^XDND#730.\.<9W@9.[&0@&?E9R V#@D5XOJ/A[48(
M9;P6,HM(Y'1IT >,$$8^9-P YQ^G/%?28+-Z.)DXTZD6]%T_EOIU=^5].CVL
M?I>"SC"XYUG0J>[0G&FY-Q492F_=46[-ZIJZ;U.(:W93]X?D:9LP>H;';U_S
MZ'Z&M22,@+G W#<O()Q[CJ/Q _'%4"N#DCY<_IG\Z]RE4YVE=7;7:UWWOI:_
MJF>K3J>_%MZ<T7T:TMIKI:ZZWOHN@Q0H()!QG)'(/&<=_P"O/6NAL D9\]&*
M,#G.=N#VYSG&#@<^OTK'B16;D^_3WP,?CUZ8[5:>;RU*+U!P,<<X&.<=^G'?
MGZ37G[=/#Q4>?9M))/:R6EM=%HM?,,7*55KEVOR^J?*K-+1K3Y)75S2G\1WO
MFHZ32120%E#H<'Y2<$$$'K^)R.<CG'U+6-0U1]UW=2W!!.#,S,0,\8R3CCK_
M %SD9SL68^F3^?>HP0>16=/!X>G*,XTHJ<=G:]N^_F;T80I*+C3IWBE:3A%M
M7L[1;3:3MM?H^A+YG3CMSSW]CZ>V/\*CHHKME.4E9VLM$DDK;=O0[.>4DKO=
M)O1>7X+H%%%%5#9^OZ(044453BGOT_X'^0!1112Y(^?W_P!?TWY6 HHHHY(^
M?W_U_3?E9-)Z,****.2/G]_]?TWY67)'M^+_ ,PHHHHY(^?W_P!?TWY6.2/;
M\7_F%%%%')'S^_\ K^F_*QR1[?B_\QK D8'K_C2*I!R<=/\ "GT4TK*RZ%I\
MJLDK=GKV_K^D%%%%,3=^WR5@IP0D9X_7U^E-J9/NC\?YFJBDW9]OU144F]>W
M^0S8?4?K_A1L/J/U_P *EHK3DCY_?_7]-^5M.2/;\7_F1;#ZC]?\*-A]1^O^
M%2$@=:3>OK^A_P *.2/G]_\ 7]-^5CDCV_%_YD90@$\<#/?_  IG/H/S/^%3
M%E(//8]C_A45')'S^_\ K^F_*QR1[?B_\R<#  ]!BFE,DG/7V_\ KTN]?7]#
M4;,<G!./J?2JV*$8;3C.>,TE!)/7FB@!K_=/X?S%0U,_W3^'\Q4-8S^)_+\D
M 4445('V%^P#_P GM?LI?]EX^&?_ *E&G45%^P"Q_P"&W/V4AGC_ (7U\,QT
M'3_A*=.HH-*:LGYRO^"_KT/]F.BBBO//4"BBB@ HHHH **** "BBB@ HHHH
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M8)'3CZ=!_+]5>3Y3DC&,  C)^HQ_C]1UK:\6WNFWGB'4KG1[5K33)IM]G;N
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M->C>5&49J+C)/[49*[3BFM+=D9Q!!P:2K<L3(RB1-I*@CD$D$GDX/J.]0E5
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M(L_\/8_VE.!_Q]>&^Y'_ #!XO8U_JH5_E:_\'#Z,W_!6']I,X!_TKPWU /\
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MJD1K(Z\#!]"<GH.<$'G/?WJS'..DG7K@<'^OZ\_GPPP$#TQR/8].S9[TSRF
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MM"7ATEK=7VW\GKJ[>G_#'3"TBN@6$H5^5P2,8'3 QWYSS]*:-%NP2\:K*%Y
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M'^''2N<XGE6+_P"?;Z+XXOMY_+R]#^-+RE]5_P"^C1L_V<^^,Y_''-?V8?\
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M\67UT8_#_A9)]/:G3DHN[=M5^&^QABJ=2<HN$7))W=K)]%U:7?[NMT?QC@@
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M?!P/RZ'_ #[5_9W_ ,0</QC/_-[O@(>W_"E]</Z_\+)%-/\ P9P?&,_\WN>
MF^OP8UQ<?E\2&SG\,8]ZF4E9V>O_  ?N%#"5XR3<;KM=7UMYV_'HM]C^,E'=
M#G!].HZ9!Z@@Y'8CD#WJY'?31D%'*,. PY*C&#@Y!Y4D'U!K^RL?\&<'QBXS
M^VWX!..Q^#.N$#/7_FI I1_P9Q?&/_H]KP /I\&=</Z'XCXJ8PIO63CT>MNG
M39MZ_AT%/ 2FVY0N_-1L]M.NC2MJK(_CG@U:["_\?4AY 0MN^7).X@B08/(Q
M@<\<BNN\+^,M?\.7B7^B73Q7PD"I/F5W9P."L>_:Q!/'/<<5_7=_Q!S?&4#
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MK)?PWW^SY;^]N?QD!"V,$<\=_P"@-22@KP1SGV]__P!?^17]FP_X,Y/C(/\
MF][P&?K\%M9_I\2!2-_P9Q_&-N#^VWX!_#X,:Y_7XD'_ #THYH]_Z^[^OD'U
M;$77N.W7;R_O+75V]'ON?QAY'J!^(J-\$]1T]_?T!K^S[_B#C^,HX'[;?P_P
M.F?@QKF?Q_XN133_ ,&<7QE)S_PVU\/?_#+Z[_3XDBJC.*>KW5NOD7'#UD_@
ME]\?+SV]-3^,' ]1^O\ A1@>H_7_  K^SW_B#A^,O_1[7P]_\,OKW_SRJ/\
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M ,\BCVL?YH].C\O+S?\ 28?5ZG\KZ=8_W?/S?W>3/XQ,#U'Z_P"%&!ZC]?\
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M$F/^CH]'_P#">\0?_(-'_$0O_P $F/\ HZ/1_P#PGO$'_P @U_E,[A_DK_\
M%4;A_DK_ /%57U2E_-+[_P#[3^KORL_K<OY(_>_Z[_TM?]6;_B(7_P""3'_1
MT>C_ /A/>(/_ )!H_P"(A?\ X),?]'1Z/_X3WB#_ .0:_P IG</\E?\ XJC<
M/\E?_BJ/JE+^:7W_ /VG]7?E8^MR_DC][_KO_2U_U9O^(A?_ (),?]'1Z/\
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MK_M\_P!6O_B(6_X)+]_VI=%'U\/^(!_[8TH_X.%?^"3!Z?M3:(?^X!K_ /\
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M_P @4A_X.#/^"3H4O_PU)HFT=3_8'B#K^-@#^E?Y4]P[[@1N )'0=N03R/\
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MW_A(>&/_ )K*_P X&BCZM2[/_P "8?6*O\J_JW^?Y[6=O]'[_B+;_P""=/\
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M?^"> !/_  @/[0O S_R*7AW_ .:>H/\ B+(_X)V_]"#^T1_X2/AW_P":BO\
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M )/;-<4H._O72Z+;:V_]:=SR*M.46U+1;;+U35K=OGY%\,FW).#CVQ],=?\
M/?O"[%L#H,GZ]&_6JJNQ)YZ=>IYYZ9/\Q5A2'('3')_EZ^^?I2:BDVDE9:>M
MM/Z[^IS<DHN_->UGM:ST_K\20?</N ?U(_3'YYJ$H#GKR#_G_/\ /FICP"N"
M3P!COR2._O\ _KIH#$?=(QU'^>M9N;OH^WWZ7_'^K%\SYDTW:Z2UMVOY^O\
MP3_3!_X-9XQ'_P $N=/P2=_QN^(3'.."='\'# _*OZ/J_G'_ .#6U=O_  2Z
MTT9S_P 7L^(/_IH\'U_1Q4\SE[TG=M)MOKH?:85WPU%OK3B_P/R/_P""[O\
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MO4*<_4?U.?\ /K3GZCZ?U-,K*4FI.S_JR_K_ (=F;DU*U]-.W5=_Q$\TO@8
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M349_$XIKFOS27NI-W[N^E][=V04445[)](1L&R<9Q]?;ZTY00.>N?7/I3J*
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M$NMSZU;?&&Y^#=\)-1N_":RL;W4-(ATK7IS+<R0A=2@TNT, EBMT8_L=\/\
M]N[]F#4_V6/#WQK?XN_#VRT6U\ 6!U/0KGQ)I$/B#3?$=CI*6=[X/N/"\ETN
MN1ZY%J<$ME#I#6 N[B'RKJ"*2SFBG<K*C3]_"X?GE+%1C5C5PRM32A1E&DHN
MI5]FJM1U?=TGRQ24VFXQWP_M:U6E2S?-9T)4,JJU:$,+C94:5:+Q5:$L;+$\
MF'EBZV%P\,+"4G"-"-2M4JNBU5IN'Y"_L0_&_P")GPQ_X)<_M\_'?P[;1^$?
MBCH7Q_\ C1XSM;2_M6EM]!\1:OKOAJYO[%H[V)4NHM-EU.[LDD9&1S"K$DC
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MI4HO'0HX?+7@E)0:K8.5.K*K*/M9RJ_6HU%!04>5\$?&G_@H%^U+^U/^V/\
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M?K595VYYZ^WIGW_P_.OHH5.?I;?K?]#ZZCB(U+*W+9=7V7HOU'44@&!C_/\
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M84444 %%%-?[I_#^8H;LF^RN)NR;[*XZBJS=#]#_ "ID??\ #^M9^T\OQ_X
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MH-IX/U_3M@]/QH(QQG))RN>Q'/YG-*G(/U/]/7K^-*_W3^'\Q78_)]M;??\
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MMKM_Q:C_ -V30?Y]*_R5 HPN>2!S^>0/P_SCG/\ K5_\%W#C_@DI^VT?^J4
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M %9_,\RO5?-)JWV;=>B\[;D"QIN''<>G]!6I:HA"Y4=/Z'_ 4D,'G/'&.KD
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MO[<9]CGIS]?3DUK&I*_(OA]>]G?S>V[[7.RCB*D;0E&T4[)Z[MK5Z[J[VU_
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M^ -I^<9/^Y_*C8?4?K_A2E3TXYQ^@/\ D5<XRY7H^GYHX,2T^J>NW6UETW_
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ME33WM^2;_%CJ0]5^O]#2TAZK]?Z&IC_$^[_VT([KU19HI,CU'YTM=1N%%%%
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MWC)IGARP\J.TEU :>OR!G6[O","65S@UF?L-VW_!/_QM^T%XN^,/[(GC+7?
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MGS1FHQJ1:YG".A7^5-_P<4<_\%8_VD1CI<>'"<]/^05'_GZ\=:_U6:_RJ?\
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M]?3_ .M3P.1GJ0<_F.OT_2@RE)-;.XHCXW'G'U' &/H1_/FEIS' '. %&><
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M,H5:LYXJ3JNI&47*G3J4XPJ1YW_/5^TF/VT?VL/C;^Q_\4M)_9<\8_#SX%?
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M=U;ZA9R'>9(R>H.\<?IZ_P#UO4>%"20?=8YZCDYSV]^OOU]:T+2ZNRP_>RH
M.JR./3I\WIG/7J1S7[SPIXPU\KP\,-FT)5H8?D5!U7*K'DC'=*;FDVUK9;ZO
M5A&OB<-2BII5DK*$6[5$M%;5>\D[.[OIH]M?<VUB",;6F3;C&,J ,8X!VY_
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MG#P<J<>:-H0TY9:K5+=-:I.S5_EL/\Y5.6&<\<C]>#Z"I1]CE&UX@%;@D,W
M/ISD].QR>U53%C');GH?YU*@0 9 )_NG@\?AP/R-6VTGRMIV=FMUII9K5-65
MK;=#H<8Q]Z*:E%W7(VM5:UDM+W\B&73+>0GR75.H ))^HY)_R,<]1C7&DS1\
MC+#CMQ] /3\<=L5T.!V '?CCW_I^-/5R#T#9[-D_R(/^'6L8UZL-*E2I+3>4
MY.^S=];^>J^9I2S7$4;6YY;7BURNWJKIZ=/37MQC6TB<$'CC ![=,9X/Y^W?
MB,+AB#U&/KW[=NQYSCCUS763K&Y;<NWYCG !QSP.AX]S^O%8=S;_ #%D+8/
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MGQ6DCDAN,#(QGZ<]2>OIU[]CI[1=OQ_X'FOO-GC8*+TY;+O:STZ+S?3OY%4
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MOCEY_!OBKQ:J62BW!TGY?#$ED6G-P-]TLN-L94_'VK?%+]KS]@WX[_ SPO\
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M5*%HRV6SY4][;.RVOOV7J<K"") ".Q&< =OKU^G&#5X(3@C _//\JLM:%7R
MI'U'IZ=OZ#IZ!XA8 Y S@XY]OY_YS43G+FWV79>?D:U,1&M:<=?=2;Z76K_K
MSN5=K_WOU-&U_P"]^IJ4@CJ*0<]CUQS4\\_YG^']=%]QC\MO7_/^KORL@R ,
M\FIHWVX +#GL<?\ ZORJ+I0#^A_P/]:F3<E9[ DWL7T92PW D^I.1_D]^@K5
MM(HV="WS+D%EV] ,GKGU'/3/3BLBTFV;\H'Y7ENV-WX\^WM6_8WH,ZKY*[2/
MFPH)VC'L>^/3TK"M&"I5&UM&ZWWNK=?Z9P8N-:UJ::BD^9N44K-+2TMNRO\
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MO:^MNFJMM^7R]#*I0YXO]W9?IIU6NN^GY&MYJG)"GJ?X@.A_W:&0$Y!Q^O\
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M!GB?PS\/_#WPT\-^%O$7CJ7Q?XATR[TW2KR&+1+2;4+!O[0NX@VI-L"2. 9
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MZBKBNC#(8%>Y!XQZURZL5&0>#WQZGGJ>.G/'4\9%2K=NJE0."".I_+&#Z_\
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MNVVUU5]-Q25HZ;JR?9I6Z+KON0AOGV]".>3SUZG/]?Q]K"R+E<L!T/7Z=/\
MZW6F*J'ZXY['Z_X<D?E373 R.3VR!Z^OK_\ 7KGY6]&G9Z/]3GE2C4DKMK5+
M\O+^OO-&(C@@@@#U!Z8Z_P!:N1S;0"'&?;GCZ#],>WI6+%+M'OT//;N>.O\
M+GOS5R.=...PXZ\@GL/K]#^/&=2"CLV]D]/+3^O,X,1AE%VO)I/33?9O;R-8
M.K<[ER>3R*> 6SM!..N!G'UQ5*(9Z=^G\S^%:(/E@$#&\9/Z<]_0YXKGJ0A!
M:2;>F]K=/+;7OV/.DN1VCJ[6UVN[=OGUZ/4B/&<\8."#P1_GI4;;7! ()'7!
MSQSCV[^AYX-32*=X7&=XW'GIR<D]^V?_ *W1R0!>>"6R/R/)S@?I_.JBHQA&
M?,[O6SU6Z[>::_#N9\Z;NGK;T5U;NM5:SM_D9$L!89V$<^F2?TS^F._UIO"Z
M'+1LO0C((!&3GJ!QC_/6NL:%8X_,89&0.GKT]\_F/Z30Z/-J,<DT0#"%6;'R
MG('. ,\^F./PS5QQRIPU4?BLVV_)?\!=/U[*68PH07,HN'-R\S;T;45;>UMG
M?N[VTUXD@DCNN>>GK_A[]<].*=E?4<>XJ]=VEQ:NV^/ /? Z9[X'!SWX'?BL
M\$9X[_7KWX.!TZD'->G&I3G",HRUE\7;I:SZ[];;=CW*5;#SHQFIQ]Y.\;Q:
MTMT6MM[::O9L<#DD'MTQ_7WX.>E3(2,8![\_YZ]\CT_&FI&3C\^.ISW]!_D>
ME2[=O'I_GVHJ1YH7Z76O]?UU//Q#C)^[%6O:]M]-O3Y?=UF#@CG@]_\ ZU2Q
MGGV(S_G\ZJ5:B[?[H_I7-*"2;N_ZL<4XJ,7)7TUM_2+R,H&"1GY/TZU.&'&"
M/;GFJ&[;SZ?_ *J3SCV)SVX'6N:=%3W;6M]+>3_-'%R7[ZMO[[?K^9L!1T//
M/5NV?KT]Z=YB*.5''<CK^E9T,DLIQD$\X]<=.3_G/H>:NE2 !@<^N?S![=/H
M<?@</9J-[NW?2WW^>_W_ '\E6A"Z4Y.23T2=K.ZO\M%>_P#E==Z'D$8))X!]
M?I4L<;RMMB1I&QG" L<9QV_R*AA3>X3 .3C&/PX/8>I[5UEAI<ENRW!(P 01
MQU.#TQQ@<=P>/>LJV)4(J.FB<;Z[*RO]WW?>17KPHP4;JZA%1N]&K*R;NM6K
MVM>YSC0RIN5T9#C!#*03G(QS_/Z>M6;?2'DB,H;<<CC!)_'L<9/;VY-=<UI#
M<RI\HR6P3@<X(QDGH ?IZ?7;ATV**/R@.64L".,8'MV/?I_4>=/&5*:C4I3C
M3FW[W+>^CLKIWZ)6T]=#RGG-+"Q]C-3YERR49/EBK\LF[Z.UVTNG4\FGLR':
M)AC+;<G*X]22?3 Z_EBI'TJ-H0%=6.. &!([9'/3@GMR.:[6]T42SX7&\M@,
M!W[\\9ZG_&N;O;*>T?:6.,'@'CKP.O!((P>N>.N:]B.:)T(OVCE5M%7DH\VR
M;L[75_DDM3?#YCB<;."PU10L]5ZM6NW=Z)OLNISAT-R&9'#!>3MRV!UR2.G&
M<9[BJ)T\HV-X'ITR>O.6S_3/7G!-=3INH1V%S,EXN4((8'GMUZ]N,]OIFLO4
MIHI97:V&U'<LG;"DE@!G!Z$'CCTKHP^(JJ$*[FI\S:Y&[\NB:?K;^K,][#XK
M'PJRA4J-P2BX3^R[VZ.RT\MG?U,">S9"03VR/U].#]>_;OFNT3#&59NI)&>/
M7N,?RK7DWE09.6P.^<#/'Z']>M52">^.H_ ]._7'\^E=<&O?G*3E*;BTV]8Z
MW:6R=]G?[NAZU/$3Y=9WYN77YJ]MUTVV?1;6S@K9PJL#W!!R?3&<\>O'IP:M
M"TN/+:8PR!!@E]C;?F( ^8CCG@>I[#(J8Q8 .><X&>/R[CI^GOP":XP(MQ\H
M]5)..,D<=^>?UJHS7-9R:U2UMIMK^/3?36Y?UB;<4I;--W=M+KS79_CH[LID
M$=01]1BDJ9P21WP<$Y_#]?7%-\MO[C?F/\*VY^\NWVK?G_7J:+%?IU?EY/M_
M5D1TF1ZC\Q3V7'N,?ES_ /J_.FT<R71=%K=_KW-HXA+6VMK.[MU6VC_KR09!
MZ'-%%%*]]>^ITPJ<]M-&OT_X?^MRBBB@T"FG)!R"#V[YX/I^1_GFG44=_/\
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M\3:;X9O;FWL[37+S2%F-]!ID]U=6T$5Y)"L#RSQ(KEG4'\)/CW^T9\?/#_\
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M^1Q?5)J2M*+LW=Z]HIO]30AOIHF7!96'?C QGJ>/?J">1TQ76:?XMN[1-GG
M@C&&(],'H/KZ9KS\R;NX)/N3T]LD?I28'I7-4RZG-W]W3:ZZZ:NV^MW;O8QK
MY/0Q4>6O"$E>^U]='OY/_@'^GC_P;%7_ /:/_!,?2KG&"?C)X^4_4:7X3/X_
M>ZFOZ'Z_F^_X-97=_P#@EU8EV+;?CA\0E&3G _L?P<<#VR37](-8R@Z;Y&TW
M&R;6STZ7/K<#35'!86DG=4Z%*">^D8)+?R1^2'_!=S_E$K^VU_V2@?\ J2:#
M7^2M7^M3_P %W/\ E$I^VU_V2@?^I+H-?Y*HZ?B1^IK:C-)I6UO?[W%?H8XG
M^/3?E_7YDL??\/ZU)5?GU(^A(_EBCG^\W_?3?XUW>T79_P!?T_Z>G-*:YGOO
MY==>Y8HJOD^K?]]-_C2Y/J?S-5%\RO\ UT&FFKHGHHHIC"F,I.,?K3Z*&D]&
M!&%VG)[\#&<Y/Y>E.\M6R,=?J?Y4C\ 'T(_K3@X'(.#G'7GKQC]#D5/+&STT
M\_S\OPV%)M)M=-?NW_#_ (!"8PGYX]_QSTZ=*N6X&1QV'\B?Y\U""&'/)[Y]
M?Q_2G!BOW3CZ5PUEUOV;_(\VO)U+)Z;Z_P#@+_3R-FW'SX/8G\P*UHTBE"J$
M+.OWL G)/3.,YR..F.!WK!BD(P03[GN"0,G)_6MZQ=XW6568%NO..!QD_IG\
M?4UYV*A.*O=;)Z-J^UMU_72^QX]>RN[M-;6O%-V5T[:ZZ_B^S'2IAU;:4VIM
MY!&>6.<\9Z]>O&/I-'8RNC7"*2H&3UP.HXZGISWX-7IA)?R1J%&0NTX/7#$D
MGCU;!Z^_I756UKY-LD1C!###9 [ =>.,D]>>N>U>?5Q,:5*FG?5;)[:WUN^R
MN^K[7N>36J3@XM2A=[TV[^[HVG?IY]=%IH<7:PB1P)%9HS\I^]A2W1N.A')Q
M^/2O3-'TBPM4B1Y1,MUA'(8MY2N,$MCH5[^G;/;%BLHXV;9&@&QCLP,=,DXX
MYQ].@%9L;W=O.?+E,46<.$? *@X(9>A&/;\JX:LJE=.-.3AHI7?7;JKM-:M[
M[]CGKR6,IS5*LZ<5HX1NN:RM'7>/*VVFE9M)/1%S6O#7VF[=8L^1S\V&(QSC
M/IUY/<^M>9:AI#6LA"#+ \=3W(/3/\NQ KZ.TFXL[NV2. +=7./G68;U) .[
MKUXSGJ"2,9JI_P (]ILT\R/;6TK 9S)&&P<<X)7(.22#@'T/4U679CB?;/"+
M#XG$U8I<L:,.:4HJW,TNS\[7L[;,Y,-GL<#&HL74E3C1<*?LYIJK/6TJG)ND
M_=?-9*2O;8^9Y&/W""&7@\=\\C].G-*!@ >F?YUVOB?0XK.\F,$:H!(V%08!
M(;!.>G YS@?UKC3N#']V,],'^9!&.N!Z<\U][3HU?JM.IB*=3"RJ14E#$0G"
M:BN]XV_&^GI?[+!XK#8[#*K0JQ<)-/F=];):)*[ZZ*RT'2=OQ_I1'D$D<<8_
M7_ZU!C=P"WR #^$@]?7W]?3\:?'"S,54DL>,?I@=0.<<C_#''[6$I\D)\SO;
MF2;BMGK=6L]=2IQ3]WF3OI?5;;^=O,=D^I_.K$7W&^G^-1O!) P60')' ).,
MX.!V]0>W4>F:GC "D8[X_05$GR2UUY;;=4K+3[UZG'.,8M6:DKWNNNWYV]/3
M8DB/0]23_P#6[?[/]#6O#$98R .PS^/?CG Q_GO6AA7 ^4?EUSG_ .MQZ8]J
M['3[>&&V(DBC9V4$,1R 1P 3S_\ K/'05YV,Q,6O=C):=;>2_P ET3LSRL;6
MAS62?,I1;5D]=/PV_P F]LZSTPR)'(3P <X/3#$$<GGIZ9_D>KC7?:'MY;E<
M#CD*.P&#V_(<UE><(4$:94KD87@<\YY[_3]>RP2RB-P)&P78D!L D@<_7&*\
M:HIS6]EWL^MO+]=V>;6<JMW-J/+44H7_ ,6M]_BU:Z&[:W$=HDA8',@"CH0<
M=<[NO)[>Y[8I;>2:><O$&Y#+N"[@-V 0>N..?4CMSSSCM/(.'?\ =DL06XY)
MZ9[=1TX]"17<^'HHWM/,P-Y8@MCDE20<D\]B"2<=AQ@U^L^$O!N6<29C7^ON
M%6=%*4Z,KM)*_+=25M8K;J]3SGEU+'9BX5JCC2]G[6<8MQ=2*Y(V4ET3:3=[
MI-ZJY'#HD\J2MO5)74[&,3DJQ[]0!QQQWR>E8%WH7]G,;BY0W1ZY2-CW)[_D
M".AS7HT9P&4<9'O_ )X_D2*CF5&7;*%=?1P6'MQR..>OY8 K^F,7X5\&XK+U
M3HX&C2K<K3JN$4E--)J:BE)O56:^?E[5#),#04GAYU::E*[_ 'TW)2LM(MMZ
M62T:L>-:@]I?W7G3PM%V92NTGIGTQ^6>M9%Y8Q2 M:Y*H<*,9(&/EZ_S/]37
ML=QH%K=Y*6\2$D\K'%SDD<YQ^ISZ=ZY&[T6'2))C*[!7+[.5Q\Q)QA<X"YXR
M.,\'@ ?A_&?A7C^'<OKYM@Z#K9?0<ZDG24WS04>:T')):*[=VKK5NX2I8K!J
M-25?GHTW&*:<I<L92BKSCRK17UM=;>IY>T+#(<'<.#U)&,XQP3C''/X^M0M;
MR-@J"<<'/'N/Z_YZ;FHPNEPY4%XVQASW(ZC('09QTYQ]!4,?RJP)ZC]<$?IT
MS[^]?DBKPGA:=6$F_:NW+]J'*T[3N]7VMI;YGK1K\D%'FA*5XJT=UJF[IZI6
MN[/7:^MC!,;*<' Z=<C)Y_/V^M'E$?.1P,9(]^!UXJ].Z\G X/&1D9XY'?\
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M'TYTZ<)U^*J>:4^64/?P4,PP=?GE9I*HZ%&=XOW[I*UVK_('_!169[;]H_\
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MI*450Y,1#WN3DM<)_P"'R/@I?.8H?V5=7;[.9<()/[2U0>:D)(RY3Y&=02%
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M;^#;=IUUJYU'7 LU\DYM4FOUTNSMIYKZ#]U;I+<RQPO^=W[:GAW]L+2/CO\
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M]A2_\$R?&DWQ.D@\M+9/&H34%\.HWE,6DU272QK3W(D12D*)ODRZ _6^L?\
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MGGOZ<9)QD&M-K*6VA,FPJ,L-K*V?E.#U[9&1ST/?&:I:5J$]B8O);*%$W)R
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M7RJU.+3=-+FMK;F2MKUV/HH-?"F[Q2O\[O=>[KY:Z:BTA4'DBF;V'4 ?@?\
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MGD]^1C\ZY/4O ]G=.\MNBKN7@-)*>1U.%XZD'(&.G'KJV=TZH#YK-G&,Y!Z
M=<=AV/T'J;YOIHK?<N7;<PP6 S[9Q^I]:_JW&X;A;-\OI4LPR6C-0I<\I4H4
MYS32BHR7)=O23=M=7WW]=)86G"%&FHQ2Y8J+LHJ5K6BM-+6M%>G<\7U7PG<Z
M>#\NY3R&C63:N 3\Q;D=  3DDUCVUH(#O=&R.!@-P>N>G/3&>F![\>XR"2^C
MV7$*;9!]XL&(P#QR??!/3(-<_<64,*7$?D"0")I(R0JD,& *\ @@Y'4Y[YXK
M^>^/N Z6782MFV1+V&#C!U)X>I%PE.*<6U'G45&R?-K:Z32]YV.+&8ZO@XPE
M-\V&J2C!R7,IQYG&"OLW%R:6NJ;M\)Y+?N9IE90  ,$8Q[<X[@>@Q5>+J.OW
MATZ]JUM4LWM\2;<!R>"!@#\\GKC^IS65$#YBC&!N!]><CH?8#_/ K\3HSE5H
M3KM_NX2Y9RYEH[I?#HWJ]'9JW4]BG:5&$XV:45>S6MTK?G_P32W.F-N!SCD#
MCL.V?8?C[XW8;^X?8AC!;:H&%(S@#J#[8Z9_PQG (^8@=?<_3Z>O'Y5?BDN4
MDCE10P4#Y1@#&!@?XXKSJTE/X==&M5;M^7Y^5F>;4M.S<8*5MY.VJM973U3\
M]M+M*]]":"\"F=E4*_.,#(XQCDYSQVQ[9XJ"VNI<$!?E#D'*\DX X(/ '!!J
M>?49)E^=0C'_ )9Y)VX&.N/XNOXGI69]J,64,8()W%LGJ<#/0\$#U_E6L*4.
M6%UJX)M7>]E?\_\ (\B4JK<E.,$[M625E9[7ZVM:Z>NCVL=/83Q$3+)U95 Y
M'JV3_G]!P;5KJW]GR,@93&S'<#\V>,#:Q8#D8'H>>YYY2"Z$;$CYBP&0&QM
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MR<7=<]M?\,7;[G^?D?[(M%%%<Q]0%%%% !1110 4444 %%%% !1110 4444
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M]/\ &GCD ^M5ZE#* .>P['_"K+%+ '!S0&#9QGCUJ-R">/3_ !IT??\ #^M
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M7?=V/G*5"4:DJ[E2>CBM6FDK/E46DNN]G?J<\X(8@@@\=>.U5L'T/Y5HW?\
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O\J'_@XD_Y2R_M+?\
M7YX>_P#33'7^J]7^5!_P<2 _\/9?VEL''^F>'NP/_,)CKIPKM.;M?W+>>LX;
M+J<V*_AQ_P :_P#29=DS\1\GIDX],TE(,]SG\,4M=Z=TGW5S@%!QV![<_6@
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M/+J5X7Y4U?;EBEY6OVW_ *V3TXZ^OU/;WQDX)[XSGK6CC.#QGL<C/MWS6;G
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M[,/_ $;C\!O_  T'P^_^9ZM.;R[?CR__ "7X![/S_#_@G^=GO/H/U_QJ6O\
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M7S_O?@?YUI W#(SG/Z#V_KF@H/<?Y]Z_T4O^&5_V8?\ HW'X#?\ AH/A[_\
M,]4!_97_ &8<G_C''X#=3_S2#X>^O_8O5E*TO=DKJZW\G%K[FT_D4J2Y7>SN
MUT[\OGTN?YVP&!@$TFWG.3G\/IZ>E?Z)/_#*_P"S#_T;C\!O_#0?#W_YGJ/^
M&5_V8?\ HW'X#?\ AH/A[_\ ,]0[244U=1:<==G[K5OO^=A^S3Y;]+6\OA\_
M/\/,_P [C./3CU_S_/BA7Q@CCG/U_P 1^H/H<U_HC_\ #*_[,/\ T;C\!O\
MPT'P^_\ F>J1OV5_V8=R_P#&.'P&[?\ -(/A[ZG_ *EVFY<VZO>W;^[Y>?X>
M8Y48R^*S]5_P3_/ AN2A& O0#D'/&/?./;CI]<W!*TCC. ..!G'4>YK_ $/5
M_96_9@P#_P ,X? 7.!S_ ,*?^'OI_P!B[5^+]EC]F+8I_P"&<?@/GGG_ (5!
M\/O[Q_ZEZN&O"GH^1:O:[\F]?.WXGC5<%&\G&:B[](7ZI6^+]#_/+@O9+= J
MA& VGY@3UXXPP_E]*Z2RU".38UPJ90@C . <CG&X\_0\\>M?Z#+_ ++/[,8Q
MC]G+X#CKT^$/P^'I_P!2]4B_LM_LRB/C]G3X$CY&Z?"+X?C^,_\ 4O5Y%:A2
M;YN1)NVNKW2??^O(\O%9:II7K-.[3:@[M.*O]OL[??W/X&[+6I"H6V90/+?A
M1G@+\W<\D9Z=.OJ*EA\5ZA:HT"I;*FX[V"2!R#UR?-P../N_RY_OST[]E_\
M9H5,K^SO\# >>1\)/ (/4^GA^A_V7_V:"7)_9W^!>?FY_P"%2> ,]_\ J7Z\
M2K@Z-6K:I",DDK)QV=[WW[O;Y=3Q'P[A4ZJ<H24^5OFHW;<6K7O4M*UW:Z=F
MV_(_A.T37#/$KR%2=N"/FQTX.,Y'Y]<$>U?7]=?4;A+3S6"(\9PN.075<'((
M(Y(XQVYXY_O/L?V9?V;HP!'^SY\$$''"?"CP&H^[Z+H JU:_LQ_LV-.[-^SW
M\#V;!^9OA/X")X/')T#/':O6X$H4<)QKE5=THU84L7&2I:P3:M;WO>LT]4^5
MV9\=B^",)4K^VEB;NC44Z,7AU*--SG#VEOWR?OVC?;973TM_"+IEXT("EW7(
M&XHVUL@8ZCCN2>/TQ7HGAW48XXPC?OUDD.[[0#)P2 5[ @ >AZD9.:_N+'[-
M7[.:R.%^ /P4 !P /A7X%  PO  T'C\*M0?LY_L]QRJ(_@1\&D &0$^%_@A0
M#GKA=#%?Z:X;CC_8<-'^R]8TJ4>98ZS?+!6?^Z7OIJ[N[U/K_P"RH1<H^U3@
MZ;]QT]%S*-U_$M9VVMIWT/X8?'-GIB26CH'C^U13-*B%$B#*$VLJA  =LCGG
M/(7ICGR>[@TR2!H6@65!(6_> ,V,$ @@9X[9)Z].E?Z"VH_LY?L]3V:&;X#_
M  9F*JX4R_"_P1(5&<8&_0SCCCBN$;]F?]G M*#^S]\$B-IX/PI\"$=1_P!0
M'W/YFOXR^DMFW]M<1Y#*&&A@E1P3<U&4:LJU3VNE2<U2H2NHOE2?-I;4^!P'
M"+IYUFF.P^9U,.JCI\E"EA^6--VC&34EB$FI:MKD5KV]?\[OQ3I.FM*_V>'8
MY'&,#G(Z #_>/<<C!SD5YI>:8(>5#=^O QD]MOX?EVK_ $;9_P!F#]FEV8O^
MSQ\#&/S\M\)? +'[S=SX?)K/O/V6_P!F0IS^SI\"#PW7X1?#\]-N.OAZOQG+
M:M:G"*56;TCZ:VOIKKYW/UC*<)B*$*,7C:E5J+O*<+N6MO\ GX[)6NE?OW/6
M?^#65 G_  2YL,$G/QP^(9YQQC2/!R]@/3-?T@5\1?\ !/WP5X-\!?L^V>@^
M!?"7AGP7H8\4Z]=C1O">@Z5X<TH74PLDFN1IVCVEG9BXE6*)9)O)\R18XPS$
M(H'V[7IMMN[=V^I^@4$XT:2;NU!*^U_S/RA_X+C:5J6M_P#!*7]M'2](TV_U
M?4;OX5&.UT[2[2>^O[IU\0Z([);VMM'+/,P16<K'&Q"*S8 !(_RCG^#_ ,5E
MY'PO^(H'J?!OB+]?^)8,?7MCWK_;.(!&" 0>H(R#^!I-B=-BX]-H_P *JF[2
MOVMI\U_6WYZ88C"NK5IU%5E!Q5K)737-'S6OR?H?XE)^$_Q4R1_PK#XB+CN?
M!?B,CZ C3.H[^O:C_A4WQ4_Z)E\0O_"*\2__ "LK_;5\N/\ YYI_WRO^%'EQ
M_P#/-/\ OE?\*W]LV[\J5[:)_P"'R\V-X:FVGJMO_;-?Q/\ $H_X5)\5"V?^
M%9_$//'_ #)?B3''3_F&?GS3_P#A4OQ5_P"B9_$'_P (SQ'_ /*VO]M3RX_^
M>:?]\K_A1Y<?_/-/^^5_PJHXAI6Y5K;J^O+_ )@L/#35].W]S_/[M#_$K_X5
M+\5?^B9_$'_PC/$?_P K:/\ A4OQ5_Z)G\0?_",\1_\ RMK_ &U/+C_YYI_W
MRO\ A1Y<?_/-/^^5_P *?UE_RKIU?7E_^2_ :P\--7T[?W/+S_/OI_B5_P#"
MI?BK_P!$S^(/_A&>(_\ Y6T?\*E^*O\ T3/X@_\ A&>(_P#Y6U_MJ>7'_P \
MT_[Y7_"CRX_^>:?]\K_A1]9?\JZ=7UY?_DOP!8>&FKZ=O[GEY_GWT_Q*_P#A
M4OQ5_P"B9_$'_P (SQ'_ /*VE'PE^*H(_P"+9_$'_P (OQ&?_<;W_P XK_;3
M\N/_ )YI_P!\K_A1Y<?_ #S3_OE?\*/K,G]E*_F]+\O_ ,E^ ?5X-;O6W;KR
M>7G^??3_ !,A\(_BPW(^&?Q P.N?!7B7]/\ B7C^1IA^$_Q7[?#'X@^__%&>
M)?U_XE@Q^M?[:'EQ_P#/-/\ OE?\*78G]U?^^1_A4+$3VMT3W[\OY7\[_-D+
M"K3]Y+IT7]W?[_ZN?XE?_"H_BM_T37Q]_P"$9XD_^5U-/PD^*P/_ "33X@_A
MX,\18_#.F'^=?[:OEQ_\\T_[Y7_"CRX_^>:?]\K_ (52KK3]VNF[_P 'DN_]
M78UA:?GTZ+KR^7][^NG^)8OPC^*I'/PT^(77_H2O$A_EIHJ1/A+\54.1\-/B
M%_X1?B4?I_9G/./3'UK_ &S_ "X_^>:?]\K_ (4>6@Z(@_X"/\*AU;_95G;J
MW_+Y^?\ 73.>"A4T<Y6=K*RT^#;;NS_%#M_A7\5,[?\ A67Q P<YQX+\2-[X
M _LP8'^><9%G_A4WQ4SD?#+XADYX'_"%>)!]!_R#N/3VK_:TV)_=7_OD?X4;
M$_NK_P!\C_"LI*,FGR16B6G_ &[_ /),XYY-3F[JO4BG;11C;[.O3O\ @?XI
MW_"J/BO_ -$N^(?_ (1GB/\ ^5U:$?PJ^*9//PP^(?X^"_$@STY_Y!GOD\8-
M?[4.Q/[J_P#?(_PHV)_=7_OD?X5G*FI6M:/>RWOR>:M:[L<\^'Z53?$U4]-5
M%)Z\G][S_P NI_BT'X0_%E5#I\,/B&0^#SX)\1X (R #_9XSUXX&?2H_^%1?
M%MN?^%7_ !#Y_P"I*\1__(!K_:;V)_=7_OD?X4;$_NK_ -\C_"L5ADFFFD[)
M747L^5_S^:^XS_U<BX\CQE1QNMZ4&[>[I?F[/7O8_P 63_A4'Q;_ .B7_$/_
M ,(KQ'_\@4UOA#\6AR?AA\0AU'/@KQ'CGZ:<?3^=?[3NQ/[J_P#?(_PHV)_=
M7_OD?X5:HNZ?.KZ6]UO?E[S\U]WF3#AFC"2:Q4^FU&"_D_O:;]#_ !7O^%0_
M%@$$?#+XA$C/ \%^)#DGCOIJYZY^\*MP?![XID,7^&/Q%#'( '@GQ%R2#W_L
M\'T'![=.]?[2VQ/[J_\ ?(_PHV)_=7_OD?X4.BY6YI)[?9_P_P![S^?4TGP[
M2J1Y7BJJO;:$5_+OKJO>VV^\_P 7RQ^&7Q:L"5;X:?$4QYSY7_"$>(RISR22
M+ /C Z9Z9XS7=:?X&^,EQ8S6\?PW^(L4;@YBC\#^(MC#D#)DLF8]L[6&<_C7
M^R3L3^XO_?(_PHV)_<7_ +Y'^%82P-&I/FG&$I6B^9P;=WRJ_P 277^M3SJO
M!>%K-.>+FY7C*[H0=FN6S2<[73D];7_,_P 7+Q%\&?BD8U<_#7XA&=RS2K_P
MAGB+@[L#Y?[-9@"#R-[?\!S@>?GX0_%@,0WPR^((P>O_  A?B3MG'33.^<'I
MTQWR/]LW8G]U?^^1_A2>7'_<3_OE?\*[J/-2<?>YHQ48J-K))*"2O=[)V^29
M[6!R:&#A&/UBI5LTW*4(Q;OR^;26NW]+_$Q'PD^*JYS\,_B"<\\>"_$>??.-
M-]Q2_P#"IOBI_P!$R^(7_A%^)?\ Y65_MF^7'_SS3_OE?\*/+C_YYI_WRO\
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LKP<CY1P1T(XZT5+<;_ F[)_@GM;R7W'=0P4:46E-M.2E\*6ZB^C[*WS/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>nt10015006x17_graphic5.jpg
<TEXT>
begin 644 nt10015006x17_graphic5.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M ,L*/^%7^!O^@'_Y4]8_^6%=]10!P/\ PJ_P-_T _P#RIZQ_\L*/^%7^!O\
MH!_^5/6/_EA7?44 <#_PJ_P-_P! /_RIZQ_\L*/^%7^!O^@'_P"5/6/_ )85
MWU% ' _\*O\  W_0#_\ *GK'_P L*/\ A5_@;_H!_P#E3UC_ .6%=]10!P/_
M  J_P-_T _\ RIZQ_P#+"C_A5_@;_H!_^5/6/_EA7?44 <#_ ,*O\#?] /\
M\J>L?_+"C_A5_@;_ * ?_E3UC_Y85WU% ' _\*O\#?\ 0#_\J>L?_+"C_A5_
M@;_H!_\ E3UC_P"6%=]10!P/_"K_  -_T __ "IZQ_\ +"C_ (5?X&_Z ?\
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MC_A5_@;_ * ?_E3UC_Y85WU% ' _\*O\#?\ 0#_\J>L?_+"C_A5_@;_H!_\
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M4]8_^6%=]10!P/\ PJ_P-_T _P#RIZQ_\L*/^%7^!O\ H!_^5/6/_EA7?44
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M "IZQ_\ +"C_ (5?X&_Z ?\ Y4]8_P#EA7?44 <#_P *O\#?] /_ ,J>L?\
MRPH_X5?X&_Z ?_E3UC_Y85WU% ' _P#"K_ W_0#_ /*GK'_RPH_X5?X&_P"@
M'_Y4]8_^6%=]10!P/_"K_ W_ $ __*GK'_RPH_X5?X&_Z ?_ )4]8_\ EA7?
M44 <#_PJ_P #?] /_P J>L?_ "PH_P"%7^!O^@'_ .5/6/\ Y85WU% ' _\
M"K_ W_0#_P#*GK'_ ,L*/^%7^!O^@'_Y4]8_^6%=]10!P/\ PJ_P-_T _P#R
MIZQ_\L*/^%7^!O\ H!_^5/6/_EA7?44 <#_PJ_P-_P! /_RIZQ_\L*/^%7^!
MO^@'_P"5/6/_ )85WU% ' _\*O\  W_0#_\ *GK'_P L*/\ A5_@;_H!_P#E
M3UC_ .6%=]10!P/_  J_P-_T _\ RIZQ_P#+"C_A5_@;_H!_^5/6/_EA7?44
M <#_ ,*O\#?] /\ \J>L?_+"C_A5_@;_ * ?_E3UC_Y85WU% ' _\*O\#?\
M0#_\J>L?_+"C_A5_@;_H!_\ E3UC_P"6%=]10!P/_"K_  -_T __ "IZQ_\
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MZC\-?!,&GWT\6B[)8;.YEC;^T=6;;)' [HVUK\J<,H.&!4XP01Q7I59^K?\
M(*U/_L'WO_I-+0!R_P -R6\$Z"6))\FZ&223A=0NU4<]E4!0.@  ' KN*X;X
M:_\ (D:%_P!<KS_TXWE=S0!P/PO_ .1&T/\ [B?_ *>-0KOJX'X7_P#(C:'_
M -Q/_P!/&H5WU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%?%_[6'[?_P"R_P#L8V]G;_&GQW)#XNU;2[G6- ^''A/3
M9_$WCO6K&WD\E+E-+MFAT_0K.]N%FMM+U3Q?JWAS1]3N;34+>QU&>;3KY+<
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MJ:1K&DZE;1WFG:II>I6,L]EJ&G7]G-#=65[:336UU;2QSP2R12*Q^&/VO?\
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MVG:_HVJ6]YX%TZPET_7=1UBY\'>.+#2/&?A_5=<NM,CCT*]L="_X234+U/$
MG^E_VY=%_P""HVI?$KPK-^PUXM^'WA_X:IX'MH_%5KXNMOA]-?S>.!KVNM<W
M%NWBWPSK=^+0Z"VA1JMO<Q6GG1S%8!,9I'_*JX_; _X*O?L__MI?LJ_L[?M/
M?%+P/+9_&7XF?!R+5M)\,>#OA5J$&I^ ?&?Q7M/ VL6K:SI'@ZQO-,O+N*TU
MBV$EG/!>VJ-%=6UQ%*8W0 _I=UCX4?"WQ#J5UK.O_#;P#KFKWK1M>ZKK'@[P
M[J>I7;10QV\375]>Z=/=7#101101F65RD,4<:D(BJ/YC/VE? _@JQ_X+O_ '
MPG9>#_"UGX5O/^%5?:_#-KX?TFW\/W7VCP[KKS_:=&BM$TZ?SW1'F\VV;S&1
M6?<5!']6-?R[_M/_ /*?_P#9X_[I+_ZC?B"@#^D"S^#7P@T^[M;^P^%7PVL;
M^QN8+RRO;/P-X8MKNSN[:59K:ZM;F'2TFM[FWF1)8)XG26*5%DC974$>D5\5
M?MV_MJ>%_P!A+X1>'/BYXL\$Z]X\T[Q%\1](^'$.D>'=0T_3;VVO=7\,^+_$
MT>I2SZDK0/:PP>$+FU>)!YS37D#J=D<E?F!X._X.$O@YXQ\7>%?"-M^SS\3+
M.Y\5>(]#\.6]Y/XH\+206L^N:G:Z9%<S)''YCQ0272RR(GSLBD+\Q% &-_P5
M$^V?M+_\%&OV%_V'-7:[N?A7,^D_%7Q]H$%_>:?;>)(M1UOQ2NOV]VUO<6CB
M[TSX>_#S7K+1]3MI5O=-7QCK*Z?*MS/+&W[)?%3]CO\ 9Q^+OP4N/@#XD^$_
M@JS^'46CRZ9X8TW0?#FDZ-+X$NOLS06&N>"9K"T@?P]K.FN4FAN[ Q?:@LMI
MJ27MA=WEK<?BM\8[P:1_P<,_L]7>MQF.PN_AW;V>DMJ;_9K68ZK\'?BSHFGR
M:=)= 0R@>))Y(;5+;/GZS'+:0D7Q8#^D2@#\!O\ @@C\7]>N/@+\=_V?_&DM
MVUS^S1\2#):/.YECTCPYX['B*YN= M8%!G6/3_%_@SQMJ[ IF277FCC&8BH\
ML_X(U^ =!_:Q^+O[5_[>7QK\+:7XU\=ZS\6+;2/AW>>*(H]=3P)/+8W.O:Q;
MZ%:Z@]S;VUQHWAS5? ?ACP[J(M5N]!T'2'TS1KN"UO+Z%O.O^"0*7VJZK_P5
MNU#P]<R7\%Y:P)I8TB::ZDU.^U*Y_:)GT2YTL6(D2]D9(Y1936[M,6O(?L@D
M%PQ'TI_P;M:A8R_LE?&'2H_LW]IV7[1>LZA=[)HFO/L.I_#3X:6VG>? O[^.
MV^T:3JGV2:3]U/+]M2'Y[>>@#FO^"Y?P$\(?#CP/\+/VU_A-X<L?!'QU^'OQ
MK\%VVK>-/#%I!I4^JZ?)::UK&A:YXABLXXX=4UWP_P"+= \.6^EZQ<H;_P"P
MZA<Z?=W-S:0Z=!9_N[\(/B#:?%OX2_"[XJV%HUA8_$WX=>"?B#96+NLKV=IX
MS\-:9XCM[1Y5)61K>'4DA9U)5RA8'!%?E1_P7DN;:#]@/6(I[B"&6]^+'PVM
MK..66..2[N4N=5O&M[9'96GG6SM+JZ:*(/(MM;7$Y410R.OQU^T]^V=K?P0_
MX)W_ +#7[*'P[\3Z=X;^-'[2W[,OP/TS4?&VO:K'X?\ #_PR^$/B/P9H6@7>
MN:EXLU5[>UT"ZUHS3^'H-4C$Z>%M!TKQ9K)N=(O['PQ=W@!P?[>OQ%\8_P#!
M33QM^T'X2^$^MS:?^Q]^P9\)?BU\4/%_CC39'N=,^*?QI\(>!/%5]H%IIDRF
M33=5T]M3TJXT3PW+$I@A\*6WCOQ=;ZQ<GQ)X6T]/T(_X(0?\H_\ P[_V5'XE
M_P#IRLJ\J@\<?L ?LR?\$S_CI^S3\(?VG_@+XL\4ZG^SA\;K?4[K2/B+X/E\
M1?%+XM>+/A7KFEWNJ0:7:ZO<WEQJ&NZFNG:'X;T=)+VZLM&L]!T"*XO&L8YI
M<7_@AE^TG\"M(_9E\#_L\ZG\3?#5G\:]=^(_Q(O='^',T]P/$6H6DBG6TGMX
M1;&W9&TK3;^^!:X4^1:RG&X!2 ?;G_!1;Q_^W/I6D?#3X4_L,?#?^W_&'Q;7
MQS#XQ^*D\5I'9?"+1?#0\(1V4\6KZ_<67@[1=<\3_P#"2:DVEWFO3ZA?FS\-
MZROAGP]J6KJFH:+^#W[(O[-7CG]E7_@M'^SU\-OB=X^B^)7Q'U7PO\0OB#X[
M\5P/JEU%=^*_''P"^+VKZU$NL:W*VL^(WCO&D:?Q'JEOI]]K5S+-?7&FV;RF
M(?V$U_.1\0/^5BOX'_\ 9+M6_P#6<?B_0!_0+\1M'\5>(?A]XZT#P-XBA\'^
M-=<\'>)M'\(>+9[1[^'POXGU/1;VRT'Q%+8Q36\E['HFJ3VNIM:)/ UR+4PK
M-&7WK^=?_!-G_@F_X?\ V(O!?B6\\<-X*^(WQS\5^*]:OK_XHV&CRSWUAX08
MVUMHGAG1-3URSCUC3;>Z6TD\0>(X;<Q"]US4WM;J[U>TT31[M?U&KY'_ &SO
MV0?"7[:_POT'X2>./&OC7P1X9TOQ[IGC?4KOP%-I%KKNL+I?ASQ5H,6A->:W
MIFLV-I83S>)4U&YD;3+MY&TR*U"*EQ)(@!^%'[0FA^%?^'Z'[-=I^R%9:-9^
M*[*?P+JO[0L?P^2VL='MKI?$/BR\^,$OB 6 M]-BUF]^"\MLOBGRW,6HWM_8
MVMTL_BN\U*&?^H^OY*/&O@#XH?\ !!KX\^!OB)X'UO0/C9^SY\=;F_\ #WBF
M+7? NBZ7\1K'2_#=]IM]J/A;_A+8(YK[3-2&F:G;:UX>NM(US3O#/BO5M)O)
M/$W@B)= TRX/]:<4L4\44\$B2PS1I+#+&P>.6*10\<B.I*LCHP96!(92"#@T
M 24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6?#7X6^,O$_P@UG1='L-)UKPIXB\)>&[_6M#TC1;VPMH9;7P]JUWIUOI.L:
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MHOB6QNM+N;/4(KG0M3GM=4B-I=03,UJ$61=QK^;S]B'_ (*.:I_P3ST[Q?\
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M0+*]FMH);B2%/K#1O!G@_P .WVHZIX?\*>&]"U/6'$FK:CHVA:7IE]JCAY)
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MV4;R16J23M+.TDK_ )G_ /!4#_@F_P#L4_ 3]ACXX?%GX2? S2_!WQ"\*?\
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M    % #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** /._AO\ \@[Q!_V-VM_SMJ]$KSOX;_\ (.\0?]C=K?\
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M$[1E\1_#;QWX-^(7AYI#"NN^!_$^B>+-&:5<[HEU30;Z_L3(,'*"<L,'(XH
M[*BBO+M0^.'P5TGQC;_#O5?B_P#"[3/B!=X^R>!M0^('A.S\8W67$8^S^&;G
M5H]:FS(1&/+L6RY"_>(% 'J-%%% #6945G=E1$4L[L0JJJ@EF9B0%50"220
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M>$?$Z>"/%?QI^$OACQG(J-'X1\0_$;P?HOB=UD!:-DT#4M9MM5974$H1:$,
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MJ?XBZE?/K_C*S\8>&;6:YD\*:Q;7VKQ#3?#UY=ZE-9>$7\-26VN>)=+N-/\
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MY&G:/'IWU;\#/^"'G[(%UX;\/_$SXU^/?B%^TOXF\7Z'8>+?$/BF]\?7.B>
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MM?ZG>33WVJ7,$FHWT\][=3ROZS_P4!_Y,=_:W_[-X^+7_J%:Q7R[_P $2O\
ME'%\$O\ L-_%K_U;/C.@#]7Z_$']I=4_:2_X*^_L>? N..+5?"7[*7@/Q#^T
MEXX%G<L9=*\6:A=V=UX6AU6",A4;3M=\/?"&_M1.239^+)@BK'=,)_V^K\0/
M^"6)'Q\_:4_X*#?MQ7)M-5TOX@?&&'X+_"G7PACO/^%??#NWAD"*@!A^QZKX
M47X1,\D4LHDOM#N0S%HRS@'[?U\A?\% ?^3'?VM_^S>/BU_ZA6L5]>U\A?\
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MK]G;2QLM/C:&PL[6RA9S*T5I;PVT;2,JH9&CA1%+E412Y!8JB@G"@  _#O\
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M*\EG'?+:^)O&.O\ CSPWKT%C!*;C^QM1TWQ,=(AU&>&+[7K?A_7H@9'M7ED
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M#?B_PGJUXTB#Q1X4U/3?&5G>>'XO$,6I:KH.MV)U07]Q?6>EWD'VQ_P;P?\
M)E?Q/_[.B\:_^JG^"=<3_P %B?\ D]3_ ()3_P#9;/\ WK'P*H ]E_X++_M2
M_%/X8:%\ _V:O@5XRD^'GQ*_:<\;2Z%J/CRUUN'0+GPOX/MKW1/#2VK:T%%_
MX93Q)XA\7:?-)XKTVYL[O2]*\+:[!',IO3)#YEIG_!(C_@E]%\)_^$,USXO6
M.M_$Z?36%[\<!\;]*L?$)U^;S9YM2LO!R^(I_ 46EB[EV0:3?Z%JE^--BBM[
MK7[O4C/K,_C'_!?7X;Z7IGQ4_8Y_: \;>&M:\5_""RURY^'/Q4T[3]0O[.&;
M2;#Q)I7C2'PW;36U]9-I6L>-/#,GCZWL]1TZ>ROG70"TM_"=/T]X_NG0/^"/
M7_!+GQ3X3TCQWX=^&4NK^#->T&S\4:/XGL_C/\4I-$O_  [J%BFIV>LP:@?&
MHMSI\VGR)=BY9UC6 [W*@-@ \!_X)(_M!?%+PM\?_P!H;_@GO\5?B5+\9],^
M"=CJ/B+X,_$VYU&'49;OP+X<U_1?#ITR"_;5=;GN=&UC1?%7@_Q%X5T/^U]4
M_P"$/M(=>T*/4;K3+?3H-._H K\%/^":VC_\$Z-4_:J^,5G^Q[\"?BKH/BWX
M):?XH\-:K\:I_'FJ>+_A!XBT&]\3-X;M(]%O[KXEZ^+_ /X3@:1<>(?!S3^&
M6AO]%T/4]3COK22R@6Z_>N@#\0?^"L(7X\?'#]@7]AFU2/4[+XL?&Y?BK\3M
M+MKEH]2M_AU\/+6:TO9)88B)#8:EX9U+XEWL3NRQ?;?"2R -);"2']O@
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M444 %%%% !1110 4444 %%%% !1110!YW\-_^0=X@_[&[6_YVU>B5YW\-_\
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M\_\ 3C>5W-<-\-?^1(T+_KE>?^G&\KN: .!^%_\ R(VA_P#<3_\ 3QJ%=]7
M_"__ )$;0_\ N)_^GC4*[Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(=8-I_PB>D:IIT<T=G97%I%?Z%JFEZ9JNFIK-QJTFD?K%7PU\3]-^!G_  4
M\.?$KX$>%_C[\5_"5_\ !/XG_P#"/_%L?!'Q#J'PU\9Z7XDLM)\4:"_@[Q#?
M^)?"-[%K7@_4'O-0OR=)M;S0M<U3P[9M#J]Y::??65P 8'_!/3]H?XK_ !R\
M$_&?PG\;'\/ZY\2/V;_CSXX_9^\0_$;PA8+IGACXGS^!DT]1XPMM,@Q9:1J]
M]]J9]:TG34@TZV:2SNK2RTN._P#[(T_W[]K#X_:5^RW^SG\6OCWJ]DNJ1?#K
MPM)J&F:3([PPZSXGU2]L_#W@[1;FXB#2VMGK'BS6-%TR\O(XY9+.UNYKI(9F
MA$3_ )U_\$LX=:^!/Q1_:]_8)CE\.>,O O[,GB?P+XB\*_%30/"NC>%]8UN3
MXM:%/KEYHGQ(?2+A8_$/B[2H+"STB#79[2XU1QX=UO3=1U/^S=-\-:98>V?\
M%AM%U#7O^";_ .TQ8Z;;7%W<0:3\/-:DBM;::ZE33_#?Q@^'WB+5KEHK='D6
MWLM+TN\O+RY91#9VD$]Y<O';P2R* ?&VKZC_ ,%2OA-^SOIW[>_B7]I3PKX]
MN;/P]I'Q>^)/[(LWPS\,Z)X$L_@_?6ZZ]<^&M \;VL$VOV'BSPKX?U22_P!6
MOH88[R=K-K2;Q+XK'AZUB\5_MU\*_B'H7Q=^&7P\^*OACSQX<^)7@CPKX\T)
M+I52[BTGQ;H=CKUA!>1J2(KR"VOXX;N'.Z&YCEB8!D('QC^U)\0_!UW_ ,$N
M_C#X_BFT>Q\)>,?V-]:;PX1=6J:2&^(WPL&C^"[/3[@0Q6TK7.J>(M%L=%C@
MAA-W>364%K'%)-$%];_8.T^\TK]B?]DRQU"![6[A_9V^#[36\HVRQ>?X$T.X
M1)4ZQRB.5/,B8!XGW1R*KJR@ ^L**** "O)_B)\7-'\ :CHOAV+1/$/C#QCX
MBBN;C1O"GA6RCOM3EM+5@DVHWQDFABT[3$<NIO9RRGR+ITC>.TNGA]8KD]>T
MY&GO=3\.6?A-?B*= N-/T75-=M%>>/3_ +5%,;>\N+%4UR308K^2&YN+&UN(
MH);LQ9>":59UZL&\.J\7BJ4JU*TOW:JNC!S::INM4BG.%",VI573M-PBXQE!
MOF6&(]K[*7L9JG.\??<%4DHIIS5.#:C*K**<:?->*FTY1DERO!\ ?%+0/B!!
MKRP66L^&]9\*7,5KXI\->*[%=)UO07N(I;BSGOH1/<6WV&_MH)KJQO(KF2*>
MWC>1O+*L@\ZM_P!I?PM+#!K\WA/QS9_#F[U:31K7XG7.DV@\*-.E]+IJW]PL
M>HR:O9Z'/?1?9(-5N=-1!=.EO<0VTHD6/PS3YO$NC#]JK0/B"J3?%W7_ (7Z
MEXHGU73'0^%]4\':1X:O]%TP^&H$L;&_L7TXWYLIEO!+->74<$DS?:+>XDG]
M*U>VTH_L6Q12@+9_\*7T2Y&(N/[5&BV%Y"=@A;EM<$9:79]XF8S+S./J)Y1E
MU#$04Z4Z]'&X[*\'1=+$2E"E3QN#IU\1B,+5C&^(2KU'#!NO#6G2DJ]*563Y
M/$CF&,JTI<LXTJF'PN-Q%15**4JD\-B)4Z-*O3<K46Z4.;$*G/XZB=*<8)<W
MUN"" 0000""#D$'D$$<$$<@CK2U^?UE!XK\2>/\ X!^!(_&WBOPUHFM_LW>'
M+GQ.OA_69;"]NFMK*YGDELY7ANH;34[B^M-/AN=4B@BOSIBW=I'=(D[(^_X0
M^'>N^(_B#\6OA1J7Q:^*I\$_#FY\)7NE1V_BHPZ_>S>-_#(OOLNIZ^UE+>W.
MD:.+.3[#I*&&Q^TR+=RPR2^;YO%4R"C1A4G6S.E#V6%6.JQ6&KSE'"/'++E)
M<KY95I8B5/EI<RCR5.>56/*T=,,UJ5)0C3P527M*_P!5@W6I13KK#?6VFGJJ
M<:*FW4LWS0Y5!W3/N*BOS>^'_CSQOX['PW^#&I>./$MDMSXY^)6EZ_XOTR^N
M-/\ %NI^'_ FDVVIZ/IT&MAI)4DO[BYNH-3D5YKY+*ULR]PZ-*EQ[1IV@:IX
M$_:-\%^&;#QKXTU?PEJW@?Q3JL/A_P 2>(;_ %J#3;RWEC@:.&YNY6N;NR5$
MMY+*'4GO)["87307(CN?*B6)X=EA)UJ-?&TEB(83&XZC3C1JRC6PN$G7IJ?M
M'RJG4KRP]64*<HOEIQYIS4G"$W0S=8B,*M/#5/8RKX;#5)RJ04J=?$1HRY>1
M7YX4U6A&<XRUF[1BTI2C]<T445\V>P%%%% !1110 4444 %%%% !1110 5XG
MXR_:'^$_@/Q'/X4U_P 17#:Y86?]HZU::-H6N^(3X=TWR1<?;M>?0].OUTZ$
M1/ [I)FYBBN[2YF@CM;B.<^V5\%?#GQ]X;^ OC_XW^&OBAIVLZ1X@\;?%'6_
M&/A/6K/PQKNMGQYH6N,USI.F:3-HFEWRSW&FM)<.UJSI;VM]JM]9&2.>UNE7
MCQ=>5!T4ITJ,:DY1G7K1<J5/EBY1BTJE)*55KEBY3BMTKR<4?1\/Y50S*.93
MJ8?&YA6P6&I5:&5Y;5IT<9BW5Q-.C5K0G/#8V3I8.G-U:L:>%JR=X2FZ=&%6
M1]B7'Q!\%VG@IOB-/XCTY/!*Z5'K7_"1"1Y+)M.E"B*2-8T>XEGEE=+:*QC@
M>_EO72PCMFO6$!Y;P/\ '#X<?$+5Y?#_ (?UB\BUY+%=5AT;7M#UOPWJ.H:0
M[.L>JZ7;Z[86!U.Q?8SF6Q,[PQX>XCA5E)_.7PS=7FM_";PWX<UC3Y]%T/6?
MVZM-\-ZOX8O'>.TT71+VTLM5NO"%U8SLI%C::G<W,\UK*RI'>6CR2CS7WCZ]
M_:5B-GX[_9B\0:?<?9=;M_C5HWAZ-H6\N[ET'Q*8;?Q'"&617:SELK5+6\38
MZ-%>;'9!(4FXX9A6J4_;QC35.G'"^U@XSYINO-1FX2<H^S4(M2@I0FY/FA+E
M?O+Z+%<(Y=@L8LKJU\95Q>-JYVL#BH5:$</AJ>6X55\*L50C0JO%3Q-13I8F
M='$X>G0I\E>DJJO"7UO17%_$C5+_ $/X>>/=:TJX-IJ>D>"_%.J:==*D4C6U
M_I^AWUW9W"QS))#(8;B&.0)+')$Y7;(CH2I^$[GQU^T-I/P$T#]HZ[^*=I*+
M"T\.SWOP[;P;H?\ 9.MZ5/XFL?#)FU'6TE?4%U'7%E@U>_GL8[$V7VJXL=,C
MT[RT9.S$8R&&DXRI5:G+1GB)NFJ=H4:<HJ<Y<]2%^7FORQ4IR2?+%V=OG,GX
M<Q&<THU:6-P&$]KF6&RC#0Q<L6IXG,,9"<\+AZ:PV$Q,8JJZ<H.M7E2H4Y6]
MK4@I1;_2"BOB#Q'XD^,WP8\>_"?4O'/Q2L_&GA[XC>(YO#7BGP\?"FE>']*\
M--<)%/;7.A7-G)/>R6^DK<2))<WMT;FZALEDNQ=O>'[$>%M8^.7Q,^&&K_'#
M2?BF/"AOXO%.M>$/AZ/"GA[4?#MEH6A7FK6<6DZ]J<UHNN7U_J?]E)(-:MKR
M!]-,S30V<R2-8PPL?%SE2^KXCVT.:4J/[CG5.,*4W4;]M[.S5:"45-S<FURV
MC)KJEPE6CAZ&.>;Y3_9N*E0HX?,?^%/ZO5Q=?$8S#QPD:;RU8N-2,L!BJDZM
M3#0PT:$(S]LY5:4)_;]%>1? 7Q'K7B_X/?#_ ,2^([Y]3US6= AO-2OY(K>!
M[JY:>=&E:&TA@MHR511MAAC3CA<YKUVNRG-5:=.K%-1J0C-)VNE.*DD[-JZ3
MULVK]3YS&X6I@<9B\%5E"57!XFOA:DJ;DZ<JF'JSHSE!RC&3@Y0;BY1C)Q:O
M%/1%%%%6<P4444 %%%% !1110 4444 9]SJVFV=]IVF75];0:CJ[72Z9922*
M+F]-E;M=79MXOONEM;J9)G V1@H&8-(BM#K.O:)X>M?MNNZK8:3:EBJS7]U%
M;+(X&?+A$C*TTN.1%$KR$<A<5\]GPIJF@?%_X7ZIK_B2\\2Z[KK>.1=W$L4=
MK865II_AMFLK#3+*/*V\,+ZA=M*ZF-;AW$OV>&0R&3;^+$MG8^-OAUJUQI\7
MBMK)M:MSX+AMQJ.L3B_MT\C6M,TWRI(I1936FZ>>^>."-K> VI6X5KBV^*J<
M38ZGEV=XNOE]+ 5\NSO Y72H8JK[9TL/CL/DM>.*Q:P<ZOMJU*GFLZT\)@I5
M)2]G'#4ZDY\U9_7PX=P4\?E&%HXZKC:./R?&9E4K8:DZ7M*^#KYO1EAL*\5"
MG[*E4J9;&C#%8R-.,?:2KU(0ARTE[7I&MZ/K]H+[1-3L=5LRQ3[187,5U$LB
M_>C=HF;RY%R-T;[77(RHS6?%XR\)S:NV@P^)-#EUI97@.F)J=HU[]HC+"2V$
M E+M<QE'\RV4&>/:V^-<''SUX5OGLH_CEXLTNR'A"X71F>R\&^2+75=)N]+T
M2[DBUO4-+:W@B@CN[F075O-:&2VE,E\)"[Q*\FI=^#]'3]GVVGALK:+4K?PG
M9>+X=46-1J,6KM!#KLUY'?B,W27+EY;8.L@86["V5UA52O-1XKS'%8.-?#8/
M!RJX?+LWS/%J<\1&GB</EF/J8*A3P<6HU\-5S&-&K77UR$IX']W1K4*TI2G#
M>KPS@,/BW1Q&*Q<:6(Q^5Y=AN2%"57#U\QP-+&5IXJ2;HXBG@95J5%K"34<8
MG.K2K4HQC&?TK17/>$=0NM6\)^&-5OF#WNI^'=%U"\8*$#75YIMM<W#!%"J@
M,LCG:J@+G   Q7@ND_$;XKZ]X-U/QGIUEX,M]/\ #;:TVHQ:A%K'VG5X])5[
MR>2PB@E$5M##9.D""2[D>>_MKAFDAB985]_'<1X' 4\#4J4<=6>88+$9A0I8
M7#.O46&PD,+5Q,ZBC)1INE3Q=.;O*TE&<8.53DA/Q<'D&,QL\9"G5P=)8'%X
M? UZF(Q"HTWB,5/$4\/"FW%N:J5,-.":C>-XRFHT^></INBOG74OB/\ $32M
M*T'Q[?Z9X7A\%:S>Z6HT:"349_$,&DZQ&LEK?7%]((;)KHJ?,\FW@,:K+#&R
M2$RS0]E?>)_&&N>,-<\+^"_^$?LK;PK:Z:^N:MK]M?7IFU+58)+VRL-/MK&\
MM5\@01A+ZXED,D+-((XP\<7GX4^*LMK-TZ5',)8B57"T\-A'A)4\3C(X[#XK
M%X6OAH590C["KAL%C*SG7G1=*&%J^VC3DHJ6M3AG,*24ZE7 QH1IXF>(Q2Q4
M9X?"2P=?#8;$T:\Z<9OVU/$8S"4N2C&LJDL13]E*HG)Q]8HKS#X<^*_$GB*[
M\8V'B>TTNSO?#6MQ:2(M*,\ELV+4/+,L]PYDFBGD!GMB\4$L<$J13(94<UZ?
M7LY=CZ&:8.EC<,JL:-65:$8UZ<J-6,L/7JX>K&I2E[T)1JTIKEE:2LKI.Z7D
MX[!5LNQ53"8ATW5IQHS<J-2-6E*->C3Q%.4*D?=FG3JP?-&Z=]&UJRBBBNTY
M HHHH **** "BBB@#SOX;_\ (.\0?]C=K?\ .VKT2O._AO\ \@[Q!_V-VM_S
MMJ]$H _.?]O?]I'XS_##6?V=OV>OV;[70+7XZ?M8^,?%/A#PKXX\5Z<=8\/_
M  T\-^#])TN]\:>.7T8&2+5=9\.VGB+3=9TNSU&RU31F@T[4Y-3TC54CATV[
M\/U[XG?M:?L*?&7]F[0/CM\=[;]JWX%_M(_$C1_@K?\ B'5_AEX5^&OC[X6?
M$_Q08D\/:GITWA"=-,U[P=K.I37]W>6&LK=:AH>BZ?/9Z=<2R6-J=2]0_P""
MD'P3A^*,O[,_BWP%\=/A;\#?VH_A7\8+;6?V<+GXK^(HM'T+XB:UK<^B6'B3
MX:PV$4LVL:O+XAEM?"TLL.B:!XGNKI+%/#=QI,=GXGGU*Q_-?]O3P?\ MA^/
M?B'^P-8_M4^+?@=H7BW7?VM/AWX:^&GPK_9P3QY>6UWI=QJ&DR?$OXH^*=7\
M>2I=?VAX2NH/"%IX>LM+CET[0]'\3:I<:IJDEU,[@ ^O=2^(_P"US^W)^U#^
MT-\+_P!G+]H.U_9<^ O[*GB&R^'6M>--)^'^A>/?&_Q*^,EL;I]8LI+/Q#);
M06'ACPCK^BZAINI6EIJFGPZKIL-K#=V^M)XEN%\+?1G[ W[1GQ?^(U_\>_V<
M_P!I.31-1_:(_92\8:%X6\:>,?#5K!INA?$KPKXQL-0U;P)X^M-*M;/3K32[
M[6M.TR\EU33;#3[*UMHGTNZ.GZ5-J3Z59^0?\$Q[FVTKXU?\%/\ P'>6:6?B
MC2_VYOB%X]OEGB-KJDOA?XF7>I7_ (.GFM9H(KK^R[B#1-4O='O&DDM-0BO+
MBZL56%S-<N_8SU"R\3?\%+/^"JWB;0C:W.A6FI_LO^#Y[ZQFBFM/^$E\*_#;
M6O#WB/3_ #8@J-J&GZUH>IP:O  TMC?I);W9$Y!< _72BBB@ HHHH *R-8T_
M0=033QK]CI%]'9ZK87^E#6+:RN4M=<@E*:9>:>+U'6#589I2MA<6VV\CED*V
M[AWP=>O-_BE\.;;XF>&H-&;5)]!U;2M:TKQ-X9\0VUNMY/H/B'1IFDL=22QD
MF@@O56*6YMI;:>58WBN796CF2*5-\*J;Q%%5J\L-2E-1GB(0E4E1B]'4Y(-3
MDHWO)0O/EORQG*T7E7<U2J.G2C6FHMQI2E&*J-:\O-)<J;^RY6CS6YI15Y+Y
MY\2R^.-"^/OPN\1?%O\ LB]\+7&L:YX9^&;^#3+%8Z%XD\56RZ;!'XL@U:S-
M_J%YJ-CY<$$]I>I:17=K]NM;>U1;FT;L_P!FV,"Z^/<UP%&IR?M >/H[LJK8
M\B+^SFM%1W7>T"O-=>0K.VR,@A5#Y>YI/P;\;ZWXL\*^*/B[\0K3QG%X#NI[
M_P *Z+HWARW\.64FLLL"6_B'6I;><M<WL/V>.XAT^&)+2UNT5H)_LKW=I>2:
M_P#"+Q]8>+O%7BCX4_$.P\&0^/GL)?%.D:IX8M=:M[;4[.U-D_B+0I3-%Y.I
M30?O+BTN83!>WDDUU=W4A-M':?55\7@,1AO[.^NX*C5>74*$L51HXRGEJGAL
MRJ8F%&,/JSQ$93H5JE:M56&5.IBE9WG.51^'2P^*I5_K?U;$U(?6ZM54:E3#
MSQG+6P=.A*K*3KJBXQJ4HTZ<'6<XT=O=C&"Q/V3HH8/"GQ*@LW9]*A^-?CN+
M1@P*A-+CAT1+=4C*1>4I<2N8Q%&%=W/EH25&)\38/$GB3]I/P?X$L?&?BGPO
MX;UOX7W]SK\7AO5Y--NIX;;5M;F5K!VANH++4)[NTTV"?4H8(K[^RTNK.*ZC
M28H_T/\ #;P#I'PR\&:-X.T=FGATV%FO+^52EQJVJ7+&?4M5N0TDS++>W;R2
MK"9I5M8/)M(G,-O'C$U#X9?;_C#H/Q8_MORO[$\'WGA/^P/[-W_:OM=Y?7?V
M_P#M7[>GD^7]M\O[+_9LN_RM_P!I7?M3D_M3#/.<UQZDE"MA<?#!U*U'VDI5
MY4/986JZ;A44*LYQC44IJU*;O*2Y;F_U*O\ V=@<*XOFIUL++$0IU.11I*JI
MUX*:E%RA&+<&HN\XJR3O8^<O"'P[UWQ'\0?BU\*-2^+7Q5/@GX<W/A*]TJ.W
M\5&'7[V;QOX9%]]EU/7VLI;VYTC1Q9R?8=)0PV/VF1;N6&27S?-X#X?^//&_
MCL?#?X,:EXX\2V2W/CGXE:7K_B_3+ZXT_P 6ZGX?\":3;:GH^G0:V&DE22_N
M+FZ@U.17FODLK6S+W#HTJ7'VSX9^'W_".?$/XG>//[7^V?\ "Q_^$+_XE7V#
M[/\ V-_PB&AW&C?\?WVV?^T?[1\_[3_QYV/V3;Y/^D[O-'RAXT^&OAOX.6/A
M"35/'FO>'->O?B?XO\2>%OBOIWA6QN-$\&WOB33-.2Z\.^*M*O=:N1?:=K-E
MI\T=O/&2));29KJ"UT]+T7'LX+,\+CJU;#RE3JUJF#R^6 Y<"Y.EFD<DKPQ^
M,]G3PSG4E2S&;K5E&,YXATXSP]/$.%*#\[$8*OA:=.LE.G3AB,4L5?%64\$\
MSHO"8?FG648QJ8.*ITVY1C24Y1JSH\]22[[3M U3P)^T;X+\,V'C7QIJ_A+5
MO _BG58?#_B3Q#?ZU!IMY;RQP-'#<W<K7-W9*B6\EE#J3WD]A,+IH+D1W/E1
M?7-?"7POCO\ Q7^T?%XBM_B*WQ;@\)^!=0L?$/C&ST73]!\,Z=-JE[-'HWAO
M1+;2VN;6XN,->ZA-=B]NENXC+BX:2RD1ONVO XBA*GB,!3JU(U:\,KP_UBHJ
M52C*56=7$5%*I3K4J%93E2G3DY5J4*M2+C5FKSN_5RB49TL5.$)4Z4L;5]E!
MU(55&$:=&#4)TYU:3BJD9I*E4G3@TX1;40HHHKY\]8**** "BBB@ HHHH **
M** "F2^9Y<GDE!-L?RC("8Q)M.PN%^8H&QN"\[<XYI]% +1W[=]OF?F1\(-7
M^!ND_ 7Q]I?Q5C\--\4S?>.H/B)I'BN72I/B#X@\3PW^I2Z;%IBZIY^LWM^@
M>SBT^:R6;[)XB%]>H8[Q[B=V>!=6U3XF:'^P_P"%/&%U/K>D:QJ?Q4UO6[?4
M0)[;69OA;)JD/A&*_:02&_&GV=FUO=6]RLD5['.OVSS?-9AZC=)\<[*X\0Z+
MJWP/\/>.OBB6U+3O!?QYMK?P3I5HFD:CYT&FZQJ\TNGQWVG7?AV&2-VTJVB6
M34%M5MA!D+?:AT.O? WQ%X \%? :\^&VG0^+?%GP)U.ZN9M&EO[71T\4Z;XK
MMY5\?QZ==:BCV]E?7^H2_;--%U,$M+9IU O;N.VAF^;A0J\L%&G-TL/0HTZD
M?JU2C5J*&-PE64:D;R6(JNC2K\ZH\\6YMQE+V]C]IQ&9X#VU>=7%8>&.S?,L
M=B\#7_MK"8[!X.KB>&<[P-&KA9Q5*>58"&8X_*OJ\L?]5Q$(8>,:U&B\KYG8
M\1:;%X'_ &MOA)<^&+6ST>Q^*'@[QMH?BZQTZVAM;?56\):5=:]I^HWEM!!'
M"U_#.=.M8M1):[^R0&RWQV[,DW??M'_%7Q'\'_!OAWQ+X9TNRUJ]O_'GA[P]
M<Z7>).S7^G:A;ZI<7-I82V\BM:ZC<M8Q6]I=O%>10/*7>RN>$KE/!7A_QQ\2
MOC/8_&/QMX*U'X=:+X(\*77AOP7X>U>^TV]UK5]4UJ:^36]=OUT^1FTVUMK&
M7[!!I]RKFY:2"_MI]@GC;H?VF/ ?BOX@^$_!FF>$-*_M>^TGXH>$?$6H0?;M
M-L/L^C:7'JBWUYYNIWEE#+Y!N81]G@DDNI=_[F"0*^WNM66%Q]3#JK!U:\JF
M&4:<HU%%PHPE*-*45)<]6-6HDX>\I<]FI7?RK>7SS[A3"9K5P6)A@LMPV$SN
MI4Q5&IA955BLQQ%.C6QU*M*C4>'P-? X2=2%=JE*C[#FC.BXQ\\UKXE_M,^#
M_''A;P)K.C?![7M7^*=GXD7P-)I4_BVQTSP[JOAR&PU'4G\33W*RW>HZ/I^C
MSRW#Q:?:PW^H7./*N[../R),RX_:1\>_#*Z^+GAKXN:7X8UKQ)X$\,:/XJ\-
M7O@M;^STWQ!%XBU+3=%T_3+BVU*::[@-OJ^M6$=Q,@%PEE!J$J6]YY$%Q=>U
M?$#P9XEUOXW_ +/OB_2]-^U>'? __"U_^$HU'[980_V7_P )+X1LM+T3_1+B
MZBOKW[;?0R0?\2ZVN_LVWS;OR(2LA^<OCY\$]:\6>//BYXKUF\T;PAX/U'X7
M^%].\/>.?$.N:1IVBVOC#2?%/AV\L[+42]]_:&F6U\T$NF-J=Q8K;0F\$D+7
M$PBMY<L0L91C7G1J8B;IUW3I*I[T'1E@HU95)-PM)1Q$I)5)/EBX*GS12DGZ
M645.&LQJ95A\SP>38>EC,JI8K'SPBE2Q4,QI<43P,,-1C3KRJ4JE7)J-.I/!
MT:;K8BGB)XOV564Z,H]QX]^(?[2OPPT/PUXA\3P_";5+/Q#XE\-:%JMKH6G^
M)+>Z\)W&M:A'"8HFOM9G@U^R>UCDMWNQ)975IJMS#)'!>Z=&[#[-K\Y_CMXS
M^-'B/PG\/-)\:_"[3/ =G=?$OP"D^HQ>.="\4S^*]774'^RZ;X:T?1(KBZ@B
MN6!UEI;NY$D-O:FQ5KAV$ES^C%=6"J<];$QC/$2IPAAG%8F-2$XRE&HYVC5A
M"=I6BVVK7OR^XHI?/<1X14,MR6O4P^44<7B,1G$:T\GK86OAJM*A/ QPRE4P
M5?$89RIJ=6*4)\W*TZR==U92****]$^/"BBB@ HHHH **** "BBB@ KRCXH>
M#O#NI:'XI\5:AIT=[K.E>!?$5KIL]P\DD-DL>F:I<K/!:%OLWVL2SEDNI(WF
MA,<36[1.FX^KUC^(=)_M[0-<T/[1]D_MK1]3TG[5Y7G_ &;^T;*>S^T>1YD/
MG>3YWF>5YT7F;=GF)G</-SC T\QRW%X6IAJ6*E*A5EAZ5:%.<?K4:4_J\X^U
M]R-2%5QE3J-KV<TIJ47%27H95C*F S#"XB&(JX:,:U)5ZE&=2$OJ[J0]O!^R
M]^4)TTXU*:3]I%N#C)-I^67=_HFF_ 33;CQ%%=3:1)\/O#EE<PV/DB]=M1TG
M3K"W^R&XS"EPES<PR1RR+(D!3SVCD6,HWFVJ:7XZTO0O E]\3);&X\">&-3T
M*[OK+2'W:[9/!ML=#F\02WELMOJ4$$MS!9ZLEC)%+(LTDJ>=.%E'OL_@73M0
M\ VO@#5II+RQ@T#2]$DO(4^RS/+I5M:QVVHPQ^9.L$T=S:0WD<+R7$0=1#-]
MHB+A^*E^&WC#7EL-(\:>.HM:\+:==V=U)IUCH4.EWFO"Q<2V\&LW4=S((X%D
M5/-BM@_V@(LI:*Z2*XB^&SC(\VQ"PD:>#Q564,@RW X987$X.EA(9EA\1*O7
MAQ!"KB*<\9E<'3PDJ=/#1Q-Z:S&$8JMB,.Y_995G&6T7B93Q>%I1EGF/QN(>
M)P^+J8F>7UZ,*-&>1RI4*D,+F4E/%*=3$2H-3> G*3HT:ZA+X,7/Q?\ C#).
M!]H2'P*EM@,0+1]$E9]C,#@%HX#(JL%:7>0IVY6#X;1QQ_$?XU+;,3:'6?#<
M@7&U1>RV.I2ZBP3:@W-</AGP3)M5BS\.W0>)?!.NS>)/^$O\&>(+70-;N-*3
M1M5M[_2X]0TW5;6&8S6L\P#QS0WMH6VI.!,9(HH+?]U"LJS;7@?P<G@_3KR*
M>^;5]:UC4KO6=?UJ2W6UDU/4KR5G:06R22QVL$,96*&VB?R4Q)*B(TSK7I8+
M+,PAF> H5,%4IX?*\^XDSN692J89T<91SEYJ\+AJ,*>(GB?;1><-5U6PU*G#
M^S^93:J8?VGGXO,<#++L=6AC(5*^99)P_D\<OC3Q"K86KE*ROZQB*TIT(X?V
M365?N'1KU)S^O6<$Z=;V?F?C.+6-9^,/A_PQ;>(M;T31]2\$W<VJIH]^]G/+
M'#?ZC(&M6,<T5M=R3P6<4MY'$ES]B6>W294E*MD>'_".IZOXK\=^!;SQYXY/
MAOP?-H-Q8I#KACU6YD\2:-]J\B]U0VS7$UAI_P!G;[+8KY=L)G$SQN^_?Z_=
M^#/M7Q TOQU_:6S^S?#]QH7]E_8]WG>?<7,_VK[=]J7R]GVC9Y'V.3=LW><N
M[:MC1?"?]D>+/&GBC[?]H_X2_P#X1S_0?LOE?V=_PC^FRZ=_Q]?:9?M?VOS?
M._X][;R-OE_OL[QC+AO$8G,WB<7AZ]2C6XHQE7$-X^<83R">05X4*3I4\5%/
M#3SJ&$E+"*'M'4_>U:7L/:2-EQ!0H9?'#X6O1A5H\.82EATL%%SAGD<ZH3K5
M%5J89OZQ'*98F,<2Y^S5/]U3J^UY(GSUI7C+Q/<>!-#\-OK]^FIZK\4?^%>G
MQ+O<:M#HD4L$DUU#=DMMU0K/':V\DKR2M$S;7,J"9.PU_P /WG@_QC\-$TKQ
M5XLN-,U?Q%):ZEI>KZ[>:G!<30V+R"Z$L[^<OVDM.][:L[V4TS0RQ6\#0X>K
MXF\$Z+X(\!W<.M:KJ\T4GC^/Q/9>)-&TN)+GPEJ5^\<=EJ5S:S:A*+G3[&:-
M;>[>.03SK>(+>V2X6*1><MGO/$WQ(^'L</Q!7XCW.C7%YJ][/IVC6&CZ1H6E
MK:1"26Z^P-<+-J&HW/V:%0TP-O*@MWA@\]0ORDXXS K!Y=FE.MB,WOPG1P,E
MFF&>(P%&&9TZ>)HSHO'K&8KZQ"G7G4K8+#8ZCB*5X8VM3CA9RI_2P>$QGUO'
MY;.E0RNW$]7&)Y;B%0QU6672J4*L*JP+PN&]A.=&$*.+KX.K0J6G@Z526*C&
MI]94445^U'Y$%%1S2I!%+-)G9#&\KX&3LC4NV!W. <#N:YW_ (2W2/[UQ_WX
M/_Q58U*]&BTJM6%-R3:4Y*-TM[7WL;4Z%:LFZ5*=11:3<(N5F]KVVN=-16/I
M^N6&IS-!:M*9$B:8[XR@V*Z(<$D\[I%X],GM6Q5TZE.K'GISC.-VN:+35UNK
MKL14IU*4N2I"4)63Y9)IV>SL^X44459 5GZM_P @K4_^P?>_^DTM:%9^K?\
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M:I<106EFAM[*UA2ULX&DCFO9+V]N_HZB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** /._AO\ \@[Q!_V-VM_SMJ]$KSOX;_\ (.\0?]C=K?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %>1_%/_F!?]Q3_P!QU>N5Y'\4_P#F!?\ <4_]QU8XC^#/_MW_
M -*B>AE7^_T/^XO_ *9J'D=?4FA_\@71_P#L%Z?_ .DD-?+=?4FA_P#(%T?_
M +!>G_\ I)#6&$WGZ1_-GIYY_#P_^.?_ *3$U****[3YP**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SOX;_P#(.\0?]C=K
M?\[:O1*\[^&__(.\0?\ 8W:W_.VKT2@#YN_:<_97^%_[5_@O1_"/Q%?Q/H>H
M>$_$VG>-? 'Q"^'^M_\ "+?$?X=>,-*8FR\1^#/$PM+[^S;^,'#QW%E>V4LD
M=I>/:'4-.TR[L_G3X>?\$Y/#.C_%CX<_&CXU_M ?'_\ :?\ &'P;DOY/A)8_
M&3Q-HE_X0\$7-U%:V]OXAM_#VE:!8MJ7C6WBL+":X\4W^HO+J6JZ?IVMWEBV
MJZ5I-U8?HY10!^?/QV_X)]>'/BE\8=;_ &@_AC\<_CE^S1\9/%GAFP\(^.?$
MOP=\365AI'CW1M-L!HUC+XM\/ZCI]R+_ %K2]#CMM-T+5;/4M/\ ['?3]+U2
MWM7U?3;2^C]X_9>_9=^&_P"R9\-YOAW\.YO$>M/K'B/6?&OC7QQXWU5=>\=?
M$#QKX@EC?5O%/B[6H[6QBOM4N(H+2S0V]E:PI:V<#21S7LE[>W?T=10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y'\4_P#F!?\
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M_AF[]JG_ (9F_L#_ (2C_A,_^+6>&OB7_P )M_:O_"._\([_ ,C%<V_]B?\
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MXFT(VMSH5IJ?[+_@^>^L9HIK3_A)?"OPVUKP]XCT_P V(*C:AI^M:'J<&KP
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M HHHH I:E_R#K_\ Z\KK_P!$25XI7M>I?\@Z_P#^O*Z_]$25XI7SF>?Q,/\
MX)_^E1/H\C_AXC_'#_TF1UO@W_D*3_\ 7A+_ .E%K7I=>:>#?^0I/_UX2_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;X6#1_!=GI]P(8K:5KG5/$6BV.BQP0PF[O)K*"UCBDFB"^M_L':?>:5^Q/\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SOX;_\
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M8N+2T*1[MWZUT4 ?)'[,7[(VF_LP77C*ZT_X^?M-_&H^,X-"@E@_:%^*=O\
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M:$I-W:;ZPBK:/KN84<53KR<(*::BY/F22LG%=)/6\OP?E?HJ***XCI"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KR/XI_\ ,"_[BG_N.KURO(_BG_S
MO^XI_P"XZL<1_!G_ -N_^E1/0RK_ '^A_P!Q?_3-0\CKZDT/_D"Z/_V"]/\
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MMW]'44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M110 4444 %%%% !1110 4444 %%%% !7%>/_ /D7I/\ K[M?_0FKM:XKQ_\
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M4I-1L(Y+^[=)+VU1T:XE971IXU964L058$@@\$$@UZU7BVE?\A33?^O^S_\
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MS9Z%1117H'R84444 %%%% !1110 4444 %%%% !1110 4444 %%%% %+4O\
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M%%% !1110 5Y'\4_^8%_W%/_ ''5ZY7D?Q3_ .8%_P!Q3_W'5CB/X,_^W?\
MTJ)Z&5?[_0_[B_\ IFH>1U]2:'_R!='_ .P7I_\ Z20U\MU]2:'_ ,@71_\
ML%Z?_P"DD-883>?I'\V>GGG\/#_XY_\ I,34HHHKM/G HHHH **** "BBB@
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M_84N/_2:SKPFO=OAI_R+\_\ V%+C_P!)K.N/#?Q?^W7^A]#G'^Y2_P"OE/\
M-GH5%%%>@?)A1110 4444 %%%% !1110 4444 %%%% !1110 4444 4M2_Y!
MU_\ ]>5U_P"B)*\4KVO4O^0=?_\ 7E=?^B)*\4KYS//XF'_P3_\ 2HGT>1_P
M\1_CA_Z3(ZWP;_R%)_\ KPE_]*+6O2Z\T\&_\A2?_KPE_P#2BUKTNN_)_P#<
MH_\ 7RI^:.#./]]E_P!>Z?Y,****]0\L*S]6_P"05J?_ &#[W_TFEK0K/U;_
M )!6I_\ 8/O?_2:6@#EOAK_R)&A?]<KS_P!.-Y7<UPWPU_Y$C0O^N5Y_Z<;R
MNYH X'X7_P#(C:'_ -Q/_P!/&H5WU<#\+_\ D1M#_P"XG_Z>-0KOJ "BBOR-
M_P""D7[>/CSX->%?BC\&_P!F3P'XT\9_'G0/AI=^.O''CVR\.SCP!^SY\.Y=
M*U'4[SQWX@\0:BL&D7OBN71=-U!_!&B))/8RZPL=S>MJ5[I\'@WQ$ ?KE17S
MW^R1XH\0>./V4_V9/&GBS5;K7?%7B_\ 9[^#'BCQ-KE\RO>ZSX@U_P"''AO5
MM9U6\9%1&NM1U&[N;NX9$16FF<JJ@@#N_C-\0;;X2?!_XK?%6\@>YM/AG\-O
M'/Q N;:/;YES!X-\,:IXBEMX]^%,D\>G-$@8X+. >#0!Z317X!_LX_#?_@I?
M\>_A#\*?B3?_ /!3_2_ ?B+XI^!].^(%E\.9?@-\)?$6MZ;X>UH?:]'NFGCE
MT:YOHKK29]-OYIDT>VBM)+X6;-(T0FE_=7P3I?B'0_!GA'1/%WB/_A,?%FC^
M&- TOQ/XN_LVWT?_ (2KQ#I^E6EIK7B/^R+1GM=*_MS4H;G4_P"S;9VM['[5
M]FA9HXE) .GHHHH **** "BBB@ HHHH **** "BBB@ KBO'_ /R+TG_7W:_^
MA-7:UQ7C_P#Y%Z3_ *^[7_T)JZ<'_O6'_P"OL/S,<1_ K?\ 7N?_ *2SPRO>
MO W_ "+5E_UTO/\ TKFKP6O>O W_ "+5E_UTO/\ TKFKV\W_ -UC_P!?H?\
MI%0\S+OX\_\ KU+_ -+@==1117S9[(4444 %%%% !1110 4444 %%%% !111
M0 4444 %>1_%/_F!?]Q3_P!QU>N5Y'\4_P#F!?\ <4_]QU8XC^#/_MW_ -*B
M>AE7^_T/^XO_ *9J'D=?4FA_\@71_P#L%Z?_ .DD-?+=?4FA_P#(%T?_ +!>
MG_\ I)#6&$WGZ1_-GIYY_#P_^.?_ *3$U****[3YP**** "BBB@ HHHH ***
M* "BBB@#AO$>M:CI^H+!:3B.(VT<A4PPO\[/*I.Z2-FY"CC...G-8L'B;67G
MA1KI2KRQJP^SVXRK.H(R(LC()Y'-2^,/^0JG_7G#_P"C)ZYRU_X^;?\ Z[P_
M^C%KY/%XG$1QM6$:]:,%5248U9J*7NZ)*5DO)>?=GUF%PN&E@J4Y4*,INC=R
M=.+DW9ZMM7OYGN-%%%?6'R85Y9XL_P"0Q)_UP@_]!->IUY9XL_Y#$G_7"#_T
M$UY.<_[FO^OT/_29GK9-_OC_ .O,_P#TJ!DZ5_R%--_Z_P"S_P#2B.O::\6T
MK_D*:;_U_P!G_P"E$=>TUCD?\*O_ -?(_P#I)MGG\6A_U[E_Z4%%%%>X>&%%
M%% 'G?PW_P"0=X@_[&[6_P"=M7HE>=_#?_D'>(/^QNUO^=M7HE 'S7^U)^RG
M\*_VNOA_8> /B?\ \))IO]@>)--\9>#/&?@?65\.>._ OBW24GBL?$/A77'L
M]0@M+Z."YN(7BO=/U"QDWQ7#6AO;.PNK3Y[^%G_!.;PMX5^+G@?XV_&7X\_'
MK]J/QQ\)[6^M/A%'\;/%-AJOAKX>27D-I9CQ%IN@Z;I=DFI>-CI]A:1WOB?5
M;NY;4]2@M_$=WI[>(].T75-*_1BB@#\^?CM_P3Z\.?%+XPZW^T'\,?CG\<OV
M:/C)XL\,V'A'QSXE^#OB:RL-(\>Z-IM@-&L9?%OA_4=/N1?ZUI>AQVVFZ%JM
MGJ6G_P!COI^EZI;VKZOIMI?1^\?LO?LN_#?]DSX;S?#OX=S>(]:?6/$>L^-?
M&OCCQOJJZ]XZ^('C7Q!+&^K>*?%VM1VMC%?:I<106EFAM[*UA2ULX&DCFO9+
MV]N_HZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/?B7_R+\'_84M__ $FO
M*]"KSWXE_P#(OP?]A2W_ /2:\K.K_"G_ (6=> _WS#?]?8_F>$U[M\-/^1?G
M_P"PI<?^DUG7A->[?#3_ )%^?_L*7'_I-9UQX;^+_P!NO]#Z'./]RE_U\I_F
MST*BBBO0/DPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6I?\@Z
M_P#^O*Z_]$25XI7M>I?\@Z__ .O*Z_\ 1$E>*5\YGG\3#_X)_P#I43Z/(_X>
M(_QP_P#29'6^#?\ D*3_ /7A+_Z46M>EUYIX-_Y"D_\ UX2_^E%K7I==^3_[
ME'_KY4_-'!G'^^R_Z]T_R84445ZAY85GZM_R"M3_ .P?>_\ I-+6A6?JW_(*
MU/\ [!][_P"DTM '+?#7_D2-"_ZY7G_IQO*[FN&^&O\ R)&A?]<KS_TXWE=S
M0!P/PO\ ^1&T/_N)_P#IXU"N^K@?A?\ \B-H?_<3_P#3QJ%=]0 5\@?M_JJ_
ML/?M<E552_[/7Q99R  78>"-60,Q RS!$1,G)VJJYPH ^OZ\X^,'PPT#XU_"
MKXB_"#Q5>:QI_AKXF^#/$7@;7K[P_<65KKEII/B;2[G2;^XTBYU'3]5L+?48
M;:ZD>TFO-,O[:.<(TUI<1AHV /)/V'O^3*_V0/\ LUWX ?\ JI_"5)^VK;?"
M:_\ V6?C-I7QT^(7B7X5?"/7/"\/A[QWX\\(V\UWKVAZ)XAUG2]$=+6W@\->
M+I9;75[F_M]#U91X?OE&D:G?M))81AM1M/9OA7\.]$^$/PP^''PF\-76J7WA
MSX7^ O!_P[T"]UR>TN=;O-$\%>'M.\-:5=:Q<V%CIEC<:I<6.F02ZA/9:;I]
MI+=O-);6-I"R01^ ?!G]BWX7?"#X!^./V;]0\2_$WXS_  [^(MWXHF\52?&W
MQ5:>+/$EY8>+=#TSP_JFB0:UHVB>%S9:5#9Z9'<:9]FMH]1TW4;FZO[74$G-
MNUN ?F;^T7_P30_8C^%7[$GC/XV?!H:_X=^(OPF^#B?%KX5?M(Z9\4O&4WC3
M6O$/@[PI8ZQX'U>'5X->C\.[/&#:7H^FZ5;^'M$TG2]*;5K>7P99Z#,ED\/Z
MI_L7?$'QM\5OV3/V=?B1\1R\GCCQI\(/ ^O^)+Z46B2:WJ%]H=I(?$DD-A;V
MME;/XGA\KQ$]G:6T%O9-J9M(HHTA"CXI@_X)$^ )?#^E_";Q%^U#^UGXN_9E
MT?5--U6U_9SU[XDZ=_PAEU%IFH6>HV_A75-6TWP]I^N3^ [:?3=/?2_#5C/I
MDVB74$FKZ3J]IKL[:JOZQ:5I6F:%I>FZ)HMA9Z5H^CV%GI6DZ7IUO%9Z?INF
M:?;QVEA86-I B06MG9VL,5O;6\*)%!#&D4:*BJ  7Z*** "BBB@ HHHH ***
M* "BBB@ HHHH *XKQ_\ \B])_P!?=K_Z$U=K7%>/_P#D7I/^ONU_]":NG!_[
MUA_^OL/S,<1_ K?]>Y_^DL\,KWKP-_R+5E_UTO/_ $KFKP6O>O W_(M67_72
M\_\ 2N:O;S?_ '6/_7Z'_I%0\S+OX\_^O4O_ $N!UU%%%?-GLA1110 4444
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MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6I?\ (.O_ /KRNO\
MT1)7BE>UZE_R#K__ *\KK_T1)7BE?.9Y_$P_^"?_ *5$^CR/^'B/\</_ $F1
MUO@W_D*3_P#7A+_Z46M>EUYIX-_Y"D__ %X2_P#I1:UZ77?D_P#N4?\ KY4_
M-'!G'^^R_P"O=/\ )A1117J'EA6?JW_(*U/_ +!][_Z32UH5GZM_R"M3_P"P
M?>_^DTM '+?#7_D2-"_ZY7G_ *<;RNYKAOAK_P B1H7_ %RO/_3C>5W- ' _
M"_\ Y$;0_P#N)_\ IXU"N^K@?A?_ ,B-H?\ W$__ $\:A7?4 %%%% !1110
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M **** "L34]?L]*F2"XBN7>2(3 PI$RA2[I@EYHSNRAX (P1SG(&W7FWC/\
MY"-M_P!>2?\ H^>N+,*]3#X:56DTIJ4$KJZM*5GH=N7T*>(Q,:55-P<9MV=G
M>,;K4W1XQTPD 07_ "0/]5;]_P#MZKK*\)3[Z_[R_P Q7NU<^5XNMBU7=9Q?
MLW3Y>6*C\7/>_?X4=&:82CA'05%27M%4YN:3E\/):W;XF%%%%>J>4>8^,/\
MD*I_UYP_^C)ZYRU_X^;?_KO#_P"C%KH_&'_(53_KSA_]&3USEK_Q\V__ %WA
M_P#1BU\;C?\ ?ZW_ %^7_MI]G@_]PH_]>%_Z2SW&BBBOLCXP*\L\6?\ (8D_
MZX0?^@FO4Z\L\6?\AB3_ *X0?^@FO)SG_<U_U^A_Z3,];)O]\?\ UYG_ .E0
M,G2O^0IIO_7_ &?_ *41U[37BVE?\A33?^O^S_\ 2B.O::QR/^%7_P"OD?\
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M **** "BBB@ HHHH \9^(_\ R&++_L&I_P"E5U7GM>A?$?\ Y#%E_P!@U/\
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M "&)/^N$'_H)KR<Y_P!S7_7Z'_I,SULF_P!\?_7F?_I4#)TK_D*:;_U_V?\
MZ41U[37BVE?\A33?^O\ L_\ THCKVFL<C_A5_P#KY'_TDVSS^+0_Z]R_]*"B
MBBO</#"BBB@#SOX;_P#(.\0?]C=K?\[:O1*\[^&__(.\0?\ 8W:W_.VKT2@
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M?\@Z_P#^O*Z_]$25XI7SF>?Q,/\ X)_^E1/H\C_AXC_'#_TF1UO@W_D*3_\
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M_KI>?^E<U>"U[UX&_P"1:LO^NEY_Z5S5[>;_ .ZQ_P"OT/\ TBH>9EW\>?\
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M_D8(?^P9;?\ H^[KSZO+J_Q9_P")GVN _P!SPW_7J/Y'U9IW_(/L?^O.U_\
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M)SX:_P"?V3_P#N__ (S6YI>KV&L0R7&GRM-%%*879HI(B) BN1ME5&/RNIR
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MW\"?_7V7_I$ HHHKR3O/&?B/_P ABR_[!J?^E5U7GM>A?$?_ )#%E_V#4_\
M2JZKSVOK<!_NE#_!_P"W,^?Q?^\5?\7Z(^D]"_Y >C?]@K3O_22&M6LK0O\
MD!Z-_P!@K3O_ $DAK5KY6I_$J?XY?^E,]VG_  Z?^"/_ *2@HHHJ"PHHHH *
M*** "BBB@ HHHH **** /"/B5_R,$/\ V#+;_P!'W=>?5Z#\2O\ D8(?^P9;
M?^C[NO/J\NK_ !9_XF?:X#_<\-_UZC^1]6:=_P @^Q_Z\[7_ -$)5RJ>G?\
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MM;&*^U2XB@M+-#;V5K"EK9P-)'->R7M[=_1U% !1110 4444 %%%% !1110
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M0E7*IZ=_R#['_KSM?_1"5<KTX[+T7Y'QD_CE_BE^;"O/?B7_ ,B_!_V%+?\
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MU_Y$C0O^N5Y_Z<;RNYKAOAK_ ,B1H7_7*\_].-Y7<T <#\+_ /D1M#_[B?\
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M[O1_Z_?^V3.CHHHKN/F3R[XH?\>.E?\ 7W/_ .B17C%>S_%#_CQTK_K[G_\
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M *[P_P#HQ:Z/QA_R%4_Z\X?_ $9/7.6O_'S;_P#7>'_T8M?&XW_?ZW_7Y?\
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M1M0T_6M#U.#5X &EL;])+>[(G(+@'ZZ4444 %%%% !1110 4444 %?-&L?\
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M\/$?XX?^DR.M\&_\A2?_ *\)?_2BUKTNO-/!O_(4G_Z\)?\ THM:]+KOR?\
MW*/_ %\J?FC@SC_?9?\ 7NG^3"BBBO4/+"L_5O\ D%:G_P!@^]_])I:T*S]6
M_P"05J?_ &#[W_TFEH Y;X:_\B1H7_7*\_\ 3C>5W-<-\-?^1(T+_KE>?^G&
M\KN: .!^%_\ R(VA_P#<3_\ 3QJ%=]7 _"__ )$;0_\ N)_^GC4*[Z@ HHK\
M7-2^(_[7/[<G[4/[0WPO_9R_:#M?V7/@+^RIXALOAUK7C32?A_H7CWQO\2OC
M);&Z?6+*2S\0R6T%AX8\(Z_HNH:;J5I::II\.JZ;#:PW=OK2>);A?"P!^T=%
M?G1^P-^T9\7_ (C7_P >_P!G/]I.31-1_:(_92\8:%X6\:>,?#5K!INA?$KP
MKXQL-0U;P)X^M-*M;/3K32[[6M.TR\EU33;#3[*UMHGTNZ.GZ5-J3Z59_9WQ
MF^(-M\)/@_\ %;XJWD#W-I\,_AMXY^(%S;1[?,N8/!OAC5/$4MO'OPIDGCTY
MHD#'!9P#P: /2:*_ /\ 9Q^&_P#P4O\ CW\(?A3\2;__ (*?Z7X#\1?%/P/I
MWQ LOAS+\!OA+XBUO3?#VM#[7H]TT\<NC7-]%=:3/IM_-,FCVT5I)?"S9I&B
M$TO[J^"=+\0Z'X,\(Z)XN\1_\)CXLT?PQH&E^)_%W]FV^C_\)5XAT_2K2TUK
MQ'_9%HSVNE?VYJ4-SJ?]FVSM;V/VK[-"S1Q*2 =/1110 5S_ (J_Y%W5O^O4
M_P#H:5T%<_XJ_P"1=U;_ *]3_P"AI6V'_P!XH?\ 7ZE_Z7$BI_#J?X)?^DL^
M=Z]E^&__ "";W_L(M_Z36U>-5[+\-_\ D$WO_81;_P!)K:OH<T_W27^.G_Z4
M>-@/]XC_ (9_D>AT445\P>X<QXR_Y%K5/]RV_P#2RWKY^KZ!\9?\BUJG^Y;?
M^EEO7S]7T>3_ .[5/^O\O_3=(\?,?XL/^O:_]*D>Y^ /^1>C_P"ONZ_]"6NU
MKBO '_(O1_\ 7W=?^A+7:UXN,_WK$?\ 7V?YGI8?^!1_Z]P_])05Q7C_ /Y%
MZ3_K[M?_ $)J[6N*\?\ _(O2?]?=K_Z$U&#_ -ZP_P#U]A^88C^!6_Z]S_\
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MJ_XOT1])Z%_R ]&_[!6G?^DD-:M96A?\@/1O^P5IW_I)#6K7RM3^)4_QR_\
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MA3_PLZ<!_OF&_P"OL?S/":]V^&G_ "+\_P#V%+C_ -)K.O":]V^&G_(OS_\
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MZY7G_IQO*[F@#@?A?_R(VA_]Q/\ ]/&H5WU<#\+_ /D1M#_[B?\ Z>-0KOJ
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MB'6=+T1TM;>#PUXNEEM=7N;^WT/5E'A^^4:1J=^TDEA&&U&TU?V7OV7?AO\
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MI.EZ=;Q6>GZ;IFGV\=I86%C:0(D%K9V=K#%;VUO"B100QI%&BHJ@ %^BBB@
MKG_%7_(NZM_UZG_T-*Z"N?\ %7_(NZM_UZG_ -#2ML/_ +Q0_P"OU+_TN)%3
M^'4_P2_])9\[U[+\-_\ D$WO_81;_P!)K:O&J]E^&_\ R";W_L(M_P"DUM7T
M.:?[I+_'3_\ 2CQL!_O$?\,_R/0Z***^8/<.8\9?\BUJG^Y;?^EEO7S]7T#X
MR_Y%K5/]RV_]++>OGZOH\G_W:I_U_E_Z;I'CYC_%A_U[7_I4CW/P!_R+T?\
MU]W7_H2UVM<5X _Y%Z/_ *^[K_T):[6O%QG^]8C_ *^S_,]+#_P*/_7N'_I*
M"N*\?_\ (O2?]?=K_P"A-7:UQ7C_ /Y%Z3_K[M?_ $)J,'_O6'_Z^P_,,1_
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MFV>?Q:'_ %[E_P"E!1117N'AA1110!YW\-_^0=X@_P"QNUO^=M7HE>=_#?\
MY!WB#_L;M;_G;5Z)0 4444 %%%% !1110 5C>(=0GTO1[V_MA&T]NL1C$JLT
M9,EQ%$VY59"?E<D88<X/(X.S7,>,O^1:U3_<MO\ TLMZVP\5+$4(R2<95J49
M)[-.<4T_)IV(JMJG4:=FH3::W346T_D><_\ "P]>_P">6G?^ \W_ ,DUV_@[
MQ%?Z]_:/VU;9?LGV/ROL\;QY\_[5OW[Y9,X\E-N-N/FSG(QX;7JGPS_YC?\
MW#?_ &_KW<?A</3PE6=.C",X^SM)+57J03^]-KYGDX2O6GB*<95)2B^>Z;T=
MH2:_%)GJE%%%?.'LA7S1K'_(6U3_ +"-[_Z4RU]+U\T:Q_R%M4_["-[_ .E,
MM>SDW\2O_@A_Z4SS<R^"E_BE^2-7P=_R,NE_]=)__22XKZ"KY]\'?\C+I?\
MUTG_ /22XKZ"J,X_WBG_ ->5_P"ES+R[^!/_ *^R_P#2(!1117DG>>,_$?\
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M]Q/_ -/&H5WU<#\+_P#D1M#_ .XG_P"GC4*[Z@ HHHH **** "BBB@ HHHH
M*Y_Q5_R+NK?]>I_]#2N@KG_%7_(NZM_UZG_T-*VP_P#O%#_K]2_]+B14_AU/
M\$O_ $EGSO7LOPW_ .03>_\ 81;_ -)K:O&J]E^&_P#R";W_ +"+?^DUM7T.
M:?[I+_'3_P#2CQL!_O$?\,_R/0Z***^8/<.8\9?\BUJG^Y;?^EEO7S]7T#XR
M_P"1:U3_ '+;_P!++>OGZOH\G_W:I_U_E_Z;I'CYC_%A_P!>U_Z5(]S\ ?\
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M5\^^#O\ D9=+_P"ND_\ Z27%?051G'^\4_\ KRO_ $N9>7?P)_\ 7V7_ *1
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M?^C[NO/J\NK_ !9_XF?:X#_<\-_UZC^1]6:=_P @^Q_Z\[7_ -$)5RJ>G?\
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M "+6J?[EM_Z66]?/U?1Y/_NU3_K_ "_]-TCQ\Q_BP_Z]K_TJ1[GX _Y%Z/\
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M +AO_M_7E=>J?#/_ )C?_<-_]OZ^CS+_ '*M_P!P_P#T[3/%P7^\TO\ M_\
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M6OUV-\RQM+&.BZ4:D?9JIS>T45?FY+6Y9R_E=[VZ;GHE%>=_V!\0?^A_A_\
M"9TK_P")H_L#X@_]#_#_ .$SI7_Q->F>85?&'_(53_KSA_\ 1D]<Y:_\?-O_
M -=X?_1BUM7G@?Q??RB>[\;0RRA!&&_X1^RC^12Q VQ.B\%F.<9YY/ JLOP[
M\3HRNOC*$,C!E/\ 8-J<,I!!P92#@@<$$>HKP,1E6(K8JI6C.BH3J*:4I34K
M:;I4VKZ=WZGT%#-</2PU.C*%9RA3Y&XQIN-[-:-U$[?)/R/8**\[_L#X@_\
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M_P#0_P /_A,Z5_\ $U)1Z)17G?\ 8'Q!_P"A_A_\)G2O_B:/[ ^(/_0_P_\
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MQ1^/85CB18T7_A&M,.U$4*HRP+'"@#)))ZDDT_\ L#X@_P#0_P /_A,Z5_\
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MYW_8'Q!_Z'^'_P )G2O_ (FC^P/B#_T/\/\ X3.E?_$T >B45YW_ &!\0?\
MH?X?_"9TK_XFC^P/B#_T/\/_ (3.E?\ Q- &7XH_Y#=W_NVW_I-%7/UO77@/
MQ;>SO<W/C6&6:0*'?^P+-,A%"+\L<B(,*H'"C.,G)R:K_P#"N?$O_0XP_P#@
MBMO_ (]7SN(RC$U:]:K&=!1J5)SBI2J)I2DVKI4FKV>MFUYGT6'S?#4J%&E*
M%=RITX0DXQIM-QBD[-U4[76ETGY'L5%>=_V!\0?^A_A_\)G2O_B:/[ ^(/\
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MI78R^'/'TT<D,GCV%HY4>.1?^$:TP;D=2K+E0&&5)&5((Z@@\UB?\*Y\2_\
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M%H6JZPEU%JGC*_GU"_M-0TRS,L$'B#2_#4UJ^KZ2-7U+1 #]V:*** "BBB@
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M(8E:2>U6:%58O@_CO^SY^V#XQ_9?_92T#]EOXB_L6?M-7O[0_P */ VN> -
M\"^$?@?JWB?X;?%R_P!/EUFVTO7=!\8^'GOM)U7PKJ*3:5=_$/Q MO*_VK5-
M6O=)M?$LK%)0#]*?V!O!OAWX?_L:_LZ^#_"OQ!T/XJ:/HGPVTF$>//#.L2:]
MX:US4[B6YO=?3P]J4]M97;Z%I.OW.IZ)I%IJ%AIVIZ9I^FV^EZIINGZA9W-E
M!]>5\&?\$R_@+X\_9K_8H^"_PH^)H>U\;Z=8^)/$6O:&UQ%<IX6N/&WBW7?%
M\7A@20 P_:M(MM:AAUE89KJW7Q VK_9+NXLS;R-]YT %%%% !1110 4444 %
M9.O6NJWVA:U8Z%JJZ%K=YI.HVNC:VUE!J2Z/JMQ9S0Z?JK:==?Z-?KI]V\-V
M;*X_<70A,$O[N1JUJ* /YYK7]DO3OV9O^"HO_!/+7M8^)WC_ .-OQA^,-O\
MM8:Y\7/BS\0K\M?^*=3\._ 2_L-$M-%\/P33Z=X3\,Z);:C?V^AZ#;7.HS:=
M97$>G-JMUIVGZ5:V']#-?F9^TAX"\<Z[_P %)?\ @F]XZT3P7XLUCP1X&T?]
MK*+QMXQTKPYK&H>%?!TGB/X/OIGAZ/Q3XAM+.;2/#SZ]J1&GZ,FK7EHVJ7Q^
MR6(GG_=U^F= !1110 5^77[:'CGQ;^T1\2=(_P""=OP/UNZT?5/&^B0>*OVL
M_B9HMPOVCX._L^W,D:7'A:SN%<P0_$3XPK+%H.D:7<I>S6_A34+C4=0T.30=
M<_M[1_U%K\O/$'_!*_P%J7Q4^+7Q=\*_M7_MS?"3Q'\:O&%YXU\<V'P>^.NC
M> M!O=2GN;V>QLUM=-^'DE_<Z7H$-_<Z?X>M]8U/5;C2M-<VD-V5:0N <%_P
M1N\*Z#X$^&/[8_@CPK8#2O"_@W_@H1^T+X5\-Z8+B[O!IN@^'O#_ ,+](T>P
M%W?SW5]="ST^SM[<7%[<W%W/Y?FW$\TS/(W[ 5^)?_!)_P#9!\8?!GQ9^T]\
M1_'?BG]I[3M2M_VDOCEX \+^#OBMK>J6?@OXE^!I)_ &I:+\?M3\/:QX9TN?
MQE\0?%DUE>64OQ4T^^71]=L[:[M[2R+PRR)^VE !1110!^;O_!6OPGH?CC]@
MKXV^&]=^)_A/X3P7,?A+4[/Q#XWU.[TWPWJ=_P"&/&.A^*HO"UTFEZ7K6MZI
M?:_!HES;:%I.A:5?ZI=Z\NF-':S6\-S&WY!_'_\ :9?]L/P]_P $_/@K\2OV
M?O%_[$_@Q/BK\-?&VH?'/XLZ#K7PY^&]E8^$M!O[&3PE\"O%/_"/36R6GB;1
M+VWU'PQ>:W<^']+L[ZU\)P:C(FE"W\3K^MW_  52^ GQ,^.'[/O@O5/A'X<@
M\=^-?@1\</A_\>K7X:72)<1?$C3O!=OKVG:KX4AL9\VE_>S67B&34(K"=7DU
M.TL+[1[&&YU#4K6UG^-_VT?VA/%/_!0;X$1?LE? O]E;]IC1_B)\4O''@#3_
M !UK/QH^#&N> ?"WP"TGP_XJT_Q3J&N>+_%%V][IMGJSQZ-:0VUI833_ &_P
MSJVKK%<C7#8^'M3 /WXHJEIEF^GZ;I]A)=W.H26-E:6;W]ZRO>7KVT$<+7=V
MZ*B-<W)0S3LB(K2NY55! %V@ HHHH **** "BBB@ KPK]HOX5^._C1\,K[X>
M> /C/XG^ ]_KFJ:4FN^/?!.G6EYXO7PE%,S^(-"\-7UU<VK^&M8URUVV=IXJ
ML96O]"<F\M[>[P]I/[K10!^(O_!+WX*>"/V=?VPO^"F7P7^',>K)X.\"77[(
M.GZ5)KVIRZSK=Y+?_#GXBZWJVIZMJ4J1"YU#5M9U/4-3NS;V]I8Q3W;P:?96
M-C%;VD/[=5^9G[)O@+QSX<_;Y_X*=^,?$/@OQ9H/A#Q]K'[*4O@3Q5K7AS6-
M+\-^-8_#OPQ\8V'B"3PEKE]9P:9XC30K^ZMK+67T>ZO%TR[N(+:],$TT:-^F
M= !1110 5_.Y^VM?7_\ P4$\%?M3_$.QO+E?V-?V,?AI\8/^%>7.GZA<P6'[
M0?[4&A>"-;@N_'$$]E=1KJ?P\^#8N!;>%[RW4:=K_B*ZN[FWU7Q#H6IZWHFD
M_OOX]\(67Q!\#>-/ .I:AK&DZ=XX\)^(_"&H:KX>NX;#7],LO$NCWFBW6H:'
M?7%M>P66L64%[)<Z9=SV=W#;7L4$TEM.B-$_XF?''_@DYIWPK_9.^+_A[X+_
M +3_ /P4(\1VWA?X3^/Y/!'P%L/C5!K'P_\ %6HOI.K:E#X*D^%WA3X<:='K
MFE>*-6N)H=2\.:1!;SZW)J-U&I-S=M(P!^GO[#W_ "97^R!_V:[\ /\ U4_A
M*OJ*OA+_ ()Q? /4?V?_ -D_X3Z)KGBGXRZWXD\7^ OAQXU\3^&?C/K<^I:E
M\+O$>I_#;PC::S\,?"FC7FC:+?\ @GP?X1O["?3]-\%ZA%<WV@7"W=I=7<DP
M=4^[: "BBB@#\=O^"T-OH]K\!_@OXYO?%/@6'5OA'^T=X ^*VA?";QW=7TMK
M\=[CPO;:Q:R_#?0O#VCZ1K6K>(=?U276+.V2$6T.C6NBWFM/KE]86TT5[!\H
MZ_\ '0?MB_\ !1S]A/\ X61\(_'G[%P^#5GXI\<:+_PT#I>K_#OX@_&KQ'KM
MOX>73?AO\/S/H*:5K6F67BC2[6R2RU/6M.NO$&D:MXLM+/3;#Q!*GAZ_^V_^
M"CWPM^)Z?%#]C']K7X<?#G7OC39?LI_$KQ1J'C_X3^$M)7Q'XVU?P9\0+;PU
M9:AXH\#>&I9(DUKQ-X3/AOS].L+1QJ+ZK>:+J,;06>D7M[9^!?'+XG^*?^"B
MGQ:_8W\ ?!#X"_'SP7X2^$7[1?@_X_\ Q8^-?Q;^%NL_#/3? $'PUCEDF\!:
M%JNL)=1:IXROY]0O[34-,LS+!!X@TOPU-:OJ^DC5]2T0 _=FBBB@ K/U;_D%
M:G_V#[W_ -)I:T*S]6_Y!6I_]@^]_P#2:6@#EOAK_P B1H7_ %RO/_3C>5W-
M<-\-?^1(T+_KE>?^G&\KN: .!^%__(C:'_W$_P#T\:A7?5P/PO\ ^1&T/_N)
M_P#IXU"N^H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH \[^&__(.\0?\ 8W:W_.VKT2O._AO_ ,@[Q!_V-VM_SMJ]$H ****
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M5DMK=KD33LK+$CD$#\MO@9_P2Q_8P\3_ +%WP[\#^(OA'X-UCQ1\0?A-X/\
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MQ*UUX5AGU+^VXTO](L9[WP/\.=2\2+KD^FV&MS^)Y/# TX _I-HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \
M[^&__(.\0?\ 8W:W_.VKT2O._AO_ ,@[Q!_V-VM_SMJ]$H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S]6_Y!6I_P#8/O?_
M $FEK0K/U;_D%:G_ -@^]_\ 2:6@#EOAK_R)&A?]<KS_ -.-Y7<UPWPU_P"1
M(T+_ *Y7G_IQO*[F@#@?A?\ \B-H?_<3_P#3QJ%=]7 _"_\ Y$;0_P#N)_\
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M\7+37]-\3KXCO]*M)+^32=%OY=)M?"'V:SFU+4=)\%;(!<ZSJEO+=WWZO44
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MK/U;_D%:G_V#[W_TFEH Y;X:_P#(D:%_URO/_3C>5W-<-\-?^1(T+_KE>?\
MIQO*[F@#@?A?_P B-H?_ '$__3QJ%=]7E6A:+\1O#NE6NCV,G@F6ULS<>5)=
MMKK7#"XN9KI_,:&*&,D23L%"QKA H)9@6;7_ .+H_P#4@_\ EQ4 =]17 _\
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M =]17 _\71_ZD'_RXJ/^+H_]2#_Y<5 '?45P/_%T?^I!_P#+BH_XNC_U(/\
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M (NC_P!2#_Y<5 '?45P/_%T?^I!_\N*C_BZ/_4@_^7%0!WU%<#_Q='_J0?\
MRXJ/^+H_]2#_ .7%0!WU%<#_ ,71_P"I!_\ +BH_XNC_ -2#_P"7%0!WU%<#
M_P 71_ZD'_RXJ/\ BZ/_ %(/_EQ4 =]17 _\71_ZD'_RXJ/^+H_]2#_Y<5 '
M?45P/_%T?^I!_P#+BH_XNC_U(/\ Y<5 '?45P/\ Q='_ *D'_P N*C_BZ/\
MU(/_ )<5 '?45P/_ !='_J0?_+BH_P"+H_\ 4@_^7%0!WU%<#_Q='_J0?_+B
MH_XNC_U(/_EQ4 =]17 _\71_ZD'_ ,N*C_BZ/_4@_P#EQ4 =]17 _P#%T?\
MJ0?_ "XJ/^+H_P#4@_\ EQ4 =]17 _\ %T?^I!_\N*C_ (NC_P!2#_Y<5 '?
M45P/_%T?^I!_\N*C_BZ/_4@_^7%0!WU9^K?\@K4_^P?>_P#I-+7(_P#%T?\
MJ0?_ "XJAN(/B=<V\]M(? 82XAE@<H?$(<)*C1L5+!@& 8E258 XR".* +?P
MU_Y$C0O^N5Y_Z<;RNYKG?"6CW&@>'M,TBZEAFN+..999+<N86>6YFN,1M(D;
MLJB4+N:-"Q4G:N<5T5 !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
; 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>nt10015006x17_graphic6.jpg
<TEXT>
begin 644 nt10015006x17_graphic6.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
M                                                          !8
M65H@        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($AE=VQE='0@
M4&%C:V%R9"P@,C P- !S9C,R       !#$0   7?___S)@  !Y0  /V/___[
MH?___:(   /;  # =?_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( AX#"@,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M ,:H_P"$AU?_ )^__(,'_P :K%HH VO^$AU?_G[_ /(,'_QJC_A(=7_Y^_\
MR#!_\:K%HH VO^$AU?\ Y^__ "#!_P#&J/\ A(=7_P"?O_R#!_\ &JQ:* -K
M_A(=7_Y^_P#R#!_\:KL?#]]<7UE))<N))$N'C#A50E1'&XW! %R"Y (4< 9R
M<D^:5Z!X3_Y!\_\ U^/_ .B(* .HHHHH **** "BBB@ HHHH **** "BBB@
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M*-K*][O]+O\ K0_-#_@DAKO_  4V^'GQ1^*W[(?[5'ACXJ>+O@]8Z3XR\/\
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MD:%HNE7-RU[<:9I.G:?<7C%RUW-96<-M+<L9"SEIY(FE)=F<ESN).37Y"?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*\_KT#PG_P @^?\ Z_'_ /1$% '44444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,-BXPX;PTH1Q-"E7C"3S2BG**JPFHMK1M6;/OS_A:/Q-_P"BC>//_"P\0_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\J:/^(:XS_H9X7_P15_^2]?Z>A_Q.[PU_P!$+GG_ (=<!_\ *#^8:BOZ>?\
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M^$K\5/\ Y@:/^'^?_!(+_H][X=_^$K\5/_F!H_XEI^D;_P!& \;/_%5<=_\
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M_G_P2"_Z/>^'?_A*_%3_ .8&C_A_G_P2"_Z/>^'?_A*_%3_Y@:/^):?I&_\
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MG_P2"_Z/>^'?_A*_%3_Y@:/^):?I&_\ 1@/&S_Q57'?_ ,X0_MC*/^AKEO\
MX787_P"6^:^\_8"BORT^&W_!:[_@EO\ %[X@^"/A5\-_VO\ P)XJ^(/Q(\5Z
M!X'\$>&;+PW\2;>\\0>*_%&J6VC:!HUK/J'@JSL8;C4M3O+:TBEO+NVM8WE5
MIYXHPSK^I=?!<7^'W'OA]BL)@N/>".+^",;F%">*P&$XOX:SGAK%8W"TZCHU
M,3A,/G."P57$T(54Z4ZU&$Z<:B<)24M#JP^+PN+C*6%Q.'Q,8-1E+#UJ=:,9
M-72DZ<I*+:U2=FUKL%%%%?('0%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y5\</CA\*?V;?A3
MXT^.'QQ\:Z9\._A1\.],AUCQKXUUF*_FTSP_ID^H6>EPW=Y%I=G?W[QOJ&H6
M=J!;6<[^9.A*! S+ZK7XN?\ !Q'_ ,H6?V__ /LDFB?^K,\"4 ?9O[.__!1S
M]A3]K+Q]XV^%G[.7[4_P>^+?Q$^'VJ7VD>)?!_A7Q3;R:X+G3)M1@U&Y\/VE
M\EDWC/1[%M*O7NO$'@TZ_H,%NMM=R:DMK?V$US\V?\%6_P#@I7K_ /P3?L/V
M.+S0?A-H_P 53^U+^US\//V9M1CU?Q9>^%1X.T_QQ#?2S>+;)K/0];.L7FGF
MT"Q:3.+""XWDM?1;0#_(A\"_B#_P3<^*/_!4S_@W7\)_\$P?A_X>T^\^%WP>
MBU/]J34/!GPN\,Z%\2#JU_\ "3PU86"_M,>.?A]X0\-:=\1OB]X8G\/>)V^*
M/BNYBO-)@\2:W=:G;:@(?$H5OKW_ (+C_P#!2O\ 91_;B_9E_P""<?[3GP0\
M6Z^OP<^"?_!9+P!\/_B/XE\<>%=4\(R:#K/PQ\"VOCKQE=G3KQ9[RZT;2_#7
MBG2[_P#M&WCD6<BZAAC:6V92 ?W&ZGJ>FZ)INH:SK.H6.DZ/I-C=ZGJNJZG=
MV]AINF:;80275]J&H7UU)%:V5C96L4MS=W=S+%;VT$4DTTB1HS#^>;_@E_\
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MQ21[]Z,!_!I\=+O_ ():?L:_\%EOVO/!G_!2#0_ _P 1]!^$?_!*/]G+X<_
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M'14445_TC'X^%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,NJ_P!;VBC_ (K9>/O_ $:CP?\ _!?&G_T4^O\ 2U/^(;Y5_P!!V8??AO\
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M_P"@[,/OPW_R@_R0O^'(/_!63_HQ3XX_^"K1O_EU1_PY!_X*R?\ 1BGQQ_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI_\ X?VY_P#G'T?\/RM5_P"C4]/_ /#^W/\ \X^C_B /BU_T2D/_ !(.%_\
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M3:9],4445_;A_684444 %%%% !1110 4444 %?J9_P $?O\ D[MO^R5^-O\
MTM\.5^6=?J9_P1^_Y.[;_LE?C;_TM\.5^?\ BM_R;CC3_LG\P_\ 33/B_$;_
M )(7BK_L2XW_ --L_J<HHHK_ "_/\^PHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&,GLW;0K_P##C[6/^CD]-_\ #3W7_P \2C_AQ]K'_1R>F_\ AI[K_P">)7]
MU%?=?\1^\5_^BFI_^&/A_P#^=?\ 5WY6^N_XC-XC?]#^'_AHR7_YWG\_/_#C
M[6/^CD]-_P##3W7_ ,\2C_AQ]K'_ $<GIO\ X:>Z_P#GB5_0-11_Q'[Q7_Z*
M:G_X8^'_ /YU_P!7?E8_XC-XC?\ 0_A_X:,E_P#G>?S\_P##C[6/^CD]-_\
M#3W7_P \2C_AQ]K'_1R>F_\ AI[K_P">)7] U%'_ !'[Q7_Z*:G_ .&/A_\
M^=?]7?E8_P"(S>(W_0_A_P"&C)?_ )WG\_/_  X^UC_HY/3?_#3W7_SQ*/\
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MRR(VN>%;TP:[I*NAO["W##(!]E45X9X(_:@_9H^)GPG\2?'KX;_M$? SX@_
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M ."Q?_CU 'W517PK_P - _$/_GKH_P#X+%_^/4?\- _$/_GKH_\ X+%_^/4
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M\"^ ?A-X O+RZU"ZNK^Y\3KXMTWX5PS:[I6M:>UC,/$.I6DIN8(U\X _D$^
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MIUE%9Z<=+DU))98-22W@M;6[O(Y-1L+/38+E+&W_ ![_ &L?V _^"@7[1?\
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MG_IOMJ^-J^R?V:_^19\0?]AU/_3?;4 ?1]%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!\E_M]?\ )BG[:G_9I?[1W_JG?&5?E!_P
M;=Z)IGQ?_P""*/["_C7XC6W_  DOB=/"WQ;\%KJDL]QISCPQ\+OVAOB[\,/
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M8?\ $.Y_]#>/_A"__FL_H+HK^?3^TM1_Y_[W_P "I_\ XY1_:6H_\_\ >_\
M@5/_ /'*/[97_0.__!J_^5A_Q#N?_0WC_P"$+_\ FL_H+HK^?3^TM1_Y_P"]
M_P# J?\ ^.4?VEJ/_/\ WO\ X%3_ /QRC^V5_P! [_\ !J_^5A_Q#N?_ $-X
M_P#A"_\ YK/Z"Z*_GT_M+4?^?^]_\"I__CE']I:C_P _][_X%3__ !RC^V5_
MT#O_ ,&K_P"5A_Q#N?\ T-X_^$+_ /FL_H+HK^?3^TM1_P"?^]_\"I__ (Y1
M_:6H_P#/_>_^!4__ ,<H_ME?] [_ /!J_P#E8?\ $.Y_]#>/_A"__FL_H+HK
M^?3^TM1_Y_[W_P "I_\ XY1_:6H_\_\ >_\ @5/_ /'*/[97_0.__!J_^5A_
MQ#N?_0WC_P"$+_\ FL_H+HK^?3^TM1_Y_P"]_P# J?\ ^.4?VEJ/_/\ WO\
MX%3_ /QRC^V5_P! [_\ !J_^5A_Q#N?_ $-X_P#A"_\ YK/Z"Z*_GT_M+4?^
M?^]_\"I__CE']I:C_P _][_X%3__ !RC^V5_T#O_ ,&K_P"5A_Q#N?\ T-X_
M^$+_ /FL_H+HK^?3^TM1_P"?^]_\"I__ (Y1_:6H_P#/_>_^!4__ ,<H_ME?
M] [_ /!J_P#E8?\ $.Y_]#>/_A"__FL_H+HK^?3^TM1_Y_[W_P "I_\ XY7Z
ML_L9333_  ?F>>:69_\ A,-<7?+(\C;1:Z5A=SEC@9.!G R<5TX3,5BJOLE2
M</=<N;GYMFE:W(N_<\?/.$99+@?KKQZQ*]M3I>S6&=+^(I/FY_;U-N7;EUON
MK'UE1117I'QH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-J/_ ,C4<D_Y9?\ @+_R#VU'_G[2_P#!D?\ /S7WG/T5T'_")^*O^A9\0?\
M@FU'_P"1J/\ A$_%7_0L^(/_  3:C_\ (U')/^67_@+_ ,@]M1_Y^TO_  9'
M_/S7WG/T5T'_  B?BK_H6?$'_@FU'_Y&H_X1/Q5_T+/B#_P3:C_\C4<D_P"6
M7_@+_P @]M1_Y^TO_!D?\_-?><_170?\(GXJ_P"A9\0?^";4?_D:C_A$_%7_
M $+/B#_P3:C_ /(U')/^67_@+_R#VU'_ )^TO_!D?\_-?><_170?\(GXJ_Z%
MGQ!_X)M1_P#D:C_A$_%7_0L^(/\ P3:C_P#(U')/^67_ ("_\@]M1_Y^TO\
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MM0>(OV-/^";?[)OQH^"_[-/QV^*OP7\2>.-2^*%CX%U&ROOAO<R7TB:AHOQ
M_:5\#:QJ=Z?"ESI&KW5WX?T&YTN:>\DM+)_M4,UG  ?VC45_'1\4/^#BOX[^
M+?\ @C5^RY^UE\+/AMX.\&_MK_M>?M6:=^S+X ^''A">3Q],B^!_'$]S\3_B
M%X"^$^MZ/XB\5>/]+U#0=$TKX:_\(O;-?ZAX9\3_ !?\(ZL/$5[J$6D:-K/Z
MX? S_@XA_P""-?[1_P 7/ ?P,^$O[:_AW5OB9\3==B\,>!]&\4_"7]H+X8:1
MKGB.Z@GFTW0AXT^*7PE\&>!].U;6YH!I7AW3]6\26%UXD\17FE>&-!BU'Q%K
M&DZ7>@'[3T5^:W_!7W]M;Q[_ ,$[?^"=7[17[8_PP\*>$/&_CGX.0_"R30_"
M_CQ=9?PGJA\>?&SX;?#'41JR^'M4T76"+/2?&E_J%E]CU.V(U&ULS/YUL)H)
M?PX^&_\ P4<_X.G_ (M?#WP%\5_ '_!(/]D#7_A]\3/!GA;XA>"O$ _:"^&^
MEG6O!OC/1+'Q)X;U@:5K7[8NG:WIQU'1-2LKW^S]6TVPU2S\[[-?V-K=QRP(
M ?UX45_$Q\7?^#BS_@J=J/PJ_;!_;8_9F_8;_9WO?^">/[-WQ@L_AQX2^+OQ
MMO?BUX2\>?$_P]JGB9/".B^,_#/AK7?$GPTU3Q"+NZNO#VN^(- LO!^EZWX+
ML?&^B:-?6.K7VA^*-0T_Z)_X*X?\'0_A7]BSX=?LQ']E#X./\3_B_P#M'_ [
MX1?M27&F?&W1];T;PG\+/@?\:?"Z^)/ %CXM/@OQ#'#JGQ+\2))-!)I?ACQA
MJOA_PY_8FJ?;-6U1[S3$D /ZWJ*_$/\ X*S?\%#OVQ?V2OBU^Q7^SW^Q9^SQ
MX'^*GQ-_:S\?^)/#%W\0?CW#XB\/?LZ^ =)T#3H;ZZ?Q+\2?#OBWP_-H/B"Q
MLCJ'BFZTB73M9O=3\*Z-J*>&M/U?Q+)IFA:E^+\W_!S%^VGX8_8'_;C^-_Q)
M_97_ &>O"G[47[$7[8_PV_9=\9>#-/\ $_BGQ3\*=1D\9WOCO0?$EO'-X=\;
MZG/=ZUX.\1_#G7+6+Q+X=^(NN^$O$UIJ%E=:5"MI:B^U4 _JH_;Z_P"3%/VU
M/^S2_P!H[_U3OC*OQ6_X-T_CS\*_@'_P1C_8C^&?Q7\3/X7\:V?AOXM^+;G1
MUT/Q#K8C\/\ Q/\ VA/BW\4/ ]__ &CX>TG5=+?^VO _C+PYK1M8[UKS3CJ!
MT[5;>RU6TO;&W_7_ /;T\7:';_L#?M92ZYK6B:/J'B']CW]H"XLK*^U.SL9;
MVXNO@QXI9X=/@O+A)[K;-<QQ*D0E?=)$AR[KN_EN_P"">/\ R8C^Q_\ ]FY?
M"+_U"='K^,?IH_2)XV^CKPCP=G_!&6<+YGC.(>(\5E&-I\4X'-<=AJ6%H995
MQL9X:&59UDM6%=U:<8RG5K5J;IMI4E)J:^BX<RG#9OB,12Q,Z\(TJ*J1="4(
MR<G4C&TG.G435F]DG?J?U@_\-N_LR?\ 11Y/_"-\>?\ S,4?\-N_LR?]%'D_
M\(WQY_\ ,Q7X"T5_G5_Q5 \?_P#HE/"'_P 1_C'_ .CW^KORM]?_ *E95_S_
M ,P_\&X?_P"9?ZN_*W[]?\-N_LR?]%'D_P#"-\>?_,Q1_P -N_LR?]%'D_\
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M(?\ Q'^,?_H]_J[\K'^I65?\_P#,/_!N'_\ F7^KORM^_7_#;O[,G_11Y/\
MPC?'G_S,4?\ #;O[,G_11Y/_  C?'G_S,5^ M%'_ !5 \?\ _HE/"'_Q'^,?
M_H]_J[\K'^I65?\ /_,/_!N'_P#F7^KORM^_7_#;O[,G_11Y/_"-\>?_ #,4
M?\-N_LR?]%'D_P#"-\>?_,Q7X"T4?\50/'__ *)3PA_\1_C'_P"CW^KORL?Z
ME95_S_S#_P &X?\ ^9?ZN_*W[]?\-N_LR?\ 11Y/_"-\>?\ S,5Z1\-/V@OA
M)\7]4U#1?A[XJ;7M2TNP_M2^MVT+Q'I0AL3<0VGG>=K6D:=!+^_GB3RXI))?
MFW;-BLP_F]K]&/\ @FW_ ,E/\>_]B&O_ *D.DU^R?1]^G[XR^*WC)P'X>\1<
M.^&N#R7BC-<1@<PQ.39-Q/ALTI4J668[&QE@Z^-XPS#"TZCJX6G&3K8+$1=.
M4TH*3C*/G9MPKEV R[%8NC6QDJM"$9052I1E!MU(0?,HX>$FK2>TEKY:'[(4
M445_K^?GX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 ?GC#_REAU#_M'CH_\ ZTEKE?H=
M7YXP_P#*6'4/^T>.C_\ K26N5^AU?7<7?%PW_P!DCD7_ *:JGBY+_P S;_L=
M8_\ ]Q!1117R)[045Q/Q*^(G@_X1?#SQS\5/B%KNF^&/ GPX\)>(?''C'Q%K
M&H:?I6EZ)X9\+:5=:UK6J:AJ>JW=AIEA:66GV=Q/-=ZA>VEG B&2YN8(E>1?
MX1;+_@X'_P""W'_!6/XR^,/"'_!%O]D'0_"GP^^$VGW6N>);WQN_PK\0Z_J&
MBZG?6&DZ!-X^\??&3Q!X+^$7AGQ!J4L-UJ?A_P"'GA2_N/$LUI+XD,=_XSTG
MPG?:]8@']^%%?Q%_L^_\%_O^"G_[#O[8OP&_8S_X+I?LS>#/AGHGQOU;3M)M
M/C_H%U\/]!E\,#Q_XAT_0/"'CG5_$O@WX@ZI^S]K?PI\#ZK+)8_%271]:T[Q
M3X-T">_\4WL^IZIX;3P;XF_MAU;6]&T"U6]UW5],T6R:9+=;O5K^TTZU:>17
M=(%N+R6&(S.D<CI&'+LL;L%(1B #3HK!T?Q5X8\1//%X?\1Z#KLELB27,>CZ
MQI^IO;I(66-YTLKB=HD=E94:0*&*L%)(-3:?XB\/ZM>7VGZ7KNCZE?Z8[1:E
M8Z?J=E>7FGR)*\#QWUM;3R36CI-')"R3I&RRH\9 =2  ;%%8\7B+P_/J\V@0
MZ[H\VNVR>;<:+%J=E)J]O&$CE,DVFI.;R)/+FADWR0JNR6-\[74G-U'QUX(T
MB\FT[5O&/A72]0MB@N+#4?$.D65Y;F2-)HQ-:W-Y%/$9(9(Y4$B+NC='7*LI
M(!U5%?S+_P#!S'_P4^_:J_X)I?LT?LT?%3]CWQEX0\/Z]\5/C-JGA+7]4U_P
M=X<\?Z;JGA:+P#J?B.P.G0ZU#=V</FWEO;7$=_9G=/;D*KM$_/\ 1+H/Q(\&
MWNGZ+%?>-?"0UV[LM.CO-//B#1HKT:M/!"MQ9FP^V">*Z^V.\/V3RA*DO[GR
MPXVT >AT5GZIJ^DZ':-J&M:GIVD6".D;WNJ7MMI]HDDK;8T:YNY885>1OE12
MX9VX4$\5G:1XN\*>(9Y;70/$_A[7+F&$W$UMI&M:;J4\4 =(S/+#97,\D<(D
MDCC,C*$#NB[MS*" =#17(7?Q!\!:?=7%C?\ C?PA97MI-);W5I=^)=&MKJVG
MB8I+!<6\UZDL,T;@K)'(BNC JR@@BNFL[RTU"UM[ZPNK:^LKN))[6\LYXKFU
MN8)!NCFM[B%GBFB=2&22-V1@<J2* +-%?SJ:]_P6X\7P?\%[_"G_  2:TKP#
M\)K+X%K\/+[6_&?QMU?Q-J=YXPN_%B? 'Q'\;K5- GMM4TSP?H.D07,7A_P;
M>:5JMAX@U*:[M-9OX]5M9-3LM,TC^A72->T/Q!;R7>@:SI.MVL,QMY;G2-1L
M]2MXKA420P2364TT:3".2.0Q,P<)(CE=KJ2 :U%<S<>-?!MI/J-K=>+?#-M<
MZ0@DU:WN->TJ&?2XS<VUF)-1ADNUDLD-W>6EJ&N5B4W-U;09\V>)6SU^)?PY
M9E5?'_@EF8A55?%6A%F8G 50+\DDD@  9)X% ';45!=75M96UQ>WMQ!:6=I!
M+<W=W=31V]M:VT$;2SW%Q/*R10P0Q(TDLLCK''&K.[*H)'.:=XZ\$ZQ>PZ=I
M'C'PKJFH7/F"WL-.\0Z1?7LYBB>>40VMM>2SR^7#%)-)LC;9%&\C81&( .JH
MHHH **** "BBB@#^*?\ X.9OB%^SK\*/^"G7_!$;XC_M:^%7\:?LY>#M<^/6
MM_%CP^/#$GC2&?PW:ZU\(]FH7WA.&1+CQ#I>@ZH^GZ_J^E6T5]=W>EZ9=QVN
MDZS<&+2KSB/^"77Q[^ 7PF_;8_X+E?\ !7_]F[X:?$CPY_P2@\+>"?ASH'@_
MPC\/_AIK_@FX^*WQ)L].^&U_XV\9_![X6>)G\*>"[RVFUZP\;^-XM.UCQ!X1
M\6>$?"_QB\'1ZCX.\)#Q;=>']*_IA_:X_P""8OPF_;$_:Z_8N_:V^(GB_P 2
M6FK?L8R_$X:%\-H-(\-:QX$^)FG_ !4TS2](\0:/X]MM<T^]N9]+^PZ9]G-G
M9M'!>P7=S!>QS0OLK]%?#OASP]X/T#1/"?A+0M&\+^%O#.DZ?H/ASPUX=TNQ
MT30/#^AZ3:16&E:+HFC:9!:Z=I6DZ98P06>GZ=86UO9V5I#%;VT,4,:( #^$
M+]F__@J?^Q[\$/\ @X5_;W_;F_: \3_$/X(_ 7]JS]AO]D#5OA1?^*/@U\4?
M&GB:2^\>_LY_L7_$+2?#/B/P]\%/"WQ5ET77K/P[8:D=88W-UH5GJ&GW&GQZ
MW<W#6RW'U]^UY\&_C3_P75_:L_9K_;J_X)P_%O\ 9I_:8_8=_8\2U\(3_ /]
MK'4_VP/V>/"5Q^V5X:U?6O'VO>-KSP'%\!=%\2^(K:P^'?CWX'C3?$G]HG3K
MF?2]7\.VJP1IXACU#^QBB@#_ #R_@-_P3\_X+4?\%&/^"6'P6_9Z^'6L?L(>
M OV1=&_:@_:)^(/C;P1XZ\:_'+1/'?QJ\1^'OVL?'_B;4?"OQ%2R^#OBJVT[
MX>:+\1['Q)<^%(?"NKZ9J6O^'Y_#NJ^()(M4L8[6#C?^">O[.'_!7OQ#\?/^
M"]O[-/[$FC?L)_LU^./&/Q&^"_PX^/&LW.M?&/P_X!^&%O#?_M%Z7I.C?LE-
M;?"KQ.-7\-W>C3^.M$U35?'GAVPU71[2?PQJ&DP/J,]Y+;?Z,U% '^;-^SW^
MPU_P4#_X)Y?\%LO^"4'[/OAOX2?L(V7Q[\ ?LH?$:'P[K_@OQ%\<)/@Y\2_"
MVI:+^U#'\1/B)\</&4WP[T?Q?_PNW4=%E\;IHEKHV@S>&Y+C3OA[I<D]AI,M
M]'8^T?\ !)3_ ((S3?\ !0IO^"BWQ'UW]M/]M7]E2#P[_P %"OV@/ '_  @7
MP!\=-X(\&>+]/<Z/KS>)]<TB\LW35-6O$\02:-->X>"?2M-L;8AA"V?]#&B@
M#^(2\_8X^#>@?\%B_P!A3_@F/\!/!]H_[-'_  2#_9 ^.?[9/Q%MOB1%/_;7
MC#XT?%CPQ:V7A_XC^'?$6CMJ,OB/Q>GQ1U_]G[QZ^C:[%X+T'2)_!GC&YTF.
M_CL;/2]<_FR^!/Q?_P""?WC_ /X(8^*OV'?"OP+USQK_ ,%;?BI^U=\/W^"M
M_P"%?@?XA\2>/-4;4?BOX+&G^*O#_P 3-"M;UCX;C^'2>)_@^W@S3[N;Q3J/
MCGQAH:Z=\/-4L6G\::+_ *Q-]\+_  )<7WC[7K#PIX:T3QC\3/#EKX7\:^.=
M)\/:-9^,/$FDZ7I^HZ;X?M=?\0PV::IKMMX;M]5OUT&TU:[N[;2EN[J.RC@C
MN9E?X-_X)D?\$N/@5_P3#^ WACX+_#F]G^)VM^$[OQZNF?&;Q[X5\'VWQ4C\
M-?$+Q-:^+=9\$1^(]"TFTN[?PB-=LK34?[$M[B.PNK^VM[^ZMY;R&*90#^?/
M_@N=^U_X>\.?\$L_VD_^"0_B_0?B]XO_ &O?@M^PK^PY\3?B3\3;318?$7P;
M\6OX9_:/_9'\'^*7T3X@:AXAB\?>(_%&H^(-4?5R=9^'^G/>V"WVHW]]#=JU
MO)^BW_!-K_@CI^SCHG[/G[ _[1[?%S]MY/'ND?!K]EGXW-X5O_VP_CC+\,5\
M7V'@GP+X[/A^]^%\_B/_ (1B3P&NLQ?V=<^ IM/_ +!?P^'\/26?]GDPU_1/
M10!_FC?M8_\ !4CX3?\ !8_]O+7?AE^W+^TOXG_91_X)!?!7QZNN>#/AYX0^
M#'[0OC/QA^U W@C6=:TOPMXJ,O@CX)^(O%/@G5_'&F7EYK%_>^+=.\)7G@7P
M?K</AG2M'U'Q<;W6=*_9;_@YO\!_L_:M_P $,O@O\0/V6_AWX=B\">)/%'['
M&E_"7Q!X<\ ZCHOBB[_9ZT[X<^+]0^$7AVX_M[1;#XAV?AK1/"VH:=)I?ACQ
M=%;7^@27,L.HZ;8ZJUY&/[(Z* /YV?\ @N[^W'^S[\$)/@=^QK^W-\(O&<_[
M '[:NB>.M!_:/_:4\.M\3$@^$3^ [SP_XK\%:/8)\-/ _B_6M0UK7/$FEZ<]
MUIFGQ2ZM+I$DEU#:P6%I?W@_AB^(WA#Q1I/_  3]_P""KOA_]D;1?B#XS_X)
M2W?[;GP9U+]F#XH>,/A?)X/U[Q;XGB\8:Y)HVDZ9<Z]-/\3/%6F:!\+K^TC?
M4==@@FDTQO#?BCQ;X8^&?BOQK+X*M_\ 6;\:>!_!?Q(\+ZOX(^(GA#POX]\%
M^(((K;7O"'C30-)\4^%];MH+F"]AM]7T#7+2^TK4H(;RVMKN**\M)HX[FW@G
M11+%&ZZ/A_P_H'A+0-#\*^%=#TCPSX7\,Z1IOA_PWX;\/Z;9:+H'A_0-%LH=
M-T?0]#T?38+;3M)TC2=.MK>PTW3;"WM[*PLK>&UM8(H(HXU /PS_ ."S?_!+
M?]DK]N[]D[7OCC^T+X=\9:Q\0/V3?V4_CQXK^#MWX<\;:OX7T_3-9/PVC\7F
M36]+T_\ T?781K?@G09?L]Y\@@AN+?[ES)7XY_\ !/'_ ),1_8__ .S<OA%_
MZA.CU_5W^WU_R8I^VI_V:7^T=_ZIWQE7\XW_  1I_9J^(/[3?_!+[]C+XO?#
MR\\+V7A:_P#A)%X&@M_%.I:AINLC6/@WXCU_X->*Y9+33M'UBU6PN?%?@'6[
MG19EOWFN]%ET^[N[:PNYY["V_P \?VB/ACQ_XG\!^'^7>'_"F<<68[+.+L;C
M<?A<GPZQ%7"X2IDU>A"O6BYPY:<JTHTT[OWFD?6<)8W"X+%XJ>+KTZ$)X>,(
MRJ.RE+VL79;ZV39Z+17WC_P[M^.__07^&W_A0:]_\RE'_#NWX[_]!?X;?^%!
MKW_S*5_DM_Q*5])3_HS/&_\ X;(__+C[W^WLF_Z&.&_\#?\ D?!U%?>/_#NW
MX[_]!?X;?^%!KW_S*4?\.[?CO_T%_AM_X4&O?_,I1_Q*5])3_HS/&_\ X;(_
M_+@_M[)O^ACAO_ W_D?!U%?>/_#NWX[_ /07^&W_ (4&O?\ S*4?\.[?CO\
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M0:]_\RE'_$I7TE/^C,\;_P#ALC_\N#^WLF_Z&.&_\#?^1\'45]X_\.[?CO\
M]!?X;?\ A0:]_P#,I1_P[M^._P#T%_AM_P"%!KW_ ,RE'_$I7TE/^C,\;_\
MALC_ /+@_M[)O^ACAO\ P-_Y'P=7Z,?\$V_^2G^/?^Q#7_U(=)KF/^'=OQW_
M .@O\-O_  H->_\ F4KZU_9#_9>^(WP)\9^*/$'C.]\*75CK/A@:/:)H&IZC
M?7"W0U6QO2T\=[HVFHD/DVT@WI+(_F%5\O!+#^@_HJ_1O\=>#OI!^&'$W%'A
M=Q9DF091G>*Q&99KC\ J6$P5&>39G0C4KU%5ERQE6K4Z:=G[TXKJ>3GN<97B
M,IQM&AC:%6K4IQ4*<97E)JK3;25NR;^1^@5%%%?[Z'Y8%%%% !1110 4444
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M9M)T,^(O!S^,/"/A#P9KRZ1J5E'\0M--WI\L_:_\%U?V"?V[OA)_P6;^'O\
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MQH=SI5E9^']/M]8OII':6Z\#_93\4?\ !Q7_ ,$#_@M\2/V,_ /_  3*U/\
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M.^)D_BVU^&%_J&N?"^YT%_%^I2^%KWXJKX$T'Q1?Z-?7FDZAJN@Z'XAO-/\
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M)UU?Q//I6GPK!;76K3KND<O(_ME !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!\E_M]?\F*?MJ?]FE_M'?\ JG?&5?EK_P &N/\
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M%_;WA"?X7>-_$,.GA?%>@>)-.^QS:CINFZA%=6,$4\GD1A;DP2.C_M!\"/\
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MA74H=.T_Q'XZ\&_LZ^*-<BT&.4WW@CXD>+9=/_L5])LH@ ?Z"%%?RH?LG?\
M!QY\5/B1\7_V.?#O[5O_  3\\:_L\? W_@HIXQ\-^ /V,_CAH/Q$\->/+/QI
MXDU"73?#^K3^*/#44MIK&EZ&GCGQ1X)T2TO8H8KBTTS79]9O[5UTV:V;M_\
M@[%^/GQK_9T_X)R_!WQM\"OCE\7_ -GWQ-JO[;7PD\)Z_P".O@I\2O&?PL\7
M3^"]3^%7QXU#6M"N?$?@;5]&UBXT2YNM(TS4[K29KB>PN+_2=-NYK2:XL;5H
MP#^GBBO\WK]I_P#;,OOAE^UI^Q?9?\$+?^"NO_!1[_@H-\</$?Q MM.UW]F3
MX[_%OXX?M%?"KQW;W;:G%>6WB.S^(2>!_#$VC1^'H=3_ .$ML-9\,(OA'P_)
M_P +-T?XA>#=4\+_ -N:#[%_P<K_ /!9#]K[7_B5XG^#7[ 7Q,^-WP>_9T_9
M&^)7AWX:?M*_M$_!'Q;J?P_3Q+^TEXLTS7M2T'X7Z=\6O /B6RUV[TGPYX>T
MCQ!%KO@W3;ZW7_A)M/OI/%EDTNDZ+'; '^A'17\&_P"W)^TE\:OCK_P7*_:Y
M_9A_:C_X*H?M$?\ !+G]DS]FK]GG6?&7P:N/@[\1/''P"TOXAVH^&F@:W'XI
MGO=&\6>&8OBGK]GXV\0:CJ=IIMI;^(]>\<V'@Z\^'G@2TTF^75KZ/\H]2_X+
M4?M^_'[]B?\ X)C?L\>/?VN/VC?A-?>/OC[\4O WQ(_:6_9OE\;ZG^U7\0_!
M'PQE^'?ACX?^$9+?P-JVB>._B?\ $/4KKQQ/ID5S:>*],O\ XAZ^^@7/CJ'Q
M'K,=]K=Z ?ZDE%?YTWP._P""O/[7W[%/_!*O]NKQYX:_;@\8?M2_'#0/CUX(
M^$_AGP/^V7%X]N_VP/V,_$7CA-=T'Q-/XW\/?$^?Q-)XMC\.SZ&=&@LI_$&I
M>"/#_P 4- U6)_#=M97EYINO_??B+_@WE_X*C>$/@Y\//VKO@1_P5J_:NU3_
M (*?CP#\-X_B8OQ(^.?CF]\">*+2RF\.>+[KX&2?$.^\2Z]J'B3X:?#?QW=>
M-K[1=(\<:3K_ ("\=V^ILVJ^#-'%S>0:F ?U5?M]?\F*?MJ?]FE_M'?^J=\9
M5_&-_P $B?\ @L1X^_8A_P""<G[+W[-/AWX+>#_'FD>"/"OBGQ%;>*-:\4:U
MI&I7\GQ:^(_C/XQWMM/86.GW-K"FCWWC^YT2UDCF9KFTTZ"ZE$<TTD:?T=_\
M%+_^"@OP%_9:_8%\1_#C]NGXI^ ?@1^TW^TK^Q+\7=*TCX:6,GBWQEHVN?%V
MY^"YT+QMX5\%^*-%\)/::EH^D_$#Q99:!I.MZU!X>75+6[L=0:UM(Y+A+;^#
M7]FS_DWWX+?]DQ\%_P#I@L:_5_";A_)^(<TS3#YS@H8ZCA\OIUJ,)U*]-0J/
M$0@Y)T*M*3;BVK2;6NU]3^6_I3\?<7< \-<,8WA#.:N2XK'YYB,+BZU'#X+$
M2K8>& J5HTG'&X;$PBE42E>$8R;5G*VA_5A_Q$<?%G_HV;X=_P#A=>)?_E11
M_P 1''Q9_P"C9OAW_P"%UXE_^5%?S=T5^[?\0SX&_P"B?H?^%68?_-9_$7_$
MR'C9_P!%WC?_  V9!_\ .H_I$_XB./BS_P!&S?#O_P +KQ+_ /*BC_B(X^+/
M_1LWP[_\+KQ+_P#*BOYNZ*/^(9\#?]$_0_\ "K,/_FL/^)D/&S_HN\;_ .&S
M(/\ YU'](G_$1Q\6?^C9OAW_ .%UXE_^5%'_ !$<?%G_ *-F^'?_ (77B7_Y
M45_-W11_Q#/@;_HGZ'_A5F'_ ,UA_P 3(>-G_1=XW_PV9!_\ZC^D3_B(X^+/
M_1LWP[_\+KQ+_P#*BC_B(X^+/_1LWP[_ /"Z\2__ "HK^;NBC_B&? W_ $3]
M#_PJS#_YK#_B9#QL_P"B[QO_ (;,@_\ G4?TB?\ $1Q\6?\ HV;X=_\ A=>)
M?_E11_Q$<?%G_HV;X=_^%UXE_P#E17\W=%'_ !#/@;_HGZ'_ (59A_\ -8?\
M3(>-G_1=XW_PV9!_\ZC^D3_B(X^+/_1LWP[_ /"Z\2__ "HH_P"(CCXL_P#1
MLWP[_P#"Z\2__*BOYNZ*/^(9\#?]$_0_\*LP_P#FL/\ B9#QL_Z+O&_^&S(/
M_G4?TB?\1''Q9_Z-F^'?_A=>)?\ Y44?\1''Q9_Z-F^'?_A=>)?_ )45_-W1
M1_Q#/@;_ *)^A_X59A_\UA_Q,AXV?]%WC?\ PV9!_P#.H_I$_P"(CCXL_P#1
MLWP[_P#"Z\2__*BC_B(X^+/_ $;-\.__  NO$O\ \J*_F[HH_P"(9\#?]$_0
M_P#"K,/_ )K#_B9#QL_Z+O&_^&S(/_G4?VO?\$S_ /@JOXY_;R^,GCCX9^)?
MA'X3^'VG>$OAG=^.HM5T/Q'K&LWMY>P>*?#'A^/3Y+>_L;6"*U:#7;BY>97:
M42V\**A1W(_;*OX\O^#=C_DZ[XS_ /9O6H?^K(^'U?V&U_.'B5E&79'Q5B,O
MRK"QP>#AA,'4C1A.K42G5I<U27-6G4G[TM6G*RZ)'^B/T>.*^(.,_##*\]XF
MS&>:YM7S#-Z%;&U*.&H3J4L-CJE*A%T\)1P]%>SII03C23:2<FW=A1117P)^
MX!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'YXP_\ *6'4/^T>.C_^M):Y7Z'5^>,/_*6'4/\
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MQ-+N_M^F)XE\"_#CPWX7UU=.OO+A^VV*ZII=T+2[\F+[1;B.;RTW[0 ?PO\
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MOA"[UOPUXZ\ _!_7(/!3^,=!\2V^O67BJ76?$OA:]TO[39K:?4W_  3_ /\
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M+Q__ ,%8/C'XO^-NLRV^G?L[7!^"/PBT#5?%MK\2[OXG>(-<\?"YCA^(6O\
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M:7,]O)I5Q8"W!N3*[1?UG44 ?R)?M5?\&U^D?&SX-_M;?M._#+QY^TM\&_\
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M6A>O@ZM?#2E.DXU+4ZT^5249N,U*$2BBBOA3]I"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /S
MQA_Y2PZA_P!H\='_ /6DM<K]#J_/&'_E+#J'_:/'1_\ UI+7*_0ZOKN+OBX;
M_P"R1R+_ --53Q<E_P"9M_V.L?\ ^X@HHHKY$]H**** "BBB@ HHHH ****
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MOT.K\\8?^4L.H?\ :/'1_P#UI+7*_0ZOKN+OBX;_ .R1R+_TU5/%R7_F;?\
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M=I^K?$'P+XKT"+3OBU?^,;CXR^/-*UFV\-7OA^>YALC]G#]L[X)_L??LH?\
M!>FY^&G[*WQ=_8%_X*'_ !"\ _ 'P?J/[(NL_%OP?H?A?P[+\1O%MU\"=)\>
M_LI>%[#X*_#[XE>"XOA/XK^/NH^-O$7PS\0_\+)=-%;X=V6G?%=)M>US6-$
M/[XOV,?VTOV??V_/@3HO[2'[,?BK4_&?PF\0:YXD\.Z7KNK^%O$/@Z]FU7PG
MJ<FD:W ^A^*-/TO5X4MKZ)XHYY;18;A0)8'>,AJ^JZ_SO_A9^RK_ ,%'O$?_
M  47^&G_  2*_8^_X*'?'O\ 84^%_P  _P#@FW\$OCSX[L9]7\07%WH'B6[\
M!_#W_A-]-@^'7@JY^'^D:OXUUKXS?%?1M+UZ74]7\+'2O#$&O^(+F_\ $?B+
M0K'PWXH_I+_X( _MZ_M$?M>?LT?'GP'^UU<^&->^-G[#/[0/C']E7QW\8O#N
MH7LEC\7W^'5E;EO'>IV>H:/I$UIJ@02V6H:JT4,GB9;6/Q#?:7HVI7M]9  ^
MN?C!_P %G_\ @EM\!OB3<?"'XJ?MN? GPM\1-+\7WG@?Q-X:F\6PWMWX+U^P
MT#6/$-W%XTET^.ZMO#-G##HLNE27^J306B>(]0T;P\\JZMJUG:R?:5Y^T?\
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MT ?Y]E%?Z"?_  [0_8(_Z-4^$7_A/M_\DT?\.T/V"/\ HU3X1?\ A/M_\DT
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M91WUS&9)-\ZVD,4 ?(_=HHQQ7L- !1110 4444 %%%% !1110 4444 %%%%
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M T&SL-*L/M^JW]]J=[]EM(OM6H7MW>S^9<W,TK@'\PW_  H3_@[T_P"CVO\
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MB379111011PPQQPPPQI%%%$BQQ111J$CCCC0!$C1 %1% 55 50  * /Y7_\
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MT>%O$&C6VNMI'B^S\2>&M#_CO_X)Y?L'_M6>+/V_?VQ?!/P?^-7P^_X)A?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_8XG_:3\'_%C]BSQ1^W#^T#\%/!?@R'X8?!"?04^#VD^,?B#9?#K4_"/Q/\
MA_X+T'QSKDND^']$T270/$FH>./$-KKUMB^UP>(?M33/^)'_  3&_8*^*?\
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MP08_X(,_\%(?V#O^"I.D_M1_M(?##P1X8^#UIX-^-NC3ZWHGQ9\!>+-26_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
AHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>nt10015006x17_graphic7.jpg
<TEXT>
begin 644 nt10015006x17_graphic7.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^P=X<_\ 3WXNK^HWQG_P3'_87TK]IG4_^"A'BCX9PI\;/")U+X@:MXS>:&:
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MW4_*&ZV8_P#'Y+PPS@\5YO\ \%&/^"MW[4G_  7#\)>$OV0?V3/V1_B!X.\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6]V_6UNG1::6^>[UM9W_ *_/:V_Y66V_\O'_  =$_!;]I/\ :1_9G^!?P?\
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M_"Q?A]_T/?@W_P *?1/_ ).H_P"%B_#[_H>_!O\ X4^B?_)U?X<7_"1^(?\
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M_P#0=UG_ ,&E]_\ 'Z/:>7X_\ .==G^'^9_N._\ "Q?A]_T/?@W_ ,*?1/\
MY.H_X6+\/O\ H>_!O_A3Z)_\G5_AQ?\ "1^(?^@[K/\ X-+[_P"/T?\ "1^(
M?^@[K/\ X-+[_P"/T>T\OQ_X <Z[/\/\S_<=_P"%B_#[_H>_!O\ X4^B?_)U
M'_"Q?A]_T/?@W_PI]$_^3J_PXO\ A(_$/_0=UG_P:7W_ ,?H_P"$C\0_]!W6
M?_!I??\ Q^CVGE^/_ #G79_A_F?[CO\ PL7X??\ 0]^#?_"GT3_Y.H_X6+\/
MO^A[\&_^%/HG_P G5_AQ?\)'XA_Z#NL_^#2^_P#C]'_"1^(?^@[K/_@TOO\
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MX)E?]$X_:Q_\-W\/_P#YZE?YHU%'/+R^[^OZ;\K'M'VC^/\ G_5WY6_TN?\
MB+^_X)E?]$X_:Q_\-W\/_P#YZE'_ !%_?\$RO^B<?M8_^&[^'_\ \]2O\T:B
MCGEY?=_7]-^5CVC[1_'_ #_J[\K?Z7/_ !%_?\$RO^B<?M8_^&[^'_\ \]2C
M_B+^_P""97_1./VL?_#=_#__ .>I7^:-11SR\ON_K^F_*Q[1]H_C_G_5WY6_
MTN?^(O[_ ()E?]$X_:Q_\-W\/_\ YZE'_$7]_P $RO\ HG'[6/\ X;OX?_\
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MRM_I<_\ $7]_P3*_Z)Q^UC_X;OX?_P#SU*/^(O[_ ()E?]$X_:Q_\-W\/_\
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M.*TM3/\ 9X%^T7,N)[F4--/+),[NV/JRWFCW3Z;?:,FEWMB3#>1^:TC>8HR
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MKW^D6%U:64GV>RUL0/>Q-&B^9):R-.@ 53M57?*[<$DG. *_3[_@A7J3R_\
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M[8IWOKW[: W>[V3MI?LNJ_(IDQK)R@9>3C)QST[Y''KTST&*C8@DD */3/\
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MDN7K!5X8;V=-R=+ZO&I!N,^5MU(5:E9JHY.<ISA-0DFFJ=.[B4[V7S%APH4
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M!OFNI.S>FK_!.^WKTOOV?]KF "HY4#C& >G3J#_G]6"ZG!)\QLGD].OKT_\
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M]/\ LV3XH_\ J/W%?0?[$/\ R9=^R'_V:_\  '_U5'A.OGS_ (+"_P#*+?\
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MH-K9^9&VD_*3TYXP"#C)/_ZQ1\M^I32BHMI/O'J]OZ\]5<MQI&WF*I)' &<
M$J #R0,\YZ<?A7=>%?AIXD\56YO=)L9[Z",A9OL:F::+.?OQ1+(X# ';E06P
M2.E<C86B27=O#*2()I8DD;+*(E<@%B>O'WCM!X[8K]*_ WAJ/X50Z-=:)KMA
MXD\+>)] TV^U]K7RDFL=1:!)(+%WEBM9HF@$]S'(ULS&1L&21RJ&O'SG-'EU
M"'LE&6(J\WL855-TY^SY75CSQ5H3<'>E&37M)I05]6OEN+,^JY)ETIX&C3Q.
M9U*=:6 PM9SIT\;4H0566&=:,7&G7J04EAU4:52IRP2LY2CROP4^#P\*SZGX
MGUZ+44ATWP]J<D]B8B]W,UW87=E 5L# ]TPCGECD<I&^R,/*P"(S#PKP_,-#
MUQ_&<]E++:Z5JKRVD,,1;[7.6F\FVE4HZB1D5BP8*!L8-CH/O_4/B'X*T..X
M\.P:[_:.E>+-"D;6=3BCB?5/"NHPO-)!9PSR*JR6UQ]GMH[A3<N3!=RG9D!1
M\6+?Z396_B;1IKNQU&S::748)A)-"988GD"O!Y:1J+DK<J6 *IN#_,2%)]+P
MOGBL\S#-7B<9_9>-E'#5,OQ6(O2I+"492EC$E.*E"<X*I!)I\T8PJ1]R<7+\
M?R3/N+,VK9CB\VRK%_5\WEEE/"X-1K826'RF5Z.-=ZE*G.CBXU9XB5:&(JJM
M4I1I2P\%3=.I/AKH:'):7VN337MA>3M*EOHL*O;OYLX"I*+IT,*VT3R!Y82N
MYT1PKAF!'@6IS!KB<L6=BS*Q7)^92!_"".Q&[D$<5[U<ZCINK%1J>H6VDVND
M6<TM@$BCDEN[R*.5[6"3S8B)8Y)A&DIE=F*MQV)\#ORQN9Y1@I+*\A* !59R
MS,0H& N6X P .,8''UW$^88/$8[ZE@*]3%T,#"%'ZU4@HQK5>5*HZ<E%*4.9
M.*M*4>5)V7-8_:>'Z,:-*I"<JSLTH2K7E*G24FJ5%5)03J*,(\W-*4YKF49R
M;C=YTN7B8XR  #GJ#U['&!_/M6=5F0RQ[U)RKXYP< <\#T//O^)JM7S#5K+6
M_7M?R\CWZDN9KTTWN]M7_3_0****1F%%%% !1110!_0?_P &NW_*9G]G/_L2
MOV@/_5'^.Z_U6:_RIO\ @UV_Y3,_LY_]B5^T!_ZH_P =U_JLUK#9^OZ(VA\*
M^?YL****LH**** "BBB@ HHHH **** "O\4?]N>20_MI_M<J3@?\-+?'+;@]
M1_PLOQ+@$#L <>G..E?[7%?XH/[=.X?MK?M<Y/\ S<O\<L<]C\2_$N..HXXK
M.IT^?]?D)]-+ZZ_U^?E>^A\PK(5&%[\DMSDGKQTP>/I^.*B8^8.I'.?4'Z#M
MW[U#D^I_,TH<@8P/\FLR6Y/9->N_3;7SZ^?8&7;CG/7^GIFFT]CG&.>O Y/X
MX)IN"1D D>N.*#.S[?AZ?YK[]=1***4 GH"?H,T"$HIVQ_[K?]\G_"@!B" "
M<XZ GIS_ /K_ /UT K=?Z_%#:[XZ3ITEE9R6MXLP:*W-P90$>";RP9$2$L3(
MJME0P*[L XYXX5(W=U1%.]L8!PO.?5L#'U[YKK8(+W3X+:[62%EW%/* +OY@
M^\ %W!N00!R#V!XJ9)NUG;7[_)_U\F3.Z47&:B^:VR:;?35.SZIIM7W31UUG
M96FERQZE>Z=>WFBB[>*.\MMUFDUS''%((UN3'*JS1ETD:+!8JRD[2:Z"[N9[
M[3B/LNF2S:EJ,5Y;W=U&DVI16=E');QV-SJ1(,5HRA/,MFCQ,ZK("N *YV6>
MYN+*S+V LX?-,;!IG_TF].WS+J:S>8M#(Z&)"RPQ*5C  SDUO6^MSZ/9ZA8-
MITK)/$@N]1M+:2X*63JKO:>8ZRV]NCR^5*TF$G#)M60(2K<<U*\7%7G=+XM.
M5-/9.WQ-.323:232LK<-;GYH2BO:5;VD^?=<T;M*]E>33?+JU:-NV/>W=EJ>
MJ7)N[;3-$\NU""WT>T6.R$\8<Q2K#&P!ED8X>;<"=J'&!BO.M62(W!2 N,M\
M[2-_K .0V#@8XX''. #P:]-T+5-"CCNQJ*M<Z8OES_V8HC$MY<PEGMDDN&VS
M+:;\BZ$5Q'*T;#RVST\UU>2*6]>:&-(8Y))"D498B*,[ML0+L^0,@#YBV._%
M=%*_-)-25E%=+7LMNMWKH^9+2TFVSIP_QN-IQ45%6EMLFK:MWUUO=?WKMVQE
M;EAD@#C([]>V>/;DU&JEB6QQR3_GOC-+(-A('&3T'/3G@^G/M3%W<[?QZ?UK
M8ZTN66S:6UN^EWU^[T\AV0'/88Q[=JE)5AM&,D$#!&23Z^W\NU,";GR02I&<
M@''8=1[\5+Y W#!([X4Y;\.HP!USVQ[DF[2[_=T_S&X-MR6WX=.OF_\ ,2%&
M4MD#C!]<Y(X]_I]:V%N+J9%M][;4 ,:%B. .",\%2.P'/45UWA;PO'K<%S&;
M;4&OR@.E&V6*.RE<;7G^VS72_*H@$Y41RQL7" 9R ?7M$^%4-H(;W4)H(041
MO(FM+S>RLH*LDIB,13'1PY4@@AL&OK.&N#LUXGQ3H8"%**I05:O7Q$U2I4Z3
MDH<W-+XG>WN1O)JSM9MKS<5FV!PKY,347/"TE!1E.;NEK&$5*3LOB=K*TK[.
MWSE]CG.9/(=&8Y)CC8C&.,@#KD<MT].E0&UN"A)1RV2%W [AW'RD\C'Y^OI]
MNW_P\TNP2&YNC:R/<6XNT-NSL98\L@2?!95?,;950K 8R%.<>3:A;:,]\8[:
MSGLXF?R;DP1AD,?.=C2B3YV=02<D<L#R17Z%F?@OF>5JG*IFV"G4J-)45&?.
ME))W]UR@DKJ_-./NM./,F<>7\08'-:3Q.72^M4-5[2FWR>Z[-)R46WS1<;)6
MYERNSV^<)8)@1]]@H&YF3:<_W<$G.,>M5WCX)/'3GKSTQ@'^5>Z>)?#]C8VT
M;HKK]H9_+5MF?+50RD@ ,&.3DX"\#O7C-[$8YV122 3CTXX_EZD^U?F&?\/X
MOA_&3P>+E"52"C)N#NK3C&<?-7C*+L];/5+8]>G6C6BJB5T]&GI:UE;1]+6W
M:\BI%$KH21R#[Y/MU_#CKUIC1J Q'!&<#//'X_THC?#,#G!)X].3Z_6F%CEA
M@DDG'.>O0"O!;32TU5[Z>EC9I:.UE=>>CMO]WG>Y'12E6 R5(&<9(.,CJ,^H
MHVL,95AGIP>?I2,Q**4JPY(('3)!Z^E 5CT4GZ F@!**=Y;_ -Q_^^3_ (4%
M'7[RL/JI'\Q0 @!) '7MBK.TQ+NZN1U)XQUX[XX[\GVZ5 JN"#M88(R<'CGO
MQCMWXXJ5][8&#S@9P<#D?AR>O/\ 2FFDGWTMIM_7H4K:::O2[VO?3[NOW;-C
MHTD8EE*LQ3<  6SU.#C&TY/Z\<#%;.FZ%J6HRHD$$D[.X&U.2Q/3 Z'IG'?!
MYJMI\+33Q1 ?,RB-=N!Z9+GICZ_09K]&O@?HOA33]/TV74+/0KT1.CNEQ/)'
M/<W'R@S-&+B*4G 7*A0AV8VD'G]%\-^ :G'V;UL!+'4\OPV%P[KU\1-*=1WE
M&,*="FY14ZDG*ZO)12BVW=Q3\[-<Q>74>=4Y5IR=H0BU':-W*<ND>B2NVVDM
M$VOBZX\ >,_"QL=8FLS:I*C7%G<23F%I$A(CE1&*G<Z,VS8&XQ@\BO9O!GCV
MWMX8UEO(X;F6&1;SSX,NQ:,*3YK2(&DR6$?RMY9^;+9Q7WSXTTWPC-IRP:I'
MH-_I4MAJ$\-K:M<)-I]U=S)/$X#NDY:W5GC9$+QN6)VO@$?EEXVTJWT7Q8T6
MGW-O=6VY9@T#2"$1L[ 1/O*G?\N#GC!7!ZFOUW-^',;X&XO+,TR?.)9E@\YK
MO"5,'BH?5\0IT?9RE57U>2TM*24HO6+E!JZ3?R&6YY1XBQ5?)\PPZAC*>&5?
M]U0_V>OAY5)TE2<JJG:<'&,JD)->\XR@Y1<DO=M7U_398&?4Y)-6M&1S'&S@
MN"5(1-Y$F C,KK\HX4 =C7#)XX\+#2?[)U3P;I\IM('^PZMIB1:;J#W>T>3/
MJ=P()I+P*R[GW&/<&8$ MD<%-+<SQDK+A-G";LJ,':5()S[]3QQSTK,F,:0M
MOY;80S<<Y&.,GKG/7@#@<XKQO$NO1XXPV'ACJ<L+#+J?UNABW5G"I4J.#@J2
MKQFZU6+3=H5I.,%=+=W^A648.4*%.2J05*2]@J-6IAW!JUFE1<8M--J47I*]
MFFB8ZGK?BV:QBN=1ADTO12Z6NG:A,#:0VV^201*'8(8]TC.5  +9/<BLC6;:
M32IYWM&@1I29D-I*LEL$GS(L<;1_*$C!"^4"?*^YDG)KJ? OBCPI:7EQ8^,M
M+;4=.-I)8V3Q@QRV,DAE9+I&C>%9&5Y-W[XRD!1A#P#=\4Z;X9L]&T:\TV^-
MY)=2ZG'<V\N,Q0072Q6$IVHA66XMCYDG)3>3L54  _F9U)4,5]7]C.-+FY(-
M4U*C4;3E)J>_-[C4O:0B^:22;O<Z/:>QQ/U66'JTZ::]ERTX^PJ2FISE[T9.
M\EROG]I"'O223FWKSWA-/$'C2]_X1^?7(;6T^S2/B]O!:VA-NCR1Q^=(Q3S&
M9!Y40&Z1R%&">?U@_P""&/PZUX_\%:OV*M6L[<ZE:^'_ (V*=4EL@9WLK:+P
MSXC#WMTD>[R;($HIN7(CW21CJPK\L[GP#J^B:5%XAFU#3K&"]@M)=/LDNH[J
M[O4FE*M(!92S?91 I$DBW)A<KD*"V!7ZR_\ !#6YL[+_ (*L?L/0Z3KVHQ7M
M[\78H]:@GD7[)J$+>&O$)^R6RPQB5N5C9_M+$$QMSC%"JR]I?"U:+I<\8\D:
M3:4U-*JW.&[:?+JFE):MV=KIU5*M">#J472E5IPE"%)N,9PJ15=SG3M:;UCU
M49146VKV_P!8FO\ .!_X/'O^4@'[._\ V:7HO_JV?BC7^C]7^<#_ ,'CW_*0
M#]G?_LTO1?\ U;/Q1KU9_"_E^:/9E\$O1?\ I43^16BBBL3 <F-ZY!(R.G_Z
MCQZU9*K(K=%*Y)8#@CL%7CKCL2.GXUD4LP4$ GN3C_/%:L)2(AI%#@ +E,!U
M Z@!\+G'7/ZT&D5)Q=DGKOIIMNFK/[[_ '"W.F-;0V\LGEL;N+S8%BD#L%#,
MA$JJ!Y;ED8[3D[2I[UF@-$P5UZ]!T]N>/\X_/J+R]T^Z2TBL+;[.8T$<KL[%
MII&=F:9PSLJE P&(PH*KTR23#>Z5;@K%;WB7DI2.0RQ*X0,Z[FB",JNS(3M.
MT$$C*Y'5(B,K-7NKWT?35)WWMTTT;V\B:*VMXXMKNCH%CD68CY<[\M'Y9)+9
M P?G'WNG:LZYF5R7?:T(8A IV@<D +UQTQCL,\GI6BME<7=MNCAD5+78KS2$
M1LS.0J*L3;2P+$ GRR #R1R:Q9K24EA(ZJ8R0.#Z]P._J0/QQ@4*SV:?SO:]
MONOH_P 1PCS2<4TVM79WMMV=EO\ TV1SS0R$"+< !T)^7WP/7IGZ?6JTDC K
MM;H,Y&1R<@_I_/I4BPC>0<DC/(5OFXYP.,?C@^O--D0NV0I0 8P0>H/?:#C)
M/?IQQR*=OZU_K3J5RVU3;::M^%_U\N_4B$DA8D,Q8C!()R1[^M6$8[U!5ESC
M)+8W8Y(5L'DCH!DG@#!Q3%1HP7/(R!A<Y[]C@_IZ>M*&1B N%/W@QR"F#\P7
M&0"<=\@=L4%*.EVVV]T]>W?36UM_T9J/;;;5;EPKVQD9=@.+B/!;#.O+*,C[
MQ'((]:QI9&D8_,Q4?<#D$@?4]_UJ\T^;9H5W !B0<\L23DN#G.23T _&LP]3
MGUH(5UIUOM]VW3H[OI9[!12X.">P_P#K?XTY4+=&7\^@]<=>.] G&3>WY+]3
MT2W\->&YO#(U8^(T76A,(T\/?8"WF1$Q[YCJ/VD!2H=R(S;MGRQR-WRX#V5G
M!;R2%G-RQ*P(C;4C(Z,Y /F$@'*84C/7@5KZ/X6_M30]:UF36+*QDT=+3R-/
MNEG-SJANKA87%BT*^4GV96\^4W!4,BD(2W%49;97>WBLTOKHIL\W?&L@+X&\
M(L";O+!+;2PW  9/>LXM-S3FY.$[2NE'ET4E#X5=6:UU;O:]]#&+UG>KS\LK
MN_*N31-0NDKI)J][O75DEEJ\NEW%C>Z7]JM=1LPA%R&8,MPI4EX<*IB^900
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M<]/9(TE73K/0/ 3RZG)XBLW_ +;TYK*"ZO5GMY'N'BLF2V-PJ1VMLMRYC<L
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M4:<(7GK)\L5%7D[M_"[MM-MN^NS9&;H"2G YY/&>_7\_05#4C.S+\QSR!V'
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M:?I4=I;(O^JB4(>V/Z3Z:=TGW5Q?JDUZ-704444P"O\ $_\ VY_^3U?VNO\
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M"BBB@ K_ !/_ -N?_D]7]KK_ +.8^.?_ *LSQ-7^V!7^)_\ MS_\GJ_M=?\
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M@;G9;XST",'+_)P"> O_  Y=:J\C:I!;2I,\B"X?9<3S0VS&&XDCAE4Q,7E
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MUYN4+MII64&X0=BI<F7RUWGY&;*CL0,XP/3GT%4:O3[#"I!8LK8'.5 /4#J
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M#:TS21J1%K;QK+?R/M0/+'#&SL>A>4A%&<#).![5RBEQG:3UYP< ^^<YS_\
MKK1CNY$"NC/&5;[T<DD<OU#H58'_ ($.>1@'-#NUH[/^O-?F3*+Z:*Z?6RU6
M][;]=?P+<UAJ$<LMH;4F6W8QN$(E&0 Q8,F5< $'<N0,<]*SY+.X@^9XQP,X
M*L"0>XSVR3S7J?A+Q/#H]REW:P6EU?/:7]O,-25+F!HKNRFMF?;.LP,R"0O&
MX0.LBH592H(9XOUCPG>:5ID.CZ3<6.KVJ/\ VM>27$DL%X[<YAC>9TC&>R1Q
MXSTQ6?M)N:BZ<K6MS)JRMIJFT[7V:O>]^C9C[>LZBBZ;Y=%S:=-&VNBNM&FV
M[]-SRB1MRD8YX)^HZC%0,V0HQ]T8_4U,K#<S$?*>F1^.>>._:H#USC&>0/\
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M_P ^^*L1QGS(^0SJRD1X^_\ ,.&'N>.^!D'H:.GW_H:)I+9I6O?76Z6WG?\
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M\>"T;!2SH6ZC[H]PPYKF02""#@@@@^A'(-6[C4+VZ,1N+B27R%*1;MHV*<9
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MG:RNKMI6\WKOMM]_8SZ*U;6T$\[($4JJY)XP<D\@9XX'^/2AX$225 HP#CD
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MB@ HHHH ***4 GH"<=< G% "44N"3@ D^F#G\J2@"S9R217,<D3*LBDE689
MX()(YR,<=*[7PMX/\1>.M8MM&T*W;4=7OIA%:6T*J&FF=U"CL &9U QZ]^_%
M6L;O/&JJ2<DX!VGIZD>^/QKTGX?^(_&'AG7[>]\'L\6M6+++!-#%),T.Q]ZR
M$1LK9#)G@CE0<@X(RQ'M8T*DZ"I^U49*FZS<:/M$KQ524?>4;N\K:VV,L0\1
M##5YX9T8UU3DZ3Q#<*//:\/:RBG)4G+XN5-VO9',:AX?U'3]9DT&_MVM=3@O
M);&6%L@B>"1HY@>.-KQL,XQD#'4&O5!\%-;?P5J_BL-$BZ1/;Q1V3R-]HU$2
MK<--+:*JD,EH8 LY+(5,J!0V>.NM)-&\633ZAXP2$^+&U5[V]U9;F&!&A:!E
MDME@D$DD<S3MO9C,QZ@QD\UM2ZCKL.DIH%AJVFV_AZ:YUJ[MC>7<4UQIUO!+
M$QC@/FPB.:_68,J-'(;EH28@H5ZY%'.,72<\#A)-81T99A5]E.IAX4W*+J<M
M6'22NH.4$[24GRM)'AXO-<7.IAZ5"="CB*<Z-3&*I"<J<Z4??K?5ZD;<S<8R
MA&\5+E<IV4E%'SMX>T1;F#5;F:^6SN+(01P6DHQ+>O-,L31Q'!P8E?S6.Y1M
M!R>U6?&?@S6O"$U@=6@6W?4[**^M]D@E62TECBE1V_NMB6,XZ@D@]*VM$B$V
MKSF=EEM+?48)KI7E2![^%9XC+"A<$ RHK(KE7"9#E6 (J/Q[)'>W=U<:797=
MMIZ2^5#!),+U;9,D;3/%'''M 3^ZHP /3.WM)?6(PTY7&\MO=;4.6.K3O=R:
M]V5U=.4=$_7C7J/%05THRC=JRNDU#EC?F3UNWK&5[:N+LGY<B"1W#, .0,<G
M/H<?2N@L +*UDFN(8I@Z[(PQRPP<9R5XZ>O4G'0UC>4\<I:,J">N[H1GJ.1^
M/)[>]1RS':%5"L8SOYRKG.,J,#;S[GIUS74]FO3\&G^ECNE#649)N,K72?*]
MU;5;->JNNI).\9)/EJORG[A)8EL8QPO'T/<YX&*]"\-Z7!JC6\<=U'#.3;QV
ML>3Y33-,!OD&"HV[@6PI^5<'(X'GMI;&XD+I&2JCOZC@8'KZ_P")KU'PI<:?
M;BVAN;%Q<!KC-RPW1LLL#1Q*5"AE,<A$A;?M YP*PQ$I1I3<+\R5U9)O1-[/
M1[>O:VYRXJ35&3I)QDEI:TWIKJI63VUV;Z.Y]!> /A[=O<ZO):^(+<:OIT+2
MO]DBBD2)4=&WNS1HT:JVT%D&_)P.IQYE\1?&_CAM3:Z\07%Q=0NVVW\Z66>V
MC5"57R(YB4PW8JJD'OQQT'A;Q='X!>]DODN]0M;R&2-YM$OX8&C\TA@ERYBN
M@Z@##1?NWRO4;37 >+/&<WC&.PTRXMXH(K&,P0311N%\KD!YB68-)CJ04R0,
M#GGP<)A<74S&I5K4J6*H.,(TZTJ=.,Z2</WGLU!.37/&%XS2LGHVKGRV$P6*
MGFLL7BJ6'QE"$(QH8B=&E3K86G*"^L1I2BG4M4J0I.4)<O*K6<TK&ZL?@OQ'
MH.F3Z/JMPWBR24IJ^E:@0L4[YD\J6V<S2LL21+"K*4C4,"-IV[F\ZUGSM-NY
M[**%&U&UN9C*L#;]C;_NHI 4QJ1CL#W%<S+8/%(RI([89E#0JV[:O][!. P'
M?UY/2FVK7$3@V_F"4.R*Y;Y@A."78@X4D#*L1R.2.M>W2PSI.:]K.<%*4XPJ
MV]V[3Y%-)7II-QBI1;6B<FDD?3X?"JFZDE7G6I.,YQA52O3<FFH*:LO9Q3:C
M%Q<K:.5DD=EX=:YOHM4<3V]E=*L,K/*!'/(ZRH,6ZJA"R1[0Y8,I &0<]>C%
MAJDX?5[K=XCM+"W+7TC.6DM44*-\LC_.^T# Y(7/!&:Z&RT/P6/#$;W5S=0^
M,9CYEND<;M9/;G:"[7 C\E'!64LKR;MH!X#"L6QU..QAU6PN-8>QMI;":)[>
MT(EBU68O&%MYS'N$<3@.6=LJ" "<MFN)UE6E4]E"<5":A:I3E'FBN6,I49KW
MI1:TA)-)2BT]$>8ZTJM2HZ%-Q<)J#5:FXJ5-<L9SHSC>4E.*:IR324M)*R=O
M,YK%+N>X:.=+2%8I)XPQ*"610S+"I4$EF(51_O#GL>4N]VQ S?=SA>N"3R">
MI().3^/>O:K^_P!)O-.LK2WT*6)+:W87%^B$O<W6TA9=XCPJ@A#Y;98\X;G(
M\XU'2WO94DCCV+Y3L6/ ;RLIT."&.WD'OG/MZ%&JYI\T)4[75I.-[*R6S:UM
M>S=UU2>AZM"O*44IPG3W23<7=+2+<HRN[Z.SUV3UVYJT=H98I_LXF1'R4?[C
MXP<-D-QCV/7/>IIYA=7$LRPK#OP4CB/RQ84 A>%R.">F<GI34DDA"KD,I&<9
M&1O'0^G3T]ZBG91L51M?/S$>O7Z=2._^%;G0];6[=7?MIYK316WNDKZ&FXTU
MM.< LEXHW,3G#XYVCYN<DC&1CUQ6!4H+R/L&"S?+CIG_  /%1LI5BK#!!P10
M*W_ TW>FGX[_ /#'^V/^Q#_R9=^R'_V:_P# '_U5'A.OGS_@L+_RBW_;T_[-
MD^*/_J/W%?0?[$/_ "9=^R'_ -FO_ '_ -51X3KY\_X+"_\ *+?]O3_LV3XH
M_P#J/W%;QV7HOR.G[?\ V]^I_C=4445@<H5,@SL)8  XYZ=3U_#COBH:FW1^
M6BX.X$[C^)^GY ' [DTUW[:Z]=5H->NVMGU_3;YFHLMN&A#!_+W@%4R25)&[
M8,@!B.F",D#G@UZCX7EM+N!(K^*Y>PB\UPMNBFY#>6RQ!VWQL5\S86 D/R[C
M@UXYYB*8RFX%2I8GJ,8.1[@\_P"%=+I?B)M,F$D,KH2&!<*2_P Z%&R<8.58
M@X'0GKW]G)<?#!8^%:LTJ$H.E6A%1]Z$TDTXR5I+NO+R3,\115:FX\UG9---
MWC*+5G%K5/HFM4KV['O<6KZI>/'-<O"ME!:PZ:C1V5JK_8X$2&*)MJ+OFV1J
MK2LQD9@2S%F),?B1H=-UBXF-[%$FO0(+B!7%M/8 J4_>)  JEE ;8'*D'J2Q
MKQZ?QJZVRVUN[M'YFYXW5@F226;''/)P,]\<]^3NM0^U7+/-+-*CMN+,Q)#>
MFT]L<#';C%?4\7<0Y5F&6X?+,HIS@E*G6Q.)FVIN<:;BH4WS-RC%S:?-M;[2
MLSR'DM*=>E6O"BH0J1JPC2IS=9S=*<'.3U4J=2FIII7<ET2DI>H'QS?:$'M?
M#4LME<HL]O)?6T\B-<V[2EOG9"K,6(5L$D$]^F>)U/Q-K.M6,%C?SQSPVTUU
M<1GRD$QFG$8E:6?'F3#$:; Y*H02O4US@GBB<M%N]!D9R#CJ#CD=L]NV:9YZ
M_/PP+ \CU(P0<@_3@CZU^;TZ%&E+F4%SO6=3><F[[R>NE[6OI=I61ZU/#8:B
MU5A3@ZTI7E4E%.H[)J+YG[RMS225[13=E9V*E%%%:F@5(BJ<$\\\CM]*CJU"
MR(I9T#@GCGIVZ?A04D[K3S7X.ZUUW!A&V J!><Y_GGV_ES2&)221SCMQR/7W
MYXX]/6FEP[-@$#M]/7ZU,[8"':5"IC)!YY/(..>#G/2@77N]/._D_P"F/9!;
ME2 '$BL2%Z@<$ =SD'Z<9^L]O%C/G(0"0<X!8\YXR1@$=<>XIUN8#Q&DDKM"
M_P S*0L<I"[6''(!R2-W/3..MV[$I< E9_E&6@(*GJ2#MWXR.#GIQD#N*[T_
MK_@:O[QN]DK:+?JM;6?;76VI1*V[72"X#B LI9(P/-9#@_*,@;A]1]:V;?0'
MU&]FBT6VO+A))6-A!M'VEH\#;YB%V&[.."[<]SVKS?8D<[+<(ODPGS%E1U21
M8U\P$JN0S-NR.HR00#T[?P1XHL/#^LVNHWDVH621Q3;9]-E"7:N57RA&P@F^
M7=DM\A!& "!USJ2G"$IP@YN*;27VFE=)6UN^FOZ,SKNI3IN5*#J3BG)1BGS-
M_P O:[6FC_S/.[NQO+&>2"\B:"Y5O+,+@AT8'D,.QZ\#)R<<FIA83B$32P3(
M@R3,5(C)ZCY\]STSU'XU[-X<\"3_ !-U#Q'J4WB;3-&-C:S:HEQXAN8()=24
MW:*D$33SVN^Y\IPYVJQW*<Q\\>P^(OB1\"H_@)#\-=+\,SWOQ)?4H;F_\1O#
M)$D*6:2*T%O/)8+%)#/),S,T=U*"D:* H))\_$YE*C4PM*AA*V/K5<30HXN&
M'<?]BI54W+$XB564%[*$5\,7*I*Z48,\G%YY5PM;!8;#9?B<TJXG&8?"XZ.$
MC!QRNE6A*I+&8N=65.,*%-0U492J2<H1C%RDD?%<J*H5B"_(X7+'&<>O]?Z5
M2N599,,NWY1@$Y.,9&??GZ#I6N\2Q22!T>-<9C60%6R,X*Y W#@8/3M@=LF=
M9'<LS*QP "" 6'0<>H[_ *5ZTM4I)63NM-O7MK^A[LDW%<J5I*[5U=/2U^G?
MJ].^Y6HH(QQ14F04444 %%%% !1001U[C/X44 U;<**4 GI4\=L\BAP5P6V\
MGOS^';U_7BBU_EJ.SM>VG<KT5=:QD7&'C;<0!AAR3CT)J-K24,%!5B3CAAQ]
M>V!WYX[B@?*[7MIM>ZW[/73<K45))$T9PVT^NTY [<U'02%%%% !1110 444
M4 ?T'_\ !KM_RF9_9S_[$K]H#_U1_CNO]5FO\J;_ (-=O^4S/[.?_8E?M ?^
MJ/\ '=?ZK-:PV?K^B-H?"OG^;"BBFN2J.PZJK$?4 D590ZO\_;_@OA\#/V@_
M^">?_!4?X=?\%2_@CHFLZ[H?B_7=(\5:AJUC8R7>D:-XOT70)/"L_AG5H8$)
M$=SX<TEM2$DT7V9FOHE6Y69&V?;GQ+_X.E;[]EG]NW]I#]F;]H+X+1Z_\+OA
M7\:O&'@?2/'?A*^\OQ+IOA[0K_[%: ^&H],2'6KMA&\KS7&LVI8R;"_R!C^V
MWP!_X*I_\$Q/^"DO@Z;X::-\4/ WB8^.K)=/U7X*?%*/2;'Q+JT#R)(UK=^%
MVO\ 5(KF);B&.1/W[$ND4@4,/EEVEHGJG?;L->JZ;/5/1K3?]'JKZG\)/_!5
MO_@M#\-?^"E7Q*_8@^*=G\-?$OPXUGX"3>)6^(^EWT^G7.G7MWK5_P"%KKS_
M  RUOJ-_<K8*='NA&NIS+<['CWY(8U]L?\%+/^#C*^_;0_9\T/\ 8H_8X^$'
MC?29O%VF>%O!WB_Q3K(L;_6-?CL8-+A33_"5IHE]=+';:A=6_P!COCJUI'BT
MFG;S8MH8?TR_%+_@VJ_X)2_%+7KG7I_@_P"(_ KW,WG'2OAKXBTWPIH<'S%O
M*MM.7PY>I##SCRU?&T 9XKZF_91_X(S?\$]/V-M>L/%_P@^!&AS>-M)D:71O
M&_C*'3O$?BS1Y7A:WDDTO5_[,L9;-Y8'EBD,2#<DTH/WN%:3;3EH[7:2Z)+R
MZ:>=M=P6FMU=M/1.ZT2TOIT?>S>FQX9_P;_?L/>,OV&/^"?7@;P7\2[9;'XC
M?$"_NOB-XCT[!$VDVOB1I-8T31[[,<>-2TRSU62TOXU\R*.YC=(IYD D/[>T
M45:T2787Z)+Y+1!1110 5_BG?MQ)C]M?]K=B=W_&2OQPP"!_T4KQ)WQZ"O\
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MU:5Y2DDFHW?CA!!Y!!]_UI*VKN"-<J K,H))7D  GGICD G'89Y)(K*8#;D
M=N0,=Q78=Z7-JG=VZKTZJ_\ F[;$5%+CC/OC],TE!/\ 7WA1110 44YOX?\
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M]6O3[P<HTTVW:RNU+1=-FFV^NF]_0GTBSG>\LUV%(KFYAM_M(1F>)3*NXQ
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M0J]<C->O_#]QK>I^)+;69K72PFF3MIEW<@2+!?+!(_EW4A=(UBE&Q%9BF"^
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M^4S/[.?_ &)7[0'_ *H_QW7^JS7^5-_P:[?\IF?V<_\ L2OV@/\ U1_CNO\
M59K6&S]?T1M#X5\_S84445904444 %%%% !1110 4444 %?XH7[<X<_MJ?M=
M$;L#]ICXY>O0?$SQ-T^@K_:]K_% _;G)_P"&U?VNN3_R<Q\<Q_YDSQ-6=3I\
M_P!"9-)*]]UMY:_H?+<2F1PI?:#GDG@8&::V58C=G!P"#D'!^O\ CZ4RBLS/
MF>COU[Z65M++2W_!)&E=@%X ']T8SZ9]<>],+,>I)^I)I/\ /Y__ *J5@ <
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M%O\ MZ?]FR?%'_U'[BMX[+T7Y&ZUDGWE^I_C=4445@<H4444 %%%% !1110
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MCRRUF*]6PT[2?#FMHWVLZ-=VFI^'XXYPKII=O?7MUJGV>2(G82;M2OD.,@@
M?"8''<3</XVC"EB'@*V#5-4\70E/+7CZ]*=\11<?:5)U\&H*DZ4)1KPJIS3<
M9*G47\\8O+^*>&\7E^#Q6 RK 4>'/;2PF.PM6KDLLXH4\-3KXG!8:I'VF/Q*
MC)O"T8RJQ6*E)S3;G.I0^*]!_9J^)_B8/<VWABYGLI+B:#3-0B2;[!?RQ!6*
MI>+ 4+A7CR>3\X)501GQ[6;/4_">KWNC:I9S:=J^G3/;R6T@8/&R_P 2@JK.
M#D%7"C(;(-?=R6'B/X?_ !"O+CP]X_TK38)[:">QT2:>ZO8-/U21IPUA#)#<
M26<TX<1^9<VK2V+B1 DC!'KU#7OAUI^M6^HZ[XT\+N?&UKI]O?:IXDE^P7>A
MWKS36SV?V2>P\Q8YA93VV^.63<KI(LBJP8#]6RKQJXBRJO&IBY99F-#&4*:H
MUJ6&J8;'NJ[1IRK\\VJL*3G"+K4YW]IRVCRS3C]_B?%3,>',RGC<YEA<UX;S
M/!Y:\KP^74XX3-<#BJZA&LL12S#&PP^.PU+;$5,MKXJM"M.-J$J;<H_GKX>\
M/^-M?L8([G3%MM*UQI8X=?UZVEBTM/(95DD%_+B.W6W$P9GRV,@D 9KJ[V23
MQI+>:=X@\26LFG:#:6.C2:I9Z<)88BUVJVXLW^UE9HO/G19KA754C+[E&TFO
MH8>(M2UI-:\,0Z!.();32KRTU#5HH_['O(]%2YCFTZ#[%)%(PNA=1@FV*S;4
MS</O\O=PWB"QO$N+*YN_!NA^ M(8-]LUJ!;^\$US&KFQ1[2.ZO9O*>Z$)A9X
M PF<>:?+&*\S/N/.(.+L1AYYU.GS82G"& 5.M0G[*#?MO:?O93JU*]2-2=)1
MIPE+FCSRII3Y3ZVAQ1]<QSI8NCA,%CZE&G/!X>CC<OJXNG3JTH5HU%3J5)U:
MU>HX5L-"EA*%9N=#VE2FHSC3CY-KGPQT72[NSM]/OK?6;V6&/9I^CQ)>QWD3
M+$RR2W,,F+2Y;Y-\124AFD7<=A)[+0X/%&@:O+H^A>$/"6JZX;A<:%K=A%K&
MM6SG8%MH[0K%+;AB0 N&!8X"G.#O66CC6/!^M7>J^)76XM[J633B8(M.7SHW
MF$5XLYM86"X&X1&;=APOEY4A>+\:_&+2O#TFER^#[O\ M[Q3:645KJGB9;<P
M6NIJH990D<Z17B%F+L&\I'4L"CY QX$*F-QM\-&/UZ<55I3=6%145.T)1E4F
ME3A[)KF@XR_?-JT'**ER[4\=F>:PJY=A:*S3%8.M7P&)GBJ5>A@Z6+6%IXNA
M6Q-1PPRE@I^TC0J/#4ZU:->7)3YX0JNCQ4]_:Z+<ZEXGU^+3K35X;^^@?P^E
MO'I[QWZ3RK*+*U9I':.UD1X'E5?DE1XV^937SSXH\6:GXKU&5[B0 /*[J.?E
M:0_/NDS\S#"EV &[C*D\5V6GZ3'K_BF-?$NL'3;?6;NXO;^2=+A?L!NVENGV
M"X1FQ([AE(5MV_<<@UQ7BFRTW1/$.J6NCW7V[3+6_NK>SON"+FV23;#/D*H'
MF("3\J]>5!R*^PP>&HTZMW[^(]E&TW%J%.GLJ=/>,4G?9MR5FVTD?I& PM"A
MB)-/VV(]C#EER25&E2^%4Z#:45%23ZN;33;LHG*S0+ PC:022??#+@J.G)(X
M)^O\^:HW,I(6/?E"=S*!CGUP?J<=A5N65&<M(A?KM9#UR<8P"#UY)/\ /I0N
M0H92H !7H.<?7_/X5ZC;M;3S:6]CVK22?,I.2MS2>UKJRMV?_ V(,XSCC.1C
MKP?P[_G2444B&[^7S?S_ ,PHHHH$%%%% !1110 4444 ?T'_ /!KM_RF9_9S
M_P"Q*_: _P#5'^.Z_P!5FO\ *F_X-=O^4S/[.?\ V)7[0'_JC_'=?ZK-:PV?
MK^B-H?"OG^;"BBBK*"BBB@ HHHH **** "BBB@ K_$__ &Y_^3U?VNO^SF/C
MG_ZLSQ-7^V!7^)_^W/\ \GJ_M=?]G,?'/_U9GB:LZG3Y_H1/9>OZ,^5Z***S
M,@'!!QG!Z>OM4LCJQ&$VX&/Y_P ^M144#3LFM-;?U^7D%%%% @HHHH ****
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M21^(%4Z=]-M>_7IMV]1)J.B3;M=/NG;\/ZOKIJ6L!N-QD?:H&X '&>YR>G0
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M;H"'W<U\<?%OXPR6]ZUEI>NZ3K31)#/;WNEW)UC1[U3*,P7UE/'!!:7$+ R
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MK+[K?E_6HRBBB@@**** "BBB@ HHHH **** /Z#_ /@UV_Y3,_LY_P#8E?M
M?^J/\=U_JLU_E3?\&NW_ "F9_9S_ .Q*_: _]4?X[K_59K6&S]?T1M#X5\_S
M84445904444 %%%% !1110 4444 %?XG_P"W/_R>K^UU_P!G,?'/_P!69XFK
M_; K_$__ &Y_^3U?VNO^SF/CG_ZLSQ-6=3I\_P!")[+U_1GRO11169D%%%%
M!1110 4444 %%%% !1110 ],8;N<# SUYY_3_/-7K&4Q/DMY>[CA0>.>#NZ
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M5-:=[OH5:[MI?39K:RZ?B^NMUT9!.JJ&50V\D[ Q#?*#AAU(!)W8QC/&*I(
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M+;LQ49PS9.,=!Q@]1UR?R[T!.UHV\^WEVT(**<Z[&*D@X.,CD'Z4V@@****
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M444 %%%% !1110 4444 ?T'_ /!KM_RF9_9S_P"Q*_: _P#5'^.Z_P!5FO\
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M]WG;C_J[U_G _P#!X]_RD _9W_[-+T7_ -6S\4:_T?J_CW_X.&_^")7[;?\
MP4N_:L^$7QB_9GMOA1/X/\&? ;3OAUK1\>>/Y/">J+XBM/'GC;Q%*+6Q70M3
M6XL3IWB"PV70G0F<3Q&)1&'?&7PO^NIZ35XR2W:7_I46?YS]+D\>W(K^F?\
MXA,/^"M/_0/_ &<?_#SR?_,C1_Q"8?\ !6G_ *!_[./_ (>>3_YD:RL^S^YF
M:C)7LOQ7]7\_7N?S.2S/*%W8^4  @8)QZXJ*OZ:/^(3#_@K3_P! _P#9Q_\
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M^@?^SC_X>>3_ .9&BS[/[F')+M^*_P S^9>BOZ:/^(3#_@K3_P! _P#9Q_\
M#SR?_,C1_P 0F'_!6G_H'_LX_P#AYY/_ )D:+/L_N8<DNWXK_,_F7HK^FC_B
M$P_X*T_] _\ 9Q_\//)_\R-'_$)A_P %:?\ H'_LX_\ AYY/_F1HL^S^YAR2
M[?BO\S^9>BOZ:/\ B$P_X*T_] _]G'_P\\G_ ,R-'_$)A_P5I_Z!_P"SC_X>
M>3_YD:+/L_N8<DNWXK_,_F7HK^FC_B$P_P""M/\ T#_V<?\ P\\G_P R-'_$
M)A_P5I_Z!_[./_AYY/\ YD:+/L_N8<DNWXK_ #/YEZ*_IH_XA,/^"M/_ $#_
M -G'_P //)_\R-'_ !"8?\%:?^@?^SC_ .'GD_\ F1HL^S^YAR2[?BO\S^:A
M(V;RD2-FE(&U0&R200,8P#GT Y('>O4-,M!8>&@9=,ECO9KE6_M3 9 I\PB!
MLL45C\OR.@8",\9#5_1W;?\ !J)_P5,BL+)7TO\ 9Z.H)<+Y\Z?&>95BA&TA
MHU'A+;(RG.!E3P,5ZC%_P:T_\%+F\-ZWHM[:_ 6XDDLFET@CXNW,:+J_R[99
MU7PLRX >?YFR/FYYP*XL5.JE2C"A6J)UH*?)"3M'GC&4M-.5<W,U*RE",G9V
M./&5,1+V:CAZLH^U@I<BUY%*,7/25K*_,U+>*EHUJ?RZ:Q?7UO8Q63321PZE
M#'<ZC$PTN>.>X))#6[6\;SVZ9 PDCQMUW \9Y"9(Y3;*((E\E?GDC+EILD[3
M*&8J&52JXC4#"Y(SFOZ4I?\ @U!_X*PE@R:?^SJWS!B&^,L@'7_L4CSCOU]Z
MF@_X-1_^"L4;DMIG[.C*4*X_X7-(<-D'(!\(_4>WTZ^QA^2,(0E9-.]WLKV;
MTV2_K32W12HN$7HDTV[+2[;2[ZM*VK?3NC^:6^@"PF5.%."0.G3@ <_USFJI
M@8K$;=6,N5=4PIW%"&SCGD!21GECP 3@5_39_P 0HW_!5IQ'OLOV>!L+,8_^
M%PLR%EP8^#X4 (;G=D<8'6H5_P"#4G_@K$$G/]D_LZK.Y0P2Q_&N:(0[64Y"
M)X1VG(4@<C:>1DU=:4'S\J3O!<NB>NE[6O;T>MVT[ZFC4KM*+2TV>G;Y]VS^
M9.::229I;D.90<,CJ$*XZC&% Z?ACI6C#;MJ,3-!#(\TDJA8T4N_EG;T1021
MC/(&?U-?TF2?\&GW_!6:65I9+#]G25W +-)\9Y6._N6SX2._\>N.E:FA_P#!
MJ=_P5FTB>.==._9V#(P(,?QJF1P<@_*Z^$<JH_N#CKZ\\512Y4X1U2TCHMME
MY+>W8)0ERWBDY6T5UOI?5[)]?POT_FUOO#8TO!O4E=G1)$%N87" HK%9B0Q1
MAT*G:1T(!KD;WRY+H&(.B%0I\S'; _@]!^N>N./ZE+K_ (-7O^"L&IW5Q/>V
M/[.L F4;EM?C \:NRJ$4M&GA)5W%5S(_+/(2[<DXY*^_X-._^"KSS!K6P_9T
M*A1N+_&20%CU/!\)$]>N>M94E4VJ1?-HVTFEK;17LM/)^MF9T%5T56-I:-VV
MV6E[VT?Y7>MT?S R+L=ESG!Z^O>F5_34_P#P:9?\%:6=F_L_]G'D_P#19Y.G
M;_F4?2F_\0F'_!6G_H'_ +./_AYY/_F1K2S[/[F:N,KNRTN[;'\R]%?TT?\
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M?X>-%?ZBO_$*!_P2+_Z%'X\_^'MU?_Y4T?\ $*!_P2+_ .A1^//_ (>W5_\
MY4UER2\OO_K^D_*^/LWWC^/^7]6?E?\ RZJ*_P!17_B% _X)%_\ 0H_'G_P]
MNK__ "IH_P"(4#_@D7_T*/QY_P##VZO_ /*FCDEY??\ U_2?E<]F^\?Q_P O
MZL_*_P#EU45_J*_\0H'_  2+_P"A1^//_A[=7_\ E31_Q"@?\$B_^A1^//\
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MO_H4?CS_ .'MU?\ ^5-')+R^_P#K^D_*Y[-]X_C_ )?U9^5_\NJBO]17_B%
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M_AZ>YN;B9S)-///+ISRS32R,SR2R,SN[%F8L2:[VB@#SO_A4/PF_Z)?\._\
MPBO#7_RLH_X5#\)O^B7_  [_ /"*\-?_ "LKT2B@#SO_ (5#\)O^B7_#O_PB
MO#7_ ,K*/^%0_";_ *)?\.__  BO#7_RLKT2B@#SO_A4/PF_Z)?\._\ PBO#
M7_RLH_X5#\)O^B7_  [_ /"*\-?_ "LKT2B@#SO_ (5#\)O^B7_#O_PBO#7_
M ,K*/^%0_";_ *)?\.__  BO#7_RLKT2B@#SO_A4/PF_Z)?\._\ PBO#7_RL
MH_X5#\)O^B7_  [_ /"*\-?_ "LKT2B@#SO_ (5#\)O^B7_#O_PBO#7_ ,K*
M/^%0_";_ *)?\.__  BO#7_RLKT2B@#SO_A4/PF_Z)?\._\ PBO#7_RLH_X5
M#\)O^B7_  [_ /"*\-?_ "LKT2B@#SO_ (5#\)O^B7_#O_PBO#7_ ,K*/^%0
M_";_ *)?\.__  BO#7_RLKT2B@#SO_A4/PF_Z)?\._\ PBO#7_RLH_X5#\)O
M^B7_  [_ /"*\-?_ "LKT2B@#SO_ (5#\)O^B7_#O_PBO#7_ ,K*/^%0_";_
M *)?\.__  BO#7_RLKT2B@#SO_A4/PF_Z)?\._\ PBO#7_RLH_X5#\)O^B7_
M  [_ /"*\-?_ "LKT2B@#SO_ (5#\)O^B7_#O_PBO#7_ ,K*/^%0_";_ *)?
M\.__  BO#7_RLKT2B@#SO_A4/PF_Z)?\._\ PBO#7_RLH_X5#\)O^B7_  [_
M /"*\-?_ "LKT2B@#SO_ (5#\)O^B7_#O_PBO#7_ ,K*/^%0_";_ *)?\.__
M  BO#7_RLKT2B@#SO_A4/PF_Z)?\._\ PBO#7_RLH_X5#\)O^B7_  [_ /"*
M\-?_ "LKT2B@#SO_ (5#\)O^B7_#O_PBO#7_ ,K*/^%0_";_ *)?\.__  BO
M#7_RLKT2B@#SY/A+\*HR3'\,_A\A(P2G@SPXI(]#MTT9%)_PJ/X4_P#1,?A[
M_P"$7X;_ /E;7H5% 'GG_"HOA1_T3#X>?^$5X;_^5E+_ ,*C^%'7_A6/P]SZ
M_P#"%^&__E;7H5% [ON_Z_X9?<>>_P#"H_A3_P!$Q^'O_A%^&_\ Y6T#X1_"
MD=/AC\/1]/!?AL?^XVO0J*!7?<\^7X2_"M3E?AG\/E/JO@SPX#^8TT&K2?#+
MX;QO')'\/O!$<D1!BD3PGH*/&1C!C9; ,A&!@J01@8KMZ*3C%[Q3]4F#UWU]
M3AG^&'PTD=Y9/AYX&DDD^_(_A+0&=_\ ?=M/+-^)-0/\)OA7)]_X:?#]\8 W
M^#?#C8 X YTT]  !]*] HH48K9)>B2#;;0\\_P"%1?"C_HF'P\_\(KPW_P#*
MRK^F_#;X=:->V^I:/X!\%:5J-H_FVE_IOA;0[&]M9"K(9+>ZM;"*>%RCNF^.
M16VLRYPQ![2BK4YQ32E))Z-*32:>Z:3U ****D HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K_-B_:@_X.A/^"J/PJ_:3_: ^&'A'Q'\#(/"OPZ^-'Q/\#^&H
M;[X.V%]>Q:#X4\::UH>D1WEY)K*O=W26%C MQ<NJM/*'D*@M@?Z3M?XG_P"W
M/_R>K^UU_P!G,?'/_P!69XFJ)MJUG;?]"9MI:=_\S]K_ /B+"_X*Y?\ 0T?
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M>[Z*VBW=O*WK<_I4_P"(L+_@KE_T-'P"_P##)Z;_ /+JC_B+"_X*Y?\ 0T?
M+_PR>F__ "ZK^:BBB[[O[V3SR[_@O\C^E?\ XBPO^"N7_0T? +_PR>F__+JC
M_B+"_P""N7_0T? +_P ,GIO_ ,NJ_FHHHN^[^]ASR[_@O\C^E?\ XBPO^"N7
M_0T? +_PR>F__+JC_B+"_P""N7_0T? +_P ,GIO_ ,NJ_FHHHN^[^]ASR[_@
MO\C^E?\ XBPO^"N7_0T? +_PR>F__+JC_B+"_P""N7_0T? +_P ,GIO_ ,NJ
M_FHHHN^[^]ASR[_@O\C^E?\ XBPO^"N7_0T? +_PR>F__+JC_B+"_P""N7_0
MT? +_P ,GIO_ ,NJ_FHHHN^[^]ASR[_@O\C^E?\ XBPO^"N7_0T? +_PR>F_
M_+JC_B+"_P""N7_0T? +_P ,GIO_ ,NJ_FHHHN^[^]ASR[_@O\C^E?\ XBPO
M^"N7_0T? +_PR>F__+JC_B+"_P""N7_0T? +_P ,GIO_ ,NJ_FHHHN^[^]AS
MR[_@O\C^E?\ XBPO^"N7_0T? +_PR>F__+JC_B+"_P""N7_0T? +_P ,GIO_
M ,NJ_FHHHN^[^]ASR[_@O\C^E?\ XBPO^"N7_0T? +_PR>F__+JC_B+"_P""
MN7_0T? +_P ,GIO_ ,NJ_FHHHN^[^]ASR[_@O\C^E?\ XBPO^"N7_0T? +_P
MR>F__+JC_B+"_P""N7_0T? +_P ,GIO_ ,NJ_FHHHN^[^]ASR[_@O\C^E?\
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MW][,.>7?\%_D?TK_ /$6%_P5R_Z&CX!?^&3TW_Y=4?\ $6%_P5R_Z&CX!?\
MAD]-_P#EU7\U%%%WW?WL.>7?\%_D?TK_ /$6%_P5R_Z&CX!?^&3TW_Y=4?\
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M?=_>PYY=_P %_D?TK_\ $6%_P5R_Z&CX!?\ AD]-_P#EU1_Q%A?\%<O^AH^
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M_&EHH]H^R_K^G_2U/:>7X_\  /\ 9:_X>U_\$R/^C[OV7_\ P[OA+_Y84O\
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MO_EA1_P]K_X)D?\ 1]W[+_\ X=WPE_\ +"O\:6BCVC[+^OZ?]+4]IY?C_P
M_P!EK_A[7_P3(_Z/N_9?_P##N^$O_EA1_P /:_\ @F1_T?=^R_\ ^'=\)?\
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M=-NIYX["&[OK.VDN601I-<PHS!I%!_Q/Z_K'_P"#/?\ Y2.?%_\ [-6\7_\
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M#BJA\2^?Y,J'Q+Y_DS_2AHHHK8V"BBB@ HHHH **** "BBB@ K_$_P#VY_\
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M:BU*3E+F;E*<D[Q;]V2UDWRO=ZJ+31Y'/$R L2#N8G/4GG'!] <C\^W6,IL
M8G.<8 ]>O)]JLSONB4YR<D\'H"3Q@=*KNP9%(_AZ_H*ZW:^FW]?K\NQ[4]&H
M[1LK_P!:[?\ #D;_ 'C[_P#ZOZ4VE8@DD4E(B5KNVW_ "BBB@04444 %%%%
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M;22>X$BI:;[=IS=H DSP6K+$$#,(P03X08+FUW$ACN(#2J%)&",!22&QQTP
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M=/70*,'KCCUI02.G\A4OF_(4Q][K]?;GUH!*+W=G\OZ[_P!;PT444$A1110
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M/\_YS2\< \]<9')Q4>'4$%<#OD'OQQ^7O6IO))-/I?6RT5GU&4444&84444
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MMA>.O8>^*$G\O@;6+#)Z'))R0WL.OU'TJN"N6W'<-I'I\Q[\8) Z_C]:T?\
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MI_\ !GK*9?\ @HG\:BWWO^&4_%.3ZC_A9/PUZ^N/PXXQWK_21K_-H_X,\/\
ME(I\:_\ LU+Q3Q_W4GX:?A7^DO6L-O5EK9;?+8_!_P#X.6/^4-W[5?\ UV^$
MW_JW?!5?Y.]?ZQ'_  <L?\H;OVJ_^NWPF_\ 5N^"J_R=ZF>Z]/U9%3I\_P!
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MS_+BDI6ZGZFDI$2W?JPHHHH$%%%% !1110 4444 %?UC_P#!GO\ \I'/B_\
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M7,_TV7^04444Q!1110 5_B?_ +<__)ZO[77_ &<Q\<__ %9GB:O]L"O\3_\
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M_)*OUM_X(0?\I>_V"_\ LMMM_P"HQXCIQW7JOS*A\<?\4?S1_K]U\T_MH?\
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MG^GSU[G?DU2Z--;]$NG1=B.BBBD9A1110 4444 %%%% !1110!_6C_P9X?\
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MLQD#J"8R62,G(P!]X D;O3C/)]S56SFBG26&Y,@#G]RL8)DW'A54%3E=VT$
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M8^-EC=+BZ%E<^,/&=B^]_F,9L$F\K<I<@Q8PI!&, 5_<[_P3AT3X"Z/^QC\
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M^Y61I2ZD7N);E-T<K@@LG"L2-I^4$  KQG'8<]ZHET9/F9MV2<#(&3Z=NO\
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MS?!+5=-M;^U^U &X6[9HVZ *(E4!3@]E;OC&>U?8_B=?^$ITD6T!WQF0#=G
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M5W?+USC[RD<G'I^=)=O%))O=R$!+("S,PZD9/)../?\  8K)62+NI ST!/\
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M8*2P('&,=J^NK^#7B-2H^U_U=Q57JZ=.MA)SLE=OECB&Y6MM'F>NFMSFCF>
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MUV\MO,)J<8KE2;O??1)N.[6O1VM?56.98(MRP5<*$P<="=V,Y],]_05$XRS
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M6KOLDNR[=@HHHI@%%%% !7^)_P#MS_\ )ZO[77_9S'QS_P#5F>)J_P!L"O\
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M@YVD<?CZT"2OY+O:_785%W-CV)_*E=,<CC'!'OFKD,T9F+/$J#80 .!GGG@
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M''=>J_,E8#*\=_\ "A24D#=L_P ^U#=5^O\ A0"6<+VR<X]L\Y_E[X[T%O\
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MR_KI_D%%%%(@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"BBB@ K_ !/_ -N?_D]7]KK_ +.8^.?_ *LSQ-7^V!7^)_\ MS_\GJ_M=?\
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MK?33X6L[I(]!*+)Y$$,/F";!,G^D!!*5D>1W*F0[<A0  16[JD>@2^!M'O\
M3O$Z2^)#?WPUC0E1Q+:6@@M6M;CS#$-PGE-PA42-M\HX"]6^>>53C5J3DE0^
ML?N*?U7VC4*2@G"=9**BJBGS:VY+S<92DF[_ "JR>O&OBJM7V5#ZY-4*$\$Z
M[<,/"G%TI8FZ4(U8U?:M>[[->T4).;;YNY\=>)=(&DN\&N12ZA/?&QFTK8T@
M^PI'*XOEN =GF%XH4"9+8E)V_*<?/NO>.IY[*VTJPGNEM;>+RG21R%9MJ@D
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M[_:Q_P"S:?CM_P"JN\55M+9^C_(WCNO5?F?XEM%%%8',%%%% !1110 4444
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MY6G*.8PE)W2:M?;\/Z^Y!9ZW5M]G?5:M/;I=K>]F?W7T4458!1110 5_B?\
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M9/*,PK9?.I[2-.;4*EN7VD$])I.[L_SOZOLIR4DNSO\ >[:.WFE_PVACJ29
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M !1110 4444 %%%% !7]8_\ P9[_ /*1SXO_ /9JWB__ -6%\.*_DXK^L?\
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M4444 %%%% !1110 4444#CNO5?F7TG"(Z\;R3@<]6Z<>@SZU%#N,C 8)(QT
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MWI^GGRS;VEQ>K"EU-$%02[YDMX0^Z1E'EJ55?FSBF60DJ&92P)D.1ECV!.,
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MGI]J4[L'@<@[?S ZDG '4YXZGG]6O^"(T44?_!6K]A8!6!7XUV8!8\Y'AWQ
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MNA^AY?0]A2IP2FIQC'G<T_>=DK7:5K6NU>]_>=[L9*FUFV9.#AMW4D=P <8
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MB4N))$E2TD8W(B:)#N<HR([!'8,0*Y^+4XYK]KB5UN8$A9EBU)FF0S@,63;
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MK_27K_-H_P"#/#_E(I\:_P#LU+Q3_P"K)^&E?Z2]:PV?K^B-H?"OG^;/P?\
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M(=O&,G::SQ-M$;>6RE23O \Q&93P2#C*GDGCD'OWJ+=.KAPJ9'3@]?4\G/\
M*EDNI) VY5W-P6 (;'H,8&/PS[TKV;MK=:Z>E_\ +\A)K1-*UU=]?^&\K?CJ
M/O[R2^G\Z58E946("&-8D*H6(.Q>,G<<GJ1C-4J>7S_"OY9S[]:92$TEL[_*
MUDMB1#A2?0_T%-9@V,9XSU_"FT9Z=./S/UH#?[E^%D%%%% @HHHH **** "O
MZQ_^#/?_ )2.?%__ +-6\7_^K"^'%?R<5_6/_P &>_\ RD<^+_\ V:MXO_\
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M7-!_\$^G_P#R/1[-?S?^2^GG_5E\A02=]>CZ=/D?X<<7A#QG$ZR+X6\0D9P
MVA:DPQZ$&T(( QP>,?A5Q/!GC%_+CD\+>(E23+;QH6I$H1S_ ,^O"G P =O.
M3Q7^XA_PBOAC_H7-!_\ !/I__P CT?\ "*^&/^A<T'_P3Z?_ /(]'LU_,_\
MP'_@^O\ 3T?(O/IVZ6\O+KIN?X<\G@[Q>'D5?"_B-\'EQH>I\@#&"/L@!'MT
MZ'J*!X4\70JK1>%_$88HZR9T/4SD$ 8P;;']['U)K_<8_P"$5\,?]"YH/_@G
MT_\ ^1Z/^$5\,?\ 0N:#_P""?3__ )'H]FOYG_X#_P 'U_IZ'(N[^_\ X'D?
MX;X\)^+C\O\ PBWB3!/3^P]2P#ZC_1N/P[>U1-X.\7$L3X5\2=>O]AZG^O\
MHOTK_<E_X17PQ_T+F@_^"?3_ /Y'H_X17PQ_T+F@_P#@GT__ .1Z/9K^9_\
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M_<B_X17PQ_T+F@_^"?3_ /Y'H_X17PQ_T+F@_P#@GT__ .1Z/9K^9_\ @/\
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M ."/4_\ Y%H_X0[Q=_T*WB/_ ,$>I_\ R+7^Y/\ \(KX8_Z%S0?_  3Z?_\
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M ."/4_\ Y%K_ ')_^$5\,?\ 0N:#_P""?3__ )'H_P"$5\,?]"YH/_@GT_\
M^1Z/9K^9_P#@/_!]?Z>AR+N_P_R/\-C_ (0[Q=_T*WB/_P $>I__ "+1_P (
M=XN_Z%;Q'_X(]3_^1:_W)_\ A%?#'_0N:#_X)]/_ /D>C_A%?#'_ $+F@_\
M@GT__P"1Z/9K^9_^ _\ !]?Z>AR+N_P_R/\ #8_X0[Q=_P!"MXC_ /!'J?\
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M?^&@\8?_ #6T<DNWXK_,/9R\OO7E_G^#['\4E%?VM_\ $%[\=/\ H^;X3?\
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M<DNWXK_,/9R\OO7E_G^#['\4E%?VM_\ $%[\=/\ H^;X3?\ AH/&'_S6T?\
M$%[\=/\ H^;X3?\ AH/&'_S6T<DNWXK_ ##V<O+[UY?Y_@^Q_%)17]K?_$%[
M\=/^CYOA-_X:#QA_\UM'_$%[\=/^CYOA-_X:#QA_\UM')+M^*_S#V<O+[UY?
MY_@^Q_%)17]K?_$%[\=/^CYOA-_X:#QA_P#-;1_Q!>_'3_H^;X3?^&@\8?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
24444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>nt10015006x17_graphic8.jpg
<TEXT>
begin 644 nt10015006x17_graphic8.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
M                                                          !8
M65H@        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($AE=VQE='0@
M4&%C:V%R9"P@,C P- !S9C,R       !#$0   7?___S)@  !Y0  /V/___[
MH?___:(   /;  # =?_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( KH$K@,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M4 ,?H/K_ $-15.PW#&<<YIGE^_Z?_7H CIR?>'X_R-(1@D>AQ2I]X?C_ "-
M$U%%% !1110!$_4?3^IIE3,NXYSCC'3_ .O3?+]_T_\ KT 1T5)Y?O\ I_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVF/V*GOS/X@\,W\U[K7Q&^&EE/)NN)M(+?VSK.JV6GVIE<I/J>G6%NEE&C)
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M34F!Z#\JHU(D^\/Q_D:FI,#T'Y4M $3]1]/ZFFKU'U'\ZFP#U /X48'H/R%
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M$-S#%<V]S%*NV2.XM9D>WG2120XD1A@L,$$BOQ,_:9_X)L^/OA?XYNOVK/\
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M?T_QI#\_3MZ^_P!,^E1U)'W_  _K0 FP^H_7_"I:** &/T'U_H:BJ5^@^O\
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M445YIZ@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ7:1WKXN_:V_8:^ ?[9'@_\ X1_XH^&8HM?LF,OAOQWI*Q6WBKPKJ $ABO\
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M\"6RRD@;S@N.%"  $ MT) !///7H:_ G]J"_'[>'_!1WX"_LW^"[K^U_A?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9C''X/,,=C,1C\1/ZMA\11AB\14P="GB%*K*JIPJT>:GR13ITY1YDXJ_4?\
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M?[%.GW=GH,\?P7^+NN^+_'D:ZOIP_L_1-1N?'3HVG.;EA?3$:]8DQVH=T,C
MK^[<!TZV0T:>*ARX>JJU:5>%2?)>"K4*J=&*=[0I3G!13Z1;TM8QHX7C.MBJ
M>+Q4LPI\N!P67SPE)R=&53 9E@%4S"[E%JKCE/$3J1NU'"0YKW3BZO@_Q?\
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MJ5QI?QN35[ZTOH[77H9-%M[&^TB&&)PVJ$AI(M60D*L?,9W+TQ[G>?'[XT?
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ME.#M>#TLFD]5:ZWO:U[Y<'F4)1E",<32:G:ZA7IU4U:<6GS6_EUL[23O=H^
M_P!AS]O[X>_M?^'I='U*TF^'?QQ\&F32?'_PP\2.+#6].UBQWVVH2:5'=P6#
MWNEW%W:78@N;."X@:%(W69U96/Z"*&0D1H(D9BSP-@JC9/SH?E7<Q^9BN?F.
M>#Q7\D__  4F_8D_;^TK_@HE:?M&?LE:'%M\6Z?X;ATK6O#NKV'AZW@N]"L[
M2WU&U\4Q&]B$\%[+)MW7[PPW,0G7:ZE\?K)^Q3_P4C?QYXFC_9G_ &M="_X4
MQ^U!X9@MK.:PUN2*Q\.^.!%"D?V_PYJ]S%8Z;?W5Z3;3I::?-?O))>*B2R$
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MK5]1^''@KQ''I?B/PW;W$QMH=(O[Y=,2X:W#E5$4NH(^_P EP/+Z< U6\?\
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ML1OEF?[S'!0(S9"@'H *^7OCG\;]8\-ZKIGPE^%&E-XW^.?CB4:/IGA_2?\
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M;@"N=FU<!AA\D#.[J3[9/X9S3ZY6K-KM_D;K9= HR!U.**8_0?7^AH6K2[M
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M9'#2:EX<TI5N,1!_L68["PB-O!'<3-+Y._'2?"WXK^#/C%X7A\6^![Z.]MW
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M5X9\*:/8:#X=T:Q@T_2=(TJSM[&QL;.UB6*"&WM;6.&"!$C1$5(XT"A=H
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MW/8Z%KFA:5<0ZBMJ\PA:VNH[J*5E>*1)(T>OUG_9X_9*^!G[,OA73_"GPI\
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MR:49)[J3UNM+6VU.&G*CFE>K"+57"8:?LZJ5FJE>%G.$E:SA"Z:>MV^R.)^
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MECC &>>^.E>1>(/VGM+A1HO#VD-=L58)-=,T9W8XXCD<?7C&>G.:^*3N1O\
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MX^'?A[3_  WX5\.6$6G:?::?;1VTERT09IKN\*8>YN+B>2>:6:>264M(V7(
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MM!AU)-7C,LA5OL3_ .CS(KH=#_@G'^PW'^RUX%U'QW\2I'\9_M(_%BX?Q/\
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M=;MR@8 'H,4445Q':%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_AD>2W2^41W$,\#/-/'+)_9\EP$F)20%5V_&WPK_ ."@O[0?[%WQ TO]GO\
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MXYV'U+@'J3U]<#\=OV:/^"M_P]\7ZYI_PP_:=\&>(/V:OC1Y=M:&Q\;Q2_\
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M7RL/E?8N<$Y(7C&1D]>:IO(J@1N<;@2^]@"$R?G9N !@@CG/(R.#7E'Q7_:
M^$'P2MM/N/BGX]\-^"TU:\BL].36]5L[2>[FE<(GD6\LR3.FYE5Y50QQ[AO9
M=PS^._[57_!0_P ?_'SQ\O[(7_!/"'_A+?B7XAM4_P"$K^-=J7N/!7PYTJ:.
M$3W1OX3:1WU[#%?6UR#I>H7$T7V>> 6TMP"L>F'PE;$M\M-J$$YSJ2M&,8JV
MMY-)VTM%:O6WE&)QM#"Q;E+VDY^["A!J52<VK**BKVN[:RM%6U=MO6/VZ/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.?LHRQ&'G4O&G%I3PT7=RUD[3IIZ*$;-7=M-OW>(/S E&*8PX0JS!N@)))X
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MJ_[:O[002'X'_ Z7X=:+<,L7_"8_$:YLXS% _'VQ='U-?#VH,%!W^3&9),<
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M.?P-X4OU,4W@+X)V\GA&]2SF.6M)/$OA;7$MY9$3Y#/-939)#%>U>)?MN_\
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M>OMVJI=W"6EK=W<IVQ65O<7<K$X58X(7E;<>,+A?6K4&[:[VM\[6_,#\6O\
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MNB:OR4U4PF(IX>K5E6A74G0E4LZT/9P<Y*I-)<Z:5K\D>UW<_0/]L/\ 93\
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MI'Q[;0-.\-ZOX\\7>'I;'P9;ZR-.CL+OQ9%<6M_+,'-[&VH".73_ +*/,8&
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M%KU,+.DK.G&4OJLXZ+EEA5*-.]GI)07O>\TWJOFOX4?\%%/V,?C3':#X?_M
M^"=9O+N&*1+#[5=6MVAE&1'(EW9VZJX/# ,0#T-?75AXGT#588Y].UW3KR*7
M!CDM[VVD20-@@KA]Q!'3@#G/7 K\^OB;_P $MOV'OBO]HN/$7P*\.V6H74DM
MQ)?Z+?\ B;19X[B0[_,2+2-=LK;*OA@GE% 1@+@D'Y)U;_@B9X(TF?[7\%?V
MEOC?\%FBD#6=EX<N]+OK.U4,#Y:-KEMJEP4*@+EW<\$DYKF]CE\[<N(K4I.W
M\2+E&+=M[/5*[>[VZZG6\1F,'K@Z=:,7K*G6C&4UI[T832M)W^!VCKI*Q^Z8
ME#G]W,'R,X5E88]<C.?P_*L#5=9TK3;B./4-3LK.:X*BW2YN8HO/<< [7<$[
M<%0%R".HZX_#:/\ X)W_ /!17P-#<K\,O^"CWCS4@''V6V\=0Z2D!B0L%CD;
M2O!L\@!& 2O;J>*^-/VG_P#@D1_P4]_:(U_0_%?BS]L+PMKFI^&K,_V$L.I>
M([.*RNT='654M/"5LK.TBM(YD#DLQP-N!6M'+\+4FXRS.@HN+:O3J)MJVC7+
MRVW^UKILS&MF6-@H..3XN;4XWM5P=E&S=TU7<KZI:0OKJ['])/Q<^!/PA^/F
MB6N@?%CP/X>\;Z3:SI<V4.KVRSF&4H^V2TO$5;A%Q*^524(2S'!-1ZA^S_\
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MOZ/=F_>V%C9OFX!;*L3B-]V<&/DY49YX)&,,VL,,44NFU%V$[-HR"3DYYX/
M'TSBO8JYO*M&+J87!SJQ?-.I*C!SFY):SEO)7=]6U>SM=*WD4<GC1JU'3QN-
MA1J*T:"Q$E1I*+3M3@M*::22Y;.UTG9M'X9>"?\ @D5XQ^+NO6GCS]O#]HGQ
MM\>]9BF%P? ]C='0_!EB_F"3R5N_#K^'KRY@B8+&OGVH+I&=X.YA7["?"[X,
M?"[X+:%:>&_ACX(\/>$-+LH(K>--)TZWANI8X4\M#=Z@8S?7K[<YEN[B:1RS
M,S%F8GTHJ1[[OO <#GKG!!XSSSSCCWD P /0 ?E]:\VMB:]724N6#VIP:4%H
MOLQLEWV6^BLT>C3PM"C+GA%2J6LZLE>JUIO4=Y.]EN^@,H<$,,@@@_0G)_6@
M*%S@=1M(/(QZ8.0.G;%+17-=]W][-K*][*_?J(  ,#@"EHHI#"BBB@ HHHH
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M'U-I;/3OAYX(62[@TF? C%UKU]-+IEDUK%++ 9XK#5)+K8[#:A5BOSO\)_\
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MI4D\-)63AB8^R:=E_,[6=[JS>C1^M513#*8^4J3A@W=<$X'/!R!S7Y<_%_\
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MT^_S&I)V\]GM?;;ON244P,04##[W4@?3GVSGWIPSSGU./IGBLFFE?SM]ZO\
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M2'Q:52TGP!UM%#*0B7%_(S L 2<:0"#CJO. ">^:]A^%/Q3\2_$&\U:W\0>
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M7*_]YJ_SU;*P&'GA\-%U7>M7E*M6?]^=GRVN[<J]U;:):6W=1117*=H4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7.>+?#^G^+/#>M>&-6MX[K2M?TR]TK489$657M;VWD@D_=
ML-KD;\@'&" 001D='52[4O&JC));[H)&X#DC(((QC(['&#33:::=FFFGV:::
M?R:_X#V%+9JW-=6:[IZ/\[G\V?P7^)^O_P#!(/XX>+?@!\=;._'['WQ*\77>
MJ?!/XK+$\FE^!&U"2&"W\+^(I7,=EI%E#!9AO/>_EF:]U!%%H!(9%_H3\+^+
M/#_C/0[#Q-X6UC3-?\.ZG;1W>GZSI5XE[IU[;3+NAEMKN,E)A*"NTJ<'<"":
MPOB[\%OAQ\<_!6K> OBAX4TCQ=X?U>!H);35[."5XB2K"XLIV1YK.YC9%DCN
M+9XIDD12KJ0"/PO^*_\ P3L_:-_8KTGQE\7OV$_V@_%UCX=\/:5J7B"_^"7B
MZ.+7M%.E:1:W&H2VVGZIKDFOZ@N+>&1(UBMK=QY48$H+ CU6Z.8S<ZM54<5)
M).<DN6LU91NHI*+MU2771GC\E;+(<D:57%86+E**IQC[2C%ZN"3LYQCHE=W5
M]6UJ?T(*WRAV5U4@D?*=P('\2G& 20!SSS3/.C Y;!SC;CGOCCK]>,>^>*_D
M[_9'_P""ZW[8?QJ\1S_#FV_95B^+OBS1;"ZN=:MO HU_4-;MFT^":6Z>XTZU
MAAAC4?9YB<* "KCC''Z.6O\ P5?^+>C633_$+_@GU^U-HUQ$QCD.D_#:ZNK4
M%<J2L][K%HQ7C@[1P,_13RG%TI*#IJ3<8U$XN/PR>FC::3Y7NM=;=G%#.L!B
M8.=.56"C-PFJF'KWC*/+S)RA3E!Z2O92;77H?M1Y@R#_  ]R1R#TZ9Z9I2W=
M60C'5C@_IG_ZW?V_%N#_ (*^:G?.(]-_8>_:WO)" =L?PQC?GC<HV^(CR"<8
M]>*OR?\ !5OQLJ%G_8%_; Z?*/\ A5KA6'!Y8:^,=.P/H>:G^S<4G_ ?SL_Y
M6GOM_P $V6982U_:/_P3B5_+?_EU9==7LM6?LH#*W01'Z2'_ .)HW/W49]LD
M8YSSQWK\8I/^"M7B6S0R7O["'[7-I&.I?X9LHQ[[_$ 'OG([_CDC_@L]HMO)
MY6H?L>_M5V#Y^9)/AS;*^./G D\2@E1R.WX8H668Q[4.VG7I_>=ONWOT8GF>
M"2_C+ITGJ]-KTXK6ZM[WI=Z'[;KDKD@Y') !.!W/.#Q].>U,,L6>)%(]>G]3
M7XP+_P %K?@?9()/$GP)_:3\.<9D-_X&TF!% ^\S;_%&0B@$GK@ DC%:=O\
M\%Q_V)#"LFJS>/?#R'J^LZ'I5LJYYR?+UN8]_0X]NM#RS&+_ )AJDO\ "F[;
M=K^?7]6)9KEVG-C<-3O:RJU8P<MMDY)]4GZJW1G[$M,J@DD=?E]#]3G'I]<T
M&95*[F0 ]?FY&>G&![YR1TK\H-&_X+8_\$Y]45A<_'#1]$9=I*ZL88&.<C&$
MFF&4_C].O->J>'/^"KG_  3P\4[AI7[4OPQ612,1WFK+"P.2 #NA;N, ?GUK
M-X#$)ZX3%.SU<8-JVFVC??774M9A@96:QV#=[+2K&W17O>VNO75]KGZ%EW!
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M #HF[6MH_3TOOZ(#,M=#T6QV"RT71K-8R"JVFE6-L!CH,0P(,?A6GC'$:QQ
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MRK;3;#2K6.RTZSM=/LXPPBMK&VAM8(@S%F$4,"QQH"22=JC).<$DFK@0! 2
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MY$@72O%%EJ=M<)<.Q41/);Z?<P J_P K,9MHZEN]?J=>^'-$U#<+[1=&O5<
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M&0.#TKQ#4?V,O^"FO[+4%[X@^ W[7\?QK\*Z+!)?0_#_ .,YU&:ZN+:T7?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+Q;/Q'IOB&Y2ROM*,XDN(II3=PV2202PH)?.A62)/,5'</\ +7E_Q&_X(_\
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MU2-EFV7N]\3"#3LU44J;3T>THJZUW5UYG[0T5^)OQ:_X+D_LA^%?AYXE\0>
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M]MT&I^#O#FLZWI?B74+"*YU?1DQI\TB*S12D2(64XR"4F?H>YZUTS,[DE_\
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M35DY5IRY:=)-*4M4G+K:,;IR=GH[]"I\)/#'B[_@KI^TZOQZ^(5CJ6F?L8_
M?Q%+IOPP\$:EYD=I\2O%6CWICF\37MO("EQ:6FJ:/<20O)!9DV6K)%$\V9GK
M^C33[&QTVTL]-TR%;:QM+6"TM+>-0D-E96D:6\5K H&%CC2.-5R#P@&3FN8^
M%WPP\$_"+P)X=^'7@'0;+P_X3\,:58Z1I>F6<4<<*6]E:Q6P=Q&B*TTHA5YG
M"+OD+,57=BO0A'& 5"* >H %1BL0J\K0BX4J7NT(7O[JW<[:-N5WI??5LUPN
M'=&/--J=6K:5>:T;:224-[*,4ETU7GHX=!CG@4M%%<IUA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5',&,3A2 VTX)7< ?=>_TJ2FONVML
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MJ1S+B40S*R@&"5D8/R20\9(S@ $Y'4'ZUPNO?##X;>)@1KGP^\*:N'_UAO\
M2;"\5\\G?YD3=>ISQSZUY9\1OVN/V7OA''<R?$;XX_#7PS<V*DW5CJ7BK1;7
M44;=L$:6L]Y'*SLV4"  D\=Z^$?''_!:C]E?3I)M+^%WA_XN?&S6 S06=O\
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M%SX"E@FLV\1Z#X2M8]+TGQ!;V<K3P0)%I[V<%D3(\GFNL$HE1@A7J0[XC_\
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M'5Y]..006\B2:-OEVH?O1G'48(QP3CTW4O\ CQN/^N;?R-?*?[(__(B^)/\
ML;-2_P#2N[KX/-\[Q^4^(WAMPKE\J.%R/,LBXNE7P-&C"G2A'A_#9%2RRE0C
M!1C3I4*>,JQY>65U&G9KE?-]#@,NP^-X3XISC$>UJ9A@,PR2G1KRJ2E*:S&I
MB_K4ZSGS2G.;HQDI)Q2;E=--)?7"DE06ZGD]^_'3VIU(O0?0?RI:_2WHWUU>
MKW?J?)!1112 **** "BBB@ HHHH **** "BBB@ I"0 2>@I::Q 4DC<...N>
M:  .""<-QZ@_Y_I^M0ED5FE8 JJ9YQDGH"0>RY#$\X&2> :?([IYFT*'=MH5
M@,(H(;// XZ=.XXXK\=/^"AG[<GBC1M=TS]C/]D^ ^+_ -I_XH1_V7?3Z?&E
MQ9_#?PQJ*O!J'B#5;N%+E;"\73X]5-C]J2U:.[M8S'<)(4(ZZ.'E6DE!M*UY
M2NURP5G*3VT7YNUKVMC7Q%+#4Y5*D7-PUC3CK*I/3EIQ6[E*[M:UM6V>"?\
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M?#_PQ':HJ1/HG@_P]IDP"@ %IK+3H)&; 'S,Q)/.<UZA&I#'*C&25.,$9'<
M <^U3US3Q6*K)*M6J3M:RE-M))*R6NEG^.QUTL'A</?V&&H4FW>3ITH0<GI[
MTN5*\G97;UT6I$D,4:A$0(H  "@  #H  ,  < 8P!Q2"",<@'CGJ<?ET_2IJ
M*Q_4Z++L1^6OO^!(_P#0<4WR\/\ *,*5)8L2WT'S$_Y]B:FJ"9MN><?)G)X
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MV# QQ%&K]>KQIQQ522YX4VG3A&.D8I_:DE:\NKV5CS,Z#JA<'R!@9QRW&?\
M@/?]..O-(=!U0AE^SJ5+;B" 0Q P,@KR,>OL>M>I. 5_B)]@/0^IYJ']Z.!N
MQ_NK_C7"L/2=GSR4DT[\S33LK-:.U]O^">]_:]>-O<3TMHM+>[Y:;/[WYH\T
M_L/5NAMU(QC! Q]?N]??K4?_  CNH;D=K.*1X\>4\J+(\1[F)W0M&SCY79"I
M=?E8D<5Z?F;U;_OA?\:,S>K?]\+_ (TWAX/>K-W[U):_#_=\E]_FA+.*RO\
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MK#THJW._.\Y:[;Z?U<'FM:6])/ULNJD]'WDF_5WW2/+O[!U4N','(4J%W':
MPP1MQM/'0XR.W;"_V%JI7:;<8QC\ ,#MS@=,UZ:3+DXW8[?*M)F;U;_OA?\
M&A8>FGS*I-.R6DY*RTLM%MMMW\T4\YKOEO23Y5:-XK1=EIHM_O\ O\S&A:L"
M#Y)X*D L2 4&%XQCBE;0]68JQ@!*_=SR!SD\$=^]>E;I<XRV>OW%_P :"T@S
MDL,=?D7_ !HCAJ:7+&I/E5](SE;5IO11ZM*_=OT(>;5&^:5&#?O*[BK^^K35
MVOM1NGW3L[J]_-3H>K'(,.0Q!.23CM\N1\HQU P.I/<UZ#IL3P64,##8T2XY
M[>N<CODG_/%K=*I&<GC.TJHR/7UQ]!4J^81N*G'/'<>_0?EUH5.-)JT^VLY:
MV6EE=+3RVNV95\=4Q:49Q:MLDM-DDV]E:VGDDKC@   &W>I]_P#./\*6DRH'
MR@X[Y!SG\,^U&1[_ )'_  HDTV[-?AY?G?\ %=SDY6M+-VZV?^0M%+@^A_(T
MC':,MP.!D\=>GYT@::W37JG_ %U044A(!P>#C=@^GK]*-RGN/QX_G3L^S^X0
MM%)D'H0?QI:0!1110 4444 %%%% !1103@$GH.30!BZQX:\-^(8O(\0>'- U
MZ$X_=ZUHVFZJF <@;;ZVG7:#T&,#M4NEZ#H>A6@L-"T72=#LE;<MIHVFV>EV
MP/' @L88(MHP %V[0.,8K3#JP!4@@X (]^E>:ZK\9/A;H=_=:7J_CG0-/U"R
ME>"ZM+F[V3P2QDJ\<B;#M92""/8UYV9YWE.2485\XS?+LIP]2;ITZV9X_#8"
MC4J)<SA"IBJM*$YJ*YG&+;LKM6.S!Y=C\QG*C@,#C,=4C'GE2P>&K8J<872Y
MY0HPG)1O9<S25[*YZ7@>X']T$A?^^1Q[=.E+7D/_  OSX-8S_P +&\,XZ9^V
MG_XW1_POWX,X8_\ "QO#&$V[C]N^[N!*Y_=]P"17@R\0^ 8KWN..#XK?WN)L
ME2]=<:CT_P#57BAM7X<S]MZ+_A'S&[\E_L^N_P")V7CC7H_#/A?5M;FMIKN&
MPM);B6&!2\C)&I9L*I#8XQQSD@=^/D/]C?Q7::OX?\2:5IZ3,G_"0WETUQ)$
M$"&661S%@,REE,PSG!(!/!Z^_7WQS^"=]:3VUQ\0O#-Q;RH4G@6[5S*C#F/:
MR '(YZC@5YM\/O$_[/OPUTNYTKP]\0?#D*WU_+J5Q,URBLS3/(S1!MK'C?C'
M ^4=.WY3Q!G&49CXL>'G%> \1> UPQP_E'%F#SC"U,_R-XR.(S6&70P\\/B'
MCU*4,0\/!5*:5J2PKGJZJ1]IE>7YE@^"^*,FQ'"7$L\VS3&Y16P-2&69A"C[
M/"3J2J.K!X>W-34Y*$G9MUKK^'K]9*, #.['&1C!^F*6O(4^/7P;VKCXB^&0
M,=/MW_V!IW_"^O@W_P!%%\,_^!W_ -A7ZL_$'@*[_P",XX0_\27)?_FUGQ;X
M4XG3:7#>?VNTO^$?,6[7T_YA_-?>>N5&[$'@]O;WKR;_ (7W\&O^BC>&/_ [
M_P"PJ,_'GX..^U/B+X98@<A;[)'4\X3TJZ?B!P%*5O\ 7;A!MZ)?ZR9,VVVD
MDE]=W$^%N)TKOAS/DENWE&8)+;J\/YK[T>N*QR,D8[[N!^)'2OFZ/XTZK_PG
M$GAV6UTD6*ZY9:,$%\W]J^7>EP]_]A\@#[/;>7R_G;<21D]:]>\->/O!WC-;
MW_A$_$6E:^VG^6MX+"X\X6[3AFA6;"@KY@1ROJ%/3&:\ZF^#=C+>W6NB]DAU
M>77+#55OHHHFE:TM?/,^G+&P\L"9I(E5]HDVQ JP.[/C<6XKB#.L)P_C?#W,
M\)B\*LW53,L7E^+P&)PF+P&&JJEBL+2Q/M*N'JUHU(U*;HP=_;0]E6G37,GV
MY-ALLP&)S##\3X7%8:JL(E1H5Z%6C7I5:CISA4G2J1A.$)4I<_/;G=-J=)--
MWZ*+XR^"I+B]A74WS:0SW#,\<2V\D%I(+>X:"83$RLDYV,-J@-D9XYN2_%?P
MM#:6%TS:I(=3/_$OMK>RCENKH9D4[(C.OR@QOR"W"YZ\5YUH7P7ETF#4TAFT
M\I<VNH16L\C>=/";Z[^U2ATEC= C2%F<G=M;"J,<4ZS^#VO:6-*N;'Q!$FI0
M%_/@GCAELVB:24Y@DDA=HSM8+^[6,'GWS\UA<X\7Y48_7,DP+E4IW]M@<+2<
ML+)8S"P=.6'QN88;Z[6EA7B9P=.=&GR^S<DZG-!^E5P'!BD_88[%.+:E'VM6
M$&XO#59+F2P]1TTJWLU.[E%:J+2LUZFGQ%\,2^0Z:A<(L^H3:.HDMX5Q?V]D
MVHRAL3$#;;*21V(''K7T7XF^%?$U^^D:+JGFWY42Q>>D44<BY),<+I+(9' 4
MEAL!"\YYX\VE^#FHR:W;SR^(G?2O[<N=>6V$4*,;JYTJ33)8 4CR0(F,@._W
M[8.QX$^%"^#]6:[C\BXLHHMEG(&9[P9+!G8;0NTJP )=N<D\ D^E@LZ\3:N:
MX&GB,AP%#*HYV\'CZ[C4EB(Y?"C3JQQ=*/UN4?9SJ1KTU5FI2<O8J=*<'(YJ
MV"X/IX'&3IYGBJN/CAXRPM#V;5.=9RJ*492<+I1BZ$GR\MDYM2NE?H]7^*WA
MK1;R?3[N\N ]O.UM+>QV\;6<=ZC!18O,TH42RR%(%4KO+R* ,D"JOPL\;ZMX
MVM=?U*]B:WL[;6;_ $S3E>)4;%G=/ "WR@DD;,Y)']>>U+X1:GJ&K7R_VP#X
M:U+6#KUS:26UN;M+_P"T+=+Y3-$TA198HB!YH!P1MY(/HW@KPO\ \(IIUSIP
M+2I<ZSJ.J;]NTXN[@3HKA0 "#V&1G(SUKNRF7'V-XKPU;-Z>&P7#^%AF:JTL
M-&I2EB*T[0PU.:GB*L,12H4_9U*6(C3I*I5G4O33IIF&,_U;PV35:."=7$9G
M76 <*M6THTJ:O*HU)03A6E)RAB(7DDHP<9.[MVL+,RDLW((7;@ Y .X]!W'2
MI:BCCP2QSN+.P'H&.<'_ #VYQWE/ R>!Z]J_3&KV:6C2:LO);^;W?J?)6LDF
M];:ZWUN_^!80G&,\ \;C@*/Q_P >]-8G#,"0@& S*-H8'.68YP,<=,=R!BFY
MB<J06D*RKE>B;L-@9R,\<\\< >]?E]^W5_P4-T']GVXL_@I\'-,E^+?[5WQ!
M1K#P-\,?#T;7]UIMW<-+%'J>LPP312QV4*VUR08DN)3,L:M#Y3.Z]%"BZSC&
M*3;Y;R:7+&\E'FG)Z1BF_><M%U,:U:-"#G4DH1VBV[.4G;EA&_Q5)/W80C>4
MFTDD[%/_ (*)?MXS_L_:=I'P3^"FG-\0_P!JSXN1#1O /@'2XC>W>E1WSO')
MXKU2& 3W5OIUO:6^I26LOV&YBEN[%HY$2+S)%Z__ ()T?L%1_LT^%]2^)_QA
MOXOB%^U-\4)YM;^*/Q OTBNY;34+XQW%QH?AR5O,2PTFVNOM$L(TY+"%A=S1
MK:Q1X6N"_P"">_[ GB7X7:OK7[3O[4>I0_$#]JSXH,U_KNIW0%[IW@BUN)(Y
MQH'AH2Q016L4+Q,[7$%A93C[3/:@F#_6?K\@"@@   G 'IV/OQ_DUOB:U.C!
MX2A:6J=6JDFW);PISMI3;>J3L[)LSP^'G6J0Q>(33BFZ%)Z<BDE[\XN[56VE
MW9K5+=D0MH@, -R0?O,>5.1U)XSU_+I4VT9)]1CVQ].G_P"JEHKSCTNENEV[
M=+O=^KZ]PP!T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/>+-
M;@\-^&/$'B&Z4-;Z'HVI:O,IR-T6G6<UVZ @@Y=82HP1R<9'6NAKG?%V@VWB
MGPOX@\.7>!;:YHVI:5,Q_@34+.:T9^ >4$I<<'D#@]*<>52CS-*/,N9O9*^K
M^XF?/R3]FKSY9<B;:3G9\J;2;6MM4FUV/YZ[']H;]IO]HS1/$/QVA_:6T?\
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MMY+H:?IFF6J0373QP+YLUZ^+27*JV"WCFM_MG?M<:$/BO\7K+X\V&H6GP_\
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M/AO]IGPK\9+>S <Z-XV-S"]RRG'D-_8OAC36VLN",72-N)!..GVZA#;2HV
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M@RA$-V+:92?[IC!'0CT]I2X26,/;S)*"!MD1U>-@>00R$@YZX'J:_F)\7?\
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M)JXBI4OB.>ZNH1=^6,=%:&KC;;;MKLV1AX4(0M0Y;73DTU>4G;6;O>_KKO\
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M4*"5BU.^@7<?+0$A8D'3G:.3UKK_ (M?+\-/&\:\.F@W&YCP3N,38]&8$C!
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MTO:/6^RT_<#)(RT/S$;!UZ],]< X&?Y],4F0H^Z1ZXY_7/\ GM7X</\ $/\
MX+9?#22UM=6^%?P2^,UHK@7-UX4M/$D%PZAA\RMKGB72E#%2>3$1D<UGG_@J
M3^V-\.2B_'+_ ()S_%ZTMTE:.YU;PKJ/A/[$D<;E6G6*7Q%J-QY1"EU&"^T\
MC/%$\!.S<:^%J6U:A6C*36CV:3UZ=';4C^T:$&U6AB<.KZ2KT*L(2?7EG:4=
M-+JZWTZG[KJQ)(Q[T^OQQ\)?\%N/V1;R>*P^)%KXZ^$6K2.L4ECXH\+>(M0,
M$YZPR7&@Z#J-L-HY+>8%X/S9P*^W?A]^W/\ LF?%!H%\&_'3P/J$MRJM#;7E
M[/HEU\PR%>#7(-.D5O9E4^U<LL'BMUAJSCI[T:;E&^E]8JWGVMJ=$,9A*B3A
MBJ#OLG447TZ2LWOTN?6-%8NE^(M"UR-9=$UO1]8B8;E?3-3L;U67LRM;W$H*
MGL03GFM??@ NIYZ8QP3T!ZCKUY'U[U@X-6O9-]'=/>VUNCW['0ES?#[WFM5Y
M?>/HIA8J/GPA/3/((_X#GM^61Z'#&E(/( &.,G.?RR??I^%"A*6UGZ/T_P _
MP8F^71WN^EM?ZU)J*C5F;H!CC/4<?B:DJ6FMQA37^XW^ZW\C3J0C((/<$?G0
MM&GV:#<@B $,6W!)"$__ %_RP/\ ]=?&?PZ\+^'_ !#\5?C)-KFDVFIB+55$
M"W(8B$F_O@[+M92,C;GKT&>F:^SH3Y<B(O*J0H!YZ$8)Z<_-GIU'&!Q7R?\
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M  3F^&W[*5G<>-_$MY+\6/C]XM?[7XT^*_B;=>:M=7LQ22>#2E8Q6=C:(]O
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M+X7\_P X#Z+U?Y1/IFBBBI$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!374LI (![$C.#ZXR*=10!"L148W Y'(V\;CU8<^O0#'UH\D$$$C+##$  D#
M..>O /'IVYJ:BC[M/)=/S%:RLF[>KTVT7D[:D)A!V@MG:,8QP<>HSR?<Y/IC
M-,6W"DL&RW;<-RJ>VU2<#\*LT466UE]R\O+R0];6N_O?2R_0RK_2+/4X7MM0
MM[6]MY4*2PW5NDT;J>J['RH0\97')&>]?*7Q-_8'_9$^+J3-XW^ GPTU.^N
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M6_V;$(AZ_-R>X4 ]<]0:18=A^4C'^TH9L]SDGN*GHIMWWMIY(25MK_?Z?Y#
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M#_A0_P -+V19X?A%\(-1CT[Q!-I4K;AI^H>+_"VK6WF3$EF=[[3IWVA4:)<
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MO?XFE?W>BLOPTVZ'33ITZ4%"G3A"*V48I.VFE[7MIW]1Y96&64!NFY%"\>F
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1_PO\4E^;+AN^W*OOLO\F21=?Q7^9JYDCH2*IQ=?Q7^9JW6*^S_A_P#D3,L
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M+M?^"SO[ %U$))?C39V/&2)_#/C8$>H.WPLW/(/J.F,U]U'X6_#*5PTWP_\
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M$XP46K6M91M'ILDEY%2.TLT ,=AIX4?=2.UBC$1SP1LC3'IP3G&:G*H3P8N
M .O '( &,X  'KCGZR;F]?T'^%1LB.Y=E!8@ GIP.@P,#CZ5/LTMDT_.<Y)Z
MIV:=U;3U_2N;77WEIO[K6UVFN;56VLD^M@RZ -M7) "E>V1@'K@GOCGZ$<T9
MS_K'8$D8Z$9[YX]?TQGI3L\;>P.0.P-%7%25^9IIVLHIQ44ELKR=_P /03:?
M?I=NS;=E=MI*^W6^@ D8PP8#H1U]\\?U/'7W4@CJ.M)13M^.]];_ (Z+RV%_
M2_4****8!1110 4444 %%%% !1110 44#J."?88R?89P,GMGBJ>HZE8Z98W6
MIZA=6]A8V,,DU[<74L=O!9VUNI:>YN)YBL,<<48:1W9@-JDG-)NS2M=O9+=N
MZ6GW_P!7!V2;;2MTUV[WV)KS4;+2+&ZU34+JTLK.QA>XNKJ]D$-M;V\8W233
MRMA4B102Y)Z#H>*_GC^)7B?QK_P5W_:*;]GKX=SZEHG[$_PC\002_&7QM;--
M#9_%74+24F?PCI\Z[G:QN8)]3LG_ '-C*D^G++'=JOEL^M^TA^T9\4?^"D_Q
M8O/V*_V/+_4M*^"%C<?8?C_^T!I8F@M6M5;R;_PIH5Y(J&47,#ZI:W&VQOK>
MXN].C99TMP&D_;+]F[]G#X<_LO\ PM\-?"GX9:1:Z9I6B6445S/%&%FU75&7
MS-2UK4I" 9;J]OI+B[D(VC=.XCC50$7JERX"'M7+_;*BO"&ZHJR2<U9^\TKI
M>]_ER1]IF%2*AR_4J6DZBNI5FFKQ@]/=C).,VVKM67NZ/U;X?^!?"_PW\):!
MX&\'Z7:Z)X=\-:5::5IFEVT8CBM[6SB6%"!EF:20AI79G=F9V);G-=C;IM9B
M"-NW" 9R!G)W9[YSTJP$7Y20"RXY]_4?_7I0BJ20 "W)([_YQ7CN4I-RD[RE
MJV][]7\SV5%)127*HI<L5HE;1)VTT7X^MTZBBBD4%%%% !136SP1VZ^F/>E;
M=CY<9SWZ8]^GZ<T +13/WGJGY-_C1^\]4_)O\: 'T4S]YZI^3?XT?O/5/R;_
M !H ?13/WGJGY-_C1^\]4_)O\: 'T4S]YZI^3?XT?O/5/R;_ !H ?13/WGJG
MY-_C1^\]4_)O\: 'T4S]YZI^3?XT?O/5/R;_ !H ?13/WGJGY-_C1^\]4_)O
M\: 'T4S]YZI^3?XT?O/5/R;_ !H ?13/WGJGY-_C1^\]4_)O\: 'T4S]YZI^
M3?XT?O/5/R;_ !H ?13/WGJGY-_C2C?GYBN/8$'/XDT .HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@"'R_FW@#<,C<>7(/8-VZ<9''
M'I5=H)7?<%1,*1N(#-G(P00>F.Q&??'6]12LM+I-K:3U:^8G?HVE:S2=K^O7
M_A]+'EGQ1^$/P[^,GARZ\)?$[P3HGCCP[?6[076D:Y:QW5I(K')RCG') ; Z
M$=>E?CE\3/\ @BKX5\+:C?>-/V+/BMXO_9F\6SSR7RZ#H&JSV_@.>;'R64^C
M:19P7S618 F)]18 @'<!7[P5"25+L1L0'!P,LW &X8YZG &.V<'-=5#&8G#I
MQIUI*,ERR@W>$EO9Q=TM4GI:QA6PF'KZU*<923O&=DJD7:UU424]N\FO(_F%
MU+XQ_P#!0?\ 8TEGL/VL/@>GQS^'UK*D;_%;X3I%8SI:!@BWE_HDEQX@UZ_8
ML [ 6=LR;P[$!2*^N?@3^VE^SM^T-#&O@?QW9Z3K:?)>^"O&P?PSK]I<*H+1
M1V6NIIEQ=[&W(&M[=PS)QVS^VUU!%>0/#,J2V\B-'+%<QDB1) 4="'P"&4[2
M".02*_-K]I#_ ()3?LF?M$W%SXBD\%R_#+XC%VO+7XA?"V:V\'^*&U!3YD,M
M]JMMI]U/=0B=0TT8,;NCS*)%,@9>R&+PM2/)5H_5I2DKU:+;HN]DY3ISYINI
MW<:D8<MERW3YN*6%Q=%/V&(6(CJU2Q,;U;O3EIU:;IPC"R2BITYRYK^_:UNH
MCC,4:N=C1S'=%)#@PL" 1M<,5/!&"#AAR,U?B8!23D8P"#PW&<D*?FP/7&,<
MU^5>O?L[_P#!3K]BRYN+SX=>*-*_:Z^#6F*)&\+^(;N#3/'NFZ<H+R*FN^(M
M6O;W4KF"%2L:V.FN\TL0$4.9%%=C\(_^"G'P2\<ZS%X&^*NB^)OV>/B3!(MC
M<:=\3M+U#1M(DN2?*DBM/$6N:?H&GW4)D $<D9*.K(R%E*DZU<.XPBZ%:GBH
M6T]DFI.-D[<MVXRLEHUHV9T\7&+Y,0_JE712A5A)Q4M+I3349*[:3BW=)NVA
M^DZ?( QS@D< $GCGH.>G-658,,C\B,$?4'D?0UDZ3K6FZU86NJ:'J^DZYITZ
M));:QH-]:ZO8NA^Z=^G37$8!&2#YO0'UXV-RL20I#?QN05$C8'S!3RH P,9/
M(//:N-=+PG3:32A4MS:6OLEY=%U\CHO%NT9QJ*U^:'PO;S?YEA/X?^ _TK34
MA2<\<8_'(]*S$_A_X#_2M%NI^I_G1+6R_KXH@]=.C3_!HNH"!]3G\,"KT7W!
M^'\A5)>@^@_E5V+[@_#^0IQUA'U?X60H?"OG^;+,77\5_F:O(0#]1C\<BJ,7
M7\5_F:N+U'U'\Z%O+U_1$3W^;_*)J+RF!UP1^><5-"" 0?\ /)J"/O\ A_6K
M$??\/ZUFM[?X7][B*._W?^E1+R?>'X_R-6$^\/Q_D:KI]X?C_(U83[P_'^1J
MH;/U_1%?_*R]5F/JOT_I5:K,?5?I_2JCLO1?D.&S]?T1>7H/H/Y59525![ #
M^55EZ#Z#^57$_P!6?I_[**F&S]?T1G3UY?1?@KG#?%3_ ))OXV/8:#=9_!XC
M_0UYY^RE_P D)\$?]>U]_P"G;4:]$^*G_)-?&_\ V +K_P!"2O._V4O^2$^"
M/^O:^_\ 3MJ-+^5^37_IG_,Z%I&W9Q_)GT2?O/\ [Q_D**#]Y_\ >/\ (45H
M(**** "C:.NXY_N\X_SWHHH :=Q.#@@XR?Q]SZ4;%]/U/^-.HI6VLVK=O^#?
ML WE>%7(Z]>_XT9;^[_X\*=11RKJK^;^7^7]78#<M_=_\>%+R<$Y&#T!Z_6E
MHHY8]OZ_I?U=@'/8@?Y^HHHHH22V ****8!1110 4444 %%%% !1110 4444
M %%%%  !DJHZL0H^IZ5\E?M*,'\5? L*02GC>U9A_= MM64EAU4;AC+8!R,'
M!KZT9BJL5 + 9&1D@CT]#[U\2?M(> O&?B3QC\-]7\-WUZEB-<C6XCB2=_L1
M"78,G[MAM'R==H WC!&0#^'?2%EFC\-<PIY3E.)SC%3SKA>4<)A''V[IT>),
MGK5*ZB]72HNG"-1)-VJ<UU&+/T+PPAA)\787ZWF.&RVG' 9NUB,6I.BIRRW%
M4XTVXRC[U12DH:I<UM]C[9C(,<9'(\N/_P! 6G@@\C_#^=9NC6LNGZ5864]P
M]W+!;11RW,I)DE< $EF;+9R=O.>@'IG2.0>5./7_ .MC)K]IPTYRP^'E4INE
M4E0I2JTV[NE.5.+E3;6C<)-Q=F[VTO<^ J**J5%&2E%3DHR6THJ32DO)JS^8
M44N#UQV].WY?K25NG?\ X9Z[:K[R HHHI@%%%% !1110 4444 %%%% !112@
M9. ,^V[9G'.-Q! ^N#0 G'S<C*C) Y./8#)/KP#QS35=6 ()YXY!!SZ$$<'V
MZTU76,C>H0N"5<#:\*JNXM-/]U4"@Y9MH/XU^=?[7O\ P4M^!W[,$D?@_3I+
MOXO?&?5MUIHGPV^&ZMXDU5=3F(ALCX@.@PZS+X?MY+E@LEUJ-G&C)%, /W;[
M;ITJU:<84:?.Y=;V45_,Y/3E77;U,ZE6G1A[2M4A"-[<KNYRD[645;=WV2;^
M>A]P?$;XD^!/A-X5U;QK\1O%&C^$O#.C6ES=WVJ:S?VMC#Y=M"\SQ6WVF6,W
M5W(J%+>TM_,N+B5DBAC>1U4_@[XO^+?[1W_!6GQW??"O]G&3Q/\ !C]C+1[@
MV'Q,^+UT+S2-=^*%B&:"[T#PVCI87T.F7]O%?6<RW&G:E8W4%[;2RR>2"LG8
M?#[]AK]J+]OWQ=IGQD_X*$:[+X6^$*W4.J^#OV7O#E^BZ<D4+K=Z3/XPEL[F
M[TG5)@?LJW,=WI-I>L]M*'\@S!%_>#P-X#\(_#?PWI'@OP/H.G^%_"_AZU@L
MM)T/2;:.QTZSMX8HX8HHH8E2'Y(XHT&T#@#U%:5*E'!27).GB,3%-2LG[*DW
M;X7>\I*VCO96V,:=#$XZ2=6,L+@FE))Z8FL]TF[N%.FU?FBX\TD])1LT_,?V
M:/V9/A1^RK\,M)^%?P?\*V'AGP_IR17%V]I%''<:QJSH'O-9U1T6,7&I:C<M
M+=WLPCC$EQ-*RQHI"+]!M X8%?F4L"X!"LQ']XGADQQMQG@#.!4\/5QDGE3@
MG)7()QGN,YQZ#CGJ9J\N=2=2;J5)<\GJV^O_  %LE>R6FR/7A3C3@H0CR12L
MHQ222\EMKOZN^@4445!84444 %%%% #=Q!;\ ![D5R%[KMS;W+Q(A.QPK X*
M@D9 Y(ST/2NM/WC_ +R?R->;ZI_Q_P!S_P!=D_\ 06JHI-Z^7XM+]1.]M--4
MOO:1J_\ "27?_/-/^^5_^*H_X22[_P">:?\ ?*__ !5<]16G)'M^+_S,N>7?
M\%_D=#_PDEW_ ,\T_P"^5_\ BJ/^$DN_^>:?]\K_ /%5SU%')'M^+_S#GEW_
M  7^1T/_  DEW_SS3_OE?_BJ/^$DN_\ GFG_ 'RO_P 57/44<D>WXO\ S#GE
MW_!?Y'0_\))=_P#/-/\ OE?_ (JC_A)+O_GFG_?*_P#Q5<]11R1[?B_\PYY=
M_P %_D=#_P ))=_\\T_[Y7_XJC_A)+O_ )YI_P!\K_\ %5SU%')'M^+_ ,PY
MY=_P7^1T/_"27?\ SS3_ +Y7_P"*H_X22[_YYI_WRO\ \57/44<D>WXO_,.>
M7?\ !?Y'0_\ "27?_/-/^^5_^*H_X22[_P">:?\ ?*__ !5<]11R1[?B_P#,
M.>7?\%_D=#_PDEW_ ,\T_P"^5_\ BJ/^$DN_^>:?]\K_ /%5SU%')'M^+_S#
MGEW_  7^1T/_  DEW_SS3_OE?_BJ/^$DN_\ GFG_ 'RO_P 57/44<D>WXO\
MS#GEW_!?Y'0_\))=_P#/-/\ OE?_ (JC_A)+O_GFG_?*_P#Q5<]11R1[?B_\
MPYY=_P %_D=#_P ))=_\\T_[Y7_XJM72-6GO[EX94556!I00 #E9(D X)[.:
MXFNA\-?\?TO_ %Z2?^CH*4HI)M+\7W&I2;6O5=%_D=O11161J%%%% !1110
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MF9'A7Q)X=\<:=;:[X-UZP\5Z)>PK+;:CHTJ7=I)&ZY5_,4 88 D#![UT)5X
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M7E&"O)_)'ZM@R %<K@C& >/^^\9''<?_ %Z^>OC]^U=^S[^R_P"')/$?QO\
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M)KH<KN3AL=$/8GD]C]?Z5"9&R<1LVT!0JX/7D=#U'3 .!3//>,*,$,6^428
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MZV^&_B6"U^%_CE--N(/B%"UM;:$7%M/JX#"S"QRPF.=1"7\A/*8;00!CBH/
M?PB^&GPHM-1MO"WAS3+&Q\0W4<^I'4Y9-3&L26\"V<:7+ZB;IG,44*1("S82
M%<<#C\S;;XB^,O%_B!?B==6'BC6_#WAO4Y)M!F^R6\=U9V_GO.?LBH80R2.A
M?$Q8YV_P\#Q"ZUOXA?$GPC\3)?$?B'QGI_@7P[\0M-UO2IK-!'=>'[%=*ABG
MBN6VI(T<EY<R.4#W$9\U> 0 %S)W;6MM.]M'J_G9NS2LO.SY>B;6NO:^GIKK
M=?<?O-%I5LMI;;;#3G2UB)L&BLK5[>Q=G?\ ?Q,8AY3%':'Y !AL=SB:/2K:
M-I)$TBQ!O%/VV>+3;-+F\D/)6^*0J7@)"G#LZEB<J3S7X^ZUXZ^*K?$J]_LW
MQ/XV3Q5:>++;3OACX1BLK#^R-?\ !2>%[:=]5OI'@,X']H'4DRCY,D" C!)-
MWQ#;_%C3/A?XO^(-[\4/%>F>(=5^(MQ%:Z/J=O9I$^D6L.E7G]EZ4+6SDD*7
M#?:+>)YS&Y>0@R@ $/F36UK-WLGIMTOJ]/1].XN1]^W1^73MZVU6J6Y^N%M:
MVEL'2TM+.R0.RM;V-E;6ELC#&1']GCCWJ.  R@ 8(ZU9KSCX0:[/XG^%_@G7
MY])U#0Y=4T*SNY]*U9574;.YEB5I8[H++,-ZY .)6Y%>CTOZVM^']>9 5T/A
MK_C^E_Z])/\ T=!7/5T/AK_C^E_Z])/_ $=!4S^%_+\T..Z]5^9V]%%%8FX4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6=JLRP65Q*<Y2&
M5T(Z[TC9P!P1SM/+<8SZUHUFZL"VGW:*,EK>=0,9R3#( /;+$<\8&>12;<4V
MMTFUZI77XC5G**:33E%23VY7)<VSB_AOLT^Q_-K9?\%4OV[?&WB#]HCQ#\*/
MV<?AWXV^%G[.GQ$G\)^*+6S&N'QU-IEMI-CJDUS"TOBBVTIKGRKT2[E@,8B4
MYB)!KZ>C_P""C.K?%SX;_L@?&+X0ZMX&\"Z9\</'6H^'/&_A7XEG6KC7HFT_
M0[_4+K1-'E\-^?IR:M;-;)>2/?3_ &0VKJHD,K%*_+3X!_%G]H?]D[Q)^W9\
M+-)_96^)OQ \?_''XP7^H>"M7L9=,M?#5M97_A/2]$^UW+7A030A4F8".[B^
M;:NX8.='5/V%/C;\$/@3_P $YO!>J^$M0U[Q=:?'OQAX\^)&E6"+<0^$X-6\
M ZA8OIUU)#*\*LR0*JS1S2VYEFC0.6RM?EV&SK.W[]*>*QKG&57%0J4IT?J5
M1YG0P]&E"HHR=6]"HY2C%J/)%N26O+_7V9\'<"2S+ TI9-P[D-.KC*4N&ZF%
MQRQ#SW*:O"&+QF.KYE@\7CL71I/"9E1I1P^+K2PU2IB*D8*DE:4OZ'_#'[>'
M[+_B[XR:E\!/#GQ5TC5/B;I=Q>Z==^'[+3?$3P6NI:4D\VJ:=)JK:*-'2ZL;
M>WEDN&?4S#L"B-V=@#ER?\%#/V/H/BO)\&3\9_#X\=Q:G+HLMD]GKPL8=:AE
M:W?2AK(T;^Q7O!<J+?REU%F,C(HSO7/X(_!_PK\6_"G[>'CKP;^S%X3^(=O\
M+?B5KOQ6F^+&@_$&V#Z/X(\3:OX7U6&'6_"]_%;:1:JMWJ:V%E;RPS:F_EVZ
M!V*%'KY,^&O[-NMZ3XCUSX ?'[2/VB;/Q5HG[2EW\0?">B^%);$^"M=N6\5Z
M1>Z9XCO+U]$U*#;J<^DQ3:B6U6"1K9%PL$GS#HGQ3G_LL,J&!HUJM7,:U"I)
MTJL*<:-.C1JQIQG[1J<I.;3J6CJVO9MIGS6%\'N"JM:O*>>YBJ-#AW+,TEA8
MXO+,1F2JXN.-6-Q=3#4L-&-"C@:V&P\'@W.JG1KQKRQZM[-?U*:A_P %(OV.
M=,^)\7P<U'XSZ1:>.;C5HM AL;K1?%D5L^N3W8L8--35'\/+I#2R7K?9TQ?[
M&8_?(P:Z;Q=^W7^S!X#^+&D_ SQ'\4]*B^*&LW.E64'A:STSQ%?W N=>C@FT
M:*XN]/T:ZTVT-]!=12Q/=WT";&+.R ''\IW[06D?M:?%GQ;+X'\4?#/QGI.O
M^#?VD_!>H:'X,\/:>8?")\(:3XTEDT_Q=>W!^UQ7.JW6G00ZA>3P:I&/.>21
MK6/>J+]5_&#0/B;\.?VYO WB_P#9S\)?$N#XL>+KSX):7\7_  3KEJM]\-_%
M/A^P\-Z9I][XBCGMK.TMX+G1;,%-MUKC3)+J$[+"VR14(\6YU4IXBK'!THT8
M8VC",YX2OS0HSG.,L.Z2K)5:JY%%U/:4_BY_9:*!%7P;X6H2RRE/.:DL5B^'
M\QQ]:C2SO*ZF$AC<'3P;H8JKF4<$EA<+B/K$ZT,+]5K2_<JBL3[[JQ_?+XJ_
M\%#/V2/@KX[MOAQ\1/C)HF@>+)&M1=:8=/\ $%ZFF"[BBGMO[3OM-T6]L-.\
MV":*7-[=P@*VXE5!(I?M(?M]_LR?LX6&EP>//BWH&A^*?&/AF?7?!.CK9Z[J
MLFMP20S?8KW.C:3J"VMK)+&(_,OI;-=V.A92?YC/CG^S]X[\,?'[]J_P7^T3
MI?QU3PO\?CX;U32K_P"%+V<UEXT@@\-6EI>:1?3R:3KZ6QTZYN3IEL;LVB+%
M:-N$B!7/N7Q*^%^M_LQ?M06/BGQS^SWXU_:2^%GQ _9O_P"$%^&%E.MM=ZAX
M<OKB?2)+:UUZ:2-(%O+9M-O9&,4-JI69=I!# N7%>?6QBGE]&A%8F.'P]14:
MTIX:$JLJ;=6$7S5FX1C.,H^QC[Z5I65]*7A!P93>0..<XW-,3BLE>=SP6%Q^
M7*EQ!['#X&M5H9=BZ].C2P4\-7KXFGB,/5^LN5##3G[6G.3BOVP_X)6?M3?$
M+]K+]FJP^*/Q*ETV?7+CQ!J>GP7&G+<K%<6,-S<?9I&%PSN"8U0=1T&0IS7Z
MC5^+?_!$GX>>/?AI^QUIN@?$'PQJ'@W5QXDU*ZM_#NIQK'<6EE<W%S/%$Z@N
MJA1*IQD8(Z\5^T@Z#MQ7V605<17R7+:^+<GB:V&A.MSJTU)W5I*RL[+;M;J?
MC/B-ALNP?'7%&%RBC0P^68?-\12P-'#2A+#PP\(PC%4I4W*,HMJ5Y)VYKK[+
M"BBBO7/B@IC@$<@'D=<^_IBGT4 5\E5PI+$GG?T /4#&#_7^D)4$[6"L"V=I
MW87CHI&#CH>2>_:KU% :=O/=K[[;K[KG(:UX.\*>(X+BT\0>'M&UFWN$,<L.
MIZ7:W8=#U7=+"S@9Y)# \'!Z5\,?&+_@EA^PW\:X[FX\2? [PW8ZU.7=->T*
M;6])OK>=OF$T<=AJUK:,ZL2RB2W="3@KCBOT6HK6->M!6IUJL._+4:3^7R1A
M4P]"LK5:-*:[.'3M>[:U73S/P+UG_@C3XR^'4K:C^RU^V9\9/A*]LIELO#MQ
M=Z;+X=\]1_HZ3LFA:CJ#0&0*LI#O)Y7W<M7;?L)_M+?'Y?CQ\3_V*?VKY]*U
MSXN_##1=,\0^'_'VCB[*>-?#FJ6]_=175T+PHPG73K&&ZD=K'3PYNB$BW @?
ML_XDUFT\/Z)K6N7[".QT32+_ %:[E8X5+;3K2:\G=CV"10LQ/8#)XK\$/^"9
M=KK/[0W[1G[5/[=/BF-I(=>\8:C\'/A^Y/!T#P#?ZMHRW,98L6CFTB_T\AT9
M5;#':!@#TZ%:MB<-6EB)<T:"C"G*23FY2:44Y))M[-W;YOQ/*Q&&I83%X2.$
M@Z:G=5H1?[N-*,;\[BVU=-Q46DFK[ZZ_MZO0?0?RJXG^K([X_H*IKT'T'\JM
MQ@$#Y S$;<\9"D#/?./7@YKDAL_7_(UI[Q]/T.(^*G_)-?&__8 NO_0DKSG]
ME#_D@_@C_KVOO_3MJ5>C?%9U7X:^,H \233Z%<QVOG.J+OW)P-S#^ZW&>GYU
MYU^R>T8^!W@V)WMGN@EY]HM8W#&)O[1U #(5B1D;6ZGKG&,47LXK?26O>_LE
M?\#I2T?39_@_GMKM^&I]$CJ_^^W\Z6D&!T& >?H3V_3WI:LD!STYZ].>G7\N
M]%5;BXALH9[V6XC@M;2*XGN[N1Q;V]K!'$7NWN9)MJ^7'"C,\@8*JAFS@&OS
MF\5_\%:/V&_!GBW4O!^J?%6YO-2T6]DTW49]*\'^,M8TJTNHIFMY(TU73-!N
MM.E EC=6>.ZD0E<Y((JH0J5)-0@Y)+1I:MNUHV[MWZW?8SJ5:=)+VLU!R:2N
M]+.VK>ZM?733OT/TCHKY(\#_ +>'[(7Q&,"^&/CGX(\VX"E+36]17P_<G?T5
MK?6S83*V3@[D&"0"!7TIHWC+P;XAB\WPYXM\*ZTC+NC&EZ[I>H))D#F/[)>3
M%CQV/4GUR"<*M.W/1JPOMS0:UTTUZZCC5I3^"K2G97?)-2M>VNG36VMM>AT=
M%(JAE!&T'/)0'&/7)SD<?0^OH$CH\B@YP,J[9X'4CCZ#OS6?,NJ:]5_7=%^G
MR[?>+11M51PP/?H1^7MP>OYTTAB0<\#'&3T^E"DI;:KH^^W3IN%FMU9]5O8=
M1115 %%%% !1110 4444 %%%% !1110 4=:*!C//3OCKB@#F?&FO1^$_!WC#
MQ,\,,K>&?"^NZ\8IG"+(VCZ5=ZA A8R(H$TEN$)+J!GJ!S7\O,/_  65_:(_
M:(:/]GOP5\.9_ GQL\?^+M9L? UUI@:.37/!&FM#<O?V4UYJ%S;2AM(-W<74
MHD4-$ 8$W<5_3%\8O <?Q7^&GC_X<?VI)H\GC#PMK/AV/48P_GVB:K875C#,
M\JHZF!&GW21A#(4#*/F85^6'[)/_  2FN?A#\1OAG\5/C?\ $JP^*/B3X$^'
M9_!7P>M=%MKVST?PUI#Z7)HES-=0:K:I<S:A=:<\<<LUO*L320HRI@"M84L'
M6PU>EC)5X\\$H2PU25&O"<;2A.G5A:4+5.5S:E?EBU[SNC'GQ%/%X2=*G"I3
MIU.>K3JJ,Z=6*:;IU(-IRC)7A96YN9Q;BG<_"/X@^ ?C9\#O%WQ*L_VA+O0O
M&NBS?V:^M6]M>ZY-XQM+[QD+V1%M666#2I+JUE,FZ/$Z1RH$92&(/VK_ ,$V
MOA%H'[5/CKXG'Q'/I]]X%\(^'=(T&#4=26ZM_B/HU]?:3+%H$MI&J0://;Z1
M%ITL4IFM[@KY< 8.2Y;Z^_;<_8+\7CXF>)OV@/#WC_1-,^%NFZ%K7BG6]"\0
MV>IZA>P>+K.T?4;*_P!*_L^/RXA%J*33H9U9DPGS'#9_._\ 9K^.S_LE?$J_
M^([>'-7^*#Z?X9\0/XKU#2M8TO3+?Q#J'C..VU?PK;A=1,;3R:;9I=6HB5'E
MA)9"JL,'^4ZF68+A/Q76-XPP^7T\HXECG,,HGCN(JF(RZE"KEF6X?'X_-,NS
M*C+#XC'8JI2P.6YK?%-YMCLTPE..7XF.7.K#]KIXRIG/!KP^1XK%RS+)(9?+
M&PHY5*%>I*IF/)@L-@*V%Q$E3H4'6JXC#R^K1EAJ6$JUGBZ3J\LOK[_@HA^R
M9^S3^RU\$]*\3Z=\,8!IVL>);*#XB>.))]1_M[6+-K?4#_94IM[\6,(O[>-;
M@F*T@C!MUW2HV%;\9-)\4^+!X]\5^.]7UKP[<1:?X'DO_!7@%H/$=G8S^$H+
MK3;0Z?9S10VRM?O+NG?[7J.Q@)V#'* _LW^WG^VY\*_VMOV4-5\&?"W2=>\0
MZO/#9Z[K>C6E]8VCP:C:V5S#<>%)$OX(C<N9KJ13<VS/:[K4_O/F0-^?G[%7
MPN\4_M->/G^"_C/QW9P7TW@V;6]&T;Q+H.O75SI$%E?V6D_V5?WUK:BR91'-
M)(GE2*NWR3N)!)U\1LKEG7%F#AP5C\MS#,<5E/\ J_F.787.L+@/[!PN"]EC
MZ5'"4,#@:M3+O[8P<UAL=5JXO+L1BLNIPP>'Q^%BH1CGPAB)9?DF.KYY@\30
MPG]H?VQ@L15RG%XI8ZM4A*B_K52=11Q-+ XA2Q6'A.AB*-#'5)U,9AL5#2/D
MOPP\$7GQZU#PYK7@?0-;^'/@30]2/B.TUJVOK.;1=1\10I+ ++2(_MFHZE;W
M)R&D_M&.*V-O'/AO-,8?]Z_@/_P4(^,]]XX^&'P"\1_!"_\ %/BO4573]?\
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MA7H%[XH^(GBS0/!VB6<,LMY?ZSJEIIWG")#(4A6YE1[F=N D,"/)([HJ(S,
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M.D^7//WNW/;GJ/SYI:*W77T]# 8NUA\_/.!T'/!'^?7%/HHH;OTMY?=_P_S
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M4^LO ?[1/P6^*&N:CX<\+:O::M?:$S3ZJ;C2+F&'2A;G]ZEY)>:9;Q1F4L9
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M+?YK;2OBAX<\2^(]4G5"=D$VH7_B6UMR[#JY1$R>0!1!^T-_P5]^#9"_$_\
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M(MM\KO&[>A\[4=6K66&I5%3J.,95*BBG*G3<K^ZWI&3NVI:-+EMT/FSX8?\
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M3_OJ3_"NB\,Q2)?REXGC!M)!EBY!/G6YQ\P SP3Z\5V7DIZ+_P!\BG)&J'(
M!QCA0/3T^E3*LY1<=-5;1OR[KR_+MJU%W6G5/\OZ_P"&)****P-@HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8D;-P))/:@#/ JEX@U*UT+0?$.O74JQVNA>'M6UB<L0 19Z==3Q1Y/&?,B&
M!R6]31RIRIM-QESVYHWO;2Z>ZMOTOJ_-I25Z=2+LX\K]UVLG_,NJ:LEV6^Z1
M\R_\$V+E]#TW]H'X=VS22:)X1^/_ ,28]&3/[BPT\WFG6]OIT"\!(K6.V 5%
M!"[S@X/'Z<+NWLV,JPC...">3QGMU_'/K7YR?\$R]-N+WX+>-?B7?P&*Y^+7
MQ?\ '7CNR=T(:31?$!T>[L&!/WHR3,5.0.O%?H\%*DG/!V*!Z <<^I]ZPQE_
MK5>[NW4;;];!@[+"X>R27LH62Z*Q)1117,=(4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 =*0,
M#T/\Z"<#Z\ >I]*@=]PC(R%W%G]E4-W^HZ>_- 'XM?\ !4GQ?XH^+?CWX#?L
M(_#R_N;.^^.WB:WO/BCJ%HS :%\.+/[?>PZA=;02(;C7_#T%DZHD[GS=IB57
MWU^JWP_\#>'?AGX/\,^!/"-A:Z3X;\,Z3;Z5IEA;1"*&""W!.V)0250NSM\_
M))//(%?E!^SC=O\ &?\ X*A?M9_$;4XTOM-^".A)\%_#0F'F+8ZDFL:!XH-S
M;'I')]GU*^C)4C(E8'K7[%MGS"S\*1L0 C (.3SVXY!^N,UZ.(3I0HX>,FZ;
MIPK.+6CJ3C&5TK+5<RUUU7HSR*#52MB,5)-3=65!=>6G0FZ:2[<SA*3[W2Z#
MY[NUMD:6YN8+:)"%:6YEC@B!)P 9)F1,DD ?-U.*^>_VA?VGOA1^S9X0?Q=\
M0_$2PK<1.-#T:Q6:\O-;NO+!B@MUL[>Z$<<LDD"_:K@Q6D:R>;+/'$KNO:?%
M7X7Z/\6_"\GA37M5\0Z9IMPZNT^AWT5G>&1&22-TDEMYU!1XT=28S@Y.<\#\
M1_\ @HA\-]._9.^$MM\1M8\8^+/BBVHZE8_#[2K?QEJ4>LWVDZ1KL\6BVGA[
M25AM+9X(-6M+M]-UB8I+:QVPC:=[>,;CY^8XO#Y;E.9YE5]K5E@,OQ>+AAJ$
M/:5L14H495(4J4>://.35_9N5/GY7!5(.2G'T\'0ECL7A<)&=&B\1B:-'V^(
MJ.EAJ"J3C%U,1549NG35W'GC"HU)Q_=N[M^FW['G[:/A#]K[P_XFU?0_#.L^
M"[_PQJ+6]YI&KRVLUU/8O+=+:WT36K2Q&&[AMGEB.\DJ1QCKU'Q>_;%^ _PG
MOM;T'7/'>A_\)KH^DOJ/_"-Q+?7EQ&1!'-;+?-9VTL-N\D<D;*)9X3AR2!@X
M_EC\(?MR_&+X V.AV'@/PQ%X;MM=O=.M/&>J6,#V_B6STM94B\(Z1IEXMRHO
M-+T[3IKJTO(+.VN_.B2%$DB!7=K^'/"&M?$?X]:-:^*5OXO$'Q?\0Z--JWCJ
MPTV_T33;OP]>M$DT'Q%.IQ/)>V-G;7=O;JRRZ>K64,I1V4JZ_B]+Q7Q>)RSA
MJGEV!P6:<1<0XG#X&#PTL9'ANGC)WKXO!PS-4JU6&*PF#E0J.I.E*G4=55\)
M#&X2G4K+[VKP5A:.:YNL;BL3@<BRKVE:7M8X>KG=?"I0HX3$0P/M:,*E+&XK
MVM&$Z;M1E3E1Q$J%=J*]&^/7[9.G_'ZV\0+^TG\)_"^N6NI6VL:5X.T_38=9
M3Q8FC&]9([CP]JEIJ;:3;W<C1Q3 :M(T)+L7@QA1\Q^!'O/A9H?P:U"'P':^
M)KKX8^.8]=OM6AGEN[+QCH-Q_:4EKH?B:R6_%Y-=VDFI6L2I8V]K;>781.RN
MX:1K]KX2\3+X^\3^"I;N_P!.B;Q3+X<\'VVA:YIQ\.VMZQD2%O[/C>YGA%\8
M7NPSRQ[ED+D_,,?LG_P36_93\1V&I^._$7QA^&/@=/"T&N6EWX$N[C0Y[;7H
M]433K*,Z@TT]ZZ_9"HO59#;([SR"5'V$!O'X-XN\4,YS9Y)A^)LPR_#4:>=K
M/<5B^'\-F.6Y?G%#%X>G4X>RK'PQ=&E3KX/*)QQ%&K4Q.8S6:SQ$E1J8'V5^
MS/,DX-P.!HYK6R>CBJE6>&IY3'"9G/"8RO0J8)5IX['8>?M:DX?6(2C35+"X
M6FZ*@JE5UN8_8#P_;6OQM^!VF0>-O"ZZ39_$/P;):ZWX4U".)Q9+?036QAFC
M229 (HDBFA"2LR.(R6RIK\U/^"9WB*^_9Z^-GQ__ ."?OB:[N6TSX77\_C?X
M*SWTC,'^%.K:E%HV@Z/:;NK6TMCJ%ZZ[5YFD/05^QD2!8(XL*J(JQK'& %A5
M.551S@ #MD#)[YK\9/VO[(_!W_@H[^QA\:].N/L-K\5;[Q%\,?%XCW(+S3=
M\+ZKJFF1W+# 9?[1U974-N^=%( 85_26%7MHUL+K.3IN4&[<W/#EGS:62DTI
M7W5F[):'Y+B9.E/#XB-HP56,9WV<:KY&F_[LG%]/>7JG^X/FQY W#+9P,'G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGMY8G5F\V)EFA<+CE)HW*?,#G 8D?ABI9+B8(0K(&9?ED*[HU/=F .<+T.2
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M **** $(SCV.:J7&Y8ID3@?99CD?>#8.W!]SGM^56R<=B><<#/\ D4UPHRS
MD%2A !/!]<=O\: /Q&_X)A_OOVD/^"E'VO<-3A_:3E#*T;([0?\ "(^$CYA)
M&7&XE<@XZ>]?KEK_ (L\-^'-*UC6-8UO2K'2=$1[C4+Z[U&TB2S"!0R7#RS(
M()3E0D<I5Y'9(D4NZ*?R&_9YF_X49_P4O_;5\":D9H;?XM^$;KX\^'(2S0I>
M&*^T'PN+.S0C_2+ASI=TRQP[G(1BL>%)'XB:RO[0G[1?[7.M^%_"/Q%^).N_
M#C]HGX[>(M.^)GPT67Q O_"L_">F6MKXBM&N5:YEB\.PO>VBV,$\EC8QF1!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=1RLU-7<Y-M>T5[/JMK6+5%%%;'GA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'XH?\%2O!GBOX4?$'X"?MV> K&XO%^!?B6WLOB[8V$!D
MN-8^&E_]NL(;&>*)6:YMXO$/B*VNYHY5,:I&9FP(RU?I)\*M/^#?B'1K7XL_
M"SPSX(@B^(%C!K\OC#POX?T.TNO$*71'SW.K:;9Q7%X?.B.XS7$YWJ3U%>J>
M/O!V@_$/PGXA\$>);.#4M!\3Z;=:/JMG<1K)');W$8/$3@K))$XCFC)P4>-7
M5E90P_"CX)?$O7?^"7'QHO?V7?CQJ&HM^RMXWUV=OV?/BWK"LMAX4GN9@(/
M_B&[FD6"WM(K>W,EO=-=:A>2ZCJEO"84@?S(N^G.6)H*G9NK16D;M.5.]_*[
MB[V6KUTLV>772PM9STCA\0TZLVU:-9**@Y+I%V]Z?PQY5>RLS]*/VK/@+IOQ
M2^'OBSQ'X7\'>#-1^+<&@RQ:%K>K>&=$OM:6WLX9Y;C0H-0NK&>^1[JV::S3
MRY"P-R2L18X/\M/C#PK^T+\'H&\4ZI#X@^$_CR*.^UQK:T\4ZUI2VUIX$C&M
M>$-*N?#B?8K26UU^Z673H(IH3'?IOB,,ZDH?[3+:ZANX8;RTFB>RND^TV\RE
M#(5EZRA0,,T@  RQSV-?FE^VE_P3_G_:C\=>#O'>@>/KCPI=Z7-:0>)[=K2W
MO;;5;'39+5M.,D%W-Y2/9[+EC&L06X,A28D $?EOB#P9F6>X>AFW#V+QF%XK
MR>A&CE4H9SB,IPTZ4\?@L9BJ-:=&-6,I-813P]/$16&>)A1C73HP<7]IPOGF
M&P%6KE^9T:-7),UK49YE&I0C6;A2I5:<9TK)U(J4*LJ=2OA5]9IT:E1T'&HX
MR/YM_#?CSQQ^WAXCT/P3\69M3_X7!IUO_P )9X>T[Q!J-[HT7B..-(]2DLM*
MT&3%K=6<86"*>&"W:*YBEC$L>T@5_1]^RI^Q;XA\%_L@:U\'?B>?"MCXR\:Z
M?XMLGUWPMX6T.QU+0=!\57MQ>16:76F16EQ>SP6T]LDHDFA<20;'();%W6_^
M">7[*W@CX5Z]J?CG3M2U&_T/0]4U/4_B+I=Y=^'O$UE%#:R3W2Z1<Z5J%M-9
MPKL8K9VU[;6\BI%&RA$4+W__  3AUGQYJ/[-NER_$"35[E[+Q=XOL/"-WKPD
M75KWP18^(=1MO"[W+S%Y;EWT*+3B+B66:2?/G/+(SL[>SPIP9'*Z=7/\QQ.9
MXCB#-,+3H9U@\5GV.SO*J$G5J5/JV6U,PITL15PZ<W4JO%7O5J571I4*7*GP
M9QGRQ?\ PE8/"X+#Y5AL1.KE]>AE^&P6.=*+CR/%?4TJ5TG:FHISC%)5*U6;
M<CSW3O\ @E?^SG_PKNV\&:NWC?4=325I[GQ:_BS78-2GN#)*R*K"^>2*%$D"
MBW2Y:-1&BA1L4+^C?AW1[7PYHFDZ':R7#6FDZ=;:=:2W4TE[<20VD:01F:6=
MFD=]B#+NS'U-;;/QM!V2C,@$F H0GJRXPK<C'!&WG/3$4\D,4,UXP2&"".26
M6XD<K"D42&263)RJHJ(Q8@# !.!SCZ++\KP&5TG0R[ X/!T91BIPPF&IX=U.
M2,80Y^114FHI*.CLET/-Q.-Q6,G"KB<77Q4Z:C&#Q%2=7EC%)))/FLDDE9VL
MDO0Y[QEXKT;P-X7\0^+?$-[!8:#X:T>]UK4KZ>58HHH+.%Y7A=F95#,%41DL
M-[LJ<9K\D_\ @FGX?U']H;XU_'__ (* >)+2?^Q?B=J,_@OX'QWD9PWPITC4
M8]8T#6(5?*1M/+?ZA:/Y/F(&AD'VF3)"^9_M!_%[Q=_P4B^+S_LC?LR:I*/@
M-X3U>W3]H[XQ:06FL;C[%=QW#>#=!NX]\%S<?:(]&NI5^U:;<RVMQ<A]UO&R
M2_N+\,OA[X4^%7@S0?AWX'TJUT3PKX3TV#2-&TNRB6*VL;.W!V0(J #(9F8D
M_,=W). :]NJWA:$J6BJXF"52#6L::E"2N[VO)Q3Z-)??YE*+Q.(A4L_9X:3E
M"5])3E!PDX]6HQFX[[ORT[<>8#"6&XX<R,O125[>Q/3\ZA;:4;9N=&+J>"S*
MQ.,@<DCDGKVSD9JV$(&%<CYLDD!B1QQSG [<=NF#S2[.O..N,  Y/?C&:\J2
MO;2ZU35W%M.UTFK6\_P/56_W?FM_D?,6O_ Z[UWQ'_:USXFN)-/_ +1MM0:R
M:Q1Y%%O(9/(CG:X,J!PQ7*JN !@$@5<M_@]K2^%];\(Q>)9UT;4X]0-HLE@G
MVFR>\EEE)^TF?SF5&E;;&652N!P%%?1;6^[=\Y 8$8  P3WR,']:7[.-H7>W
MRD$'UQZ^WMD=Z^$AX:\)4\3CL;2P.(I8G-'B5CZD<RS**Q%'&PI0Q6&G&GBX
MQ>'KJC3=6BER2E3C*UTF?0OBK.G0PM"6)C.C@G1EAJ<\/0G[&="HJE.K!SIN
MTE)6ONTVG=.2?S_<_!U]0TS6[/4==EFNM9T==,:^2SCB>SDAC@ABN(%27$;+
M# ,E&C)=BQ8$DTND_!>STW2] TU=5FD?0]/FM7NV@ DU"626Y=9IV,Q,FQ;A
M1\[2?ZH<] /?&M2S!_-8'&UAM&&'';/!X'(]*:;/).96P5*J ,;0?0[N>_7L
M2*T_XAUPB\7]>GE7/BI85X.=:IB\55G*A+'4\QE&;J5I.<I8RG&O*I)NI*2E
M!R<)-/-<39TH\JQM2,5-34(PHQBFL/\ 5THQC!))4FX)))16J7,DSY)\7?![
M6;VP^&.@K>2:DVBZV_\ :NH1PBW=M-M[6:>%9)8G<LGVHI]Y\>_(!^M[&-(K
M=8X\!4)&!C ( R!CCW[=>E M/E"^8<!0,[1G.<[LYSST(STQZ"K$4?EJ5W;L
ML2. , XX[YQCJ>>W:NSA[@[*.&L?FV89=3KQKYU#)Z>)]K5]HJ5+)<MCEN"H
MP;DY6A14Y3?O<]6I*;;W6&99WC\UH8.AC*D9PP4L;.DHQY4YX_$?6L1*RLM:
MOPZ+E@N5$E%%%?6GD!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=JZG&<6XSBXR6Z?^6Z_K5DQE&24HRYHO:2M9K=/33;L.HHHI%!1110 4444
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M&2V,YVD=#CG'%)]JBW*N6RX) V],#//H3T ZD\#- KK3SM;SN[*WJ]/4L45
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MG%8FRE*4TW"G!M)<]M$Y-7C%M-VOLKKE].^'/[?W_!0RXM_%?Q1\8:I^R?\
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M(:3>R??\;?FR>BHO.CP>22.P&6/T Y)H:9% 8[L'L%)/XCKQW].].Z>B??\
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M3A2<&I/\W_V1++_@I?!_P43\9W/Q6B\50_!J35?&1U&;6[6^7PA-X9?4)_\
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ML6G2WQ:ZBLX;R&2YE$V88CO88-?7OPT^(?A#XJ>&--\:^!]6M]9T'4ED,5S
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MV9_"7B?6&%OXO\--??#[QI$^U;F/Q)X*NIO#-Y=3184C^TKK2;F\B+!&9')
M(K[3^3<H< JY6-P0#E6X(P>^._7'>OQO_81-O\%_VXOVV/V=XB;72=7U_P (
M?$/PII*\VUO#/X:EU+Q#+:HQ&T7.I>((Y9MHP9.<^G7&U;"UX2^*@O;4]4E&
M+:4TEOJE?M>QS2DZ&)P\HVY,1-8>I;24IV<J371I<LD]=$V[.UE^UT>-BX.1
MCJ1C/X?Y]J24XC8XS@9QTZ$=Z6/[BY]/IW/''''2DF&8W&,Y'3.,\CO7EWM&
M[Z*[TOT[+?T6_0]1;KU7YGFGCSX@:?X)T=-5NT>XDNKH6EC;PKN,\S% %;:0
M0/FSD!C@8XQ5W1/$]KJ.GVSZDJZ-?W'FW!M)B1*5BC\Z4H'V,T:HKG=@#"DX
M&*Q?BIH\>K^&KC3%\/#78;D\PHTT<D$H:-DECF@VR0LK(I+1LI(!!.TD5\^1
M>"/B7I&GZ)<16+ZF]I_;]I;V,]Q=&6TL+O2&MK.%Y0C2RLDDK?O)6:0GDL<5
M^4\0<3<2Y#Q/6:P&*S7(?[+P$HT\!@,37E@L3+'TJ6.KXB-'"UJU64L/5C4P
MD,+5JN/LZD*]&$4JQ]9EN599F&4-5,50P>8PQ-2+>)Q%.FJ].5/FHQI2G.,(
M*+A)5G5BDVXN$W?E7NMS\6O#.G^*6\/7FI:;;Q3V-M=V-U/=HAG:X\S"J#]X
M HIX8D[L^F>CO?'OA33;>YEN_$-A_H5L;VYCCGB+) (S*93AA\FQ2P8@!AT)
M'%?*0^'/CR*TTJ:;PC9ZA>W7A<:1*LDMS)+I=U/826S7*RF%I-UN\OFC<?E,
M60<\C7TKX6^*].U>VLK;2U:TG\*+IVN3WAEN8;V[BT]85427,<AC8R></W83
M)8CL,?(99X@^(=63]IPIB:T,;C:M2A.KE^<4IY=A<;5E+ JM3]A1I5^2,H^V
M2K>TH4J/[R*J347[=;AGAMTE46=45.CAN:5&.)P<HXBI1C>LE)59RI.5HJDG
M!JI.>EDFU]!:5\3O FK6-OJ$/B/3Q;7LS1VTDMU&HF='V':/-(^5N.">O?O=
MO?B#X)M!= ^(].DN+6TEN9+:&\1I'BCVDL$$BDD;E'<#/7FO"?"GPPU:XU+P
M>VI:'#9V7AT^(8YHPK1V\C3ZE!+9.%\M5D*Q1-@NO5N,YK$3X;^/=6\<M=:I
MI]O'IL=KJ%H94MTB#V\MU&UNC!+=5(\A4 )Y.*[J?B!XC4,!E3K\)PQF.Q]?
M"X&4J6%S6C"E5CE.#Q>/Q.(IRJ<]#"O%UJV&PTO?=3V+<U![8+AOAB5>I3EF
MOL88:C7Q%>]?"SC)4\14I0HT)*A+VE2=.G"HU*45^]@DW;3Z,L/B1X,U;2;#
M68M=LH]/N]X@D:Y17E$<TD3@8<])(W4_,3QCZ=6^N:5;V*ZFUY;III@\Y+MK
MC]T82^P/O/R_ZPA>OIDU\;7?PN\5S6WAAY-"NK>UT^WO;"]TBSBD$;++J5S/
M'= @1LA,;(=PP27/KFO5?%WPXUF^^$ND>%]&DN[6ZTU4\Y&:1KF2(7!E\G+%
MW<@O]UF/ Y/:O0RKCOC;$83/JN,X+DL3D^3QKX5Q^LT?[8QZ6"YJ-&-2C%0I
M16(Q+;]I*:]BUR-.YAC.'^'J57+X8?/I.&-S"4:\I1I3AA,'%U%&<I0G?VDN
M2G9<JA:JO>NF=OKGQ,TZQ&B?V<L.LKJE]>:?)+:W!:*VDLK%KYC+Y(*C(&#N
MP>1UX!U(/B-X5BLK&;6=<TC2YKZRAO193W42LB3!F5R7VL0VTA=R]1US7SS'
M\+/$.+&?3[&\MW36-6U"\BN&F7S);K1VM4>./YQ&K.% 5 HR,!<YRZW^$6MW
M]G='5-,BDNF\%^%].@$LLX:.\LKN\>]V@KE7,,BA@ "1@'BO._UT\3%BL2X<
M,4:L)X?$UL'1J?6%A82H8+ZS3IU*U/DK>VKUZ$J'+R3C&6+:3DJ,>;LED/"D
M:6&I_P!JM2C4@L3B(>S=6HJE>5)M4I3]GR0C4ISNG%RC3>S;2^A+SXA:"]M;
M76CZA8:M$;VSM9!:7"NT2W<Z0K(/*W$1\L220"$(YYK2M_'?@Z\NWLK;Q%IK
M7JM*DD$=Q$TJ26S%9D<!]P,;95@1E2".M?-EY\)/$5OJD?\ 9-FD%BMGX'\R
M.&XN%47&F7+RW[':G)((,A)^;'S=JF@^%OB?3].2_L=/@;7!XA\27,T^Z5B;
M2]U-IK12/*(93 1U4\>H%=%#CCC^%:I]8X1A-454E6C3CCI1E'#9DL$W@W*,
MW.I7H3>+A"<H+V<7S)=>:ID'#?+!PSN3=:I&-/F5*+IJ=&%2#K\K?+"+O";B
MI-3:235SW;4OBAX,T?2]4UJ;7K&:WTM99+U8YHBUO'!O$K,H<8^X<[B.><TW
M3_B/HU\]V_VFUAT:VLH[V;5))P%2.>**>,LQPJKLF!W;P!@=CQ\QP_#'Q]J?
M_":2:QH\#C5]"O[6WMU1DAENA"(8#L6%4W$9+80[F)+9)XZ6X^'7C*[MKBXA
MTA8UMX-. TPM-'%J/V6QB@>U94CQL=E((4'I@BO.P_B%XA8N?UW_ %2Q6&P,
M.6E1RZK@\8L76=".;U:V+J5X0DX490I99R8>G&=3GG4IJH^:,GT2X:X<HQC1
MCG-"=26M6K[:G[.,I/#+EI*RYK2G5Y92Y8-1O)):KZ,7QYX':QFU$>)](^QQ
M2"WGO'O(C!%*R^8$D!;8&*8."02IR.*ZG0=6TC6K(7^BWUOJ%G*V5N+:598F
M.!]UD)4 XZ#BOCJR^%WB6_U1-1U#08]/TZ[\56][=Z.KSF V4>C"T):-D'_+
M>-6P1@YW$Y)KZ%^$_AC4?"\'BFUO+46EM=>(6N=+B1W:,6)LK9!Y:N%$:B59
M!L0;1C/4FOL.%.*^+\VS2E0S;AZ&!RZIB,RP;Q<*69TYJ>"H4Z]"NXXR$(QP
MV*YI4J<I+GE5A)**M=^+F^49-@L).IA,QGB,5'V,O8MX64+3DH5(<U&<I2G2
MW;@E!JS2/6J***_4CY0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MIP 48'UI:*0;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %5YXT=?FSGA01C(W'!Z]FZ'U (JQ4#GYV
MX)RJ\XX!S_/U]!S1U3V:::?F@LGH]GHUY'X4?#6^7]B7_@I5X\^%6L2QZ?\
M"7]KW3H?%WP^U&\9H[#2O&OARVENO%-A<3C9;"[\1>(O$JIIT0$<LFU$/FN,
MU^W+R^6&8@DC.(QRVU>#+D9#(3R%'S$$=^OQ/^W_ /LC)^U/\&VL_"]P-$^+
MWP_U6U\=_"?Q2,1SZ5XQT!Y-1T>VDF 25=/O-32T:]CCGMMXMT/GH5##S;]@
M;]LX?';PY=?"CXL1+X+_ &DOA,\/ACQSX6UN9+"_UN73$ELXO%6AVUT(9=6T
M[6([$:K<O8&^6S-_:QW-TSS1-+Z4O]II4Z\;\\(\M>UKR=[QDU9O5:-ZVLO,
M\M)X6K.BY6A.7-1TT2=N:"MHG=\R75.ZV9]B?'/X<77Q?^%7C?X=V^K2Z!-X
MGT"ZTZ/4[=C'-;/.%V,K[7^7&"P"D^F*^._V"/V-_%W[+FG>.U\7>+],UV\\
M77_G6VGZ-'>0Z9$D:6T:2S179=S=,EOEY!+LW.^$YX_1YMFX&<B9'# N3][)
MP?E.2,= #GCU%1"*&(;HXXPH/!"[7ZY[G)^@&,?C7DU<!AZ^,P^.DG[;#)QA
M9OE5WK=)Z[]>K/J\#Q5G&7</YMPSAZN'659S4H5L=3J4*<Z\IT7!P]C6E3E4
MIKW5?EFD[/HV5M0U*WTNVDOKV[M+'3[6/=>75[/%:VUJ@./.GNIW2".+)"DL
MX^8CGD _(_[6'C3XAZU\ ?$>L_LTZ]IWB/Q$GV:$:GX4U6RU&>-3=VHNAI]W
M97;PQ7*6[R-AV<J""5Y +?V\?@=\2/VB?V8OBA\*?A-XJF\(>+_%>EQ6FDWH
MDEBAN)8=2T^]ELY7BFMQ#%<V]M/"7DE$69 &)'RGXX_X([_L5_M!?L9?"7QC
MX<^.?BB*ZU'Q#X@N=3T?PE;7:WMGH=O+%I\8F%U;WMW9.TOV:6-HX2C* &(P
MX%>5F&*QU;,89/1P&*^HXO!3=3.*4XQCA*C4N5M6NYQE&,;;MS32<4V?1\/Y
M5P]A.%L3QKBN(LLJ9_D_$."H83@?&X:=6>;X'V<:E7%^T4DOJT7S<T.5J]/W
MI*4HQ?U)^P'J?Q^U/X,M-\>GU-];BUN^ATB77Y1/K4NF1+9FWDO9DD9))&4O
MEE2,%MWRX%?<_P!I<MC83G+EB.%C'S L>,M(N< 9((YY(I(QC+NX=XPJ(B\Q
M( 3NP,]64XZ@@8^E9NOZYH_AS2=0UW7]2LM'T+2K6;4-1U#4;J&RM;2VMHVG
MEGFNKEXH4BAC1G^9@ JG)%>OE^&J83"X;!5*]7%U:5-0GB*OO5:M3W6Y2M>[
M>WSM?0^-SW-%G&:X_-HX/#97'&XB6)C@L'%4\+AZ<K)0IP^S%=F]KMZGA?[6
M7Q_T7]FGX ?$3XO:O- UQX;T*^ET'3W?;-K?B"2SN)](T:QCYDEOKV6 PQ(@
M8L^0!WKYP_X)4_ W7?A5^SH?&7CA7;QY\;_$6H?$WQ TJD2C3_$M_J.M^&+6
M=9!YJRV6B:S%;RI(Q*.I4*NW%?%RW_B+_@JO^U'H@T>'4+3]BG]G7Q1;ZO>2
M7,,T$'Q1^)>@7GFZ5<6C3QQPWVD:;J>FZI:22+9W44UE?HT5Y&DZ.?W\M;*#
M3[6WL;"(6EI9VD%I;V\:;(X(;:)(;>*(# "0Q($0+D;0 ,8KTJ[^KT?8+W:M
M67-4::NH+E<8NRE9:.5M-7?L>-AH_6*SQ#=Z5.'+2NG:4E\51/K>ZBGLTFU>
M^FJ@VJ!G.,\_B?Y=*=3(QA%'MW]^:?7G['HA1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5&Y *Y+<<X7.._7'^>U24F#G.>,8QCOZY_I
M0!3FM;>Z96DMTD*D$%P 01T/(Y(]C_,U3U\A- ULH!@:3J/ Z9^QS?YXK7VG
M:1NP3W QCVQT^OKDUQWCK7;'0/"NO7]]O6SBTZ_CN)$0N8_,MG16"Y&X%W4'
M!'&<=*:W7J@/FO\ 8OG>?X>^*DEY'_"PO$J =>!%IV1U/;\R>G%?8,<,4/"C
M&[UYSZ?S_G[U\'?L0^--#O\ PQXJT*PF>YU!?&>MZO*@3$<>FZ@+*.SGWAF!
M>62WE5H\?( "&;.*^]B!G. 2!QS^GM]>?TI?U^G]>8/^M;BT4#ISP>XZXHH
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M\26T2I&VMW7C"TM8/#.BRW.^*9K275KAH0TPDE5H7 _67P9\0OA]X_TB#6O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4I.K[.-7'.$<1.359^V4[QG*%*VD(FW1117OGY@%%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>nt10015006x17_graphic8x1.jpg
<TEXT>
begin 644 nt10015006x17_graphic8x1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI*U].6I*<;]UI=:D@X ^@I:!T&>O>BN$[PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHR.F>?2@ HHR/449'J*
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M'W?1?NK@8 Q4U%'W_>_RV_JX=+65O1?U_3[LA\E?4]\<#C)!.1C#'@#+9('
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M M'I/B_X<^,I$CM=%\:211PW)TC47TC6(-25HH[$2%(3]/@,SI8NFFWR5?\
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MG?%S58I3=6FCP7"33V5C)<:=IEMIUM&MO';PHQ?]8?V&OV%]-_9>TGQ!X_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!KG"D\?CP.M?G1^U#^WWI'P8\>:=\!/@[\
M,_$7[1G[2>N6<.H6?PM\%W=O8V7AW3KEV6WUCQ]XIEM[N#PK82*K7("Z=J=\
M;;;<?8_)F@DE^\/'&MR>&O!?B[Q'%'YTN@>&==UJ*'IYLFEZ7=7R19'/[QH
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MW9-I=$?5"=#]?Z"GU"/,7(,>P*>#G=O!^8-G [$#  P!@],F16W'&,<9Z_\
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MK32XSNEGO=&M8['P_K]Q#$A8V6A>&9+ZYD!"2<G'T=^S;_P4&_9S_:2UJY\
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MWX(&]LKOQ'\$/@!X2U#3)O&-M8WCW(T?Q)X]U[Q#JK7>E7)6$W%O:>'+*4[
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M=XI/V@_^"KWB\_\ %)?L4_"#X?Q22A8[CQ_\>+O4KB*$D?-+9Z?\-M/*G;U
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MM_UL A. 3Z4TA)%*NJLI&"K ,/H0001^%/(!X-( !T%-.VJNI)_*W9_U_P
M/FOXV_LB?LW?M%:>UC\9/A!X+\9'!6#4+_1[<:K92GA+G3]2CC2\MKB/K'*!
M\A /I7Q.?^":_P 3O@J7O?V+/VPOBM\'+:&5Y++X9_$*ZN_B=\+2>)$M8=&O
M[M(-(M-Q8%H-.O9%5F8+GAOUL(!QGG'3)/IC^5 4*,#./3)/\R:ZJ6-KT5R0
MJ-TG:]"I"%6B[=>2=U?I>U[-[7,)87#SESRI6JI65>G.5.LEI[O/&SY=+VNU
M=+32Q_/?^UI\2?\ @NQX$^'Z^'_A[\-_@[XNURPN5GO/BW\)-1M;[4-2L8 I
M2V?P7XRLO"XM+RXD1I+E-,@O+=(I56.9G!4?1?[-?_!7+X03?#OP5HG[84GC
M']G_ ..\&B6-GX[TOQU\+O'^B>';CQ @2.^NM.\2VOAFY\*I:23CS"/[8C15
MR_W$+5^PH  (&0&&#R>GY\?ABN1\5?#_ ,!>.+=K/QMX)\*>+;.1&CE@\1>'
M]*U="C*00/MUI.P)SC*,C8X# 5T2QF%KTXT:F HTN6?,JN$7L)N]K\\6Y*>S
MLKQ6R.6.$Q=&O*O1S'$34H*'U?%J.(HQ:::E!_NYQEHT_>>]];6>7\/?CS\%
M/B[:17WPQ^+7P[\>0.B/_P 4EXPT#7IHE<;E6[L].OKBYMW(ZQ7$,<@/!4'-
M>K;5;!8[P.1AN"O0$#.,8^HX_"OS:^(G_!+#]BOQ_<OJMC\,-0^&7B9F9X?$
MGPB\5:_X&OX9"VY)8["UOKC0!)$Q+*9=&E3DAD9< >/S_L&_M?\ PHD=OV8O
M^"@GQ M=*MA_H?@[]H/PIH_Q4T94#92TCOM!NOA]?I#&N$'FRSR #EV))K%T
M,))VIXF5.^RQ$&M?6E[16[.33;Z=3I^L8V'\3!PK1OOAZT->EW'$>PY=7?EC
M*:6GO-Z+]DNV,<8Z?T]*^ /VY/V+?A-^TQ\./$FJWO@"RO/C%X0T34M9^%OC
M/0FCT'QMH/BFRMI+K3GTCQ%;B.XMOM5U# CK)((Y&B4;U/S#YYM_B9_P6 ^&
M&Q?%?P/_ &</VA=-A&#J/@/Q[KGPLU>Z1.KC2=6T?Q]&9)% (1;L ,<;L<G4
M;]N_]M.Q#6VI?\$R/BG-JP'EQOH_Q.TO4=&E8!22=5;P1:.D6XXWFR; !POK
M=/"XFC4A5H5<-*<)*47'%48Z75[\TXZ-73M?JNNN=;%X6M3G1Q-#%1C.-I1G
MA*\M7HFG"G.-TVFKO6UUM=?)'_!)/]NS]IOQ=X@/[(O[</@7QCX7^,&FZ9JM
MU\.?&OC+2[FPO/B!I/A@W"ZKIUU=W V:OJ^FV]C=W"ZE:S7<-[:6PG>Y:=R#
M_0$1@$<GYB5)()VDGE^^Y^#[ $5^3/P:^%G[5_[0_P"UMX!_:S_:<\!>%_@1
MX8^#7A?Q-H?PA^$FB>(9/%_BF^U;Q=8ZCI^K:WXSU]M,T.WM4AL=2>&/3(-+
M.9+>.;[3\[J?UHQN=F89&6VG)^Z2"K$Y&&DP6*XP,<8YSIF,Z<JZJ0I4Z+E3
MBZU*C)3I1J[-PDM'S?%*S:4F]69Y;"K3PO)4K5<0H590HUJ\>2M.AHX^TA:+
MBX7<%=)N,(N71MB]1]14]-"J.<?SIU>9*2=K(] KU,GW1^/\S1L7T_4_XTX#
M' IRDFK*^_\ F 4445 !1110!7KY+_;+T3X@>(_AIX9T;X<:CXAT?7;KXC>'
M'GU'PVTZWEOIEO#J$]RTQA:,K:SO'%!*2^WD$C!(KZZV+Z?J?\:7 QC (!#
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M0,*&ALH(A)(P ,DLI>5W)9W+'-=J8T;JN>O<]Q@]_2LWB_96^J0]C*.BK/\
MBVOOI>,6TM5&VKWTUW^I.M?ZY4]O"6^&Y4J#6EU+3FF]+7FGHE[J/B'X&_\
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MLWY1EM89M&T6"Z.D6XF:,S7>O2Z9:0J1NG!8 _'MQH?_  4>_;KD!\7:LO[
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MB #DY_9X\/ GCID>(B<?GTJ/JU'3_:L-_P"!2MT[P?\ 5];LT5>O:[P.)_\
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MX;_"3PE\+].:U\/VAEU*[(DUG7[XB?6-9GP=\M[>-NE;<[,X7<0,XR17I;,
M H+97ISQ@\XQZ#]?;I51Y;^[O\_+_@?U</Z_K^O^#X-X:_9G^#F@.EW<>$X/
M%.JAE=]7\93W7BF_EE')D,FN37^P.WSM&H6,M\VW->SV'A_0-*54TO0M$TZ-
M5V+'8:1IUG&JY!P$M[:-1]T=NU::=#WY_P *?42E*^]K?UV5_F ?,.%8H.RI
MA%'8 *N!QCMBFLH8@DL648#%BS $8;!8DC>,@XXP<=*=12YI=_R *_/'_@H9
M^T1H?P;^'%IX*\2Z;J*Z1\7[#Q'X:N?%5K=?8K?PREO#8-',9YCY*W5T]V_D
M 8+^0596 K]#J\B^,VH^+]%\%WNK>!OAYIGQ1UNQN[>:;P?J5[9V$NI:7R-1
M72)M046+ZHD:H;:.]N+*VD8E7NHRO.V%E&-:+G#GBMXMV^=_+IYVOH145XM7
MM?K_ ,#K_ET>Q_'=XVLK-=4^&D%G8^,_BEX<U'6X-#T&=/"/B7Q)<?\ "5W5
MN;'PS;:I'802^'X+74M=DL8[KR+.*XD,TOV)X[@Q,.Z_:1_:<^,%G;>$_!/Q
MG^)*>$_ _P /M(U^UT[2KCP+-/>63+_9EOIMUXFTN*P%A-/()+B+0CK]I/NC
MCOE >;RF3]S_ (W>%?#OQLT.VT?X)?LM^+-#^+=W?Z-KFE?$6_T_0? ME\)O
M&FFZC;:II>K>(-4N-46^UR/0]4@@O=0M?!]CXCM]2AMY;.&=UGW5^:O[3WP'
MT?5O$/QL\*?!X:IK7B[POX5U7Q'XUL_$=[<2^$M'U^PTB>TUKQ%;:'<6QN;?
M0=,M=1U6'2HIK:*>YU/5K6>QMY[*TU2[L/IL-B(5'%5XJ+>D6[2<%I&+7+S<
MFGNIV3EZIL\6MAZE)3=.3<7;W4GK9Q;2OJ]D]'ZZGT1\._"W['FH?L#_  5\
M5_'3Q=+ ?BEJNL:C-K7PZU+5]"U+QOKUSJ2Z.EE/I_AZ[LY4F/AS0_#MM>6:
M0I'831RK!#;F:0/\\_&GXO?#OQ!\0/B1>?!KX1VW@JTL=*O? WAGQW->ZK+/
MI6G2%O#7B?4;+PMKE[<^"?!GB:TTU]2M=$TK4- @UH2BWGTU5U#R)1VWP0_9
M[^/WCWPO\,_@YJ?PBETWX<W/A'P9XD;Q-?/H4GA"[F\2>&M"L]9UV$66IW5U
M'97&DZ+I%W):0V/]HO>W%S')9I'%%/-^DEC_ ,$[;/PM^T1X4^+W@3Q[%X<\
M$Z'_ &FFK>"IM'_M2[UW2-3TZYT^;PA=RS20VK>'XH[D_P!G32R//I,,5O;V
M]K,+>.0\TJU&A5J^UJU)2<'*BX2BXI<RLM%K:UK25K26EFSJC2G.$.2"C\*E
M+E][F6C?O;6\NNM^_P"3?[.G[&/QC^+>B?#W5O#.@BZ^#_Q$URT\3^/M5U+5
MKJQM;ZUT'4;::[N;J+4;M?$EZNMRK +[PY=7,^DR7-M9:EIVG1"Q>5/Z:/!7
M@+P?\.?#UGX6\#>&M#\):!8B1[72- TVSTW3XYK@^9<71@LXH8YY[J0F:6><
M232.Q:1V8DGHX+*VMH;>WMK:WM;:VCQ;001+'';NHV((D15156)I$R%! 8C!
M!)JV!@  8 [9S^IKR<7CJF*LKN,(_#33;22V>O566OR76_90H4Z-Y124Y?%)
M)7=U9[*R6ZWUO=MWT88P>^/38!&1Z_,FUCD\Y)[XZ4TP(>ID)]6DD?\ ##L1
M^E345PW?KUU2D]7?=W^[;IL;_P"5OEM^B,O5=+T[5+">PU2UM;[3YHGCGM+Z
MVAN[21) %<203(\;J5X*LA!X)Z5\FZYX=U?]G.^G\5>#5U*^^%EQ=22^+O"$
MMQ=7[>%HIG(FUS1#(\MS;VEMO^TO:!S:QQJPCA2,!1]B/D(V%#''"GH?K6;<
MV4-_;364\4%Q!=V[0S17*G9<1NI62$Q2()'A8$JV8^1G /?XOC'@ZCQ/0HXW
M!XB>3\595&I5X=XGPE.V-RK$WIU?8UG!PEF&38RI2ITLUR2M-X3,*%^>$:U.
MC6I^_DF?U<JG4P^(C]=R?&\E/,\JJ->QQ=%.W/2YE*.&QU%-RP>.A#VV%J>]
M%RBW!P:-K=CK6EZ?JNGW,-U8ZC9QWEK<PGS(Y8'"[7#*Q7DLJD$C#9%;*DE0
M6QDYZ=.IQU]L9]\U\;_ #4O%OA?QIXS^%6O:<='\/:)-<:KX8%U/;^==6NHW
M$?EV6EJ9O])LK7R7<F M]G>2-9DB\V/=]BF0*H8@A0@8D G@9 PH&YV)!W>6
MK*&S@D8)O@+BF?&7#&#SFMEV+RO'*MC,MS7!8O#8C"_5\WRG$U,OS2GAHXF%
M.=;!+'4:RP6)4>7$8=0J1;NVUQ+D\,CS:O@J6*H8S"N-'$X*O0K0K^TP6+IJ
MMAG6E3E**Q"HN"KQ5E"JYK:Q+1D#&>_ ]S@G&3PO3J>.W4BN0U[Q_P"!O"M_
MI6D^*?&7A3PUJVNSK;:)I6O>(]&TG4-8N)'\N.'3+6_O;>6^EEE(AB2V61I9
M66.,,[*IZI)5E V99.=^!E#@ A"PRKJ^X$.FZ/ )W"OL^22Y7*+2;5FT[/6V
MCV9X*U=EJ][=>^V_RW*&LZQIN@:3J&MZU?6FF:3I=K/>ZCJ5]/';65G:6\0D
MGN+FXE98H(H5W,\DC*A49!P,U^4OB'_@I#XP^-GB#6/A_P#\$\/@OJ'[1NJZ
M=?3:3J_QIUDW6A_ +PM=P.8KJ1_%WFZ?9>)I+9@=UAHFMQWDVUO(63!!^:?V
M@?B-\._VQ?VU/&/[,OQ^^,&@?"3]E[X!:UX/T#6/AUK?BN+PSJG[1/Q1U_2M
M.\3P6$\%S+;RWO@O2=/US2=.D#H]K<W<6H0AD.V6OW@\"> O _PV\,:=X4^'
M_AK1_"OAC2K.&VTK1]"LX++3K.VBB"Q) MNH0AD Q)SD?,<X!KO<*.$C"=2G
M.I5FE.$9)QH.$K?$WK*5T[\KY;;ZHX85*N-=14:E.EAZ<I4YU(M/$NI%I2Y$
M[QC!6=G*+<M7%6:;_*K3_P#@F_\ &S]HB]L_$/[>_P"T_P"-_'UBK^>GP1^"
MVJZE\*/A-:%F\P6VH3>$&\.^)?$D408P-'K^I:E!*H8N9-Y)_1_X-_LQ_ 'X
M!Z&FA?!_X2> O %@86M[M_#OA?1].U#5%RP:36=4@LTU'5YY<DS3ZE<W,TS,
MS2N[,S'W!2"5R@(494G;QGK@Y+9..ZC/3Z17&HV5C#+<7]S!96T"L\UU=S16
M]M$@RS,\TSJBHB\LS,%4 [B,&N:KBZ]=Q7/RQVC2I)1BGT]VFELM+N_J=E/!
MT*/O.FISW]M5YJD[=G4JN4KO?1VTTTL5-/T31] LX].T+2M.T:P1W:*RTFRM
M=-M(GE?S)&CM[.*"",R/\\FU!O8DMD]=%D4#IC<0#Y>000"06*8.3W)./SKX
M@^,7_!2#]C3X*SSZ?XE^-OAWQ!XEA5XHO!OPW@U;XG^*I[O=L2S&C?#[3O$M
MU:W,DF(E%\EM&C-NE>-%9Q\C1?MD_MY_M-326'[*/[)5Q\(_!U\SQ6_QI_:H
MU2R\-0BWQM6^TCP'X>E\5^([LR*RSVT&MZ'I\;*C+<-"Y52X8/$5$JDER4[Z
MSK25-/9ZN7O-:;I/5V3UL*IC</3:C&7M:E[*-&,JTKJVC4$XPT?VG%6U;2;9
M^Q6HZKIVC6%WJ>J7EII^GV43W5Y>7<\<%M:PPKNDGN)W952.-06=G;"@9) Z
M?F%\1?\ @K!\%D\2WOPU_9C\+^+OVP_BQ;//:2>&?@?8S^(] TF^AWHZ>)_&
M>FV^I:)X?@@E4K<S7\L218(=T/(X.R_X)B:_\8KZW\0_MU?M+>/_ -I.[$J7
M3_#72)+KP1\%;.=#N:R@\*6]Y/%JED/]5)-)9:9)=(O[R%"37Z2_#/X._#'X
M.^'+7PI\+_ GA?P)H%G''!!IWAS2K:RB6%$V%'=(UEG+K]YI'R2<DGG.CA@Z
M"7-.>(J;\O*X48VZ.=^>IWNE'1V?<QE4QU9KV?L<)2M\4H2JXB3TU47*-&FN
MEIN3T;LKV7Y@W?P&_P""BG[81!_:2^+ME^RE\([\I*_P9^ 4EN/B-J=FS%_L
M?B3XE%M1U/34>$B&Z7PSKFF&1V<20#:NW[C_ &=/V,OV</V7-,\CX0?#/0]&
MUVY\YM8\>ZK"WB#XD>()YW+7,NN^/=;>_P#%>I&5RV(KK5I88D(BBC2)54?4
M2JP^7""/G* ':W/&4Z+@=P>ON,T\ *,#.!TR<D<YQGT'0>@P*57&5IP]G%PH
MTVT_8T%RT[)?:?Q2UUM)M._D.GAJ5.:J/FK5%&WM:ZC*HMGHM81VWA&.B2]4
M"D @,1G)R  <GOG&21V/4<\\TN.A[@8)P,GIR3U/XD]3ZG*T5Q\SUVUWLDOT
M.B^_GO\ A]VRVV"BBBD 444TL0<!2V,YP0.P(.20 "> Q(&01GBFDWMTU_3\
MVD!3U&_L=*LKW5=4O+:PTS3+.YU'4;V\D2&VL['3X9+N[NIYY"J01001222R
MNRHD:LS$*&S^._[*6C:C^WM^UCX@_;K\7VDA^ OP:;7/A;^R%H=XC-8ZY>F\
M@'Q"^,$5O,OESO?W.GZ+HF@Z@@;[.VFZY!"RMYI.G^W1\0?&'[4/Q:T#_@G)
M\!]:FL3XLM;?Q!^UA\0M(DE*_#KX-P/%>:AX):XMV61?$7Q(@^R^&VL%R(M%
MUR]ENRHCFA'ZP?"WX>>%?A/X#\*?#CP3I5MHOA;P;H=EH.BZ=;1)"D5G91+&
MCLB#9YT[+)/<-DM)-*[O\Q)KM?+AL*V_]XQ%HQB_^75"\7*36ZG5;LNT4VK)
MG+&^+K.-O]FPE2,YNVE7$M1<(KO&DK2DU>/.[/6+MW26RHRMO<E3D!CD#C!P
M.V0 "1UQDY))JS117">D%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% $6/O$J21R> <YR=JD%2?Q[_ %!J0=!G'X#'Z9./SI:*
M "D) QD@9.!GN?3]*6N<\7>*_#?@;PUK/C#Q?K.G>'O#/ARPN=5UK6]6NX;'
M3=,T^UC9[B[O+JX>.&&&*,%F>1U4<<YH2;:23;;226[;=K+S8I.R;;22U;>R
M75OY'0[U_O#CC\Z-Z_WAW_3K]<>U?D?>?\%;_A3XLO+FQ_9L^"?[0W[44-M-
M/:CQ-\(_AEXJU?P+-<P3>5-'!XTM]'O] N"C?>:.X;8N#G!!KYPLOVU/^"N.
MI_&S4]?@_P""?M\?V<9%-OH_A34;^ST#XF.O]GQH;RYUG4;VWBM':^$DOE/8
MQJ$(C*-R3W0RW%S4I2C2HV@II5ZU.E*2>W+&3O+KJE;3N<,LRPB=-0E4K*I/
MDYZ%*=:$'97<Y07+%)Z:N^VEG<_?DNI +;=W8@%L?7D>V.?6F;LD?,  /F.W
M!)XZ<MG'O@XK\EV_;M_;6L?*?4_^"8'QE:'C[0VE>/O"&K3QICEDM;.">1VP
M. $))['.2YO^"GOBSPZ]P?B/^P+^V3X/LX/)$VH:;\*?$_C2T5Y ^]A)X>\.
M21F*,(,R!ROOG.%++L7HO9PE=V2IXBA4E?2WNTZLI6N]VK7ZWL/^T\)%ZSG#
MSJ4*\%WT<J7*W\TS]92RCDOQR06(4$*,G)P,  Y/)QG.: 4?))&!D,OWL=L#
MH1SU/0X^AK\GG_X+/?L(V&GZH_CKQYK_ ,+=7TNSO;JX\,?%+P=K7@?7)_L:
MR&2TLM.U^TLY[ZYD:-H$MX8V:68&$*6RHVOV2O\ @K=^R-^U;X(^*?C[1O%+
M?#K3OA&JWOC&/XAW-MH,D&@S^?\ 9O$$#7AM8[C2W, 1I4W"VDFAB=E,\8>7
ME^.A%U'A*T8+[?L]$FXI.^[3>S3^0H9IE\ZD:4,;0E4E'G5-33EHDW[KMT3;
M3C=:_/\ 3RYL+"_5H;VSL[M,8\NXMX;C>&R,%9$9<$#D$'OD]QYQX@^!/P7\
M50S0>)?A#\-M=CN$=)?[5\#^&K^1PV<YFNM,ED^;/8DC)YJO\%/CM\)?VAO!
M5C\1?@MX[\.?$3P5?7EU8P^(_"^I66J:?)=VA43VS7-G)+&)H3(N^+<&3<"P
M&X$^S5SWJ4VX\U2#B]N>2UTULGZ6W[]3LBZ56*J1]E5C-7C)1A)6VT=GI=.U
MG]Q\)>*_^":G[#GC/S7UK]G+P/;W$BLOVKPT-:\'7$>[JT3^%M5TD(P_A.T@
M'M@X'@]]_P $??V=--:6X^%/Q&_:3^"-]N,EK)\/?B]=SVMNXP44VOC?2?&"
MO$K[FV!D)+$;L8Q^LM%:QQ>*CK]8JO\ QS<U]TKKYV[K;0PG@<'-6>&HKK>$
M%!OIJXVZ?U>Q^.-U^QM_P49^%SBZ^!O[?8\9V%D1);>%?VAOA=:>,5NDC!"6
MDFN^$_$7@66)7C5$>7[&[>8S2[<-L#/^&H?^"C7P(C8?M$?L7:/\8?#]JKO?
M>/OV9_&%U/<VUM'\TEZ_@#7-*O[C'E!Y#"?%>$;;'NS\X_9&H+A=T9&,D<@!
M2Q)P<  <C)P&(Z+NY%:K&\R2Q&&P^)BE9\U*-.I)76OM*7))R5KIO6_6VAB\
M!R-/#8O%8:UK1C6<Z*V23I55./*[*Z5O*S/@S]EO]O\ _9E_:X:[TSX6^.UB
M\;:.9$U[X9^+((]%\>:#<6[^5<PWFEB>XAF-O,&BD-G<7&U@-^S< ?M@.I&0
M01@G(] <$_@00?0CFOY5/VX_V'?V8?V0OCE:_'G]GGXN>,[+]MOXE_%;0=9^
M#WP3\/\ B%;NZO=>U;4D/B@7&D6DTFMWGA&_M5+:C!JXFT2&YBAB,:>>RM_4
M[8&>2PLVO1Y%Z]M;/?11G]W!<M!&]U%"1UA$YD#GG'S9/&:Z,=AL/!8>MAI8
MCV->*<8UZ#I.+NHR5-O^-!=)QTO>+U3OS8'$8FI+$4<5'#JK0FXN6'K*JIQ:
M3C*HKWI5&GK3E>RM).SLK.#Z'\C4JD  $@'T/!ZTX=!CIVJ%_O'\/Y"O.OSZ
M;=?R_P W^'S]$FR#T.:*8G0_7^@I]0U9M=@"BBBD 4444 %!!((!ZCD8R2!R
M0/3IG/H#12-C')P,_P#UL?XTUNO5?F!Y'\:?BAIWPD\!ZKXFU!9F/E26>EM&
MN;<ZK<(5M8;EQ\R D[P0I'RUS'[-?A2VT3X:Z3KLTYU+Q'XUW>)O%6M2*5FU
M+5=3D:ZEB#R*)1:61E\FU0_=BBC!!QSZOXT\%>'?'^BR>'?$MFMYI,EW;7I@
M;D&6US@CGU/./7T)%=#!!%:V\%K;P16UO;PQPP6\"B..*&)0B1HJX"Y50/E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"+9+=2Q,6W:W3R/V/8/_ !# X)[''XG\J>N,#'3WK\$_@'XW_P""ZVA>!_\
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MUXNO2A*#A>.%G%24I>_*,6DI)K]9E\4:FL:CRX&;RT;>=PCVNH93(C('5@K
M?<*G .X<4Z'Q/?2SQ(T*JCND99-A\QC(AW(RL6V@ \$#&1G  S^,/PZG^+5K
M^V/I6OMJGB2/X,:AXOC\.:??0WU_?66KP2_"E;C3]'N=*OX76T\-IKS17\&M
MFY^W/*$CG8@NM?KY;A5NK3C;(+A4= P901(H.Q0H"J<#!+L7'3 4YZL#F$\9
M2E4]C4I*.(E0DJJ492LXQ]I!)N]-RVYM='9'FY]PUA,DJ8:$*^&QKQ6 HXUR
MI<\987VT9-X>I%N:6(I\C52"J3C&\;R3]U>O)U?.<EMV"<D95?\ /YT^FL "
M& Y+@$^Q1,BG5ZLK:+KRJ_S2:_,_/'=-J]TF[>G^84445(!1110 4444 %%%
M% !2'C&,KU 91]PE6^8X(P,\$C/)'%+1_P#K_P ^OT/%-.S3^_T \'_:2\!7
M7Q%^#/C;0-&T'0?$WBE-&N;_ ,(Z;XD@BFTT>)K:)Q8W!DG5H8&!)VRNT8C)
MW,P S7\X7P'_ &O=<_82^)^G:!XS\&Z/:Z-XUG?PIKFE"702WAS6+*)V-AI6
MO:3JFJ27V@V>LVT=K?:Y/';)JVK)Y\$;Q3B0_P!5\XB\B<3,J0M'(9F8D(L>
MQ@Y;'(4)G(''?%?D?KW_  3Q_8B^(UI\1-0UGXGZKK_AWQGK7B'6]4MU\9>#
M,^$I;_4;F]FM="O)M!DU?1K/0+EQ<06\]Q<.CV:"Y:X D#>O@*U'DJ4J\9NE
M.:NH0E)MZ:7CHGHK*Z;?R:Y,3"JY0J4'!58II.<XQ2C=-W3U:[M77='XE1>!
MOBG^UY^TI\9;C3OAU<:_XWUOQ#KGQ.TV"/5-%:33],MXK?0=-CE@GU*+P_#H
M5_\ \)(;FVOK/6;C64FTQKI](1K:%9NCT'X/^'_@7K'Q-^%GQ)\,#X@?$71;
M+3['XD:UH^A^)_%Z0V>K:+9^)ET+Q)JEKH<D;VVAZ?J]IID=RY7[5!9QF+=&
MBX_?_P#X)TQ:3K?P:U/Q7#H.E3&'QGXA\(>$?B0N@VNCZ_\ $?X;>&3IUMX=
M\2ZIY4*+'=W5Q+>6DL-G';6$XLDN/LWFG?7W/%X2\+17&LWL?AK0HKWQ$0?$
M%VFDV"W6ME(4M4_M>Y6W6;43':Q16R&[:79!&D*!8T51^4>*OACE_B3D^*R/
M,,[SO)JL\;EN)CG&1XN6&Q^'GE;G4H4<(N94:6#G6]E6J8:I"M%SI4ZM/V&*
MIX?$T/L^#N+<5PCCZ>987 8+&Q>&Q%*6"QU-SPU;ZS!1=;$.+4ZV)AK&%9M6
MA*=-QG3E*$OA'_@FYX+M]$_9K\*^-O\ A._$7BT?%'2M'\7FUUC5)Y]#\)65
MW9QO9>&?#-I=K"VFV%FLZ0/"(XS--$LFP=!^AB8]AM&-O4C.#D'&",!<G/)Q
M@8Q7S1^T-;VW@CX.QV?@^VM?#%G8>(O ]C8V>AVT&FVEG9R^*]&M9+:VM;6.
M*""%K=FA\N.-5"$A0*^B=+RUC9.Q+,;*U8L2226A7<3ZDX&2?ZG/IY5GF'_U
MCS+@BE0Q#GPSPSPMFCQ]?$3K/%T<XKYWEU"G.56=6O*K1_U?K5*DJM2=_;TU
M[2H_:-<>/P%:6687B&I4I..<9GFN$>'A#D5&I@(X#%5'&*2A&G)YE35/E:_A
MSO""Y4]*BBBOK#PPHHHH **** "BBB@ HHHH ***:W3[VSWQDG@G ]#QU]NA
MZ4TKM+N[ )(2J,P&2!D#CKVZXKF_%?BSPWX%\.:SXQ\9ZQ8>'?#/AS3+[6=?
MUW5KA+;3-,TRQ@DN;K4;QW."4A1C'%&K2R,1&B%F .S>WMG8VTUU?7<5E:6M
MO)<WMS=R)#;6MO&K,\L\SLD<:(BEV=B %Y)Z5^(WBBXU[_@K+\;[OX=^'=0U
M;2_^"?/P:\036OQ(\2:7<SV$_P"TMX^T>618?"N@:C'L:+X<Z1J$0DU:>W,U
MSJL=E&L-U:"_C:#KH4>9MU)*G1BN:=1IM6=K1BK:REK96MU>B,*];V2C&G'V
M^(JMQH4$TKR3BYU)MVM3I1?--KF=E:,92:3\X_9O^(GA/_@KA^UYXJ^(?B+Q
M+%<?L\_LD:SIMS\)/@H899%\<>(M;DU:VLOB_P",X_\ CR6TMUT*^L?"NCW)
MGOHC<:M<20644BF]_HI@1$BC1%541 J*J!%1 ,*JH  @5<*%   & ,5\J?LP
M_L5?LV_L>:;XETO]GWX;:=X"@\87]K?>([B'4-5U.^U-M/2X33XI;O5[V^G2
MVLOMEW]EMH9(X(FN)W$>^60M]7J !@>_YY.3^)YHQM>E7JKZO&<,/37+1A4Y
M5**:7,Y*+E&[:N]7ZZV'E]"O1H)XJ5*>+JOGQ-2CS>SE/9<G/&,N51LES1C:
MVVK%HHHKC.X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HKS_Q+\5?ASX,NH++QAXX\(^%+NZ94M;;Q
M)XGT+1)[EV8*JP0:EJ%M/)DD898]K$@*22*=K_Q3^'/A5;!_$OCGPCH$>JHL
MFF2ZUXET32HM1C< J]C)?7T"W:L&4AH"X(=2,@U:IU':U.H^97C:G-\R23;C
M9>]923=KV6^SMFZU&-^:K3CRNTN:<8\KULI<S7+>SM>U^ESOJ*YH>,?"[7.D
M62Z]H[7VOV\EYHEBNJ6#7>K6<*[Y;S3+<7)EU"VC0AWFM$F14969@#6-XF^*
MGPW\%W5O8^,/'7A'PM?7A'V2S\0^(]&T>ZN@W*M;0:A>V\LRD'.8T8#N0 30
MJ<Y2Y(PG*5F^51;=E+E;22U2EH[=4UT&ZM*,>>52G&%U'FE.*C=Q4DKMI7<6
MG;LSOJ*YK3_%_AK5KVXT[2];TO4KZSM[2[N[33]2L+VYM;:_\XV5Q<P6MS++
M;P78MYC;32HL=P(W,3/L?:ESXQ\+V>N6GAF[U_1K7Q'J$#76GZ#<ZKI\.LW]
MJA97N;33'N!>W$"E6#210LH*MD_*:GEE=QY9745)IQDFHR5TVFMK?=U'SPY5
M+G@HN7)&3G%*4N;DY4V[-N2<4E>[370Z:BN#'Q0^'9\0/X4/C?PDOBB.9[>3
MPZ?$NA_VZD\88O"VC_;_ .TA*-I!C^R[P>2NT$B.+XJ?#J;Q WA2/QOX2?Q,
MC.DGAY/$^@OKD<D84O&^CKJ)U)9%#H60VNX!U)&&&:]G/^2>L>?X7\.FNWFB
M?;4M/WD-9<B]Y:R6\5KJUK=*^S[,] HKF=/\9>%=6U'4M(TKQ%H>J:KHWEC5
M],T_5].O-0THRH'C&IV5O<R7%@75@P%U'$Q4A@-I!K)T7XH?#GQ)J<^B^'?'
M7A#7M8M1(;G2=&\2Z+J>IP"%MLQDL+.^FNE$)SYI,7R$;6PQ"E<D]?<GHDW[
MLM$]F]-$^[#VM+W?WM/WVXP_>0?-*+2E&.OO--I-*[3T>IWE%<9<?$7P)9WF
MKZ?>^,?#%E?:!:QWVN6=WK^DV]SHUC,Q2*\U6"6[273[:1U,:S7:PQEQMW9(
M%8-O\;O@W=&06WQ6^&]QY41N)/)\<^%Y=D 7<9GV:JVR,<Y=]J_*>:?LZCVI
MU'I?2$GHU=;+JFFNZU0G7H1^*M26K6M2"U3LUJ]T]&NCT>IZC17.W/BSPY::
MC:Z/<:UI4.KWMG/J%GI<NI6$>H75A;8-Q>V]H]RL\UK IW2W$4;Q1J,NZC&<
MGP[\2_ 'B^\U#3_"GC+POXEO])D6+5;'0O$&D:M>::[&0!;^UL+VXGM#F-P/
M/CCW,K 9*MA<D[-\DK))M\KLE)M1=[6U<6EKT?8I5*;DH>TAS2;C&/-'F<DH
MR:M>]TI1=K=4=Q134=7&5(([X(..,X.">QS3JDL**** "BBB@ IK*'4J20#C
MH2#P0>",$=.U(\@0@$$Y],>N.Y'X 9)/ KG]?\7^%_"EB^J>*O$&B>&=,B!,
MNHZ_JMAH]C$ I?,MUJ%Q;PH-H+?,_ &3QDAI.348IMO9)-MV\D#:BG*32BMV
MVDNG=^:-_P I/FPJ@MQD*N<<9&<9(X[Y]\TGE+@#T! P %P>#\@ 7I[5X#9?
MM9_LO:EJ']DV/[1'P3N]2SM%E;_%#P5-.Q+;0JB/6F5F)XV!M^0?EKVW2]?T
M37+6.^T75],UBSF4/%=Z7?6NH6TBGD,EQ:2S0LI'((<@^M.5*<=9TZD;?S0E
M'2^^J5XW>^Q$:E.3M&<)/M&49/\ !L^</CG^Q5^R]^TA"W_"XO@QX$\6ZF6$
MD/B>;P]IEGXPLI5!V3:=XMLK:#Q#I\T9)*2V>HPR*V"&R*^(F_X);>+?A=<2
M7_[*'[9W[1/P6CBE9[3PEXE\67/Q@\%1@?-'!%I7Q+E\5+8VR-N AM(8U"-P
M.% _7TS(,]3@X/08Z]V(!S@_=S^HJ,,"S%0 '&2"1N..C<'H/_K8Y!K:GC<3
M2BH0KN4+_!5E[2#\DI\UGMJK,PJX'"U9*I.BHR6JJ4W*C)?.G*'-H[VE==;7
MU/R//A3_ (+%> '6/3/B5^RK\=K-"$$OB[PKJ?@[6[F%#@?:/^$;A\-:2MRZ
M@%FC7R@3C)P<6'^,W_!6RQ\VVNOV,_@1K1AQ_IVB?%[3--M;MEX^2WU'QP+B
M(-RP\X*HQA@&P*_6A49AD$#!QPYZ^OW3ST[\=.U/$;#OGW))/\JU6-_FPN$;
MZ^Y..MO[M2,?N27DM3)X&]N7&XQ1Z?O:<DK6WYZ4YOJM9/[]OR*;QS_P6$\:
MHEGI?P*_9=^#JS/Y1U7Q1XPO_&L]DKX)NA;^&O%6IV\YCQ\L4MK*"2-T9 -5
MY?V(/VXOB^\;_M#?\% _&6BZ>6,DOA3]G[PSX<^'MI&#\QM5\2V&A:/XG>%/
M]6LDVHR2,!N+,W)_7PQ$]"!C.,$@$GU&,$4+&P"@[01P0"2K#Z;00?SQD\FD
M\;4BU*C1P]":UYH4^9WT_P"?CJ?\!A_9].::K5\575K<DZLJ<-;7NJ*HW?2[
M3:U2?;\P?!?_  1__8MT"\M]9\=>#_$OQV\20NLLFM_'?QOXL^*[W$RG=YCZ
M=XWUC7=-0[MS;8[95&<8Q7WUX%^#/PG^%]DFG?#;X;>!/ %BBJHM?!OA+0?#
M,!5,A08M&L+)"!D]0<DD]2:]+HK&IB<15TJ5JDUO9R?*G:VD;\JT[(VHX/"X
M;^!AJ-+JW3IPC)ONY)<S>BU;9 +=5! )P>2,  G&,D# /XC'M2E"",<@Y4\*
MH"X)Y*@'@@=,5-5:[GBMH)+B>2.&"%))9II9%BCABCC=Y)9)'(1$1%9G=F55
M4%F( -8-)IK2[LKV3>]EY^1TMO=MZ>;]>_D..%7J2N,DEVZY[98'KTX^O:JY
M&3M$8R2022%CW'N$; 8<\X!R<XZU^)O[5/[?/Q=^-4WC#]G3_@FKX1\0_$OX
MLV-PNC^*?CM%;65C\'OAA<HX%U:'Q+JMY:OX@U^!0&:V\/6&K6L$4A,MTLQ$
M)3X6? S_ (+.W'@31_#WQ%_:Y^ ?A._@M UUX@TCP#J?CCQ6\LN9"EX^H:5H
M-H)(2PB+PW\H(7@L#SZ$<NG"$95*U##U)*+4*NDW%I/GM%2LGT3L[IZ'FRS*
M,JGLX8?$UX*_-6HQO24EHXN4I1YFNO*FK6LV[G[8C(SN(4;68$J%"GG#'=RH
M09 .0,'DY-?B'^V?XR^&OQ4_;U_8J\!_ U[3Q/\ M.?"CXD2^(OB9KW@Y([J
MX\#? N\BM$\2Z5\0=7TW<EM8ZO>6MK+I>C:U,"/L^H2VD -Y*9?2;G_@G'\;
M_B7$;;]HK_@H#\>_'6D73(^I^%?AU:I\*?#=_'G]]97=E8^(=;CNK.52R.KP
MQ%E(^45]F_LZ?LB_ /\ 97T.YT7X+^ ].\,-J3K-KNN./MOB3Q%<JTA$VMZQ
M,!<WAS([!"RQJ6RJ \DA#"X5.H\1*O5M:-.C2E"F[I:SG)WE%:^ZHZN^MDF*
MM+%8SDHNA"AAW*,JE6I6YZ]HN]J<8*T9.2C>3FK1YO=/9_$%A=W;V_V:!W\J
M-D8  89Y'<D]/E<-YBGH489YS7-#1-6"E5M9.059<@JZYSAUY!"N%=0P(#HC
MCE01ZBB%"1_"3D?,2>>6)R.K-EN^T' )Q2,K%B5./^!'I[_*1VK@G1I5)N4I
MR]YIV232;MW6VFM[^F]_:HYC6H4H4XPA)02CKU2;LW\G?<\O_L76,<VD['&W
M>TTC.0"2 6)W$#. ,X"@+]T #&;P)'+K\'BJ;P_;R^([73)M%MM9*!=0MM*N
M9I;FXL;>X51)!!/<3S2S+$RB4RNDFY&*GVC9+_>_\>_^PHV2_P![_P >_P#L
M*3P]&33E.[NG?EAO[NOP]-?N\F:QSG$0OR4HPNFGRN4;IV33LUHTVFMFM'I=
M+S$Z/KGR$6KJT>=C  ,N2, ';G &5(/#JS*X*LP*'1-6/6P)7=O*$Y0NWWSL
M*E0L@";HP!'\@(49;/I^R7^]_P"/?_84;)?[W_CW_P!A3C1IIIJK/YV>_+?1
MQ:ZO[O42S>LG=4*:;:D[)K72ST:U3=UV:OH[V\N_L/6?F_T6;<W);S&SO+[R
M0,8"ER6\L#RU8[@H.<O_ +&UK()M)C@$<R.2 01\C?>C(!."A4@\]0*].*R
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MV, 2-Z$;61R "589W*3@Y-6+;1]46Y@:6U>.-9HV9ER!MCR5W  *Q7D!F!8
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M$DMK:;>%CIX:IC<74P=-TL'/$57A*4FW*%#GE[.,KZN7)RO=_?<4G'/;ID]
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M+?1)*+R4V["H*X Q@#ISD$#/)YZXJ0# P,X]R2>N>IYX[>@XI:*Y3L"BBB@
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MS?SU?LY>/8?AGXR_X)V^*?BYXDN?#'AN'P=^TK;Z%J_C6YOD-OX+N/&_BH>
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MOX?1V]M^T[^Q;\6/!T$486^\:_"J^MOB7X7W*V)+IHI-,\.RV5N%^8H;R\<
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MV8  )Z6T8 ^\,8SZ\\>M?$/[>O[1?Q;_ &:/A9HGQ"^%_AK0]:LU\3I8^/\
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MM_ ?AY=8L=3M_!Z7+C1M3U/3M<N[R]%W/9F![DI=3KDO+M1,A?TT,K.!L=V
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M5Z4:JDE;2S>CTW3OT\SEEA,-)^T]G.G5U2G1JRIM;/=)MKR>C=F]5K\=Z?\
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MJMQ8VE_)?6TASREQ;Q2 _*5!!QZVIW<J=P<94LQ;.>C# (Z].<'TK\2/&?\
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M*EI""BBB@ HHHH **** "BBB@ HP.N.?6BB@ P/04F!Z#\J6B@#P7]H?X!>
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M3CK:[G24G;SM9+5V/V3AE\T9XX;& "",J3@@\@\U\F?';_DN/[-/_8U>(/\
MU%==KY#TG_@KW\+-#E2R^.G[/O[4/P$NTXN;OQ=\+'\1Z,)(T(F:&^^'6J^,
MII(8W#*)'M8]P7<J[>:U->_;;_98^-?Q-^"7BWX??&3PU?>'_ _B/5+KQAJ&
MN6^M^#D\-6]_H&K6%K/K">,-*T*2SADO[JUL_-D7RQ<7$2,PR2,9X7$4F_:4
MI*SC?E]]?%%[QO?37\-SHP^,PV(;C2K0E**:::E3:=GTJ*+_ #[GZPKT'T'\
MJ6N"\-_%'X;^+XHI?"GCSP=XECE53&^@>)]#UA'##*E'TZ_N5<,.5*%N",X/
M%=N)T(R-Q], '([$8.,'MR/?%8.,H_%&4;[<T6K[=TNYT1E&2O&49+O%J2^]
M-DU%1B4'!PV"-V<#&,XZ@D4I<  D'!X'3))Z #.>:FZ_K^O-#[>;LKZ:CZ*8
M7 &6#*/<$_H,GO2"12<#/3(."!C^?YBF"UVU]-22BF>8OO\ D?YXQ^>/>C>/
M0_I_C2NNZ_K_ (=?>%GV?W/R_P T/HI"V.<''KQCG\<_I49F4$@AN.^!CU[D
M4TT]G?TU#;5[=R6BHA,A&<X&<9)4#IG@DX/X&G"0'. >#M[<GVP>: WV'T4P
MN!U!'UQ_C2&55QD-ST^4G^6:+KNOO7EY^:#[_N?EY>:)**8'!Z GZ8_QIC3H
MI((?(]%_^O1OM_6W^:^] 345!]H3^Z__ 'S_ /7IPF0]-W_?)H\NO;^O5"NN
MZ^]>7^:)&Z'Z'^5?._[2I_XL_P")#_T^Z"?_ "X-/KZ#,HP1M;TR1Q]>N?TK
MQ'X]:#K'B3X9>(-%T*PEU/59I=-N(+&!X$EG%CJ5K?R1HUQ+!$)'B@98_,D1
M#(0&=%RP^+\2,-B,9X?<;X/"T*N(Q6*X4S[#8;#T:<JE:O7KY9B:5&E2IP3E
M.=2I.,(1BFW)I'O\)UJ.'XIX<KUZM.C0HYUEU6K6JSC"E3ITL90J5)SG)J,8
MPA%RDVTDE=G8:>1_9VF]%/V&PD5@VUU=+6, B12&!(9@V6!88# @#%MVW LQ
M*AG*[@X;*O\ >0#)92W)+ 9!.0<FO Y/BKXVT>PM_M_P?\2VD-I:01237GB#
MP7:1_N851G9Y_$L:+DKGEL8(Z&O*O$W[:_@#P9')+XM_X1;PT8!EUUCXJ_"B
MTE7DY1H9/&WG*P&"/W>2#D#!&?GJ/&^2NA3C'"<6\].A3NH<$<;6YHQA&24H
M\--73O9J6][/J>M4X>QJG*3K9,E*JW>7$G#RM>3E'19CS)-6WTTL]S\OOVJO
MAK/X:_::^*WAW1/!OQ4^-5CK/ANX\;7]A<:1XL\?V/@Z#Q2T<NMZ/ITMU#JM
MC:^'O(U&[1-%MV4P6I6"UMTB1$#_ (:_\$UM!^,/[+G@CQC\)=5T_P &?$'Q
MQJ=SKGB^W\=:5J#:<+*76=.:3PS!I\]K+J&B0Z8NBQW5A81P6L%S/*YNXY(H
MHF3[$U__ (*S_LG^%IKT7GB+1M0O;:&,W'_".WMAXIO+B,!?+B,WA^34#=A1
M@81WCVC@\"N:TC_@L)^R]J2&T\/>&OB;?Q*V$M],^&?B]HE4N"2/(T?R"&<G
M)W@$D'(KX6AD_ -+BGBOB_$99Q_FF,XMPF7T,RP>.X/X\Q& PN&P5>-6C3RF
MG'AM3P\JN)C.I5=.;JPE.2HNG3DXGN5,RS^ME.29#3S#A/"4\AKXFMA:N&XB
MX9HXZK5KPLIXE5<W<*M2G&=E+V";IQIJIS2A&2_'[X\_L??$OX;^*O%OAO4?
M 7BR+P[X+TVQUC4?BI+H0T;0=3TD:YKFL2W,'C*"VM;%GTF>^G^Q:##J+3B!
MH(GLMJQK7-_!_P"(5[I/B:'XD>-[GXB?%;PIX6T#P>UMX(T>36_!7P\_X2+X
M27.D^*OAOX?GUNV.E>'?B'X[OX/"]A</937.LZGJ/B B!H[AI'1OWG?_ (*!
M_"WXCZ+=Z!<_ SXO^)]"UNW>PO\ 3KWX=:PMA?V=P71H)DOX[8>6T;!,.4&2
MXWK]ZNE^#GB;P;X&\-1^#?@Y^Q]XJ\*Z)<3R:M8Z7/I7AW3=*_M.1787#OJ.
MM3W%N0S&,3-"TT43$*@8;*]3A#,N&^"LZK8W+H\<5<KQ.7XW!3R7'<$<=.&!
MACLPK8]4\IE1X8P_U*A1E6M["*<N:$).3Y*2AQY[@<VXAP%&AB)<.4\5A\;A
M\7]>P_$?#J>(=#"TL/)XRD\VDL16K.GS>U=E&+C",8Q2/?/B%XC?QG\!/#_B
MR31M1\/3>(9O FM/H&K1?9M3TS[;JUA,;6YAD5"DEM]R12H(RN.M?7-K*!;V
MPP2&@C8D X7<H;'3K@]\9K\UOB7XP_:J\<>'[GPUI?P!TC3K>6:UOOM%UXXM
M6D^UZ5=17VG0?N+"016L]Q;PQ7;H2T4)8Q0RL E>4)J__!9#QH L&C_L@_".
MSE2<)-<^*/&_C/4+9 [1VS?8Y/ASIUK(YC5)'07@4,Q0,0-U?9<$8FCQ!QCQ
M9F^!HYCA,NJY!PC@J-7-\JS/*/:8G!8KB>IBZ%*&8X+"U9SP\,;A95+1LE6B
MUU1X?$G-E/#^0X'$.CB<5',L[Q-2GE^+P6-<*.(PG#\*%2;P>(K1A&K/#8B,
M5)K6G*_8_88S<X 7/)P6P<9X)7J/?CKCGJ*K7>HP6,$ES=306UO$K/+/<2+%
M%'&HRTCR.RHJ+W8M@9&<5^1(_94_X**>/ &^)O\ P4-C\'0W$=LU[IWP8^$$
M.CRQND2"Y@L]<N?%^FW"QL^[;<-IRL 0WD9)4$7_  2;^#/B>X2]^._QF_:+
M_:%NRPDN;7X@?$.=/#]PXZYTBTADD12"RA/MQ"H[)EAS7ZPL'1B_WF+B]5[M
M&G.HY+2]IOE@GOJ]+:]+/X5XVM)?N<%4\I8BM3I1NDMXQ=2LEOIR7?=7NOJ7
MXN_\%'?V+_@C-+I_CG]H+X<+XAC+HOA+P]XCT[Q1XMEF7A;>+PUH=S>ZS)<2
MO\D4"V9E=OE52:^67_X*5?'+XS/]A_8[_8H^+/CVVN6=++XD?&/3KOX/?#L*
M,[+T+XS_ .$8U/5+)N&5M+N7>12!&"64GZT^%?[&7[+'P1CB3X7_  *^'WAF
M:WVF*^&CIJ.H$J<AGN]2-W-YA;YC(K@AN0N37TO!$EO&L,,4,,2KM5+>*.".
M->R1P1JL:J. ,8X'"BJ4<+!KDI5*K76NU&'3[%-Z]=Y775:7(<L;4?OXFC1@
MU;DP]"<JD7??VU67+IY4>C>J:1^3-W^R;^WC^TFZS?M9?M8M\,O!5PXDN?@[
M^S!%+X6CGA<Y>QU/Q^D%CXPN(&C9H9XEUV\M),%XRV5:OL/]GK]BG]F7]EV"
M23X/_"SP]H_B2[+2:MX^U&U36OB!KD\AWRS:SXPU5;K7[]F;Y=MS?RQJBJB*
M$50/J<C>?G.1@C!4,OX*2 ._.3UH 51A> .G&/KQDXY[9/UK1UZC7+%JE!QL
MZ=)>SCTTERZR2LM)-WW=^BAAZ<)<[7M9K3VM9JI4[Z)IQCZQ2["@L 5!(!)R
M!CD,<E2<9*$]5/'M31GIG@?=4  *.X '3.,GWI:*RLNR-@HHHH *#G''7W^O
M^%%1DD,VU68@=,8WL!GRT8X7?M((W%5.<!BP*JG_ )?G^O0".\O+33;*]U34
M+N&PL--M)[V^OKF5(;6SLK6,W%Y=3RR%8XH;:VBDGEFD*QQ1QLSL%S7Y!_LO
M:3J'[?O[7&K?MK>*;>=_V>O@%<ZY\-_V3=)O8I$M/$WB1KF >/?C%;0S(HN(
M9GL='T+0;X;T26SUJ*%HW24/8_;0\>^,OVM/C%IW_!.CX"ZW<Z9IVHPVVN_M
M;_%#2)Y!%X"^&,3PW5W\/+.XMV#2^*/B%"8/#\]HS116NC:KJ,\\CR6TEF_Z
MW_"SX=^$OA-X#\*?#CP-I%OH/A7P;HEGH6C:7;QQQK%:6<:1J[B,X,\[A[FY
M?EI9IFD<[FK6JUAJ#U_VC$6BHM?PJ%DW)]>>JG:.UHW>YE3@\572O_L^$J1G
M+3^+B;1<(^<*2M*6C3E9.W*SOUA56#@G< %!P!\HZ@XZD]R<GD\],3445Y9Z
MH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 9UW96U];26UY:175M<Q/!<VMS$EQ#/"XP\<L,P>!XW&5=)
M(G#KE3D'-?FE\?O^"4_[-_Q=U2X\=?#RVU[]G'XO(SW-G\1O@MJ+>%IKB];D
M?VUX5>.^\&ZM;,X5IWE\/I?RC<HO54X'Z?45K1KUL/+FHU9PNK2BI-PDKIVE
M!WC):+22:T6AC5H4:ZM5IQG;5-I7B^\9;Q:Z---=&C^=GQ!X3_X*,?LE-+%\
M1?AYI/[9OPHTZ-1'X[^%5O<^&/B];Z<N5,FK^$8Y=8TW5KNVC7S9KFQLM+BN
M2,!8B21V?P<_; ^ 'QKO&T3PYXQ;0?&EJ7@O_ 7C:$^%_%NE7,;;9K&YTR_E
M=+F:"0;'FMKD#<I7R!N&W][)5+$CJ&4 CGCYB2RE<L&'&#TX]C7Q[^T=^PS^
MR_\ M2P _%[X5^&]<\26X9M,\>:?81:3X^T*X4&.&YTGQ?IB0:W82P;]R^1?
M1C&>,9KL^N8>L[XG#N-32];"J--<VEG.FTX)-+504;Z-W>IPRPN)PZ:PE95(
M.W[C%U96:T7+&NHSJ7;UO-5&MDEN>"VS$K\PR.2K@AE*CJ589!SG/#$\GMBK
MZD*,$XR<CZ' %?*WB']A#]M?]G-9;G]EC]H&U^.'@BR!:V^"_P"T3*-1U6.&
M/!6T\-?$&Z$NL13>7^[A.J:_96L8C&2=S*?+K?\ ;LLOAKKUGX,_;!^$'CW]
ME/Q3+,++_A*/&.D3:I\)-3G4E/M6G_$BQ@O/!UG;3$&1/M^L@Q(P$SJ=U:TZ
M#G>I2J0K0<KJ%).6(3TT=!M3EWYHZ=%JG:?K:IKEQ5*6&2M>=2=-4'\/O+$)
MRC%-NUJD83NG[MG%O]#H@0RJ>&;) /&1CM_G-:D'W1_O?U%<AX;U_P .>,=$
ML/$'A36]%\5>'KX"6PU[PWJ=KKNC2J5#KY-]I\]S#\RG@"0=3QVKL(26 )&/
MFQCYNV!_$ W.,\BHLHN44[I0>KWTM_72QT):Q]5^C_"^I?/_ "S_  _I5N/H
MOU_K50_\L_P_I5N/HOU_K6:WEZ_HAOX_G']"T@)* >U7T5L 8/?^9JC%]Y/P
M_E6K'T7Z_P!:4GK%?WD_N_X<RD[*_F78 =Z\= <^WRD?SK2A^]_GT-4(.K?0
M?SJ_#][_ #Z&KFK679Q7XI_J$_A?R_-&E!]Y?][^@J^O^L'T'_H54(/O+_O?
MT%7U_P!8/H/_ $*LW\7RC_Z6C*.Z]5^9H1]%^O\ 6KT/WQ]#5&/HOU_K5Z'[
MX^AH6T_67Y%R^%?X?UB:$6S."N>I+D_/@<<= 2??.?4U>3< 65G0#A#NW,1U
M+%=HVY)XP3Q@^U9Z=3]/ZBM*/[H^B_\ H"U4K65U>S5O)MI7NK= <FE&S:NE
M>S:NE9V=N^@ZXLX-0MVM]1AAOK=U(>*\@M[L-&RD.BQW$<L!+KE0CQ-NSU%?
M"W[0'P(^"^M_$SX-^'=1^%7@";1?'FOZS8^,M/M?#6F:9#XEL[?0M2OK:#66
MTR"RN+MK>\MH+L;I@/.A23!=5(^\TZ+]4_D:^9/C1_R6?]F__L:O$/\ ZB^M
M4.<H+W927*TKJ33U<=;K7K^?<<%">DX*:T5I>]>[W=UK:W7TVT/!?$/_  28
M_8CUAWN-"^'WBWX<ZB[.POOA[\6/BAX<:%]QS)!9KXNN=)154H(H$TY4 '0C
M KA6_P""7%WX:D:X^$G[;W[8GPZ:/BWTZ3QKX.\6:1"HR%18_%/@75KYU4=#
M)?NV/O,3DG]7VZCZO_-*2MXXG$)*U:;5MI\M3M?6:DU>W3J[][X_4\+HO805
MKV4+TUJ[O2FXK\-G9=+?E(G[(_\ P47\*&(>!_\ @H[>Z_;00L(K#XI?";PO
MK2RN.46XNO#:^%I<$?*Q4J>^035J'PY_P62\+F+[+\6OV._B'%""OEZO\.?'
M6@SS@$D-)-!\4?*61@<';"$ 'W1DX_5&BJ6(?VZ&$JJVT\+2WTN_<4;O1[WW
MZB6$A%WIU\93>B?+BZ\E96T2JRJ**TV273I=/\N4^)/_  6'T9I6U/X)?LF^
M-(U&47P_XS\2>&IFP#QC4M=UT,7(W!@ J@A2I8$EVF?M&?\ !5NTF=M8_87^
M$VHP@-A=&^/L-I,PW*=P-UX9U%2NT'Y @8DJ=V 0WZB<]@<>H[?CG(Q[4BL5
M)VY)QT)8<$CIG\JS<Z3DY/"X=NZ?+!3IP6B37+&5DNJ2?GK=E*A537^W8S3^
M:K&2Z;IT]=.GIT5C\R;S]K__ (*,6)"G_@FV+Z09+FR_:!TUXFZY"-_PKMP,
M]LY]N>E#_AM+_@HQ_P!(QK[_ ,2!TS_YVU?J099",'@'J=QX_7\*9N']\_\
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M^R=\+FTJ34[KQS\6/&]X?%?QF^*FLD2^(_'OC;4"UUJ6H3W&W-OI,%U<7/\
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M:4_@E_V[_P"G(&U/>/I^A]5-U'U?^:4E*W4?5_YI24X[+T7Y""BBBF 4444
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MI+W>GLWD:A9_!GPM<PQ:WJ6L21O)]@UW5U\/06[H;F(L5A$O<?#G_@G'X_\
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M&/E!'U#,/Q'4>E.$Z$D#=QG/  _,D=?;\<<4?=]Z\O\ -!WT>EKZ;7VOV)2
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MVD<C[Q. %YZ] >IK\^;O_@F%\7/@XKW7['O[:?Q4^&UI:@OIOP^^*EA'\6/
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MKI9O1Z[6;?9I[-'2^[MKZ>25[?)$]%0_:(^.N2"0/ER0.N/F[=\XZCUI?.7
M)# %@N3MZD C.&/J!QDY[55T]G<7]?>2T4U7#YP#P<9..?I@G]<4Z@ HHHH
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MAWV?3\-$%%%% CUBBBBN<Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7?#_ ,02>(?$NC:3<>)K37_$OB:UU:UOE\-W;[+"UTHEH9&2>,%8J][^'O\
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ML/#HNO!W@+Q+XW+1^%]!\7:N+Q3I>KZM<@V<=J\,C+<AX]P*M4ND_P#!2[X
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MDFZ$(++I4:+I8NG4PU2.)O3J82O2KTX^UIRF_L[2/^"H?[/&K_!.[^/KZ/\
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MJC\E_5_Z;Z:GVJQ&['<%\CTY4<_B#^5%"R-,D4C!HR\8D\J48DAR=YA;."&
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M[B(23W-M:IYDC>4,/WEK9?GKIOYWNWJGTL'NM;OI>[MVZ?+Y6U=K'VW<>'-
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M44 %%%% !1110 5\:?MV?M+ZI^R=\"9/BWH_A.T\:7\/CWX9^$H]%O=6DT:
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MJM@C(R W0X)&1R,^N")Z*:;3NM&@:3T:375-73]4]&9Z6!7&Z=W'.X%% (Z
M #A%&!A1P3DD?,<S"U51A7*G;C( !R<Y;C'))R<8YJU10VWU?RT_*W9?<NP6
M6NFKT;>K=E;=^6_=ZN[U*$FGQRNLCNS,H8#(!!##!W#HQQD D$C)I[6:$ ;W
M&-N"#C[N<9YR< D=:N44MMK+2VB2TNG;[TGZZB22V2U=W=7N[6N[WN[:7?30
MK?9P/NNRC_9 !R1@G=USGYL]<\DFD-JG\)*D @$= "<\+T'//0\X/85:HHUO
M>[T\W;[KV_ ?R6]]M;W3O?>]TG??0I+9JC1LKMMC.\(  &?DDY'0,3EE PQ
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M,XWNXRC%7_[>2YK]M=RE0A&_LE[)O9PTC%]U#X%?9^[LV]ST'X3?%WP1\:_
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MD89GS]=H"% (QUXSGN?3_(Z4SRR5"X"C=E@I)RH!P,D#G.,]N*D48 ! 7&>
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M%=ZA\:OCOXAE6_\ &?QN^)*QZKXJU[4Y2'NI-/MIFN+/PY8QR%EL+2Q,T]M
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M/U/^-.HHN^[_ *_X9?<'+'LOZ_X;\^[&[%]/U/\ C1L7T_4_XTZBB[[O^O\
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M_P"?'Z5Y<MWZO\SNCLO1?D%%%%(84444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\1_$SPAI%\+AX7@U#7+.WE6>*6"*16B,K&%89[BVCE+.4B::(2%1(M?G</\
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M,3AHX"I*A#$4,-5J5J<J-3&4JU7#Q]A2J)2Q,H>UJ145&$:E&6(HU_F[5_\
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M%RGE>+=:O2IUH8*K#"0S'"XKZC)U(U(8O!U*;G&FFGB*=2=&O)^Q%\1/A/\
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M43XD_P""D/B&S\,?L,?M-ZA=L)=_PK\06%M%T-Q=:A&8+:VB'\4LK$E5ZDC
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M2<9)QE%V:>_]-:KR.J$XU(QG!IQDKIKJ@HHHJ2@HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]JCCN+:9)H)$;YH@LBEE;;E&&1@'<#NR3CIP<*;W8"9'V#>4CW[4,CC^!20
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MS8WV3^ITL/[*BTZE&BZT96=>O&3^5_ /[+O[1NE>//@G-/H7Q"\#^ ?".A>
M;;1_#_AOQ;X(OSX O_#\>KP^,8M>GN_%]K+=6'BE+FRCE;PVNLS30@+<0+L*
MC]R8"QB0M@$@\#(XW''4 YQC/'7ID<UBZ=+%J>GV.IV;R2VVHVEM>V[OM63R
M;F))X XVM@B.0%@&X;Y<GK6X@8(H8Y8#!/7//7H.WY=.>M>_@\#1P4:BHSJS
M]M)5)2J3E*\N5*Z3TC=624;*RVLD?F6>\0XW/YX5XS#X3#O!4IT(1PM'V7-S
MR4I2JR<IU*L^9>]*I)N]W=RE-M]%%%=IX(4444 %%%% !1110 4444 %%%%
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MS=_^T;K-EJ3Z=#\.]8U6#^TM4T.WU)+VRACN]4TC38-3N8Q  CH!9R3R.I
M/E@_*1GWL_#[PV_A>/P?/;3WFC6UQ97*"]G^T7#SV%]!J,+O,XW.T=S;1R!F
M4'*C')S6>WPI\%[DG.EPF2+5-1UJ%V()CO\ 5+!-,NI<8.2]FOE'C@,3ZUZ6
M9</>+5:I@)Y;QA@L'..2<.83-:WL<+-8K-\)BL9'/\31PE?+<3@\/3Q6$Q%*
MK25"A2OBJ,*<U"DG)<&"S/@RFL3#%Y'B<1#Z_F=;!1]M5C*GA,10HQP-*I4I
M5Z-:;H5:<I.]3X9MIN]GXSJO[22:=;V6I6O@O5+_ $X>$M.\6:S=I>6T?]D:
M?=WU_83QM Q!G-I+83XVHXZ@?-TO7_[0LME>:_;0>$=0N[?3/%%OX+TRY2\M
M(#JWB"]ODL8+=0P4QVT<K[IYB%$:(Q=PN:U+K]GCP3JOB:QUJ\A-SI6E>'K#
M0M+T(,T=I&NG:E?ZDQN 0$E1Y;]SM8'I@ @Y/>WWPF\#ZSI>K:5>:1%]AUG5
MSX@NL,$E35OM!NENHG4'RY4F^8.IXP0":\S#95XZU7F3Q/$>44*D)-9?">&R
MV2K3HX3%T_:<M/):WL<+B<54P$XQKUJN(HTZ,ZK_ '56IA)=U;&^'5-8-4LJ
MS'$*5I8J:K8RE[.G.OA)QA>6-E[6M3P\<5!R@J5*7MH17-*$:IY$_P"T_I-F
M+4:QX8O=+FDCUFU?S;F&2/\ X2#3;O1K1-"@905FGO!JJSPF/+.EK,5.T,19
MLOVD[*^\07NB1>$]6,6F"X@U&^A=&6RO[/2+'4[NWFBVLT"1F\%MYDBJ"T;D
ML>_H<WP4^&LNF>'M&D\.V\EEX>U<:UI9;:\D=^J,'N'8IES(=K/]XEHDS]T5
M>_X5%X-_M[4_$46G-#>ZMYCWB1W!2VF>>VBLI7\A003):V\.\GEF!)&36T<D
M\=E5P\I<8\.QI0Q>3U*M.&5TO:O#?V;-9Q2E4JX2K3?_  H0IK#SC2IRG"K4
MG:AR1ISR6/\ #M4ZM\CS7VT\-C(TV\75=.%?ZQ2^I3C&G7I3:=#VOM.:=11E
M&"49IN2\/T_]J6YNA8W,_P -]6M--N8_#-[+?C5;.6*VT[Q9?6%AI=YY2%G;
M?)J5N1&%RP.T*<C/01_M):5=Z[K^DP>&=4N+#1(]9)U5&#0/>Z-;6$\EO<;5
M'V,S)J2"-Y@D>8W R37IH^#'@06@LUTB$6[66A::Z%MP^P^&[JRO=)C V<F"
M?3[5\^J$*.:(?@WX(M]1U34HM+$<FLVUS;ZC D["VD%RL4<THMS&H\TQV\2M
M)P^%((QC,TN'O'6G]4A/C;(<5%8S#5\;6J99@85?81GF4<7AJ4(97&G[*IAY
MY9*G*3]K&O"N^?E:4KGF7AU4]K+^PLSHVIRA2IT\56E3YO9X5QG)U<55J<_M
M5B-I.*BX>[V\&U3]I;Q+_84T^E> YK#78;GP9-'IVI7]K+%=Z/XK,!M)X9H&
M00/()':,R, 6!)RIP/L#3[J:YL+>XNX_LUQ-#%-/ TGF"-FC#21J^2",Y"X)
M!(R.]>:ZG\&/ NJ:?>6-YI:?9=1TS2=+N2L@5S9Z!$L6E+&X!96ME12C+RKY
M(QG%>GV-C#9V<%E;#9!;Q1PP(2S,8XT"+O.#G( Z^G/?'V7!N5<?Y=F&9U>+
M\_PV=86M@Z%+!>PAAZ4J6*I9KFM:4YX;"X#!4DYY96RVC.<)J/M,//\ =[SE
MX.>XWAO$X?!PR/+JN K4Z]>IB75E.HZE.KA<&H0C.=6H^2EBHXOD4H\SA*#E
M.]T;*D%5(Y! (/MBEI!P /0"EK](/E_Z_K8**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>nt10015006x17_graphic9.jpg
<TEXT>
begin 644 nt10015006x17_graphic9.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M%C>3:9;0Z1';7#ZJT]Q&=.$$PO!"8G"^!_\ #PW]@[_H\C]F;_P]?P]_^7]
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M_P '&<6M_LC_ /!9;_@GC^W%H:ZI'IFH7'PDU;6EL[B6UL=3U7X*?%*WDO\
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M+)Y$F1#9:-X2^#&IZWH:Q;1]H\4:W.21=+(?];3XUP0VWP.^+=M;Q1P6]O\
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MTR^S?:^O;I:_ZB;M;M?6_DG:_E>VG>W8^WOVM?\ @@C^QO\ #CX\?"+XE_\
M!-'_ (* ?!;]D/X@?"KQG</\0='^+?Q_7Q!J/A7Q)X3O[632M3\)36^IMXIM
M=;L]8L+W3O%/A?Q#JMO:29Q%=6@CN-/DF_X/"M0GU?\ 9N_X)J:K<^(-#\6W
M.IZS\5]0N/%7AAU?PUXFGO? OPEN9?$'AYTN+M'T/69)6U'272[NE:PN;<K<
M3 B1OPI_X++K_P $9/&'B'6_B7_P3D^,W[2/QW_:5^./[0/B7XH_%*Z\4Z+J
M&D_!C1?#OCZX\<^)_%FB>%](\5?";X:^/&\32^.M:\,?\(W#&?$&F6OAJ#6+
M;4-3NM4:UDK].?\ @XRT36?#/_!*+_@@[X<\2:1J?A_Q#X?_ &>_#>B:]H.M
MV%UI6LZ)K.D_LX?L]6.J:1J^EW\4%[INIZ;?6\]G?V%Y!#=6=W#+;W$4<T;H
MN<FN622ZQ=T[KXH_U\AQ:UM9*S=T[K6.O1)-6U_'N_[Q?V8O^3:_V>O^R'?"
M;_U M K^%#_@Z0T_X1ZM_P %G?\ @G]I7Q_U.;1?@/J7P2_9_P!/^->L6\FI
M17&E?"6\_:J^+]O\1]2@ET:UOM8BFL?!\FLW,<FE65YJ2/$&L;6XNA%$_P"\
M_P "O^#D'_@CAX-^"?P;\&^(OVL[NP\1>%?A9\//#.NV(^ W[1MTMEK6A^$M
M(TK5+07=G\)I[.Y%M?6L\(N+6XFMI@GFP321,KM^ G_!R!\0_P!G_P 7?\%@
MO^"7?Q7^*-U9Z_\ LL>)_P!GW]E+XA?$.]U+0_$5UI^M? '6OVG_ (G^)/%E
MU?\ AJTT_P#X2RXL]1^'=S?S76AVVE?\)#-!-)80Z?\ VDRVU6[<J5UM'JGV
MWL]A:.,MFO=OV^*.Y^<W_!4KX0?\$1O#WAKX26?_  2"^,7QK^*G[3&O_$[1
M-'O?"%C#\3=0\,P>%[K3M82&\T_5?'7P^\(:J/&]WXK;PU9:+9>&]:UAW@DO
M#<Z=8.+>YF_L@_;F^(W_  6A^'O[%/\ P3R^!G[%_P ,[OQI^U]\8O@]X6\'
M_M3?%J^L=+\0)\'?&WA7X4?#>'QAXBU7QIXBO!\/O#][KWC/5O%SIXF\23WS
M7UUHTK>&[74-1D1#_+;_ ,%COBY_P;O>,_V:=.L_^"9W@B#3?VJ;?QYX8N?#
MWB3X;> OCG\-]&TKPQ#<NWBB'Q5!\2;3P[HVK"\M!$NBG3-(U'6[/6(K66"]
ML+,WR7?]M?\ P1#U+XZ:O_P2G_8KU+]HZ;Q)<_%*\^%4LMQ=>,!(/$]UX(/B
MSQ(/A/<ZPTZK<RSW'PJ'@R6WN+S=J%U8/:7.IR2:C+=.R2U:NM4G>+T6NW];
M K:V\K6M;;RZWW[JVV[_ )-_^#9?X?\ Q!^$_P#P6C_;O^%OQ:\4+XW^*?PU
M\'?'+P#\2/&2ZA?ZLGBOQWX/^.>B>'O%GB*/5-5CAU/48]9UW3K_ %".]U"&
M*]NDN%FN8HYG=%_T&9$65'C<!DD1D=3T97!5@?8@D&OX7_\ @A__ ,K('_!7
MK_LH?[9G_K6#U_='50^%?/\ -@MOF_S9_G[?\$;_ !UX>_X)M?\ !<O_ (*5
M? 'QYJC^&_A?)X)_:'UJ>$PFWTZVTKX.:W/\;-%UE(V*1O!H?PV@\9V>G,#L
MFBU!A$Q\P9_GO\$_%?XUZ!^U'\*_^"O'BJTEL]$\?_\ !0'Q?XHU'6O*NC8:
M9XOTKQ'X2^*OB.Q%T=L(L6T7QWJ%EH=I$0%@\+:I (T@M46OUO\ ^#ICP!XS
M_9=_X*F'XZ^ +F\T*P_:H_9JMOMVJ6\7E6=S=C1]=^"GQ-\,Q-'Y?F27GA2P
MT'4=8!+;QXN5I-PG9*^X?B[_ ,$[UTS_ (-,OAO>2Z"(?B!X:U/PE^WD[;6>
M98O&NJW^E"[#E?.\F\^"/C2UNVMAB);QXW*GR@]19ZK^6[7;HUU]=]KAILOL
MZKU;4ETZ:K[M-+B?\%"K2#_@H'_P<^?L7_L]Z:]OKW@7X2:+\&/$'B2UE07-
ME'X:\/\ A34?VH/&=G=L-T,<6M^$AI>GV[N K7NK6L2[WFA5OK_7?^#<NW^+
M/[8/[7/[:_\ P5A_:'\.?$[X.>,;'QQXWT+_ (0[QQXT\$W_ ,/T:<KHLNOZ
MKKMC#9:5X2^&G@6RL],\.:18:M/I<!TG3+&XL;C2;;[+-\!?\&G7AGQK^TE^
MW=^T_P#MH_%6:;Q)XB^'G[/W@;X1V'B.]B\XR:UK%KX.\*6=TLTK2R1:O9^
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MIT'B&:UOA8:D4;0] N-1UXVT5E-+>)I;6</ER3K(G\-/_!2__@IC_P $@_\
M@I#_ ,$W/B/\=/%'P<\(_#3_ (*G^*->\,:/X<T/0_#'B"X^*>C:AX.\:Z+H
M^GZ[K'Q:LO#^E:!XF^'UU\&M-EM)M.\0:C=R6=Y/%HVG:/#J^D:5K-HY6M;2
MZ6E^WEYZ?T@>RV5D[>6U[7VV7O6OUU/M#_@K/H?QV\-?\&OO[).A_M*R:\_Q
MGT[Q3^S]#XN7Q3=3WOB>VC-A\09/#MEXANKJ6>YFUFQ\+OHUIJ!N)I9TN87C
ME<NC8_?W_@@?_P H??V$?^R17O\ ZG?B^OY7OVJ+SXRW_P#P:1?LM7?QPN/$
M%UXFE^/N@#PW<>*C=/KTGPUC\<_&6/X=&[DO?](DLQX533QH$CD[_#8T=@S9
MWM^CG_!([_@O9_P2K_9?_P""<'[)WP"^-_[3%UX-^*_PR^'5UH/C7PPGP8^/
M'B)='U63Q9XCU-+4:UX8^&>LZ!J -E?VDWG:9JEY;CS?+,HE21%F/QWNDN1;
MM+?DLM;?TNPVU:+;M===]V?V 45XK^SK^T-\(OVKO@OX$_:$^ WBIO&_PD^)
M>GW^I^#/%+Z'XA\--J]EIFM:GX=OI6T/Q7I6B>(-/,&L:/J-F8]2TJTDD^S^
M?$DEM+#-)[56H!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5_*M_P="_\%*/C9^R5\&/@[^RU^S-X@U#P;\6OVKKS7[7Q'XYT&[;
M3_%GAKX<Z3/IFCC1_"6I!HFT?6?'VMZM)I,OB&VN(+_1M(TC4XK&:UN]4M]0
ML?ZJ:_B'_P"#P#X _$.RNOV,_P!M?PKX?U#7/"'PNU?4_AKXYU"R@EN+;PIJ
M<FN6OCGP#=ZR(A(UGI?B&[MO$FEKJLL26-MJ5GIVFW-RMYK.E6]S,KV=@>SU
MMZ>JN_DKM>:*_@+_ (-&OASK'[-6F>*/BS^UQ\1=-_:J\5^#+?Q)'J$":.OP
M]\/^,=2TV'55\-746JW$FOZ]9P7<BZ=J>N)JUE<[WFOX+&41113?L/\ \$%/
MV=?^"D7[)G[/GC[X"_MW^,_A]XT\'>%M2M;C]GO^R/B@GQ)^(7A'0)CJ<?B+
MPOKU_9Z=/8-X-\]=,U7P7#+XHU34=!%WJ>B"VM-)32['3?SD_;?^-_\ P2Z_
MX+,_L;_LS?$_QC_P5:\$?L87_P &-"UKQ'XX\"3Z[X?@^+TOB?5?"^@V/B7P
MQ=?"?4O&?A3QWKL^D:CH=T- N_".C>*++Q,MP7\/R7R2H[_ 7_!HWKVIZE^V
M_P#MK:9:^._%?CWP3I/P$OK7PQKGB"[UHQZIIUO\7/#,&C:R^F:K/*=,OM3T
ME5NVM)$CNK99YH' V2 3HFK+?1.^][:M#T=K6V>V]DNO?;?5]WL>^_\ !F3>
MWEYJW_!3\7=W<W0BU?\ 9+\H7$\LXCWW/[56_9YKMLW;$W;<;MJYSM&/Z6?^
M"T,LD/\ P2J_;MEAD>*5/V?/&#))&[1R(V+3E74AE/N"#7\C?_!IM^UE^R[^
MR_J__!1H?M)?M$_!/X"'QQJW[,9\&#XP_$[P;\./^$K'AJZ_:6'B'_A'?^$M
MUC2?[9_L+^W]#_M?^S_M']G?VQIGVOROMUMYO]+W_!3+]K3]EO\ :?\ ^"5/
M_!12/]F_]HOX(_'J3P;^SSK;^+D^#_Q0\&?$9_#":Z9%T5]?7PEK.K-I*ZLV
ME:F--:^$ O3IUZ+<R&UFV-?!\I?J$6N9*ZO=?F?Q)_\ !,'_ ()Z_P#!-3]J
MK]C[QC\8OVQ/^"BD/[*7Q?T?XE^,O"VE^%M5\?>"K!4\'Z+X<\':EHGBY_#'
MB&^M==U..^U76M<T]5LYDCO'THP6K&X25:_9?_@TJ^)_QYL/%_[<GPL@\6^-
M_BA^R-\.=*37OA[KVL2ZO<>%$^(%KXFO;2V3P>-3>XBT&Z\:^$X[S6M:TG2A
M%%>2V=E?7\#W$%N[_FI_P1I_8Q_X(9?'[]BSQAX[_P""CGQ_^'WPG^/UG\8O
M'6@:5INM?M2:3\)/%D?PWT[PGX$OO#NM:7\/M0UI7U42:WJ7BB&QU(>'M2BU
M.XLY;$0W;V+0CZG_ .#9'XNZ_P##_P#X*I?M/?LG_LT?$GQI\3?V#;[3OC+X
ME\-WGB&"_;3[W3_"'BC3-+^&'Q+N;%K/3K'P_P"*/%6A?9;'4;@:9ITNJ6\B
M6CVZ_9H4BE*SB]K]GKLM[_C;H[>LQ>B7NZQMI=N_*GKHNBOUM))Z*[?Y]?\
M!:G]MW_@I[^W;\*_ 'QU_:%^"NK?LT_L4VOQ?U/P?\"?!K6=WX>?QMXVN/#>
MJ:I-XGNI=;:T\6>.H]+\-:5<6L7BA=+T_P %V-YJ5YINAI-JK:REG_I'?L:E
MF_9!_949V+,W[-WP-+,Q)9F/PP\+DL2>22<DD\D\FOY>_P#@\O '[%_[)P
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M#ZIJ&C07=OITL,GC37]=?3D@BO;D&+3S;1RF3=*KE$*_=]%% !1110 4444
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MNUM<0-OAFCMM<EU*S\V)\/&[6Y9'"NI#*I'Z0*JHJHBJB*H554!555&%55&
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MN[FSA"M!I]V[>77TU))'%&\LKI%%$C2222,J1QQHI9W=V(5$1069F(55!)(
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M.EU;P7,:NJ7$,4Z+*I214F19%61#DHX# .I)*L".U34 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5^.O_  6L^._Q]^!7[.OP0?\ 9S^*5Y\'
M/'?Q;_;!_9X^!=WX\T_0=#\27FC^&_BIXM/AG5[BWTKQ#:7>GW,MNEU%>1QN
ML32/;+#Y\22.U?L57X(_\'"WPS7XP?LL?LU_#>[TGQ#J^A^,?V^_V3O#?BF+
MPPVIP:O;>%]?\>C1==O;;4='4W^C26^GW\QBUB!X9--G,5U'/%+&C ?]=/Q
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MK2+7Q3+#>JLL>G7VEV6H:9J,UM<QV5].8)"O\U_[+4^J_LJ_#?\ X(L?MO\
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MU?6/$<EKI6A^&3*^OZO<ZAIJV-A,-1LS-Y;^S9_P5P_9 _:H^*^E_ SP'?\
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M&N[34+IM)DT.[N+JZN!IM]+?C^5OD[_J--+_ (*TMOJO5+J]+Z'X8:W\9/\
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M77_!5OXN?L+_ !'_ &D?A9J[^$O&WQ4^&?PV\,?$C1/^$JNKA'O]+U3Q+?\
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M>YMGN8;JWO8;3X2_:=_X*X?&_P")'CG_ ()"_$G]D'X,?&+Q#\&?VF/'>O\
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MKJ_1;_?;^KVOTV/[:&M[=XO(>"%X<J?):)&BRKAU/EE2F5<!U.,AP&'(S4V
M1@@8QC';'ICTK\B/V>_^"JFJ_$;]KKPE^QG^T-^Q]\;/V0/BI\6/AMXA^*7P
M0_X6=K7@KQ-IOQ(T'PI!<7WB323<^"M3U.'P_P"*='TJQU/4[W1[R><0P:9<
MQO<K+):+<<__ ,%KOVL_C=^SM\!?@M\)/V8-7M?"W[1O[;/[2'PU_94^&7CR
MZA%T?AQ_PL"^:'7_ !OI]DT4JWFM6=LMIH6D!E!TZ]\11Z[$SW.DP6\Y?^NO
MW;A:VGZH_99550%50JJ,!5   '0 #  'H*9Y47FF?RX_.,8B,VQ?-,08N(S)
MC>8PY+!,[0Q+ 9)-?R_?M&?\$U_#7[(_A#PCXT_9T_X*G?$#X+_\% O#S^#_
M !G%XF_:S_:^M8_AY\?((=?M+?QJ/'OPM\<ZC/I5IX3UM;776TY/#>@RZ8;F
MQ/AS5X]4CN+N_M/C/_@L;^UE^T9\"?\ @J/^Q?\ M">"?B?J3?"SX%?L8_ K
M]I'X^^ /ACXPU?6/A9XZ\#ZO^TAXV\"?%#4_#T$%U::;XFLY] \10CPYK-_8
MR2:A8V>BSSI$D0\HO97:MMUO^@[7VN_DM[I=_,_M1HK^2K_@YR_;'^)MG\%/
MA1^SO^RE\1=;\-^)-8\ >*/VV?BM\0?AYXAO]-OM'_9W^'"6'@WP2C:IHMS!
M-_8'Q4^(_P 0=.AT^_BG\E]0\(V4#;X+]@WUI_P6R^)/_!1K0/V(O&+?LFMX
M'^&7P=\-?LKZK\5_CY^TKK/BG43\5[8>'M,BNV^%WPD\/:<(YM*\2>*K2T5M
M3\>Z@]_%:Z;JEU:6*Z+J<<6JN7WT=U^-]B>MO*_3;3:[U>NQ_1#17@G[*VIZ
MCK7[,?[.^L:O?76IZKJOP0^%FHZGJ-]/)<WM_?WO@C1+B[O+NYE9I9[FYN))
M)IYI&:265V=V+,37O=-:I/N 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?V;44DN[O^';_(+]+:=?PO\ EYGX2_LV>&OVA/VP/^"GEK^WYX__ &:/B?\
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MZGX?OK;2-(NKS6;3^Q2BER[>7DM[I_):;?Y!?;39W6O_  /)6_%,_D#^$/\
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MO)%836[_ -W]%#5^K6G3UNON_4%)KTZKH[VO?3RT^>Y^'FO_ +''C;X9?\%
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M3X<^'_B7=:%%X*U;Q?H\@^RW&FV^L&.?47ATJQN;O5+FVLYE==T.S^[7\O\
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M,/\ ;'_Y/T_X)#_]EV_:K_\ 6(?CA7Z>5^8?[8__ "?I_P $A_\ LNW[5?\
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MY^S[_P %F_V"?V;_ !;XZ\!^$;7XY:9^U!^S)XBT+1-1\7:W96?A"#XR>%O
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MDI/;YQ_-#CNO5?F?I11113$%%%% !1110 4444 %%%% !1110 4444 %%%%
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MPK?M ?%*;_@H1\4_A=^U#\:?B%H/P&^#VNZ?X8^"]C^U+X$T3XR_'O\ 9?\
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MMSX@\2_$;XE6'@G2OA6?&'CK3]7U?3-!\,6/B/['97VIV>VZMKVSCM]0_P!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI>';:.*[_O\ +50EM;HLDLP2")1-,=TTH6-0))FPI,K@;I#M&7).!TI)I_\
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M0A2P.*Q:E1C7Q4Z3DY8=0?/&249-VND?U14445_.Q_H"%%%% !1110 4444
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M#7\T_2$^/A;_  YM^>7G^D'T!O\ =/$O_L(X8_\ 3>=&K1117\VG^B 4444
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M>RFFN;B^NKN>:3^]:W=);6%X&7RWA0Q,LBSH 4&W$JLZRA>F\,P?&=QSFO\
M.DA_X)%?&G4_AEX,^!-W_P $M/CIX8_:Z\.?'7^WOBC^V3XP_: TZ#]EC6/A
MY%\3M3UK5[A-!LM9ACF\+ZA\/C:^&K#0=*M],OM.FACUN+7K^\=[/4/Z\?\
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MZZ;$[8KRWC3^[B^_9R^"&I?'[2/VIK[X<:!=?M!:#\.3\(]'^*<JWA\2:?\
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MX,N-=U^R2UF\0B]U?3K/1B\<=Z;V+]2-._X)S?L-Z3^TA=?M>:;^S'\*[/\
M:/O-8O?$=Q\5(-!*ZX_B;4ED&H^*%M?/.C1^)[]YI;F[\0QZ8FL7%_++J4EX
MVH2RW3^,?MC_ /)^G_!(?_LNW[5?_K$/QPHLTK.VZU7JM7?KW&W>WZ]-$M-7
MV?W]]3[+\)>(_C]??L^6GBGQE\-/ ^@_M)/\.=3U:[^%&D^/;G5_A_#\38=)
MO9])\(Q_$9]!M+J3P]>ZO'86-WXD_P"$>\RRM;F>Z2PN3;JDO#?LE^-?VO?'
M'@GQ'J/[8_P.^%OP(\=VGBE[+PQX<^%'Q9O/B[HVL>$AI.F3IK6HZU>>%_"S
MZ9J;:Q-JMB=+2UN5^RV=O=_: ;@QK]5451)\9?#+Q_\ MQZQ^TS\1O"'Q5_9
MX^#?@S]E?28/$[?#+XR>&OC9?^*?B3XNGL]7TF#PI'XA^&,O@W3+7PXNM:-/
MK&H:H8_$5^-)N[&VLHVO%N?.7\HO^"SG_!<7QY_P25^,OP(\(M^S;X;^,'PT
M^+7AZZU_4_$K?$B^\,^+M-;1=?73]?T[2M!7PQJ>F32QZ;)!<Z;=7^J00W-Y
M*89DAAB:5OZ*J_@0_P"#SW_DIO[%/_8B?$?_ -2#3JF3:3:_K43TBWU23_%+
M]3V;XE_\'H'@>/0H6^#W[#_BN[\3?;XA<1?$OXJZ1IVA#3/+E\]H9_"_A[5-
M0-^)?)\I'MQ;F,REY%8(#J'_ (//_A;_ ,(.[C]B+Q^?B3_PC\C1VQ^*/AT>
M!SXJ^QL8HGO1H1UX>'S?[5DG6P.HBSW,ML9L)7\!E%9\\N_X+_(SYWY?U\S^
M]_X:_P#!Z!X'DT*9OC#^P_XKM/$WVZ46\7PU^*ND:CH1TW9'Y#33^*/#VEZ@
M+XR>;YJ);FW">7LD9BV/WJ_X)(_\%)/VC?\ @IKX;\3_ !YUK]F?P!\&_P!E
M6\O?&FB?"[Q?:?%^[\7_ !0UGQ-X8\4Z;I]OHGB[P.?"6DZ=HT4GAR[N=1O=
M7T[7-0M5U2U2RM8I8+CSXO\ (VK_ %)_^#5+_E$5X"_[+/\ &/\ ].^FU49-
MO5]/+_(J$G*]^BO^*7ZGZW?%OXA?MU:'^TC\,O"7P:_9T^#/CS]E[6/^$,_X
M6K\8/%GQNOO"'Q&\&_VAXHU.S\<_\(U\-(?!VJ6OB?\ X1WPG#I>M:,)?$6G
M_P!MZG>7&EN;-;<7#_R7_P#!0_\ Y/;_ &E?^RGZU_Z!;U_='7\+G_!0_P#Y
M/;_:5_[*?K7_ *!;U^^> '_)2YS_ -B.7_J?@S^(?IW_ /)M^$?^RWI?^J'.
MCXRHHHK^L#_+ Z/P=_R-WA;_ +&/0_\ TYVM?VU:A\0/VY+']H[X>>"O!O[.
M_P &M>_9#O=$\,MXN^.&K?&W4-'^*6ARSZ#<S:RFF?"=/!=W9ZI]@U6+3[*S
MW>)X5OK6YENGDMFB,2_Q*^#O^1N\+?\ 8QZ'_P"G.UK_ $.-"_Y >C?]@K3O
M_22&OYI^D)\?"W^'-OSR\_T@^@-_NGB7_P!A'#'_ *;SD^6OVN?'7[9W@;P[
MX0N_V,_@)\)?CSXEO]:O[?QII7Q9^,5[\'[#0-#BL5DT[4-(O[+PEXK.M7=U
M?E[:XLY([(6L*I,KSF0K'Z=\5O$/QXT3X(:UXB^$/PX\$^./CW;^&=-O-#^&
MWBGQW<^$_!&H^*I5LSJNC77CR'0=3N;33;-I+X6FI_V$S7GV:#?;VWV@F+VR
MBOYM/]$#P#]F_P 3_M&^+?A+I^N?M0?"OP#\(/C'+?ZS%J/@3X<_$2Y^)GA2
MUTZWN630[J'Q==>'_#LTUQJ-L%FO+;^R\63G8)9B2%\K_9:^(/[=7C/Q)\0;
M3]K?]G/X,?!+POI9B_X5QK'PO^.%_P#%?4?%6Z_N(IAKVF7G@OPNN@"/3TMK
MI'2YNR\\KV_E@(9!]IT4?/\ +7\/RL!\47WQ#_;NC_:VC\#Z?^SC\%KG]C8O
MIXD^/%Q\<;^W^*ZQ2^#K:_U)U^$*^"Y+-GM/&SW7A^VC_P"$IQ=:1#%K+20O
M,;:.Q^UY\0/VY? O_"N_^&+_ -G?X.?'S^U9?%*_$O\ X6U\;+WX/?\ ")16
M7_"-_P#")/X>^Q^$/%?_  D;:W]K\4?VHLO]GC2?['T[:;G^TV^S_9]%+YO\
M/\@&H6**74*Y52Z@[@K$#<H; W '(!P,CG Z4ZBBF 4444 %%%% !1110 44
M44 %%%% !1110!_GM_L-_%BV\,:AXT\.:!^T3_P1&^#VBVW[77QLCTSX*_M8
M>!;CXB?M ^ K&Y^.'B)[7PQHGQ?M(]/@^).F/!)'/X!\9_VYXH%Q8WFG1#6T
M2T73[#_0AB.8XSE&RB',8Q&<J.4&3A#U49/&.:_S</%7[37QMNM%\1_&SPW\
M</\ @E-IOBJX_:]U[X.:+^S1J_\ P3]_9WD_;#TNU_X7'<^"]-\:ZM\.Q\*;
MW5/M]A;F/Q;JL4_BV2XBL;>X5O$]UXE5M/;^UW_@D9^UE\5OVS/V+_#GQ9^-
M?_"'ZE\1=$^)/Q@^$^M^./AUI&IZ#\/OB@GPJ^(6M^#[#XC>#=%U<O>Z9IFO
MV6GP0WUJ9/LZ^(=/UI[2UTJU>'1M.B/;Y^6RZW?]=MBFK*][[=^RMO\ \#]%
M^FM<O#X(\%VVK>)M>M_"'A>#7/&MG8Z=XRUF'0-)BU;Q;I^EV]U::98^)M12
MT6\UZSTZUOKVVL;;59KN&TM[RZAMTCCN)E?J**LD\W\-?!OX0^#/#6L^#/!_
MPL^'/A7P?XB>Z?Q!X4\.>"?#6B^&]=:^C,-Z=8T/3=,MM,U/[5"?)N!>VLPE
MAQ"X,8"C:\$?#_P'\,]"B\+_  Y\%>$_ /AJ&XGNXO#_ (+\.Z1X7T2.ZN2I
MN;I-+T2SL;(7-P54SSB#S9BJF1V(%==10!^:_P#P2[_Y(_\ M!_]G\?MT?\
MK2'CJOTHK\U_^"7?_)'_ -H/_L_C]NC_ -:0\=5^E%*.R]%^0!1113 ****
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MC^QQ\$;O]GYX[L6OPJL_'WC:P^+4$CZ8T-B\_P <YM.U'PG<K;:P4U"ZC3X
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M%NL?L_WOA/QQ;^,)_ =_?W4!M/%EKXG;P1]DN["VU;4;*PEU&]ATF[@M[DQ
M'\2WPK_X(R?M _M#_"[X+_'_ ."7P#^'/[3.L?&[Q+J^GZW^TBG[3=Y+X?\
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M^>7G^D'T!O\ =/$O_L(X8_\ 3>=&K1117\VG^B 4444 %%%% !1110 4444
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MT)XUO/[&\4Z']HN_[(U[3O-^RZIIWVJX^R7D4L/G2;-Q_5*B.R]%^0!1113
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M[*'_ "E$_P""MG_8(_X)^_\ JDOB%7ZJU^57[*'_ "E$_P""MG_8(_X)^_\
MJDOB%7ZJT#>_RC^2"BBB@1_F-?\ !W)_RE;TK_LU;X/_ /J4?$ZOY?*_J#_X
M.Y/^4K>E?]FK?!__ -2CXG5_+Y6,_B?R_)&,_B?R_)!1114DG^H)_P &F?\
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M<V_/+S_2#Z W^Z>)?_81PQ_Z;SHU:***_FT_T0"BBB@ HHHH **** "BBB@
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MN?$-S<Q>)O&L/B'Q,!'JEY++IEHVK&TT6W6WT[1K>PTZSM+2#[Y
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M_)^/Q(_[%?X:_P#J#:-7Y=U_?W G_)%\*_\ 8@RK_P!0Z)_A)XY_\GD\3O\
MLM^(O_5EB HHHKZL_*C^T[_@DC_R8'\#_P#KM\2/_5I^-*_2*OS=_P""2/\
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M*_I'_B(O W_1491_X4KR\O-'^=7_ !+YXV?]&SXK_P##=+_Y(/!W_(W>%O\
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MO$EV-5OS-C3[5=,9)S%-OFA"9/V-3!IK<****!!1110 4444 %%%% !1110
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MK\JOV4/^4HG_  5L_P"P1_P3]_\ 5)?$*OU5H&]_E'\D%%%% C_,:_X.Y/\
ME*WI7_9JWP?_ /4H^)U?R^5_4'_P=R?\I6]*_P"S5O@__P"I1\3J_E\K&?Q/
MY?DC&?Q/Y?D@HHHJ23_4$_X-,_\ E$KI7_9Q7QG_ /0?"=?TR5_,W_P:9_\
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MSKFN:A::5I&E:?:H9;F^U+4KZ6"SLK2WC4R37-S-'#$@+.X S7+>&?AS\-M
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MAU+%/&'P]U"S\,>+M.^&7B;3OBAJ]VD.J7US;B?6$NV*ZUI^IZAJ#7GZ._\
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M3RVZ'YT?!GQ7_P %+_AK^US^VE^T3J'_  2K\97^B_M,VG[-EIX?T&#]L/\
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MFM?%HT<6^GBQU;QM<W8N+/\ LQ_.F,GER>:NQ1M.?U4_X:\_X*)?](C?'_\
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M?^$@\7:[XDB$%M>>,7N(_L\.KQVLGF,=\L+R+A&4#ZB_X:\_X*)?](C?'_\
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MN9G["G[.GP=_;\^$?P\_9^^/X_:]_9A_X*)_\$[-*N]!\1?M#_"GXI^(M/\
MB)J^A_%'Q)XBU^\\8_#GX_:MIOC[P7XZ^%_Q4U.;6K_2- U"'51H5O#=V/@H
M6FE:7//;_P!$/[*?[)_P>_8U^%$7PA^"^FZW#HEQX@UCQIXJ\1^+=?OO%?CG
MX@^/O$@M3XF\?>._$^HG[3KOBOQ"]E:-J-Z(K2TCCMK:STZQL=/M;6TA]&^#
M?P:^&/[/OPR\&_!OX-^#M(\ _#3P!H\>@^$O"FAPO%I^DZ:EQ<7CQHTKRW%Q
M/=7UY>:A?7EU-/=WVH7EW>W4TMS<S2OZ;32LE_7]=%YV!N[?2_0***_,+]K?
M_@J%X$_9;^,T7P$T+X!?M#?M*?$S2?A@_P ;OB/X>^ /A70O$=W\,?A$FMP^
M'SXU\06VM>(M"O-4A;4IDC32?#%MK.K&-HY&M46:/<Q'HG[6_P"URWA7X;?M
M!?#G]D'QW^SS\6_V]_A_\-M8\2^!OV8M=^+7A-?'EQJMO8Q:DDNK_#O3-9D\
M:/+!H;W.MZ+H]U8:1;>)KV#3M(FUK1K/56U>U_FI^#_[=O\ ;_['W[/WQH_;
MV_9:_:(_:S_9(\ ?M(Q>)?B;^V-\</$OAC3+[P+\==>U&[\+^+?)_9JTF#^T
M+S]GSX6^+O$6M?#_ $G1_$5QJB27NF2K%ID9;3M,MOF?1?A#\!?%7A[X[^-=
M&^$/Q0_:K_97^//QK^(/Q[_99_X*$?L:^!-;U_\ ;Q_8Z_:+\2O#J^J_!G]H
M+PWX>AE^)4\_A+Q/+I_V8:LMSH^HZ3?_ /"1QQP6/BXKH']"/[)O[ 5O^V#\
M /V/?C]_P4G\'?$O6/VC? ?@+PW:^(OA7XD\=>+_  ]\*]>NO _B[7-7\ >+
MOB7\ K'58? UYXVU"VN+'Q3X@LM<TJ[G36;V6RUA;K[,8%G5OJM/ETU\]-NZ
MZIWM6BZIJ_2]]K[7_P"#?[CU3]G/_@EF?V6_C=\3_#'PX\?^&_$W_!-OXO\
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MTV/:W79]5M;5?.Z^_N?)7[!W[ 5W^PC8>+/"^E?M;_M3?M"_#O5K#P]8^#/
MO[17C'PUXULOADND6\B:D_A75M-\*:%JRQZQ<.#]CFN!8V5G%% UO>WHDU.3
M]#:**HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ6T[MZECX<_"#X6_"&'Q3;?"WX?^$OA_;^-_%VK>/?%T'A+0[#0X?$?C371
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M5/%MM9^$[KQ1X\\&ZOK^FPR^'_$=OXFT:+Q%X3L].DTB"SL[J74]6S_V//\
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M^W;5ZW>FM]=?/N]>H4444Q!1110 4444 %%%% !1110 4444 %%%% !1110
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MJQW>HFV@^T>6$M?-.S37E;2UV^GXO8;T\NEO\]/7S3MM8_/K_@F-^P+^T/\
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MU']-Z**HF]_R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>nt10015006x17_graphic12.jpg
<TEXT>
begin 644 nt10015006x17_graphic12.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
M                                                          !8
M65H@        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($AE=VQE='0@
M4&%C:V%R9"P@,C P- !S9C,R       !#$0   7?___S)@  !Y0  /V/___[
MH?___:(   /;  # =?_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( 0($@ ,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,&5@&5E(965AD,I&0000002"#D5_ 1_P5!\1>,OV*_\ @I!^W';^"4?3[/\
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M\?+V34?#6NZFS+D-X?D\.?"GPE;@, \MW"Y#@Y7Z>_X(>76O?MD_\%(OVO\
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M-;KQ;=>*5.HZGIMMI5X-0M(;ZS?2KN^NIH8FF:&!99;>."$*JC\+_P#@C_\
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M&A:)%X%\/WB6TMP0RYGRIVU=_2R>O]=PY5S?W5;YMVLO5MG]38_X*6_"1?\
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M/\/V5Y?_ &:*"V^VW-MI\4UU]G@A@\]Y/*BCCVH.XHH%?IV_4**** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_B"WDU87C26Q&E16LEO%&]O-, 9#_1/122Z-W7:RZ6_R_KJ^;JDD^ZZ_UO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !115>[N[6PM;F^OKF"SLK*WFN[R[NI8[>V
MM;6VC::XN;B>5DBA@@B1Y9I9&6..-6=V"J2 "Q15+3=1T_6-.L-7TF^M-3TK
M5;*UU'3-2T^YAO+#4-/OH([FROK*[MWD@NK2[MI8[BVN8)'AGAD26)V1E8W:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+;_@I)I'QIT[_AI?QK\,M(_:.^!>H?&;X(Z%\,_ /A&3P;K_ .Q[X0^*L?Q
M\3^'O$GQ)T*T&F^"9OBEJ.A:U;_#L>+?$M]I.BZ7=V/A;4M9N[J&3^CVU_X]
MK?\ ZX0_^BUH3O\ =?[P>BMV;_0GHHHIB"BBB@ HHHH **** "BBB@ HHHH
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MP5I/BB[U.Q@T635B4@%A:7VFJ^_EO_6WKKIU*<;6\WI_GHWW\S]3Z\L^.?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQXDN/'/CG6IK\:5!X-^'EE<^+?$FGI?V-DU[>PZCK-YI^C.ET+C6VM$AG?\
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M&6Y^/_BJ2Y_9:@^ &G?"WQMX5N]>_P"%0:_\((?%-AHOQ!N]0TR#PWXCEM=
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M /[)_P#]Z."/"S__ '2E_P!A$?\ TW5/S8HHHK^T#Y,_U5/V!?\ DQ3]BO\
M[-+_ &<?_5.^#:^M*^2_V!?^3%/V*_\ LTO]G'_U3O@VOK2O\L\\_P"1UG'_
M &-,P_\ 4NL?HM/^'3_P1_\ 24%%%%>66%%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_(_\
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M+]GCXS>)_#6IW6C>(-"^'?B?5-'U:QD\J\T[4+339I;:[MI,'9-#(H=&P<,
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MK=U_Z8M$K_3AK_,>_P""PG_*3/\ ;'_[*W=?^F+1*_H_Z-'_ "56?_\ 9/\
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MC]FC_LW_ .#7_JNO#E?0%?/_ .R;_P FL?LT?]F__!K_ -5UX<KZ H$%%%%
M!1110 4444 %%?%WQO\ VRA\!_\ A8.I>)?V:?VF?$'@KX:Z3J.OZ_\ $;PA
MX1\#ZGX-FT#2-'&MZKK.FW-[\1-,U>ZLM/M%N%N!)H\%QY]I<1Q02;4:3K_A
M/^TKK'Q3\1Z7HDO[-?[1WPYTS5M.GU.#QE\1O"_@K2_"D,,=G]LMHKF[T;X@
M:_J*3Z@A2*R1-+D5YG59GA7+@O\ U9_UU_JS'RNU^GJO\SZBHHJ&YN;>SMY[
MN[GBMK6UAEN;FXGD6*"WMX$:6:>:5RJ1Q11JTDDCD*B*68@ F@1-7QO\-?\
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M?Q\_\'7?W_V"_P#=_:B_G^SO7]@U?Q\_\'7?W_V"_P#=_:B_G^SO7ZQX'?\
M)T>%_P#NM_\ K.YN>;F__(NQ'_<'_P!/TC^/VBBBO]"#XD_JI_X-7/\ DN_[
M5W_9)/ W_J8WM?VOU_%!_P &KG_)=_VKO^R2>!O_ %,;VO[7Z_@/QZ_Y.7F_
M_8'E'_JMPY]IDW_(OI?XJO\ Z<D%%%%?C9Z@4444 %%%% !7\C/Q_P#V]/\
M@I3^S/\ \%+/AO\ LMZU^U';_$?X3ZM\;O@EH/BS7;K]GG]GOX<:,^A?$[QU
M\-UN_AWI$MWXCU;QUJFIQ^$?B)90:=JVDVYUS7(M'\::MH5K/_P@WB:YTS^N
M:OYJ/VB_C-\5-?\ ^"N%]\(;OQIX]D^'7PZ\??LB:MX7\)>&=:_8D\)Z+IE_
MXCMXKC5-2U[2?COHMS\;O&J3MJ>JP6_B/X7ZJNKVEEJ.N>%?"EO8:ZAFOD^F
MKW6W7UU5EIOK]S8UUT6W7Y;>>I^E'_!7/Q+^T+X'_80^.'Q _9T^+MK\%?$W
M@#PQ=>,_$7B^V\./KWC"Y\,:!LOKOPWX%O9-4L=/\)ZUXDN8[;2+[Q9>6.M7
M6CZ!=:K+H5E:Z^VF:MI_X,_MG_M_?MN_"C]L']H"T^#GQU\=7GC+P;X"\5>&
M_!O[+L.C^'/$7A1/A)9_\$W].^/?_#2T?AVY\,WVK:AXF\-_'Z\>]B\4/?2Z
M1=RQP_#O4[*^L(;_ $N\_L-N[.TO[:>ROK6WO;.YC:&YM+N"*YMKB)QAXIX)
ME>*6-APR2(RL.H-9Y\.^'SJC:X="T<ZT]A_93ZN=,LO[4?3,Y_LYM0\C[6UA
MGG[&9C;YY\O-#7G;57\TN@)V5K=_QMY>1_,7\%_CY^T5\5/^"1'_  4K.D?$
M<?MB>$O!%G^TQ\/?"/QW^+?CN'0?$.O?!Z^_8T\$>.?$^K:?K'A?X?:G8>/=
M2\)>//&OC?2=(MI+70K62*WC\,3:[:R>'Y67]\)_%7[5\?[/FC>(],^#OP=N
MOVCY3;KJGPON_C-XBM/A?:6IUZXM7FM/BE'\+;G6[R8>&$L]76"3X>VJG5I[
MC2/.\BW34KCB?V\M%T;P_P#\$^/VW=,T'2=,T338OV0_VFY(M/TBPM=-L8Y)
MO@WXVDF>.TLXH8$>61FDE98PTCDLQ+$FOLNU_P"/:W_ZX0_^BUH2LDNRL-NZ
MOWE)_D>9>,]8^,=CX\^%VG> _!'@?Q#\.-7N_$:?%_Q1XB\=:IX<\3^"K*UL
M]/D\+3^"O"]GX0URR\;SZO?2:G;ZM!J7B#PFFD06MI<03:BUW)%;?+_[6'[6
MGQ*_8[^''[4/[1'Q)^#_ (9U[]G/X#?#'3_'/A/5O"'Q(NI?BGX^U<-H5MKN
M@ZKX+U3P59>'_"-G8W^HZC%I^KQ>,?$$E];6-K/+IUJ]])!9_>E?DQ_P78_Y
M1$?MZ?\ 9#-3_P#3[H5#T3?9,G^OZ]?^&L?SY6/_  >>_"YO#FNRZE^Q)XYB
M\6)/?#PW:6?Q4T.709[8*G]G-K5[-X9BO[>9W,@O%LK.X1%5#"S%B%-0_P"#
MSWX7+H/AZ32OV)?',OB:2ZL!XJMK[XIZ'#HMK9M%(=2;0KJ#PU+>W=S'.(EL
MDOK:UCDB,C3-&P53_ 7167/+O^",O:/M';S^_??\/(_TY_\ @GO_ ,'+/@3_
M (*)_MK?#']D_P"'/[+_ (J\ Z7X[\/>,=5U#QMXP\?:5?WVE7GA+P]K'B*2
M"TT31]#\B]MKNVT^WMU>74;:5)IY6*E(D$G]#/A37OCW>>,?BI8^,_AU\.=#
M\"Z/)&/@YX@T+XDZSKOB#QO$8KDR/XX\/77@/1[3P*ZS+:HJZ7K7B\%)IFW$
MP*)O\PG_ (-@/^4QG[/O_8G_ !H_]5?XCK_5>K2+;C=[W:^Y+_,T3ND[)7[7
M_5L^'M6^//[0,'PE\2VTO@+X5>%?VD(+75;+1=&N/%7B;QQ\(-*UU7,.F7.L
MZQ::+X(\5Z]IMKD7.H6.G6.@W%^(C96NJ:>9Q?P?,&K?&#_@IO%-X(&A^.?V
M%KV"]DMQ\17U+]GWX]Z?+X?B9+$W+>$4MOVJ=07Q/)$[ZBL*:J_AA9EM[-G>
M$W4JVOT=X^_Y'7Q1_P!AJ_\ _1[5R-5\OQ?W[_\  \AINRVUL]EY>5['9?##
MXZ_'K3M6?3?C/#\)/%^BFTN[F/Q=\,/#_C#X<WRWK/:K8Z0_@'Q7XR^*<3P0
MHM[-=Z^OQ#1KAI;6WA\/6H@EN+GW7P1XH_:#UC3?BK>^,/AG\-- FTZ[U%_@
M9!HGQ/UK7D\>Z/\ V?>7&@W?Q!FN?A]I!^'M[?WBZ;;ZC9Z1'XVCT^&YNYX;
MB^:TBBN_EBOT,T/_ ) NC_\ 8+T__P!)(:.GZZW_ *_$5]?EZ;65].]]?PL?
MC=^W/J?Q-UCP!^S_ *E\9/"?A3P/\2KJ'QZWBCPKX'\6W_CKPMI,\>J:=#IZ
M:3XKU/PUX0OM7CN=(CT^^N7N/#FFFUO;FYL$6YBM4O+C\W*_63_@IY_S2#_N
M</\ W 5^3==M/X(^@PK]?_V$+WQQIO[-/Q>O_AIH'A_Q5X_M/&6KS^$?#GBK
MQ#=^$_#FM:Y'X3\,FQT_6?$EAHGB.\T6PN),)/J%MH6JRP+\RV<O2OR K]KO
M^":/_)'O&_\ V4J[_P#47\,4JO\ #E\O_2D!M?MB^(/VA1^QAK]Y#\-/AH_C
M/6_!=];?&[0I/B=K::%X!\-77AK59/%&J^ =>'P^>Z^(&JZ3J4>GVNDZ3JNC
M^"X-7MKFYN9]2TU[9(9OY-Z_LY_; _Y-;^/O_9+/%_\ Z:;BOXQJXQ]%ZO\
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MA1X!:[DO_'6@>(3.)/"FK:?/%!KD$4\T(C2)C7N/C/\ :UL?!GP4^&GQL?\
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M@A?1-5M+^QG+R6LAKC/!'[4=GXX^#GQ:^,D?P%_:B\+0?"74?'VFS_#3QO\
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M(]QIGBG4K;3=-U73M4L9)M.N?PB_:B^&3W?_  6<^,GBWQA\-O#\VC:IXO\
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MRR2.G[4$NF_!T?&>%7UX:PL,=A'\,D^&)CBL0?#R%_ 32G2B7:1M1Q>US?\
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M>O"_Q!TA=)6^_:;T;3?A#)\8_$)TW4Y;^Z.JV.I_#6_^&:'6+:1-*O\ ^SO
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M_P %,/C'\+_A?_P49^(?B%/!/CFSUSPAH?[(T/Q;@\*_MQ?%/X!?%CX^Z?\
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M'O\ L.:3_P"E]O6'6YX8_P"1E\/?]AS2?_2^WK,B.Z]5^9_N7>%?^18\.?\
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MW_;YMM>O9+ZXCOK72=&BCM[<VCO/]U_#'_@JE\5_A[HOA3X;?#_X)?LZ>!?
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MOV?_ (->"?A-^R5X]_9\^$W[4^G^*/''Q*\,_"C4?$6O?M(:!9^.?V@-:L_
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MUI\)?A?X\^$^A?#G]H#P%\-+[4O&GA;Q%J6@^*/#&K_$Z0?"Z;4? /AR[L?
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M4P_Y1Y?MM_\ 9KOQM_\ 5?Z[7^6O7]E_1G_Y)SB/_L=T?_4"B?*Y_P#Q\/\
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M*>$:_$ROVS_X)I?\D8\9_P#93]1_]13PC2J_PY?+_P!*0'UA^T9_R;W\=_\
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MT]K>>Y8?MK'X._;LCCCC'QN_9L(1%0'_ (4-X]Y"J%_Z+7[4+5)[7_KI]_\
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M^-SJ=_I'@3PQI?A;3;W43;_&>*W-]=6>E0SW9@BBA-Q))Y4:)M4;7BOX<?\
M!176([)?#/[4'[.'@^2!YVO)8_V9_%&O&^218Q#&4U3XU%;80,LC;H?FE\W#
M\(M?PKFE>GBLSS'$T9<U+$8[%UZ3:<7*G6Q%2I!N+2<6XR3:=FG=,^P@FH0B
M]&HQ3]4DNA]X45^"WQZ_X)N?MR?%%?'?C_5?VO/!VM_$"^\+ZD=/L/!WA?\
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M&5E8'!4@C@U/]??M]X6?9_<?I%^S_P#\>7B;_KZTS_T3>5ZSX_\ ^1$\:_\
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M+;^9OK_5M3]+**^7OAEXA_;2U#Q?8VWQE^$7[+WA/P$\%ZVI:W\,OVB_BO\
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M$-O;1KKY?\-W_3;6]]E322ZW=GVLOZ].^V_NU%%(2%!9B%502S$@  #)))X
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M3?$VK?%2;QY!\(K#X2^!/A+\1/B-X1^)_A[]EWX32>*9O'S?!+P+XS\*^ ?
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M>*O#5_\ &O0/)_:,^(=EXLF\4VGC_P#9W_;P\&^+O ][X+^*<OP$\>0:7?\
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MIVNGW,D5H]Y=6OTU;PV]O;P06L<4-K##%#;10*J016\:*D,<*( BQ)&JK&J
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M#5=+CE@GBNHH37KM?S$_LX2:K_P4[^)R?M(V?[.WQ2_97_:C\+IHOB#X,_\
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MM^$=;^+/CF_TCQA=?#S1/%5KX"\2:5X#DO/"%_<>/?%UO:^&- C::6[OM/\
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MNN_L_P!]>>$);BZT+XZ_%7P;?:XGPZT[Q+>Z/:V4FE7FJS6.NO:QZ+=?&?\
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M%CN[M_*L[-M6U^^T[38[J\FQ#:PRW4;32':O0D?C)X1_;7_:DM?VFO''@/\
M:P\*>#/V??"O[3_PH72/^"=7@OQ??^'?&GP(\8^-K*Z\5_;O"GQY^*?@^VU6
M]3XY^-+"3P_KT7@?PYXFE^'FH_#"6+3_  7<>(?'%OK-U<L/7;^O)GPW^UM^
MW[HWQPU#Q1\>(?BQ\4O _P #/A)X2_8S\::E^Q5X[\!0VL?QY_9L^.OQW@\+
M?'7XL^/_ (:3Z?XP\,_M$_ [XC?!_P 9^$O#'A@:!K>I7O@KQ3)=:1KOA_PU
MX@U/2I_$'ZC_ +$?[(?B>U^/WQK_ &[_ !?XG^,_P\T;]IO7K#XG>"/V.O%9
M3PE9?"+4]9^$WPJ^&/B36OBSHWA[7+W3O&OCG6=-^%&@77AO0M;@CL_A;ID[
M67]G'QA+?7>F9_[&/_!)/P3^S'XV^%/Q:\6_%7Q?X_\ %WPM\!>*M#\'?"S3
M[3P_I'[/7PH\5_%1_#NH_%R^^$&AW^BZI\4-)\':UKGAJRU+PG\._$?Q-USP
M#X#U"[UO5?!GA+PY-J5A:Z%^OM+7K^']?\#KN]!M=--/T\M[]6]_+J445X?\
M?/VA/AY^SEX(N?&GCN76=4N&#1^'/ /@G3/^$I^*/Q OXI(/M.C?#CP#9W$>
MO>-]:LK29M4O=,T*"ZNK32+6]U*=$M;660,6YQ7[5W[3MA^R=X'TKXJ>*/!V
MI>)OAEI>K7<WQ=UW0+RXN_$7PS^'UGH>J7M[\1K+P-I>C:UXA\>Z3H6K0:2G
MBZPT..UN?#?A&ZUOQK/-<VOAR73+_P#+3]@[]JO]K/\ :G^/_C-O%NK^"O&7
MPBUV76]*^.W[.E]'X<N+'X > O&V@^(]?_9N^-/[//QFT72-,TK]J'X#_'CP
MQHTWAW5;ZXM[;6(-<DO=>BALK&WET2'Y4^$S?&W_ (*A_'CX_P#Q@^#?QG_9
M_P##?CGX9:M?_LQ^)_$-_P"!/B ?'_P/^$^J>+==\?\ PD^.O[,EKXM635?A
MO\5/B)\#?'.H?#GXU^!?B!HUJDWQ)\&W<UY/IUAH\?AB'^ESX9?"KX;_  8\
M'Z;\/_A1X*\._#[P1H\FHR:3X5\*Z;!I.AZ9_:NJW^MW\>GZ?;*D%G;S:KJF
MH7HM;=([:&6[F%O%%&P0)7;WTTVZ[:736FFJ=_RM3LEY_-6V:?KT_-=Z7P9^
M$/@7X!?"OP)\&/ACIEUHWP^^&WAVQ\*^$-(O-4U'69M,T+3E9+*P74-5N;N]
M>VM(V\BSMS,+:PLT@L+""UL+6VM8?3***9(4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(2%!9B  ,DD@  =
M22> !ZFEK\G/^"M6B>(]0^''P!UG6_"OQ9^(7[+GA7X_Z+J_[8WP_P#@=>>,
MK7XBZY\&KCPIXITK3];^R_#N^T[QYXB\#^!O'E_X9\7^/O"?@ZZ3Q!K.AZ7Y
MMI%J$.GW6D:D M6AW_!13]O;0/@IX>^+/P*\$ZI\6?#'Q6@^$6C^(O$?QZ^'
MGPQMOB9X'_91M/BIK>L>"/AA\1?C!:OJ,%[;Z'?^)='U*:]BT/2]<U;1/#EC
M=^*KJULK*.QNYOC3]AG_ ()*^'M8U#X8_&_X]>"_'7PJUOX::C+J]K\#[SXA
MZ_XV;0/V@-#\0Z7+XU^-_P %OVB=.\?R^/KC]G7]I-=-?QEXN^ _C:VU#2-?
M\0WUGK.IBUFTD0ZIZQ\ /V>/@5_P43\<_$CXY?$G]G;Q/X:^!7PQU3P-\!OV
M4_%=SK/[0WP6\1?M+_LY> ?"OAWQ+)!\>?AOXG\4Z'K/Q%\!>'/C#>Z\? \O
MQ"\/6<GB&WTZY76-)N[5M3_MG]T8XXX8TBB18XHD6..-%"I'&BA41%4!555
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M\1>,9[OQIJGPO^#LGQ*U_P ->!)/$EPFJ7>F!;Z^M+)Y8-.L/OZBD) !)(
M)))P !R22>  .23TI[$[BU^??[='_!1#X/\ [$GAC5H?$+7'B'XJ2> -8\=^
M&_!ZZ/XW?PIINDVNH0^'-(\3?&#X@^$?!GC/3/@U\-]5\97NF^%/^$_\86<&
MC1:M>"$,R07<UM;_ &U/V\_AG^R[\/?$FG^&/%'@#QM^T]XB^%GB?QG^SI\
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MVS?@];ZOK/P3\9:W\2/V<OCS^R+\._#4OQ$_:J_8>\6>'O%6N^$_A]\:M$\
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MJO\ S5>"OAK\;?\ @K-\>)OBA\5/#NIZ_P##Y?$_BG0O"]IXO\*>)/ 'PR\
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M)J.HZAB%+2RMK:SB^B:**9 4444 %%%% !1110 4444 %%%% !1110 4444
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M/]EZ?J]YJ4NG66G::VGZ5IWVY113_33[A!7YT?\ !27X\:7X ^$>E?L[Z=X
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M1(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5E)\=_A9IFD>$-%UKX9^%?B#X&TC2O#>IZC<^/[_ $/4OB9JEYXK7]_0
M  , #@ #H .P%       & !P !T '8"BA*RM_5_Z_#3H#;;NPHHHIB"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
<* "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>nt10015006x17_graphic13.jpg
<TEXT>
begin 644 nt10015006x17_graphic13.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **_F[_X.8OVQ/VB/V-/V//AOX]_9Q^(VJ?#7
MQ9K?QHT'PYJ6LZ1%9R75QH]SX8\97L]EF\M[F-8Y+K3K.5BL88F!1N R#_#-
M_P /\?\ @JW_ -';>._^_&A__*JI<DG9WZ?C9_DQ-I;NWROV_K^M/]=VBO\
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MP\;NVL!K/BG6=.T+33>WLT=O:6HO-3N+:W,]Q/+'%#%YF^21U1%+, ?Y@O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)P@).30KWVLK6W3[::=OZ[$NW>]]_P"O^"_U?V!1115""BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=,BF,:*9$L( Q/E)A)O2]K/7S2W3UW_#=!96^:_%?\!]-/.]U^V?Q\_X+?\
M_!.;]G/XAZQ\+O'7QK.J>,/#E[+IWB:Q\&:+/XCM_#M[!(T-Q;ZM>QSVMM$]
MO*DD<I@>X561@&. 3]O?LY?M;_L\?M9?#D?%7X!?$_P]X_\ !2+)]OU+3IVA
MDTB6%6:YMM6M;E8IK*:VV2+-O4Q90M'+)&5=ORP_8,_X(W_LU?L%?L[_ !0L
MOVD!\._CAXI\5WWB3Q1\4OB]XV\.Z<&O?#LP>[^P7UWK$,DQMK-?-;=+)F61
MD54)6-:_&#_@CK\()?C;\<?^"MO@']COQ!=?"O\ 9E^(.C>,O 7PU\5Z;974
M'AW1?$>HZA9Z5!?>&HH8XHP+91J;P/9HDD%GYFW#X0I-W5[:].J^?7STW?8=
MDT^G6[VZ:;>?1?>?OA\5_P#@O-_P3-^$'CO5OA[K_P =6UK6O#]^VE^(;SPE
MH%WK>AZ%?QL!/;:EJAEM(T>V#!IS EPB*>&9LJ/T>^#'[2'P0_:#^%MG\:?@
M_P#$;PYXV^&5Y;W%POBO3;O;86RVD23WD=]]H6&6RFM8I$:>*XC1D# C(()_
M*7]EC_@DU^Q/^P3^Q=XC\&_M)Z)\*_B$LMIXD\4?'?XO>._#VEB#Q(]W=7UY
M/=7<^I6TUUY%MI?V> 0 /-//!+-'"TLI!_ __@E!\,?C)\4?V#/^"QGA_P#9
MD;7_  K\#?']Y>:9^RU#?WC:1;6>N6EQ>7/BQM/NGGCAMY+O0!X?M9;N%U@D
MB-M%Y[*C!'=W2WO=V731:?I?J]M 23VTU];IV7EMOTW7?3^A[Q;_ ,%^/^"8
M'@WXA7/P[U#X]B^N['4WTC4O$VC:!>7_ (.TV^CG^SM'=ZT)(I%42@J)(;*9
M& )4D8S]\?$/]LS]G'X9_ )?VGO$7Q(TJ?X)2Z?I^J6_C?1A)JEC=6.J/!'9
M36\<069O.>YA4HZ)(A8B15*L!_!S^RC^UK_P2G^$O_!*GXK_ +-OQ^^#UDO[
M5\&GZKX8\46&I>%+'6=<\0?$1"+73-6TWQ9;QWME9I::DL]P[S:I;L(VD$2R
MF8J?Z)_^" G[+?B'6/\ @EKHOP]_:J\(67BSP/\ $#Q)K7B;P=X'\8FR\2V=
MIX#U'5[[4= MY8II+^U$4EK+974,18F,;"RHX("3OI=;7TZ>3U_5 TM];:>?
M;\?B\KJQ]&?\1#/_  2JV[C^T(RKC.6\,ZF !C.23QT[YQ7W?^R)^WK^S%^W
M/HOB;Q!^S7\0(_'FE^$;VUL->N([*:S^QW5XL[6\965F+;UMYCD$8V$&OYV_
M^"[WPM_8I_9(^ WA#X&_L^?LD_!V]_:F_:QUJ;X7?":WTOP5H,>K:))J3V6E
M3Z]920V2S6VJQW&KVRZ(^4$MU#,%D4QYK]I/^"2'_!._P/\ \$Z/V3/!_P ,
M-'MX+OX@^)K6U\6_%3Q-Y"QW.L>*M1M(7EME)421V6F1X@@M\^6D[W<J*#.Y
M83=[.VB3=KK=7Z[_ -.X.UM+_P!6]?/SU70_4:BBBJ)"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK^9?_
M ()L?\% /VG/CW_P6<_;Y_98^)?CM]<^"_P;\ >+=9\ >%39V\$6BZAI'Q7\
M'>&+.>.:-!-(5TC5+V!Q([;VF+GE5 3:6_5V^8']-%%%%, HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HK\"O^"0/_!57XT?\%!?VA?VYOA1\3O"'@+PWH'[,VO>!M,\&
M77A'3]7M-2U*W\3WWCBUO#KLVHZYJL-U)%'X:LC"]K;6 5Y;@LCAD$?[ZTDT
M]4'5KMOZA1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** /Q7_X+@D#]FCPGD@?\7)T8<G'/]D>(>*_E&R/4?F*_OJ^/W[.?PT_
M:4\*6?@WXH:==:EHECJL&L6\-K<"VD6]MX+FWBD+F.3($=W,,8'+ ]J^/O\
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M7O\ @WX^"/@G]G+_ (+E?\%%/@M\.8KZ#P7\/_@AXS\/^'XM2N$NKV/3]/\
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MH HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_;A^-?QC^+O['?\ P3*_94\=:I\._$_[5T'A/6OB#K6E2W.FZJVB?$F/2E\
MZ;::S:+'J%A:S*WB!M3-E<0S,ZV!9\1E#B?M7_\ !LW\-/@O^R/X\^+7P"_:
M#^.$/[4/PF\(W7Q#;X@:IXQU6+_A,V\*6QU77;+54@OP;6+^S;>_U"S>S2*9
MKVUMH)#Y,LJGXO\ VES-H/\ P<B?\$NG\2/Y\-Q\(?V)K&PGF'E107K+?[.6
M^7S+< !R,$@ '&*_N(_:?GMK7]FK]H6XO&1;2'X'?%B2Y,F"GD)X#U\RA@<
M@H"".^<=Z=DW*^O3]?SW\^BZTOLZ6UM^$=5][UWV[(_&+_@V\_;[\??MS?L(
M+%\7=?O/%7Q5^ GB-/AMXJ\3:A##%=ZMI;I>W/@U[N6&WMUO+VU\,V=E;7U_
M,);V]N8Y+K4+FXNY99G_ * #JVE*2K:GIX8$@@WML""#@@@RY!!X(/(-?QI_
M\&@>C2:W^SG^WUY-Q-::'XG^-NAV6F36_P"[*P7O@[6+9;RT?!V/;1R$1E<A
M7P>HKVOQ9_P:Q>$?%'BGQ+XF?]N3]IJS;Q%X@UG76LX?&4XAM6U?4;G4#;1
M6F!% ;@Q1@<!% %.+=EI?YVV=NSZ7_K0C_)?/3?Y[GBG_!L(RO\ MJ?\%=61
ME96\7?" JRD,I!U?XM8((R"/<&O[/*_B(_X--?!"_#7]I/\ X*B^ DU6^UM/
M">I?!/1%U?4I6GO]0%EJ?Q:C%S=S-\TDTG5G;D]Z_MWHA\*^?YL/M2_Q?H@H
MHK^&+_@YI_X*@?MS_L6_ML_"WX8_LR_M ^+OA1X(UK]G3PQXQU30O#R:4;:\
M\1W_ (]^(^E76IS->Z?=RF:6PT?3;<@2! EJF$!+$MNRO_6X:6;;LEOUZI?F
MS^YVBO\ (H_XB /^"NO_ $>E\3?^^/#_ /\ *:C_ (B /^"NO_1Z7Q-_[X\/
M_P#RFJ/:+L_Z_I_T]%S0_F?_ (#_ ,$_UUZ*_P BC_B( _X*Z_\ 1Z7Q-_[X
M\/\ _P IJ/\ B( _X*Z_]'I?$W_OCP__ /*:CVB[/^OZ?]/0YH?S/_P'_@G^
MNO17^11_Q$ ?\%=?^CTOB;_WQX?_ /E-7]'?_!LC_P %/?VY_P!M7]M[XM_#
M+]IO]H+Q?\5_ ^@?LS^)O&FDZ!X@32A:67B:Q^)/PPT:UU6(V6GVLPN(M-UO
M5+509#&8[N3<A8*5:FFTK6O_ %_7]6.:+T3;?I;]3^YRBBBK&%%%% !1110
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M_P!!&/\ _!M+_P"4GP__ !'7BK_H"R;_ ,)L3_\ -G]7?E;_ $FF_P""Z_\
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M3QCXQ^)DGAZ^\1Z]<W^P+I^H:E!I&DVU\UU<F.TL+'[((S<7)"1EI"#^$O\
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MEC:^*OMMI)!:2.VR*T-OX=L7@MX$CAC!9E4>8<B;TNT[J^BMV_S!I6=M+?\
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M]<QWEA=_V:FG7%O86'AEKZ:RBN-0U*.WU)Y'@6/[*YD6:']B_P#@L#_P2?\
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MB $7<(ICE=V!R*^/OVD_^"R?_!PO^R7XN^'_ ,/_ (Y?#CP3X3\>_%&\ALO
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M**Q, HHHH *_K3_X,ZO^4C7QS_[,^\8_^K<^#=?R65_6G_P9U?\ *1KXY_\
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MAN(9K>9/AKX=#PW$4D$R'^S+7AXI5213[,H-?;G_  I7X2?]$Y\'?^"#3?\
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MPSI E@B=+[0;5KAYUCB\Z:**XDGN)<, \AQW7_#DG_@EE_T9;\#O_"&\/_\
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M0)<RJ& =LNS;5VM+VT>[25]_O2^71)W6UG9VOK;;]/)W]3^(#]F'X^?L?_\
M!2+]H,_MN_\ !6_]L[X>>&]%\/:V]W\'OV3'N?$]WH?ARRCNA/IZ:\+;0[JQ
M2WLX8H5GM+>V$U_>@7$EQ MNT=S_ %J>-/\ @H!^R[XN_8J^-WQ;_9*_X07]
MJSP)\'? >KV^L_#?PG/J6CZ3<:+I.DRPW>@31WGAU[BWMETF&:/9'IDX>",B
M/=D-4?\ PY)_X)9?]&6_ [_PA?#_ /\ *ZOK;]GS]C/]F+]E;P[XC\*? #X,
M>!/AAX?\72-)XETOPMX?TS2[76F>(P,-1BM+:%;I/)8Q;)@ZA"5 P3E)-=5K
MVO>^F]]'U\O+45[VNM5;KH]KZ6NNO5]%MM_'Q\,-._X-S?%?P4N_VXO'?ABT
M\$>/?L&N^(?%W['\/BF]U+3[7QK9W]^?^$8L/#Y\.Z4VIW6MF&VNK=Y=4LK?
M-_'#.UOY;A?U"_X-B?@'XK\#?LB_$SX\^,_#<OA.]_:(^+FM^)?"FCO:R64;
M?#W3;6TC\-:A%:RI') D\]]JUL(2&5/L09))%?-?HYJ'_!&#_@F?JGQ E^)=
M[^R9\)Y?$UQJ+:O<2'PKHPL9]3>8W#7LMA]A^SO.TQ\QG9"2PR3FOTTT?1]+
M\/Z5I^B:)86FE:1I5K#8Z=IUC!';6=E:6Z".&WMH(E6.**- %5$4*!T%"6S=
MM.RUV2NW]]ET&Y777SUZ:;==U\^M^FE1115$A1110 4444 %%%% !1110 44
M44 %%%% !7\K_P#P<&?L@_M23?%?]D[_ (*0?LC^"IOBKX__ &2?%6G^(-<^
M',%G?:[?WL/AG6;+Q)X8OM,\,V+M?ZM$+Y-435H=&@EU*2)+-%"@AQ_5!7Y/
M_P#!5C_@J_\ "G_@E[\-O"6M^)/"6I_%3XI_$[4=1T?X9?"C0M4BTC4?$5SI
MD=B;^YN-0?3]7:TM+=]3L$4+ILYN6ED >)87:D[6U=MM?G\QK=?U_7];GX=Z
M7_P=A^(-"T6UT'XC?\$TOVCK;XH);+;WEKIR76C:3-JJ($E:WT/6=#N=<CMQ
M/]Z![QYP&"!P>:XC_@F1X,_;5_X*>?\ !6X?\%1_CS\%/$/[./PC^$.AR6'@
M70=:T76_"+Z^9O#9\&Z)HL%AX@>+6O$ANM&FGU_5=91+W08+^R\NWELEN]-M
M#[Y_P3D_X*Z?&S]KW_@H-HG[+_[3W[!OP\^!\'BWX7Z]\2/#4OB;X<#3O'JV
MEO=Z#_9&J?;=>@=M1TK4K75'DCNK?3[9+HJDL4VT8/ZUZ%_P4_T/1O\ @J)X
M@_X)D>+_ (-3^ 7B\ Z5XJ^%GQ,@\06DVC>/+V[T/1?$,V@6'AJ#0K,:?]CT
MB^U*66YCU:Z6&?27M'M@\VZ&59ZN5TFK:6ULO)=6_+;7N^_IK=6[/KK^73?6
M_P"NE%%%62%%%% !1110 4444 %%%% !7\8G_!'/_E8E_P""I?\ V2SX@_\
MJ^/A]7]G=?QB?\$<_P#E8E_X*E_]DL^(/_J^/A]4R^S_ (E^H']G=%%%4!_
M!_P>@?\ )8_V'?\ LF7Q;_\ 4K\*U_$M7]M/_!Z!_P EC_8=_P"R9?%O_P!2
MOPK7\2U8S^)_+\D9U?B7^&/Y!1114F84444 ?T/?\&M7_*9'X$?]D[^/G_JH
MO%-?T._\%</^3U/&_P#V!-$_]'ZG7\\7_!K5_P ID?@1_P!D[^/G_JHO%-?T
M._\ !7#_ )/4\;_]@31/_1^IU_-WTH?^2"RO_LI<+_Z@8\_J7Z)?_)QL?_V3
M&8?^IV7GYF4445_!!_HV%%%% !7]&G_!!O\ U7QO_P"NFF_^@Z;7\Y=?T:?\
M$&_]5\;_ /KIIO\ Z#IM?KW@/_R=7A7_ *_8_P#]5>-/Q#Z1?_)H>*/7*O\
MU;X(_HLHHHK_ $R/\M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#^*?\ X+@:MX\_8;_X+ ?LB_\ !2SQU\*_$7QA
M_9M\(Z"NAZC%967]H:9X2U*;PQJ/A.XM9&2"XATZ>*XGD\66TNHQB.>^\F.S
M9KN2%!^B*?\ !U9_P22;PLNLO\1OB:GB$V/GMX2/P?\ B"UPE]Y6_P#L[^V%
MT#^S&;?B+[6'^S9RP8J#7Z$?\%.O^"A'[#_[#7PNLC^V/#I?C"S\;K/;^&_A
M6?#>E>,=:\4%5F1[F#0M3W+#8Q/#*DFJI%(]K)&SQ(TD8Q^,G_!,OXW?\$9_
M^"I7[0'Q"\"_#;_@GQX=\$>+O GAF#QA'K?B1M5N+'6;":^>U93HD"Z5IVGS
M1N'D$;QW:NHV@*,5.S:4EJ]GK9_?U2_)#WUNE;T;LK)67-%^MN_;;YN_X(<^
M-?B!^W-_P6'_ &L/^"AWPY^&.N_";]F;Q%X;U71+BVN--:QTGQ=K.K+J:Z$;
MB_\ LMO8ZOXBTXO]OU1--8O917ME)=PQ)<0-)_;77YF?LA?MQ?L9^/\ ]H+X
M]_L*_ 'PG<_#'XB?LQZC!:>,O!;>!+'P-H5]-<"YMY[[PXMHT?\ ;36RZ8$U
M&[DMEF6+[(SRRHR[/TSII66]^_KUM\P;OO\ AYZ_F]NFSU"BBBF(**** "BB
MB@ HHHH **** /XQ/^#8;_D];_@KM_V-_P (?_3O\6J_L[K^,3_@V&_Y/6_X
M*[?]C?\ "'_T[_%JO[.ZF'PKY_FP?Q3_ ,3_ "05_FS_ /!X=_RD7^#'_9IO
M@S_U9OQ:K_28K_-G_P"#P[_E(O\ !C_LTWP9_P"K-^+5$_A?R_-"E\$O1?\
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M!2VWMMK\U^HX[K^NNGXV[>J/YV;[_@JI^P7KO_!?3P/^V9:?'/P[HW[/%O\
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MVG2_]V]%?PD?\10G[7?_ $2'X5?]_P"__P#D"C_B*$_:[_Z)#\*O^_\ ?_\
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MB:9X2;38?"WAV0)I4\<\=K.41)"UO;>9<"19%>/S0PK]2?\ @HM?_P#!.O\
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MDS"BBB@#^A[_ (-:O^4R/P(_[)W\?/\ U47BFOZ'?^"N'_)ZGC?_ + FB?\
MH_4Z_GB_X-:O^4R/P(_[)W\?/_51>*:_H=_X*X?\GJ>-_P#L":)_Z/U.OYN^
ME#_R065_]E+A?_4#'G]2_1+_ .3C8_\ [)C,/_4[+S\S****_@@_T;"BBB@
MK^C3_@@W_JOC?_UTTW_T'3:_G+K^C3_@@W_JOC?_ -=--_\ 0=-K]>\!_P#D
MZO"O_7['_P#JKQI^(?2+_P"30\4>N5?^K?!'\-7[0?\ R7GXU?\ 95_B%_ZE
MFK5Y!7K_ .T'_P EY^-7_95_B%_ZEFK5Y!7^[M#^!1_Z]4__ $B)_P T./\
M]^QO_87B?_3TPHHHK4Y HHHH _T1O^#<C_E&%X!_[*E\7O\ U*&K]VJ_"7_@
MW(_Y1A> ?^RI?%[_ -2AJ_=JOYIXC_Y'^<_]C+&?^GYG]\<$?\D;PI_V3N3?
M^J_#A1117BGU 4444 %%%% !1110 4444 %4KK4M.L65;V_L[-G&Y%NKF&!G
M4$C*B5U+#((R,C(([5=K^,7_ (.NOV0?CEXE7X+_ +;?PX\3^/1\-_A?X7T[
MX6_&#PQX)US5M*N=&T"3QEK>O0>,HH-/G$5S-=-XGDTVYN)+:0V5OI44LOF1
ME41-VZ7\OZ3_ "8?U_7]>1_9%_PD.@?]!O2?_!C:?_'JAN?$^@6]O//_ &SI
M+>3#+-M_M&T^;RT9]O\ KN^W%?Q&_LS?\&W/PZ_:G^ _PR^/_P ,_P#@H)\<
M-4\&_$SPQ9Z_IEQ#K^JRB&8M)::II[O'=E6ETW5;:\L)2,;GMRVU<[1[==?\
M&GMO!:W,X_;R^.C&&":4*=;U@@^7&SX/^E#@XP>:$V[:;_WO3^[Z_AVU-C]F
MO^"7?_!3?Q-_P4 ^)_[</@+7_A_X=\&6?[*?QVU7X4^'=1T&?4)Y/%&D6.K^
M(--@U353>ZIJ,1OI8]&BF9[%+.U8S/LMU4+C]B*_CM_X-4_AT_PB\=?\%2/A
M:VJ7^NCX=?M(6O@==>U,R-?:V/"M[XKT3^U;N24L\ES?_8OM4[LS,TLK%F)R
M3_8E0FVM>[_-_D 5\S?MD>%?VAO&_P"S+\7/"O[*'CC3?AM^T-K/A^TM_AAX
MWU>STZ_T[0-:CUW2;B\N;FTU>SO]-E6XT2'5+%/M=G/''+=1RA0Z*Z_3-%,#
M_-M^+O[)7_!<F'_@K'^SQHOC+XV1>(?VO;GP?KUS\-_C]8>"_"\O@CPEHD?@
M[6/M]KJE[8^&QX.A>?2!?:0C:G;&1;NXC1#]H>-C^P4W[%?_  =*7$4D$O[?
M7P\,4R-')M\/_".-MC@JV'B\*)(AP3AD97'52#@U]+_\%BO^"GW[5_P<_:]^
M"?["_P#P3W^#_@?Q]^T[\1] ;5]0\4>*O#MQKNHZ+93V5SJD6CZ(VGW6G76F
M%='2+6;_ %:YN[BQAL!=12V2JK7*?DWX4_;,_P"#E7QQ^U9XX_8ST'4/@LWQ
MZ\ >'+3Q=XF\-7&JZ59:59:/J%JM_ ;?7KC6AI]S.MM(A>V29I4)$9+2!@,[
M)-J\O57W=OO?Z>8[+3W>UM6[647_ #+1))^74_73_@D/_P $5/VC?V3OVK_B
M9^W-^VI\=M#^,?QY\;Z%>:'IC>'GO9VM?[=BN8/$5YK4]S9V]BIN('M$L+;2
M)6MXWCNI)(8C(ID_IIK^2K_@AU_P4 _X*3?M'?MJ_'S]G?\ ;@\3>#M%OO@?
MX?:V\2?#2[TB;0O&T?B&>;4H+>ZTVTNM1>>ZL+22Q+WTHLV187A?<@D5J_K5
MJHVMIMY]?ZV^0/IZ?/K>][N][O7O\@HHHJA!1110 4444 %%%% !1110!_&)
M_P &PW_)ZW_!7;_L;_A#_P"G?XM5_9W7\8G_  ;#?\GK?\%=O^QO^$/_ *=_
MBU7]G=3#X5\_S8/XI_XG^2"O\V?_ (/#O^4B_P &/^S3?!G_ *LWXM5_I,5_
MFS_\'AW_ "D7^#'_ &:;X,_]6;\6J)_"_E^:%+X)>B_]*B?R7T445B8!1110
M 5_6G_P9U?\ *1KXY_\ 9GWC'_U;GP;K^2ROZT_^#.K_ )2-?'/_ +,^\8_^
MK<^#=..Z]5^94/B7S_)GZ"_\%"O^3POC9_V,D7_IMLZ^+Z^T/^"A7_)X7QL_
M[&2+_P!-MG7Q?7^2W%G_ "5/$G_8^S?_ -6&(/\ 93@7_DBN$/\ LF<B_P#5
M9A0HHHKY\^J"BBB@#^I__@AE_P D#^(W_8[P?^D]W7[@U^'W_!#+_D@?Q&_[
M'>#_ -)[NOW!K_3KP0_Y-7P?_P!@.)_]6.-/\G_'/_D[7''_ &-H?^H6$"BB
MBOU8_)PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"CJ>F:?K6G7ND:M96V
MHZ9J5K-97]A>1)/:W=I<1M%/;SPN"DD4L;,KJPP0:_'C]KO_ (*,?\$Y_P#@
MB[X.T3X=ZUHK>%=2\42WVO>&_@I\%O#FG:CX@O9;^5Y+G7+G3+_6]$LK*TNK
MQT669[][R5ITDMK&>,,R_JMXA^+'PL\(ZBVC^*_B5X \,:ND4<[Z7XA\9>'=
M%U%()MWE3-8ZEJ-M<K%+L?RY#$$?:VTG:<?Q(_MHR?LKVG_!R#X,^)O[:.J>
M!?B%^S5\2O G@JU^%&LSZMX?\9?#?2O%6@^"-"T-W\86-C=:I:6^G6VKVEY:
M21WMH6.J"SU61/LT+WD:;M9+O;TO;6WW?>AKYM>7>Z7SWZ:Z]-S[.TS_ (.V
MOV9UU=Y/$W[+O[2&D^#T=7_MRR\*6EYJ"VF09)Y;"\U33+!-D>YL?VN8S@9D
M"Y(_<7_@G_\ M,?L(?MHZ3XU_:9_9 7PQ<>)_&-W9Z?\6+P:1:Z+\1(=5L;:
M&>SL/&UG!=WJM-!;W<1M[FVO+VQDWO'%=R313QQ]]XUU3_@GE<_#/5M*\<:Q
M^RIJ'PKLO#EU-JFD:EJ_PUU/PV/#5I823SJNE)<W,5S:+8([0VUK;3/,FU+>
M*1V13_+K_P &W_AGPS?_ /!2?_@I/\2/V7M*ET;]C:\N='\/>"N1%IUS)9W^
MI3V^FZ=:MMFB-C=W+WN'MX4%E<VJH[[0JK6ZU33\K;+?33U?=^8;='=Z=NE]
M?NVT=VMS^V:BBBJ$%?@5_P %;O\ @G3^T?\ M ?M$_L5_ME?L<2>"9/C;^S%
M\0K;5M>T+Q[KUSX<T7Q3X9T_6-#UG1+)M3M-(UJ5(;*\MM:-[;FQD%S%?QH&
MCVL6_?6OYZ?^"WG_  4B_:7_ &:-=_9Z_9&_8:T.TU?]JS]J'7YM&\/:I=V.
MC:L/"UE-=Z;I6CRQZ=KHFTLRZWJ-_=Q+>7\'V>T.FY:>W61I0G:VM^FV^^EM
M^HUNK=/7]#C?^"SO_!/#]L;XM_$[]F;]O7]@W5=#L?VK?V<X+JQU3PIJ)E>Q
M\5:?J<.G7336DZ1DZB=&O=(2TCT6YLXHM4AU W$EW:?8_LMU\D?\$T_^"?/_
M  4[^/W_  4@T7_@I'_P5 AT7P7KGPH\.7EG\._#&EV9TJ[N]=N-)3PI!8P>
M%XTCM-%T%/#][JM[<WT-Y</+J=O:QFR(O99[?S7_ ()Q?$S_ (*E? __ (++
M^%/V3OVY_P!I.?XH/XO_ &?-;^(NL>#](UW7=4\*:3)J=UX6N=,@;3]5M;#3
M[/6]/BN[B&=])M)+:'S'CM;V:)B6_2G7?V]_VF?@Y_P7IT7]BKQ_XPTSQ+^S
M7^T%\-;.Y^$'A=/#VB6.J>%?%%AX1T[Q-K.IW&MVUE'J]ZHN-)\0:=%:W-]-
M;R07J7+1)+#&$G1N^N]K?WM+-ZZ=ON';=;65WKW2?FG>ZM;1Z=3^B"BBBK)"
MBBB@ HHHH **** "BBB@ K^,3_@CG_RL2_\ !4O_ +)9\0?_ %?'P^K^SNOX
MQ/\ @CG_ ,K$O_!4O_LEGQ!_]7Q\/JF7V?\ $OU _L[HHHJ@/X /^#T#_DL?
M[#O_ &3+XM_^I7X5K^):O[:?^#T#_DL?[#O_ &3+XM_^I7X5K^):L9_$_E^2
M,ZOQ+_#'\@HHHJ3,**** /Z'O^#6K_E,C\"/^R=_'S_U47BFOZ'?^"N'_)ZG
MC?\ [ FB?^C]3K^>+_@UJ_Y3(_ C_LG?Q\_]5%XIK^AW_@KA_P GJ>-_^P)H
MG_H_4Z_F[Z4/_)!97_V4N%_]0,>?U+]$O_DXV/\ ^R8S#_U.R\_,RBBBOX(/
M]&PHHHH *_HT_P""#?\ JOC?_P!=--_]!TVOYRZ_HT_X(-_ZKXW_ /733?\
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M_9GWC'_U;GP;IQW7JOS*A\2^?Y,_07_@H5_R>%\;/^QDB_\ 3;9U\7U]H?\
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M(SJ_$O\ #'\@HHHJ3,**** /Z'O^#6K_ )3(_ C_ +)W\?/_ %47BFOZ'?\
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M^1_G/_8RQG_I^9_?'!'_ "1O"G_9.Y-_ZK\.%%%%>*?4!1110 4444 %%%%
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MFYUW4O$&F^']%M;W2+O38=+>ZTQ8KVRN+==0O8(K.0*LR,8W%?L=_P %%O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _F_\
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M?#ZO[.Z_C$_X(Y_\K$O_  5+_P"R6?$'_P!7Q\/JF7V?\2_4#^SNBBBJ _@
M_P"#T#_DL?[#O_9,OBW_ .I7X5K^):O[:?\ @] _Y+'^P[_V3+XM_P#J5^%:
M_B6K&?Q/Y?DC.K\2_P ,?R"BBBI,PHHHH _H>_X-:O\ E,C\"/\ LG?Q\_\
M51>*:_H=_P""N'_)ZGC?_L":)_Z/U.OYXO\ @UJ_Y3(_ C_LG?Q\_P#51>*:
M_H=_X*X?\GJ>-_\ L":)_P"C]3K^;OI0_P#)!97_ -E+A?\ U QY_4OT2_\
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MAJ_=JOYIXC_Y'^<_]C+&?^GYG]\<$?\ )&\*?]D[DW_JOPX4445XI]0%%%%
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M\I%_@Q_V:;X,_P#5F_%JB?POY?FA2^"7HO\ TJ)_)?1116)@%%%% !7]:?\
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M.GZ/J5WJ-[9Z=9Q65SYUY?W,-G:0*T+KOGN;AXX8D!.6>1U51DD@ FOYTO\
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M?_!G5_RD:^.?_9GWC'_U;GP;IQW7JOS*A\2^?Y,_07_@H5_R>%\;/^QDB_\
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M_P"P)HG_ */U.OYN^E#_ ,D%E?\ V4N%_P#4#'G]2_1+_P"3C8__ +)C,/\
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MOX@;1=8U#P]>64UY9VUZ8MN7N$D^RP2F%9%&WX[\"?MD_P#!3[_@CQ_P48^
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MMX<:[TH:C%XIDO5T"/3X=.BTV**WN=."2RQ2[O,;^HROQ"_X**?\$'?V0/\
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M1I_P0;_U7QO_ .NFF_\ H.FU_.77]&G_  0;_P!5\;_^NFF_^@Z;7Z]X#_\
M)U>%?^OV/_\ 57C3\0^D7_R:'BCURK_U;X(_AJ_:#_Y+S\:O^RK_ !"_]2S5
MJ\@KU_\ :#_Y+S\:O^RK_$+_ -2S5J\@K_=VA_ H_P#7JG_Z1$_YH<?_ +]C
M?^PO$_\ IZ84445J<@4444 ?Z(W_  ;D?\HPO /_ &5+XO?^I0U?NU7X2_\
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M[:6=K>98_P"Q:G&]M?E?=KSW$]_S];OTZ6Z>NH44450@HHHH **** "BBB@
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MJ0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=*?4+L74M[91Q@M+<.\<:@?TP_$CX?\ A;XL_#SQU\+?'&G_ -J^#/B/X/\
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M3>(WB+3Y=/>1[V[L%6Z:)8DE>"1?I_\ XAG/^"2O_1#M:_\ "MN?_D2ON?\
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M.QM[:*S2&UCA6.Z<NPB\UV"[G(XK].J**8@KC/B'\1? GPE\&:_\1?B;XO\
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M?&S_ +&2+_TVV=?%]?Y+<6?\E3Q)_P!C[-__ %88@_V4X%_Y(KA#_LF<B_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% #2Z*RJS*K.2$4L SD#)"@G+$#DXS@<GBG5
M^6'_  55_9$_:H_:F^%OP]U/]CK]H_7?V>_C9\%/%U[X_P##@M=9UK2/"WQ#
MG%I:*GA?QBNC)<C4; &R;['I^J:=?:1=SW<MMJ*P6D\TR_F/^QW_ ,%WO''P
MQ^)MI^R!_P %<OAC?_LR?'&ROT\/:%\8[W2S%\+OB!,66VL;J[U31A>:1IU]
M=SC=<W]G%9^';.UGLY[^XM&-TZJ]M]//I_P/G8=K[:OM_7]7:2NS]G_VE?\
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MH **** /XQ/^#8;_ )/6_P""NW_8W_"'_P!._P 6J_L[K^,3_@V&_P"3UO\
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M_@4?^O5/_P!(B?\ -#C_ /?L;_V%XG_T],****U.0**** /]$;_@W(_Y1A>
M?^RI?%[_ -2AJ_=JOPE_X-R/^487@'_LJ7Q>_P#4H:OW:K^:>(_^1_G/_8RQ
MG_I^9_?'!'_)&\*?]D[DW_JOPX4445XI]0%%%% !1110 4444 %%%% !1110
M 4444 %%%% !7YB?\%2/^"E7A;_@FW\&_#GC:7P%K7Q:^)?Q&\6V7@;X8_#'
MP]YQU+Q#KM[9ZC>?:)%MH+BX:PM%T\Q3K"L;O-=6\:SQELG].Z_''_@L%_P3
MX\5?M[_##X>?\*/^)ND?#3]I3X#>.[#XD?##5M4:WN[.XFM[#4[:?1+^R:[M
M7M$U&>[L[B/4I'V0K9/&(V:998D]GWZ?>K_A?Y@MU_7YG\XO[??[6WQ]_:3^
M%Z>,?^"DG_!'B_\ #?PD@6Q%O\=?ASHOC;PY\9/A+:ZD\$&F^(Y/$%SK&IM&
MFA3W%O=_V)XAT^;2;B\A2T^PK=/"4U? NI?ME?\ !,'X>_#3XO>/?A?X=_X*
MA_\ !,'QKX5TGQ;X-\1^-/ V@^/OBO\ !SPEK,8U4VUU+J.D7NO:--H/GR7&
MKWFM:7J'AFTA,]G9?9[BTE^S_1_Q7_8^_P"#EW]L/P-<?LU?M%^.?V:_ OP0
M\8/I^C^._&?A#6-.U+Q-J&@6=];74LMUIR^)[M[N6Y-G'))#!;Q-YCG:4QQ_
M4_\ L[?L]>%_@/\ LV?"G]G$QVGBOP[\._AWH?@B_;5[&"[L?$$MG8+%K-W<
MZ;=K<0?9-4U"2]N5LIA.L,$ZV[O-L,CRE=W7,M-W9.^FFVJ];_G>V[+I?R?3
M?[+7X^;3UT\)_P""?O[;?[&?[9?PBT[Q-^R/K_@:RTJVMX;C7?A?H5GHGA?Q
M-X(NKA K0Z_X'T^*QO-*222&6"VOI]-M[>_^R2FW9A"P3[[K\JOA;_P1_P#V
M1O@'^VE#^V[\#]/\5?"GQC<^'?$VB^*OA_X8UV"U^%?B.?Q#' CZW=^')]-F
MNH-1A$<@(AUB/3T'DFUL;9TE>;]2K2_L;\2&QO;2\$+^7,;2YAN!%)S\DAA=
M]C\'Y6PW!XX-6K]?P)=NG]?U_5]W;HHHH$%%%% !1110 4444 %%%% '\8G_
M  ;#?\GK?\%=O^QO^$/_ *=_BU7]G=?QB?\ !L-_R>M_P5V_[&_X0_\ IW^+
M5?V=U,/A7S_-@_BG_B?Y(*_S9_\ @\._Y2+_  8_[--\&?\ JS?BU7^DQ7^;
M/_P>'?\ *1?X,?\ 9IO@S_U9OQ:HG\+^7YH4O@EZ+_TJ)_)?1116)@%%%% !
M7]:?_!G5_P I&OCG_P!F?>,?_5N?!NOY+*_K3_X,ZO\ E(U\<_\ LS[QC_ZM
MSX-TX[KU7YE0^)?/\F?H+_P4*_Y/"^-G_8R1?^FVSKXOK[0_X*%?\GA?&S_L
M9(O_ $VV=?%]?Y+<6?\ )4\2?]C[-_\ U88@_P!E.!?^2*X0_P"R9R+_ -5F
M%"BBBOGSZH**** /Z7O^"1G_ "9=^TE_UZ^+/_43URO\^>X_X^)_^NTO_H;5
M_H,?\$C/^3+OVDO^O7Q9_P"HGKE?Y\]Q_P ?$_\ UVE_]#:O]EOH@_\ )ILH
M_P"P6E_ZGYN?X%?3V_Y/!B?^QCGO_J)PR0T445_51_#@4444 %?Z<'_!%W_E
M%Y^QW_V3?4O_ %./%=?YC]?Z<'_!%W_E%Y^QW_V3?4O_ %./%=?G'B7_ ,BG
M ?\ 8Q7_ *C8@_=_ /\ Y*'.O^Q,O_4[#'Z@4445^+']4A1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<UZ2[EAFM(X3JTMQ;27<2;S96[2.E?L-115)6T%>_P"04444 %%%% !1110
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M(_Y(WA3_ +)W)O\ U7X<****\4^H"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K^=?\ X*6?\$6OC9^T;^T#KO[:'[''[9'Q"_9P_:(O_#F@:%<:#87&
MI:=X;\0)X;M!9Z:!XJTK7+?4/#47E K=1V^@:J+DR<M$%._^BBBDTGN--K;^
MOZ\C^)G6?B1_P=A?LGP67A9_!7@W]J'1-(*6_P#;?A7PW8_$76-3@B7 GO\
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M5C$2K7Z:T4TK=V^[?WV[7"_3IV_'R6_9(****8@HHHH **** "BBB@ HHHH
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MN%_]0,>?U+]$O_DXV/\ ^R8S#_U.R\_,RBBBOX(/]&PHHHH *_HT_P""#?\
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MZD,K*2K @@D&@+/L/K^,3_@CG_RL2_\ !4O_ +)9\0?_ %?'P^K^SNOXQ/\
M@CG_ ,K$O_!4O_LEGQ!_]7Q\/JF7V?\ $OU _L[HHHJ@/X /^#T#_DL?[#O_
M &3+XM_^I7X5K^):O[:?^#T#_DL?[#O_ &3+XM_^I7X5K^):L9_$_E^2,ZOQ
M+_#'\@HHHJ3,**** /Z'O^#6K_E,C\"/^R=_'S_U47BFOZ'?^"N'_)ZGC?\
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M_P!L'6&MPZV[:I\4O!.H- LA4R+";OX5S&(.54N$*ABJELX&,G_B#\_X)O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MROV8?^"6/P&_95_:U^/_ .V'X!USQC??$;]HB.WB\7Z=K-ZL^A6*V[;A_9<
M8M&7;!.\<8P.M?IK1119+96 **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _!W_@IE_P %R/!W_!-_]JS]G_\ 9>UWX#>)?B;?_'/2O"^L+XLTGQ=I
MFA6?AZV\2^/+KP-'"^FWFFWD]]-:RVKZB[+<0I)$RP*%?+C]SM#U2/7-$T?6
MXHG@BUC2]/U2*&1@TD,>H6D-VD3LH"L\:S!&90 2"0,5_ '_ ,'27_*6_P#X
M)^?]B/\ "K_U?^L5_?#\/O\ D0?!'_8H>&O_ $RV5)/62[6M\T)=?)_HG^IU
M]>0_'SXW> OV;O@U\1OCG\3]7M=#\"_#/PS?>)=>O[NXAM4,=OL@LK"&6<B/
M[=J^I3V>DZ=%\SW%_>VT$:222(C>O$@ DD  9)/  '4D]@*_AD_X+[?M@_$K
M_@H+^V)\+/\ @C[^R)J5SJUE_P )K86?QKO]%DDDM=5\2VBSSW^B75U;[T;2
M?"%JE_+JMI)&7'B+18!Y\:H 1NR\]EZE+_+YZI?UV5V?:O[(G_!U/\)OVL_V
MJ_ /[-VB?LK>./#-A\1_%DOAC0?'%YX]T>\6"-Y)8].U2\T5=!M[@QWH6&22
MT$T,UJLQ5W=HFW?UC5_F4:-^RMX&_8J_X.'_ (&?LU?#Z!4T3X9:Q\ M*O+Q
M0R_VSXEN_A#X!U;Q;KWELSF!=<\3ZAJVJQVWF2"UCNUMQ)((O,;_ $U))(X8
MWEE=8XXU9Y)'8*B(HRS,QP H )))P!1&]M7=\S7W)?YBUU3L[/=7U32?7U/D
M;]N?]L_X4_L#?LW>./VD_B_<$^'/"4<%KINAP7<-IJOBWQ'?+/)IOAG1#,DI
MFU2]@M+VZ2**"XD6ULKN?RC'"Y7\4O\ @F/_ ,')'P^_X*/_ +36F?LV:;^S
M+XN^%VHZWH^IZMIWB;4?'>D>(;.,Z:JRM:75C::-93,TL.]A.DR*KH%,9W\?
MC1_P4,^,7Q%_X+U?\%5/ G[!7[/FN7+_ ++/P.UZ\E\:>(K%);C1-2_LB]M+
M3Q=X[NS$ZP:G8VT8B@\-+NM2+/4M05IW:0X\1_X)!?##P;\%?^#C/XU?"3X>
M:9_8O@?X;_$[X]^"O"FE^89C8Z!X:\3Z[H^DVSS,%,KPV-G!&\I52[*6*C.*
MCF;>FU[=-=4G^?W#LUKIYZ.^J^6S3^?D?Z-U?+O[97[6WPK_ &'_ -GCX@_M
M'_&*_%KX0\!Z9+<K81W,-OJ/B/5VAGET[PWHHE5_M&L:JUO+'96\44\LA1RL
M3A&%?4+,JJS,P55!9F8@*J@9+,3@   DDG ')K^!S_@JM^T!\1/^"W__  4J
M^&7_  3'_9AUR8? 3X6>)BGQ)\5V"RW6EW^JP7<,GC3QG=-!(D.HZ-X4T2TM
MGT6V+VKF[AUN,WC"Y0);=EY]%W!*_P#7]?\ #)OH?JS_ ,$Z?^#FGX<_\% O
MVKO"7[+^E?LO>,?AS=>-(=2ETGQ=?^/='URTMFL)K6.-+S3;?1+.=Q<)=;P\
M<T7E%-K(=V5_I"^,GQ+TSX,_"3XG?%W6;*YU+2?AAX \7>/M1TVS=8[O4+/P
MEH-_KL]A;2NDB13WD=BUO%*\<B1/(LCHRJ5/^=E_P3K^"_@O]G;_ (.7O$OP
M.^'>GC2_!?PM^*7Q)\%>';(.7,6G:!K%CIT!9VY9W6#>YP,LQXK^^/\ ;U_Y
M,B_:Z_[-N^-'_JO=?I1;:U[_ .0):V=OC<7;:RY?\S^6C3_^#QWX;ZY<7T?A
MS]@/XOZ]#9-(SRZ=\4= N&6V#LL5Q-'%X+=H%D4!L2!2I.T\@U]._LN?\'9?
M[%'QM^(.E?#[XR_##QY^S)<ZWJEEHMCKWBS7;/Q9X?MKZ]F6!'U_4=.T'1K;
MP]I\+NK7.H:A.+>VB+23,J(37Y[_ /!G9X(\%^+?!_[6S^*_"'A?Q,]KXDT"
M.V;Q#H&E:TUNCZ7H99(&U*TN3$C%F++&5!))())KUW_@[5_9$_9@\&_LS?##
M]H7PCX'\'^ /C7'\1;;PC$_A;3['09/%WAF^2WFOFO=+L4@M9SX=E"/#=6UM
M#,IUF1;J2=!;B&??MS73V=K)=O)?/K?N*ZM?K9M[VM9.R][>RW>E^EG=?VBZ
M+K6D^(M)T[7="U&SU;1M6M(+_3-3T^XBNK*^L[E!)!<VMS"SQ30RHP9)(W96
M!R":TZ_%/_@WL\3^./%?_!*#]F&^\=7%Y=W=GX?FTK0;N^EDGN+KPQ9I:'2Y
MC-+EY%,DUXJL6; 7:#@8'[65:=TGW5P_K[_U[KHPHHHI@%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%->O-,.GPFWM4^'GQ6O=UWHFGSQQ*BS0-X?A600.+F'S<,Z+-M:)-JS[7O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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61110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>nt10015006x17_graphic14.jpg
<TEXT>
begin 644 nt10015006x17_graphic14.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M.O:'J]C(6>RUGP[XBTK5=!U>UW.D.H:=<+%+-#Y<KI-/9I@?0E%%%, HHHH
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MLDC@TV]*1!+.7:1:<H]+MWM=NVF[>^W1?B*[ZW5[IWN]4^KV7H[VZ.Q^=O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ]>62^O);&XE675+B\EN"ER\J#]V*_ ;_@A)\)_VT_@QI7[:7@?]O+XR:?\
M''X\V7QY\&W&I>,]/^+)^+"MH]Y\$?AW<Z+82ZA>FUU_17L],EM($TO7M$T6
MX,,<=S9076FRVE[/^_-..RO?Y[_U^@M.E[66]D]NMM+A1113 *1F55+,0JJ"
MS,Q 55 R22>  .23P!R:6F21I+&\4BAXY4:.1&&5='4JZL.X9201W!H _P P
M>_U+]K:;7O\ @M;<_P#!*?PM=^-_V%_&<?C#3?VCM<\9>&-!OO$MAX(^P>*;
MCQ7%X,FFN)-0":7HM]XGN5FM_/U*'PZ+359H+>_#BOZE_P#@E]^U?\'_ -E;
M_@WZ^$_QQ_9<^'7Q,^/^G?!K1_$.G>*?AK!;PI\1]4^+&L?$B_U7XE::]MI$
M6J016UAK?BR?4M#:V@D$O@]M$NI8UDFE:OSJ\6_\$+_^"OG[*?BC]K[X0_\
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M D9.,#(]:FI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !17R[^V9^U+X9_8R_9T\?\
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M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO@Y?^%]*T'P=XO:/2KWP1+XLUC4/"&HOHVL"6/3[BXT.6Q\JXM-@OM,CTUY
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M"%2,U=KD4=4G]IVNDK))<UVGNU9-'U/1117Y2;A1110 4444 %%%% !1110
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M%O0__39:U*^*7R_+^OZV;VCZ?JSI****H04444 %%%% !1110 4444 %%%%
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M@ HHHH _E!_;O_Y6G_\ @D9_V;#\0O\ TP?M@U_5]7\H/[=__*T__P $C/\
MLV'XA?\ I@_;!K^KZA;/_$__ $F /=_]N_\ I$0HHHH **** "BBB@ HHHH
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MCZ?JSHZ***H04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ ^GZ)9WATRTN?(GUF\\9S0Z;!+M>]GM)(K=9)$VC\T?V)OVB_V8_@!^U?\
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M_!KXW_\ F%H_X?._\%4/^D,7Q5_\&OC?_P"86L_^(;\2_P V1_\ B29'Y?\
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MO8<#Z#@=N*E?%+_MW\AO:/H_S9T=%%%4(**** "BBB@ HHHH **** "BBB@
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M.E.M6<XVE4DW4J5%##N#;51Z1G&G>,7[-3DI-]I.ZTNK6Z6T/Y[?^"EG[?\
M^W7\+/V/OV8_VROV3/@SX0U?P!XWT?2O%WQR\,^)_">I_$O6_AK8ZQ8:5K.A
MM)J&GWF@M!X=N"=4T35O$Q\+0KIMTEA--/I<^HV,+_A]^U-^T1XI_P"#@_\
M:_\ V'?A9^S?\!OBAX#\._!NVO+_ .,'C[Q/I^EPR^#;7QIXB\%77Q%\376H
MZ+JE[I=IX-\%Z7X*LW\%7&IZUIFO>+/$>M3:'8:!9:O>Z7:ZC_>F0""" 01@
M@\@@]01W!JI9:?8:;$T&G6-G80O+).\-E;0VL3S2G=+,T<"1HTLC<R2$%W/+
M$FN/(^.\MR&E2K8+A7!PSK 2S3^R<UAC:L)8>GF2J0A''4?82>93P5*?L*,Z
MM:GSTEJJ=1SJ5'4H2J/6K+D?(Y1LM90=TXO[*E]I+JC^#SPW\==5_P""-_\
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M445\&:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4 %%%% !1110 4444 %%%% !1110!^'7_!2+]J#_ (*@R?%%_P!F_P#X)6_
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MSWW^&)/5Z6^'_P!)B%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ^CSP206UG9Z^VDQZ9IEMIWFM/:V=EHT5I+<B.>]ANI(HF3]AJ*5E>]E?OU
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MIP2IRHSQ>#48.#G)U/:R:E&,>1\UU%1U$KTX1G*ZTE-P5NKNH3^ZW^1^A?\
MPG'@O_H;_"__ (/])_\ DNC_ (3CP7_T-_A?_P '^D__ "77Y(?\.(OV"O\
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MT73[GX ?#?Q!+I.CP322Q:9I\^LZMK>M2V5DD%K)JNJ:IJ+QF\O[J:;\+O\
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MVD>9;DSQ=:<>7ZM-:Q=_>?PRC+^3K9+YG^S!_P +8^%@Z_$OX?\ _A9>'/\
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M\I:^0_U#XT_Z);/?_#;BO+_IWYHT]O0_Y_4O_!D/\S]WJ*_"'_B)$_X)2_\
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MA_W^MO\ &C[=XB_Z$^P_[_6W^-3_ &'Q[_T&M#_\%,O_ ,<H^P^/?^@UH?\
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M_P O+;G^HW^Q)-+/^R#^S5+/+)-*WP7^'P:25VDD;;X=L47<[DL=JJJC).%
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M9TYI5Z3;A*RYU=W5E;7NT?HM_P $N?\ DP;]F;_LG5A_Z4W5??=?SG?L0?\
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M1FV^V^9]I'[,_P *0@;[#')+L\HS9W 1[MN3NV _@_\ V;\.O^>VK?GXA_\
MD:OWS_X.*WO8_P#@KG^U4;"RM;Z8Q? 0-#=W+VL:Q_\ #-?PE+2+(EM=%G#!
M%">6H*NS;P5"M^'WVCQ'_P!"[HO_ (.9_P#Y3U_5>&P="MD_#-2IEN Q4O\
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MV;\.O^>VK?GXA_\ D:NR^T>(_P#H7=%_\',__P IZ/M'B/\ Z%W1?_!S/_\
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M6%GIU@?$%JLZ:;86]I:,;2UB1/J"FMM[^?>XG\]EO:^WDE^6H4444Q!1110
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M3I_S7V>^7_4+_P /_P!O,+3[5_\ PFI^7][T^[RTN_\ ".W/_0U:[_W^LO\
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M[5<VMS/N9HA.(XUC3S%_B-\4U^,K? E;^_\ ^%!#QP?AH- _X1_3#IH^&?\
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M^N_$#4OB1I&DW)L7\&&&]T83MXN271+>9=1N]6UNW0Z7+J*76UM,8SK T:/
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M[.?\E7_P@H?_ "?E^?=G<_V=XR_Z&32O_"9;_P"7-']G>,O^ADTK_P )EO\
MY<UPW]F_"W_H%ZI_X ^-?_C5']F_"W_H%ZI_X ^-?_C5']I8+_H=9/T_YO1Q
M5_=_ZDWE\O\ MT/9S_DJ_P#A!0_^3\OS[L[G^SO&7_0R:5_X3+?_ "YH_L[Q
ME_T,FE?^$RW_ ,N:X;^S?A;_ - O5/\ P!\:_P#QJC^S?A;_ - O5/\ P!\:
M_P#QJC^TL%_T.LGZ?\WHXJ_N_P#4F\OE_P!NA[.?\E7_ ,(*'_R?E^?=G<_V
M=XR_Z&32O_"9;_Y<T?V=XR_Z&32O_"9;_P"7-<-_9OPM_P"@7JG_ ( ^-?\
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MS:AX2ET"[73T5X(;9K<016XW1C]%::V5_P"OZ[]1/]%^7]?\$****8@HHHH
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M'C"U_LC2?^$0DNM9E2\AEM[QOM::E:Z(D,;0VDVUHGF8LH!10=PU;CX >'O
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M-K]LY<W_ .@GC3_P@X'\O^H+S_!]CSK1[8?_ ,"Q'EY^O];/_M+6?^A/F_\
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ME1^U%\#OVG?VM?"7QQ\#?\$W/'/['WPG^(_Q \5>'_@A\</A7XN\0>$_@_\
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MZA:'_4+T^QB?+^[_ %K?=VM?:?&'_0*T/_P?7?\ \I*/M/C#_H%:'_X/KO\
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M<+]N"M>M;DM:E_#4U&]I]*B4K]WU/<:***_GX[PHHHH **** "BBB@ HHHH
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M+NR?]$BO\SS_ (+Q?!KQY\8OVT_C?8^!&L$N=%^-7CFYU WVH3:>ODWB:;'
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MZE_X3-W_ /&*/MOA3_H5]2_\)F[_ /C%?J]LJ_GX-_\ #IFOEY>?XKY\?O\
M:O\ ^ P\O\OP7RW?[&TO_H*ZC_X.I_\ X[1_8VE_]!74?_!U/_\ ':POMOA3
M_H5]2_\ "9N__C%'VWPI_P!"OJ7_ (3-W_\ &*+95_/P;_X=,U\O+S_%?,]_
MM7_\!AY?Y?@OEN_V-I?_ $%=1_\ !U/_ /':/[&TO_H*ZC_X.I__ ([6%]M\
M*?\ 0KZE_P"$S=__ !BC[;X4_P"A7U+_ ,)F[_\ C%%LJ_GX-_\ #IFOEY>?
MXKYGO]J__@,/+_+\%\MW^QM+_P"@KJ/_ (.I_P#X[1_8VE_]!74?_!U/_P#'
M:POMOA3_ *%?4O\ PF;O_P",4?;?"G_0KZE_X3-W_P#&*+95_/P;_P"'3-?+
MR\_Q7S/?[5__  &'E_E^"^6[_8VE_P#05U'_ ,'4_P#\=J]IVFV-M=)+!?7=
MQ( 5$<^I2W288C+>4\C+D=F(X[8KE/MOA3_H5]2_\)F[_P#C%;&AW.A2WZ+I
M^B7EA<;6/VB?1Y[! @(W)YTL: ELC" DGDXP"1W99_9O]HX'V<^%'4^M4.3Z
MKF.95,2Y>TA;V$*B]G.JV_<C/W92<5+2]YGS<DKJM:SWC!+INUK;3IV7R_V*
MOV5O^37_ -F__L@OP?\ _5>^':]ZKP7]E;_DU_\ 9O\ ^R"_!_\ ]5[X=KWJ
MOX^S+_D8X_\ [#<5_P"GZA[H4445Q %%%% !1110 4444 %%%% !7Q_^W5^Q
MMX&_;V_9P\6_LR?$GQ)XD\*^"/'&I>';KQ!JGA+["OB%K'0M6@U22QTVYU&"
MZM+*:^\@6_VZ2TNS;*QD6VE8!:^P** V/Y./B/\ \&N?_!&#X/:$/$WQ4^,7
M[0WP\\/F46Z:QXQ_: ^'WA^PDN"C.((KG4OAE;QRSLJLPBC+.0"0N*]H_8$_
MX(8_\$M?@U^T#\,/VK_V)?VA_B+X_P#%OP;UZ_OKRTNOBQX"^*7AO4;/6-!U
M;0Y=+U.TT#POH5[HT[?;C=VNH"\D.;9H3:RI*7C^?_\ @N8_[%NG_M6^']1_
MX*A>%_VEO$W[.C_"[1$^ )^$\T\?PRTKQ5#>7S?$&Z\5&"&6)/%\EQ)IT%C)
M=&-ETB:)8V99=J^"?\$C+S_@G#J?[<WPDNO^"2_AC]J?0(Q!XM7]I"X\;7%Q
M<?".\^&:^'[S[)'KC/ EM_PDEOXF_L<Z!MD:=))IE5521C4Z)VTW2WUZ6T]4
MONOU*2MJN5:-Z6OHEMIY6OTLS^UJBBBJ)"BBB@ HHHH **** "BBB@#^4']N
M_P#Y6G_^"1G_ &;#\0O_ $P?M@U_5]7\H/[=_P#RM/\ _!(S_LV'XA?^F#]L
M&OZOJ%L_\3_])@#W?_;O_I$0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /P_P#^"_14?L4^%BV-H^/G@LMNP1M'A'X@EL@\8QG.>,=:_P YK]H"
M.X\>7/AD?LDI(\&DIK"?$#_A4-M/H<2W=W)I_P#PCB^(AX9@LEN)Q':ZZ--%
M]YDD*C4!!L$DV_\ T9/^"_:[_P!B?PPG3?\ 'KP8F?3?X/\ B$N?PSFO\Z>+
M41^P4US;:A%_PG!^+$YU&)K)C;C2SX2,D4L<@G%F7%V?$R&/;YNT6S;BNX;O
MZ'X1Y9^'&"H9A4EEO#=;-,W_ +=XDPU94<QR/V>)RJ>5K \L:M:7]IX[EP6)
M]EAZW+0D^?DB^>/DXC3&3E#WJRI4_9TF[0FG*:FY:?8C=K5:]SL_#VN?";2O
MA3:^%_&*>$4^/L.C7UM?P:QI%A<?$4>)I[V[GTW[1J%S9R:V^K&QELGMI7N3
M<I 8 C*$4+Y/\"K'Q-X'\1ZG?_M61ZHGA*XTMHM!?XM)>:SHRZPL\?G?8(?$
MD=Y:Q7QB>$/)#&LIC*JS;2 =MO@9<_$.Z/[5D>LV^G0:H[>,1X7<2R311Z.3
MI36C3+;,ADF&FF4,+DJIE&6X*U+=>.(_VZ?^*!T^Q;P2WAE)=>EOKR3[0MRD
M\EO$MO&L'VPAU-L69F15P< YZ?4N>(EBLKJ8BG'#YO@Z>/AP-E-/&P^J<<X%
M8.$:>.SMQC*G&O/#JGB)?6:F#DJE25X7O%0E'EFE*].4I/$U.9WH2:C>%-VO
M:+OJN;EWUN<1\6-(^(GBSXCW/B#]G2/Q(_P?V:*B-\-6U/3?!QU&TLK0>(_+
ML- %MI@N_,4_VEM@$TSX:?>6!/LWQ.U?X8>*_AQ_8'P'7PK+\8Q'I+Q)X TJ
MRTWQJC6\:KK;"^T>SMM54K(Q&H8GS(Q/G!B37'Z?\8(/V03-^S]=Z1)XLN8[
MI=7&O6TJPP%?%UI9RQPF.5K60&USMD/D8/\ "7QDQ6GP:G_9:D_X:(N=7@\3
MP(@,F@P++!,1XFVW */);PQ@VQ !5K@@\@%OO5+?++-GAJCQ,L;' _\ $0X5
M,9%+P]4L'4]O_J_S4XJ3H<^8<GU3Z]S?V?AW&_N<XM53YG;D?^R-2O\ 6=%R
MJIH[W7+>[BGS-Z6L;7P'NO#_ ($T#6+']K%=/B\47NK?:_"[?%VP76=2;P^+
M.VAD&DW'B6VO)XK!=2CO"\-LZPBY,KE-\C,?+W\/_%0?&1O%Z1>+/^&</^$Y
M;7@PDU8_#7_A4YU4WOFC2AG0O^$/_P"$;/F"S%K_ &8-)_=B 6PV#N[SPP?V
M\DA\:V-PG@B+P29/"SV=V6N)+V2;;JYN5:&.\545+Y8L%D;<C':00:L_\+Z@
M2(_L>G0I?MJVK? 7_A+1,OV7SOLQ\&#7?)W^;Y6<7OE_9-^/E,.?EKS*D<'+
M!9;0Q68XC"\/86KS\&\04L;;,.,<PYW)9?G"C0G56'=?GH7Q-#"PY(1?/:S;
M3ES2E%*567*L32<KJA"R7-"ZM=KWM&[^5K%WX\77AWQYX?T:R_9.&F2^*K'6
M/M7BC_A45BFC:JGAYK*YAB_M6X\-6UG<2Z>^I-:[(;EWA-RD;JOF(I'1?"?6
MOA5X1^'UCH/[0P\)Q?%R-M5EU!?B-I5EJGC%K>YN9GT-Y[W7+.ZU22(VYB%@
M&F98XPL< 55"CA[/PLW[!J3^-[ZY7QO%XW:'PHME:%K>2RDMA+JXNF::*S5D
M9;5HB!(S!F4[<9-)>?!*?]K>2'X_VNL0^%(-2B%G'H=PLD\T?_",R26K2.\=
MO<QG[2T3.H6<X4J#L;-=M&KFT<YJ8RAEV&K\>3A"EC^ YX^D\BP&3\E+ES?#
MMI87ZW.,,&Y*&-G4;Q=5^RW4<[4_9J+J-85-..(YW[2=3F5X/W4^6[DMMHZ/
MJ<1\)M"^*'A;XD6/B']H6'Q4OP@@_MG^T&^(S:KJ7@]+J\TZ^M_#9NK#71<Z
M8T_]ISV2:9O@:2*[:![<+(BLO^A__P &[$NGS_LW_%V?23;'2I_'_AV;2S9J
MB69TV7PP'L3:1QJL:6QM6B\A(U5$BV*JJH '\ %Q\<H/VLG7]G^RT.3PM<ZM
M<"^&O74PE@A_X0Y9-<=?+A:ZD8W?]F>0@\G \W<Q3&1_?G_P;CZ2V@_LO_$[
M0GF6X?1/&7A+2'N%4HL[:9X0BLFF53RJRF R*IY4, >17A\11P%+PVS^CD>9
M8C/LC6*R:I#/,=7E6QL\TGF7+CLL:J4L/56%P.'A@J]!NC[-SQU90JSDIQAO
M1N\73=1*%;DJ)THN\5!*/+/M>3<DVF_AMI;7^B2BBBOYS/5"BBB@#_,+_P"#
MD(:(W_!6K]J<:]93WUGN^ /EQ6\-Y.ZW/_#,_P *=DA2R990HB\Y"S$Q@NH(
MW%"/P<\OX<?]"]J?_@OU[_XY7[[?\'%S:JO_  5R_:J.CI:R7/E_ ,2"[D:*
M,0?\,U?"4L0RJQ+^8(@%Q@J6.>*_#KS?''_/OHO_ (%R_P#QJOZPP>7T\3DO
M#%6658/&-\+</1]M7X#I\0U';*\*N5YC+'X=R479*C[->RO;F=[KQIS:JU5S
MSC^]GHL1[-?$M>7E?K>^MGV..\OX<?\ 0O:G_P""_7O_ (Y1Y?PX_P"A>U/_
M ,%^O?\ QRNQ\WQQ_P ^^B_^!<O_ ,:H\WQQ_P ^^B_^!<O_ ,:K3^R*/_0@
MRWI_S:>E_=_ZFWI]_DK3[1_\_*G3_F,]/[G33[GV..\OX<?]"]J?_@OU[_XY
M1Y?PX_Z%[4__  7Z]_\ '*['S?''_/OHO_@7+_\ &J/-\<?\^^B_^!<O_P :
MH_LBC_T(,MZ?\VGI?W?^IMZ??Y*Q[1_\_*G3_F,]/[G33[GV..\OX<?]"]J?
M_@OU[_XY1Y?PX_Z%[4__  7Z]_\ '*['S?''_/OHO_@7+_\ &J/-\<?\^^B_
M^!<O_P :H_LBC_T(,MZ?\VGI?W?^IMZ??Y*Q[1_\_*G3_F,]/[G33[GV..\O
MX<?]"]J?_@OU[_XY1Y?PX_Z%[4__  7Z]_\ '*['S?''_/OHO_@7+_\ &J/-
M\<?\^^B_^!<O_P :H_LBC_T(,MZ?\VGI?W?^IMZ??Y*Q[1_\_*G3_F,]/[G3
M3[GV*?A-?""ZQ"=#TF\LKTJ1Y]Q:ZI AAWH9(]]Y(869L*0N"YV[E'RDC_9!
M_9B_Y-K_ &>O^R'?";_U M K_'>T=_$K7\ U:+3DM"R_-:7#R2^;O7RP59%&
MPG(8@D].*_V(?V8O^3:_V>O^R'?";_U M KX3Q4P\<-PQP]3CA*.#3SG-)>Q
MH9!'AR#O@\"N=Y?'$8E2E)))XGVB]HHJ')%4KOMP;YG5?,Y:4]ZGM6OCTYK+
M[ME\SW&BBBOP8[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH SM8U;3]!TG5-<U:Y2STK1=.O=6U.\DW&.UT_3K:6\O;F0*"Q2"VA
MDE;:"VU3@$\5_G\_MF_\%1_^#<[]H/X_^,/'/Q)_X)>?&CXV>,-/\1WUEJ?Q
M;\"3O\)=+^(E_IEU);R^(-1TOP'\</ G_"5+?/&6&I^,M#DU>_@$9O$,>Q:_
MOF^(EQH=G\/_ !U=^)K1[_PW:^#O$UQXAL8EW2WFAP:)?2ZM:1K@[GN+!;B%
M%P<LX&#FO\XW]FO_ (*:_%[X->"->\"?LZ?\$=_A%^T!\"M/^(OC^[^%?Q%^
M(/P-76_&UWX0U+Q/J%[8:7XB\3Z=X-OHO$UUI,LUQ9P:G+<O-'91VVG,$6Q1
M%F3V3LD^ZOLUT]+CM?OOLHN3>JVM\[^JMJ?UU_\ !#O]N_X"?MM? OXJVW[+
MO[,]I^RS\ O@'\1=*^&'P]^'R6>B:5J4UO<>!_#GBG6-4UG1_#CW6CV5]-K>
MLW\:S0ZEJ=YJ5ND.HZI=MJ%Q< ?MQ7\[G_!OI\??&O[1_A7]M/XC^/\ ]EWP
M'^R/XEN_V@O"EA>_"?P!X+N_ ^F6O]G?!7X>V<6J76E7%IIT<E[J<4"7LMW;
M:99)<M.9Y1<SR2W4W]$=-7LKZ_UZ(5K=WHMU9[=5T"BBBF 4A( ))  !)).
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M8=<FBTK[7="6ZN+6^U1;N$6+>5'+.RQQ&,,G,_LE:_XQ^*/B'7M9^-\5Y?\
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M7Q\_+LM^3WONT[Z'R'_:/B7_ *%>V_\ !];_ /R!1_:/B7_H5[;_ ,'UO_\
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MUT[[,_V$OV5O^37_ -F__L@OP?\ _5>^':]ZKP7]E;_DU_\ 9O\ ^R"_!_\
M]5[X=KWJOXDS+_D8X_\ [#<5_P"GZA]"%%%%<0!1110 4444 %%%% !1110
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M>_LI_$.\U0S'4[SQ1X*NM2:XC:*=K^Y\%V\UXT\3JKQ3&Y>4R1LJLCEE*@C
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MFU+].VES=^Q7W_0^'_OYI_\ \<H^Q7W_ $/A_P"_FG__ !RL+'@G_H1-6_\
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MG);_ !6'@8Z1#:"7[68]?&A'Q$-1N"OEB;[*=1_L0[ROG?84W>4LBZ[9?M]
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MFKMKRVO@/JEK^R_IFO:-^T'K,.BZMXIN[*_\/BYEN]>-S9Z;'<PWK)-##<&
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M<JJMBE"I&A33]R=!P?/.4M5S*#JNSJ1?-&-HNZ4O]2O]A_\ Y,^_9I_[(OX
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MW_H,?^7%??\ R=1Y/@W_ *#'_EQ7W_R=3_[0TO\ Z$[5_P#PGX_\:/[0TO\
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M]_\  O\ 8S1([J3ROVM_!LI%K#ITS*$N-*;<XU&:%%C&W+-"S3!02BE@H/\
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M6B D:0(V+JTZKJ-*66?V+/%\]+DP4/\ B-7LZ$&[)PI+,ECE0M[L<[<UGO\
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M!5C<VUQ?W?\ 8;7*2BP%I;W,KV9T\/)&&!MRS;3B\52IJ&._LN68QS)T*,>
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M:E&EX:X'$9JEC>$:.:9Q_K+D5"3AF><.KBLHIY*\OG#V%>/]G9DXXS%^QS'
M\U!.-18F'[E^3B$Y8R<:=XXAT:?LJK5X07-/VBDG=7E&ZC>$M=N7<:/CS_PK
MF7_ADH^%/[9.E[_!G_"P/[=_L\3_ -LEM6_M+_A%/['OO*^S_P!I?9_L?_"2
MR>=Y/F_:HO,\N.)? O\ PP6S_$$ZI_PM;_A)XI- _LC[%_P@WV$02V\OVO\
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M.GIRP5N5<T7=OW;V:NWHC^ABBBBOY]/6"BBB@#_,/_X./GL4_P""M?[4YO\
M0+GQ'"3\ @MC:Z=;:G)%+_PS1\*"MTT%U)'&B(@>$S!BZM.J 8D8C\(_M'AO
M_HEFL?\ A(Z/_P#)5?O;_P '%::G)_P5S_:J&E7%C;7 B^ A=[^VN+J$P_\
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M1]1Q?_0GS'_Q"^%O+_J8>?X/L%_^GL?_  ?4_P#D?ZN_*W)_:/#?_1+-8_\
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MJ,(M]V"WJOF4M*>JDY[<_5I/Y;+IN>XT445^"'>%%%% !1110 4444 %%%%
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MZH[_  -_8VV)<N1^UGX0)%MI>C:HP'GZ629(]:=(X8QCYIK;-R@R\0WJ@/\
M2AX/_P"12\+?]BYHG8#_ )AEKV' ^@X'0<5*^*7R_+IW&]H^C_-_Y_EW.CK^
M$C_@O21:_M/_ !6UF^MVU_PSH<WA_4/%GP^CM8KV?XCZ*-#MXG\+V]I,3#<2
MR7#PW:Q2QR(XMR"O0C^[>OX3/^"[.\?MB^+9-!%N_P 38M<\//\ "B#4EF.A
MS^,AX<01QZX8GAVV'V W98M=6P+A0)02%/Y?XH.U'A1M74>)J<I75HJ,<JS1
MRE.I\6&IQBG*IC8?O,#!2QE-.I0BC\,\>:<JO#O#5.$E%OC3*&YRITYPA".%
MS&52=2I5]W"484XRE6S&*=7*Z2GF-&,JV%A%_@)<O]AA\,W^L:')XFT3XF36
M5K\!?"T/A[3Y)?V0;ZY2WAL=7U='++IB:+=:CHEY(]D+1K?_ (1:5(R!&I6W
M;:/XLG\0WWP_L_%4>E_&CPW!!K?CG]J)]$LXM*^*OA1XH;F+X>VNI)*+J>>T
MT_4-%T=EFN95BE\,S(L8"*$+(W":C\27\(1Z!)XSN[?'[=\=_#JOV'3-"-IJ
M(UUOAP?M,2S7*Z:WC-K,6DNM-OCL%9))"JS8#)\,#X#\-VFKO"O[&L7B(/\
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M,&O/O 7PA\3?LT^+?^%^>/[C2Y_!82ZWPZ%<RWNKJ/$CK<6)%G)!;HPC08N
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M!OQ@CCTG2?!EK;^)]);P?%_9%W-J-Q,VE.MW-J*ZJLMLEK<RE8HHXF$I#LY
M"UF>/OC#XM_97\3#X%_#:VT[4/!NGVUI=V]YXEM)=3UA9?$9>XOP]Y92Z=;-
M''+*S6ZFT!12%D:10*\WDX<_L+"+%5*Z\)UF:>4RIJO_ *POB+DJ\_UF]/\
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M7EEGBPO[C#9?[.MP\WF4JR'4QF91A45>I&,XT\>L4L=0Q=*O&I2IJ?$*S2.
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MO_/'2_\ O[-_\11O\2_\\=+_ ._LW_Q%5?\ A&Y_^AJ\3?\ @9I__P K:/\
MA&Y_^AJ\3?\ @9I__P K:_;/J^:?] _$G_B297_\M\U]YY_-'O3Z?\N7_=\O
M^'OYZ6M_B7_GCI?_ ']F_P#B*-_B7_GCI?\ W]F_^(JK_P (W/\ ]#5XF_\
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M07>IR6!T!=5708K=;N8)IVM"T^U;W@'VD0[1++G_ $8_^"_:[_V)_#"9QO\
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M<AE46)A[+GI*JFHRBYNK4E&<HXJVE&/*FZ#=W;G2E!>\F_:I<NMG_I]_L/\
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MIK9;Q2O)>2WT[Z?["?[*W_)K_P"S?_V07X/_ /JO?#M>]5X+^RM_R:_^S?\
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MTVVO?"J?%>6ZT'2_[>:Z$%PVER^));*WN-0&GO*'CMW>=+9I&*B,L:Y[XO\
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MM*__ .B:WO\ W^T;_P"*K8_LGQ9_T-(_\$NG?_&:/[)\6?\ 0TC_ ,$NG?\
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MH4TV19#,Z.6D3:I )KI8?CKX2T#PZG[*5S8:]-XS&F'X6_\ "00VUC_PCO\
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MC2KC(I<\-98255K$Q[T6FJB?+9\UB9?#+2.SVP_*]E]JVFV_2[9_L-?LK?\
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M8;%4G"6&G1CFZQCRR@UAYX:M*DN)5DW-2R?%2H1\-93R^KF%H&MM2%PFC?\
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M1Y_@K_H=+G_PK-0_^3*U/[8\2_\ 0AW/_@^T+_Y)H_MCQ+_T(=S_ .#[0O\
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M9C?A2=Q%3);_ !!/Q"30;+4O!J?MM'05NX_&$L.I'X>#X7%X&M].,9TE[?\
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M6\#Q0!F$>2US62U27?7731>7I;TN)VW[]$_)6_FMZ?=U/XS_  !_P4?\#?\
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M<V\O[WE^'FPMY/I_S!P\O^#^/=6O?V9XH_Z&6#_P3P?_ !^C^S/%'_0RP?\
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M>%2]P#X]UE19O"]\(FU65);B6UDN)-!MXB@95)A%S>K*GB)OAOK-_;ATL/\
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M>/)%8V5Y;(DTD;FW47#DIM+[22JV_A1KFM?MBWVK^$OCV6L]#\)6EOXCT/\
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M][DO]J>+?^A4B_\ !M8?_'J/[4\6_P#0J1?^#:P_^/5%_P (WK/_ $/>M?\
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M8GD>#P7*T\@C# ^R;4N7F7UCFYW4?(Z9W8)Q;K<O);]W?D]I;[?_ #\;E?\
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M\1"ZDN;N6VK=NNC?5=O5C2NGW[6;^>GGH]+*]S^TC]F/]JGX9_M6>%?%VO>
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M)OAG&QJ9A44Q47FW-"2IXOVGM<+4C.&?X&AB?;QP#H4:E/-I8%8>ACE@+X;
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M-EDT>WDM)89;%5LY-)3Q \LPFO(2R2Q6Z[-S"1BNT\G8_M!:OX[UVW_9<O\
MP_I]GX4U"^B^%K^(+6[N&UV/2;69-"CU!4DB-B;\P1+,X,(@,I8*BJ0!TWC'
M1[#]A*VM/$?@(77C"Y\:3MHE]!XIGCBAM8(HVOEEMCIEO YE,EBB$2%EVNV
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M %%%% !1110!_*#^W?\ \K3_ /P2,_[-A^(7_I@_;!K^KZOY0?V[_P#E:?\
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M9J#JX6>8^R?%JIRK\9?V?B\/A(3N"#0/[&O-37P%/'\,8-3$/B;X#-X<M/\
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M;XHLFE&/^R]-L=(U&,Z7&L>KN=1L<7T>V3_7<;Y2<."QP>$O_B_??L@ZK/\
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M_,93_N_W/+\_(YO'@/\ Y[ZY_P!]:E_\31CP'_SWUS_OK4O_ (FND^T>+?\
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M4V7B#XN>(+".^^$OQPM="5O#OP8\,2.WE>$=?EC3[ E\$CNX@E\))I&OH]Q
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M_P#^@W_Y4]2_^.5M:!=>%9M01-&U(W5YL9O*%Y>W \H%0[,DS-& "5PQP02
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M]LE_9NMM96;X2:ZFL?%X?$+4/B(IA:VLO%(\LWG]A?;OL*SBYLX8([?SF\[
M.-:XU/2I-&\+VFJ>-+C2_ &G37<GP1^(EK\4[X:Y\>M8^UN4T7QC.NFQ3W5M
MYQO+9([NXO8Q%:Q"4%PK#:77?$(\2:Q?Q6VG2_%VYLI8/'/P7;XF7!\*> ?"
MC6[K+XOT2V?2/L\>IPVQN[N*2.T@E\ZUCWRA55D_/(QJ1Y9*6*I\CE.,XX^&
M'=-X5?5Z=2.(JPE3PLL%3D\)1Q=:,J'#5";X?S6&)S*M#$Q_":=&O3BDI9I2
M5*&7NZXC67JBL#0C@TU.=.;R>.7J;P$:M1U9<$JH^#\3]:Q&84L3"O#-XO\
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M//F.=TLTXD_LKA2<G' \2JI_94,?]<4OW$GDV%;S+#>VDN6K&]-.6AY&*?\
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M!-Y_X2NK_P#RNH_M#PE_T";S_P )75__ )757M,H_P"AKP=T_P"9[Q+TY?\
MJ8^7]7T5I_RU_P#P71\O+^ODS(_LZP_Z*EJO_@^TC_"C^SK#_HJ6J_\ @^TC
M_"M?^T/"7_0)O/\ PE=7_P#E=1_:'A+_ *!-Y_X2NK__ "NH]IE'_0UX.Z?\
MSWB7IR_]3'R_J^A:?\M?_P %T?+R_KY,R/[.L/\ HJ6J_P#@^TC_  H_LZP_
MZ*EJO_@^TC_"M?\ M#PE_P! F\_\)75__E=1_:'A+_H$WG_A*ZO_ /*ZCVF4
M?]#7@[I_S/>)>G+_ -3'R_J^A:?\M?\ \%T?+R_KY,R/[.L/^BI:K_X/M(_P
MH_LZP_Z*EJO_ (/M(_PK7_M#PE_T";S_ ,)75_\ Y74?VAX2_P"@3>?^$KJ_
M_P KJ/:91_T->#NG_,]XEZ<O_4Q\OZOH6G_+7_\ !='R\OZ^3+'AJTMH-4A:
M'QM?>('( -A<:I8W<87>F9Q%:X?=%V9LH-QR,[2/]C7]F+_DVO\ 9Z_[(=\)
MO_4"T"O\=G0[O0I]1A33;&XMKG()DET2_P!.7RPZ;U^T7-I!&2W&(]^YNH4X
MR/\ 8F_9B_Y-K_9Z_P"R'?";_P!0+0*^(\498>7"_#[PV(R[$TUG6:)U,LQ6
M-QF&4E@L!>+JX^M7K*JE9S@IJFDXN,5*4K]6#34JMU):4W[ZC%OX];125NW7
M=/8]QHHHK\).X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** //_'FJ> +S1M>\$>,O%7AW1H?$_A[4](O['4]=TG3;Z32=<LKO2[B6
M*"_N(W*2127"12F)XFD1A\VQEK^5R7_@D%_P5?UC0/B-X0U#]L7X4Z?X1_9G
MATCQ?_P2[\;>$- \'>'_ !#X UW2]5FE33/%NHZ7\,K/4;?P_KW@*9O#GBS^
MV-5\4Z=K>J6FCWLD4VF+>7$?W3^T1^QY^S=^W1_P68\-Z-\=/"^D>([']E']
MCCPS\3%\'-+)IS?$O7OBG\5?$FA>&Y/&?V.:WO/$OA/X=0^"M5N;72Y9!9PZ
MQXLM8[II;.]N[*Z_=Z/PSX?A\-IX.@T;3K;PK%H:^&8?#]K:Q6VDP>'TL!I<
M>C6]E L<-OIT6G 645K"L<45LJQ1JJ*H"WNNFFS^>MOZZ]BM5;7?7].CWW7I
MV>WXF?\ !!W]D#]MW]D;]G_XW6G[<WC30O$OQ'^,GQ]\3?%_3=+T#Q+I7BFT
MT:'Q+IFEKX@OVO/#<</A/3I?%7B:VU/Q%)I'AB+^SHFOC>3&&_O+JTM_W/K\
MFO\ @FM?7OPS^*/[=G[&7_"4ZKXJ\'_LN_'GP^_PD?6=2N]<U#PS\+/C+\-O
M"_Q4T3P-<:Y?W%U>ZBO@W5/$.L:!9_;)Y+FUL+*VMY6)C&/UEH6R^[7R$U;3
M?_+H%%%%,04444 %%%% '\P7_!S_ /8?^%%_L9_;HM&E7_AK?P:8AK*^*&C$
MGVC2MIMO^$7EBF%P#@H;XM8A@AF4Q>8#_2UX.Q_PB/A;&,?\(YH>,9QC^S+7
MIN^;'INYQUYK^9+_ (.D[NYM/@/^Q:UM+=1&3]K[P3'(;6[DM&9&N](4K(8R
M#)&0Q#1GA@2#P37]-G@WGPAX5S_T+>A_^FRUJ5\4OE^0WM'T?YLZ2OX3?^"[
MKR6?[6?Q"UJUAG\1:CH5_H&HZ=\,8)UB_P"%K7*:!#$/!LD3QW:7*2K(;[RF
MTO5ANM0_V-MN]?[LJ_A-_P""[*-/^U_XTLM(,=AXYOM8\/6_P^\3W4$MQIOA
M/Q*?#L;)K6IQJZ0_9$LUN8";DF(O*J\,0:_+_%%7H<+)J\7Q+%36T'3_ +)S
M3VGM9)J=/#^SYOK%:BUB:-#VE7"_[1"D?AWCNX1X>X9E5BI48\:93*LI1<J:
MHQPF9.M*O*#5:EAHTU*6*Q&%?UW"X=5<1@4\92H)_@@ESJ&GS:EJ5MINK>+K
MKXGB"V\5^##J]O(O["45U!)%/KUI!]CO/[$;05U&YU(O'9> R&\&+(L]L(0]
MG5CTPW%E:?#N3XB:WH_AKPY?1:UIO[9'_"10BY^-M](TMX_PLEU874+WT-G/
M?W&@FR/C'7%QX.1!I4?D?9[.]:VES/>^,[?PY+9Z/XG\.1K+^U=K-WHM]]D^
M/6E0VUXVK6'@LR2>5--?V<'B6VA&C;GC?6[1%RYASE%O!$7A/0]>U+PO/>?L
MU:AJZV?PO^#$6@ZNOBSP1X]2XOHKGQ7K$:R_VK'ITVKP>)=02:[7[*D&LVF,
M(T0'QL:4E5ARQJ\_M*7)R0HSK>W]B_J2HTJE3V%3&?4^=9/A:UL#F>4>TS'/
M?^%NG3M^$5985XJ@J>&KNI]=PL:4*.#P=7$O%5L-7J8"EAL/B9_4\3FF)RCV
MF(R/+L;;),XX6CB.(N*G#CFAA4:G]NZU)=Q_$9OAKJEKXFL;!=&@_8N&H6XM
MO$MF;L(/B<VD#1$BDF= )S>GP5<[D C.I;L.(39R6-OJ/A&V\6ZUXHT;QO<W
M>HZ[^T/_ &[%)-^RU< 1RIX)M[\O=MI48DLX=-2V3Q%X6,0\1.K6)63RKC4;
M3?&2^*K;P_<>(='E_::GT476A?&M=&N!X0TOP-]IWKX6N&$HTH:BL0*>1(?M
M(8^:0%Z8D?\ PC,^A>*-3T+0FTOX-Z-J5S#\>_AS<Z+JG]O?%7Q.TEK&=<\-
MH\GV^2S%Z^CW7F:<OD31Z=.%;:DI5JE'EIJ$(\G)@?9.C*=6GR*NW@7AYXBK
M[2O1^L<ZR2MBO]HS;,%5P>?VRVG1,*<LO=&A[&C"<7A\K>&E@Z=7%0J0JUZT
M,CGE]7,)^VQ]#$XE5:/!M;-DL7Q9F,<3E_B%RY+0P;<A%Y?Q:;:W$VM>$XOA
MB&7PKKRZW#%_PW2+:)4A>\<06G]N-K@L8+L,]QXZR?%4CG[0)2]U<CU'5+>]
MN/&$?@[5=;UGQ@+32M:_9P;4H)(/V<[.2)X)/'T&F_V5,FGM A.JO*GASPZ7
M=#(NH*09!3N(;2"W\%R^(;6#5](\1*/^&4["VT74O/\ @.KQ6O\ 9:>,Q%*9
M(#903Z!%<?VP5(?2;E" 5D TK>RUZ3Q%KVE:9J>F6/QKTJTM[KXS_$J72;M=
M ^)/A*.V+3:!H$CRG3VOY-/+V:_8=TL,C ']Z0"1II0?-&'(HXI2YYU(T/92
MKQ^M>TJTZOMX85XRW]I8BE_M> S?ERW*[Y'*;(I3RU4U*="BL.J<)2E*.)6#
M6$I5O98J<\52E_:,,LHYPUA\PS"C?.\#Q4X\.9(I<#2G(R&T@2:9_P *Y;XE
M:Y9>&F=M;;]M7_A(H5NTOWG>0_#)M;^U))B W,NGF ^-0NS1EB.EH4\N"PVJ
MZO?W5KXRN/ NK>$M;\&VRZ5H?[,8U."*W_:0M%< ?$"73/[(M(]0D<2/-Y[^
M&/$A']EIF_RJM%F2R> U\'C7[GPG<S_LQ#4#9/\ !)-#UAO%Y\<B:?SO% @$
MAU?^S9+M-3N%&!"4OHI<[#'NVKBP\2P^(?#^D>(M6TO5_CEJVFPW7P3^*5KI
M%VWAWX;>$#)(8_#OB"2*;^SA?1QQWJE;]O/D:[0L/E6G.D[R]I&;E>K[3VJA
M2J<_LX+,/;0H5/9TJRHN']O4L/\ N,HP3I8KAI?7IUC*M+!*3]MAG"48YO'$
M+%X:&%E!T:%.>?1QRR^;IX.6%I.A4XV667H\)4982OX:<^/Q6/1&@N[(ZA'!
M-J_B9/B ]P_B/4#K$,I_8]9HU?[%:$PW7]D"T9!#&L<G@XQLX81H,+78?#JT
MDN?&G@;PO-XCU30=(\&ZUI]WHOQT?5XV;]IN5MJ/H%U<H]J^JI'L6ZDB.O>)
M@[W E$"@,7XRWBMIE\6/H=K!I=KH4ERO[2%K<:1J(;XR7 "I<S^%?-E#2K/(
M$D#:6"& :.,CG'6_#XZ#!XB^&.IZKI#7_P *=6\0V$7P,\"6^F:A#KGPNU@%
M=U_XA8R_:8(&@:&$'4@$C\LQ$,[XKES"$E@L;93Y_88AQM"FZGMGE]14>2G.
M;H2Q*P5_J>'J)X3$9.YYGC;YY")AFKPCR_,%'#8A8CZM4A'DP-!XWZU+*76I
MPAA9U/J$LSJ93?$T<OJ?\)%;AA/B3'/_ %WC")_I"_\ !,7_ ),3_9[_ .Q?
M\3?^I_XMK[RKX-_X)B_\F)_L]_\ 8O\ B;_U/_%M?>5?LO!/_)&<(_\ 9,9!
M_P"JK"']J\#_ /)%\(?]DOP__P"JG"!1117TY]0%?YOG_!:3X :7\?/VV_V@
M--U3Q%?>'X_#WQD\97D4EA907CW+W_V&(HXGFB6-8Q;9! 8L7_AV\_Z0=?YF
M'_!>WQO\6/!/[:?QKN/A3<ZY;WU]\:_'D.K#1-'367DMH8]+>V^T0M87_E*D
MCS>6X6/)9P2V,#]5\,<5E6#I\88G.\OJ9KE=+(L,\7E]&G&K4Q,99SE\*<8P
ME4I1ER5I4ZKO4C90<KMJSX,=&I+V$:4U"HZDN63V7[N3?1[JZVW9^4%O^T/-
MX]NX?V5;CPG%IVDZC-#\*F\80ZT]QJ,5I:R1Z"NL#2GTN*V>X:.$7#6AO%CW
MDQB;&&K6UC1K']@F&+Q)H!N?B-+XVD.AS6NKRQ^'TL$B4W_VB*6S@U(SLS6*
M1^6R1 "1FWD@"O1-=\&?#?1OA"_Q(\+Z7HD?QMA\(V?B2TU"RO'N_$8\;RV$
M-[/<1Z&;R>-]2_M-Y7:Q_LUE2;,0ME"[!YE\ ;_7OC1JFM6'[3\,VK:7I%@+
MOPW'XTL?^$6@BU"2XM897M)(HM$-U*;>2X4HSS!4+L%&,C]?Q7]K4LRPF68S
M$X;$\9YDL=B.#.)(9=A'@>&\I483_L_&Q^K0C*L\/3Q=+FG@L8^:O!NM>TH<
M*Y'"<X0E'#0YEB*+7OUIWC[T%=W5W%WYX[/3OH6/P-T?]JBP'[06K:WJ7A#4
M-121CX:T^"VU6SA_L++1@:C<"SF?[00=Y-JOE@@ .1DY6G?'67]KF^7]GO6/
M#$?@O3M<,MQ)XETW5VUB]MSX41]<A5-.N=-LH'%Y)I:V\A:Z4PI,SKO*!6Y;
MXM>-?BQ\-_']SX)^";:SI_PJ@6R^S6OAS0EUO1$6\9AJFS5WL-2=@5SYQ-^W
MDCH8P!CWCXP>$O 7PQ^'=]XW^ ^F:1I_Q4L9=)32[SPQ=/X@UQ8M2O;:RUSR
M=*ENM5699-,N;U+EC8R&"%I)0T93>O)"M5JK/'@*=/"PR&>._P"(I1J9=A&^
M._9T:CQ7]E)TJG(L0L/FZBZ;RO\ Y&%%VC:/LFU9T^9.4JB_V)I76&3A'E]I
MJK6;ATG?E=_/SG6O$<7[!!MO#&@:>_Q&A\?+)J\]WJ]ZOA^337T1EMDABCL[
M/4UN5N!J;,SNT)C\E0%;<2--/@)H_B"S7]K677M1MM8-NOQ6_P"$-2VMI--%
MUH\8U*/1_P"UF9;KR)C8+"]Y]C\Q?,:00':$-CX 6EM\:-,\0:E^T]:PZOKF
MC75A:>&6\:(?"]Q;Z?=)=R7ZV5M$=%%Q%)-#:F:4Q3%&6,;UW8;S+4_&_P 7
M+'XP#X8Z6^N1? C_ (2S3O#7V"#0ED\-#P1=W%K!J%O_ ,) =/>0::]K/=++
M??VINC1G87*%=R\E7&86G@<LS'&X%8GA'-*]'#\$</0R["?7.%\ULX?7L?)1
MA*5)8F&(K6GB\<G"K']UM"+C&3FXQ=J\/9O$U?L5J=E[D'WM9?#"S3UU;.OT
M?Q^O[>4TWPPU_2#\.K3PI&/'L6K:1J']OW%[<6C#P\NG26MY8Z;'#"\?B&6Y
M,ZS.X>V2,1E9&94UKXQ/^Q)<0_!71/#R>/[%[4>+QKNJ:HVA7:RZ[//:R6)L
MK73]1B9+?^RA(D_GJS^>4,2^6&?K_CYI.C?!KPKI7B+]F.QM-*\::EX@@T76
MY_!A;Q1J$GA>73=2OKB*YL99-:6"S.K6&DNUV+:-DG2&$3J)S')J?!'PUX/^
M+?@9/%O[1FG:9JGQ%.J:AIGVGQ=._AO5ET*S$+Z9$--BN-(46JR7%XT,_P!D
MS*SR_O7V@+T\G$#SA9)3S#!P\2XX;ZU7XU>68+^RZN2N]LLC'ZFZ?ME"5&/,
MLMBVZ;7MM6W"=/V:J.G)X/1+#6_>*HI*\WK>V_V^J=M=.5OO@%H_P)MKK]J:
MQU_4O$.KZ#')XR7PC=VUMI^G7,_BT&PN+%M4A-S<Q16:^()9(9A:2-(UM&KQ
M@.Q'7?!+XBG]K#QYI/CC5-''@NX^!$S7%A86%^=9A\1-\0;2\LYUO)KBSL'L
M%TP>%89(C"EP;DWDBOY/E*S^&>!?''Q=\8_%NT^''Q+?7+OX(W>MZ]I6HV6L
MZ$-,\.2>']*MM3G\/1SZ\EA92):I=V.DFUN/[30W3K C2S"<K)]1MHWA[X;?
M%SX0Z/\ !.SLM,\,>,[SQ3'\38_#4AUJSNXM$TZQE\*#6;N274CI:PW&HZV;
M$I/9?:WDN58SB +'?#&)AC*^"S'(L-#*>#<-G>58#/.':^ PL,=F7$];'8*C
M@<]P]10K5*>%PF88K),74Y,9AU&&5UVL-.[A6552BG&I+FQ#A4E2K)>Y3I*%
MY4Y;).454BGRR=YIWUNO]03]A_\ Y,^_9I_[(OX _P#4>LJ^IJ^6?V'_ /DS
M[]FG_LB_@#_U'K*OJ:OYJSW_ )'F<_\ 8US'_P!2ZQ[E/^'3_P $?_24%%%%
M>46%?Y#'[>^HM8_MJ?M7J-(U/4_,_:/^-QW:?!;3+%M^(_B$;93<75N5+YRN
MT."%;.,#/^O/7^0Y^WI_:G_#:G[6/]G_ &79_P -'_&WS?/#%MW_  L?Q%MV
MX(&,9S[U^X>#$JL9<4NA+$PJ_5,JY983"TL;75\954N3#5DZ=1.-U-R7N0YI
MKWHH\_'V_<W2:YY?%)Q6RWDFK'R#_;[_ /0J^(__  !T[_Y94?V^_P#T*OB/
M_P  =._^656/^*E]=._)_P#&C_BI?73OR?\ QK]J]OFG_03Q%T_YIC+?+_IW
MYO\ 'MKYZ4=-*73_ )?/^[Y_\-K_ "HK_P!OO_T*OB/_ , =._\ EE1_;[_]
M"KXC_P# '3O_ )958_XJ7UT[\G_QH_XJ7UT[\G_QH]OFG_03Q%T_YIC+?+_I
MWYO\>VHE'32ET_Y?/^[Y_P##:_RHK_V^_P#T*OB/_P  =._^65']OO\ ]"KX
MC_\  '3O_EE5C_BI?73OR?\ QH_XJ7UT[\G_ ,:/;YI_T$\1=/\ FF,M\O\
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MZ/X8UCPKH_A:SO/$NEZ1>ZS=:SK>NVZS7-G:#36B6WDTZ\U)6N3:^-?MB_\
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M^?U7],77=?>C^U[KS^Y_Y']7-%?RC?\ $7A^P?\ ]&J_M\_^&Q^#7_S^J/\
MB+P_8/\ ^C5?V^?_  V/P:_^?U1==U]Z"Z\_N?\ D??/_!?I0_[%'A9&^Z_Q
M[\%HW;Y6\(?$%2,]N">:_P Z+X\ZC-^QG<^'(/@;%#HT7Q)&LWOBI-;63Q$;
MFY\,R6":4]JVJ23&R$:>(-2$R0;5G\R(N/W*5_2A_P %.?\ @XR_91_;7_9Y
MTGX1?#3]G7]L?PWX@L/B3H7C*74/'/P]^&MCHS:;I>@^*-*GMXYM ^+GB*]-
M\\^N6TD*-8+ 8HIR]PCB-)/Y8?V7?C/;?!>/X@+XV\!_$O7&\4ZAH=UI1T;P
MY%J'V2'35UP7*71U;4M,,+2'4K8Q+;"=7\N7S&39'O\ V;AKB#)(<*Y+P_4S
M2ADF<5\PSZM2XIC.I]<X4IQ>6U^:E3HQIU9KB"E0JY9/V6-PSC34G45:#]D_
M-Q%.HZ]2M&$JM-4Z4?8.*Y:SYI+7FNOW=U+6+3\CZ(T#X1>!_''PRM_VCM?T
MZYF^*6HZ3?>*;G5K?4+VUTYM7TR\NM/M)$T:&8:<D*6EA;1M L&QRK2,"[LQ
M\K^"/C+6/VPO$&I^#/C;]DUC0?#^EG6-.M]%M_\ A'IEOYYXXWDEN=,>*>6/
M;;QA8F?8IW'G<:^</%OBS5==^/%[\3;'PEX]@\+W/B&QU6/2I]$GCU);2VLK
M2WEB:SAN)=.$KRP2.J+?&)@P9I%8L![E^T]\==-^,WA;1]%\%_#_ .)^BW^G
MZC<7<]QK'AFVL(9(9?LFU(Y=*U;4IF?]P^Y7B1.5PYR<>M#BSAN<,9BXXK"8
M3#Y)4S"CF601JU'1\3ZDZ'L(YICI1I0I4*F(JPEBN7%X?-)QG6?[UR3G*?8U
MO=CRR;J\[C6<5S8-.,;4X+=J]U>,J=TM4EH3_%'XI>*_V8?B'<_!/X2R6&E^
M U&BZFECJMDFMWR7?B:RLY-6;^TM0:6[9)7YBC:0K!R$PN /8/B1\+O!W[.W
MP];XX?#+3[C3OB"D6EG^T=2O[S5[)SKT:SZF6TR^FELOWTHW)LB4PCY8BHKS
M']GC]H71?A1\*SX)\6?#OXIZOKAU77;XWVE>%[.]LO)U)($M4^T:EK&GWADB
M\H^8IMMB#;Y;OT'SY\#?&.H_#7XMCQUXE\(>/M3T +K(&G:;H<UW>C[?,LEM
MBVO[FRL@(E&U\77R=(PXJZW%/#T/J4I9KA<:N(%E_P#9-.52K;PCMA*=.3R[
MFIS^L/!RKTHKZDLHURFFURN5/V*C1J^]^[E'V3]]\J_VZT7?GVMS6?Q>T^*W
M<^N/@AH6E?MDZ#JWBSXXV@UK6/"6K_\ ".:+)HLUSX=A@TR2SMM3D2:#2IH$
MN)6N[R9O.E#,$*QC 7GS9_C3XV3XO-^R\)M._P"%2+XS/P;_ +,.GQ?VK_P@
MO]H_\(M]A_MO/]H?;?[&/V<:EYOVL28N/,\[YJ\[_:F^)LGQK\0>&-5\$>"O
MB+H=KHVBS:=>Q:SX?_L^6>XDO[BZ62%=(OM3CDC6*54+3/&X8, A4!C[>O[2
MOA\?L_?\*L/PW^*W_"5_\*I/@C^UO^$5L/[+_MS_ (1@Z-]O^V_VU_:7V+[;
M^_\ M'V#[9Y7[S[-YW[NN-9_DM6KB<OI\24L%B\GIO$9AQ;">(>(\1*27M/[
M(QE.+A7I4Y0DL*Y8G%YC3:II^Q:M!+V55*,O8N2J."C1<8J.#>B=2#U4FM](
MP:[K5F_\;] TG]C;P_I/B[X'6?\ 8NM>+M87PWK4NM3W7B*"?2X+*[U...&W
MU6:>.WE6[MHF,T05V3<C9!&.B^%_PG\%?M,> [#XT_%;3KC5/'>H?VG:W%]I
M>H7VBV0AT"YGM]-5-.T^>*T4Q1QKYC&,M,V3(6KY._99^)DGP4\0^*=6\;^"
MOB+KEKK6BVNG6,.C:!_:$L%Q#?)<R2S)J]]ID<<;1*4#0R2R%B R!?FKDOV@
M/&&I_%+XJS^-_"OA'Q]I.A2V>C0+8:GHDUG>"33TVW+&WTZYOK/;*?\ 5D7)
M9Q_K%2L8\7\-4J%//9X3 XG*Z^)CA:7A=*LU@,JKQBT^(:=>6%GA)59NC4DX
MPRNE5OF$T\0[2=1JA7O[*\U.*YGC>1<U173=)J_-:S6\VO<ORWV]T^%?QB\:
M?M*_$2Q^"GQ3FT_4O FHG6+N[LM+T^+1KZ2?PO87NK:0RZE8F.ZC$5]86TLJ
MQNHG56BDS&[JW^AI_P &ZVFVNC?LW?%O1[%76RTGQ]X<TRS61VDD6TT_PN+2
MV5Y&^:1UAA0,[?,[ L>37^?=\>?VD=!^)WPNO/!?ACX<?%72];N+_P /W4=]
MJ?A:QM+-(]*U&VN[M&N-/UF^NPTT$4D<06V*NS!92B,S#^A3_@DA_P ' '[,
MG[ ?P*U_X8?%K]G_ /:Z\5Z]JVH>%[N&^^'G@#X>ZCI2)HGAJ#1KL33>)?BK
MX7O \MU$TEOLLG#P$/*T4F8A?$6>9/2X1SS(I<3TN*\VKQR3%4<^J^VCB\30
MCF=>3R10KSQ-14LHC2J8V,GBW3D\TFH4*;C*=6Z%.I[>%5TG0@HU(NBHKEB[
M1M4O%)7FGRM<M_=NV[M+_06HK^4;_B+P_8/_ .C5?V^?_#8_!K_Y_5'_ !%X
M?L'_ /1JO[?/_AL?@U_\_JOP^Z[K[T>E=>?W/_(_JYHK^4;_ (B\/V#_ /HU
M7]OG_P -C\&O_G]4?\1>'[!__1JO[?/_ (;'X-?_ #^J+KNOO077G]S_ ,C^
M=C_@XL;4T_X*Y?M5'2;>PN;CRO@('34;F>U@$/\ PS7\)2SI);VUTYE$@C54
M,:H49V+@JJM^'OG^-/\ H%>%_P#P<:I_\IJ^XO\ @K#^VKX&_;Y_;?\ C-^T
MO\+OA]^T'X%\$?$;_A63:-IGB?PUH6C>-+9O!7PB\%?#[4X=7AT'Q%XKT9+>
MZU;PY?7MFMIJ]TTMDUA-.;6Y,]G%^;.ZX_YY?'3_ ,!K?_XU7])X+C7)J.49
M!AJ>?XNC+"\/Y+A:]+"9U@,#2I8K#Y?AZ6(I.ABLLQ%55*=6+C4DJKA*4;QL
MDSRIT:CJ5'[&,DZDVG*E.3:;NM8SBK6\KKJ>B>?XT_Z!7A?_ ,'&J?\ RFH\
M_P :?] KPO\ ^#C5/_E-7G>ZX_YY?'3_ ,!K?_XU1NN/^>7QT_\  :W_ /C5
M;?Z\Y7_T4>:_^)+E'E_U)?3[O+2?8U/^?%/_ ,$U?_EOK_2U]$\_QI_T"O"_
M_@XU3_Y34>?XT_Z!7A?_ ,'&J?\ RFKSO=<?\\OCI_X#6_\ \:HW7'_/+XZ?
M^ UO_P#&J/\ 7G*_^BCS7_Q)<H\O^I+Z?=Y:'L:G_/BG_P"":O\ \M]?Z6OH
MGG^-/^@5X7_\'&J?_*:CS_&G_0*\+_\ @XU3_P"4U>=[KC_GE\=/_ :W_P#C
M5&ZX_P">7QT_\!K?_P"-4?Z\Y7_T4>:_^)+E'E_U)?3[O+0]C4_Y\4__  35
M_P#EOK_2U]$\_P :?] KPO\ ^#C5/_E-1Y_C3_H%>%__  <:I_\ *:O.]UQ_
MSR^.G_@-;_\ QJC=<?\ /+XZ?^ UO_\ &J/]><K_ .BCS7_Q)<H\O^I+Z?=Y
M:'L:G_/BG_X)J_\ RWU_I:^KZ1)XA>^B&JV6BVUMN0B33[^]NIS+YB;%,=QI
M]J@C(SN82%AQA2":_P!A[]F+_DVO]GK_ +(=\)O_ % M K_&@T;5IM'O5O&T
MCXPZH -IMM5TV*ZM@"Z,9%B0P$3*%PCE\#)XYK^]+X/_ /!V#^P_\/?A+\+O
M .K_ ++W[=MWJO@?X=>"/!^J7>G?#/X0R:?=:CX:\,Z9HM[<6$ES\<[6Y>RF
MN;*62U>XMK:=X&C::WAD+1K\5XC<297G.0Y+A\+FE3'XO#9IF%:M#$8ZAC\1
M3H5<+A(4I.MAL+A**I2G"I&%/D<XR4W*34HI=>$A*FZCE#DYN2W+"44[<U]&
MY/JNMM?4_K^HK^4;_B+P_8/_ .C5?V^?_#8_!K_Y_5?HK_P3A_X+G_LJ?\%,
M?BCXG^#OPE^&W[17PO\ '/AOPQ)XOBLOC5X#\.Z)I^OZ-:W,5KJ,FDZOX,\:
M^.M.AN-/DN+8S6VM3Z1)<+.OV#[6ZR(GXW==U]Z.Q._?[G_D?M)1113&%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?S.?\%Q_V7OVYO _
MQ;^$/_!4+_@FQ<:WJ'Q\^"W@J[^%_P 7_AWH%HFL7_Q&^#Z:O<>)M,B'A>=9
M8/%]GH6K7FK?VCX9$$]Y>6^J+?6$,UWIT<3_ ($WW_!T3_P6$^(^HK\$_A_^
MRO\ #K0_C'<EM"CMO"GP?^)FN?$:+6)-UJ)I?!WB'5M;L;>]@N SRPS^'H;6
M%T?SXHXHWV_U[?MD?\%.?$_[+?[5WP/_ &1/!'['/Q>_:8^(?[0'A34_%'@>
M;X7^,/AYIUO;P^']36P\4?\ "46?B35+2Y\*Z/H%O<Z=J5UXI\0-IWAZ:SN;
MMH+YCI&I>1\]?\%:O^"L=M_P2CD_9'^*'C/X"Q>+?"GQHF\>Z7\3/!N@W/AJ
M'Q]X?U[2O"_A[5-)AT?Q8PDT2[&BZMJ=]::L\9DMM8CA1[&[AC996A]7=I*W
M-\VDK/OJMK]- =[;V6O;IKU3:^^VOJ=E_P $,OV//VB/V:OV</'_ ,4_VQ-8
MU/6?VK_VM?B9??''XPC6[J.]UC0;C4--LM,T+P[J5Q!+-;K?6>FVBW5[9VTA
MMM/O+V>RAPL.*_;:OS6_X)<_\%-OA+_P5/\ @#K7QV^%7A+Q-X!C\,>.M5\
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M729_@[XKDTIXX]3,JJ-.;XPM;K9+H0CT9;#!1'07@EV'[(,?PO\ \&>_Q?\
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M+O7_ (,R?%PD1F_;U\.,@ELV9!\!]64M%%IS07D8;_A:+!6N=1*WL4A5A;P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>nt10015006x17_trichart1.jpg
<TEXT>
begin 644 nt10015006x17_trichart1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M$L<\$\:30S1.LD4T4JAXY8I$)22.1&5T=2592&4D$&I*Y#NWV"BBB@ HHHH
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MK_9Z7YI? [3_ -F;QE\*?VUOVG_VRK3PMXBUC6OCA\4/A[XAO?$]G;:[XC\
M^"?#<NG>%_!_@KP7IDT5U?:'K2?:A<:1_8$$6I74US83)*ZVX9?V-^ _A3PM
MX'^#'PP\*>![CQ+<^#-'\$Z!!X5D\8R7+^)U\/36$-WI%OK0O+>TNH+VTL;B
M"U>SN;6WFL5A6SDAC> H/--;_8H_95\1_$Q_B_KGP0\$:EX_FU:#7[O5KFPF
M>SU#Q!;<V^OZEX?^T#P]J.MQ/^^75+W2I[PW(%T\S72K,/J0      #  X
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M="G4Q.:5L7BJ+<X>TA1Q. IY=ELZT(NJJ5"J^247&$OR,^.=K\$_@Q^VY^S
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MAZ\>&W1?"T&J:;<3:'###%&MO<-(T44\LT2>F_%C]C3]F/XW^*T\<?$_X/\
MA?Q-XN^R1:?=^("-0TG4]6TZ"-8H+#7;G1+[37UVSAA1((8-6-XL5NBV\>V
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M'9O1S+!82-:<*2G4G4I2ABJ,56A2P4:N&G.U>DY?7          &  .  !P
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M[]]:N-,DOGU"W$:+!?O,UW"JJL4R* *2SZE6PZH8N&*?-4CB:U:C5BJU:O\
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M,I!K\V_@A\%O#OQZ_;5^./CKXR>&]&^*/_#+7P@^#7P$T&P\3Z?:>(]"O?B
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M2>'P]:,8R]MB*&,Q5+$RA"-VZ5+"X5UK)N3JXG"TU*U3F6,^+\0J&)G'+?\
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MJ5%%*<U%MM*4DY)-MI.UV%%%%9FH4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<O.N:U]3C1\// Z^.Y/B>/"NB#XAR^&T\'R>,OL$)\0/X6COFU-- .HE?/\
M[+74':\^R!A$;@^806P:\OT#]E']FOPM\0I_BMX>^"/PWTCXBW%]<ZFWBVR\
M,:?'JL6I7A<W>HVK^48;*_N6DD>>\LX8+F5W9WE+,37T%12CB<1!24*]:*G3
M5*:C5G%2I*Z5.24DI4TFTH.\5=V03PF$J2A*IAL/.5.JZ].4Z-.4H5W:]:#E
M%N-5V5ZD;3=E=Z'%^'OAUX%\)ZQXR\0>&O">AZ)KGQ#U*WUCQSJNFV$-M?\
MBO5+6U:QMK[6[F-1)?W%O9LUM#),S&.%F1, FO.=7_9;_9UU_P"'FA_"76/@
MS\/M0^&OAG5)=:\/>"Y_#MD= T75IY[RYGU#3;)45;2ZGFU"]>>6$HTPNITE
MW)(RGWJBB.)Q$)*<:]:,DX24HU9J2E2@Z=*2:DG>G!N$'>\(-QC9-H)X7"U(
MN$\-AYP<:D7"=&G*+C6FJE:+BXM.-6I&-2HK6G.*E).23(+6VM[*VM[.TACM
M[2T@AMK:WA4)%!;P1K%##$@P$CBC1411PJJ .!4]%%8[[G1ML%%%% !1110
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MTMD(S>1>&-#O[ZWU/7I+02Q&Y32K6[:#S$\T+O7-+P;\6_A5\1=5\2Z'\/\
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M-KW[57Q)^%/Q2FTWX@ZY:#P!\+_B'X-U'P+H_BKXE?#^X\,>!9?']AXJ\1>
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M$7P4^)GPU\3>)/%FM1?"_7O$?CWP.=#^-O@BWL7L(+_QOX3N;*TT>TAA,/\
M6#H7@+P1X8L;[3/#?@SPKX<TW5$\K4].T+P_I&D6&H1")X!'>VFGV<$%W&89
M)(MD\;J(I'C VLP/C/Q>_9,^"?QF^'>E?";Q'X3MM%^'FG?$/P5\2KGPMX*M
M],\*Z3KFN> _$-GXGTBRUZTL-.\C4-$O-5T^S?6[$1P2ZA##'";J)0Q/G9=Q
M;PO3QV9T<5PTX9!FV(RV4\OHU8Q>"AA</0PV+KTG3A3E5KUO]KKX>A5;PV'Q
M5>EB::C4PZE5N5.IRVC4]]*5I/9WNX\R6C4=+=E=;ZGXSZ'_ ,% _P#@H#X=
M^(,>@_%0? "QA^&WQ+_X)Y?#+XQ>![3X:>+;3Q)?:U^V59Z18>-K?1/$P^*=
MUIWA^?X=Z[J,SZ7%<>'M;%^;=K>[N'BC!G\INO\ @M1^T+IWP^L]9T[1_@YX
MZ^)7A_\ 9W_;4^(_Q-^'&B:-K2:KX-\;_!']HK2?A=\+D\2:5;>,KO6/#&BQ
M>!=0N?%OB_1=1$>K:Y:6$FHZ9?:1:3P _P!+MUX-\)7MU=7EYX5\.W5Y?WFC
MZE?W=QHNF3W-[J7AZ19M O[R>6W::YO="F59='NIFDGTV1%>SD@95:J5M\.?
M %GJ%]JUGX'\(6NJZH-3&IZG!X;T:*_U$:U]G&L+?W<=FEQ=C51:6@U(3R2"
M_%K;B[$H@B"XT>+.%&X3QG ^!JRA+#SY,/6AA:,_9X&5"M2G&.&<_9UL76K8
MSGC/VT'##TG4G&BD-TY_9J-+W=[-Z2N]?.*Y>_7J?SG_ +27[4GQ&^&OQC_9
MQ_:0TSXE_!G]KKQO\+OV/O\ @HKXNT;6O@9HUSHGPXU^[\.Z-\!]4M-)U72-
M.^(GQ!G<^'9)1?\ B9[#Q3#<RZ/;Y@M=,O\ +UD>&OVYOVH_C7H?[.6N?&2P
M^$YBM?V]_P!F71?!WB;X5?$KP<?[>T#Q_P#"[XI:UX@TCQAX8_9Z_:C^,ECI
MT^A:AIMM)I&E^/?$JZ?XBTC4K636O <FH:;-)#_23I7P\\ Z%'I\.B>"/"&C
MPZ5:ZI8Z9%IGAO1[!--LM;:%]:M+!;6SB6TMM7>VMFU."W$<5^T$+7:S&*/;
M%IGPV^'>BVEO8:/X"\&Z58VFKIK]K9:=X8T2QM;;7DB>!=;@M[:RCAAU:."6
M6%-2C5;Q8I)(EF",0:7&F2+#86C+ABC5Q.#I5<-1Q\YTJ=>.&GCL;C%3HPPM
M&CA\*HK%U*4HTZ4HU8U:D917+2<$J<[_ ,1V;BTE9)6Y4[Z:\UGOHGKHVS\7
M_P#@F[^W_P#M/_M&?%#X/^%_CK-\'-4\.?'C]DSQ=^T/X>'PZ\$^)O!^K^"]
M5\"?&V?X3W6AZE=ZUX^\86GB2TUVSV:U)<PV>B26-Z@M((F@5VF^#]!\:^*A
MXT^"WCBW\6^(]*\3_%[_ (*$_P#!5J[^)MKI^OZEIZWL_P /?@'\1/!?@;1]
M5MK2[B6ZM?"_ACP9X6ET:TO?.73'AM[VS$+K#(G]4&D^"_"&A26,VB>%?#FC
M3:9ITNCZ=-I6B:9I\VGZ3<70OKC2[*6SMH7M=.GO1]LFLH&CMI;O_27B:;YZ
M\D^&/[,GPC^$VJ_$G5?#'AU9W^)WQ6\3_&?5;37?LFM6.@>.O&WA_2?#OC&[
M\&Q75EYOARR\36VE&\UFTMYY/M>H:KK,AD6VOS:QWAN,\CPN*SC%X3AZ& AC
M<,J%# 8>5)T)7HYSA>2<_8QITXTJ>98"N[47[:ME:E)QJU>=#IR:BN=Z--M[
MZ.FWJFKW<9=-$]W9W_D@\8_M._MX>'?V5O\ @F]XB\)Z)KOASQ!8_L2_M7ZY
M\-_&VB?&?6_B)XJ^,$^D? S0I)O&WB;P,?#.C/I?B3P+I33^)/#-KK&K>.KD
MZF1);7$<UK(;S]&?B%I'[+'@#X$?LO?%#]DOX[:M\7O'WA_]KO\ 8A\3:Y?7
MW[0_B[XT^(M8USXH>*)_A;XJU+Q#I/B'Q=XE'@KQ!X^\%^-/&Z^)](T[3/"E
MK?+HS6TNBP+I @3^B&W\&^$K)=!6R\*^';5?"]I<:?X92WT7385\-V%Y!':W
M=GH(CME&D6EQ:Q1V]Q;Z?]GBG@CCAD1HT51XGXY_9/\ @EX]U3X8:CJ'@ZQT
M2#X4?%C2OC5H>C^$;73/#&BZW\0-!T?7-(T'5_%]CI>G1?\ "0)H;:[<:QID
M-Q+&8=;M=/O)'E6V,,GH5?$/*L75P/\ PB5,HHX7%YEBL3#+:ZG1S2CC<?F&
M/C@LPI8B$Z]6G&.*5&FEB84:-:OBJM.C2P[I4*,1HSBI)U'-M4TN:ZMR*,6U
M;2]^:2VWUNUK]'IR!\NW  QTQP.,?0#'M@=C3Z:J[0!Z#'\L^@Y(ST^F*=7Y
M)%6276VNWZ:>6FG;0Z0HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%)_/Y;_U_2 _+
M?]N_X::]XP_:@_X)@^(-#\!ZKXHTGPG^U5XSU/QYK6E^&KK6;'PSX=G_ &=/
MBUIUGJ/BV_M;*XBTG1)=9N+#3[:]U:6"Q.J75E:1R_:[FU0_AW^T5XP_X*2:
MK\1_VO/V8OA3\4_VE0O["VO^,/B5H/C?X6^-/%NL_$'XH^&?VL_B1\+M1_9W
M\ :Y:Z+)?:OXA@^#WP]D^,=Q:65[#>6%MIVC68N;2"STP))_87@?X>OY]<^_
MO7%:!\-O 'A7Q/XU\:>&O!?A?0/%WQ(N](O_ (@>)]'T/3].U_QK?>']-&C:
M%=^*=6M8([W79]&TD?V;I<FI37#6%D6MK8QPNR'[')N*UEE'#TL1E>$Q_P!1
MP:H8%8J$*T(UWFD\9.O451248O!XK'8-0C&2YJE"NUS4(VCDU;3:;DIZ:=%&
MRMMLFWHW;5O8_G4_;@\/?MG?"OX@S?#3X4?$;]O_ %Z+PK^SA\-G_8PUWX;Z
MGX^\>Z9\2OVF;_XK:S/\1X/VJ_'%AHNJ:#J-K::!-H(6V^-6H>'_ (=6/@1-
M0@T;;JD44;>"_'8_MT>);W_@HAX&NK;]JSXW6&J^+/A=XI\$:S<>"/C)H?@#
MX=WNE_M8_#RS7X/?#GX8^+O"-QX,\5Q:!X*M-:U[1?BU\"M;U'0?$WP]M9-=
M^(<,FNW,,NE?UM8YSQGUQSC\_K^8]*7'^?\ /'Y5OA>,UAZ.%A+(LMK5,.J4
MI5Y1A"I5JTJN#J>T;A04X>T^JRE5IQJ\L\1BL16DY0DJ":C:2ES2=G=+2VZE
M;[UH]7;3S7\O^BVO_!271/BWK?Q'\$^,OVL];\4>)_VJO^"DWPL\/?#GXB7?
MB?4O@1IOPR\.? ?Q_P",OV7=;7PKXATJ+0="T"?XPV/AK3_!OCR_U%-/OX+F
M/PIINIMH36^E0_2W_!&7_AL"[O?B)JW[1_QD^/?CFTU#X>?#VX\2^ ?CO\(_
MCWX0O? 'QNN)]3?QG!X7\;_&]+?3M=MBD=Q:ZQX?^#L=Y\)[ 1Z'J'AEM*BN
MFL9_WIP>YR".1@<\8Y_S^E*!BN3'\5+'8"O@O['R[#SK4Z5/ZW1HT574*6)K
M5U&4I8>4GRPJTZ5*5.=*I!4ES59Q;IB4+2OS.VUNENW_  Y_'=^R_P#L^?MW
M_#O]G/P5X,^&_P 0/VO/A/>>/?V0OVQO'M_X9U^_\6>%_ WPK^-_P=_:5'C3
MX*:1X?LKS2-&@^&$WQ1T9M4LO$=I>7<=UX_\*>)-8N[IK_3TA-ETFE_%/]N;
M]I'X2_"+]J?QSXD_;(T+X ?M=_%/]HCQ->_#[]EN?QEXL\9?#'2_!GPI@^&?
M[,/@9= \.Z3XAGT3P%\0_'OA;QEXL\61+I'_  K?Q'K'B'P]J?Q&N[>PN93%
M_6WJVD:;KVEZCHFMV%GJNCZQ87NEZMI=_;Q75AJ6G:A;R6E[8WMK,K0W-I>6
MLTMO=6\JM'-#(\;JR,P.;X1\'^%O /AC0?!7@GP]HOA+PAX5TJRT/PUX8\.:
M9::-H.@Z-IL"6UAIFDZ581065A8VEO&D-O:VL,<,,:*D:JH 'KSX]C6E6Q-7
M(LNEC:N-K5_:^RI75'%1Q4JR5:5*<UB(5IX"6'JNG/V?U!W<G7J)G*[Z/W;-
M6ZIVBDT]]$F]7:]FT^G\G_[-7PR_X*'^'?@%\17^'NH?M6> /%W[/?\ P3 _
M9A7]G;X-RR^*O"_PXU3XX^(_ _Q0T3XG1KX&U^PM=&\6_$[P7IFG65YH_A*Y
MD>"S\;WGAJ_\2:'J.H6WAT6VEJ>N?\%#4\">/Q^R;XC_ ."@7B^0_'3]FNZ_
M9+O_ -I*U^)&FZUKOC:U^$_BW5?VK-!^.$?Q.TGPQXA_X9QM5A2VTN/QU:Z?
MX4G^*R:!:_#74;R#,A_K1P>.?KZ&C'8_EVQV']?K[5A+CIU,37Q-7A_*:LJM
M>E6C3K4X3I+E^J2J0K)4XSKPJ5L).;;G!\F.Q].7M'B(SHI4[14>:5DE'S24
MN96:M9ZM?/I8_DUB\;_MN:?XS_83^ 'A3XH?M86NG_\ !1#X;_!"W\>>(OC/
MXU\>:!\;/@!X[_95\9GQ7^V3J6DV7B&2UUKPJ_Q'\%ZK_9J-I5M:>'M7AMM,
M?1I)M">R#>!?%N7_ (* _"'X Z!X-^!?@S]K_P"&FO0_%_\ ;I^*NAZQ\,O#
M/QQEM?$WBT?M2:M>^#O"VN>#?AKX7S.^O>"KB_\ &.DZU\8]6D^$VN^$H[VT
MT_P_K^O7^DEO[%+_ .'7@75O''ASXEZIX/\ #.H_$'P?H^O^'_"7C6]T73[K
MQ3X:T/Q5)ITOB72-#UR>!]1TO3]?DTC2WUBULKF&+43I]F+E9!;Q!.SQZ8SC
M'(_PQQ6\..Z%+V"AP]E\Z:E3KXJE4Y(PQ&*HU,9"A*7LZ252G3P5;"8>4:L.
M6<\/5JJ$'B).*]FWO-KWM-;^[9)IW3U\]6NG2W\IGQ5\;?\ !3BP\<_M]VWP
M:U3]K#XBZ]K'PLB\3^#O$<GA+XL^"/"_P96/XA?#?2_$'PS^%_PZ\:>&++X:
M^._'7_"N_P#A-O$7PY^(GP!\33>(-3L+?55\4Z:_C&[T$:9]9_!JR_:1'_!*
MK_@H!#XT^+?Q=^,>N7'PY_:";X.:Q\4OAG\=_AMX_P!&T:;X&1R3^&[%OVCD
MM/C'XMTVT\4OK4FC>(O%$3,E[<7NCZ3?WNCZ;8&+^@ C_'GU'2H+NTMKZVN;
M*\@ANK2[MYK6ZMKB))K>XMKB-HI[>>&4-%-#-$SQRQ2(R2(Q5E()SYM?BV%:
MGAJ<,DP&&>'Q> Q,JM&-+VE;ZF\)>$V\,O9W6$M3^K^P4(UJ\:BKRJSFZY/[
M\OM6VTO%16JMLK_-WOT/XTOVC/@G\2_B;\&O&NM? CX4>/\ Q3X*\8_\$M?^
M"6&@?##5?"GP_P#$?B/2-5OM"_: \(>(+G1](32;%XM7O_"_AR)==\0Z-83?
M:M*T:&2]U%K*T9;@>W_M8?LP?ME^*_CM^V_J?CWPC?\ [16E_P!E?\$V/&WC
M:V^%'P?U_P"'7AGXY_!GX1_%_P <^*/BW\)_!>A>(_&_C6V\8>*-,\.PI>ZW
MX<T_QM>7^LC['IJ:5!/?V5G>?U.^"?!'@_X;^%-#\"^ /#&@^#/!GABQCTSP
MYX5\+Z59Z'X?T+38BS1:?I&D:=%;V.GV41=S%;6L,<,>XA$%=1M'?MT[8]N.
MN*].7B'BX5*'L,NPLJ6&]I"E*N^;$3IRK9/4C*=;E=2E4:RF#E["I&/M*KGK
M*C29+I)I)R>DKW5T^FFC79ZO77?8_!WXU_$SX4?%W]HW_@EGXD^!7PZ\9?#W
MQ._[:'C9?)\;_ [QI\!O$VM_#W1?V5O'MG\5=1'A;Q[X4\'^*M1\.:9ITO@;
MPS-K=WHR:5)J.EZ7I^F7=[:6%I/7[QC/?U/Y9X_2N,U3X=>!-:\:^&/B/J_@
M[PSJ?C[P3IVNZ1X/\9W^BZ?=^)_"^F>)Q9KXDT_0-:GMWU#2;37DT^QCU>&Q
MN((]0CM(([I94C51V=?(YGF5+'TLMHTJ-:E# 8:O0OB*ZQ-63KX[$8I+VW+!
MRITX581BG"%I^T<81@XQ5QCRWUO>W2R5ELE_6M]6%%%%>24%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!RGCSPI_P )UX)\
M6^"O^$D\6>#?^$L\.:SX<_X2WP'K'_"/>-O#/]LZ?<:?_;OA+7C;7G]C>(]*
M^T?;=&U3[)<_8=0AM[GR)?+V'\+_ /@FK\1-'\<_MG_M"KI7C?Q??+H=Y\=/
M"<_@SXB_MF^$OBWXVL;KP/\ &:T\)WNKW_[/F@_!#PC/X&LKV[TJ6^T;64^)
M_BNSTK1-4T_3)/[4N-6^V67[G>/?'7A+X7^!_&'Q)\?:Y:^&? _@'PSKGC+Q
MAXBOEN'L]#\,^&]-N=7UO5;F.TAN+N6&PTZTN+EXK6WGN95C,=O!+,R1M^2W
M_!/6_P#V4D^./Q'M/@3\??VNM1UCQ/:?$[XE6?[/_P"T%X'\1_#3X>6NC>.O
MB7:>+O%WCWX2^'/%WP6^'=_>Z19>,/%*6D9T_P 2:K_8]OXI":IIJ/J-I=T=
MM?\ @C6TM'TV3?5;M>7X=EOW7[<?[/\ \8_CU^T]^Q[)I'P(T#Q;\!/@_P#$
MOP1\<?B%\2=%\4?#WP_\6;GXA?#CQ1<7GPP\'Q7/BR6TU?3OA9X1O-2U/Q_X
MQ@\._P!JZWXSNOL/A?2H]"B;5[O5)?V(?V9_C]\$?BQ^TM9:E;ZO\,_V</&5
MM>7OPT\+ZUXP^%?Q'\>Z=\5_%7Q(^)_C/XA?$#PEXI\*?#?P]/8> -2M?%N@
MW'AGPG\4O^$QU[3-=M]2%Q'%I'EV,WZKT4K:W_R[)>O0+NUO)+KT=^]K_+T/
MFW]ESQ5XM\5>!/&8\9>);_Q=JGA+XZ_'OX>66OZM::)9:K?>'O /Q8\5^%?#
MG]I1>'=)T/1Y+Z#1M,L[>YN;/2;);F2(SR0B5W9OI*OE']D+_D3/B[_V==^U
M?_ZOOQU7U=3Z+_#'_P!)0@HKR;QM\?/@5\--87P]\1OC3\)O &OO:0WZ:'XV
M^(W@_P *ZP]A<-*EO>KIFNZS87K6D[PS)#<B PRM%*J.QC8#\Z?"WQ3CTS]M
MOQS\9]?_ ."C_P"S;JO[+^M^"-,T/PS\#Q\7OAWYVDZY:+JQ:[\YM=2SA>TO
M+P:E+?P.;_58]2ATR^G>S\.Z7&RNOT_K\/O&HM]'Y:/7;167G^NQ^M]%>9>
M_C9\&OBG>7^G_#'XM_#'XC7^E6T5[JECX#\>^%?%]YIMG/*8(;N_MO#^JZC-
M9VTTP,,4]PD<4DH,:.7!%>FTQ>J:]59Z^3"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _"O_@H9^W)K>G?%[Q'^S!X>^&?PPGT_X(7_ .SK\?\ Q?XO^+?[:GPV
M_9'U+Q3=Z#XU@^+OACP[\-],\>>#/%3^./##WGPX@T+Q[JYETW2)5U+4O"RW
MEC?0W.H6WZZ?L^_&'2_V@_@=\)OCCHFBZOX;TGXL_#[PK\0-/T#75B_M;1K;
MQ1I%KJL>FWTEN6MKB:T%P8OM=JSVMXBI=VS-;SQ$_E#^V_\ "/X-:]\<=7U7
MQ3_P4^^%7[/OBR>#2-3G^$/Q_P# '[%/QLLO!]L^FVD%E=> M-_: \'S>/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+BL.KXC#8B@N;DO6HU*2Y]?=O.,?>T?N[Z/302:>S3ZZ/IW.EHHHKG&%%%%
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MD_3_ "*/Z_K[U]X"T4@(/0YQQ2T %%%% !1110 4444 %%%% !1110 4444
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MT"\TS0]0F/B:)K.Z2'Z%TW]M7]E6^\0+X)O?CW\*O#_Q&@^'5M\5-:^&>O\
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MU,7B*F'QZ7U.*5*AA:E"A*DH\LY493E2E*7,_P"D,1XA_1?GC\=6P_@1GM'
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M<^2YTV6*^BBNT_:RBBR[+[D.[[O^O^&7W'Y9?L\?\$5_^":'[*WQ6^''QO\
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M'K_7H[3^UM/\/SZ9X=\.0Z?HU[>VLFL3:>+64?VO?ZE?^8)+V4'[,KX&6_\
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M=LTMIITD;)=RQ,I \I^*O[9O[,'B3PCX<&A?&#PQK+/K/PH^,2264.K7"O\
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MV7XZ>2T;LM5\^KO8^MZ^3+?_ )/JU7_LTSP__P"KA\35]9U\F6__ "?5JO\
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MKGB3P=K]QXD_LV'1A::9!'7(VO[;/QH7_@G/\=?C=JG[<WCFUU;Q?^TEXO\
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M*5:55<L)4?9I13C5J/F3LTFI/EM+E2?O+ENI+JKW7+K9W2>UK'P[_P $^?\
M@L)\(OVZ/VA_VQ_@QI,^@Z!IGP*UZYU_X2Z_)?&U'Q(^".@_8_"WBKX@W3WT
MHA@@TWQI#_:SW#?8(;?PGXU\(K=6J7EIJ=P\O[!'_!8GX'_MD_"[]L;XK:O>
M:5X$\/\ [*GC?QUK&I1O=M/?7G[.^GV&I:OX"^*%U;2K'*MYXCT[P[XD@N],
MM?.%MJNEK91/(UY9^=Z7XB_9Y^(WP,CT+Q#X+TW_ ()[:-J7B[Q?X.^%-[>>
M&O\ @G]KWA2_.A_$SQ)IOA+5XKF_TG]K9;B^TTVNH-+>Z),5L]6CC%I=.D;%
MQZ%H/['WQ$\+6OB&P\,G_@GUX=L?%FC2^'?%%GH/_!/37='M?$N@3R)+-H?B
M*WL/VOH(=;T>66*.673-12XLI)(TD:$LJD>WBJO"\UC*F'P-7#PQ4<MA@?\
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MI_@;P]'KFC^*/AMK&I:>E]XJ\7^ _B=87'B_P9H^G7NI:M;QVUK-$GWMH/\
MP2Q_8M\.>&/BMX+T_P "_$:;PI\:]<U#Q7\0_#^J_M$_M$ZUI>I^--3\9:9\
M0+CQYI5KJWQ3O4\+>/H_&&C:7K=GXV\+_P!C^*+">RA@L]5AM UNWI'@O]@7
M]E3P!'\)(_#?PXOT/P2^*GC;XY>!)M9^(7Q)\3W1^,7Q#TC5=#\5?$SQE>>)
M?%VK77Q(\9WFFZWJD-CKOQ"F\3WNAR7DESH4FG7*QS(K/OI;OK>Z;Z?)>G1:
MCYHZ^[JK6T5GI_B[]_Q>IQ_[2W[27Q8^&?Q[_92^!OPVT+PAJFM?&/PQ^TA\
M0_&W]O67B74%/ASX#?#/2M3M]"\-Q^&HKW6(+_Q%\1/&_@JP>_M]%\2ZC%HL
M6HP:=X<U34[NV6+\G=)_X+/?M1:]X8U;PCI'P3^#4/Q[\)>+OVM+_P 3V7CB
MV^,WPKTA/A5^R;\%OA]\8]6.J?"7QWI.G_&/X;?$+XB)\0+7P[X4T_X@6]A:
M6]EII\:S6%[H^JV-B/V0_:+_ &3+7X\_&;]FOXN'Q/+H9^"7_"Z_"WBO1(FU
M:SD\<_"[X\?#E_!GC+PW8Z]H&J:/K?AK6K?5M*\(>(='UW3KV.:RGT:1X3'=
M_9+F#RW5/^"3G[".N: =!UOX1^(]7DG\7>+?&VJ^+-1^-GQVN_B1XDUKQ[X/
MTKX?>-;?Q;\3YOB4_P 0O%?ASQ1X%T/1_".M>$/$7B74O"M]H&F66G2Z.88$
M &F[ZV7Z>[_P032M=7^3;OKO=KR]>IH?%C_@I!\'_@=\%/V:_C'\0/!/Q=U5
M_P!I[P5;^,/!'@?X6^";CXB^*K58?A+_ ,+C\06>HVEK<Z4(8- \)PW\UWJ<
MWD6NZQE>86T9ROCUW_P6D_8WL?A'XL^,=[9?'#3M$\,^(_A?X?L?#FM_";4_
M#7C/QG;?&?P?J?C[X8^*?"6C^)M0T:UE\)>+O".@^(=:T[5]?U/P^RPZ%?07
M-K!>3:9;ZA]S?$G]E7X#?%N'X86OCKP'#J-G\&M/\5:5\-;+3=<\2>&[+POI
MOC3X?:E\+/$-C:VGAO6-)M[FVNO >KW^@VL5_'=+I<<J7FE?8M1@M[N+\\?V
MO?\ @D#\+?C'\*/#G@?X 'PS\*M7T+Q+\#K[5(O'=W\7O&?A7Q?X2_9]^&_C
M+X6_#+PEJDGAKXK>#/&N@_\ "+>'O&=U=6VM^%?%.E:KKE]86Z>*9]9AN;IB
M]>Z^?IY6Z_T@7+I>]_PWZ^5NJ_X*\;_:Q_X*??%B;P/#\7OV2(?^$:\%?#C]
M@?QG^W/\1-/^+_P^BN+O5;3QW/8>$_V:? /B:QM]6^T^&)?$$H\:_$Z_@TCQ
M%8:I>Z'X/TZU_M".PU.Z1_H.U_X+2?LC7OBOX.>"=$TOXS>,]5^.7B;PYX:^
M'FM>%/A[:2^&/%%GXK\?W/PN\,_$'1;[6/$^D76J_#?Q1XVTKQ'9:%XBTFQU
M&6XTSPYJ&OS:?!H=YH&HZSW'[/\ _P $S/"'@7X*?';X3?M(?$WQ/^U;?_M*
M^&?AWX'^+_C#Q/#J/@75=;\!_#3X9>'OAQX;\&6=YX7\2/K]CI]DNEZUKBZI
M;>((-:N-1\2ZA<7EW<7S3WUW\Q>//^"+>E6/[8O@?]I']FCXEZ1^S]X4TC7_
M  9XIUOPMI]E\4=:U_PUK6@?$GQ'\1?','PGBC^+6F?#30?#GQG'B.]\-^-O
M"?B3X>^(?#&A65SJFK^"]'TC6];U:ZNU[WWVOY:J]M-K;Z_\$]W:RZN^RZ;]
M7;6U^BMO8Z#]NC_@IE\<OV9OVS?!7[-'PG^&/@+XH_V[\*/AA\1[/P!<:#\6
M]6^+GQ3U'QQ\9-;^&^N^%?AUJG@+3-?\*>%IO"GAK29O'-YK?C_2(M"2PT_4
MTNM0@15DA;X)_P""F7Q^\4:A\'/C?<_";X0P?L>?'?\ ;,N/V,O!=I:^+/%C
M_M$:-JUSX_\ %'PN\-_%;Q'!/IJ>!9-$U;Q?X2O)=2^']C;QZ_H&@ZC9WDGB
M'49K2\C;[\_9L_8Q^&O[.DF@^+(=4\4_$+XSVOPSG^%WBKXP^,/$/B&\UKQ?
MH&H?$WQA\8M2@F\/W.MWWAW2+0?$'QYXEOM%M[*TDO=#T*;3?"L&JSZ+H]A!
M'P\G_!-C]E+3/&^K?%/P5X#N_"WQ(?Q5XY^)WA"YN?&_Q-\2_#'P%\:/'=AJ
M-MJGQ?\ #7P(U3QV/A%IOC4WVIW6JR:II'A;2+^2]N;VXMK^QN[Z>\+L^^FC
MMUZ:=5WO^>H)Q5E:^EF^^VMMU?6S5[+IL?%'QT_X*E?&CX0_\%)M*_9+L_A3
MX/U?X'Q^._V;/ ?BOX@:AX>^*NGWF@R_M$:-XG>SUO5_BY:V.H?!7PA/I7B#
M1=/TSPWX)\8R:7XD^)%UJ*Z/X5E>]6XNK+E_!/\ P4L_;(^.=]\#/#7P0^&_
M[-MGXO\ B+X2_;N^('B*U^)]]\1]/T&;1/V0?V@_#?P=T3P]H.L:'J=Q+H6L
M>-=-\1P7^I:YK5CJVE:3?Q23KIXLU%J_VSX"_P""5O[(W@_6?AUXRUKP_P#$
M'XB?$/P!H?P?T^Z\6>-OC+\8-3L/'>N_ RR>#X<^-/'WP_\ ^$[7X<^*_$WA
MO49[K7-&O=;\+:A_9.KS)>6(BGM+22'0US_@EA^Q+K^E>#=%N?AMXQTO3_ E
MG\9=+\/Q^%/CK\>O!=PVB_M ^-;;XA_&#P_K=_X1^)>BW_B;P_XW\665IJ6I
M:'XANM3TR!(([#3K6STY1:4DI:ZK6_7;6-NCVL^G7S"\>BVLMM[):[ZWZ[+=
M=$SA?V&/V^=>_:[^)5U97?AS3/#O@;QY^R+^S?\ M8_"W2XH)V\2>&]/^*FL
M_$SP-X[\&^+=:^WRV'B6;1?&'P[-YH&MZ=HWAZ*ZT?55CGT]Y8!.WZ.^,_%/
MA;PAX?OM6\8:]X?\/:.8WLVO?$VK:=HVES7-S#*L%@]WJMU9VC37>UTCMS.L
MDP#A <,1\P?!?]D;0_@Y^T/\3/C-H=QX>TWPOK'P3^!G[._PC^'/AGP^^BZ;
M\,OA5\&9/&FM1Z.9_ML\&I3ZMXI\=:I=0R06EE'8Z38:99,MS,DMPWM_QI^!
M_P (_P!H#P5+X$^-7PS\&?%?PC%?PZ]:^%_'/AS1O$^D1:]I]I>VVG:M;Z=K
MUO=:<FJ6D5_>0VEW)&/)2ZF0L(I90U+2W=?IZ=R;*^EDM-EY?+7N]F[V[GX>
M_P#!%70_":>)=8U+4_AO^U/X8^*OA3X!>%OAK"/C=\7?A-\3?A'\+OAYI7BQ
MM27X/_L^0^!/$5_XNT[P4FNW$.IV$WQ#M-8U\:)HNCZ7=>*)Y=/$=Y]&?\%D
M?C9X=\-_ 5?A)H_QV\/_  L^)EYKWPW^)^N^&=2^.OC']G&^\9? S1?B+I?A
M_P <:0?BSX%\,>)?%/AK3O$M_?V7ADR:!##J4]U=()?/TJ'4K2Y_)O\ X(R>
M/OV8/V9_VM?%OP:^(7CSX>_"+X_Q_#OP5^ROX<^#OAKX#:7X0OO'5_9>,-:\
M5Z/XN^+?QB^&'Q%^.'PG\5?&;6Y!/H(M-*\9>"4O!:W4-UX7>]M]*ALOWK_X
M*5?M!?%[]EO]GNU^,WP4^#WACXS>)=-^(G@GP_XI\/>)_#7CSQ)9V7P\UN[O
M(]?U81?#/1O$OC&UDMM0CT:UM+ZR\+^);.QO;^&ZU'19[5)9[:%\.ON]VOEK
M96UM_5C1_'>SW5KO1.RV;6J]%U[W'_\ !+[Q%X?\5?L=> -:\,7&GW.CW&M>
M-8X)-,_:(\>?M2V8DM_$^HPSI'\8OB3H'AGQ7K965&+Z=>Z/;0:&Q.FV;36\
M*2O^@U?C3_P2^_X**_%;]M_XE_M&>&O&'P-T_P"#_P /_AU:^%->^&UG'X/^
M)?A/Q;I6F>(/$WCOPY)H'Q*/CW2-%T;6?$6L0>#K?QKHM]X(TVQTV#P[KL-A
MJMLNJVTDTGZ2?$#]IK]GKX4_$CX??!_XE?&?X<>!OBC\5IHX/ASX#\3^*M)T
MCQ/XPEGN9[*U31=*N[B.YN?MU_;7.G::Q5%U+4H)M.L&N+V-X!2:LON[>7XD
M-.[^_OY_AU.8_:4_UW[/7_9S/PS_ /2'Q37TS7S-^TI_KOV>O^SF?AG_ .D/
MBFOIFF'1>K_*(4444""BBB@ HHHH *9(BR(\;A61T9&5P&1E8%6#*>&4@D,#
MP1D&GT4 >)K^S;^STO!^!?P>;T)^&O@S/7DG_B2CD9XQP.O!.:D_X9O_ &>O
M^B%?!_\ \-MX._\ E-7L[9P<$@X.".H..HR",^G!^E>*?$7P1X#8:MXY\;^.
M_&O@O2=/LHKC6-2M_C1XY^'GA'2;*TC2(WEW;Z7XLT3P[ID8!!N;V1(/.F;S
M;B1I"6/F5<OR^G"4UE^76BG*;JT*%*$8Q]Z<Y3]C.R23E)R3MNVK,^CPF?\
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MT?P_?^)-#N[&_P!%\07NCZ?I%OIUUK6CWVEZ;>:7JD]O)?6%UI]C<6D\4UK
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MPJ\1>$?B'X5^ 6KWFC^*?"?Q5E\<^+=6^,OQ\\7_  BUG3_#'Q2\.ZH/A/\
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M:OUUNFVW?3ZJKY,M_P#D^K5?^S3/#_\ ZN'Q-7UG7R9;_P#)]6J_]FF>'_\
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MCX&\S^R/%-O_ &@;,^'O[?-^#_I(?_A(A;_:<,;8Q9B/VA7S-^TI_KOV>O\
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M7]?C7_\ 7]:L>(?@I>ZKXAU[5%BU<IJ6MZI?H8O@U\3=4BV7=]<3J(]2T[X
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M ,$W_P!AB_N_C5?W?[,WPTGN_P!H:RU+3OBY,^GWV[Q)::SXAA\7ZU'IZKJ
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MKVUTSW;]H#]F#]K/XT_\%)O&/Q"^%WCCQ'\+? OPM^%O[,GBSPKXPO\ Q/\
M%ZSTG6O$.AZW\=;[QE\./!7A+1_$FE_!W74\=*OA'P]\5KWQSHOB.ZT;PS?V
M%SINFC4I+"Z@K1Z]5?U^[Y*UQ6:NF]$M]^BT[K>VGGNC]5OA;^RY\ ?@IJ>B
MZS\*OAEH/@K5/#O@*\^&&B7NDRZFTNF^ K_QEJ/Q"N_#4"WU_=Q&QF\9ZMJ/
MB!FECDN1>74BK.+8+ O%6W[$G[.5S^S;HG[*7C3P-#\3OA#HTTVIBP^(%PVI
MZ[?>*+GQ)J/C&[\;OKVF)HU[I'C.7Q9J^I^(+?7_  N= NM(U&\=M"_LN!((
M(OPY_9Q\=_$[]G#Q/\ _COX\\,_ME:%+\-OV<OBA+_P5#O/BU'\8-<\-?$'X
MZ:WJ_@KP_P##K0/A%H?Q'UJ7P-XT\=ZI\5[G7+[P%/\  &!/#:?#W4%T675%
M;4M/T.7Y3?X>_M^V/B?_ (*/3^&=(_:GU9_&?@S]L73]'MM/LOVB?#4?AW5H
M?VH=$UKX%ZIX;U+QGKNI>#OB-K?BGX?W.O67@!O@!9>&!X+\$V5[;>*K;5FU
M*VNK=77\O3HMDTM.GI_VZ^B"S=VY;V;;?567?I>ZUU3NMV?OU9?\$A_^"?=O
MI>G^'+WX$IK_ (/T'Q3XE\7^$_!/B/Q[\1]9\)^$=5\;PZ&GCVVT72;KQ8RS
M:%X]O?#NF:SXR\.:[+K.A:]K2W>H7FGM+?WHG^F?A)^S/X/^$'Q=^.'Q>T"\
ME?4?C+IOPA\+V_AZ#2]*T?P[\/O 'P3\)7WAKP3X&\)V.EP0B/1K.[UWQ1KA
M$V%BN=>DM+6""UM8@_X;MX%^.%Q^UUXNG\.^'/VH+?XI7?[=/@:^\5^*/$$_
MQNLOV<O^&!5_9[\ V?QCTS7[OQ3=)\ -5TO4]:B\2V&@Z+X=@N_B)%\0&M-4
MM$LK6VO+X?J7_P $G-6\1:W_ ,$YOV2K[Q-+=7%ROPMMM/T6[O97N+J^\#:/
MK>LZ1\-]0EN9"9+HW_P^L?#-XMW(SR723K<.[M*78TO:VWZ)6_\ 2FO*WW)W
MLO>O=;/SL]+]-%JO0_0ZBBBJ)/QQ_P""SZ0/\!O 2ZIJWQ1TC06\;7PO)OA_
M\??V6?@%H\FK+H<TGAX>-=7_ &J=+U/POXDL8KY'GTO1O#:0ZW#<QW%[))Y$
M28^]?V,)/&<O[)7[-[_$3Q1H_C;QV?@Q\/E\7>+M \5:5XXT;Q)X@3PW8)JF
ML:=XOT)$T3Q%;7UTLDZ:IHX.EW1<O8/+:^5(_P"4G_!>BXL_"/P__9C^,-]X
MA\)Z#;?"KXH>-=0N4UCP_P# 7XC^+=5M?$7@"\T*XL?AY\%/V@]0TOPQ\7O$
M1699$\.Z!?0^+K*1;34M%6>:,VTWZ/\ [ GQR\&_&[]G'P5-X3@^(]K=^ ='
M\/\ @CQ5;?$_]GW6_P!FCQ FOVOAO2-5,T/PPOM&TKP]I.G7NGZI8WEM%X%N
M-8\)V8G;3K#4WEM)XHDMW\NW^5^_=;E/X8ZK=Z:W7Z6?E;8^35_:4T+2/^"T
M]O\ L\)^U3#K6F>)_P!C_P 0:M??L\ZE\2O"#Z=X4^+VF>.?"=YH^EZ)X"TY
M;'5K7Q;>_#1=8\9/#K*:IXEO/#]YJ.K1W+>';>UAT_ZE\(:GXSU#]O;QU%XK
M\)Z5X:LM/_9ET2U\+7FF^*V\22^)-#7XP^*/*UC4;1O#^B?\(Y>2X3?I N-:
M$6X_\3&3;\WV=_8>B'4?[8.CZ7_:V,?VI_9]I_:./+\G'VWR?M./*_=8\W_5
M_)]WBOF"W_Y/JU7_ +-,\/\ _JX?$U"^_5BT=WV2_!I7^>I[M\3=5^)&B>"=
M:U+X1^"_"WQ!^(%NMK_8'A+QKX\O_AGX9U222]MX[P:IXUTSP/\ $>_T:.VL
M'NKN%[;P9K3W5S!#9-';)<->6_\ 'E_P4._:K_X.=O#'[4OQ<T;]G?\ 9NU?
MPW\(;'X3177AS3/@KX-TS]HCP/9V+:7HTFOZ[X4^*OB#X:>"-=\5_%2/5YKR
M/3/#)\)V>OP0_:[71/">KP6(U:;^TJBAJ_5KT#^NG==TUT[=3_.^\9?ME_\
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MU65UMK=W>O5Z65DBBBBO-*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=.TRV2\N&:XTVPOWN[6+XM_;UATFR_;N_P""9?CFQ^&OQD\5:]\.OB_XQO\
MQQXQ\#_"_P"+WCKP?X0^&7C7X-_&+X?Z4=9U3PKHFK^"-*N;KXDZ_P"'$U<2
M&/Q'8Z3)9:WK1@\*V27D#6R^2[6O9:[[=2;7;_3^EO\ U=GWA^TI_KOV>O\
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M0^%+EK>6'<8Y(9+JZD1U(:YG(,KX?_"N['_H=_#'_AQ;#_YCJ_T>HS_=4O\
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M_9S/PS_](?%-?3-?,W[2G^N_9Z_[.9^&?_I#XIKZ9H'T7J_RB%%%% @HHHH
M**** "BBB@ HHHH 3 ]/\G^7X4  =/YG_(I:* "BBB@ HHHH **** "BBB@
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ML=)76ZV>^M_(^9GA,2YS:H56G.5G:+37-HU>HW9K7]%L?!7]GW'_ $<#=?\
MB3_PY_\ HM*3^SIB1_QD!=$X '_&3WPZ[G X'[6@R 3R.H]#T/WM_P .J_\
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M;H_X1/\ ;._Z+Y^S#_XB+\5O_HVZ^GJ*++S^]_YA=^7W+_(^8?\ A$_VSO\
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MBY97FFQV27]O+I,/A^QNIKJYM+Q-9@ALIK&_]AHHIVM_P[?YB"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_G$_P""GG[2
MWQT^''[9MKX'\$_&WQY\,]>T'X5?LF>)_P!E7X2>%M8.GZ)^T=\3_B)^UZ?
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M9_\ H<:/^%@_M@_]&R_![_Q*;6?_ *'&OJFBCYO\/\OZN_*Q==E^/^9\K?\
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M^9HP/0=,=!T]/I2T4[+L F ,8 &.G X^E+110   = !]**** "BBB@!  .@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
